data_2lrg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lrg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 72.54 110.005 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.42 -95.08 0.29 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.458 -1.057 . . . . 70.4 110.458 156.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.34 126.95 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 104.667 -2.345 . . . . 74.43 104.667 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -108.87 142.14 39.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.432 -1.692 . . . . 73.52 106.432 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -137.23 152.74 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.658 -1.238 . . . . 73.3 107.658 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.29 154.38 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.695 -1.224 . . . . 74.21 107.695 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 t -136.67 142.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.272 -1.751 . . . . 71.45 106.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.84 148.58 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.309 -1.737 . . . . 74.3 106.309 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -135.51 153.46 51.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.302 -1.37 . . . . 75.34 107.302 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -140.87 154.0 45.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.769 0.795 . . . . 70.24 109.888 166.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 p -151.64 173.09 15.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.712 -0.676 . . . . 72.34 109.333 171.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.68 -143.13 16.55 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.537 -1.425 . . . . 62.33 109.537 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.34 65.59 0.88 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.783 1.233 . . . . 75.02 112.17 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -64.21 -30.48 71.53 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.466 -1.396 . . . . 64.44 110.517 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.25 -30.82 64.97 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.783 1.233 . . . . 75.21 111.52 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.47 23.48 5.12 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 71.32 112.644 -168.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -124.88 118.49 26.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.273 1.029 . . . . 73.32 108.72 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -78.69 136.92 37.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.44 -1.319 . . . . 72.21 107.44 163.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -141.98 111.21 2.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.1 -1.815 . . . . 70.44 106.1 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -125.61 126.77 45.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.648 1.567 . . . . 65.01 110.662 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.53 130.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.025 1.33 . . . . 73.44 109.696 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -78.13 127.43 32.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.595 -1.632 . . . . 72.24 106.595 165.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.47 138.83 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.689 -1.967 . . . . 74.41 105.689 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.32 179.82 46.98 Favored Glycine 0 C--N 1.334 0.451 0 O-C-N 121.356 -0.84 . . . . 74.5 112.661 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.76 -176.63 48.02 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.185 1.374 . . . . 73.53 110.437 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.31 159.83 40.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.905 0.882 . . . . 71.12 110.295 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.74 -177.34 5.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.431 1.093 . . . . 74.3 111.116 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.78 59.28 0.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.756 2.022 . . . . 65.2 108.909 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.74 21.87 0.02 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.582 -0.566 . . . . 61.3 112.665 -160.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.98 -154.0 20.15 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.459 1.129 . . . . 74.34 111.439 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -62.58 142.81 91.3 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.83 1.686 . . . . 73.53 109.191 166.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.52 149.07 31.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.997 -0.742 . . . . 73.23 108.997 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -69.32 146.94 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.764 0.711 . . . . 75.13 109.781 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.84 154.81 26.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 126.119 1.768 . . . . 73.11 108.59 169.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.33 151.29 50.99 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.404 2.281 . . . . 75.4 107.902 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -95.04 173.97 7.32 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.848 1.259 . . . . 74.42 110.4 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.99 21.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.229 1.411 . . . . 71.03 113.903 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -109.83 6.54 23.51 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.678 1.991 . . . . 75.33 110.102 163.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.92 7.05 80.66 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.335 -1.258 . . . . 72.0 112.87 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -103.18 143.77 32.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.888 1.844 . . . . 73.5 109.895 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -65.26 151.38 46.34 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.83 -0.804 . . . . 75.3 108.83 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.17 1.03 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.005 0.743 . . . . 75.4 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.29 -174.06 33.45 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 120.288 1.404 . . . . 73.31 110.328 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -121.18 -2.88 9.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.017 2.127 . . . . 74.5 112.165 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -153.17 142.38 21.48 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.692 1.597 . . . . 72.4 108.822 161.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -173.0 176.78 2.93 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.578 1.951 . . . . 73.42 108.038 164.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.0 p -122.17 159.25 27.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.508 1.123 . . . . 63.34 109.057 165.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.97 130.48 29.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.088 -1.078 . . . . 73.21 108.088 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.85 140.08 40.51 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.066 -1.087 . . . . 71.12 108.066 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -73.99 94.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 104.51 -2.404 . . . . 75.23 104.51 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -120.23 44.29 2.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.852 -1.166 . . . . 73.22 107.852 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -141.71 166.43 24.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.221 -1.399 . . . . 75.32 107.221 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.49 78.79 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.136 0.974 . . . . 63.22 110.391 170.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.7 p -130.32 156.86 43.98 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.367 -0.975 . . . . 75.34 108.367 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -146.66 159.63 43.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.023 1.329 . . . . 75.24 109.52 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 p -165.31 155.55 13.41 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.412 1.085 . . . . 75.04 108.453 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.6 m -143.0 157.67 44.33 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.072 -1.455 . . . . 74.41 107.072 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.9 p -144.1 169.23 18.25 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.685 -0.635 . . . . 75.54 110.839 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 p -105.82 -170.25 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.121 -1.437 . . . . 73.21 107.121 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.75 -167.91 1.41 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.51 -0.922 . . . . 75.5 108.51 148.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.36 172.57 7.41 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.89 -0.884 . . . . 74.53 110.89 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.96 84.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.596 1.159 . . . . 73.23 108.861 -164.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.69 165.58 35.84 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.53 1.132 . . . . 65.31 108.305 156.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -132.91 -0.45 3.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.326 1.05 . . . . 74.33 113.404 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -166.88 175.59 7.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.964 -2.236 . . . . 65.33 104.964 162.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ttt -140.55 145.48 36.84 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.705 -2.702 . . . . 73.43 103.705 157.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -116.58 150.9 37.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.003 -1.11 . . . . 73.23 108.003 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.5 t -147.91 89.54 1.75 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.564 -2.013 . . . . 65.32 105.564 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.25 135.15 55.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.94 -1.133 . . . . 74.15 107.94 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.09 32.8 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 118.724 0.693 . . . . 72.04 112.011 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.4 p -139.41 167.28 22.44 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.331 -0.934 . . . . 73.11 110.336 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.67 148.21 31.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.2 1.8 . . . . 74.43 106.736 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 p -142.97 160.89 39.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.173 0.442 . . . . 62.45 111.139 155.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.81 156.17 41.97 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.745 1.218 . . . . 62.25 108.173 164.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.22 49.81 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 126.26 1.824 . . . . 73.31 109.463 -172.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.0 p -129.07 -173.9 3.12 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.196 0.999 . . . . 53.51 111.809 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -66.71 165.33 15.18 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.118 0.967 . . . . 73.02 112.118 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 161.04 14.62 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 112.998 -1.91 . . . . 74.21 113.514 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.99 2.32 81.95 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.861 -1.522 . . . . 74.45 114.431 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -70.12 114.82 8.64 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 120.1 1.95 . . . . 73.11 106.001 165.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -104.4 155.9 18.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.313 -0.995 . . . . 72.11 108.313 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 tp -143.16 159.13 42.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.543 -2.021 . . . . 65.25 105.543 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -143.97 145.97 32.6 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.946 -1.501 . . . . 73.43 106.946 165.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mm -134.37 140.59 45.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.677 -1.971 . . . . 73.45 105.677 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 m -131.43 125.83 33.56 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.89 -2.263 . . . . 73.33 104.89 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.24 116.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.737 1.215 . . . . 73.41 107.93 -170.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 mp -138.62 131.22 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.066 0.946 . . . . 72.32 108.719 -162.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.79 141.44 16.39 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.792 1.187 . . . . 62.34 111.4 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -131.45 153.94 49.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.122 2.169 . . . . 72.24 108.72 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.72 139.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.179 -2.526 . . . . 73.41 104.179 167.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 t0 49.82 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.121 2.968 . . . . 72.43 110.954 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -133.75 15.49 3.97 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 120.599 1.545 . . . . 72.34 113.948 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.85 155.71 42.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.529 -1.357 . . . . 72.1 111.467 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -84.82 135.32 34.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.907 2.083 . . . . 74.13 106.341 165.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.09 -1.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.831 0.678 . . . . 64.14 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -155.94 145.61 21.11 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.771 -1.206 . . . . 64.34 109.769 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -158.3 142.79 16.03 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 124.073 0.949 . . . . 74.11 109.973 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.07 170.55 15.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.872 0.844 . . . . 73.02 108.935 155.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -129.23 155.71 45.12 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.615 -1.624 . . . . 74.13 106.615 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 160.34 43.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.727 -0.842 . . . . 63.42 108.727 173.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.15 138.29 28.06 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 106.345 -1.724 . . . . 71.42 106.345 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 123.544 0.527 . . . . 74.34 109.661 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.56 136.35 21.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.159 -1.423 . . . . 73.11 107.159 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 p -67.33 136.84 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.301 0.64 . . . . 71.25 110.255 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -109.19 -5.9 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.736 1.214 . . . . 74.41 112.615 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.59 -29.97 5.05 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.132 1.825 . . . . 71.34 110.913 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -82.68 170.52 15.02 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.035 0.934 . . . . 71.44 110.554 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -54.26 136.63 42.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.412 -0.959 . . . . 70.32 108.412 164.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -93.21 135.6 34.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.057 -1.09 . . . . 70.03 108.057 168.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.7 mt -149.05 142.35 18.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.151 -2.166 . . . . 74.44 105.151 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.28 171.09 17.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.888 1.275 . . . . 74.45 109.339 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.1 p -140.06 157.68 45.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.736 1.214 . . . . 71.43 109.859 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 169.75 22.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.482 0.713 . . . . 73.42 110.638 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.89 134.57 1.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.72 0.808 . . . . 73.34 110.364 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.9 t -142.64 100.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.374 1.87 . . . . 71.11 106.112 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.45 139.49 41.86 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 74.53 109.762 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.7 p -92.73 26.69 2.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.232 -0.917 . . . . 71.42 112.551 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.426 0 N-CA-C 107.345 -1.354 . . . . 74.4 107.345 161.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.134 0.492 . . . . 73.32 109.796 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.66 -133.56 5.8 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.04 -2.424 . . . . 64.21 107.04 -166.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.03 136.91 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.045 -1.465 . . . . 73.34 107.045 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -113.69 158.05 21.39 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.724 -1.213 . . . . 74.52 107.724 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -154.11 147.27 24.71 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.798 -0.815 . . . . 74.05 108.798 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mm -135.53 120.45 28.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.909 -1.886 . . . . 74.4 105.909 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.41 153.44 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.688 -1.967 . . . . 74.11 105.688 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.53 155.2 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.304 -0.999 . . . . 74.1 108.304 165.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -138.46 164.17 30.05 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.367 0.667 . . . . 73.14 110.747 163.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -142.39 156.29 45.2 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.624 0.77 . . . . 72.04 109.553 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.93 161.47 40.69 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.123 1.369 . . . . 65.23 108.059 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.5 -117.66 4.41 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.857 1.218 . . . . 74.32 110.685 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.37 104.11 16.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.36 1.064 . . . . 65.03 109.222 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.4 p -115.26 16.84 16.82 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.829 0.451 . . . . 72.12 111.23 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.99 -13.05 15.59 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.405 0.682 . . . . 64.44 110.48 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.81 23.69 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.462 1.105 . . . . 71.4 113.131 -164.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -131.97 119.33 20.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.022 0.915 . . . . 71.4 110.274 172.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.53 81.25 7.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.937 2.095 . . . . 72.21 109.141 174.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.88 106.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.947 -1.501 . . . . 73.24 106.947 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -98.14 146.05 25.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.799 -1.556 . . . . 70.3 106.799 161.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.77 152.22 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.043 -0.98 . . . . 73.0 108.67 156.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.3 t -97.25 148.25 23.3 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.11 -1.811 . . . . 71.01 106.11 159.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.5 mt -128.07 145.74 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.309 -1.738 . . . . 72.01 106.309 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.55 176.42 47.85 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.517 -1.033 . . . . 64.3 110.517 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.61 173.1 43.84 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.771 2.129 . . . . 72.15 107.925 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.26 159.73 41.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.548 1.174 . . . . 65.23 111.116 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -137.22 -173.29 3.42 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.42 2.288 . . . . 74.11 110.013 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -65.62 -10.73 38.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.673 1.189 . . . . 74.23 113.624 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.87 36.53 1.97 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.676 1.131 . . . . 71.15 113.316 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.88 -160.16 13.35 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.693 1.246 . . . . 74.24 111.752 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.08 156.2 67.39 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.033 1.822 . . . . 71.41 110.065 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.4 144.8 25.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.502 1.121 . . . . 74.1 109.942 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -69.51 139.78 53.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.05 0.841 . . . . 72.1 109.745 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.63 157.46 16.92 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.611 1.164 . . . . 74.34 108.413 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.2 146.81 52.27 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.703 1.201 . . . . 74.34 109.837 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -82.11 179.62 7.74 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.633 1.573 . . . . 70.12 111.109 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.49 1.43 6.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.128 1.529 . . . . 71.1 115.128 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -101.01 -9.57 21.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.595 1.089 . . . . 73.01 111.007 165.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.77 13.92 76.79 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.654 -1.081 . . . . 74.01 112.426 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.48 148.24 27.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.556 1.942 . . . . 74.13 106.69 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.96 152.83 26.56 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.111 -0.7 . . . . 74.1 109.111 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -144.08 12.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 114.442 1.275 . . . . 73.1 114.442 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 -173.74 22.16 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.345 -1.102 . . . . 74.53 110.345 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.266 21.3 p30 -125.29 2.51 7.8 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.928 1.291 . . . . 74.32 112.856 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 m -153.63 140.5 19.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.525 1.93 . . . . 73.22 108.41 162.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -168.85 171.71 8.27 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.281 1.032 . . . . 74.3 110.594 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 m -118.28 145.99 44.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.96 1.704 . . . . 73.4 108.163 167.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.54 157.06 46.64 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.564 1.946 . . . . 65.12 107.939 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -109.49 135.68 50.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.648 1.579 . . . . 72.31 108.465 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.23 87.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.445 -1.317 . . . . 74.11 107.445 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 35.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.873 1.269 . . . . 74.21 110.303 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -146.2 160.05 42.5 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.178 -0.464 . . . . 71.44 110.756 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.99 -37.85 75.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.815 0.446 . . . . 73.12 111.341 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 142.74 46.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.78 1.632 . . . . 72.21 108.516 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -135.54 163.33 30.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.626 2.37 . . . . 64.31 109.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.9 p -165.62 130.44 2.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.987 0.915 . . . . 71.24 110.456 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.8 m -139.53 154.4 47.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.905 1.282 . . . . 64.34 108.947 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -146.75 -179.81 7.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.209 1.004 . . . . 74.02 111.243 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -124.81 178.92 5.22 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.912 1.285 . . . . 74.34 110.695 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -91.56 -178.29 5.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.455 1.102 . . . . 74.12 108.691 162.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.24 10.74 52.99 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.37 0.986 . . . . 73.53 113.694 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -98.82 69.65 1.82 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.797 -1.927 . . . . 65.11 105.797 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -170.08 172.28 6.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.043 1.337 . . . . 73.52 110.638 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -130.36 -13.01 3.94 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.084 1.754 . . . . 72.55 112.782 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -159.86 174.66 14.1 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.052 0.941 . . . . 72.21 108.754 170.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.2 ttt -136.89 155.21 50.05 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.465 1.906 . . . . 70.01 106.21 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.8 p -113.14 177.5 4.61 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.706 1.203 . . . . 74.13 108.841 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.9 t -157.84 33.24 0.26 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.104 -1.039 . . . . 72.04 113.157 150.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.51 132.53 53.43 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.488 -0.758 . . . . 73.01 110.746 -172.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.69 175.65 29.6 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 109.711 -1.356 . . . . 73.34 109.711 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.6 p -136.79 160.12 39.81 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.908 0.861 . . . . 74.13 110.721 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 69.1 t -117.52 135.36 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 106.678 -1.601 . . . . 72.43 106.678 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.35 124.85 10.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.114 -0.699 . . . . 74.14 109.114 167.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -119.2 142.98 47.52 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.232 -1.395 . . . . 74.01 107.232 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.86 17.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.179 2.192 . . . . 74.43 109.315 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -88.3 179.33 6.37 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.706 1.241 . . . . 64.33 110.733 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.2 165.48 18.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 113.258 -1.792 . . . . 74.41 112.369 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.94 155.09 20.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.608 -1.178 . . . . 74.34 113.293 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.86 79.68 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.386 -0.674 . . . . 72.33 113.486 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -67.85 156.91 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.306 -1.739 . . . . 73.42 106.306 155.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -139.51 158.35 44.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.359 -1.719 . . . . 73.12 106.359 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tp -156.15 157.25 35.63 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.438 -0.949 . . . . 74.42 108.438 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -147.32 111.71 5.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.172 -1.788 . . . . 70.34 106.172 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mm -101.66 143.44 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.777 -1.564 . . . . 73.41 106.777 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.2 m -119.34 136.21 54.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.023 -1.843 . . . . 74.03 106.023 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 108.47 3.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.481 1.512 . . . . 74.45 109.696 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.0 mt -123.66 140.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.796 -1.187 . . . . 64.23 107.796 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.9 154.18 20.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 124.569 1.081 . . . . 61.04 111.531 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -142.84 152.12 41.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.183 -1.008 . . . . 72.11 110.265 -161.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.1 125.88 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 104.798 -2.297 . . . . 72.51 104.798 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 44.95 55.89 5.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.584 1.154 . . . . 72.11 112.19 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 67.31 26.85 8.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.036 2.134 . . . . 73.35 114.43 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -134.94 161.6 34.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 120.15 -1.594 . . . . 74.22 110.196 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -97.25 127.68 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.032 -1.84 . . . . 70.43 106.032 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.15 -2.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.33 0.863 . . . . 65.24 113.33 -172.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.32 138.56 13.65 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.576 -1.639 . . . . 72.34 106.576 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.17 128.87 8.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.163 0.438 . . . . 72.41 110.839 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -142.61 171.49 13.98 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.934 0.873 . . . . 72.34 110.897 166.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -137.95 165.87 25.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.001 1.72 . . . . 74.24 106.386 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -146.46 166.57 26.01 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.422 -0.584 . . . . 74.22 109.422 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.44 132.59 33.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.126 1.37 . . . . 73.14 107.838 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -127.43 154.15 45.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.442 -0.948 . . . . 74.4 108.442 171.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.3 mt -147.03 139.91 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.355 -2.091 . . . . 72.41 105.355 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -86.54 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.448 -0.783 . . . . 74.01 110.224 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -123.75 8.83 8.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.219 . . . . 72.02 111.564 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.78 -6.85 41.32 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.328 1.442 . . . . 71.13 111.505 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -102.22 174.85 5.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.84 1.256 . . . . 73.12 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.09 111.75 6.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.402 -1.333 . . . . 74.04 107.402 169.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.94 138.0 49.69 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.756 -1.201 . . . . 74.43 107.756 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -153.58 131.16 2.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.901 -1.518 . . . . 73.33 106.901 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -158.07 175.66 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.453 1.501 . . . . 73.33 111.87 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -146.64 152.29 38.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.139 1.776 . . . . 73.43 110.059 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -147.43 168.45 21.84 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.739 1.215 . . . . 73.22 109.318 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 p -168.89 128.11 1.08 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.543 0.687 . . . . 74.21 111.897 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.09 113.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.664 1.986 . . . . 73.31 106.1 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 m -97.25 158.35 15.5 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.575 -1.269 . . . . 73.22 107.575 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -107.39 38.48 2.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.705 0.684 . . . . 61.33 109.165 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptp . . . . . 0 C--O 1.235 0.296 0 C-N-CA 125.555 1.542 . . . . 73.43 107.561 172.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 108.699 -0.852 . . . . 72.13 108.699 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.68 -98.41 0.11 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 127.62 2.533 . . . . 53.14 107.106 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.23 135.66 61.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 125.502 1.521 . . . . 73.33 107.093 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -97.58 145.15 26.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.55 1.14 . . . . 72.51 108.7 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -141.05 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.901 0.88 . . . . 72.1 111.678 166.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.9 mm -130.86 152.16 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.035 1.734 . . . . 74.52 106.59 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.63 141.31 46.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.714 1.606 . . . . 70.11 106.942 166.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.0 mt -131.62 151.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.028 -1.101 . . . . 74.53 108.028 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -142.72 164.63 29.59 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.723 0.809 . . . . 70.53 110.992 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -156.65 139.89 15.6 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.515 1.126 . . . . 65.21 109.687 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -152.9 147.72 26.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 128.313 2.645 . . . . 70.24 107.647 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.83 -134.8 11.29 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.323 -1.111 . . . . 50.33 110.323 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.19 58.75 0.72 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.022 1.729 . . . . 45.4 111.428 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.472 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.8 p -76.13 63.22 1.8 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.365 -1.46 . . . . 72.32 109.031 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -148.93 -40.06 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.858 1.263 . . . . 74.53 110.653 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.84 60.88 1.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 124.268 1.985 . . . . 72.43 110.114 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 0.2 OUTLIER -141.53 160.18 40.69 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.582 2.753 . . . . 72.52 108.449 176.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.69 107.17 3.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.17 0.895 . . . . 74.12 108.806 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.46 92.84 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.419 1.887 . . . . 71.53 109.568 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.92 113.74 27.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 75.24 109.414 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.03 149.12 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.537 1.062 . . . . 75.51 110.078 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t -82.52 150.32 27.03 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.278 1.431 . . . . 75.14 109.413 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.61 116.01 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.56 -2.015 . . . . 75.14 105.56 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 173.53 35.15 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.811 -0.516 . . . . 54.44 111.811 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.34 169.49 36.49 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.582 2.039 . . . . 71.11 111.039 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.83 39.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.577 1.151 . . . . 74.2 111.026 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.48 -168.39 1.77 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.711 2.004 . . . . 74.43 113.258 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -77.74 77.62 4.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.146 -0.687 . . . . 64.1 109.146 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.04 49.56 0.72 Allowed Glycine 0 N--CA 1.453 -0.231 0 O-C-N 124.609 1.193 . . . . 75.53 111.768 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.79 -164.07 28.83 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 120.12 -0.267 . . . . 71.43 112.923 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.27 173.09 13.74 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.921 3.747 . . . . 72.51 110.56 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.39 117.82 35.72 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.477 1.111 . . . . 75.42 109.46 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -60.02 124.14 19.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.285 0.948 . . . . 75.41 110.396 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.02 162.83 15.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.163 1.385 . . . . 75.23 109.455 -174.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -131.03 152.76 49.99 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.358 -0.979 . . . . 75.3 108.358 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.287 1.5 p30 -79.05 -152.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.596 1.558 . . . . 73.33 110.228 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.86 2.32 32.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 119.727 -1.858 . . . . 75.11 113.231 174.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -106.2 -2.52 22.38 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.838 2.055 . . . . 74.52 111.63 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.46 56.87 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.46 1.505 . . . . 73.53 113.262 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -113.99 141.2 47.71 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.874 1.337 . . . . 72.21 109.86 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -66.94 135.06 53.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.208 1.803 . . . . 75.32 109.309 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.68 32.1 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.205 1.002 . . . . 75.31 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.1 176.18 27.81 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-O 122.432 1.018 . . . . 71.54 110.702 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.22 6.53 35.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.872 1.269 . . . . 62.42 112.524 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 p -167.48 125.62 1.26 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.908 0.883 . . . . 62.4 112.139 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -167.86 -175.43 2.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.561 0.744 . . . . 75.44 111.007 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -122.84 160.74 25.42 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.068 1.347 . . . . 72.43 108.571 162.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.16 127.83 17.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.83 -1.545 . . . . 61.53 106.83 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -78.69 149.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.921 -1.14 . . . . 74.42 107.921 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mm -86.42 112.75 23.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.108 -1.071 . . . . 71.54 108.108 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.26 37.77 3.69 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.861 1.265 . . . . 74.22 108.902 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -142.0 160.44 40.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.722 -1.214 . . . . 73.54 107.722 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 -16.92 62.69 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.277 -0.889 . . . . 64.11 113.235 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 p -145.22 150.85 37.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.703 1.601 . . . . 73.5 107.506 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmm -142.69 166.96 23.24 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.783 1.633 . . . . 74.21 110.641 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.6 p -162.26 151.89 16.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.251 1.42 . . . . 73.24 109.566 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.9 m -143.25 145.66 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.363 1.865 . . . . 64.32 107.665 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.8 p -143.82 -179.86 6.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.492 0.587 . . . . 65.43 111.254 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.1 p -129.34 -171.24 2.45 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.462 1.105 . . . . 73.12 110.633 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.6 -154.47 0.46 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.17 -1.048 . . . . 74.14 108.17 165.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.38 35.83 4.63 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.914 1.245 . . . . 74.52 112.526 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -135.86 87.95 2.36 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.694 -1.595 . . . . 74.2 106.694 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -171.2 166.17 7.23 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.33 1.452 . . . . 74.11 111.025 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.81 -16.11 7.23 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.476 1.51 . . . . 74.41 112.815 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.78 165.19 36.15 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.892 -1.151 . . . . 74.1 107.892 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 ttt -131.1 156.38 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 104.569 -2.382 . . . . 72.21 104.569 164.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -130.94 152.4 50.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.682 -0.859 . . . . 72.54 108.682 167.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.17 87.78 2.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.381 -2.081 . . . . 71.12 105.381 167.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.4 136.77 53.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.15 1.78 . . . . 71.23 107.123 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.98 -148.65 5.06 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 121.564 -0.71 . . . . 73.12 111.477 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -150.25 171.49 16.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.388 1.475 . . . . 64.13 109.427 161.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.53 143.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.058 1.343 . . . . 65.4 108.1 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -142.18 163.05 33.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.267 0.354 . . . . 62.52 110.777 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 t -135.68 160.01 39.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.946 1.698 . . . . 75.2 107.885 165.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 pt -133.95 21.08 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 128.233 2.613 . . . . 74.44 108.987 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -81.19 -177.75 6.6 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 123.145 1.45 . . . . 64.5 109.881 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -73.99 170.62 15.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.029 -1.896 . . . . 64.2 109.275 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 165.29 3.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.669 1.188 . . . . 71.51 112.514 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.64 71.77 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.579 1.561 . . . . 61.3 114.111 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.45 134.94 36.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.736 1.768 . . . . 74.4 108.269 -176.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -125.99 129.16 48.66 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.745 1.157 . . . . 71.2 111.124 -169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.29 158.95 25.05 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.285 2.234 . . . . 74.21 105.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -161.14 101.38 1.24 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.146 -1.798 . . . . 74.33 106.146 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.71 143.78 21.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.258 -1.756 . . . . 72.34 106.258 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m -131.46 144.74 51.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.716 -1.587 . . . . 73.54 106.716 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.24 112.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 125.702 1.601 . . . . 54.22 109.231 -164.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.22 143.96 39.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.395 1.478 . . . . 74.21 107.046 -170.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.67 140.49 11.84 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.897 -0.881 . . . . 65.53 110.897 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -134.64 144.91 48.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.158 1.383 . . . . 74.42 110.099 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.65 118.6 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 105.193 -2.151 . . . . 70.12 105.193 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 t70 43.91 71.32 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.64 1.576 . . . . 62.31 112.153 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.08 27.29 3.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.251 2.221 . . . . 70.33 113.694 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -129.8 158.56 39.11 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 120.799 -1.188 . . . . 74.21 110.94 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.82 134.87 40.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.228 1.411 . . . . 72.15 107.456 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.51 -0.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.852 0.861 . . . . 71.14 112.101 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -161.87 153.52 18.8 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.399 -0.963 . . . . 73.51 108.399 165.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.62 122.86 3.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.691 -1.596 . . . . 74.25 106.691 170.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.49 171.25 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.895 0.747 . . . . 71.22 110.753 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.05 168.8 14.81 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.614 1.966 . . . . 74.44 109.376 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -150.86 170.6 18.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.585 -1.265 . . . . 71.21 107.585 162.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.55 154.91 51.23 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 127.852 2.461 . . . . 73.54 107.727 169.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -137.79 154.83 49.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.987 -0.746 . . . . 71.14 108.987 164.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -145.27 134.16 17.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.707 -1.22 . . . . 74.1 107.707 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 p -75.58 131.81 40.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.687 0.795 . . . . 74.14 109.929 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -128.64 66.26 1.41 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.06 0.933 . . . . 73.2 108.793 161.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.21 15.71 79.78 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.703 -0.68 . . . . 63.53 114.26 163.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.55 162.97 32.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.58 1.552 . . . . 74.21 110.273 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 105.69 1.35 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.342 -0.844 . . . . 75.23 109.896 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.08 133.14 50.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.335 -0.987 . . . . 73.13 108.335 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -149.37 138.62 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.854 -2.276 . . . . 74.44 104.854 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.58 166.92 32.01 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.66 1.184 . . . . 65.23 111.484 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.1 p -136.81 153.7 50.74 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.143 0.977 . . . . 74.44 111.182 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -142.97 174.47 10.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.005 1.722 . . . . 73.53 108.943 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 t -164.38 144.08 7.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.503 -0.748 . . . . 63.23 109.621 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -143.19 109.61 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.134 -2.173 . . . . 74.51 105.134 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 128.1 55.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.172 1.389 . . . . 65.5 107.574 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 5.4 44.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.924 1.083 . . . . 74.12 113.924 -172.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.292 0 O-C-N 120.116 -1.615 . . . . 73.52 106.775 171.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 108.777 -0.823 . . . . 63.45 108.777 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.49 -97.72 0.11 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 106.859 -2.496 . . . . 53.21 106.859 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.49 147.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.624 -2.362 . . . . 72.01 104.624 167.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -107.12 146.73 30.91 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.725 -1.583 . . . . 75.14 106.725 166.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -142.66 145.36 33.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.932 -1.507 . . . . 72.4 106.932 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 tp -119.95 152.28 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.792 -1.558 . . . . 74.14 106.792 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.2 t -126.82 137.43 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.561 -2.385 . . . . 74.53 104.561 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.1 151.6 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.358 -2.09 . . . . 73.42 105.358 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.62 166.35 24.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.29 -1.004 . . . . 72.51 108.29 170.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -138.4 171.63 14.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.413 0.685 . . . . 72.33 109.426 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -161.78 174.14 13.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.053 2.141 . . . . 74.23 107.686 164.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.82 -147.68 18.58 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.317 -1.513 . . . . 65.33 109.317 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.88 78.67 3.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.056 0.931 . . . . 72.1 111.197 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -73.29 39.63 0.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.676 1.59 . . . . 73.33 112.534 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -142.49 -11.38 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.439 1.496 . . . . 74.23 113.239 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 14.05 1.04 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.579 1.081 . . . . 73.22 113.134 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.49 167.19 18.65 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.008 0.923 . . . . 74.24 110.061 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.3 111.62 6.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.264 -1.754 . . . . 70.43 106.264 163.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 112.83 33.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.801 -1.926 . . . . 74.53 105.801 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -110.03 121.71 45.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.783 -1.192 . . . . 53.44 107.783 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 m -95.26 137.53 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.368 -1.345 . . . . 72.22 107.368 163.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.94 145.36 34.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.161 -1.422 . . . . 73.53 107.161 155.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -130.08 123.26 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.041 -2.207 . . . . 73.54 105.041 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.81 167.78 37.38 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.913 0.768 . . . . 51.04 111.487 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.72 39.38 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.972 1.748 . . . . 72.13 109.003 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.96 164.32 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.654 1.227 . . . . 71.21 111.425 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.18 175.85 9.25 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.923 1.689 . . . . 74.34 112.722 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -74.71 78.54 2.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.526 -0.916 . . . . 74.02 108.526 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.54 35.82 1.38 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-O 118.572 -1.127 . . . . 74.2 113.554 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.21 -172.12 30.8 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.918 1.859 . . . . 72.32 112.692 162.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.06 134.28 21.09 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.423 2.082 . . . . 70.33 107.662 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.91 131.06 42.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.406 1.082 . . . . 64.51 109.625 -167.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -61.68 122.24 14.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.433 -0.58 . . . . 70.22 109.433 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.09 154.97 17.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.177 1.791 . . . . 71.51 107.768 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -133.84 141.96 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.718 -1.586 . . . . 74.53 106.718 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -73.58 -154.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.439 1.896 . . . . 61.34 111.457 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -100.14 -3.17 32.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.02 1.728 . . . . 65.42 112.773 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -111.48 17.37 20.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.198 2.199 . . . . 70.5 110.109 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.09 19.06 69.71 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.634 1.588 . . . . 51.31 114.234 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -102.58 156.52 17.56 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 119.694 1.747 . . . . 71.22 107.958 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -85.43 150.48 24.68 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.47 -1.307 . . . . 72.2 107.47 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.2 pt -150.67 23.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.876 0.87 . . . . 74.31 112.927 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.32 -172.18 14.08 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.578 -1.326 . . . . 54.32 111.955 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -119.18 -4.99 10.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.843 2.057 . . . . 73.43 112.544 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -164.38 134.87 4.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.208 -1.405 . . . . 73.34 107.208 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -168.4 -173.86 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.013 1.725 . . . . 73.2 108.651 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.44 165.58 14.75 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.206 1.002 . . . . 74.33 110.17 159.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.84 133.06 26.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.963 1.305 . . . . 73.32 107.985 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -78.95 136.46 37.25 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.605 -0.517 . . . . 74.24 109.605 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 mm -78.86 74.43 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.778 0.831 . . . . 73.14 109.516 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.38 13.78 12.8 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.178 1.177 . . . . 73.42 114.178 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.4 p -118.52 161.11 20.56 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.989 0.916 . . . . 64.33 109.386 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.7 92.57 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 73.13 109.29 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.4 p -132.82 140.23 47.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.721 1.208 . . . . 74.43 108.671 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.05 168.42 19.64 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.325 1.85 . . . . 74.12 110.956 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.5 p -165.92 144.18 5.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.396 0.678 . . . . 64.53 110.885 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.3 m -127.1 157.77 38.78 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.487 -1.301 . . . . 64.41 107.487 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -146.86 -176.92 5.39 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.152 0.887 . . . . 72.3 110.611 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.0 p -134.91 177.75 7.55 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.353 0.661 . . . . 74.32 110.571 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -73.45 -172.53 1.2 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.074 1.35 . . . . 74.31 112.0 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.42 -5.54 72.98 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.783 -1.198 . . . . 73.34 115.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -130.82 109.25 10.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.767 2.027 . . . . 73.0 107.99 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.2 165.56 24.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.178 2.191 . . . . 74.5 110.103 166.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -117.55 -19.29 9.48 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.203 1.401 . . . . 74.52 113.268 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -159.86 172.51 17.5 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.89 0.768 . . . . 73.3 109.327 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.3 ttt -141.17 155.83 46.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.529 -2.026 . . . . 65.12 105.529 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -139.3 156.95 46.69 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.966 0.906 . . . . 74.53 108.911 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.54 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 2.1 t -123.94 16.27 9.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.727 1.611 . . . . 74.22 111.798 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.4 129.14 21.36 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 125.752 1.621 . . . . 73.3 110.632 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.7 -179.83 31.09 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 64.44 111.263 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.89 150.73 43.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.246 2.218 . . . . 72.33 107.809 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.295 1.6 p -138.04 155.89 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 74.24 110.552 169.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -151.73 179.18 8.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.214 -1.402 . . . . 72.4 107.214 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.5 t -161.91 164.69 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.218 1.407 . . . . 70.13 108.417 165.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.11 -0.11 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.914 1.286 . . . . 74.13 112.115 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.84 -176.5 1.69 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.752 1.263 . . . . 72.22 109.253 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -72.51 175.59 6.15 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 73.11 111.107 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 166.88 8.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.693 1.597 . . . . 74.53 113.169 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.43 37.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.312 1.911 . . . . 51.02 114.805 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -87.67 115.34 25.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.382 1.873 . . . . 74.52 106.987 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 167.59 9.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.573 1.149 . . . . 74.44 109.776 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.87 97.15 1.54 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.757 -1.201 . . . . 74.3 107.757 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -87.86 138.9 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.621 -1.622 . . . . 75.33 106.621 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 mm -128.28 140.05 50.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 106.157 -1.794 . . . . 74.23 106.157 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m -124.03 135.72 53.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.156 -1.794 . . . . 74.34 106.156 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.59 110.94 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 108.126 -1.065 . . . . 71.34 108.126 -172.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.55 141.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.929 1.292 . . . . 75.32 108.497 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.58 144.56 15.69 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.361 0.981 . . . . 75.13 113.3 -173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -128.82 158.58 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.049 1.74 . . . . 74.33 110.82 -169.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.72 110.35 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.454 -2.054 . . . . 73.54 105.454 168.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 t0 72.6 -67.41 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.924 2.489 . . . . 75.02 110.012 168.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -153.97 10.45 0.4 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.784 1.634 . . . . 74.21 112.971 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -123.15 152.38 41.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.571 1.078 . . . . 72.24 111.486 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.46 121.51 39.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.537 1.535 . . . . 73.31 108.091 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.09 -15.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 73.23 112.881 -169.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.38 141.63 25.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.545 1.066 . . . . 75.51 108.689 -170.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.61 158.08 3.3 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.661 0.784 . . . . 73.25 111.469 173.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.14 172.62 16.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.119 1.512 . . . . 75.12 108.432 156.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.21 163.96 16.97 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.789 -1.189 . . . . 71.43 107.789 169.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -143.68 165.95 26.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.043 1.337 . . . . 74.35 109.409 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -162.53 120.95 2.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.439 -2.164 . . . . 75.31 109.507 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.465 ' CZ ' ' HG3' ' A' ' 117' ' ' GLU . 26.8 m-85 -131.5 149.43 52.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.077 0.861 . . . . 75.51 110.316 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mt -144.73 118.32 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.81 -1.552 . . . . 72.12 106.81 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 p -64.6 142.43 58.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.925 1.29 . . . . 71.42 110.993 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.56 51.73 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.313 2.245 . . . . 73.3 107.675 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.5 7.21 85.27 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.927 1.251 . . . . 73.42 114.338 167.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -127.68 179.59 5.44 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.295 2.238 . . . . 74.52 108.98 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -63.5 134.7 56.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.164 -0.68 . . . . 71.54 109.164 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.453 HD11 ' H ' ' A' ' 116' ' ' ILE . 18.5 tp -95.39 135.36 37.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.7 2.0 . . . . 74.1 107.563 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.453 ' H ' HD11 ' A' ' 115' ' ' LEU . 45.7 mt -164.76 133.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 128.68 2.792 . . . . 73.32 110.643 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.465 ' HG3' ' CZ ' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -159.55 167.03 29.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.268 2.627 . . . . 74.52 112.838 -176.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -136.33 158.57 44.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.554 1.541 . . . . 72.41 110.42 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.11 164.92 28.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.365 1.866 . . . . 74.41 108.512 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -150.89 129.54 12.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.089 0.471 . . . . 75.4 110.081 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 8.8 p -129.9 131.06 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.274 -1.75 . . . . 63.15 106.274 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.9 m -128.69 -179.61 5.16 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.3 p -135.28 33.84 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.566 -0.709 . . . . 73.33 109.103 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tptp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 106.585 -1.635 . . . . 75.42 106.585 174.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 107.185 -1.413 . . . . 73.11 107.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.42 -90.76 0.08 OUTLIER Glycine 0 C--N 1.338 0.64 0 O-C-N 121.032 -1.043 . . . . 54.14 110.706 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.8 145.68 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 104.965 -2.235 . . . . 74.42 104.965 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 23.6 m-70 -120.73 148.97 43.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.912 1.233 . . . . 63.43 108.601 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 161.22 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.832 . . . . 74.15 109.714 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mm -140.35 136.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.25 -1.759 . . . . 65.22 106.25 170.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.5 t -113.95 144.87 20.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.17 2.188 . . . . 65.35 107.031 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.22 154.13 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.84 -1.541 . . . . 72.32 106.84 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -144.73 168.35 20.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.696 -1.224 . . . . 71.43 107.696 172.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -146.72 164.53 32.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.301 0.572 . . . . 72.44 111.358 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 m -157.05 172.14 19.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.159 2.584 . . . . 73.03 108.291 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.46 -151.56 19.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.026 -1.23 . . . . 62.41 110.026 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -76.04 64.86 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 123.444 1.592 . . . . 75.25 110.423 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -61.57 -14.28 28.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.495 . . . . 73.33 113.151 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.82 -30.64 62.82 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.397 0.679 . . . . 73.34 112.146 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.0 1.14 11.42 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.122 0.786 . . . . 62.22 113.122 -162.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.17 111.46 21.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.751 -1.574 . . . . 73.35 106.751 -173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 150.88 38.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.138 -0.69 . . . . 74.33 109.138 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.04 111.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 106.899 -1.519 . . . . 75.41 106.899 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -112.73 127.69 56.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.946 -1.131 . . . . 73.54 107.946 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.26 147.96 32.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.777 0.831 . . . . 62.32 109.361 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 t -117.92 120.68 38.6 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.201 2.201 . . . . 74.53 107.739 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.3 mt -120.35 125.31 74.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 74.54 108.39 -156.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.01 169.1 35.87 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 121.267 0.37 . . . . 72.22 113.099 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.05 174.21 39.34 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 127.303 2.383 . . . . 73.21 108.239 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.43 147.23 50.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 119.898 1.849 . . . . 72.35 110.227 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.07 179.49 4.03 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.752 2.421 . . . . 44.1 111.383 -172.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.37 76.2 0.16 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.825 0.85 . . . . 64.22 110.561 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.42 34.0 4.32 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.775 1.178 . . . . 74.34 111.734 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.9 175.42 47.5 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.637 1.218 . . . . 72.32 112.759 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.48 134.16 34.78 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.66 2.24 . . . . 72.32 108.921 159.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.87 128.23 34.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.831 -0.804 . . . . 73.14 108.831 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -56.0 123.25 13.75 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.271 -0.64 . . . . 72.44 109.271 169.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.69 164.6 13.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 124.222 0.951 . . . . 74.51 109.16 169.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -137.38 143.36 41.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.417 1.887 . . . . 72.12 107.926 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -69.59 -152.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.267 2.627 . . . . 75.23 110.944 174.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -99.91 -3.64 31.97 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.403 -1.435 . . . . 74.32 114.322 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -98.74 -3.5 35.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.321 -1.487 . . . . 75.3 111.6 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.99 9.49 56.01 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 127.356 2.407 . . . . 55.5 112.396 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -110.32 142.39 42.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 120.589 2.195 . . . . 75.12 108.334 -165.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -64.32 131.32 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.439 1.496 . . . . 74.44 108.704 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.54 9.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.063 0.945 . . . . 73.33 111.81 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.87 175.62 22.99 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.441 -1.063 . . . . 74.51 110.441 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.98 11.62 17.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.075 0.95 . . . . 75.33 110.727 166.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -162.3 157.13 22.36 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 126.791 2.036 . . . . 64.34 106.415 151.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -176.99 -174.99 0.56 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.493 1.917 . . . . 75.23 110.878 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.7 p -122.38 158.3 29.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.613 2.365 . . . . 75.3 108.369 161.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.96 106.06 3.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.299 -0.63 . . . . 73.34 109.299 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.43 145.09 52.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.598 0.714 . . . . 75.53 110.049 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mm -75.68 135.58 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.058 -1.46 . . . . 75.23 107.058 167.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.1 7.74 3.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.356 1.062 . . . . 71.02 110.816 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -139.51 152.39 46.91 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.073 -1.017 . . . . 72.32 108.874 -148.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -31.22 64.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.99 0.359 . . . . 72.41 111.937 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -134.99 164.18 28.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.827 1.251 . . . . 72.33 109.328 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.28 171.2 15.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.814 2.045 . . . . 75.23 109.912 170.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 p -173.46 156.78 3.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.668 1.587 . . . . 74.44 111.17 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.6 m -150.06 165.81 31.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.482 2.713 . . . . 72.34 107.416 162.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 p -147.88 -179.85 7.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.125 0.97 . . . . 60.24 111.28 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.8 p -102.9 164.91 11.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.662 1.185 . . . . 74.41 109.334 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.42 169.42 4.75 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.235 -0.586 . . . . 74.44 109.608 152.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.36 36.94 1.78 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.072 0.844 . . . . 65.54 113.123 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -146.33 90.17 1.93 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.237 -2.134 . . . . 65.43 105.237 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.6 141.94 17.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.319 1.847 . . . . 74.35 106.977 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -86.09 -22.43 27.15 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.446 1.098 . . . . 73.44 111.832 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.407 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 25.6 p90 -157.38 167.33 30.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.697 1.199 . . . . 74.33 108.481 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.57 148.86 49.24 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.302 -2.11 . . . . 74.25 105.302 159.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.6 t -140.55 157.83 44.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.302 -0.999 . . . . 74.34 108.302 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.47 79.06 1.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.923 1.289 . . . . 73.11 109.157 -169.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.43 156.33 31.19 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.222 -0.659 . . . . 64.43 109.222 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.4 174.49 41.21 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 121.947 0.748 . . . . 72.45 112.662 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.6 t -146.33 148.59 32.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 126.337 1.855 . . . . 74.51 107.724 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.05 136.41 53.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 126.097 1.759 . . . . 73.45 106.718 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -148.57 151.86 35.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.698 0.799 . . . . 74.45 110.906 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -150.15 151.08 32.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.126 0.97 . . . . 72.32 108.462 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 5.15 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.367 2.267 . . . . 73.41 110.827 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 p -63.01 169.46 3.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.185 0.994 . . . . 62.45 110.322 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 168.18 9.68 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.319 1.057 . . . . 73.05 112.252 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.4 19.14 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.561 -1.654 . . . . 72.21 112.854 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.85 57.88 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.873 1.225 . . . . 73.13 114.014 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -75.19 167.07 22.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.21 1.505 . . . . 74.25 107.313 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -153.87 174.03 15.14 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.952 -1.093 . . . . 74.32 111.118 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tp -158.46 152.78 24.21 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.338 -0.986 . . . . 64.32 108.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -140.57 131.38 25.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.409 -1.7 . . . . 73.14 106.409 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.51 116.97 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 106.429 -1.693 . . . . 72.44 106.429 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -96.99 139.33 33.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.24 -1.763 . . . . 74.42 106.24 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.36 132.07 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.004 -2.221 . . . . 73.13 105.004 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.1 mt -142.58 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 107.727 -1.212 . . . . 74.25 107.727 -172.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.27 143.95 17.97 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 109.002 -1.639 . . . . 72.51 109.002 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -132.88 152.59 51.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.239 1.015 . . . . 72.55 110.333 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.1 mt -132.52 124.26 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.609 -2.367 . . . . 74.35 104.609 167.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 44.77 68.4 0.56 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.198 1.799 . . . . 70.54 110.804 163.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.6 1.83 3.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.148 1.536 . . . . 52.41 115.148 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -132.11 153.11 50.82 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.072 1.306 . . . . 74.22 111.227 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -86.02 148.23 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.113 0.482 . . . . 73.54 110.034 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 m -135.27 1.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.938 1.295 . . . . 71.43 111.657 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.56 140.68 8.53 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 120.908 -1.12 . . . . 74.13 108.605 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -158.54 144.47 16.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.999 0.919 . . . . 70.41 109.311 162.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.18 108.02 2.53 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.829 0.823 . . . . 74.24 109.435 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.64 157.76 37.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.621 -1.299 . . . . 72.22 108.997 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 173.69 7.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.823 -1.547 . . . . 72.33 106.823 159.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -145.94 132.29 19.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 74.33 106.301 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.5 165.62 20.36 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.898 0.772 . . . . 73.04 110.246 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.9 mt -150.47 137.03 12.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.968 2.507 . . . . 73.24 105.783 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.2 144.72 30.49 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.993 0.917 . . . . 74.41 108.875 170.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -129.68 13.5 5.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 64.02 111.599 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.5 55.36 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 121.314 -0.866 . . . . 71.23 112.94 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -90.17 170.27 10.44 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.559 1.544 . . . . 65.32 107.892 160.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.59 139.66 58.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.808 -1.182 . . . . 72.31 107.808 161.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -97.65 134.22 41.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.699 -1.223 . . . . 74.13 107.699 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.8 mt -145.5 141.93 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.251 -2.129 . . . . 74.43 105.251 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.74 168.23 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.632 1.573 . . . . 65.41 109.318 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.2 p -140.91 157.61 45.11 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.687 1.195 . . . . 74.51 109.152 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.25 171.88 18.51 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.394 -0.821 . . . . 73.45 109.129 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -151.93 142.83 23.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.421 1.088 . . . . 64.55 108.419 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.87 85.78 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.767 -1.938 . . . . 73.31 105.767 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -64.88 170.02 4.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.59 -0.893 . . . . 71.13 108.59 160.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 p -127.87 -12.13 5.36 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.549 -0.719 . . . . 74.42 111.444 159.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 106.413 -1.699 . . . . 74.45 106.413 -169.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.815 0.817 . . . . 73.23 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.02 -119.8 0.93 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.799 3.095 . . . . 71.03 106.311 -166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.01 103.93 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 74.33 108.456 -167.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.472 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 50.1 m-70 -74.38 154.86 38.64 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.962 -0.461 . . . . 73.01 109.771 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -145.86 152.26 39.19 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.817 1.247 . . . . 75.22 107.905 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -127.24 152.43 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.294 2.238 . . . . 71.32 105.489 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.83 136.04 54.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.396 -2.076 . . . . 72.23 105.396 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.4 mt -122.91 150.82 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 105.959 -1.867 . . . . 73.34 105.959 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -142.9 163.36 33.01 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.053 -1.462 . . . . 64.21 107.053 166.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -136.93 154.45 50.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.625 -1.25 . . . . 72.25 107.625 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -145.36 171.01 15.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.785 -1.561 . . . . 64.23 106.785 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.29 -137.47 14.22 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.023 -1.631 . . . . 74.32 109.023 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -89.98 65.42 6.58 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.521 1.529 . . . . 75.35 109.79 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.8 p -75.42 35.5 0.12 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.161 2.184 . . . . 72.04 113.338 -164.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -142.6 8.48 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.244 1.417 . . . . 72.44 111.644 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 m -149.19 7.64 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.106 1.762 . . . . 63.25 111.412 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.75 141.91 50.03 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.074 -1.016 . . . . 74.04 109.103 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -116.1 116.56 28.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.229 -1.767 . . . . 74.22 106.229 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.75 90.14 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.462 -0.94 . . . . 72.34 108.462 -171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -86.89 145.23 26.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.046 -1.033 . . . . 72.34 108.298 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.14 129.12 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.316 1.046 . . . . 73.13 109.469 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -64.59 138.12 58.22 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.723 -1.584 . . . . 74.44 106.723 160.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 122.27 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.129 -2.175 . . . . 73.31 105.129 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.69 167.38 35.22 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.048 -0.821 . . . . 41.42 111.048 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.04 170.95 44.13 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.388 1.947 . . . . 73.2 109.065 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.69 164.78 21.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.852 0.861 . . . . 62.12 109.999 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -131.24 -164.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.255 1.822 . . . . 74.42 111.074 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -79.82 71.59 6.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.845 -0.428 . . . . 71.42 109.845 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.58 -22.6 2.01 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-O 119.035 -0.869 . . . . 53.2 114.2 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.69 -154.8 8.09 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.102 -1.199 . . . . 74.14 110.102 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.1 154.92 42.4 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.726 2.284 . . . . 74.12 110.515 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 110.79 20.77 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.214 1.406 . . . . 74.41 108.993 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -45.46 116.25 1.11 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.988 1.715 . . . . 72.24 111.531 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.71 160.2 15.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.956 0.884 . . . . 74.13 110.09 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -129.09 152.09 49.06 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.677 1.591 . . . . 75.42 107.897 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -96.5 172.75 7.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 73.3 110.424 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -65.47 -9.47 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.096 1.758 . . . . 73.43 113.978 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -87.52 -8.52 56.28 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.652 1.581 . . . . 71.2 111.152 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.1 59.09 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.921 1.724 . . . . 73.23 113.741 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -104.7 147.15 27.99 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.698 1.249 . . . . 74.02 109.251 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -66.29 135.76 54.87 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.003 -1.11 . . . . 71.13 108.003 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -136.63 28.83 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.713 0.805 . . . . 74.04 111.509 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.06 18.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.4 -1.08 . . . . 73.0 110.4 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.04 2.95 55.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.134 1.773 . . . . 70.24 113.246 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -165.77 157.38 14.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.565 1.546 . . . . 73.31 108.375 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.3 p90 177.92 -173.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.578 2.351 . . . . 74.23 109.726 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 m -119.28 153.0 35.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.648 1.179 . . . . 73.41 108.246 154.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.79 110.29 7.02 Favored 'General case' 0 CA--C 1.523 -0.086 0 C-N-CA 124.328 1.051 . . . . 75.42 108.332 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -73.19 145.1 46.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.096 0.958 . . . . 74.42 110.383 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -80.51 118.78 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.734 -1.58 . . . . 75.22 106.734 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.55 29.37 2.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.037 1.335 . . . . 75.21 108.604 167.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 p -135.51 157.25 47.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.446 1.098 . . . . 75.03 108.862 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.52 -40.66 79.22 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.28 0.632 . . . . 63.24 110.408 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.5 p -133.76 163.67 28.96 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.74 0.816 . . . . 55.51 110.878 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 mmm -142.43 170.62 15.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.297 1.839 . . . . 74.03 111.563 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 p -160.9 154.76 22.49 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.22 1.808 . . . . 72.34 108.641 165.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.8 m -143.91 150.43 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.203 1.801 . . . . 74.44 107.851 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.6 p -149.15 179.74 7.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.164 0.983 . . . . 75.04 110.529 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -119.29 -174.65 2.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.28 -1.748 . . . . 74.23 106.28 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -92.37 -176.57 4.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.533 -1.284 . . . . 75.33 107.533 158.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.76 64.33 2.63 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.961 -1.087 . . . . 61.4 111.684 173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.94 71.75 1.35 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 103.883 -2.636 . . . . 71.4 103.883 169.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.89 32.94 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.134 -0.978 . . . . 71.2 111.247 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.09 -7.13 2.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.172 1.789 . . . . 74.1 112.552 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 29.6 p90 -157.29 170.66 21.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.36 -1.348 . . . . 73.24 107.36 163.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.7 ttt -146.29 147.66 31.61 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 105.136 -2.172 . . . . 74.43 105.136 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.5 t -135.36 164.97 26.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.82 0.819 . . . . 71.01 110.002 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.32 106.91 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.703 -2.332 . . . . 74.22 104.703 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 142.97 41.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.906 -1.887 . . . . 72.32 105.906 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.54 -151.05 5.55 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 120.94 -0.648 . . . . 74.11 111.813 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.24 175.49 10.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.137 -0.69 . . . . 74.24 109.137 147.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -137.15 147.46 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.661 1.584 . . . . 74.23 109.273 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.5 m -149.32 167.71 25.35 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.43 -0.794 . . . . 73.04 112.743 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 t -143.47 151.61 40.51 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.771 2.029 . . . . 72.41 107.05 158.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.02 48.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.839 . . . . 74.12 107.616 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.1 m -127.72 174.62 8.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.292 1.037 . . . . 70.15 112.499 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -55.14 158.53 2.91 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.631 1.972 . . . . 65.31 110.817 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.8 167.14 1.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.196 1.398 . . . . 65.14 112.974 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.52 -13.65 33.75 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.043 1.306 . . . . 50.54 114.157 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -67.43 132.45 47.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.119 1.46 . . . . 74.22 108.215 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.0 mtt85 -110.38 159.78 17.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.711 -1.218 . . . . 74.41 107.711 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.67 141.42 26.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.87 -1.529 . . . . 71.33 106.87 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -145.79 92.92 2.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.993 -1.484 . . . . 73.25 106.993 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.61 143.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.442 -1.688 . . . . 73.14 106.442 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -119.28 136.47 54.22 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.493 -1.669 . . . . 72.02 106.493 165.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.51 115.07 12.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 125.655 1.582 . . . . 74.12 108.842 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.67 153.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.348 -1.723 . . . . 73.44 106.348 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.16 158.18 27.61 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.695 -0.962 . . . . 71.45 110.695 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -143.35 152.92 42.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.947 0.899 . . . . 74.24 110.369 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.8 mt -121.81 120.76 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.288 -2.115 . . . . 73.24 105.288 165.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.5 t0 72.39 -83.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.122 2.969 . . . . 73.02 110.197 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.73 24.73 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.58 1.952 . . . . 64.41 108.702 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -135.74 132.85 37.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.266 -0.896 . . . . 75.42 110.746 -166.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.31 136.17 57.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.992 -0.744 . . . . 74.45 108.992 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.59 -25.55 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.16 0.984 . . . . 74.01 108.823 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -145.89 142.92 29.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.512 1.525 . . . . 74.23 107.768 -168.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -167.23 112.0 0.72 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.642 1.177 . . . . 74.43 109.095 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.07 173.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.551 0.532 . . . . 74.21 109.893 162.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -128.3 172.76 10.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 72.21 108.068 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 147.12 33.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.704 -0.85 . . . . 71.13 108.704 164.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -120.61 136.11 54.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.655 -0.869 . . . . 65.41 108.655 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -138.65 155.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.044 0.938 . . . . 72.21 108.849 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.88 135.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.17 -1.419 . . . . 72.01 107.17 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -65.86 144.23 56.95 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.076 0.95 . . . . 54.13 109.328 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -137.0 21.34 3.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.97 0.804 . . . . 73.34 112.546 164.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.12 -24.1 31.62 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.15 1.833 . . . . 72.12 111.336 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.47 159.08 27.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.789 -0.819 . . . . 63.33 108.789 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.42 120.64 21.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.759 -1.571 . . . . 65.13 106.759 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.1 21.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.42 -1.696 . . . . 70.42 106.42 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.03 142.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 105.699 -1.963 . . . . 73.12 105.699 166.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.59 179.1 8.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.835 0.826 . . . . 72.11 109.555 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -135.68 173.01 12.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.387 1.875 . . . . 62.34 107.692 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -164.81 165.62 20.44 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.245 2.218 . . . . 74.32 108.621 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.5 149.82 27.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.558 0.617 . . . . 73.04 110.717 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 t -145.28 84.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.943 -1.502 . . . . 71.14 106.943 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.62 129.2 37.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.177 -1.786 . . . . 74.35 106.177 175.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.0 p -85.72 5.84 30.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.38 0.991 . . . . 74.33 112.049 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.239 0.515 0 N-CA-C 107.563 -1.273 . . . . 74.14 107.563 177.284 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.139 -1.43 . . . . 75.33 107.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.0 -90.52 0.08 OUTLIER Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.85 2.166 . . . . 64.11 109.437 -163.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -139.36 135.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 127.468 2.307 . . . . 75.02 107.378 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -103.71 152.6 21.63 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.529 -0.732 . . . . 72.24 109.725 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -142.68 147.37 35.59 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.841 -1.17 . . . . 72.12 107.841 169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.9 mm -119.16 151.08 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.349 1.86 . . . . 75.43 106.267 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.93 139.13 46.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.118 -1.808 . . . . 73.44 106.118 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.67 154.36 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.325 -1.361 . . . . 75.42 107.325 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -142.8 168.9 18.64 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.52 1.128 . . . . 75.44 109.106 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -136.39 150.38 48.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.674 1.59 . . . . 75.42 108.355 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -154.25 162.39 41.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.303 1.841 . . . . 61.54 108.107 167.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.11 -163.69 31.84 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.329 -1.508 . . . . 75.4 109.329 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.1 99.13 3.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.953 1.701 . . . . 62.11 109.049 -169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.9 p -85.76 -10.24 55.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.836 1.254 . . . . 73.12 114.259 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.1 -12.66 46.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.709 -1.244 . . . . 75.22 111.661 -171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.59 30.84 1.88 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.221 1.408 . . . . 71.34 112.613 -169.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.83 155.23 43.23 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.794 -1.192 . . . . 73.13 108.443 170.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.06 121.68 18.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.369 -1.345 . . . . 72.3 107.369 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.97 105.08 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 123.908 0.883 . . . . 74.44 109.079 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 145.98 25.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.694 -0.854 . . . . 72.3 108.694 162.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.45 131.59 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.605 1.562 . . . . 73.33 108.996 163.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 t -68.39 140.08 55.82 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.257 -1.386 . . . . 74.54 107.257 161.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 HD12 ' HG ' ' A' ' 63' ' ' CYS . 54.5 mt -130.43 108.54 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 104.297 -2.482 . . . . 74.3 104.297 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.39 166.43 26.82 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 109.382 -1.487 . . . . 55.11 109.382 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 172.04 44.96 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 108.314 -1.915 . . . . 71.34 108.314 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 164.75 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.521 1.129 . . . . 75.14 108.773 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -144.08 145.46 32.17 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.196 0.998 . . . . 71.12 109.306 156.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 45.2 -8.15 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 130.525 3.53 . . . . 73.54 117.829 -160.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 33' ' ' ASP . . . 138.51 -19.47 3.19 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 126.408 1.956 . . . . 63.1 110.796 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.96 -171.5 32.69 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.213 2.34 . . . . 62.2 111.711 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.7 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.281 2.654 . . . . 75.54 110.688 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.84 138.73 47.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.103 0.478 . . . . 73.34 111.902 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -65.14 110.59 2.59 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.749 1.62 . . . . 72.02 110.485 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mt -89.14 160.93 16.76 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.439 1.018 . . . . 74.33 108.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -130.4 144.29 51.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.335 1.054 . . . . 74.2 109.797 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.03 176.99 6.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.816 1.246 . . . . 75.5 110.808 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -72.03 -13.25 61.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.83 0.852 . . . . 71.24 112.86 -169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.82 -13.85 62.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.814 1.246 . . . . 74.4 110.635 168.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 14.27 72.69 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 126.542 2.02 . . . . 72.24 112.544 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -106.64 154.81 20.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.697 1.599 . . . . 74.22 110.337 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -76.03 152.02 37.01 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.211 -0.663 . . . . 75.32 109.211 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 pt -153.49 10.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.877 1.066 . . . . 74.41 113.877 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.19 167.09 11.13 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.814 -1.179 . . . . 75.12 110.574 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -111.66 -0.65 15.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.805 1.242 . . . . 73.3 112.443 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 m -148.34 141.85 25.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.068 -1.827 . . . . 74.33 106.068 159.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.06 -173.63 2.4 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.422 1.089 . . . . 73.13 108.578 166.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.3 m -130.23 153.87 48.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.493 1.117 . . . . 72.2 108.116 161.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.68 160.71 38.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.322 1.049 . . . . 61.52 108.827 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.196 0.598 . . . . 72.24 110.565 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.96 81.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.859 1.264 . . . . 63.52 108.417 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 29.42 7.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.623 1.169 . . . . 75.31 110.359 172.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -141.89 138.61 32.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.991 -1.115 . . . . 72.12 107.991 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.86 49.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.687 0.795 . . . . 71.23 111.94 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.9 p -141.6 159.87 41.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.931 1.292 . . . . 71.1 107.515 166.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -145.23 163.67 33.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.028 1.331 . . . . 73.34 109.897 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -172.59 153.82 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.365 1.466 . . . . 75.23 110.912 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HG ' HD12 ' A' ' 29' ' ' ILE . 16.1 m -143.73 152.66 41.56 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.375 1.87 . . . . 73.21 107.292 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.4 p -142.35 177.62 8.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.842 0.857 . . . . 71.41 110.589 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.4 p -101.08 171.21 7.76 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.837 1.255 . . . . 63.11 109.923 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.48 177.2 1.6 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.269 -1.011 . . . . 73.42 108.269 152.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.01 34.69 0.9 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.73 -1.039 . . . . 71.41 113.13 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.11 131.35 11.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.778 1.789 . . . . 75.22 107.769 164.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -174.2 152.31 1.81 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.814 2.446 . . . . 64.31 108.315 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.23 -18.11 12.61 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.571 1.548 . . . . 73.42 112.856 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.39 177.35 11.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.688 2.395 . . . . 73.52 107.072 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 ttt -150.93 150.15 30.49 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 104.803 -2.295 . . . . 72.34 104.803 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 t -122.41 155.44 36.07 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.204 -1.406 . . . . 74.32 107.204 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 t -155.19 98.45 2.0 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.19 -2.152 . . . . 72.11 105.19 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -129.84 144.3 51.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.048 -1.464 . . . . 51.2 107.048 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.98 -149.74 5.08 Favored Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.577 -0.609 . . . . 63.44 111.577 -164.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.06 175.46 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.901 -0.777 . . . . 73.3 108.901 145.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -122.34 156.08 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.753 1.621 . . . . 72.5 107.674 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t -151.38 163.8 38.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.836 1.254 . . . . 73.44 109.289 161.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.44 134.84 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.47 2.308 . . . . 74.4 105.392 168.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.68 12.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.242 -1.022 . . . . 75.22 108.242 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -75.0 -176.66 3.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.796 -1.187 . . . . 72.1 107.796 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -62.38 167.3 4.32 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.368 1.08 . . . . 75.4 112.254 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.45 153.03 16.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.312 -1.767 . . . . 71.42 113.3 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.78 6.35 85.46 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.403 -1.221 . . . . 51.31 113.574 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -76.11 172.51 12.67 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.604 1.702 . . . . 74.51 108.599 160.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -147.47 150.86 35.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.591 -1.263 . . . . 75.15 107.591 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.69 115.34 3.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.088 -0.708 . . . . 61.4 109.088 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -118.89 124.66 47.66 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.982 1.713 . . . . 75.55 108.401 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.3 mm -113.75 142.88 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.526 -1.287 . . . . 74.23 107.526 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -122.87 133.66 54.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.21 -1.774 . . . . 75.15 106.21 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.59 132.23 35.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 125.73 1.612 . . . . 74.4 109.517 -173.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mt -143.76 152.31 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.54 108.333 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.2 151.24 23.51 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.554 1.074 . . . . 54.21 111.553 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -136.19 155.79 49.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.327 1.851 . . . . 74.1 110.372 -166.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mt -141.89 138.12 31.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 127.003 2.121 . . . . 73.42 105.395 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.75 -85.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.739 3.616 . . . . 64.44 109.955 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -152.27 37.2 0.54 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.444 1.498 . . . . 75.0 110.593 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -141.49 153.43 44.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.623 1.169 . . . . 75.33 110.975 171.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.54 148.36 42.39 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.041 0.936 . . . . 64.14 108.906 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.39 -18.38 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 75.1 112.685 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -136.6 137.69 40.42 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.23 1.377 . . . . 74.22 108.765 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -151.8 138.4 18.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.544 1.138 . . . . 74.51 109.751 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.8 168.95 18.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.648 0.737 . . . . 74.25 110.498 155.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.06 156.12 43.28 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.414 -1.698 . . . . 72.42 106.414 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 164.14 34.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.684 -0.858 . . . . 75.32 108.684 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -153.5 148.45 26.62 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.276 -0.268 . . . . 73.13 110.276 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -148.44 137.69 21.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.582 1.153 . . . . 74.31 110.358 -167.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.2 mt -124.85 135.92 62.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.007 -1.479 . . . . 75.14 107.007 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.54 137.91 38.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.634 1.973 . . . . 75.21 108.634 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -141.75 31.16 1.65 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.777 0.798 . . . . 74.14 112.02 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.39 -3.92 86.3 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.368 0.985 . . . . 75.31 112.607 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.63 -155.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.497 1.919 . . . . 71.32 108.512 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -118.9 110.82 17.62 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.188 -1.782 . . . . 71.24 106.188 166.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.13 120.28 10.58 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.426 -1.324 . . . . 72.12 107.426 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -148.19 144.11 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 103.976 -2.602 . . . . 75.44 103.976 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.48 169.72 18.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.991 -0.744 . . . . 74.53 108.991 169.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 p -134.85 162.47 32.31 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.797 1.239 . . . . 75.42 108.361 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -151.8 175.78 12.09 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.036 1.334 . . . . 75.32 108.68 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 t -160.58 148.52 16.19 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.716 0.769 . . . . 72.12 109.445 168.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.6 107.16 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 127.314 2.246 . . . . 74.4 106.393 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.24 118.47 30.54 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.084 1.354 . . . . 72.4 108.437 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.1 p -86.43 33.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.92 0.888 . . . . 71.23 111.847 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tptp . . . . . 0 C--O 1.235 0.33 0 N-CA-C 107.199 -1.408 . . . . 74.44 107.199 167.52 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 111.285 0.106 . . . . 74.33 111.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.43 -90.04 0.11 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 108.808 -1.717 . . . . 61.11 108.808 154.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.24 131.93 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.638 -1.986 . . . . 71.22 105.638 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -126.69 157.16 39.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.568 -1.271 . . . . 73.12 107.568 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -148.94 151.33 34.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.317 1.047 . . . . 72.43 108.257 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.34 134.94 52.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.858 -1.905 . . . . 74.34 105.858 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.54 131.26 50.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.711 -1.589 . . . . 70.05 106.711 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.3 mt -135.2 143.09 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.475 -0.935 . . . . 70.31 108.475 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -134.47 161.75 34.15 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.381 1.072 . . . . 75.21 110.3 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.23 141.86 29.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.33 2.652 . . . . 71.14 109.961 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -141.83 172.49 12.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.56 1.544 . . . . 60.22 107.343 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.33 -155.63 24.4 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.886 -1.286 . . . . 74.55 109.886 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.21 33.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.548 2.339 . . . . 74.15 111.106 -173.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 t -65.04 8.29 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.163 2.185 . . . . 73.54 113.798 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -17.83 64.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.841 1.656 . . . . 72.51 111.149 162.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.7 m -130.95 16.33 5.18 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.937 1.295 . . . . 73.53 113.019 -163.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -126.26 116.02 20.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.352 1.061 . . . . 72.43 109.261 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.22 127.08 31.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.28 -1.378 . . . . 74.45 107.28 166.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 t -136.74 106.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 105.557 -2.016 . . . . 74.14 105.557 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -114.87 145.86 41.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.768 1.167 . . . . 65.44 110.082 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.77 139.19 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.363 1.065 . . . . 64.42 109.595 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -66.84 139.39 57.76 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.768 -1.567 . . . . 71.33 106.768 161.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -132.9 124.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.591 -2.003 . . . . 62.11 105.591 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.98 176.97 47.8 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.702 -1.359 . . . . 64.2 109.702 -171.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.44 172.76 43.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.337 -1.905 . . . . 64.41 108.337 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.8 163.61 27.85 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.783 0.833 . . . . 63.4 109.863 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.39 -170.82 2.68 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.215 1.006 . . . . 74.2 112.039 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -74.94 67.47 1.68 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.317 1.047 . . . . 74.13 110.674 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.36 -32.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.533 -0.593 . . . . 53.14 112.729 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.93 -156.71 15.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 119.907 -1.139 . . . . 70.32 114.627 -162.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.18 139.44 9.38 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.927 3.084 . . . . 65.4 110.567 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.14 117.95 23.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.081 1.352 . . . . 73.4 110.576 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -60.21 117.61 5.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.661 1.119 . . . . 74.43 110.482 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 159.16 16.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.004 1.321 . . . . 74.12 109.401 171.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -128.16 143.88 51.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.0 1.32 . . . . 74.21 109.306 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.75 165.87 20.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.182 -0.917 . . . . 71.22 109.864 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -74.45 19.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.654 1.582 . . . . 73.44 113.457 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -100.76 -10.95 20.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.159 1.383 . . . . 71.33 110.9 163.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.59 56.54 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.001 1.762 . . . . 73.13 113.339 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.19 160.88 14.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.553 1.141 . . . . 74.03 109.429 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -74.96 157.7 34.53 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.815 -0.553 . . . . 74.41 109.923 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.22 6.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.127 0.788 . . . . 72.44 113.127 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.18 -172.45 24.18 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.186 -1.565 . . . . 70.23 109.186 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -125.03 8.73 8.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.037 1.335 . . . . 72.04 111.943 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -170.85 124.48 0.65 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.477 3.111 . . . . 74.3 106.864 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -163.18 -173.39 3.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.238 1.015 . . . . 74.33 110.211 171.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -121.11 157.46 30.06 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.261 1.024 . . . . 73.22 109.249 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.55 142.27 50.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.923 -1.139 . . . . 74.01 107.923 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -96.29 132.71 41.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.554 -1.647 . . . . 72.35 106.554 170.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -74.99 100.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.673 -1.603 . . . . 71.34 106.673 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -127.09 35.1 4.63 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.87 1.668 . . . . 72.14 109.875 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -134.31 169.01 17.85 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.117 -1.068 . . . . 73.34 108.117 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.33 9.95 34.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 118.643 -0.694 . . . . 54.45 111.443 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -178.51 159.85 1.2 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.901 2.48 . . . . 71.34 107.485 145.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 mmm -125.42 165.13 18.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.173 2.189 . . . . 73.41 109.572 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.4 p -159.56 163.07 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.238 -0.892 . . . . 72.34 111.317 158.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.4 m -147.87 163.09 37.86 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.469 2.308 . . . . 73.23 106.624 162.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.35 -176.81 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.23 1.812 . . . . 61.11 108.789 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.27 156.42 47.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.565 1.946 . . . . 73.4 107.362 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -82.4 179.61 7.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.217 0.207 . . . . 65.22 110.699 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.07 32.56 0.52 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.784 1.659 . . . . 73.32 115.752 -171.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -128.2 80.74 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.705 -2.331 . . . . 72.13 104.705 168.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.76 18.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.123 1.329 . . . . 65.34 107.546 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -128.62 -13.89 4.71 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.363 1.065 . . . . 70.44 112.955 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -164.11 167.88 19.71 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.407 1.883 . . . . 73.02 107.5 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 ttt -130.87 145.5 52.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.225 -2.139 . . . . 72.01 105.225 169.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 t -111.85 161.98 15.78 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.57 0.7 . . . . 71.21 109.981 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.42 40.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.312 1.445 . . . . 74.04 110.284 170.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.64 58.28 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 121.439 -0.788 . . . . 73.24 108.993 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.47 -174.95 38.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.747 -0.941 . . . . 74.23 110.747 -173.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.8 p -134.9 168.42 19.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.722 0.772 . . . . 72.41 110.892 -173.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.69 147.14 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.046 1.738 . . . . 73.21 106.731 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 t -152.09 164.5 37.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.092 -0.707 . . . . 44.35 109.092 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.12 155.64 43.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.667 -1.235 . . . . 72.35 107.667 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.82 22.39 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.421 1.488 . . . . 72.43 109.343 167.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.36 173.75 12.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.498 1.919 . . . . 73.51 110.368 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 176.39 8.18 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.687 1.195 . . . . 71.22 112.474 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.98 153.92 42.71 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 113.652 -1.613 . . . . 63.55 112.959 -173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.65 -10.51 44.89 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.663 1.125 . . . . 54.31 114.278 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -64.6 117.34 7.26 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 106.622 -1.621 . . . . 74.41 106.622 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -102.4 168.37 9.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.155 0.582 . . . . 75.24 110.074 -168.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -157.53 150.19 23.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.41 -1.7 . . . . 73.34 106.41 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -141.04 132.92 27.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 105.814 -1.921 . . . . 71.15 105.814 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 mm -127.64 133.81 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.767 -1.568 . . . . 73.13 106.767 -172.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.81 129.03 41.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.882 -1.525 . . . . 70.12 106.882 -168.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.17 121.05 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.315 1.046 . . . . 75.05 108.399 -173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.51 141.54 45.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.013 -1.477 . . . . 73.31 107.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.97 144.35 15.93 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 124.76 1.171 . . . . 73.12 111.155 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -131.63 151.39 51.65 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.67 1.588 . . . . 74.15 111.303 -165.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.5 mt -137.92 140.96 39.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.109 -1.812 . . . . 74.3 106.109 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t0 61.02 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.678 1.991 . . . . 74.11 110.829 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.67 20.82 1.31 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.52 1.528 . . . . 74.03 111.076 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -143.94 158.01 43.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 120.55 -1.344 . . . . 75.42 111.954 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -80.82 156.1 26.3 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.249 -1.019 . . . . 75.32 108.249 168.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.88 -5.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.01 0.524 . . . . 73.35 112.181 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -151.8 130.15 12.08 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.802 -1.186 . . . . 74.14 109.226 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.53 142.88 18.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.642 0.777 . . . . 74.44 110.153 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.48 169.21 21.43 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.896 -0.779 . . . . 72.15 108.896 159.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.98 135.73 37.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.617 -1.623 . . . . 73.25 106.617 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.72 167.35 17.37 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 123.83 0.852 . . . . 74.23 109.547 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.56 131.22 7.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.774 -1.103 . . . . 75.54 108.143 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -145.16 146.97 31.99 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.849 -0.797 . . . . 72.44 108.849 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.25 147.02 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.716 -1.216 . . . . 71.53 107.716 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -77.07 138.66 39.68 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.627 2.371 . . . . 74.45 111.172 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -125.88 55.11 1.47 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.467 1.107 . . . . 73.13 109.281 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.59 3.96 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.047 1.308 . . . . 73.52 112.558 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.07 -174.97 5.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.505 1.522 . . . . 72.52 113.967 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.0 142.4 58.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.098 1.359 . . . . 72.35 109.161 165.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -108.05 143.08 37.26 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.743 -0.836 . . . . 74.15 108.743 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mm -143.21 158.83 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 128.929 2.891 . . . . 73.45 106.017 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -172.82 170.61 4.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.606 2.362 . . . . 63.45 109.074 158.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.5 p -143.13 150.69 39.79 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 72.34 110.179 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -147.04 168.73 20.82 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.617 0.767 . . . . 72.11 110.689 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 p -158.39 111.58 2.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.102 -0.374 . . . . 74.21 111.185 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.62 88.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.189 -1.411 . . . . 74.14 107.189 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 155.52 19.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.449 -1.315 . . . . 63.41 107.449 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.9 p -91.78 30.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.725 -1.234 . . . . 70.2 109.727 174.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptm . . . . . 0 N--CA 1.452 -0.343 0 O-C-N 120.605 -1.31 . . . . 74.42 108.517 -179.025 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.239 0.537 0 N-CA-C 109.249 -0.648 . . . . 74.14 109.249 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.22 -115.42 0.65 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.929 -2.068 . . . . 71.33 107.929 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.52 82.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.621 -0.881 . . . . 74.11 108.621 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -64.16 153.33 38.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.864 -0.791 . . . . 73.04 108.864 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -138.33 153.01 48.99 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.367 -1.345 . . . . 74.42 107.367 167.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -122.28 140.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.982 -2.599 . . . . 74.34 103.982 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.37 133.7 61.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 105.753 -1.943 . . . . 74.3 105.753 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -138.57 129.06 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.65 -0.87 . . . . 74.34 108.65 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -117.05 161.72 18.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.014 0.526 . . . . 74.42 110.517 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -147.77 146.35 29.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.784 0.834 . . . . 72.24 109.766 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.78 -177.16 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.111 0.964 . . . . 72.22 109.713 166.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.64 -95.49 0.7 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.714 -1.355 . . . . 74.43 109.714 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -122.81 122.62 39.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.175 -2.528 . . . . 62.0 104.175 157.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 p -118.66 9.54 12.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.361 0.665 . . . . 73.41 111.274 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -88.48 -33.62 17.75 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.827 1.651 . . . . 71.3 110.032 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.87 26.15 6.68 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.921 1.688 . . . . 72.14 110.049 -167.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.93 148.06 50.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.929 0.891 . . . . 73.43 109.504 165.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.04 154.38 19.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.262 1.825 . . . . 65.1 108.748 163.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.76 102.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.413 -2.439 . . . . 74.3 104.413 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 p -97.44 148.15 23.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.419 -0.956 . . . . 73.31 108.419 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.62 120.42 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.234 1.014 . . . . 73.13 110.667 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 t -59.58 136.04 57.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.359 -1.349 . . . . 71.24 107.359 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mt -130.43 116.37 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 105.124 -2.176 . . . . 64.3 105.124 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.12 174.57 36.08 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.01 0.814 . . . . 72.13 111.5 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.34 172.17 35.75 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.139 1.828 . . . . 72.43 110.219 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.07 168.94 18.55 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.108 0.963 . . . . 70.32 111.439 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.06 179.31 7.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.316 1.446 . . . . 73.22 113.987 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.69 71.81 1.01 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 74.21 109.946 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.24 -0.5 3.22 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 117.73 -1.594 . . . . 74.11 115.336 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.91 -166.78 39.46 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 120.509 2.154 . . . . 71.2 115.037 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.07 135.97 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.186 3.257 . . . . 70.42 109.102 163.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.77 102.78 12.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.954 -1.022 . . . . 70.14 108.864 -172.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -46.22 118.02 1.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.204 1.001 . . . . 74.44 110.898 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.42 154.67 26.27 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 120.254 1.388 . . . . 73.4 108.953 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -123.6 141.15 52.29 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.819 1.247 . . . . 74.43 110.346 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.9 173.36 12.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.799 -1.091 . . . . 65.34 110.9 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -80.48 8.36 7.88 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.44 0.904 . . . . 73.11 113.44 -170.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -105.43 -1.87 24.46 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.8 1.64 . . . . 73.1 111.266 165.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.81 55.51 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 118.766 -1.019 . . . . 74.04 114.656 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -107.28 150.79 26.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.15 1.475 . . . . 74.31 111.393 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -70.49 152.63 43.8 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.472 -0.566 . . . . 64.4 109.472 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.88 2.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 114.034 1.124 . . . . 74.13 114.034 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.25 -173.63 35.41 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 108.429 -1.868 . . . . 53.51 108.429 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -124.76 0.21 8.06 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.915 1.358 . . . . 74.33 113.451 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -151.3 150.72 30.87 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.938 2.495 . . . . 71.4 105.979 158.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -171.68 -178.08 2.16 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.397 1.879 . . . . 74.14 107.552 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -135.73 103.97 5.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.631 0.772 . . . . 73.41 109.434 172.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.44 154.52 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.528 0.604 . . . . 70.23 109.801 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.885 -1.524 . . . . 74.23 106.885 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -71.45 96.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.415 -1.328 . . . . 74.0 107.415 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -109.04 22.92 15.27 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.691 -1.256 . . . . 74.42 110.067 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -137.16 154.54 50.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.478 1.111 . . . . 65.13 108.69 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.3 67.22 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.605 0.595 . . . . 74.32 112.605 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -151.54 173.66 14.35 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.484 -0.76 . . . . 74.31 109.644 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.425 ' C ' ' HG ' ' A' ' 62' ' ' SER . 3.2 tmm? -152.6 163.29 39.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 129.388 3.075 . . . . 72.12 108.801 -170.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.425 ' HG ' ' C ' ' A' ' 61' ' ' MET . 4.1 m -158.8 157.82 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.383 1.473 . . . . 74.41 109.564 159.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.31 144.81 33.41 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.285 1.834 . . . . 64.43 106.804 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 p -127.77 -172.78 2.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.801 1.24 . . . . 62.43 110.044 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 p -125.01 -179.47 4.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.642 1.177 . . . . 64.14 109.2 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -74.22 -177.25 2.91 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.84 -0.8 . . . . 72.3 108.84 153.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.58 44.58 1.83 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.405 1.002 . . . . 71.03 110.896 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -142.92 89.4 2.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.878 -1.527 . . . . 72.03 106.878 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.07 179.83 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.895 1.678 . . . . 71.03 109.991 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -132.36 -16.0 2.78 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.888 1.07 . . . . 73.24 113.888 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -161.36 169.57 21.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.577 -1.268 . . . . 72.43 107.577 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.0 ttt -136.98 158.7 43.87 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 105.607 -1.997 . . . . 73.23 105.607 164.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -135.26 161.52 35.15 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.657 0.783 . . . . 73.11 109.935 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 104.48 3.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.798 1.239 . . . . 73.23 108.592 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.84 140.21 42.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.425 -1.324 . . . . 63.0 107.425 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.96 -150.73 5.83 Favored Glycine 0 C--N 1.331 0.269 0 O-C-N 121.186 -0.946 . . . . 65.01 113.176 -159.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -148.85 171.04 16.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 61.03 110.325 159.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.31 147.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.301 1.841 . . . . 70.12 106.472 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -155.02 167.59 29.86 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.09 -1.006 . . . . 71.03 111.655 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -139.42 148.98 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.237 1.815 . . . . 72.44 107.54 166.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.77 32.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.376 1.871 . . . . 62.42 107.737 170.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.16 -175.08 2.7 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.836 1.254 . . . . 74.12 110.522 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.34 163.31 23.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.402 1.881 . . . . 73.2 110.123 176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.59 163.05 2.63 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.321 1.848 . . . . 70.22 111.965 165.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.93 36.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 118.422 -1.21 . . . . 62.14 114.23 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -64.14 154.3 35.09 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.674 1.737 . . . . 74.12 108.066 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -136.98 161.72 35.27 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.043 0.937 . . . . 72.42 109.001 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 tp -155.8 133.69 11.27 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.982 -1.118 . . . . 74.41 107.982 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -132.26 88.76 2.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.196 1.398 . . . . 63.31 109.068 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.31 138.12 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.076 2.15 . . . . 73.04 108.441 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.9 m -126.14 140.3 52.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.161 -1.422 . . . . 74.43 107.161 169.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.64 124.58 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.468 1.507 . . . . 73.32 107.565 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mt -133.38 147.7 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.472 1.509 . . . . 72.31 107.532 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.5 141.8 11.42 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 124.458 1.028 . . . . 61.4 113.067 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.66 153.31 47.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.722 1.609 . . . . 74.01 110.896 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mt -121.24 107.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 N-CA-C 106.47 -1.678 . . . . 73.24 106.47 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t0 73.36 -64.7 0.39 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.864 2.066 . . . . 61.33 110.62 172.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 -7.66 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.311 2.244 . . . . 71.02 111.78 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.5 129.93 56.17 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 114.075 1.139 . . . . 74.12 114.075 -163.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.39 121.73 26.6 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 -1.53 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.698 . . . . 71.01 112.886 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -149.0 139.5 22.52 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.606 1.094 . . . . 65.14 108.225 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -157.42 149.21 22.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.578 -0.897 . . . . 70.33 108.578 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.72 164.06 36.27 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.474 -0.565 . . . . 74.24 109.474 160.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -137.03 147.55 46.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.987 1.315 . . . . 71.42 108.129 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -142.85 169.15 18.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.703 0.683 . . . . 73.21 110.391 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -139.91 139.86 36.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.376 -1.713 . . . . 63.21 106.376 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.93 153.26 51.89 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.55 1.14 . . . . 72.44 108.375 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -141.29 138.23 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.754 -1.573 . . . . 74.14 106.754 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 p -81.01 147.67 30.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.173 0.897 . . . . 73.34 110.214 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -136.62 28.85 2.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.712 0.805 . . . . 74.0 111.46 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.45 -26.33 13.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.132 1.349 . . . . 73.44 112.601 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -77.34 168.31 20.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.562 1.545 . . . . 74.43 109.278 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 m -67.12 112.34 4.37 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.847 -1.168 . . . . 74.42 107.847 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.07 135.65 44.85 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.782 -1.192 . . . . 74.04 107.782 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -146.64 153.64 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.274 -2.491 . . . . 72.41 104.274 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.33 169.63 15.59 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.023 0.929 . . . . 63.23 110.697 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.3 p -138.25 148.64 44.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.408 0.623 . . . . 73.22 109.453 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.01 173.89 11.15 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.404 1.882 . . . . 70.0 109.09 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -168.61 119.78 0.77 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.855 -0.528 . . . . 62.21 111.026 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.06 92.27 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.089 1.356 . . . . 71.44 108.335 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 m -88.27 159.82 17.94 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 71.12 108.878 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.15 -2.81 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.634 -1.291 . . . . 70.33 112.608 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? . . . . . 0 CA--C 1.521 -0.17 0 N-CA-C 106.95 -1.5 . . . . 71.43 106.95 -166.477 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 110.24 -0.281 . . . . 72.3 110.24 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 -114.93 0.84 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 106.132 -2.787 . . . . 55.22 106.132 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.3 mt -130.24 110.15 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.359 1.064 . . . . 75.41 108.265 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -68.76 148.81 49.79 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.767 -0.583 . . . . 74.02 109.779 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -135.41 154.61 51.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.552 1.541 . . . . 72.34 107.414 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mm -130.87 148.92 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.312 -2.106 . . . . 64.22 105.312 170.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.32 140.79 45.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.974 -1.861 . . . . 75.33 105.974 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -139.2 134.52 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.247 -1.02 . . . . 75.51 108.247 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -137.1 161.7 35.4 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.146 -0.687 . . . . 74.33 109.146 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -136.47 155.05 50.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.332 1.053 . . . . 75.51 110.739 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.5 m -140.58 166.27 25.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.688 -1.227 . . . . 55.23 107.688 150.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.08 -161.48 19.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 124.717 1.151 . . . . 75.22 111.539 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.06 61.87 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.397 2.279 . . . . 73.53 107.909 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -66.82 11.26 0.1 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.635 2.774 . . . . 75.32 114.343 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -8.22 46.16 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.1 -1.625 . . . . 72.11 112.31 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.57 25.86 2.85 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.639 1.976 . . . . 73.45 111.853 -160.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.0 166.59 21.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.151 -0.968 . . . . 72.12 112.265 -170.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -134.65 126.79 29.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 127.657 2.383 . . . . 73.51 105.46 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.93 110.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.155 -1.054 . . . . 74.11 108.155 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -125.26 121.3 33.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.867 -0.79 . . . . 62.41 108.867 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 m -110.96 126.39 68.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.324 1.449 . . . . 75.1 109.806 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 t -72.01 130.25 40.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.623 -1.991 . . . . 74.2 105.623 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.18 110.41 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.392 -2.077 . . . . 64.54 105.392 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.11 177.26 30.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.602 -0.727 . . . . 64.4 111.351 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.63 170.11 38.79 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 127.337 2.399 . . . . 74.31 107.568 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.48 161.89 32.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.531 0.666 . . . . 73.24 110.601 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -140.5 178.27 7.43 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.474 2.31 . . . . 74.24 110.426 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -78.62 81.18 4.95 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.82 -1.178 . . . . 73.01 107.82 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.65 -31.6 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-O 118.68 -1.067 . . . . 51.53 111.607 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.14 26.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.722 1.761 . . . . 64.54 111.488 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.36 141.54 56.7 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.034 2.489 . . . . 52.2 110.254 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.14 118.79 15.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.96 1.304 . . . . 53.22 110.469 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -57.23 109.83 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.969 1.258 . . . . 74.12 110.717 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.63 162.93 16.07 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.41 1.484 . . . . 74.3 110.77 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -131.94 138.73 48.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.035 1.734 . . . . 74.14 107.863 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -77.67 173.41 12.08 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.364 -0.835 . . . . 60.21 110.402 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.07 -8.87 33.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.344 1.458 . . . . 73.22 114.435 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -88.59 -14.79 36.71 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.842 1.657 . . . . 73.21 111.631 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.58 19.16 30.51 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.994 1.283 . . . . 72.43 114.1 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -109.59 147.25 33.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.619 1.709 . . . . 75.24 111.715 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.81 131.7 44.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.542 1.537 . . . . 74.1 110.163 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -130.63 4.32 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.781 1.233 . . . . 73.34 112.926 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.25 169.26 11.78 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 109.945 -1.262 . . . . 74.32 109.945 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -101.14 10.7 40.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.42 1.088 . . . . 73.42 111.426 172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 139.01 1.07 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.394 1.877 . . . . 70.32 108.24 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -175.82 -173.33 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.406 1.482 . . . . 74.41 108.65 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -134.79 122.13 21.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.788 1.235 . . . . 65.21 108.722 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.59 147.82 22.58 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.13 -1.063 . . . . 73.34 108.13 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -95.61 148.57 22.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.193 -1.04 . . . . 74.4 108.193 166.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mm -86.38 118.05 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.874 -1.158 . . . . 75.21 107.874 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.44 18.29 6.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.599 1.16 . . . . 74.43 110.954 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 p -134.26 153.98 51.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.719 0.808 . . . . 72.13 110.157 -163.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.64 -53.66 55.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.636 -0.505 . . . . 62.42 109.636 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 p -140.31 120.36 13.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.485 0.66 . . . . 71.31 110.636 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 mmm -110.69 165.01 12.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.281 1.832 . . . . 72.0 111.013 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 p -157.06 166.16 34.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.679 -1.146 . . . . 75.42 110.536 160.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 61.3 m -144.03 163.47 33.41 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.005 2.122 . . . . 73.0 106.419 165.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 13.9 p -142.51 -172.06 3.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.978 -0.749 . . . . 74.04 108.978 168.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.76 176.73 5.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.473 1.909 . . . . 75.03 107.092 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -77.27 169.78 17.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 155.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.83 78.63 1.99 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.567 -1.013 . . . . 75.44 110.567 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -151.44 -17.16 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.674 0.789 . . . . 73.23 112.602 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 167.02 16.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.188 1.395 . . . . 64.02 111.581 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -124.39 -7.22 7.56 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.083 1.353 . . . . 75.41 113.223 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -162.05 170.95 18.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.631 1.572 . . . . 75.52 107.408 168.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.4 ttt -143.44 138.75 29.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.412 -2.07 . . . . 75.22 105.412 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.9 t -126.57 143.92 51.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.297 0.953 . . . . 75.53 110.438 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.7 t -129.3 46.23 2.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.409 3.083 . . . . 74.31 108.527 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.91 35.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.178 0.991 . . . . 73.52 109.562 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.41 -151.71 6.03 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 120.44 1.473 . . . . 63.13 113.297 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 100.0 p -153.86 171.34 19.11 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.888 0.475 . . . . 75.33 112.263 160.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.5 150.66 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.597 1.959 . . . . 75.32 107.661 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -152.62 165.79 34.13 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.509 -0.744 . . . . 74.45 111.236 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.6 t -144.44 158.75 43.6 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.926 2.09 . . . . 74.21 106.265 159.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.07 13.45 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.068 2.147 . . . . 73.15 108.472 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -73.64 -177.35 2.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 73.31 108.805 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.84 167.71 21.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.627 -1.17 . . . . 62.45 110.85 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.47 168.32 2.18 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.937 1.295 . . . . 63.14 112.247 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.19 -0.78 78.45 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.479 1.038 . . . . 75.42 114.288 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -88.75 114.33 25.26 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.2 1.4 . . . . 75.55 108.663 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 159.92 15.62 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.339 1.056 . . . . 75.25 108.385 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.19 135.76 14.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.013 -1.477 . . . . 74.14 107.013 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -132.9 127.79 35.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.409 -1.33 . . . . 75.42 107.409 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.0 140.11 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 124.982 1.313 . . . . 74.54 107.629 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.9 m -127.25 131.15 50.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.214 -1.772 . . . . 72.21 106.214 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 112.71 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.463 1.505 . . . . 75.44 108.658 -169.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.91 152.99 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.18 1.392 . . . . 71.21 108.594 -169.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.64 144.75 12.83 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.761 1.172 . . . . 61.04 113.531 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.64 159.78 35.36 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.235 1.814 . . . . 71.1 110.993 -168.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.22 111.99 18.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.149 -2.167 . . . . 74.43 105.149 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.6 t0 60.93 -72.84 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.898 2.479 . . . . 60.04 113.292 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.77 15.07 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.177 2.191 . . . . 73.04 110.942 -173.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -128.11 153.16 47.15 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.003 -1.686 . . . . 73.43 109.987 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -93.9 139.53 30.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.113 -1.069 . . . . 71.3 108.113 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.94 -26.23 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.958 1.095 . . . . 71.24 113.958 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -118.75 135.34 54.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.615 2.007 . . . . 72.31 107.568 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -154.25 145.76 23.15 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.183 0.516 . . . . 75.51 112.009 159.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -141.92 174.37 10.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.917 -1.038 . . . . 75.15 111.145 152.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -130.59 165.66 22.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.763 1.625 . . . . 74.25 107.418 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 162.77 39.78 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.677 -0.64 . . . . 64.43 109.481 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -142.29 146.51 35.15 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.07 0.948 . . . . 74.13 109.587 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -148.88 153.62 38.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.021 1.328 . . . . 72.24 108.959 -173.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.59 134.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.54 -1.282 . . . . 74.54 107.54 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -62.47 128.69 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.621 1.168 . . . . 74.55 108.543 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -116.45 -5.12 11.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.418 1.487 . . . . 71.25 112.073 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.29 8.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.093 2.283 . . . . 73.41 110.981 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -76.61 170.45 16.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.293 1.047 . . . . 71.41 108.649 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -72.37 113.15 9.09 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.205 -0.934 . . . . 73.33 108.816 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.18 113.95 5.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.117 -1.438 . . . . 74.15 107.117 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.52 141.06 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 104.433 -2.432 . . . . 73.23 104.433 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.95 166.77 31.05 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.638 1.175 . . . . 75.12 109.223 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -139.61 155.23 47.57 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.757 1.623 . . . . 75.31 106.743 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -154.76 164.03 39.4 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.76 1.224 . . . . 74.51 108.616 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -166.45 146.78 6.1 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 123.185 1.469 . . . . 64.34 113.576 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.67 134.27 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 112.177 -2.283 . . . . 74.1 109.428 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.23 135.27 35.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.638 -1.616 . . . . 73.21 106.638 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.25 -10.74 51.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.098 0.863 . . . . 75.24 113.139 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 106.61 -1.626 . . . . 75.33 106.61 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 106.445 -1.687 . . . . 75.12 106.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.83 -109.49 0.54 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 107.153 -2.379 . . . . 51.23 107.153 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -140.65 110.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 129.665 3.186 . . . . 75.31 103.638 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -74.2 158.75 33.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.258 -1.016 . . . . 62.23 108.258 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 153.42 34.11 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.008 1.323 . . . . 63.11 108.789 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mm -141.54 149.78 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 106.238 -1.764 . . . . 72.33 106.238 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.64 135.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.323 -2.217 . . . . 71.42 106.626 -164.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.55 144.1 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 107.382 -1.34 . . . . 74.31 107.382 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -129.95 165.45 22.07 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.422 0.689 . . . . 73.05 109.437 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -139.47 169.88 16.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 71.42 108.283 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.21 168.42 25.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.62 -1.622 . . . . 73.03 106.62 161.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.62 -144.37 18.22 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 119.579 1.081 . . . . 51.54 112.607 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -78.44 74.01 4.98 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 123.724 1.726 . . . . 42.25 108.276 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -73.76 15.05 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.935 1.294 . . . . 74.11 113.372 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.37 16.79 4.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.046 1.738 . . . . 72.05 111.951 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -145.41 7.6 1.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.543 1.537 . . . . 72.42 112.48 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.78 112.17 13.35 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.813 1.245 . . . . 72.45 109.1 -159.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.64 126.01 28.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.185 1.394 . . . . 63.34 108.51 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.8 113.57 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.397 -1.705 . . . . 73.01 106.397 164.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -112.33 148.57 33.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.79 0.805 . . . . 73.05 109.732 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.81 118.19 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.704 1.602 . . . . 74.04 108.65 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -77.94 129.86 35.85 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.344 -1.725 . . . . 72.03 106.344 166.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -126.86 149.32 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.732 -1.21 . . . . 74.12 107.732 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.21 174.46 46.76 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.711 -0.956 . . . . 73.41 110.711 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 169.45 42.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.125 -1.99 . . . . 43.1 108.125 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 126.28 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.947 1.699 . . . . 74.31 109.679 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.6 -171.14 1.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.332 1.053 . . . . 72.34 110.759 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -72.28 79.35 0.99 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 73.31 109.079 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.21 61.57 0.93 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.436 -1.466 . . . . 72.14 109.436 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.43 -176.48 30.64 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-O 119.566 -0.574 . . . . 74.14 113.199 158.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.78 135.78 24.24 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.986 2.457 . . . . 73.1 108.827 155.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.14 115.61 24.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 117.884 -1.055 . . . . 71.14 109.173 -170.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -47.72 111.58 0.44 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.824 1.193 . . . . 65.42 112.123 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.73 168.71 19.34 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.768 0.827 . . . . 74.42 109.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -135.33 163.11 30.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.637 1.975 . . . . 72.2 109.824 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -111.7 -176.96 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.008 1.723 . . . . 74.14 110.827 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.89 -16.26 60.67 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.504 0.927 . . . . 74.31 113.504 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -71.37 -24.06 62.02 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.984 -1.073 . . . . 74.22 109.375 168.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.21 27.56 25.25 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 125.684 1.611 . . . . 43.24 112.118 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.75 152.37 20.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.257 -1.386 . . . . 74.4 107.257 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.43 35.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.639 1.109 . . . . 74.01 108.066 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 pt -138.21 37.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 174.48 40.27 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.465 -1.454 . . . . 63.42 109.465 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.95 0.58 18.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.757 1.223 . . . . 74.34 112.563 -173.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.7 p -170.55 165.7 8.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.383 1.473 . . . . 54.21 109.536 152.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -179.52 -179.25 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.966 1.706 . . . . 73.22 107.853 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m -116.11 154.44 29.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.237 -1.394 . . . . 73.23 107.237 155.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.28 172.44 11.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.206 1.403 . . . . 72.0 108.018 171.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.14 129.01 37.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.71 0.804 . . . . 73.44 109.205 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -74.74 104.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.178 -1.416 . . . . 71.43 107.178 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 38.35 3.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.909 1.284 . . . . 73.22 109.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -147.92 169.76 19.16 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.704 0.802 . . . . 74.01 109.017 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.41 -43.33 77.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.101 -0.999 . . . . 72.15 110.327 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 p -137.64 147.44 44.95 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.277 1.431 . . . . 74.14 109.019 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mmm -140.12 165.96 25.95 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.163 1.785 . . . . 74.04 110.008 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.6 p -171.4 162.54 6.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.768 -1.56 . . . . 52.11 111.016 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.08 163.53 32.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.657 1.983 . . . . 74.31 107.339 160.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.6 p -140.09 -166.9 2.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.655 1.182 . . . . 71.42 109.902 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.02 156.96 43.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.405 1.082 . . . . 71.24 109.222 -168.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.91 159.27 28.99 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.012 0.911 . . . . 71.24 109.464 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.58 66.9 3.82 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 114.95 -1.023 . . . . 74.21 111.006 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -140.67 -12.68 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.611 1.565 . . . . 70.24 110.25 162.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.11 166.4 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.529 1.132 . . . . 65.1 112.31 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -127.61 -0.8 6.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.744 2.018 . . . . 74.12 113.152 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.31 -179.07 4.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.187 2.595 . . . . 74.1 107.99 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttt -154.28 146.24 23.56 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.009 -1.848 . . . . 71.24 106.009 160.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -124.36 170.41 10.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.503 0.721 . . . . 74.32 110.751 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.63 21.09 0.71 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.461 1.504 . . . . 74.42 111.944 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 115.3 2.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 127.017 2.127 . . . . 70.14 109.78 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.25 -179.62 30.53 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 109.638 -1.385 . . . . 65.25 109.638 -156.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 34.4 p -149.15 158.53 44.26 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.905 -0.647 . . . . 74.44 110.772 -165.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.8 146.62 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 105.216 -2.142 . . . . 73.22 105.216 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.5 m -152.32 170.55 19.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.444 -1.41 . . . . 74.31 110.932 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.78 165.98 27.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.427 1.491 . . . . 63.15 109.071 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.5 pt -155.73 10.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 127.564 2.345 . . . . 74.32 110.993 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -99.39 -170.6 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.045 0.926 . . . . 70.44 109.964 -167.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.32 163.07 8.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.41 1.084 . . . . 70.41 109.339 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.55 158.88 9.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.086 . . . . 51.45 111.318 165.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.01 1.5 59.66 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.708 1.147 . . . . 74.55 113.989 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -72.93 114.82 11.51 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.446 -1.687 . . . . 73.43 106.446 167.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -83.65 163.13 20.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.484 0.714 . . . . 74.32 109.864 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.41 136.65 10.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.588 -1.634 . . . . 64.23 106.588 171.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -129.28 143.98 51.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.219 -1.771 . . . . 75.32 106.219 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 mm -128.74 144.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 126.068 1.747 . . . . 63.31 108.25 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -146.88 133.83 20.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.602 -1.629 . . . . 75.25 106.602 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.42 120.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 107.211 -1.403 . . . . 75.04 107.211 -168.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.5 mt -133.06 156.3 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 107.965 -1.124 . . . . 73.12 107.965 -168.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.05 138.2 8.69 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.257 1.408 . . . . 72.14 111.11 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -132.45 147.64 52.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.733 2.013 . . . . 75.34 109.83 -162.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.02 114.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.953 1.701 . . . . 75.25 108.281 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.261 7.1 t0 49.51 -64.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 131.475 3.91 . . . . 73.13 114.267 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.38 39.43 0.66 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.939 1.245 . . . . 75.14 112.984 166.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.21 148.65 49.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.807 1.243 . . . . 72.44 111.184 177.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -79.4 143.7 34.81 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.225 -1.769 . . . . 63.41 106.225 161.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.91 -28.08 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.052 1.13 . . . . 71.12 114.052 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -148.11 142.32 26.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.391 1.45 . . . . 75.43 108.255 -163.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -172.13 155.91 3.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.264 1.026 . . . . 75.24 111.105 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -150.1 173.48 13.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.532 0.606 . . . . 61.43 109.782 161.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -134.75 152.9 52.12 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.432 -0.951 . . . . 75.45 108.432 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.1 170.55 15.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.415 0.686 . . . . 74.43 110.383 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.64 153.08 41.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.289 -1.745 . . . . 61.21 106.289 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.402 ' HH ' ' HG3' ' A' ' 117' ' ' GLU . 55.5 m-85 -142.58 154.57 44.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.242 2.217 . . . . 74.31 106.977 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.64 134.13 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.222 -2.881 . . . . 63.54 103.222 162.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -70.88 148.54 47.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.81 10.19 3.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.671 0.388 . . . . 74.12 111.07 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.59 -9.93 16.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.828 2.156 . . . . 65.53 112.152 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -85.06 168.51 14.82 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.355 -1.085 . . . . 74.34 109.873 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -59.94 160.99 7.07 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.648 -0.501 . . . . 64.15 109.648 154.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.19 129.96 36.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.306 -0.998 . . . . 74.15 108.306 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -152.98 141.14 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.292 1.837 . . . . 72.44 106.501 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG3' ' HH ' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -161.78 168.11 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.389 1.875 . . . . 74.55 109.319 177.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 64.7 p -130.97 172.9 11.54 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.76 1.624 . . . . 74.54 108.764 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -151.55 166.9 29.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.158 0.583 . . . . 72.04 110.519 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -152.5 132.07 13.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 122.508 1.147 . . . . 74.21 111.532 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -141.85 96.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 130.415 3.486 . . . . 74.04 103.759 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.5 t -81.5 -179.13 7.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.836 -1.542 . . . . 71.03 106.836 157.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.0 p -130.04 14.42 5.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.385 1.074 . . . . 71.23 111.055 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.188 0 O-C-N 120.449 -1.407 . . . . 73.33 107.62 166.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 106.511 -1.663 . . . . 64.24 106.511 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.74 -100.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 125.122 1.344 . . . . 74.4 109.906 168.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.2 mt -108.63 97.49 5.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.255 -2.128 . . . . 73.11 105.255 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.73 154.13 22.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.87 -1.159 . . . . 75.41 107.87 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.04 150.41 41.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.224 -1.398 . . . . 62.04 107.224 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 mm -120.92 150.44 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.56 -2.015 . . . . 75.25 105.56 165.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.88 133.37 64.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.047 -2.205 . . . . 75.35 105.047 171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.97 140.88 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 108.399 -0.963 . . . . 74.43 108.399 -171.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -147.58 156.02 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.105 0.866 . . . . 75.12 111.798 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -139.72 154.03 47.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.652 1.581 . . . . 73.23 110.637 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 m -150.03 156.14 41.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.674 2.79 . . . . 71.43 106.712 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.88 -112.71 2.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.373 -1.491 . . . . 72.54 109.373 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -117.1 99.09 6.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.352 1.461 . . . . 75.13 107.381 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 p -74.78 -1.03 20.23 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.571 0.952 . . . . 71.01 113.571 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.1 -19.86 13.21 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.851 1.26 . . . . 73.44 110.32 -166.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.3 m -120.15 37.44 4.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.641 1.976 . . . . 75.21 110.888 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -150.23 122.93 8.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.544 1.164 . . . . 73.21 109.16 171.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.23 90.87 6.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.433 -1.692 . . . . 74.34 106.433 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 23' ' ' PHE . 4.8 t -81.16 113.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.939 2.096 . . . . 63.44 108.042 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -114.63 144.57 43.2 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.485 1.039 . . . . 63.31 109.231 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 m -137.65 122.87 24.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.393 -1.276 . . . . 75.25 110.328 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -68.98 141.66 54.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.677 -1.601 . . . . 71.43 106.677 160.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.4 mt -130.7 107.41 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 103.916 -2.624 . . . . 73.43 103.916 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.1 30.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.367 0.508 . . . . 72.13 111.907 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.82 172.01 43.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.429 1.966 . . . . 61.24 109.483 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.86 163.28 16.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 121.599 -0.942 . . . . 72.41 110.759 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -138.88 -172.76 3.39 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.933 2.493 . . . . 74.11 109.502 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -71.65 -19.48 62.09 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 55.34 113.014 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 -31.52 10.74 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.446 -1.062 . . . . 75.43 110.446 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.41 -95.69 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.522 2.011 . . . . 73.41 108.416 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.68 135.2 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.695 2.263 . . . . 75.35 111.532 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.93 122.99 28.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.588 0.755 . . . . 73.32 109.103 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -61.13 121.34 12.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.044 0.538 . . . . 74.04 110.26 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.0 165.89 14.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.945 0.898 . . . . 75.22 109.526 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -129.98 157.37 42.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.803 1.241 . . . . 75.14 109.103 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.43 171.17 9.93 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.726 0.81 . . . . 72.22 109.487 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.05 -25.34 66.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.975 0.731 . . . . 75.31 112.975 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -71.63 -25.18 62.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.081 1.353 . . . . 74.33 110.668 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.35 17.73 9.74 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 125.085 1.326 . . . . 74.35 113.612 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -94.53 145.95 24.45 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.771 1.786 . . . . 73.14 110.253 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.16 146.64 54.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.553 -0.906 . . . . 73.14 108.553 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.09 -16.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.998 1.481 . . . . 75.45 114.998 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.65 164.17 29.07 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 120.062 1.301 . . . . 55.24 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.7 5.68 23.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.381 1.091 . . . . 74.22 112.445 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -166.29 145.55 5.87 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.503 2.321 . . . . 74.05 107.055 156.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -168.59 -179.76 3.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.96 1.304 . . . . 75.01 108.433 168.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -120.11 161.52 20.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.924 0.89 . . . . 60.45 108.94 160.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 120.79 14.07 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.129 -1.434 . . . . 72.33 107.129 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.39 134.33 45.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.197 -1.038 . . . . 73.04 108.197 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.13 91.35 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.315 -1.735 . . . . 75.41 106.315 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -100.58 46.08 0.96 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.136 0.974 . . . . 75.23 109.591 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -150.35 163.39 38.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.536 1.134 . . . . 75.33 108.411 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.7 -35.92 73.0 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.191 -0.943 . . . . 74.15 110.802 169.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.2 p -140.23 152.3 45.84 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.071 0.948 . . . . 72.43 110.951 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mmm -153.08 172.46 16.84 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 126.571 1.948 . . . . 63.32 111.326 -168.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -167.4 166.09 14.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.418 1.887 . . . . 63.43 111.163 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -156.98 160.87 39.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.921 2.888 . . . . 60.42 106.983 160.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.82 -179.78 6.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.478 0.656 . . . . 73.33 111.658 165.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -123.85 -176.87 3.58 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.784 1.634 . . . . 72.22 110.148 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.17 157.49 26.86 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.657 0.741 . . . . 75.25 111.735 173.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.69 96.53 0.1 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.015 2.245 . . . . 72.44 108.607 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 178.78 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 130.874 3.67 . . . . 75.11 105.731 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.4 173.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.648 1.979 . . . . 63.13 114.857 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -134.88 -12.47 2.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.711 2.005 . . . . 75.2 113.757 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -158.21 174.41 15.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.43 1.014 . . . . 73.14 108.887 166.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.3 ttt -137.81 155.13 49.34 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.635 1.974 . . . . 74.34 106.65 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -143.94 167.03 23.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.875 0.761 . . . . 73.02 110.72 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.0 t -143.9 29.61 1.35 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.614 2.766 . . . . 72.03 109.351 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.08 113.14 3.72 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 72.21 109.209 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.49 -154.13 8.08 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 110.367 -1.093 . . . . 62.21 110.367 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -154.51 171.73 18.93 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.702 0.763 . . . . 60.12 111.477 155.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG13 ' CE1' ' A' ' 23' ' ' PHE . 93.9 t -120.97 145.58 27.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 125.932 1.693 . . . . 74.22 107.983 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.1 t -151.87 160.67 43.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.506 0.594 . . . . 75.41 111.173 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 t -140.69 158.77 43.5 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.927 1.691 . . . . 71.43 109.057 166.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.85 24.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 126.69 1.996 . . . . 73.25 110.032 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -97.08 -176.48 3.56 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.494 1.043 . . . . 73.11 110.595 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.32 167.73 3.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.238 1.415 . . . . 72.43 110.276 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.92 167.16 1.26 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.958 1.303 . . . . 74.02 112.937 159.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 -13.07 52.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 117.753 -1.582 . . . . 72.13 114.776 168.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -57.11 161.13 3.28 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 119.432 1.616 . . . . 64.42 108.413 159.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -140.16 162.0 36.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.627 -1.249 . . . . 74.41 107.627 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.34 145.57 22.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.596 -1.261 . . . . 60.25 107.596 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -140.69 117.99 11.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.65 -1.982 . . . . 60.15 105.65 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mm -96.52 151.22 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 72.32 108.508 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -139.11 131.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.648 -1.612 . . . . 71.14 106.648 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.3 126.38 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.399 1.479 . . . . 73.45 109.114 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.88 140.32 46.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.597 -1.631 . . . . 75.34 106.597 -173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.75 133.13 6.9 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.224 -1.15 . . . . 72.22 110.224 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -120.24 154.59 34.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.286 1.834 . . . . 75.34 109.973 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.8 mt -148.62 137.19 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.803 2.041 . . . . 72.3 105.693 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t0 44.52 53.88 6.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.19 1.796 . . . . 75.3 111.982 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.27 23.87 14.05 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.038 1.735 . . . . 72.34 113.969 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -132.52 153.78 50.61 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 120.751 -1.218 . . . . 71.42 111.923 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.78 145.6 46.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.95 -1.5 . . . . 74.03 106.95 164.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.43 -6.14 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.618 -0.706 . . . . 60.12 112.847 161.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -159.77 143.47 14.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.542 1.519 . . . . 75.4 110.046 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -165.45 124.47 1.7 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.511 -0.922 . . . . 74.03 108.511 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.57 169.14 18.32 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.106 0.879 . . . . 75.12 110.932 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -126.59 171.61 10.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.274 . . . . 73.44 108.703 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 161.13 43.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.303 -0.629 . . . . 75.15 109.303 166.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -127.37 135.89 51.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.26 151.77 48.89 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.509 1.124 . . . . 73.41 108.581 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -143.62 124.46 10.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.361 -2.089 . . . . 75.34 105.361 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -64.13 130.41 43.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.329 -0.619 . . . . 73.14 109.329 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -105.4 -1.18 25.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.081 1.352 . . . . 74.32 111.863 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.33 -24.65 10.38 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.46 1.505 . . . . 74.23 111.129 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -82.22 163.63 21.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.009 0.923 . . . . 75.35 109.531 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.13 106.18 1.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.426 1.09 . . . . 74.32 110.296 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 131.55 46.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.618 -0.882 . . . . 73.41 108.618 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 mt -148.87 138.36 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.708 1.603 . . . . 73.21 107.715 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.8 170.13 4.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.051 1.74 . . . . 64.02 110.164 -171.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.4 p -141.55 170.41 15.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.471 2.308 . . . . 75.05 108.161 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.8 164.88 38.18 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.097 1.759 . . . . 75.12 107.61 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.4 p -152.64 123.73 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.186 -0.946 . . . . 72.23 110.475 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.7 t -135.67 92.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.755 -2.313 . . . . 74.24 104.755 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.53 148.59 24.05 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.342 -1.725 . . . . 74.23 106.342 163.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.1 p -110.71 29.39 7.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.089 0.956 . . . . 74.0 110.113 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 105.8 -1.926 . . . . 75.21 105.8 166.5 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.712 -1.218 . . . . 74.43 107.712 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.29 -98.24 0.3 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 106.777 -2.529 . . . . 73.32 106.777 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.89 159.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.337 1.855 . . . . 73.34 107.093 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -125.57 137.5 53.92 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.446 1.899 . . . . 74.45 107.579 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.93 150.52 44.64 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.251 -0.906 . . . . 75.33 108.887 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mm -140.74 150.34 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 105.748 -1.945 . . . . 75.33 105.748 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.26 132.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 127.221 2.209 . . . . 71.35 106.861 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.33 153.13 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 107.699 -1.223 . . . . 73.21 107.699 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -141.49 163.48 32.83 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.067 0.947 . . . . 75.23 109.53 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.28 156.15 39.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.86 1.264 . . . . 60.43 108.824 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -159.17 147.88 18.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.498 1.519 . . . . 61.44 109.92 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.89 -131.39 6.61 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.783 -0.927 . . . . 73.03 110.783 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -71.94 50.5 0.2 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.845 2.858 . . . . 74.32 113.577 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -63.22 7.19 0.1 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 74.14 114.552 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.08 -18.01 12.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.779 2.032 . . . . 75.02 112.062 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.34 36.64 3.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.755 2.022 . . . . 75.12 112.111 -169.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -123.42 155.47 37.36 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.466 1.106 . . . . 71.03 108.689 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.51 121.0 29.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.93 -1.878 . . . . 73.5 105.93 171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.4 t -137.84 106.84 4.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.081 -1.822 . . . . 75.45 106.081 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 112.32 20.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.015 -1.476 . . . . 75.11 107.015 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.34 135.09 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.285 -1.746 . . . . 74.25 106.285 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -90.82 139.14 31.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.952 2.101 . . . . 75.24 107.778 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.42 133.1 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.293 -2.114 . . . . 75.45 105.293 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.16 168.18 41.12 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.965 2.221 . . . . 63.43 108.976 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.68 175.74 39.85 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.074 -2.01 . . . . 73.21 108.074 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.25 157.32 31.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.403 1.101 . . . . 53.21 109.487 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.59 -171.13 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.956 1.702 . . . . 74.25 111.852 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -78.06 64.01 3.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.713 1.205 . . . . 74.15 110.101 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.21 3.1 1.97 Allowed Glycine 0 CA--C 1.517 0.172 0 CA-C-O 118.0 -1.444 . . . . 53.04 113.798 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.26 35.16 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 119.709 1.754 . . . . 74.34 112.588 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.86 144.3 24.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.467 2.778 . . . . 74.21 109.14 162.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.42 115.42 16.15 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.502 1.121 . . . . 72.55 109.699 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.31 128.7 36.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.382 0.992 . . . . 75.51 108.543 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 166.49 11.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.008 0.923 . . . . 73.44 109.732 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.7 155.73 42.22 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.758 1.623 . . . . 73.21 111.07 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.93 169.16 9.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.57 -1.65 . . . . 64.54 110.238 166.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.13 5.57 2.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.726 1.611 . . . . 73.52 112.908 -170.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -90.4 -8.88 49.5 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.488 1.515 . . . . 74.43 111.133 168.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.17 17.37 69.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.961 -0.911 . . . . 60.35 112.974 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.35 147.0 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.126 1.463 . . . . 62.54 108.522 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -75.0 159.58 31.6 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.03 -0.73 . . . . 73.24 109.03 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -144.88 23.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.73 0.812 . . . . 71.53 112.799 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.92 -176.99 16.51 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.41 -1.476 . . . . 64.41 109.41 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -121.15 11.51 10.9 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.538 1.135 . . . . 73.42 111.876 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -169.39 150.65 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.902 1.281 . . . . 75.54 110.459 165.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -176.19 -175.15 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.454 1.502 . . . . 63.45 109.218 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -141.21 102.84 4.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.113 0.965 . . . . 64.25 109.689 172.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.24 115.4 21.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.766 -0.828 . . . . 73.55 108.766 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -66.23 142.39 57.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.844 -1.169 . . . . 72.41 107.844 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -82.8 120.96 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.065 -1.828 . . . . 75.42 106.065 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -142.51 43.55 1.62 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.573 1.549 . . . . 74.42 108.961 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p -146.24 168.72 20.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.986 -1.116 . . . . 73.3 107.986 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.09 72.09 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.624 -0.672 . . . . 73.14 111.661 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -154.26 162.14 41.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.37 1.068 . . . . 74.23 108.971 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 mmm -143.38 171.72 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.75 2.82 . . . . 74.23 110.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.17 166.63 23.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.291 1.436 . . . . 61.12 110.928 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.3 m -149.9 167.64 26.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.999 2.519 . . . . 74.55 107.963 160.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.67 -174.89 4.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.853 1.261 . . . . 52.32 111.007 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.8 p -128.43 175.77 8.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.278 1.831 . . . . 74.34 109.748 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.85 -169.48 2.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.55 -0.908 . . . . 73.15 108.55 159.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 37.54 0.54 Allowed Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.833 -1.167 . . . . 61.42 113.976 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -140.73 78.14 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.158 1.383 . . . . 63.53 107.572 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.55 34.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.525 1.53 . . . . 74.14 109.954 159.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.46 -9.13 9.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.037 1.735 . . . . 75.31 111.693 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -161.49 172.37 16.54 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.608 -1.256 . . . . 75.44 107.608 167.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.9 ttt -152.59 111.67 3.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.462 -2.051 . . . . 75.45 105.462 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -95.51 154.62 17.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.53 110.026 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.556 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.6 OUTLIER -137.18 90.92 2.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.962 2.105 . . . . 63.24 105.498 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.79 46.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.93 -152.79 6.49 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 109.935 -1.266 . . . . 71.14 109.935 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.38 168.13 23.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.163 -1.051 . . . . 73.45 108.163 156.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.63 148.08 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.988 1.315 . . . . 75.32 108.844 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.88 171.32 14.99 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.296 -0.631 . . . . 63.11 109.296 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.8 t -151.38 149.44 29.31 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.374 -1.713 . . . . 75.41 106.374 163.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.44 10.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 124.526 1.131 . . . . 74.12 110.031 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -80.48 -173.54 4.15 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.034 0.934 . . . . 63.41 111.321 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -72.08 163.44 27.89 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.983 -0.448 . . . . 74.41 111.387 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 162.27 3.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.701 1.6 . . . . 72.2 113.539 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.33 4.33 90.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.431 1.015 . . . . 62.1 114.36 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -83.63 163.91 20.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.349 -1.352 . . . . 74.4 107.349 168.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -153.35 153.24 32.2 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.307 -0.854 . . . . 75.02 110.812 -163.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.9 tp -154.95 136.43 14.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.843 -1.54 . . . . 74.44 106.843 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -136.93 97.8 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.453 1.501 . . . . 74.34 108.775 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.43 132.42 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.916 1.286 . . . . 74.24 108.176 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.0 m -110.2 147.55 33.54 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.269 -1.012 . . . . 60.41 108.269 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.76 103.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.064 1.746 . . . . 74.53 110.201 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.4 mt -112.59 157.43 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 107.472 -1.307 . . . . 63.31 107.472 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.71 132.81 4.56 Favored Glycine 0 C--N 1.336 0.529 0 O-C-N 120.454 -1.404 . . . . 53.05 111.324 -170.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.01 147.83 48.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.44 1.496 . . . . 75.24 111.455 -170.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 128.939 2.895 . . . . 74.35 105.161 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.63 63.49 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.771 1.229 . . . . 51.43 111.749 164.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.42 18.75 5.85 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.414 2.286 . . . . 72.32 116.101 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.11 151.77 46.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.316 -1.49 . . . . 74.34 112.552 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -86.81 136.46 32.97 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.433 -1.321 . . . . 75.13 107.433 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.42 -10.51 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 73.33 113.12 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -144.9 141.02 28.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.737 1.153 . . . . 73.53 107.907 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.94 132.04 9.99 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.602 -0.518 . . . . 73.33 109.602 167.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.16 -175.8 4.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.575 0.702 . . . . 64.45 109.861 160.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.8 179.87 7.52 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.832 2.053 . . . . 74.34 108.399 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 176.22 12.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.05 -1.463 . . . . 63.42 107.05 171.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -147.29 137.88 23.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.391 -1.337 . . . . 75.25 107.391 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.22 157.45 46.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.571 0.748 . . . . 61.41 110.213 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mt -147.02 142.95 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.221 -1.77 . . . . 72.04 106.221 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -82.48 147.3 28.78 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 118.92 0.782 . . . . 73.43 110.394 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.57 26.25 2.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.923 0.868 . . . . 74.41 112.235 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.9 -16.02 61.36 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.196 1.855 . . . . 74.11 111.883 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -83.17 171.68 13.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.076 1.35 . . . . 75.11 109.463 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.69 111.09 2.25 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.855 -1.153 . . . . 72.11 109.425 162.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -73.12 132.23 43.03 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.808 -1.923 . . . . 75.31 105.808 163.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.3 mt -154.31 148.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.375 -2.454 . . . . 61.23 104.375 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.16 173.17 10.49 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.849 1.66 . . . . 71.53 109.357 168.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.0 p -129.33 172.95 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.234 1.492 . . . . 74.41 108.09 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.87 154.41 29.76 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 126.675 1.99 . . . . 72.25 106.103 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.4 p -155.97 127.13 7.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.228 0.537 . . . . 75.15 110.222 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 15.0 p -133.03 152.35 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.317 1.447 . . . . 74.34 107.874 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.6 t -134.82 -175.75 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.996 -1.113 . . . . 35.22 107.996 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.0 p -134.05 38.74 3.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.571 1.149 . . . . 75.45 109.061 167.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 107.532 -1.284 . . . . 75.43 107.532 166.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 107.703 -1.221 . . . . 70.23 107.703 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.76 -106.23 0.24 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 107.684 -2.166 . . . . 72.13 107.684 -172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.38 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 N-CA-C 106.129 -1.804 . . . . 72.4 106.129 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.99 143.44 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.497 -0.927 . . . . 74.02 108.497 171.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 162.84 34.39 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.171 0.588 . . . . 74.52 109.98 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 mm -129.66 153.24 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.065 1.746 . . . . 72.43 107.322 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 t -124.66 134.57 66.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 104.128 -2.545 . . . . 74.44 104.128 163.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 105.972 -1.862 . . . . 74.35 105.972 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.15 165.85 17.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.671 -0.492 . . . . 72.45 109.671 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.03 155.56 40.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.692 0.62 . . . . 73.34 111.623 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.0 m -145.1 142.94 30.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.578 1.151 . . . . 62.52 108.328 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.52 -150.71 23.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.29 -0.881 . . . . 74.42 111.545 -169.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.4 68.82 9.87 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.781 2.032 . . . . 72.12 107.258 170.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -78.79 24.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.174 1.546 . . . . 74.42 115.174 -158.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -135.33 12.82 3.53 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.47 1.108 . . . . 61.25 110.427 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -131.81 17.44 4.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 62.55 111.87 -168.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -133.25 130.19 38.67 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.366 0.985 . . . . 73.43 109.433 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -89.73 68.29 7.51 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.256 1.822 . . . . 74.41 109.069 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.31 92.08 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 127.518 2.327 . . . . 65.32 113.173 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -89.57 139.62 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.745 1.157 . . . . 73.34 109.519 165.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.56 164.5 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.345 -0.983 . . . . 74.14 108.345 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -127.23 129.83 48.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.868 2.867 . . . . 73.44 105.499 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.53 121.27 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.54 -1.652 . . . . 72.03 106.54 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.18 172.44 38.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.63 1.11 . . . . 51.11 110.392 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.2 176.26 43.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.11 1.338 . . . . 73.35 110.01 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.01 46.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.262 0.625 . . . . 70.05 111.884 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' CG ' HD21 ' A' ' 68' ' ' ASN . 2.7 p30 -130.92 139.35 50.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.945 2.098 . . . . 63.0 110.865 162.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.308 16.1 ttpp 43.16 32.93 0.5 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.521 1.929 . . . . 63.44 114.308 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 33.98 23.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.529 -0.732 . . . . 71.44 111.86 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.69 175.23 36.57 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.314 1.911 . . . . 74.13 109.856 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 152.04 45.59 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 74.23 112.492 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.09 130.61 56.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.44 1.096 . . . . 74.33 110.627 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -64.06 116.68 6.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.087 0.858 . . . . 72.23 110.612 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -96.05 158.58 15.38 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.921 2.088 . . . . 70.31 109.51 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.84 139.83 50.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.021 1.328 . . . . 73.21 110.988 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -78.35 177.19 8.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 113.748 -1.569 . . . . 74.15 110.777 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.11 -5.62 18.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.535 1.534 . . . . 74.34 114.51 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -114.19 20.63 15.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.122 1.769 . . . . 74.33 110.938 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.41 8.24 87.06 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 124.306 0.955 . . . . 72.23 114.379 162.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.52 149.45 26.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.826 2.45 . . . . 74.53 108.849 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -76.1 161.46 28.83 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.421 -0.585 . . . . 74.25 109.421 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.36 -11.83 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.787 0.835 . . . . 72.11 112.359 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.36 -171.39 35.83 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 109.055 -1.618 . . . . 70.34 109.055 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -110.05 3.02 19.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.143 1.777 . . . . 70.11 111.181 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 p -173.36 117.11 0.27 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.53 1.132 . . . . 65.15 109.292 -166.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -171.48 -178.27 2.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.291 0.95 . . . . 73.23 111.177 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.93 161.78 18.8 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.702 1.601 . . . . 72.43 109.593 166.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.7 29.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.319 1.448 . . . . 70.32 107.586 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -111.81 141.19 45.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.926 2.09 . . . . 73.04 110.299 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.79 86.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 121.035 1.743 . . . . 72.25 110.317 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.66 18.63 20.63 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.889 0.876 . . . . 74.35 112.363 175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -117.32 158.98 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.92 1.288 . . . . 61.31 108.782 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -49.94 62.07 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.543 -0.723 . . . . 75.45 109.125 168.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.5 p -141.29 113.77 8.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.398 0.679 . . . . 74.35 110.736 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mmm -115.18 167.98 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.113 2.165 . . . . 71.43 111.145 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.1 p -150.96 165.65 33.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.03 0.932 . . . . 71.14 110.524 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 m -143.88 159.14 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.594 -1.632 . . . . 73.54 106.594 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.5 p -148.09 -168.2 3.01 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.816 0.735 . . . . 64.32 109.792 166.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 t -124.7 179.25 5.05 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.893 1.677 . . . . 71.43 106.971 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.53 -176.39 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.831 0.853 . . . . 65.03 109.427 163.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.09 23.75 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.157 -0.802 . . . . 72.41 113.324 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.413 HD21 ' CG ' ' A' ' 33' ' ' ASP . 6.0 t30 -135.23 94.68 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.598 -1.63 . . . . 72.14 106.598 -175.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.32 158.99 16.77 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.957 1.303 . . . . 71.04 110.02 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -114.12 -28.06 7.45 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.453 1.501 . . . . 74.02 112.214 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.75 170.49 19.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.512 -1.292 . . . . 74.13 107.512 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 ttt -146.93 154.09 40.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 102.935 -2.987 . . . . 74.35 102.935 171.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.0 t -140.78 149.02 41.55 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.234 -0.916 . . . . 70.02 110.421 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -125.6 66.09 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.119 -1.808 . . . . 72.23 106.119 -177.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.86 143.73 55.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.974 -1.491 . . . . 74.21 106.974 167.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.28 178.73 43.5 Favored Glycine 0 CA--C 1.509 -0.309 0 CA-C-N 119.999 1.272 . . . . 65.25 111.987 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -142.5 159.21 42.67 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.556 1.142 . . . . 74.05 110.38 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.81 131.59 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.232 -1.395 . . . . 73.15 107.232 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -137.92 169.3 18.02 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.931 -0.557 . . . . 64.12 110.379 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -142.09 169.88 16.75 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.539 1.136 . . . . 65.35 109.921 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.96 0.55 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.358 2.663 . . . . 64.43 111.244 167.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -73.81 177.47 5.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.682 1.193 . . . . 61.32 109.866 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -68.79 174.14 4.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.897 0.879 . . . . 53.41 111.817 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.32 158.52 23.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.785 2.034 . . . . 71.11 112.763 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.36 -0.4 41.19 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.605 1.098 . . . . 42.14 114.337 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -70.58 131.25 43.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 104.916 -2.253 . . . . 70.25 104.916 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -111.39 162.02 15.49 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.412 0.685 . . . . 75.41 109.47 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.17 121.43 1.43 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 105.905 -1.887 . . . . 65.42 105.905 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -111.3 137.06 49.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.311 -1.737 . . . . 74.34 106.311 169.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 mm -117.73 121.63 67.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.702 -1.592 . . . . 74.34 106.702 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -95.09 131.03 41.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.896 -1.891 . . . . 75.53 105.896 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.11 104.05 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.939 1.296 . . . . 73.33 110.176 -174.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.26 152.71 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 75.51 108.338 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.61 152.88 22.27 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 124.456 1.027 . . . . 71.22 112.403 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -136.45 155.25 50.26 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.953 1.301 . . . . 75.24 110.826 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -130.32 83.24 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.104 -1.813 . . . . 74.33 106.104 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.285 3.0 p-10 49.64 7.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 1 C-N-CA 132.126 4.17 . . . . 73.11 117.369 162.02 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.86 -41.34 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.767 2.027 . . . . 72.14 109.644 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 158.66 44.13 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.595 1.158 . . . . 71.43 110.603 -167.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.44 146.79 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.444 -2.428 . . . . 71.5 104.444 163.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.68 -3.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 123.448 0.699 . . . . 73.31 110.836 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -156.77 141.06 16.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.047 -1.033 . . . . 72.24 108.496 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.95 129.27 12.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.995 -1.113 . . . . 70.24 107.995 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -132.49 160.58 36.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.286 -1.005 . . . . 71.45 108.286 163.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -145.39 121.79 10.97 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.126 -1.805 . . . . 72.22 106.126 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -131.31 161.56 32.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.658 0.663 . . . . 72.25 109.892 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.82 156.17 47.55 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 126.625 1.97 . . . . 74.54 110.839 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -151.63 124.79 8.72 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.891 1.677 . . . . 71.31 107.092 -165.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -135.7 130.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.536 -1.283 . . . . 74.14 107.536 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -72.26 152.96 41.83 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.437 1.095 . . . . 72.22 110.0 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -148.31 28.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.38 -0.825 . . . . 73.33 111.966 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.94 -48.63 0.92 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.517 1.532 . . . . 71.33 109.793 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -74.76 173.42 10.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.915 1.286 . . . . 71.05 112.441 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -72.43 100.46 2.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.34 -1.355 . . . . 71.33 107.34 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.68 134.58 57.22 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.157 -0.925 . . . . 72.21 108.824 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 mt -152.57 133.5 4.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.526 1.53 . . . . 74.12 107.881 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 74.02 112.071 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 p -144.12 150.72 38.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.115 0.966 . . . . 73.23 112.196 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -133.3 173.85 11.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.595 1.558 . . . . 72.31 110.191 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 p -156.39 119.73 4.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.253 1.021 . . . . 72.42 108.611 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.497 ' CG1' ' HB3' ' A' ' 74' ' ' CYS 0.313 10.4 p -121.88 86.42 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.964 1.364 . . . . 64.04 109.106 174.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 p -70.21 173.4 6.73 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.216 1.406 . . . . 63.25 110.127 164.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 p -130.55 9.69 5.11 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.316 -0.865 . . . . 70.23 112.877 166.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 tptt . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 105.852 -1.907 . . . . 74.14 105.852 177.181 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.4 p . . . . . 0 C--O 1.237 0.433 0 N-CA-C 110.446 -0.205 . . . . 73.51 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.57 -116.82 1.98 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 106.572 -2.611 . . . . 74.22 106.572 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.93 128.99 68.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.535 -1.283 . . . . 74.24 107.535 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -97.85 157.96 15.79 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.541 -0.911 . . . . 65.2 108.541 171.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -143.1 150.42 39.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.815 -1.55 . . . . 74.33 106.815 167.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.58 155.45 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 106.197 -1.779 . . . . 73.44 106.197 165.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.59 126.17 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.434 -2.432 . . . . 74.11 104.434 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.1 mt -121.93 154.27 26.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.582 -1.636 . . . . 73.13 106.582 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.12 168.22 20.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.457 0.572 . . . . 70.12 110.331 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -148.25 158.87 44.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.939 1.296 . . . . 74.33 109.193 164.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.175 1.39 . . . . 72.13 107.509 163.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.87 -120.04 4.12 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.463 -1.455 . . . . 54.23 109.463 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -96.22 118.09 32.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.275 -1.38 . . . . 70.44 107.275 159.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.5 p -100.54 -5.78 26.37 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.139 0.975 . . . . 74.12 112.108 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -37.32 38.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.07 0.948 . . . . 75.23 110.133 -169.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.33 18.74 13.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.533 1.133 . . . . 73.21 112.754 -161.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -121.44 113.4 19.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.693 0.797 . . . . 73.3 111.021 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.89 136.65 36.72 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.892 1.677 . . . . 72.04 108.112 168.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -148.77 106.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 105.497 -2.038 . . . . 74.01 105.497 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -114.96 123.51 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.421 1.009 . . . . 73.04 108.946 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.52 140.92 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.033 1.333 . . . . 74.23 110.036 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -76.12 145.41 40.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.857 -1.905 . . . . 73.44 105.857 157.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mt -127.57 110.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 104.962 -2.236 . . . . 72.43 104.962 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.67 172.41 35.54 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.91 -0.586 . . . . 65.51 111.774 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.35 41.74 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 128.014 2.721 . . . . 71.2 108.597 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.49 34.41 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.89 1.276 . . . . 72.24 109.792 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.07 -177.46 4.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.117 1.367 . . . . 74.5 112.501 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.98 79.25 0.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.708 -0.849 . . . . 72.11 108.708 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.12 -65.02 0.29 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.268 -1.933 . . . . 71.33 108.268 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.34 -154.32 6.87 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.849 1.214 . . . . 73.22 110.586 -156.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -67.04 142.25 60.97 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.526 2.151 . . . . 54.23 109.868 172.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.9 130.3 39.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.79 -1.189 . . . . 64.33 107.79 172.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -59.47 137.73 57.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.968 -0.539 . . . . 72.1 109.592 168.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.45 154.56 23.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.572 1.149 . . . . 73.51 109.081 170.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -132.65 154.19 50.35 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.136 1.374 . . . . 74.1 108.737 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -77.63 178.28 7.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.726 1.61 . . . . 75.11 110.721 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.18 8.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.092 1.357 . . . . 62.44 113.551 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -119.18 -6.02 10.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.549 2.74 . . . . 75.42 111.147 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 9.38 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.304 -1.276 . . . . 60.22 114.576 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.66 142.25 27.66 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.528 2.164 . . . . 74.12 110.142 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -62.07 136.58 58.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.744 1.618 . . . . 72.22 110.856 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.38 9.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.562 0.949 . . . . 74.42 113.562 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.17 171.25 12.24 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.665 -1.374 . . . . 62.22 109.665 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.1 p30 -103.11 1.56 33.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.231 1.012 . . . . 74.4 110.774 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -159.14 129.04 5.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.238 2.215 . . . . 61.5 107.671 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -161.87 -179.64 7.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.69 1.196 . . . . 74.22 109.216 161.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 p -117.13 161.68 19.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.143 1.377 . . . . 74.22 109.614 159.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.02 166.7 24.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.834 0.854 . . . . 74.31 109.175 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -114.9 139.91 49.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.621 1.168 . . . . 70.2 111.033 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mm -82.04 72.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 107.288 -1.375 . . . . 65.22 107.288 172.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 17.06 7.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.088 1.355 . . . . 75.42 111.527 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 p -137.65 147.07 44.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.998 -0.741 . . . . 73.14 108.998 -171.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.92 66.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.152 0.981 . . . . 74.41 110.633 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.6 p -135.05 162.56 32.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.153 -1.055 . . . . 71.31 108.153 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.9 169.46 24.53 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.095 1.758 . . . . 74.04 109.388 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.66 148.61 6.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.125 1.37 . . . . 75.44 110.671 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 64.7 m -134.99 150.8 50.4 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.55 -0.907 . . . . 74.34 108.55 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.2 p -142.9 -179.08 6.14 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.287 0.635 . . . . 73.14 112.09 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.3 p -132.26 -177.72 4.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.883 1.673 . . . . 73.31 109.438 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.76 -173.98 2.43 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.031 -1.1 . . . . 74.21 108.031 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.0 -13.43 26.8 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.697 -0.627 . . . . 53.12 114.362 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -88.23 83.75 6.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.458 1.129 . . . . 73.5 108.774 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.29 178.03 7.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.343 1.057 . . . . 73.21 110.961 157.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.75 -22.34 4.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.357 1.463 . . . . 74.32 112.81 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.48 177.21 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.353 1.461 . . . . 73.32 109.272 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.5 ttt -147.44 154.1 40.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.914 1.685 . . . . 73.2 106.589 163.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 t -128.34 155.55 44.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 74.43 109.905 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.518 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -140.51 42.37 1.88 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.629 2.371 . . . . 63.33 109.904 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 120' ' ' SER . . . -69.09 142.39 54.48 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.048 -1.032 . . . . 72.22 110.971 165.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.78 -176.03 39.81 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.852 -0.899 . . . . 73.44 110.852 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 86.7 p -131.81 167.53 19.4 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.076 0.95 . . . . 72.54 110.53 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.68 153.3 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.224 -1.399 . . . . 73.3 107.224 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p -159.79 142.89 14.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.254 0.934 . . . . 72.34 111.705 166.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -148.37 159.79 43.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.233 1.413 . . . . 64.13 108.509 173.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.86 25.75 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.267 1.827 . . . . 73.12 110.163 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -73.61 -159.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.075 1.35 . . . . 73.43 110.394 174.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -83.99 169.02 15.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.156 0.982 . . . . 72.42 110.136 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 162.47 7.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 73.34 112.028 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.83 -2.27 80.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.276 1.417 . . . . 54.5 113.891 174.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -72.79 115.62 12.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.617 1.709 . . . . 74.41 106.658 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -96.05 164.81 12.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.638 -0.875 . . . . 74.32 108.638 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.1 tp -155.78 147.59 23.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.963 0.801 . . . . 72.32 109.035 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -148.15 98.17 2.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.813 1.645 . . . . 71.33 108.255 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.74 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.997 2.119 . . . . 71.4 108.124 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -128.19 146.46 50.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.103 1.361 . . . . 72.41 108.383 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.34 105.97 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.573 1.949 . . . . 74.14 110.749 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.02 139.05 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.198 1.399 . . . . 45.33 108.995 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.31 146.21 17.91 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.658 1.123 . . . . 64.32 111.464 -166.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -131.85 157.62 43.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.252 1.421 . . . . 73.34 110.2 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -131.41 130.76 63.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.949 -2.241 . . . . 73.44 104.949 167.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.65 -76.44 0.06 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.6 2.36 . . . . 70.23 111.031 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -149.37 1.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.519 1.928 . . . . 71.13 112.664 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.88 145.63 50.17 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.621 1.1 . . . . 71.42 111.412 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.81 126.08 33.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.353 1.461 . . . . 73.13 109.883 -172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.43 -1.44 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.687 0.995 . . . . 74.32 113.687 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -154.51 128.01 8.56 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 74.22 108.184 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.42 123.73 18.07 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.127 0.876 . . . . 71.43 110.204 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.43 175.11 9.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.562 0.696 . . . . 74.22 110.47 160.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.25 173.88 15.0 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.836 2.854 . . . . 71.04 107.104 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.48 176.0 9.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.062 0.945 . . . . 74.42 108.76 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -139.17 137.98 36.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.68 -1.23 . . . . 74.03 107.68 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.602 ' HH ' ' CD ' ' A' ' 117' ' ' GLU . 2.1 m-85 -132.43 160.88 35.12 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.138 -1.06 . . . . 73.23 108.138 170.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -143.51 148.11 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.646 -1.983 . . . . 74.43 105.646 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.4 p -76.32 139.35 41.0 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.038 -1.097 . . . . 73.33 108.038 164.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.91 2.9 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.194 1.398 . . . . 70.11 111.124 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.28 38.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.866 1.698 . . . . 53.35 111.366 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -90.6 159.99 16.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.682 1.241 . . . . 71.4 107.687 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.1 113.14 1.77 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.975 0.91 . . . . 74.33 109.775 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.82 130.24 41.75 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.55 -1.278 . . . . 72.22 107.55 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -162.18 153.73 3.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 103.901 -2.629 . . . . 73.23 103.901 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.602 ' CD ' ' HH ' ' A' ' 108' ' ' TYR . 1.3 pp20? -165.58 176.15 8.35 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.004 2.121 . . . . 74.22 106.512 160.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.2 p -141.87 142.24 33.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.067 -0.716 . . . . 54.22 109.067 167.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -125.92 169.02 13.1 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.512 1.525 . . . . 73.22 109.865 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 10.5 p -170.23 143.11 2.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.362 1.065 . . . . 70.43 108.731 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 6.3 p -162.77 128.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 102.641 -3.096 . . . . 74.34 102.641 -167.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 m -134.85 143.42 47.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.686 -1.227 . . . . 74.23 107.686 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.84 -16.71 58.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.325 -0.55 . . . . 64.1 111.28 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.7 tptm . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 105.888 -1.893 . . . . 71.41 105.888 171.462 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.745 0.307 . . . . 72.1 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.98 -129.15 6.91 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.642 -2.183 . . . . 64.23 107.642 -162.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.0 123.08 50.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.904 1.682 . . . . 73.54 110.427 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -95.11 147.06 23.84 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.504 1.122 . . . . 73.5 109.426 170.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -148.88 151.81 35.34 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.113 0.965 . . . . 72.2 109.044 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.25 149.46 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.702 2.401 . . . . 74.23 106.572 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.19 131.76 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.345 -2.094 . . . . 74.44 105.345 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.7 mt -127.96 149.01 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.877 -1.527 . . . . 74.11 106.877 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -145.58 161.72 39.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.536 -0.542 . . . . 72.41 109.536 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -153.32 159.86 42.59 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.756 0.788 . . . . 65.03 112.627 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -145.48 174.39 11.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.635 1.574 . . . . 72.13 108.882 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.12 -154.92 19.54 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.885 1.231 . . . . 75.03 110.538 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.12 50.67 0.15 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.09 2.156 . . . . 65.12 111.191 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -54.48 -36.22 63.92 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 129.454 3.102 . . . . 74.23 111.662 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.87 -28.68 64.38 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.645 1.178 . . . . 63.43 111.223 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.7 m -93.33 -0.48 56.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.809 1.644 . . . . 73.23 113.432 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE1' HG13 ' A' ' 78' ' ' VAL . 1.2 t80 -119.77 123.06 42.79 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 123.525 1.631 . . . . 73.42 110.964 -169.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.72 79.48 8.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.001 2.921 . . . . 72.14 110.697 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.467 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 4.0 t -75.88 91.83 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.331 1.453 . . . . 72.03 107.774 176.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -94.98 129.94 41.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.132 -1.433 . . . . 73.23 107.132 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.79 154.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.645 -1.613 . . . . 74.21 106.645 174.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -112.07 152.08 28.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.365 1.066 . . . . 65.41 109.172 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.3 mt -122.15 157.39 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.035 -1.098 . . . . 63.12 108.035 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.96 179.54 48.05 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.824 1.202 . . . . 64.12 110.515 172.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.78 166.89 35.08 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 127.053 2.263 . . . . 65.3 108.438 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.46 165.51 27.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.959 1.379 . . . . 73.03 111.418 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 34' ' ' LYS . 31.7 t70 -140.07 179.24 6.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.498 . . . . 73.24 110.587 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' H ' ' CG ' ' A' ' 33' ' ' ASP . 20.1 ttpp -75.5 72.01 2.47 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.534 1.534 . . . . 70.02 109.536 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.46 -5.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 118.459 -1.189 . . . . 63.12 114.333 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.41 -159.0 27.68 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.27 1.535 . . . . 63.31 110.872 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.35 161.72 41.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.605 2.87 . . . . 65.01 111.856 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.51 121.52 31.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.211 1.404 . . . . 70.44 109.29 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -62.4 153.77 30.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.163 0.892 . . . . 74.14 109.929 168.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -133.26 160.55 36.97 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.702 1.201 . . . . 72.1 109.711 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -138.01 160.55 39.05 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.81 0.844 . . . . 75.53 110.077 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -94.85 -179.4 4.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.156 -0.929 . . . . 61.25 111.399 178.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.35 1.95 3.41 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.826 2.451 . . . . 61.43 113.709 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -112.11 -3.34 14.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.409 1.884 . . . . 74.21 112.908 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 6.19 85.3 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.279 0.942 . . . . 74.31 113.691 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -76.06 144.85 40.54 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.628 1.214 . . . . 73.24 107.856 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 122.96 20.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.362 2.265 . . . . 71.43 109.665 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.9 pt -132.86 9.79 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 115.251 1.575 . . . . 74.22 115.251 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.77 -158.77 23.65 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.302 -1.119 . . . . 71.42 110.302 167.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -128.18 -2.66 5.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.338 1.055 . . . . 74.41 111.911 162.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -151.84 123.06 7.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.601 0.76 . . . . 72.43 109.901 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -173.93 -179.46 1.73 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.678 0.791 . . . . 72.24 109.55 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.7 p -137.19 119.43 15.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.264 1.426 . . . . 61.11 108.012 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.81 111.12 23.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.771 1.629 . . . . 74.12 108.128 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.17 147.9 49.57 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.351 -0.981 . . . . 73.12 108.351 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mm -97.05 125.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.188 -0.671 . . . . 72.12 109.188 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 27.3 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.65 1.98 . . . . 73.21 111.777 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 p -124.8 175.47 7.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.206 1.002 . . . . 73.04 109.033 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.71 66.35 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 64.33 110.182 163.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -137.88 155.62 48.76 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.238 1.015 . . . . 63.03 111.404 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.9 mmm -139.26 167.98 20.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.826 2.051 . . . . 72.11 111.518 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 p -151.56 152.63 33.18 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.122 0.969 . . . . 72.34 110.161 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.6 m -145.69 148.63 33.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.208 1.403 . . . . 71.03 108.349 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.4 p -137.98 174.83 10.15 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.419 0.554 . . . . 73.44 111.295 167.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 p -108.09 168.25 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.535 -0.913 . . . . 73.1 108.535 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.5 169.77 3.6 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.32 108.795 159.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.01 -26.1 67.47 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.08 -0.844 . . . . 72.24 112.302 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.72 90.39 3.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.604 1.702 . . . . 74.43 108.09 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.89 173.35 14.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.038 1.335 . . . . 72.41 110.413 159.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -131.25 -12.79 3.54 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.539 2.336 . . . . 74.12 113.198 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -159.08 170.19 22.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.214 -1.402 . . . . 64.33 107.214 167.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.1 ttt -133.55 155.41 49.65 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 105.452 -2.055 . . . . 74.33 105.452 167.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -130.06 161.2 31.56 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.129 0.572 . . . . 63.04 109.505 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.85 41.64 0.85 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.734 1.214 . . . . 74.21 110.705 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 134.41 56.09 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.327 -0.858 . . . . 64.41 110.284 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.43 179.19 26.42 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.481 -0.648 . . . . 71.21 111.481 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.91 130.93 34.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.917 -1.142 . . . . 65.15 107.917 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 23' ' ' PHE . 90.6 t -90.06 146.66 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.205 -1.035 . . . . 72.41 108.205 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.1 t -150.79 159.36 44.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 118.501 -1.279 . . . . 63.41 110.328 155.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 t -147.88 143.97 27.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.614 -0.884 . . . . 71.23 108.614 164.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 pt -117.84 19.48 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.581 1.952 . . . . 74.21 109.404 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.8 p -79.45 175.69 10.38 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.719 1.208 . . . . 72.11 111.593 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -70.22 167.03 18.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.155 -0.93 . . . . 72.02 110.741 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.63 158.11 10.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.745 2.018 . . . . 70.12 113.055 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.73 -10.2 57.25 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.514 1.53 . . . . 74.14 114.046 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -67.09 159.31 29.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.744 1.617 . . . . 73.05 108.335 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -144.6 170.97 15.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.764 0.826 . . . . 73.11 111.06 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 tp -159.97 162.29 34.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.638 -1.245 . . . . 74.44 107.638 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -145.16 116.69 8.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.595 -1.261 . . . . 70.01 107.595 164.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.14 147.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 124.978 1.311 . . . . 74.01 107.624 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 m -127.7 138.64 52.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.304 -1.739 . . . . 73.35 106.304 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.2 112.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.527 1.931 . . . . 74.22 108.459 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -129.08 150.8 34.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.43 -1.693 . . . . 70.14 106.43 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.62 152.06 22.76 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.182 0.896 . . . . 70.44 111.245 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.54 150.23 46.15 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.795 0.838 . . . . 74.3 111.388 -164.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.8 mt -146.08 136.0 17.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 104.774 -2.306 . . . . 74.4 104.774 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.0 t70 44.5 52.68 7.42 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.744 2.018 . . . . 63.34 113.683 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t0 60.25 25.12 14.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.115 0.966 . . . . 71.13 112.795 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -126.75 156.92 40.4 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.326 -1.484 . . . . 75.12 111.308 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -97.49 119.58 36.29 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.97 1.708 . . . . 74.4 107.267 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.8 m -124.97 -2.6 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.647 0.98 . . . . 73.4 113.647 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -162.36 133.73 5.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.372 -1.344 . . . . 73.22 107.372 -172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.37 118.43 2.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.723 0.692 . . . . 74.33 111.703 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.06 168.83 18.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.59 0.709 . . . . 72.05 110.826 166.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.82 166.47 20.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.589 2.355 . . . . 74.35 108.423 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -149.14 162.33 40.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.835 -0.802 . . . . 74.31 108.835 171.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -147.94 118.37 7.41 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.008 -1.849 . . . . 72.42 106.008 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -118.35 152.9 34.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.661 -0.866 . . . . 72.43 108.661 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.1 mt -138.36 153.77 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.281 1.432 . . . . 74.01 107.32 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -99.45 150.86 21.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.138 0.975 . . . . 72.34 110.214 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -130.45 15.1 5.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.908 1.683 . . . . 71.11 110.9 169.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.04 -24.44 18.81 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.549 1.547 . . . . 61.41 111.635 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 162.86 28.51 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.92 1.288 . . . . 73.32 109.345 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 106.73 2.68 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.254 0.622 . . . . 70.13 110.113 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.85 136.28 58.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.46 -0.941 . . . . 72.05 108.46 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.4 mt -152.68 147.49 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 104.83 -2.285 . . . . 72.33 104.83 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.83 176.49 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.59 1.156 . . . . 71.14 109.467 163.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -131.15 160.87 33.49 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.307 1.043 . . . . 74.11 108.735 163.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -149.16 165.49 31.66 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.207 1.003 . . . . 74.22 108.704 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -165.74 142.07 5.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.447 0.641 . . . . 53.53 111.413 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.4 t -143.89 109.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.049 2.54 . . . . 73.32 104.825 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.1 144.91 29.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.983 -1.488 . . . . 70.11 106.983 169.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.0 p -92.36 44.2 1.15 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.598 1.09 . . . . 74.11 109.011 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.7 tttm . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.795 1.238 . . . . 74.32 108.034 171.54 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 106.934 -1.506 . . . . 75.01 106.934 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.64 -91.1 0.14 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.444 -1.462 . . . . 53.23 109.444 163.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -139.78 110.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 105.824 -1.917 . . . . 74.42 105.824 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -78.23 140.97 38.89 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.544 -1.28 . . . . 74.14 107.544 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -135.74 157.47 46.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.55 -1.648 . . . . 74.34 106.55 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.1 tt -135.41 153.94 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.69 125.91 26.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 105.713 -1.958 . . . . 73.3 105.713 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.0 133.79 63.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 105.529 -2.026 . . . . 72.23 105.529 -170.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -140.68 159.97 41.05 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 119.562 1.074 . . . . 72.33 109.103 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -140.27 150.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.051 0.453 . . . . 75.44 110.76 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -134.34 163.24 30.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.388 -1.338 . . . . 64.41 107.388 158.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -152.15 18.81 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.752 0.691 . . . . 72.44 111.719 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.22 72.07 9.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.399 1.095 . . . . 75.45 109.209 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -70.93 17.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.883 2.073 . . . . 74.53 115.099 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.87 -3.89 5.81 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.866 1.061 . . . . 64.41 113.866 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 t -101.22 1.32 38.83 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.945 0.793 . . . . 74.33 112.942 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -117.81 148.47 42.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.137 0.975 . . . . 74.23 112.112 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -92.29 141.55 28.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.799 -1.926 . . . . 64.31 105.799 163.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.45 81.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 63.31 111.714 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 109.36 21.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.557 0.694 . . . . 75.32 110.366 -167.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 m -91.76 122.29 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.246 1.019 . . . . 73.45 109.695 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -66.77 133.72 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.175 -1.787 . . . . 72.11 106.175 160.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.38 126.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.733 -1.951 . . . . 72.21 105.733 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.22 177.86 38.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.022 0.82 . . . . 63.34 111.896 -171.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.85 167.16 29.08 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.039 2.257 . . . . 62.11 110.179 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.86 162.66 32.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.131 0.972 . . . . 75.24 111.637 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.99 -171.2 2.62 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.766 2.026 . . . . 75.14 112.332 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -78.62 65.74 3.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.586 0.755 . . . . 64.12 111.415 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.85 43.77 0.29 Allowed Glycine 0 C--N 1.323 -0.169 0 O-C-N 121.88 -0.512 . . . . 73.44 111.976 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.54 -154.9 22.75 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.053 -0.859 . . . . 74.23 111.961 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.03 159.78 37.31 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 124.267 3.311 . . . . 73.41 110.721 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.983 -1.118 . . . . 75.34 107.983 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -72.21 141.67 49.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.427 -0.953 . . . . 75.4 108.427 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.63 150.42 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.088 -1.449 . . . . 73.43 107.088 -171.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -131.46 134.22 45.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.542 1.137 . . . . 71.22 108.16 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -77.07 175.78 9.29 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.398 -0.819 . . . . 74.21 109.787 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -5.87 48.13 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 62.04 113.825 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.08 -5.21 50.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.277 1.431 . . . . 75.42 110.445 165.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.51 84.14 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.72 2.105 . . . . 73.32 113.131 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -101.96 142.42 33.27 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.045 1.338 . . . . 71.14 110.24 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -67.54 128.13 35.29 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.55 1.54 . . . . 75.3 109.159 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.57 20.57 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.544 0.738 . . . . 63.44 112.0 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -172.71 14.35 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.336 0.969 . . . . 65.4 110.958 174.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -118.68 9.25 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.957 1.303 . . . . 73.42 112.109 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -156.93 159.22 37.9 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.448 0.699 . . . . 71.43 110.196 150.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 p90 179.37 -175.39 0.24 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.988 1.715 . . . . 73.11 107.683 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 p -127.43 161.79 27.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.795 0.807 . . . . 73.32 109.333 157.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.77 155.23 50.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.244 -1.762 . . . . 75.04 106.244 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.77 144.79 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.412 -0.959 . . . . 72.53 108.412 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.78 83.17 2.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 N-CA-C 107.338 -1.356 . . . . 74.41 107.338 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -113.63 34.23 4.7 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 123.912 0.885 . . . . 74.51 111.546 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 p -140.92 146.95 38.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.637 -1.616 . . . . 72.04 106.637 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.78 -37.47 63.49 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.491 1.116 . . . . 71.03 110.171 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.0 p -140.94 142.62 34.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.543 1.537 . . . . 54.25 107.88 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.21 169.8 17.02 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.543 2.337 . . . . 71.41 109.485 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.9 p -167.43 161.95 14.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.993 2.117 . . . . 73.04 108.792 172.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.1 m -144.41 165.24 28.48 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.417 -1.697 . . . . 75.4 106.417 157.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.16 -178.73 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.537 0.735 . . . . 75.41 110.256 172.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.2 p -125.84 177.18 6.45 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.632 1.173 . . . . 75.0 108.79 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -87.49 178.96 6.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.298 -1.001 . . . . 72.04 108.298 162.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.23 17.74 3.82 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.382 -0.824 . . . . 63.1 114.647 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -105.25 85.87 2.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.094 -1.817 . . . . 61.34 106.094 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.05 172.62 18.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.563 1.074 . . . . 75.33 111.509 165.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -122.95 -17.96 6.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.2 -1.363 . . . . 75.43 111.652 164.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -157.12 173.72 16.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.999 0.92 . . . . 75.21 110.267 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.1 ttt -140.59 161.79 36.91 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.104 2.161 . . . . 74.12 105.86 165.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -140.35 160.23 40.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.478 1.111 . . . . 73.02 110.178 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.7 39.25 0.86 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.037 2.535 . . . . 74.12 108.94 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 123.53 22.25 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.231 1.012 . . . . 73.31 109.973 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.92 29.03 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.8 -0.92 . . . . 63.35 110.8 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 95.1 p -127.24 167.43 16.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.905 0.482 . . . . 75.44 111.448 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.32 132.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 126.744 2.018 . . . . 75.41 105.952 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -144.5 162.66 35.99 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.456 0.571 . . . . 75.42 111.575 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.13 159.76 38.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.135 0.974 . . . . 60.35 110.531 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -139.48 32.03 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.204 1.802 . . . . 73.21 110.91 -169.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -132.78 176.34 8.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.921 1.289 . . . . 63.52 110.742 -167.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -45.35 160.72 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.877 2.471 . . . . 75.54 116.096 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.72 157.21 21.57 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.09 -1.868 . . . . 62.32 113.002 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.1 -0.64 82.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.389 -0.673 . . . . 62.55 113.795 172.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -75.16 114.64 13.89 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.408 1.604 . . . . 72.52 106.739 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -95.88 158.66 15.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.704 -0.851 . . . . 72.43 108.704 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.7 103.0 1.53 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.502 -1.666 . . . . 75.11 106.502 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -105.07 118.53 36.76 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.881 -1.137 . . . . 75.32 109.207 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mm -107.56 134.82 48.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.759 -1.2 . . . . 75.23 107.759 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.9 m -113.13 126.53 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.77 -1.937 . . . . 74.22 105.77 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.4 127.67 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 106.976 -1.49 . . . . 74.15 106.976 175.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.8 mt -137.55 134.42 46.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.535 -1.654 . . . . 73.45 106.535 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.13 124.13 5.75 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 109.861 -1.295 . . . . 63.01 109.861 -169.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -113.95 144.22 43.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.788 1.235 . . . . 74.13 112.192 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.8 mt -135.22 107.85 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 104.475 -2.417 . . . . 74.34 104.475 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t0 44.44 66.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.275 1.03 . . . . 73.34 111.317 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 74.79 0.78 3.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.93 2.492 . . . . 75.02 116.069 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -117.38 163.25 16.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 120.665 1.575 . . . . 74.32 113.46 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -98.91 153.86 18.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.613 -1.254 . . . . 63.33 107.613 165.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.77 3.93 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.091 0.404 . . . . 73.42 112.091 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -165.18 132.96 3.1 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.515 -1.291 . . . . 73.05 107.515 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -158.61 130.25 6.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.199 0.6 . . . . 74.04 110.083 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.41 108.05 5.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.313 1.054 . . . . 74.43 110.863 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.61 156.92 34.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.341 -1.355 . . . . 75.55 107.341 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 119' ' ' PHE . 22.4 mtmm -142.72 170.21 16.12 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.113 -1.44 . . . . 74.55 107.113 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -145.6 145.31 30.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.093 -1.817 . . . . 71.33 106.093 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.26 153.42 46.51 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.523 -1.288 . . . . 71.32 107.523 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.0 mt -144.31 140.15 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.301 -1.37 . . . . 75.52 107.301 166.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -66.15 145.7 55.5 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.939 1.296 . . . . 72.15 111.168 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.8 63.77 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.667 1.222 . . . . 74.14 111.125 163.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.05 -32.13 4.16 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.821 2.153 . . . . 53.21 112.634 168.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.73 174.33 10.58 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.557 1.943 . . . . 75.22 110.065 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.4 168.7 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.391 -0.596 . . . . 71.32 109.391 159.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.71 134.0 44.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.902 -1.147 . . . . 75.11 107.902 168.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.4 mt -150.9 133.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.148 -1.427 . . . . 75.34 107.148 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -152.5 169.35 22.83 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.034 1.734 . . . . 72.21 109.876 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 53.6 p -134.74 167.84 20.11 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.755 0.822 . . . . 75.15 109.514 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.458 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 22.9 p90 -156.04 168.62 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.398 -0.819 . . . . 71.51 109.836 172.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -161.12 138.85 9.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.878 0.847 . . . . 62.12 108.989 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -145.67 100.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 104.653 -2.351 . . . . 72.14 104.653 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.06 140.3 29.9 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.632 -1.618 . . . . 64.4 106.632 168.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 p -94.78 27.73 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.087 1.312 . . . . 63.13 111.007 170.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 tptm . . . . . 0 CA--C 1.512 -0.488 0 O-C-N 120.049 -1.657 . . . . 73.43 108.53 161.506 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.936 0 N-CA-C 108.485 -0.932 . . . . 74.13 108.485 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.57 -101.4 0.15 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.826 1.203 . . . . 64.11 110.88 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -134.14 117.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.202 -2.148 . . . . 75.53 105.202 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -84.38 151.16 24.87 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.759 -1.213 . . . . 74.25 109.236 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -137.67 158.43 44.39 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.387 1.075 . . . . 75.23 108.125 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.1 mm -139.3 129.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 105.315 -2.106 . . . . 72.54 105.315 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.0 t -113.11 140.17 34.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.927 1.691 . . . . 74.54 106.459 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mt -130.55 144.27 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.471 -1.677 . . . . 72.11 106.471 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.13 162.4 35.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.589 -0.893 . . . . 75.44 108.589 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -153.25 173.76 15.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.165 0.507 . . . . 73.23 112.192 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.24 150.85 20.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.052 0.941 . . . . 72.21 108.621 161.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.2 -108.38 0.37 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.145 -0.782 . . . . 61.24 111.145 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -130.34 54.88 1.84 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.547 1.539 . . . . 73.54 108.917 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.7 p -54.92 -4.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 130.938 3.695 . . . . 73.32 116.586 -165.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -95.26 -11.94 27.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.359 1.064 . . . . 73.33 111.877 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.57 33.78 4.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.545 2.338 . . . . 73.45 110.366 -170.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -133.14 143.61 49.36 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.086 0.954 . . . . 73.13 110.098 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.14 58.38 0.6 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.595 1.558 . . . . 75.42 108.629 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.13 125.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 124.759 1.223 . . . . 74.35 108.377 165.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.29 121.98 18.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.245 -1.02 . . . . 74.32 108.245 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.8 120.83 55.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.603 1.161 . . . . 74.23 110.004 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 t -66.1 134.63 53.21 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.54 -1.652 . . . . 75.24 106.54 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.82 112.95 27.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.589 -2.004 . . . . 72.32 105.589 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.9 35.29 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.531 -1.028 . . . . 64.32 110.531 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 168.81 38.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.638 -1.385 . . . . 72.01 109.638 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.21 153.41 31.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.275 1.43 . . . . 75.22 110.331 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.08 170.83 14.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.302 1.441 . . . . 62.21 111.219 174.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -66.58 73.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.397 1.879 . . . . 74.42 110.195 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.47 6.18 2.74 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.332 -1.815 . . . . 64.03 113.992 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.49 -156.41 27.25 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 120.99 2.395 . . . . 74.04 115.427 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.67 125.79 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.698 2.932 . . . . 73.15 110.022 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.81 120.13 14.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.267 -1.333 . . . . 75.22 108.832 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 144.89 55.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.678 0.217 . . . . 74.23 111.057 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 145.41 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.716 2.006 . . . . 75.22 108.62 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.848 1.259 . . . . 74.44 110.945 -170.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -82.12 175.67 10.14 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.311 0.645 . . . . 64.22 110.651 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.09 -12.73 61.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.736 1.013 . . . . 52.32 113.736 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -87.35 -7.54 57.65 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.058 -1.026 . . . . 74.31 110.928 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.66 56.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.449 1.976 . . . . 75.32 113.596 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.25 148.99 21.71 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.892 1.346 . . . . 72.31 109.855 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.54 144.83 56.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.426 -1.324 . . . . 73.51 107.426 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.73 5.8 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.411 0.685 . . . . 72.22 112.397 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.08 -175.3 36.89 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.001 0.818 . . . . 63.13 111.495 166.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -121.0 0.29 10.2 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.911 1.284 . . . . 74.32 112.183 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.7 m -165.84 115.6 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.217 1.807 . . . . 73.31 108.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -153.49 -178.84 7.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.745 1.157 . . . . 75.44 111.958 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.3 155.59 39.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.648 0.779 . . . . 75.23 109.488 163.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.54 171.61 10.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.945 1.698 . . . . 71.32 107.683 171.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -124.05 139.15 54.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 128.062 2.545 . . . . 74.45 109.269 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mm -90.65 98.88 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 119.262 -0.975 . . . . 74.55 110.102 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.47 14.35 13.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.948 1.092 . . . . 73.52 113.948 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.7 p -128.69 173.89 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.713 0.688 . . . . 62.11 109.837 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.78 90.52 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.736 0.415 . . . . 74.21 110.597 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.6 p -145.7 143.46 29.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.001 0.429 . . . . 71.52 110.465 -166.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -138.22 163.48 31.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.843 2.057 . . . . 61.21 109.754 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.64 152.53 6.9 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.042 1.337 . . . . 75.22 108.849 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 53.0 m -147.36 160.36 42.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.506 1.923 . . . . 75.43 109.409 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.2 p -152.42 173.39 15.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.486 0.714 . . . . 53.42 111.834 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -109.29 -174.98 2.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.56 1.144 . . . . 75.44 109.694 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -91.97 -171.65 2.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.544 -0.91 . . . . 63.44 108.544 151.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.56 -17.72 79.17 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.54 -0.725 . . . . 74.21 114.068 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -78.17 89.65 4.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.383 1.092 . . . . 72.24 108.207 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.38 15.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.662 0.785 . . . . 75.45 109.758 154.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -123.7 -10.28 7.83 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.191 0.811 . . . . 75.23 113.191 172.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.573 ' CB ' ' HE3' ' A' ' 124' ' ' LYS . 52.5 p90 -152.2 -170.64 3.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.011 1.324 . . . . 74.32 108.84 172.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.1 ttt -142.37 162.4 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 104.561 -2.385 . . . . 72.55 104.561 146.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -133.74 158.66 42.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.301 1.048 . . . . 74.44 108.874 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -134.13 99.11 4.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 102.089 -3.3 . . . . 61.15 102.089 166.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.14 113.45 14.5 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.519 -1.66 . . . . 73.22 106.519 168.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.8 -151.22 6.81 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.72 -1.752 . . . . 60.34 108.72 -161.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.8 p -149.28 -179.2 6.87 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.707 -0.479 . . . . 73.14 109.707 151.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.38 157.27 21.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.955 1.302 . . . . 75.03 109.434 170.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.02 171.72 14.07 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.924 0.89 . . . . 64.14 109.358 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -159.26 162.46 36.12 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.267 1.027 . . . . 74.13 108.534 162.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.26 12.36 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.359 1.864 . . . . 73.45 111.597 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 p -83.88 176.64 8.76 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.254 1.022 . . . . 74.11 111.002 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -59.55 164.5 3.46 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.731 -0.668 . . . . 74.04 110.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 166.6 4.17 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.44 1.114 . . . . 75.01 112.938 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.09 -8.71 50.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.041 1.781 . . . . 75.31 114.348 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -62.62 158.85 17.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.532 1.166 . . . . 62.22 108.886 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -135.65 156.6 48.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.459 -0.571 . . . . 74.13 109.459 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.71 109.41 1.23 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.549 -2.019 . . . . 74.25 105.549 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -101.11 137.44 39.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.196 -1.779 . . . . 75.21 106.196 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.17 129.14 74.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.023 -1.103 . . . . 74.34 108.023 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -106.97 126.09 51.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.126 2.17 . . . . 73.33 106.008 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.39 109.84 16.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 125.297 1.439 . . . . 71.5 110.857 -165.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 mp -128.67 138.63 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.354 1.862 . . . . 73.21 106.747 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.49 177.07 21.24 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.167 -1.173 . . . . 71.31 110.167 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -156.26 153.95 29.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 118.674 1.237 . . . . 75.5 109.742 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.9 mt -129.16 110.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 108.239 -1.023 . . . . 73.54 108.239 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.0 -74.21 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.885 2.474 . . . . 71.14 110.107 -171.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.7 -1.41 2.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.717 1.006 . . . . 75.1 113.717 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -105.8 156.9 17.87 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.104 -0.997 . . . . 75.34 113.459 -171.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -118.22 103.8 10.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.817 1.247 . . . . 61.44 109.161 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.37 -6.92 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 115.022 1.49 . . . . 75.43 115.022 -168.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.85 99.49 1.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.382 -1.34 . . . . 73.33 107.382 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.89 123.11 11.54 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.347 1.059 . . . . 71.1 110.915 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.43 176.63 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 73.44 110.487 171.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -136.55 158.01 45.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.113 2.165 . . . . 74.5 107.97 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -160.51 166.86 28.35 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.349 0.66 . . . . 73.3 109.61 169.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -140.05 147.42 40.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.264 1.826 . . . . 75.32 111.322 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -139.08 134.44 32.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.948 1.699 . . . . 75.41 108.251 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.0 mt -144.59 126.96 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.494 -1.669 . . . . 75.42 106.494 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 134.34 48.43 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.814 -0.439 . . . . 74.43 109.814 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.45 -17.04 33.1 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.564 1.146 . . . . 75.13 112.576 168.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.21 10.23 11.0 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.085 0.85 . . . . 63.33 112.486 -172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.34 -177.39 4.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.347 1.859 . . . . 74.21 108.989 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.55 111.85 2.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.598 1.159 . . . . 74.14 112.593 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 tp -81.13 135.63 35.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 124.528 1.131 . . . . 74.45 108.304 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.4 mt -150.2 132.22 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.999 2.52 . . . . 74.25 106.04 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.38 171.25 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.779 0.832 . . . . 71.32 111.279 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -142.71 160.96 39.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.194 1.397 . . . . 73.41 110.159 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -148.01 163.32 37.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.731 -1.122 . . . . 75.1 108.997 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.6 p -152.93 135.23 15.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.629 -0.67 . . . . 75.4 112.671 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 7.6 p -135.5 103.64 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 128.207 2.603 . . . . 74.33 105.495 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.57 -158.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.454 -0.943 . . . . 75.21 108.454 170.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 82.8 p -134.24 -3.88 2.73 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 161.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.573 ' HE3' ' CB ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 124.565 2.126 . . . . 74.41 112.793 -154.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.238 0.462 0 N-CA-C 108.229 -1.026 . . . . 73.33 108.229 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.49 -96.88 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.653 -2.179 . . . . 63.44 107.653 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.76 118.38 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.775 1.23 . . . . 74.31 108.264 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -80.88 141.02 35.01 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.475 -0.784 . . . . 71.12 109.951 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.39 144.63 42.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.637 2.375 . . . . 74.43 108.829 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.95 156.2 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.475 -1.676 . . . . 74.13 106.475 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.02 138.89 45.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.918 -1.882 . . . . 74.43 105.918 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.0 142.42 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.591 -1.263 . . . . 64.13 107.591 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.35 173.27 11.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.377 1.071 . . . . 63.22 109.41 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -152.17 170.93 18.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.407 0.683 . . . . 73.14 111.79 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p -158.99 136.88 10.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.948 0.499 . . . . 73.33 111.523 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.88 -128.81 5.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.086 1.327 . . . . 55.15 111.722 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 61.41 3.58 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.402 1.881 . . . . 75.14 110.642 -166.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 p -75.91 48.11 0.47 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.32 1.848 . . . . 73.3 111.452 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.62 -20.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.0 0.92 . . . . 73.52 112.733 -172.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -142.19 42.06 1.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.205 2.202 . . . . 72.42 109.735 -170.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.53 160.04 36.4 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.371 2.269 . . . . 71.32 109.359 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -133.87 107.91 8.13 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.16 1.784 . . . . 74.53 108.319 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -125.1 80.7 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 125.438 1.495 . . . . 75.23 113.386 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.42 117.61 30.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.109 -0.7 . . . . 71.12 109.109 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.59 133.53 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.854 -0.795 . . . . 75.34 108.854 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -66.08 151.28 47.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.579 -0.897 . . . . 51.3 108.579 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.51 117.52 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.231 -2.137 . . . . 72.53 105.231 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 173.47 35.99 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.786 -0.926 . . . . 64.34 110.786 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.64 179.67 44.88 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.086 -2.806 . . . . 75.42 106.086 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.2 163.47 28.48 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.296 0.569 . . . . 74.25 109.498 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -174.32 3.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.963 1.705 . . . . 75.24 110.055 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -64.22 -28.81 69.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.741 1.015 . . . . 75.24 113.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.68 -52.67 11.54 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.203 -1.959 . . . . 64.54 108.203 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.96 -80.32 0.19 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.284 -1.526 . . . . 74.3 109.284 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.48 131.72 15.29 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.207 2.004 . . . . 73.32 111.751 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.63 134.77 34.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.809 -1.091 . . . . 74.33 108.885 165.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -83.95 128.59 34.65 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.339 0.972 . . . . 72.33 109.243 159.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -100.3 152.58 20.15 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.877 1.271 . . . . 74.02 108.314 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -124.36 155.06 39.41 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.05 0.928 . . . . 74.32 110.594 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.67 160.76 14.63 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.494 1.518 . . . . 72.1 109.795 168.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.83 0.93 9.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.649 1.98 . . . . 70.3 113.803 -171.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -77.23 -24.73 51.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.795 2.838 . . . . 73.21 110.743 165.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 4.35 50.32 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.22 1.867 . . . . 64.24 112.808 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -89.07 165.74 14.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.001 1.401 . . . . 73.03 108.183 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -84.77 151.94 24.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.861 -0.792 . . . . 65.4 108.861 165.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.29 -5.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.942 0.897 . . . . 70.44 112.659 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.81 40.69 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 119.708 1.14 . . . . 65.21 110.613 169.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.328 0.8 OUTLIER -121.87 14.96 10.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.289 2.235 . . . . 71.33 110.438 169.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 149.09 9.59 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 127.724 2.41 . . . . 70.14 106.947 151.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -169.23 179.86 3.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.146 0.979 . . . . 74.3 109.921 157.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -140.04 106.26 5.25 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 126.155 1.782 . . . . 74.52 107.185 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.12 150.26 20.39 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.483 -0.932 . . . . 71.12 108.483 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.27 147.33 26.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.502 1.121 . . . . 72.31 109.251 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -85.32 71.16 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.977 -1.12 . . . . 71.4 107.977 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -92.59 38.09 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.416 -1.427 . . . . 74.02 113.195 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 p -147.29 128.34 14.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.126 -1.435 . . . . 74.11 107.126 -165.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.95 65.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.549 0.613 . . . . 62.22 110.447 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 p -140.7 134.3 30.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.946 1.298 . . . . 72.24 107.95 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.488 ' HE1' ' H ' ' A' ' 62' ' ' SER . 6.0 tpt -125.26 159.93 30.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.469 2.308 . . . . 74.11 106.999 176.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.488 ' H ' ' HE1' ' A' ' 61' ' ' MET . 11.9 p -164.62 143.82 7.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.679 1.592 . . . . 74.03 107.409 168.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.6 m -136.86 147.63 46.62 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.417 -1.327 . . . . 75.01 107.417 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 p -146.56 -173.43 4.2 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.039 0.381 . . . . 64.22 110.735 170.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 p -135.49 172.92 12.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.705 1.202 . . . . 75.42 111.436 -162.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.99 170.2 11.32 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.569 -0.9 . . . . 64.14 108.569 163.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.96 60.96 3.78 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.124 0.869 . . . . 71.32 111.641 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.83 89.84 1.72 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.824 -2.658 . . . . 75.04 103.824 169.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.83 23.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.232 -0.413 . . . . 62.11 111.272 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.4 -8.18 2.92 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.04 0.756 . . . . 64.54 113.04 166.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -163.01 169.31 19.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.879 1.272 . . . . 73.52 107.736 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.3 ttt -138.74 151.47 47.14 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 104.382 -2.451 . . . . 75.42 104.382 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.0 t -138.53 157.84 45.4 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.615 0.766 . . . . 75.42 108.999 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.58 45.85 1.03 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.089 0.956 . . . . 64.31 111.244 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.59 141.29 58.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.787 0.835 . . . . 75.24 110.037 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.13 -149.13 4.9 Favored Glycine 0 C--N 1.336 0.532 0 O-C-N 121.427 -0.795 . . . . 71.22 111.201 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.6 p -142.85 178.52 7.6 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.217 -1.031 . . . . 62.42 108.217 149.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.67 149.71 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.988 0.915 . . . . 72.55 109.045 160.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.4 t -152.51 161.77 42.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.32 -0.622 . . . . 74.52 109.32 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -157.25 153.51 27.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.3 1.84 . . . . 75.33 106.323 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 26.8 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 127.07 2.148 . . . . 74.44 108.0 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -90.44 173.52 8.05 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.823 -1.173 . . . . 71.13 109.021 169.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.12 169.29 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.141 -1.845 . . . . 74.5 110.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.62 162.63 6.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.429 0.692 . . . . 75.43 112.243 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.95 71.53 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.71 0.672 . . . . 73.25 113.309 172.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -111.97 136.39 51.37 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.214 1.806 . . . . 75.54 106.846 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -125.6 159.38 32.28 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.581 -0.699 . . . . 72.51 110.605 -166.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.87 102.5 2.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.516 -2.402 . . . . 72.43 104.516 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.22 149.04 22.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.267 -1.753 . . . . 64.35 106.267 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.99 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.227 -1.768 . . . . 71.41 106.227 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -119.17 135.97 54.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 74.15 106.172 163.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.52 119.55 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.895 -1.521 . . . . 75.32 106.895 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 mt -135.06 134.68 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 107.358 -1.349 . . . . 55.54 107.358 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -119.98 132.44 9.41 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.701 -1.359 . . . . 75.35 109.701 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -126.44 152.94 45.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.145 1.378 . . . . 72.42 110.055 -170.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 mt -136.85 112.4 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.536 -2.394 . . . . 75.25 104.536 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 74.38 -54.12 0.67 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 127.726 2.411 . . . . 74.03 112.962 163.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.34 6.57 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.183 1.793 . . . . 75.04 112.947 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.98 155.65 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.239 -2.163 . . . . 75.13 109.996 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -72.11 159.0 34.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.955 -1.128 . . . . 64.02 107.955 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.11 -6.02 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.377 0.51 . . . . 71.44 112.377 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.1 136.64 12.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.846 -1.168 . . . . 73.43 107.846 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.49 158.36 26.42 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 119.308 0.958 . . . . 73.51 111.432 168.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.43 171.41 14.67 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.302 1.049 . . . . 64.34 108.692 155.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.72 161.56 24.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.091 -1.818 . . . . 75.21 106.091 160.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.63 169.21 24.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.633 -0.877 . . . . 74.55 108.633 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -155.48 149.06 25.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.05 -0.352 . . . . 75.32 110.05 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -148.29 138.4 22.55 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.774 1.23 . . . . 63.32 108.864 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.81 137.67 53.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.452 -0.944 . . . . 75.41 108.452 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -74.42 133.79 42.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.694 -0.854 . . . . 73.14 108.694 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.24 57.43 1.13 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.252 1.025 . . . . 75.53 108.921 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.67 -38.15 1.68 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.799 2.142 . . . . 62.15 111.774 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -62.8 152.43 35.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.363 1.065 . . . . 75.33 108.991 172.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 m -74.29 113.94 12.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.021 1.329 . . . . 74.52 109.044 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.03 115.14 6.41 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.8 mt -149.71 138.53 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 103.043 -2.947 . . . . 75.45 103.043 170.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 170.58 21.01 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.965 1.416 . . . . 73.13 108.846 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -138.29 153.83 49.03 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.316 -0.994 . . . . 74.15 108.316 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.71 161.71 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.718 1.207 . . . . 75.22 108.165 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.6 t -160.2 144.37 14.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.853 -1.165 . . . . 75.42 107.853 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.32 118.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.1 -2.556 . . . . 73.15 104.1 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 132.5 51.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.335 1.054 . . . . 73.52 108.249 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -95.14 14.13 23.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.484 -0.76 . . . . 73.15 112.17 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.46 0 N-CA-C 105.217 -2.142 . . . . 74.43 105.217 162.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.731 0.301 . . . . 74.35 111.689 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.58 -105.94 0.44 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.174 -1.57 . . . . 74.43 109.174 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.87 83.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.43 106.172 -162.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -84.04 122.97 29.52 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.847 -1.538 . . . . 54.23 106.847 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.05 151.43 49.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.755 1.161 . . . . 74.53 110.574 -167.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 mm -135.01 146.38 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.357 1.463 . . . . 74.11 107.696 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 t -141.84 133.62 27.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.912 -1.514 . . . . 71.34 106.912 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mt -130.5 149.67 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.067 0.947 . . . . 70.11 109.214 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -135.84 167.34 21.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.677 0.672 . . . . 74.35 111.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -140.7 139.88 34.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.776 1.231 . . . . 72.21 109.239 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -149.82 152.9 35.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.484 2.313 . . . . 72.31 108.147 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.7 -145.33 18.68 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.55 -1.42 . . . . 63.43 109.55 -168.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -85.57 75.41 10.15 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.038 -1.467 . . . . 61.55 107.038 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.1 p -75.16 71.02 2.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.395 -1.706 . . . . 72.32 106.395 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.72 -48.31 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.506 1.122 . . . . 71.43 108.71 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.93 67.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 124.002 1.858 . . . . 72.42 109.462 -163.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 1.1 p90 -148.27 166.69 27.24 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 128.251 2.62 . . . . 73.52 108.22 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.79 150.52 49.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.556 1.943 . . . . 74.15 108.423 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.13 85.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.576 -0.898 . . . . 74.31 108.576 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -86.63 136.04 33.19 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.809 0.814 . . . . 73.15 108.874 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.519 ' CG1' ' HG ' ' A' ' 74' ' ' CYS . 1.6 t -136.09 132.91 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.836 -1.913 . . . . 73.22 105.836 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -85.34 140.8 30.5 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.778 1.631 . . . . 74.55 106.926 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.7 mt -124.64 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.409 -1.7 . . . . 74.34 106.409 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.56 172.88 42.57 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.193 -0.763 . . . . 65.33 111.193 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.46 175.29 40.51 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 127.176 2.322 . . . . 71.35 108.25 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.45 46.47 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.857 -0.79 . . . . 73.31 109.031 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -136.85 -178.55 5.24 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 125.835 1.654 . . . . 71.52 110.688 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -80.25 70.33 6.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.081 0.553 . . . . 74.14 110.29 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.68 -34.74 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.228 0.918 . . . . 73.34 111.652 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.24 -164.89 26.72 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 117.698 0.749 . . . . 63.34 113.273 -164.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.42 140.02 26.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.906 3.071 . . . . 72.31 109.337 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.62 26.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.293 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -54.49 120.1 6.17 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.039 0.935 . . . . 73.25 109.701 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.67 168.6 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.497 -0.927 . . . . 71.44 108.497 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.74 142.09 46.65 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.837 0.855 . . . . 74.43 109.079 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.34 170.81 16.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.552 1.141 . . . . 73.25 109.773 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -74.93 15.28 0.41 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 73.42 113.877 -169.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -100.37 -16.56 17.6 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.315 . . . . 72.51 111.559 162.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.48 67.36 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.37 0.986 . . . . 72.15 113.124 -168.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -79.97 161.52 25.44 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 1.116 . . . . 70.43 109.626 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.02 137.59 34.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.812 -0.81 . . . . 74.43 108.812 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.33 16.72 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.012 1.325 . . . . 72.35 112.944 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.17 172.21 14.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.867 1.222 . . . . 73.11 110.462 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -112.17 9.83 20.17 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.227 1.411 . . . . 62.34 111.159 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -167.05 148.78 5.96 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.071 2.148 . . . . 72.15 108.097 165.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -179.96 179.34 0.55 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.141 2.576 . . . . 74.43 109.186 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.4 p -129.39 159.09 37.32 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.33 1.052 . . . . 73.11 109.426 163.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.45 114.72 7.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.1 -1.074 . . . . 72.25 108.1 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -71.69 128.18 34.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.967 -1.123 . . . . 73.42 107.967 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.36 117.05 3.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.417 -1.327 . . . . 73.43 107.417 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -137.51 35.95 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.861 0.839 . . . . 74.33 110.856 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.21 147.71 26.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.456 -1.683 . . . . 73.12 106.456 -161.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.75 -37.47 71.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.95 0.5 . . . . 74.13 111.771 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 t -149.72 161.99 41.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.228 -1.027 . . . . 74.33 108.228 167.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 mmm -134.75 165.93 24.13 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 128.632 2.773 . . . . 71.22 108.883 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.5 p -164.94 162.28 20.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.507 -1.224 . . . . 74.33 110.058 171.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.2 m -150.94 166.02 31.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.046 2.138 . . . . 70.12 107.261 165.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.05 -178.68 6.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.934 0.894 . . . . 62.25 111.839 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 p -129.07 175.6 8.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.649 1.979 . . . . 74.23 108.987 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.2 172.32 7.66 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.398 -0.814 . . . . 74.25 109.162 159.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 55.01 4.99 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.092 0.853 . . . . 63.12 113.06 -169.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -133.38 -8.79 2.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.586 1.154 . . . . 63.51 111.215 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.59 165.12 23.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.834 0.826 . . . . 73.55 111.121 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -119.72 -1.8 10.51 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.906 1.682 . . . . 73.23 112.065 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -177.12 172.03 2.0 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.289 1.835 . . . . 71.41 108.022 171.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ttt -132.66 163.64 28.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.832 -2.284 . . . . 65.41 104.832 161.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -146.94 166.59 26.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.277 0.561 . . . . 63.25 110.253 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.519 ' HG ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -151.11 65.18 0.9 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.595 2.358 . . . . 72.12 107.711 179.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.39 41.03 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.742 0.817 . . . . 74.52 108.95 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.65 179.74 32.25 Favored Glycine 0 CA--C 1.502 -0.731 0 CA-C-N 119.082 0.856 . . . . 70.23 111.9 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 90.3 p -135.34 169.37 17.58 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.377 -1.411 . . . . 73.45 109.535 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.54 153.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.422 1.489 . . . . 70.25 107.254 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.0 164.0 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.914 -0.772 . . . . 71.41 108.914 166.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.7 p -145.65 162.45 37.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.612 -0.514 . . . . 71.32 109.612 154.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 pt -133.63 15.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 128.653 2.781 . . . . 63.33 109.313 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -81.02 174.55 11.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.015 1.726 . . . . 74.13 111.28 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.3 163.83 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.227 -2.261 . . . . 71.21 110.626 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.89 160.16 15.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.203 1.401 . . . . 72.11 113.289 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.42 87.0 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.907 1.241 . . . . 61.13 114.164 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -66.66 167.47 11.05 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.564 1.182 . . . . 65.53 108.273 167.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -149.5 160.05 43.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 121.572 -0.705 . . . . 74.44 110.083 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.3 tp -152.87 130.45 11.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.591 -1.633 . . . . 74.24 106.591 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -129.16 109.25 11.0 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.389 1.876 . . . . 72.34 106.185 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.83 134.18 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.053 -2.203 . . . . 72.33 105.053 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 m -112.06 137.49 50.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.142 -1.799 . . . . 74.55 106.142 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.16 113.31 3.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.583 1.553 . . . . 74.33 109.194 -171.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.84 141.09 45.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.727 -1.583 . . . . 74.23 106.727 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.82 155.85 25.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 123.869 0.747 . . . . 61.21 111.483 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.13 154.46 42.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.051 0.94 . . . . 73.23 110.366 -165.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.9 mt -122.89 117.89 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.824 -1.176 . . . . 73.34 107.824 163.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 t70 69.28 -58.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 129.06 2.944 . . . . 74.21 111.666 165.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.68 8.5 0.51 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.043 1.497 . . . . 74.45 115.043 158.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.44 143.51 32.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.992 1.317 . . . . 74.35 111.267 -170.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.16 118.2 12.68 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.043 1.737 . . . . 64.12 107.203 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -8.31 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.735 0.779 . . . . 74.12 109.825 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -162.44 130.85 4.05 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.215 -1.402 . . . . 73.21 107.215 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -153.65 110.79 3.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.188 -0.671 . . . . 73.12 109.188 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 pp -142.25 179.51 6.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.783 -1.099 . . . . 73.43 111.296 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -145.9 171.27 15.07 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.171 2.589 . . . . 74.54 106.301 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -146.99 160.42 42.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.687 -0.857 . . . . 71.11 108.687 170.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -128.25 136.16 50.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.437 1.495 . . . . 72.33 107.057 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.16 152.8 51.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.141 0.977 . . . . 71.33 109.055 168.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.0 mt -144.21 154.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.219 1.808 . . . . 74.24 107.424 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -95.79 141.17 29.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.928 0.891 . . . . 72.12 110.223 176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -121.67 4.99 10.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.343 1.857 . . . . 73.23 110.489 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 113.61 -34.91 4.78 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.715 2.102 . . . . 51.43 110.309 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -79.42 161.67 25.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.939 1.296 . . . . 74.42 110.622 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.36 105.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.765 0.826 . . . . 74.13 110.126 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.8 tt -68.02 134.61 50.96 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.392 -0.966 . . . . 74.42 108.392 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -150.61 133.97 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.026 -1.842 . . . . 70.54 106.026 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.17 174.55 14.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.958 0.786 . . . . 52.35 111.608 171.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 73.9 p -139.65 161.64 37.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.81 1.644 . . . . 72.42 110.797 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -151.2 176.7 10.95 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.309 1.444 . . . . 74.45 109.606 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -160.74 147.48 15.34 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.561 -0.903 . . . . 62.23 108.561 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.2 t -146.31 88.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.236 -1.765 . . . . 72.31 106.236 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.5 m -77.82 166.78 22.49 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.06 -0.718 . . . . 70.52 109.06 165.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.1 p -135.17 58.3 1.77 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.11 -1.07 . . . . 71.53 108.11 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 124.507 2.098 . . . . 73.21 110.724 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 109.81 -1.316 . . . . 73.3 109.81 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.19 73.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.134 -1.802 . . . . 70.52 106.134 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -160.03 -165.98 1.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.864 2.466 . . . . 73.24 107.435 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.86 83.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.367 2.667 . . . . 54.24 114.216 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.72 104.32 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.16 -1.422 . . . . 73.1 107.16 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.92 127.65 18.15 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 126.223 1.809 . . . . 72.13 106.733 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -133.98 179.66 6.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.337 2.255 . . . . 72.54 110.005 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.42 -95.08 0.29 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.458 -1.057 . . . . 70.4 110.458 156.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.34 126.95 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 104.667 -2.345 . . . . 74.43 104.667 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -108.87 142.14 39.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.432 -1.692 . . . . 73.52 106.432 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -137.23 152.74 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.658 -1.238 . . . . 73.3 107.658 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.29 154.38 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.695 -1.224 . . . . 74.21 107.695 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 t -136.67 142.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.272 -1.751 . . . . 71.45 106.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.84 148.58 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.309 -1.737 . . . . 74.3 106.309 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -135.51 153.46 51.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.302 -1.37 . . . . 75.34 107.302 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -140.87 154.0 45.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.769 0.795 . . . . 70.24 109.888 166.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 p -151.64 173.09 15.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.712 -0.676 . . . . 72.34 109.333 171.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.68 -143.13 16.55 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.537 -1.425 . . . . 62.33 109.537 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.34 65.59 0.88 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.783 1.233 . . . . 75.02 112.17 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -64.21 -30.48 71.53 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.466 -1.396 . . . . 64.44 110.517 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.25 -30.82 64.97 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.783 1.233 . . . . 75.21 111.52 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.47 23.48 5.12 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 71.32 112.644 -168.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -124.88 118.49 26.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.273 1.029 . . . . 73.32 108.72 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -78.69 136.92 37.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.44 -1.319 . . . . 72.21 107.44 163.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -141.98 111.21 2.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.1 -1.815 . . . . 70.44 106.1 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -125.61 126.77 45.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.648 1.567 . . . . 65.01 110.662 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.53 130.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.025 1.33 . . . . 73.44 109.696 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -78.13 127.43 32.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.595 -1.632 . . . . 72.24 106.595 165.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.47 138.83 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.689 -1.967 . . . . 74.41 105.689 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.32 179.82 46.98 Favored Glycine 0 C--N 1.334 0.451 0 O-C-N 121.356 -0.84 . . . . 74.5 112.661 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.76 -176.63 48.02 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.185 1.374 . . . . 73.53 110.437 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.31 159.83 40.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.905 0.882 . . . . 71.12 110.295 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.74 -177.34 5.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.431 1.093 . . . . 74.3 111.116 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.78 59.28 0.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.756 2.022 . . . . 65.2 108.909 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.74 21.87 0.02 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.582 -0.566 . . . . 61.3 112.665 -160.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.98 -154.0 20.15 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.459 1.129 . . . . 74.34 111.439 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -62.58 142.81 91.3 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.83 1.686 . . . . 73.53 109.191 166.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.52 149.07 31.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.997 -0.742 . . . . 73.23 108.997 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -69.32 146.94 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.764 0.711 . . . . 75.13 109.781 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.84 154.81 26.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 126.119 1.768 . . . . 73.11 108.59 169.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.33 151.29 50.99 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.404 2.281 . . . . 75.4 107.902 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -95.04 173.97 7.32 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.848 1.259 . . . . 74.42 110.4 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.99 21.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.229 1.411 . . . . 71.03 113.903 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -109.83 6.54 23.51 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.678 1.991 . . . . 75.33 110.102 163.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.92 7.05 80.66 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.335 -1.258 . . . . 72.0 112.87 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -103.18 143.77 32.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.888 1.844 . . . . 73.5 109.895 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -65.26 151.38 46.34 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.83 -0.804 . . . . 75.3 108.83 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.17 1.03 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.005 0.743 . . . . 75.4 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.29 -174.06 33.45 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 120.288 1.404 . . . . 73.31 110.328 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -121.18 -2.88 9.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.017 2.127 . . . . 74.5 112.165 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -153.17 142.38 21.48 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.692 1.597 . . . . 72.4 108.822 161.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -173.0 176.78 2.93 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.578 1.951 . . . . 73.42 108.038 164.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.0 p -122.17 159.25 27.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.508 1.123 . . . . 63.34 109.057 165.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.97 130.48 29.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.088 -1.078 . . . . 73.21 108.088 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.85 140.08 40.51 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.066 -1.087 . . . . 71.12 108.066 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -73.99 94.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 104.51 -2.404 . . . . 75.23 104.51 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -120.23 44.29 2.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.852 -1.166 . . . . 73.22 107.852 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -141.71 166.43 24.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.221 -1.399 . . . . 75.32 107.221 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.49 78.79 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.136 0.974 . . . . 63.22 110.391 170.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.7 p -130.32 156.86 43.98 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.367 -0.975 . . . . 75.34 108.367 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -146.66 159.63 43.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.023 1.329 . . . . 75.24 109.52 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 p -165.31 155.55 13.41 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.412 1.085 . . . . 75.04 108.453 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.6 m -143.0 157.67 44.33 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.072 -1.455 . . . . 74.41 107.072 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.9 p -144.1 169.23 18.25 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.685 -0.635 . . . . 75.54 110.839 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 p -105.82 -170.25 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.121 -1.437 . . . . 73.21 107.121 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.75 -167.91 1.41 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.51 -0.922 . . . . 75.5 108.51 148.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.36 172.57 7.41 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.89 -0.884 . . . . 74.53 110.89 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.96 84.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.596 1.159 . . . . 73.23 108.861 -164.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.69 165.58 35.84 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.53 1.132 . . . . 65.31 108.305 156.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -132.91 -0.45 3.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.326 1.05 . . . . 74.33 113.404 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -166.88 175.59 7.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.964 -2.236 . . . . 65.33 104.964 162.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ttt -140.55 145.48 36.84 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.705 -2.702 . . . . 73.43 103.705 157.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -116.58 150.9 37.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.003 -1.11 . . . . 73.23 108.003 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.5 t -147.91 89.54 1.75 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.564 -2.013 . . . . 65.32 105.564 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.25 135.15 55.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.94 -1.133 . . . . 74.15 107.94 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.09 32.8 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 118.724 0.693 . . . . 72.04 112.011 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.4 p -139.41 167.28 22.44 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.331 -0.934 . . . . 73.11 110.336 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.67 148.21 31.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.2 1.8 . . . . 74.43 106.736 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 p -142.97 160.89 39.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.173 0.442 . . . . 62.45 111.139 155.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.81 156.17 41.97 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.745 1.218 . . . . 62.25 108.173 164.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.22 49.81 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 126.26 1.824 . . . . 73.31 109.463 -172.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.0 p -129.07 -173.9 3.12 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.196 0.999 . . . . 53.51 111.809 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -66.71 165.33 15.18 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.118 0.967 . . . . 73.02 112.118 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 161.04 14.62 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 112.998 -1.91 . . . . 74.21 113.514 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.99 2.32 81.95 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.861 -1.522 . . . . 74.45 114.431 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -70.12 114.82 8.64 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 120.1 1.95 . . . . 73.11 106.001 165.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -104.4 155.9 18.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.313 -0.995 . . . . 72.11 108.313 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 tp -143.16 159.13 42.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.543 -2.021 . . . . 65.25 105.543 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -143.97 145.97 32.6 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.946 -1.501 . . . . 73.43 106.946 165.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mm -134.37 140.59 45.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.677 -1.971 . . . . 73.45 105.677 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 m -131.43 125.83 33.56 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.89 -2.263 . . . . 73.33 104.89 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.24 116.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.737 1.215 . . . . 73.41 107.93 -170.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 mp -138.62 131.22 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.066 0.946 . . . . 72.32 108.719 -162.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.79 141.44 16.39 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.792 1.187 . . . . 62.34 111.4 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -131.45 153.94 49.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.122 2.169 . . . . 72.24 108.72 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.72 139.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.179 -2.526 . . . . 73.41 104.179 167.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 t0 49.82 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.121 2.968 . . . . 72.43 110.954 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -133.75 15.49 3.97 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 120.599 1.545 . . . . 72.34 113.948 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.85 155.71 42.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.529 -1.357 . . . . 72.1 111.467 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -84.82 135.32 34.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.907 2.083 . . . . 74.13 106.341 165.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.09 -1.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.831 0.678 . . . . 64.14 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -155.94 145.61 21.11 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.771 -1.206 . . . . 64.34 109.769 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -158.3 142.79 16.03 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 124.073 0.949 . . . . 74.11 109.973 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.07 170.55 15.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.872 0.844 . . . . 73.02 108.935 155.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -129.23 155.71 45.12 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.615 -1.624 . . . . 74.13 106.615 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 160.34 43.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.727 -0.842 . . . . 63.42 108.727 173.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.15 138.29 28.06 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 106.345 -1.724 . . . . 71.42 106.345 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 123.544 0.527 . . . . 74.34 109.661 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.56 136.35 21.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.159 -1.423 . . . . 73.11 107.159 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 p -67.33 136.84 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.301 0.64 . . . . 71.25 110.255 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -109.19 -5.9 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.736 1.214 . . . . 74.41 112.615 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.59 -29.97 5.05 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.132 1.825 . . . . 71.34 110.913 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -82.68 170.52 15.02 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.035 0.934 . . . . 71.44 110.554 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -54.26 136.63 42.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.412 -0.959 . . . . 70.32 108.412 164.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -93.21 135.6 34.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.057 -1.09 . . . . 70.03 108.057 168.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.7 mt -149.05 142.35 18.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.151 -2.166 . . . . 74.44 105.151 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.28 171.09 17.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.888 1.275 . . . . 74.45 109.339 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.1 p -140.06 157.68 45.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.736 1.214 . . . . 71.43 109.859 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 169.75 22.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.482 0.713 . . . . 73.42 110.638 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.89 134.57 1.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.72 0.808 . . . . 73.34 110.364 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.9 t -142.64 100.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.374 1.87 . . . . 71.11 106.112 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.45 139.49 41.86 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 74.53 109.762 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.7 p -92.73 26.69 2.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.232 -0.917 . . . . 71.42 112.551 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.37 144.85 5.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.345 -1.354 . . . . 74.4 107.345 161.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -128.67 164.3 23.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 127.407 2.283 . . . . 70.34 108.386 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.024 0 C-N-CA 127.293 2.237 . . . . 74.53 106.117 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 109.259 -1.536 . . . . 51.44 109.259 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.01 92.92 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.61 -1.256 . . . . 64.53 107.61 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t -174.74 108.29 0.11 Allowed 'General case' 0 C--O 1.237 0.427 0 N-CA-C 104.324 -2.472 . . . . 52.21 104.324 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.12 133.3 37.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.571 -1.27 . . . . 70.44 107.571 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -144.41 91.39 2.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.483 1.913 . . . . 73.43 108.346 -165.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -117.22 123.15 45.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.072 1.749 . . . . 72.41 108.467 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -129.77 176.1 8.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.895 2.078 . . . . 73.32 109.796 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.66 -133.56 5.8 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.04 -2.424 . . . . 64.21 107.04 -166.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.03 136.91 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.045 -1.465 . . . . 73.34 107.045 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -113.69 158.05 21.39 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.724 -1.213 . . . . 74.52 107.724 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -154.11 147.27 24.71 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.798 -0.815 . . . . 74.05 108.798 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mm -135.53 120.45 28.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.909 -1.886 . . . . 74.4 105.909 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.41 153.44 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.688 -1.967 . . . . 74.11 105.688 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.53 155.2 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.304 -0.999 . . . . 74.1 108.304 165.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -138.46 164.17 30.05 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.367 0.667 . . . . 73.14 110.747 163.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -142.39 156.29 45.2 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.624 0.77 . . . . 72.04 109.553 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.93 161.47 40.69 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.123 1.369 . . . . 65.23 108.059 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.5 -117.66 4.41 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.857 1.218 . . . . 74.32 110.685 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.37 104.11 16.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.36 1.064 . . . . 65.03 109.222 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.4 p -115.26 16.84 16.82 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.829 0.451 . . . . 72.12 111.23 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.99 -13.05 15.59 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.405 0.682 . . . . 64.44 110.48 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.81 23.69 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.462 1.105 . . . . 71.4 113.131 -164.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -131.97 119.33 20.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.022 0.915 . . . . 71.4 110.274 172.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.53 81.25 7.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.937 2.095 . . . . 72.21 109.141 174.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.88 106.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.947 -1.501 . . . . 73.24 106.947 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -98.14 146.05 25.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.799 -1.556 . . . . 70.3 106.799 161.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.77 152.22 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.043 -0.98 . . . . 73.0 108.67 156.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.3 t -97.25 148.25 23.3 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.11 -1.811 . . . . 71.01 106.11 159.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.5 mt -128.07 145.74 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.309 -1.738 . . . . 72.01 106.309 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.55 176.42 47.85 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.517 -1.033 . . . . 64.3 110.517 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.61 173.1 43.84 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.771 2.129 . . . . 72.15 107.925 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.26 159.73 41.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.548 1.174 . . . . 65.23 111.116 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -137.22 -173.29 3.42 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.42 2.288 . . . . 74.11 110.013 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -65.62 -10.73 38.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.673 1.189 . . . . 74.23 113.624 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.87 36.53 1.97 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.676 1.131 . . . . 71.15 113.316 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.88 -160.16 13.35 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.693 1.246 . . . . 74.24 111.752 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.08 156.2 67.39 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.033 1.822 . . . . 71.41 110.065 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.4 144.8 25.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.502 1.121 . . . . 74.1 109.942 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -69.51 139.78 53.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.05 0.841 . . . . 72.1 109.745 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.63 157.46 16.92 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.611 1.164 . . . . 74.34 108.413 171.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.2 146.81 52.27 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.703 1.201 . . . . 74.34 109.837 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -82.11 179.62 7.74 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.633 1.573 . . . . 70.12 111.109 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.49 1.43 6.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.128 1.529 . . . . 71.1 115.128 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -101.01 -9.57 21.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.595 1.089 . . . . 73.01 111.007 165.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.77 13.92 76.79 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.654 -1.081 . . . . 74.01 112.426 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.48 148.24 27.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.556 1.942 . . . . 74.13 106.69 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.96 152.83 26.56 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.111 -0.7 . . . . 74.1 109.111 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -144.08 12.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 114.442 1.275 . . . . 73.1 114.442 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 -173.74 22.16 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.345 -1.102 . . . . 74.53 110.345 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.266 21.3 p30 -125.29 2.51 7.8 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.928 1.291 . . . . 74.32 112.856 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 m -153.63 140.5 19.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.525 1.93 . . . . 73.22 108.41 162.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -168.85 171.71 8.27 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.281 1.032 . . . . 74.3 110.594 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 m -118.28 145.99 44.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.96 1.704 . . . . 73.4 108.163 167.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.54 157.06 46.64 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.564 1.946 . . . . 65.12 107.939 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -109.49 135.68 50.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.648 1.579 . . . . 72.31 108.465 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.23 87.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.445 -1.317 . . . . 74.11 107.445 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 35.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.873 1.269 . . . . 74.21 110.303 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -146.2 160.05 42.5 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.178 -0.464 . . . . 71.44 110.756 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.99 -37.85 75.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.815 0.446 . . . . 73.12 111.341 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 142.74 46.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.78 1.632 . . . . 72.21 108.516 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -135.54 163.33 30.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.626 2.37 . . . . 64.31 109.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.9 p -165.62 130.44 2.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.987 0.915 . . . . 71.24 110.456 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.8 m -139.53 154.4 47.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.905 1.282 . . . . 64.34 108.947 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -146.75 -179.81 7.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.209 1.004 . . . . 74.02 111.243 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -124.81 178.92 5.22 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.912 1.285 . . . . 74.34 110.695 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -91.56 -178.29 5.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.455 1.102 . . . . 74.12 108.691 162.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.24 10.74 52.99 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.37 0.986 . . . . 73.53 113.694 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -98.82 69.65 1.82 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.797 -1.927 . . . . 65.11 105.797 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -170.08 172.28 6.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.043 1.337 . . . . 73.52 110.638 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -130.36 -13.01 3.94 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.084 1.754 . . . . 72.55 112.782 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -159.86 174.66 14.1 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.052 0.941 . . . . 72.21 108.754 170.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.2 ttt -136.89 155.21 50.05 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.465 1.906 . . . . 70.01 106.21 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.8 p -113.14 177.5 4.61 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.706 1.203 . . . . 74.13 108.841 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.9 t -157.84 33.24 0.26 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.104 -1.039 . . . . 72.04 113.157 150.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.51 132.53 53.43 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.488 -0.758 . . . . 73.01 110.746 -172.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.69 175.65 29.6 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 109.711 -1.356 . . . . 73.34 109.711 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.6 p -136.79 160.12 39.81 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.908 0.861 . . . . 74.13 110.721 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 69.1 t -117.52 135.36 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 106.678 -1.601 . . . . 72.43 106.678 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.35 124.85 10.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.114 -0.699 . . . . 74.14 109.114 167.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -119.2 142.98 47.52 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.232 -1.395 . . . . 74.01 107.232 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.86 17.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.179 2.192 . . . . 74.43 109.315 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -88.3 179.33 6.37 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.706 1.241 . . . . 64.33 110.733 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.2 165.48 18.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 113.258 -1.792 . . . . 74.41 112.369 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.94 155.09 20.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.608 -1.178 . . . . 74.34 113.293 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.86 79.68 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.386 -0.674 . . . . 72.33 113.486 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -67.85 156.91 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.306 -1.739 . . . . 73.42 106.306 155.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -139.51 158.35 44.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.359 -1.719 . . . . 73.12 106.359 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tp -156.15 157.25 35.63 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.438 -0.949 . . . . 74.42 108.438 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -147.32 111.71 5.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.172 -1.788 . . . . 70.34 106.172 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mm -101.66 143.44 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.777 -1.564 . . . . 73.41 106.777 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.2 m -119.34 136.21 54.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.023 -1.843 . . . . 74.03 106.023 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 108.47 3.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.481 1.512 . . . . 74.45 109.696 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.0 mt -123.66 140.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.796 -1.187 . . . . 64.23 107.796 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.9 154.18 20.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 124.569 1.081 . . . . 61.04 111.531 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -142.84 152.12 41.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.183 -1.008 . . . . 72.11 110.265 -161.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.1 125.88 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 104.798 -2.297 . . . . 72.51 104.798 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 44.95 55.89 5.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.584 1.154 . . . . 72.11 112.19 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 67.31 26.85 8.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.036 2.134 . . . . 73.35 114.43 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -134.94 161.6 34.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 120.15 -1.594 . . . . 74.22 110.196 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -97.25 127.68 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.032 -1.84 . . . . 70.43 106.032 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.15 -2.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.33 0.863 . . . . 65.24 113.33 -172.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.32 138.56 13.65 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.576 -1.639 . . . . 72.34 106.576 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.17 128.87 8.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.163 0.438 . . . . 72.41 110.839 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -142.61 171.49 13.98 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.934 0.873 . . . . 72.34 110.897 166.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -137.95 165.87 25.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.001 1.72 . . . . 74.24 106.386 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -146.46 166.57 26.01 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.422 -0.584 . . . . 74.22 109.422 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.44 132.59 33.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.126 1.37 . . . . 73.14 107.838 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -127.43 154.15 45.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.442 -0.948 . . . . 74.4 108.442 171.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.3 mt -147.03 139.91 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.355 -2.091 . . . . 72.41 105.355 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -86.54 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.448 -0.783 . . . . 74.01 110.224 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -123.75 8.83 8.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.219 . . . . 72.02 111.564 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.78 -6.85 41.32 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.328 1.442 . . . . 71.13 111.505 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -102.22 174.85 5.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.84 1.256 . . . . 73.12 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.09 111.75 6.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.402 -1.333 . . . . 74.04 107.402 169.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.94 138.0 49.69 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.756 -1.201 . . . . 74.43 107.756 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -153.58 131.16 2.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.901 -1.518 . . . . 73.33 106.901 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -158.07 175.66 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.453 1.501 . . . . 73.33 111.87 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -146.64 152.29 38.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.139 1.776 . . . . 73.43 110.059 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -147.43 168.45 21.84 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.739 1.215 . . . . 73.22 109.318 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 p -168.89 128.11 1.08 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.543 0.687 . . . . 74.21 111.897 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.09 113.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.664 1.986 . . . . 73.31 106.1 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 m -97.25 158.35 15.5 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.575 -1.269 . . . . 73.22 107.575 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -107.39 38.48 2.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.705 0.684 . . . . 61.33 109.165 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -174.1 145.04 1.03 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.555 1.542 . . . . 73.43 107.561 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -147.76 131.3 16.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.723 2.809 . . . . 70.41 104.15 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.109 1.363 . . . . 72.33 110.536 -167.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 109.398 -1.481 . . . . 74.42 109.398 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.25 166.0 15.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.818 0.847 . . . . 74.15 109.65 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 p -162.14 177.3 9.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.49 1.116 . . . . 62.54 109.226 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -66.35 160.63 24.24 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.797 -0.565 . . . . 73.43 109.652 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -148.78 103.5 3.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.276 -1.75 . . . . 65.35 106.276 161.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.09 103.64 9.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.999 -1.482 . . . . 74.22 106.999 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -160.7 173.47 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.152 1.381 . . . . 72.13 108.699 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.68 -98.41 0.11 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 127.62 2.533 . . . . 53.14 107.106 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.23 135.66 61.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 125.502 1.521 . . . . 73.33 107.093 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -97.58 145.15 26.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.55 1.14 . . . . 72.51 108.7 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -141.05 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.901 0.88 . . . . 72.1 111.678 166.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.9 mm -130.86 152.16 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.035 1.734 . . . . 74.52 106.59 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.63 141.31 46.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.714 1.606 . . . . 70.11 106.942 166.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.0 mt -131.62 151.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.028 -1.101 . . . . 74.53 108.028 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -142.72 164.63 29.59 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.723 0.809 . . . . 70.53 110.992 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -156.65 139.89 15.6 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.515 1.126 . . . . 65.21 109.687 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -152.9 147.72 26.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 128.313 2.645 . . . . 70.24 107.647 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.83 -134.8 11.29 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.323 -1.111 . . . . 50.33 110.323 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.19 58.75 0.72 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.022 1.729 . . . . 45.4 111.428 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.472 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.8 p -76.13 63.22 1.8 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.365 -1.46 . . . . 72.32 109.031 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -148.93 -40.06 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.858 1.263 . . . . 74.53 110.653 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.84 60.88 1.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 124.268 1.985 . . . . 72.43 110.114 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 0.2 OUTLIER -141.53 160.18 40.69 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.582 2.753 . . . . 72.52 108.449 176.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.69 107.17 3.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.17 0.895 . . . . 74.12 108.806 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.46 92.84 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.419 1.887 . . . . 71.53 109.568 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.92 113.74 27.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 75.24 109.414 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.03 149.12 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.537 1.062 . . . . 75.51 110.078 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t -82.52 150.32 27.03 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.278 1.431 . . . . 75.14 109.413 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.61 116.01 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.56 -2.015 . . . . 75.14 105.56 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 173.53 35.15 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.811 -0.516 . . . . 54.44 111.811 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.34 169.49 36.49 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.582 2.039 . . . . 71.11 111.039 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.83 39.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.577 1.151 . . . . 74.2 111.026 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.48 -168.39 1.77 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.711 2.004 . . . . 74.43 113.258 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -77.74 77.62 4.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.146 -0.687 . . . . 64.1 109.146 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.04 49.56 0.72 Allowed Glycine 0 N--CA 1.453 -0.231 0 O-C-N 124.609 1.193 . . . . 75.53 111.768 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.79 -164.07 28.83 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 120.12 -0.267 . . . . 71.43 112.923 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.27 173.09 13.74 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.921 3.747 . . . . 72.51 110.56 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.39 117.82 35.72 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.477 1.111 . . . . 75.42 109.46 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -60.02 124.14 19.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.285 0.948 . . . . 75.41 110.396 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.02 162.83 15.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.163 1.385 . . . . 75.23 109.455 -174.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -131.03 152.76 49.99 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.358 -0.979 . . . . 75.3 108.358 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.287 1.5 p30 -79.05 -152.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.596 1.558 . . . . 73.33 110.228 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.86 2.32 32.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 119.727 -1.858 . . . . 75.11 113.231 174.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -106.2 -2.52 22.38 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.838 2.055 . . . . 74.52 111.63 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.46 56.87 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.46 1.505 . . . . 73.53 113.262 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -113.99 141.2 47.71 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.874 1.337 . . . . 72.21 109.86 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -66.94 135.06 53.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.208 1.803 . . . . 75.32 109.309 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.68 32.1 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.205 1.002 . . . . 75.31 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.1 176.18 27.81 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-O 122.432 1.018 . . . . 71.54 110.702 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.22 6.53 35.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.872 1.269 . . . . 62.42 112.524 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 p -167.48 125.62 1.26 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.908 0.883 . . . . 62.4 112.139 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -167.86 -175.43 2.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.561 0.744 . . . . 75.44 111.007 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -122.84 160.74 25.42 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.068 1.347 . . . . 72.43 108.571 162.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.16 127.83 17.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.83 -1.545 . . . . 61.53 106.83 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -78.69 149.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.921 -1.14 . . . . 74.42 107.921 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mm -86.42 112.75 23.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.108 -1.071 . . . . 71.54 108.108 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.26 37.77 3.69 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.861 1.265 . . . . 74.22 108.902 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -142.0 160.44 40.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.722 -1.214 . . . . 73.54 107.722 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 -16.92 62.69 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.277 -0.889 . . . . 64.11 113.235 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 p -145.22 150.85 37.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.703 1.601 . . . . 73.5 107.506 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmm -142.69 166.96 23.24 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.783 1.633 . . . . 74.21 110.641 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.6 p -162.26 151.89 16.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.251 1.42 . . . . 73.24 109.566 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.9 m -143.25 145.66 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.363 1.865 . . . . 64.32 107.665 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.8 p -143.82 -179.86 6.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.492 0.587 . . . . 65.43 111.254 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.1 p -129.34 -171.24 2.45 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.462 1.105 . . . . 73.12 110.633 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.6 -154.47 0.46 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.17 -1.048 . . . . 74.14 108.17 165.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.38 35.83 4.63 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.914 1.245 . . . . 74.52 112.526 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -135.86 87.95 2.36 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.694 -1.595 . . . . 74.2 106.694 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -171.2 166.17 7.23 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.33 1.452 . . . . 74.11 111.025 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.81 -16.11 7.23 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.476 1.51 . . . . 74.41 112.815 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.78 165.19 36.15 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.892 -1.151 . . . . 74.1 107.892 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 ttt -131.1 156.38 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 104.569 -2.382 . . . . 72.21 104.569 164.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -130.94 152.4 50.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.682 -0.859 . . . . 72.54 108.682 167.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.17 87.78 2.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.381 -2.081 . . . . 71.12 105.381 167.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.4 136.77 53.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.15 1.78 . . . . 71.23 107.123 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.98 -148.65 5.06 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 121.564 -0.71 . . . . 73.12 111.477 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -150.25 171.49 16.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.388 1.475 . . . . 64.13 109.427 161.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.53 143.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.058 1.343 . . . . 65.4 108.1 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -142.18 163.05 33.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.267 0.354 . . . . 62.52 110.777 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 t -135.68 160.01 39.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.946 1.698 . . . . 75.2 107.885 165.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 pt -133.95 21.08 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 128.233 2.613 . . . . 74.44 108.987 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -81.19 -177.75 6.6 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 123.145 1.45 . . . . 64.5 109.881 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -73.99 170.62 15.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.029 -1.896 . . . . 64.2 109.275 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 165.29 3.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.669 1.188 . . . . 71.51 112.514 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.64 71.77 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.579 1.561 . . . . 61.3 114.111 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.45 134.94 36.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.736 1.768 . . . . 74.4 108.269 -176.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -125.99 129.16 48.66 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.745 1.157 . . . . 71.2 111.124 -169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.29 158.95 25.05 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.285 2.234 . . . . 74.21 105.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -161.14 101.38 1.24 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.146 -1.798 . . . . 74.33 106.146 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.71 143.78 21.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.258 -1.756 . . . . 72.34 106.258 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m -131.46 144.74 51.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.716 -1.587 . . . . 73.54 106.716 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.24 112.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 125.702 1.601 . . . . 54.22 109.231 -164.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.22 143.96 39.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.395 1.478 . . . . 74.21 107.046 -170.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.67 140.49 11.84 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.897 -0.881 . . . . 65.53 110.897 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -134.64 144.91 48.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.158 1.383 . . . . 74.42 110.099 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.65 118.6 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 105.193 -2.151 . . . . 70.12 105.193 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 t70 43.91 71.32 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.64 1.576 . . . . 62.31 112.153 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.08 27.29 3.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.251 2.221 . . . . 70.33 113.694 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -129.8 158.56 39.11 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 120.799 -1.188 . . . . 74.21 110.94 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.82 134.87 40.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.228 1.411 . . . . 72.15 107.456 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.51 -0.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.852 0.861 . . . . 71.14 112.101 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -161.87 153.52 18.8 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.399 -0.963 . . . . 73.51 108.399 165.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.62 122.86 3.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.691 -1.596 . . . . 74.25 106.691 170.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.49 171.25 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.895 0.747 . . . . 71.22 110.753 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.05 168.8 14.81 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.614 1.966 . . . . 74.44 109.376 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -150.86 170.6 18.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.585 -1.265 . . . . 71.21 107.585 162.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.55 154.91 51.23 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 127.852 2.461 . . . . 73.54 107.727 169.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -137.79 154.83 49.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.987 -0.746 . . . . 71.14 108.987 164.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -145.27 134.16 17.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.707 -1.22 . . . . 74.1 107.707 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 p -75.58 131.81 40.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.687 0.795 . . . . 74.14 109.929 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -128.64 66.26 1.41 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.06 0.933 . . . . 73.2 108.793 161.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.21 15.71 79.78 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.703 -0.68 . . . . 63.53 114.26 163.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.55 162.97 32.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.58 1.552 . . . . 74.21 110.273 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 105.69 1.35 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.342 -0.844 . . . . 75.23 109.896 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.08 133.14 50.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.335 -0.987 . . . . 73.13 108.335 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -149.37 138.62 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.854 -2.276 . . . . 74.44 104.854 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.58 166.92 32.01 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.66 1.184 . . . . 65.23 111.484 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.1 p -136.81 153.7 50.74 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.143 0.977 . . . . 74.44 111.182 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -142.97 174.47 10.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.005 1.722 . . . . 73.53 108.943 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 t -164.38 144.08 7.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.503 -0.748 . . . . 63.23 109.621 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -143.19 109.61 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.134 -2.173 . . . . 74.51 105.134 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 128.1 55.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.172 1.389 . . . . 65.5 107.574 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 5.4 44.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.924 1.083 . . . . 74.12 113.924 -172.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.3 116.52 6.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.116 -1.615 . . . . 73.52 106.775 171.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -133.65 168.34 18.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.125 1.37 . . . . 64.42 107.951 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--O 1.251 1.149 0 N-CA-C 105.153 -2.166 . . . . 74.11 105.153 -175.897 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 108.889 -1.684 . . . . 54.52 108.889 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.63 167.51 12.94 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.109 0.954 . . . . 74.05 109.357 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -153.89 72.92 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.66 1.184 . . . . 75.33 107.942 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.98 136.29 36.58 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.502 -0.925 . . . . 75.32 108.502 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -151.51 119.92 6.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.076 1.751 . . . . 75.44 108.789 167.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.37 99.8 6.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.39 1.876 . . . . 75.05 108.091 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -135.65 -174.36 3.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 128.415 2.686 . . . . 63.45 108.777 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.49 -97.72 0.11 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 106.859 -2.496 . . . . 53.21 106.859 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.49 147.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.624 -2.362 . . . . 72.01 104.624 167.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -107.12 146.73 30.91 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.725 -1.583 . . . . 75.14 106.725 166.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -142.66 145.36 33.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.932 -1.507 . . . . 72.4 106.932 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 tp -119.95 152.28 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.792 -1.558 . . . . 74.14 106.792 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.2 t -126.82 137.43 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.561 -2.385 . . . . 74.53 104.561 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.1 151.6 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.358 -2.09 . . . . 73.42 105.358 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.62 166.35 24.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.29 -1.004 . . . . 72.51 108.29 170.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -138.4 171.63 14.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.413 0.685 . . . . 72.33 109.426 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -161.78 174.14 13.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.053 2.141 . . . . 74.23 107.686 164.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.82 -147.68 18.58 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.317 -1.513 . . . . 65.33 109.317 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.88 78.67 3.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.056 0.931 . . . . 72.1 111.197 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -73.29 39.63 0.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.676 1.59 . . . . 73.33 112.534 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -142.49 -11.38 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.439 1.496 . . . . 74.23 113.239 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 14.05 1.04 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.579 1.081 . . . . 73.22 113.134 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.49 167.19 18.65 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.008 0.923 . . . . 74.24 110.061 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.3 111.62 6.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.264 -1.754 . . . . 70.43 106.264 163.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 112.83 33.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.801 -1.926 . . . . 74.53 105.801 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -110.03 121.71 45.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.783 -1.192 . . . . 53.44 107.783 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 m -95.26 137.53 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.368 -1.345 . . . . 72.22 107.368 163.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.94 145.36 34.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.161 -1.422 . . . . 73.53 107.161 155.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -130.08 123.26 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.041 -2.207 . . . . 73.54 105.041 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.81 167.78 37.38 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.913 0.768 . . . . 51.04 111.487 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.72 39.38 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.972 1.748 . . . . 72.13 109.003 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.96 164.32 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.654 1.227 . . . . 71.21 111.425 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.18 175.85 9.25 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.923 1.689 . . . . 74.34 112.722 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -74.71 78.54 2.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.526 -0.916 . . . . 74.02 108.526 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.54 35.82 1.38 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-O 118.572 -1.127 . . . . 74.2 113.554 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.21 -172.12 30.8 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.918 1.859 . . . . 72.32 112.692 162.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.06 134.28 21.09 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.423 2.082 . . . . 70.33 107.662 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.91 131.06 42.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.406 1.082 . . . . 64.51 109.625 -167.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -61.68 122.24 14.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.433 -0.58 . . . . 70.22 109.433 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.09 154.97 17.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.177 1.791 . . . . 71.51 107.768 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -133.84 141.96 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.718 -1.586 . . . . 74.53 106.718 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -73.58 -154.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.439 1.896 . . . . 61.34 111.457 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -100.14 -3.17 32.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.02 1.728 . . . . 65.42 112.773 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -111.48 17.37 20.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.198 2.199 . . . . 70.5 110.109 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.09 19.06 69.71 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.634 1.588 . . . . 51.31 114.234 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -102.58 156.52 17.56 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 119.694 1.747 . . . . 71.22 107.958 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -85.43 150.48 24.68 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.47 -1.307 . . . . 72.2 107.47 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.2 pt -150.67 23.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.876 0.87 . . . . 74.31 112.927 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.32 -172.18 14.08 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.578 -1.326 . . . . 54.32 111.955 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -119.18 -4.99 10.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.843 2.057 . . . . 73.43 112.544 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -164.38 134.87 4.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.208 -1.405 . . . . 73.34 107.208 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -168.4 -173.86 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.013 1.725 . . . . 73.2 108.651 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.44 165.58 14.75 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.206 1.002 . . . . 74.33 110.17 159.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.84 133.06 26.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.963 1.305 . . . . 73.32 107.985 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -78.95 136.46 37.25 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.605 -0.517 . . . . 74.24 109.605 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 mm -78.86 74.43 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.778 0.831 . . . . 73.14 109.516 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.38 13.78 12.8 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.178 1.177 . . . . 73.42 114.178 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.4 p -118.52 161.11 20.56 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.989 0.916 . . . . 64.33 109.386 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.7 92.57 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 73.13 109.29 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.4 p -132.82 140.23 47.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.721 1.208 . . . . 74.43 108.671 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.05 168.42 19.64 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.325 1.85 . . . . 74.12 110.956 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.5 p -165.92 144.18 5.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.396 0.678 . . . . 64.53 110.885 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.3 m -127.1 157.77 38.78 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.487 -1.301 . . . . 64.41 107.487 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -146.86 -176.92 5.39 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.152 0.887 . . . . 72.3 110.611 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.0 p -134.91 177.75 7.55 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.353 0.661 . . . . 74.32 110.571 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -73.45 -172.53 1.2 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.074 1.35 . . . . 74.31 112.0 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.42 -5.54 72.98 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.783 -1.198 . . . . 73.34 115.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -130.82 109.25 10.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.767 2.027 . . . . 73.0 107.99 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.2 165.56 24.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.178 2.191 . . . . 74.5 110.103 166.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -117.55 -19.29 9.48 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.203 1.401 . . . . 74.52 113.268 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -159.86 172.51 17.5 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.89 0.768 . . . . 73.3 109.327 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.3 ttt -141.17 155.83 46.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.529 -2.026 . . . . 65.12 105.529 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -139.3 156.95 46.69 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.966 0.906 . . . . 74.53 108.911 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.54 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 2.1 t -123.94 16.27 9.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.727 1.611 . . . . 74.22 111.798 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.4 129.14 21.36 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 125.752 1.621 . . . . 73.3 110.632 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.7 -179.83 31.09 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 64.44 111.263 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.89 150.73 43.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.246 2.218 . . . . 72.33 107.809 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.295 1.6 p -138.04 155.89 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 74.24 110.552 169.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -151.73 179.18 8.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.214 -1.402 . . . . 72.4 107.214 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.5 t -161.91 164.69 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.218 1.407 . . . . 70.13 108.417 165.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.11 -0.11 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.914 1.286 . . . . 74.13 112.115 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.84 -176.5 1.69 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.752 1.263 . . . . 72.22 109.253 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -72.51 175.59 6.15 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 73.11 111.107 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 166.88 8.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.693 1.597 . . . . 74.53 113.169 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.43 37.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.312 1.911 . . . . 51.02 114.805 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -87.67 115.34 25.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.382 1.873 . . . . 74.52 106.987 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 167.59 9.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.573 1.149 . . . . 74.44 109.776 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.87 97.15 1.54 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.757 -1.201 . . . . 74.3 107.757 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -87.86 138.9 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.621 -1.622 . . . . 75.33 106.621 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 mm -128.28 140.05 50.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 106.157 -1.794 . . . . 74.23 106.157 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m -124.03 135.72 53.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.156 -1.794 . . . . 74.34 106.156 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.59 110.94 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 108.126 -1.065 . . . . 71.34 108.126 -172.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.55 141.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.929 1.292 . . . . 75.32 108.497 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.58 144.56 15.69 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.361 0.981 . . . . 75.13 113.3 -173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -128.82 158.58 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.049 1.74 . . . . 74.33 110.82 -169.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.72 110.35 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.454 -2.054 . . . . 73.54 105.454 168.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 t0 72.6 -67.41 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.924 2.489 . . . . 75.02 110.012 168.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -153.97 10.45 0.4 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.784 1.634 . . . . 74.21 112.971 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -123.15 152.38 41.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.571 1.078 . . . . 72.24 111.486 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.46 121.51 39.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.537 1.535 . . . . 73.31 108.091 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.09 -15.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 73.23 112.881 -169.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.38 141.63 25.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.545 1.066 . . . . 75.51 108.689 -170.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.61 158.08 3.3 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.661 0.784 . . . . 73.25 111.469 173.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.14 172.62 16.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.119 1.512 . . . . 75.12 108.432 156.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.21 163.96 16.97 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.789 -1.189 . . . . 71.43 107.789 169.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -143.68 165.95 26.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.043 1.337 . . . . 74.35 109.409 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -162.53 120.95 2.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.439 -2.164 . . . . 75.31 109.507 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.465 ' CZ ' ' HG3' ' A' ' 117' ' ' GLU . 26.8 m-85 -131.5 149.43 52.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.077 0.861 . . . . 75.51 110.316 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mt -144.73 118.32 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.81 -1.552 . . . . 72.12 106.81 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 p -64.6 142.43 58.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.925 1.29 . . . . 71.42 110.993 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.56 51.73 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.313 2.245 . . . . 73.3 107.675 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.5 7.21 85.27 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.927 1.251 . . . . 73.42 114.338 167.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -127.68 179.59 5.44 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.295 2.238 . . . . 74.52 108.98 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -63.5 134.7 56.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.164 -0.68 . . . . 71.54 109.164 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.453 HD11 ' H ' ' A' ' 116' ' ' ILE . 18.5 tp -95.39 135.36 37.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.7 2.0 . . . . 74.1 107.563 170.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.453 ' H ' HD11 ' A' ' 115' ' ' LEU . 45.7 mt -164.76 133.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 128.68 2.792 . . . . 73.32 110.643 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.465 ' HG3' ' CZ ' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -159.55 167.03 29.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.268 2.627 . . . . 74.52 112.838 -176.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -136.33 158.57 44.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.554 1.541 . . . . 72.41 110.42 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.11 164.92 28.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.365 1.866 . . . . 74.41 108.512 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -150.89 129.54 12.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.089 0.471 . . . . 75.4 110.081 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 8.8 p -129.9 131.06 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.274 -1.75 . . . . 63.15 106.274 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.9 m -128.69 -179.61 5.16 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.3 p -135.28 33.84 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.566 -0.709 . . . . 73.33 109.103 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -173.74 117.74 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.585 -1.635 . . . . 75.42 106.585 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -134.3 169.31 17.41 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.753 1.221 . . . . 73.31 108.111 163.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.382 1.473 . . . . 73.54 107.904 -175.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 108.982 -1.647 . . . . 74.33 108.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.72 86.89 2.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 103.068 -2.938 . . . . 74.25 103.068 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -163.02 151.92 14.67 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.63 -1.618 . . . . 73.13 106.63 -162.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.82 87.74 1.64 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.432 -0.951 . . . . 62.25 108.432 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -136.2 98.93 3.98 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.007 0.923 . . . . 73.33 108.869 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -110.94 106.09 15.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.969 1.708 . . . . 64.53 108.114 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 p -147.72 172.42 14.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.726 2.41 . . . . 73.11 107.185 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.42 -90.76 0.08 OUTLIER Glycine 0 C--N 1.338 0.64 0 O-C-N 121.032 -1.043 . . . . 54.14 110.706 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.8 145.68 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 104.965 -2.235 . . . . 74.42 104.965 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 23.6 m-70 -120.73 148.97 43.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.912 1.233 . . . . 63.43 108.601 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 161.22 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.832 . . . . 74.15 109.714 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mm -140.35 136.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.25 -1.759 . . . . 65.22 106.25 170.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.5 t -113.95 144.87 20.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.17 2.188 . . . . 65.35 107.031 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.22 154.13 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.84 -1.541 . . . . 72.32 106.84 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -144.73 168.35 20.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.696 -1.224 . . . . 71.43 107.696 172.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -146.72 164.53 32.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.301 0.572 . . . . 72.44 111.358 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 m -157.05 172.14 19.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.159 2.584 . . . . 73.03 108.291 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.46 -151.56 19.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.026 -1.23 . . . . 62.41 110.026 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -76.04 64.86 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 123.444 1.592 . . . . 75.25 110.423 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -61.57 -14.28 28.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.495 . . . . 73.33 113.151 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.82 -30.64 62.82 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.397 0.679 . . . . 73.34 112.146 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.0 1.14 11.42 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.122 0.786 . . . . 62.22 113.122 -162.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.17 111.46 21.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.751 -1.574 . . . . 73.35 106.751 -173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 150.88 38.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.138 -0.69 . . . . 74.33 109.138 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.04 111.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 106.899 -1.519 . . . . 75.41 106.899 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -112.73 127.69 56.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.946 -1.131 . . . . 73.54 107.946 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.26 147.96 32.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.777 0.831 . . . . 62.32 109.361 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 t -117.92 120.68 38.6 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.201 2.201 . . . . 74.53 107.739 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.3 mt -120.35 125.31 74.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 74.54 108.39 -156.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.01 169.1 35.87 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 121.267 0.37 . . . . 72.22 113.099 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.05 174.21 39.34 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 127.303 2.383 . . . . 73.21 108.239 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.43 147.23 50.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 119.898 1.849 . . . . 72.35 110.227 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.07 179.49 4.03 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.752 2.421 . . . . 44.1 111.383 -172.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.37 76.2 0.16 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.825 0.85 . . . . 64.22 110.561 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.42 34.0 4.32 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.775 1.178 . . . . 74.34 111.734 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.9 175.42 47.5 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.637 1.218 . . . . 72.32 112.759 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.48 134.16 34.78 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.66 2.24 . . . . 72.32 108.921 159.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.87 128.23 34.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.831 -0.804 . . . . 73.14 108.831 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -56.0 123.25 13.75 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.271 -0.64 . . . . 72.44 109.271 169.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.69 164.6 13.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 124.222 0.951 . . . . 74.51 109.16 169.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -137.38 143.36 41.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.417 1.887 . . . . 72.12 107.926 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -69.59 -152.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.267 2.627 . . . . 75.23 110.944 174.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -99.91 -3.64 31.97 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.403 -1.435 . . . . 74.32 114.322 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -98.74 -3.5 35.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.321 -1.487 . . . . 75.3 111.6 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.99 9.49 56.01 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 127.356 2.407 . . . . 55.5 112.396 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -110.32 142.39 42.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 120.589 2.195 . . . . 75.12 108.334 -165.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -64.32 131.32 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.439 1.496 . . . . 74.44 108.704 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.54 9.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.063 0.945 . . . . 73.33 111.81 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.87 175.62 22.99 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.441 -1.063 . . . . 74.51 110.441 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.98 11.62 17.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.075 0.95 . . . . 75.33 110.727 166.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -162.3 157.13 22.36 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 126.791 2.036 . . . . 64.34 106.415 151.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -176.99 -174.99 0.56 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.493 1.917 . . . . 75.23 110.878 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.7 p -122.38 158.3 29.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.613 2.365 . . . . 75.3 108.369 161.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.96 106.06 3.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.299 -0.63 . . . . 73.34 109.299 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.43 145.09 52.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.598 0.714 . . . . 75.53 110.049 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mm -75.68 135.58 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.058 -1.46 . . . . 75.23 107.058 167.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.1 7.74 3.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.356 1.062 . . . . 71.02 110.816 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -139.51 152.39 46.91 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.073 -1.017 . . . . 72.32 108.874 -148.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -31.22 64.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.99 0.359 . . . . 72.41 111.937 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -134.99 164.18 28.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.827 1.251 . . . . 72.33 109.328 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.28 171.2 15.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.814 2.045 . . . . 75.23 109.912 170.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 p -173.46 156.78 3.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.668 1.587 . . . . 74.44 111.17 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.6 m -150.06 165.81 31.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.482 2.713 . . . . 72.34 107.416 162.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 p -147.88 -179.85 7.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.125 0.97 . . . . 60.24 111.28 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.8 p -102.9 164.91 11.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.662 1.185 . . . . 74.41 109.334 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.42 169.42 4.75 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.235 -0.586 . . . . 74.44 109.608 152.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.36 36.94 1.78 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.072 0.844 . . . . 65.54 113.123 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -146.33 90.17 1.93 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.237 -2.134 . . . . 65.43 105.237 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.6 141.94 17.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.319 1.847 . . . . 74.35 106.977 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -86.09 -22.43 27.15 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.446 1.098 . . . . 73.44 111.832 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.407 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 25.6 p90 -157.38 167.33 30.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.697 1.199 . . . . 74.33 108.481 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.57 148.86 49.24 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.302 -2.11 . . . . 74.25 105.302 159.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.6 t -140.55 157.83 44.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.302 -0.999 . . . . 74.34 108.302 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.47 79.06 1.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.923 1.289 . . . . 73.11 109.157 -169.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.43 156.33 31.19 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.222 -0.659 . . . . 64.43 109.222 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.4 174.49 41.21 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 121.947 0.748 . . . . 72.45 112.662 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.6 t -146.33 148.59 32.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 126.337 1.855 . . . . 74.51 107.724 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.05 136.41 53.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 126.097 1.759 . . . . 73.45 106.718 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -148.57 151.86 35.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.698 0.799 . . . . 74.45 110.906 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -150.15 151.08 32.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.126 0.97 . . . . 72.32 108.462 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 5.15 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.367 2.267 . . . . 73.41 110.827 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 p -63.01 169.46 3.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.185 0.994 . . . . 62.45 110.322 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 168.18 9.68 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.319 1.057 . . . . 73.05 112.252 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.4 19.14 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.561 -1.654 . . . . 72.21 112.854 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.85 57.88 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.873 1.225 . . . . 73.13 114.014 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -75.19 167.07 22.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.21 1.505 . . . . 74.25 107.313 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -153.87 174.03 15.14 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.952 -1.093 . . . . 74.32 111.118 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tp -158.46 152.78 24.21 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.338 -0.986 . . . . 64.32 108.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -140.57 131.38 25.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.409 -1.7 . . . . 73.14 106.409 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.51 116.97 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 106.429 -1.693 . . . . 72.44 106.429 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -96.99 139.33 33.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.24 -1.763 . . . . 74.42 106.24 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.36 132.07 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.004 -2.221 . . . . 73.13 105.004 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.1 mt -142.58 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 107.727 -1.212 . . . . 74.25 107.727 -172.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.27 143.95 17.97 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 109.002 -1.639 . . . . 72.51 109.002 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -132.88 152.59 51.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.239 1.015 . . . . 72.55 110.333 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.1 mt -132.52 124.26 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.609 -2.367 . . . . 74.35 104.609 167.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 44.77 68.4 0.56 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.198 1.799 . . . . 70.54 110.804 163.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.6 1.83 3.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.148 1.536 . . . . 52.41 115.148 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -132.11 153.11 50.82 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.072 1.306 . . . . 74.22 111.227 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -86.02 148.23 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.113 0.482 . . . . 73.54 110.034 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 m -135.27 1.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.938 1.295 . . . . 71.43 111.657 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.56 140.68 8.53 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 120.908 -1.12 . . . . 74.13 108.605 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -158.54 144.47 16.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.999 0.919 . . . . 70.41 109.311 162.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.18 108.02 2.53 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.829 0.823 . . . . 74.24 109.435 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.64 157.76 37.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.621 -1.299 . . . . 72.22 108.997 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 173.69 7.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.823 -1.547 . . . . 72.33 106.823 159.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -145.94 132.29 19.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 74.33 106.301 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.5 165.62 20.36 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.898 0.772 . . . . 73.04 110.246 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.9 mt -150.47 137.03 12.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.968 2.507 . . . . 73.24 105.783 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.2 144.72 30.49 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.993 0.917 . . . . 74.41 108.875 170.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -129.68 13.5 5.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 64.02 111.599 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.5 55.36 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 121.314 -0.866 . . . . 71.23 112.94 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -90.17 170.27 10.44 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.559 1.544 . . . . 65.32 107.892 160.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.59 139.66 58.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.808 -1.182 . . . . 72.31 107.808 161.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -97.65 134.22 41.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.699 -1.223 . . . . 74.13 107.699 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.8 mt -145.5 141.93 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.251 -2.129 . . . . 74.43 105.251 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.74 168.23 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.632 1.573 . . . . 65.41 109.318 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.2 p -140.91 157.61 45.11 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.687 1.195 . . . . 74.51 109.152 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.25 171.88 18.51 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.394 -0.821 . . . . 73.45 109.129 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -151.93 142.83 23.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.421 1.088 . . . . 64.55 108.419 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.87 85.78 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.767 -1.938 . . . . 73.31 105.767 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -64.88 170.02 4.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.59 -0.893 . . . . 71.13 108.59 160.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 p -127.87 -12.13 5.36 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.549 -0.719 . . . . 74.42 111.444 159.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.13 112.76 5.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.413 -1.699 . . . . 74.45 106.413 -169.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -151.23 -172.56 4.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.741 -1.207 . . . . 73.35 107.741 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.31 -1.329 . . . . 74.42 108.436 165.47 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.242 -2.343 . . . . 72.35 107.242 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.27 58.85 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.036 -1.098 . . . . 72.25 108.036 162.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -136.23 155.96 49.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.833 -1.543 . . . . 62.21 106.833 163.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.25 113.2 16.66 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.082 -0.386 . . . . 72.02 110.474 -153.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -126.26 94.39 4.07 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.13 0.972 . . . . 74.23 110.022 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -115.59 102.03 9.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.537 1.935 . . . . 74.41 106.846 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -153.78 -178.32 6.97 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.815 0.817 . . . . 73.23 111.338 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.02 -119.8 0.93 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.799 3.095 . . . . 71.03 106.311 -166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.01 103.93 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 74.33 108.456 -167.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.472 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 50.1 m-70 -74.38 154.86 38.64 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.962 -0.461 . . . . 73.01 109.771 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -145.86 152.26 39.19 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.817 1.247 . . . . 75.22 107.905 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -127.24 152.43 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.294 2.238 . . . . 71.32 105.489 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.83 136.04 54.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.396 -2.076 . . . . 72.23 105.396 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.4 mt -122.91 150.82 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 105.959 -1.867 . . . . 73.34 105.959 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -142.9 163.36 33.01 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.053 -1.462 . . . . 64.21 107.053 166.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -136.93 154.45 50.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.625 -1.25 . . . . 72.25 107.625 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -145.36 171.01 15.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.785 -1.561 . . . . 64.23 106.785 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.29 -137.47 14.22 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.023 -1.631 . . . . 74.32 109.023 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -89.98 65.42 6.58 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.521 1.529 . . . . 75.35 109.79 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.8 p -75.42 35.5 0.12 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.161 2.184 . . . . 72.04 113.338 -164.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -142.6 8.48 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.244 1.417 . . . . 72.44 111.644 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 m -149.19 7.64 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.106 1.762 . . . . 63.25 111.412 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.75 141.91 50.03 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.074 -1.016 . . . . 74.04 109.103 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -116.1 116.56 28.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.229 -1.767 . . . . 74.22 106.229 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.75 90.14 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.462 -0.94 . . . . 72.34 108.462 -171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -86.89 145.23 26.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.046 -1.033 . . . . 72.34 108.298 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.14 129.12 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.316 1.046 . . . . 73.13 109.469 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -64.59 138.12 58.22 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.723 -1.584 . . . . 74.44 106.723 160.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 122.27 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.129 -2.175 . . . . 73.31 105.129 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.69 167.38 35.22 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.048 -0.821 . . . . 41.42 111.048 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.04 170.95 44.13 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.388 1.947 . . . . 73.2 109.065 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.69 164.78 21.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.852 0.861 . . . . 62.12 109.999 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -131.24 -164.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.255 1.822 . . . . 74.42 111.074 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -79.82 71.59 6.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.845 -0.428 . . . . 71.42 109.845 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.58 -22.6 2.01 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-O 119.035 -0.869 . . . . 53.2 114.2 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.69 -154.8 8.09 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.102 -1.199 . . . . 74.14 110.102 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.1 154.92 42.4 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.726 2.284 . . . . 74.12 110.515 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 110.79 20.77 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.214 1.406 . . . . 74.41 108.993 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -45.46 116.25 1.11 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.988 1.715 . . . . 72.24 111.531 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.71 160.2 15.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.956 0.884 . . . . 74.13 110.09 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -129.09 152.09 49.06 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.677 1.591 . . . . 75.42 107.897 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -96.5 172.75 7.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 73.3 110.424 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -65.47 -9.47 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.096 1.758 . . . . 73.43 113.978 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -87.52 -8.52 56.28 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.652 1.581 . . . . 71.2 111.152 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.1 59.09 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.921 1.724 . . . . 73.23 113.741 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -104.7 147.15 27.99 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.698 1.249 . . . . 74.02 109.251 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -66.29 135.76 54.87 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.003 -1.11 . . . . 71.13 108.003 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -136.63 28.83 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.713 0.805 . . . . 74.04 111.509 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.06 18.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.4 -1.08 . . . . 73.0 110.4 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.04 2.95 55.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.134 1.773 . . . . 70.24 113.246 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -165.77 157.38 14.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.565 1.546 . . . . 73.31 108.375 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.3 p90 177.92 -173.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.578 2.351 . . . . 74.23 109.726 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 m -119.28 153.0 35.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.648 1.179 . . . . 73.41 108.246 154.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.79 110.29 7.02 Favored 'General case' 0 CA--C 1.523 -0.086 0 C-N-CA 124.328 1.051 . . . . 75.42 108.332 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -73.19 145.1 46.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.096 0.958 . . . . 74.42 110.383 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -80.51 118.78 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.734 -1.58 . . . . 75.22 106.734 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.55 29.37 2.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.037 1.335 . . . . 75.21 108.604 167.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 p -135.51 157.25 47.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.446 1.098 . . . . 75.03 108.862 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.52 -40.66 79.22 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.28 0.632 . . . . 63.24 110.408 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.5 p -133.76 163.67 28.96 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.74 0.816 . . . . 55.51 110.878 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 mmm -142.43 170.62 15.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.297 1.839 . . . . 74.03 111.563 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 p -160.9 154.76 22.49 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.22 1.808 . . . . 72.34 108.641 165.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.8 m -143.91 150.43 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.203 1.801 . . . . 74.44 107.851 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.6 p -149.15 179.74 7.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.164 0.983 . . . . 75.04 110.529 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -119.29 -174.65 2.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.28 -1.748 . . . . 74.23 106.28 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -92.37 -176.57 4.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.533 -1.284 . . . . 75.33 107.533 158.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.76 64.33 2.63 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.961 -1.087 . . . . 61.4 111.684 173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.94 71.75 1.35 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 103.883 -2.636 . . . . 71.4 103.883 169.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.89 32.94 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.134 -0.978 . . . . 71.2 111.247 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.09 -7.13 2.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.172 1.789 . . . . 74.1 112.552 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 29.6 p90 -157.29 170.66 21.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.36 -1.348 . . . . 73.24 107.36 163.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.7 ttt -146.29 147.66 31.61 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 105.136 -2.172 . . . . 74.43 105.136 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.5 t -135.36 164.97 26.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.82 0.819 . . . . 71.01 110.002 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.32 106.91 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.703 -2.332 . . . . 74.22 104.703 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 142.97 41.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.906 -1.887 . . . . 72.32 105.906 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.54 -151.05 5.55 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 120.94 -0.648 . . . . 74.11 111.813 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.24 175.49 10.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.137 -0.69 . . . . 74.24 109.137 147.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -137.15 147.46 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.661 1.584 . . . . 74.23 109.273 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.5 m -149.32 167.71 25.35 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.43 -0.794 . . . . 73.04 112.743 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 t -143.47 151.61 40.51 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.771 2.029 . . . . 72.41 107.05 158.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.02 48.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.839 . . . . 74.12 107.616 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.1 m -127.72 174.62 8.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.292 1.037 . . . . 70.15 112.499 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -55.14 158.53 2.91 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.631 1.972 . . . . 65.31 110.817 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.8 167.14 1.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.196 1.398 . . . . 65.14 112.974 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.52 -13.65 33.75 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.043 1.306 . . . . 50.54 114.157 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -67.43 132.45 47.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.119 1.46 . . . . 74.22 108.215 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.0 mtt85 -110.38 159.78 17.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.711 -1.218 . . . . 74.41 107.711 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.67 141.42 26.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.87 -1.529 . . . . 71.33 106.87 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -145.79 92.92 2.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.993 -1.484 . . . . 73.25 106.993 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.61 143.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.442 -1.688 . . . . 73.14 106.442 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -119.28 136.47 54.22 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.493 -1.669 . . . . 72.02 106.493 165.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.51 115.07 12.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 125.655 1.582 . . . . 74.12 108.842 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.67 153.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.348 -1.723 . . . . 73.44 106.348 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.16 158.18 27.61 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.695 -0.962 . . . . 71.45 110.695 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -143.35 152.92 42.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.947 0.899 . . . . 74.24 110.369 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.8 mt -121.81 120.76 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.288 -2.115 . . . . 73.24 105.288 165.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.5 t0 72.39 -83.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.122 2.969 . . . . 73.02 110.197 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.73 24.73 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.58 1.952 . . . . 64.41 108.702 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -135.74 132.85 37.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.266 -0.896 . . . . 75.42 110.746 -166.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.31 136.17 57.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.992 -0.744 . . . . 74.45 108.992 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.59 -25.55 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.16 0.984 . . . . 74.01 108.823 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -145.89 142.92 29.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.512 1.525 . . . . 74.23 107.768 -168.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -167.23 112.0 0.72 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.642 1.177 . . . . 74.43 109.095 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.07 173.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.551 0.532 . . . . 74.21 109.893 162.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -128.3 172.76 10.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 72.21 108.068 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 147.12 33.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.704 -0.85 . . . . 71.13 108.704 164.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -120.61 136.11 54.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.655 -0.869 . . . . 65.41 108.655 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -138.65 155.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.044 0.938 . . . . 72.21 108.849 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.88 135.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.17 -1.419 . . . . 72.01 107.17 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -65.86 144.23 56.95 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.076 0.95 . . . . 54.13 109.328 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -137.0 21.34 3.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.97 0.804 . . . . 73.34 112.546 164.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.12 -24.1 31.62 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.15 1.833 . . . . 72.12 111.336 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.47 159.08 27.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.789 -0.819 . . . . 63.33 108.789 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.42 120.64 21.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.759 -1.571 . . . . 65.13 106.759 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.1 21.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.42 -1.696 . . . . 70.42 106.42 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.03 142.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 105.699 -1.963 . . . . 73.12 105.699 166.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.59 179.1 8.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.835 0.826 . . . . 72.11 109.555 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -135.68 173.01 12.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.387 1.875 . . . . 62.34 107.692 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -164.81 165.62 20.44 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.245 2.218 . . . . 74.32 108.621 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.5 149.82 27.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.558 0.617 . . . . 73.04 110.717 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 t -145.28 84.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.943 -1.502 . . . . 71.14 106.943 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.62 129.2 37.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.177 -1.786 . . . . 74.35 106.177 175.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.0 p -85.72 5.84 30.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.38 0.991 . . . . 74.33 112.049 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -143.17 133.69 24.93 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.563 -1.273 . . . . 74.14 107.563 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.29 134.98 33.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 105.709 -1.96 . . . . 74.45 105.709 162.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.248 1.017 0 CA-C-O 115.803 -2.046 . . . . 73.22 109.619 178.076 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.702 -0.959 . . . . 64.11 110.702 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.18 169.38 24.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.298 2.239 . . . . 72.31 108.129 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 p -89.64 -21.99 22.52 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.001 1.111 . . . . 64.41 114.001 -168.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -106.52 118.26 36.21 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.656 1.182 . . . . 75.31 111.503 -166.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.93 96.83 5.01 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.878 1.271 . . . . 74.23 110.185 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -136.91 110.78 8.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.452 1.901 . . . . 74.24 108.982 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -165.58 -178.55 4.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.139 -1.43 . . . . 75.33 107.139 165.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.0 -90.52 0.08 OUTLIER Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.85 2.166 . . . . 64.11 109.437 -163.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -139.36 135.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 127.468 2.307 . . . . 75.02 107.378 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -103.71 152.6 21.63 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.529 -0.732 . . . . 72.24 109.725 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -142.68 147.37 35.59 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.841 -1.17 . . . . 72.12 107.841 169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.9 mm -119.16 151.08 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.349 1.86 . . . . 75.43 106.267 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.93 139.13 46.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.118 -1.808 . . . . 73.44 106.118 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.67 154.36 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.325 -1.361 . . . . 75.42 107.325 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -142.8 168.9 18.64 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.52 1.128 . . . . 75.44 109.106 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -136.39 150.38 48.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.674 1.59 . . . . 75.42 108.355 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -154.25 162.39 41.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.303 1.841 . . . . 61.54 108.107 167.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.11 -163.69 31.84 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.329 -1.508 . . . . 75.4 109.329 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.1 99.13 3.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.953 1.701 . . . . 62.11 109.049 -169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.9 p -85.76 -10.24 55.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.836 1.254 . . . . 73.12 114.259 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.1 -12.66 46.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.709 -1.244 . . . . 75.22 111.661 -171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.59 30.84 1.88 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.221 1.408 . . . . 71.34 112.613 -169.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.83 155.23 43.23 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.794 -1.192 . . . . 73.13 108.443 170.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.06 121.68 18.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.369 -1.345 . . . . 72.3 107.369 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.97 105.08 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 123.908 0.883 . . . . 74.44 109.079 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 145.98 25.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.694 -0.854 . . . . 72.3 108.694 162.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.45 131.59 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.605 1.562 . . . . 73.33 108.996 163.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 t -68.39 140.08 55.82 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.257 -1.386 . . . . 74.54 107.257 161.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 HD12 ' HG ' ' A' ' 63' ' ' CYS . 54.5 mt -130.43 108.54 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 104.297 -2.482 . . . . 74.3 104.297 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.39 166.43 26.82 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 109.382 -1.487 . . . . 55.11 109.382 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 172.04 44.96 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 108.314 -1.915 . . . . 71.34 108.314 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 164.75 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.521 1.129 . . . . 75.14 108.773 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -144.08 145.46 32.17 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.196 0.998 . . . . 71.12 109.306 156.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 45.2 -8.15 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 130.525 3.53 . . . . 73.54 117.829 -160.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 33' ' ' ASP . . . 138.51 -19.47 3.19 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 126.408 1.956 . . . . 63.1 110.796 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.96 -171.5 32.69 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.213 2.34 . . . . 62.2 111.711 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.7 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.281 2.654 . . . . 75.54 110.688 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.84 138.73 47.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.103 0.478 . . . . 73.34 111.902 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -65.14 110.59 2.59 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.749 1.62 . . . . 72.02 110.485 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mt -89.14 160.93 16.76 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.439 1.018 . . . . 74.33 108.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -130.4 144.29 51.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.335 1.054 . . . . 74.2 109.797 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.03 176.99 6.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.816 1.246 . . . . 75.5 110.808 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -72.03 -13.25 61.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.83 0.852 . . . . 71.24 112.86 -169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.82 -13.85 62.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.814 1.246 . . . . 74.4 110.635 168.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 14.27 72.69 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 126.542 2.02 . . . . 72.24 112.544 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -106.64 154.81 20.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.697 1.599 . . . . 74.22 110.337 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -76.03 152.02 37.01 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.211 -0.663 . . . . 75.32 109.211 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 pt -153.49 10.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.877 1.066 . . . . 74.41 113.877 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.19 167.09 11.13 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.814 -1.179 . . . . 75.12 110.574 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -111.66 -0.65 15.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.805 1.242 . . . . 73.3 112.443 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 m -148.34 141.85 25.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.068 -1.827 . . . . 74.33 106.068 159.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.06 -173.63 2.4 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.422 1.089 . . . . 73.13 108.578 166.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.3 m -130.23 153.87 48.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.493 1.117 . . . . 72.2 108.116 161.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.68 160.71 38.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.322 1.049 . . . . 61.52 108.827 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.196 0.598 . . . . 72.24 110.565 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.96 81.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.859 1.264 . . . . 63.52 108.417 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 29.42 7.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.623 1.169 . . . . 75.31 110.359 172.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -141.89 138.61 32.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.991 -1.115 . . . . 72.12 107.991 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.86 49.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.687 0.795 . . . . 71.23 111.94 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.9 p -141.6 159.87 41.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.931 1.292 . . . . 71.1 107.515 166.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -145.23 163.67 33.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.028 1.331 . . . . 73.34 109.897 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -172.59 153.82 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.365 1.466 . . . . 75.23 110.912 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.462 ' HG ' HD12 ' A' ' 29' ' ' ILE . 16.1 m -143.73 152.66 41.56 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.375 1.87 . . . . 73.21 107.292 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.4 p -142.35 177.62 8.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.842 0.857 . . . . 71.41 110.589 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.4 p -101.08 171.21 7.76 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.837 1.255 . . . . 63.11 109.923 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.48 177.2 1.6 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.269 -1.011 . . . . 73.42 108.269 152.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.01 34.69 0.9 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.73 -1.039 . . . . 71.41 113.13 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.11 131.35 11.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.778 1.789 . . . . 75.22 107.769 164.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -174.2 152.31 1.81 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.814 2.446 . . . . 64.31 108.315 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.23 -18.11 12.61 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.571 1.548 . . . . 73.42 112.856 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.39 177.35 11.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.688 2.395 . . . . 73.52 107.072 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 ttt -150.93 150.15 30.49 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 104.803 -2.295 . . . . 72.34 104.803 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 t -122.41 155.44 36.07 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.204 -1.406 . . . . 74.32 107.204 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 t -155.19 98.45 2.0 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.19 -2.152 . . . . 72.11 105.19 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -129.84 144.3 51.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.048 -1.464 . . . . 51.2 107.048 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.98 -149.74 5.08 Favored Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.577 -0.609 . . . . 63.44 111.577 -164.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.06 175.46 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.901 -0.777 . . . . 73.3 108.901 145.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -122.34 156.08 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.753 1.621 . . . . 72.5 107.674 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t -151.38 163.8 38.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.836 1.254 . . . . 73.44 109.289 161.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.44 134.84 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.47 2.308 . . . . 74.4 105.392 168.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.68 12.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.242 -1.022 . . . . 75.22 108.242 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -75.0 -176.66 3.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.796 -1.187 . . . . 72.1 107.796 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -62.38 167.3 4.32 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.368 1.08 . . . . 75.4 112.254 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.45 153.03 16.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.312 -1.767 . . . . 71.42 113.3 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.78 6.35 85.46 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.403 -1.221 . . . . 51.31 113.574 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -76.11 172.51 12.67 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.604 1.702 . . . . 74.51 108.599 160.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -147.47 150.86 35.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.591 -1.263 . . . . 75.15 107.591 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.69 115.34 3.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.088 -0.708 . . . . 61.4 109.088 -175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -118.89 124.66 47.66 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.982 1.713 . . . . 75.55 108.401 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.3 mm -113.75 142.88 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.526 -1.287 . . . . 74.23 107.526 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -122.87 133.66 54.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.21 -1.774 . . . . 75.15 106.21 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.59 132.23 35.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 125.73 1.612 . . . . 74.4 109.517 -173.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mt -143.76 152.31 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.54 108.333 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.2 151.24 23.51 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.554 1.074 . . . . 54.21 111.553 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -136.19 155.79 49.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.327 1.851 . . . . 74.1 110.372 -166.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mt -141.89 138.12 31.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 127.003 2.121 . . . . 73.42 105.395 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.75 -85.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.739 3.616 . . . . 64.44 109.955 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -152.27 37.2 0.54 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.444 1.498 . . . . 75.0 110.593 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -141.49 153.43 44.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.623 1.169 . . . . 75.33 110.975 171.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.54 148.36 42.39 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.041 0.936 . . . . 64.14 108.906 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.39 -18.38 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 75.1 112.685 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -136.6 137.69 40.42 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.23 1.377 . . . . 74.22 108.765 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -151.8 138.4 18.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.544 1.138 . . . . 74.51 109.751 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.8 168.95 18.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.648 0.737 . . . . 74.25 110.498 155.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.06 156.12 43.28 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.414 -1.698 . . . . 72.42 106.414 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 164.14 34.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.684 -0.858 . . . . 75.32 108.684 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -153.5 148.45 26.62 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.276 -0.268 . . . . 73.13 110.276 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -148.44 137.69 21.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.582 1.153 . . . . 74.31 110.358 -167.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.2 mt -124.85 135.92 62.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.007 -1.479 . . . . 75.14 107.007 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.54 137.91 38.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.634 1.973 . . . . 75.21 108.634 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -141.75 31.16 1.65 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.777 0.798 . . . . 74.14 112.02 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.39 -3.92 86.3 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.368 0.985 . . . . 75.31 112.607 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.63 -155.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.497 1.919 . . . . 71.32 108.512 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -118.9 110.82 17.62 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.188 -1.782 . . . . 71.24 106.188 166.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.13 120.28 10.58 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.426 -1.324 . . . . 72.12 107.426 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -148.19 144.11 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 103.976 -2.602 . . . . 75.44 103.976 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.48 169.72 18.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.991 -0.744 . . . . 74.53 108.991 169.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 p -134.85 162.47 32.31 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.797 1.239 . . . . 75.42 108.361 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -151.8 175.78 12.09 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.036 1.334 . . . . 75.32 108.68 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 t -160.58 148.52 16.19 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.716 0.769 . . . . 72.12 109.445 168.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.6 107.16 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 127.314 2.246 . . . . 74.4 106.393 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.24 118.47 30.54 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.084 1.354 . . . . 72.4 108.437 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.1 p -86.43 33.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.92 0.888 . . . . 71.23 111.847 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -169.47 114.68 0.55 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.199 -1.408 . . . . 74.44 107.199 167.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -130.53 -165.0 1.49 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.034 0.933 . . . . 71.13 109.373 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--O 1.248 0.984 0 CA-C-O 117.024 -1.465 . . . . 73.55 111.944 171.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 N-CA-C 110.742 -0.943 . . . . 63.12 110.742 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.7 94.68 2.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.026 -1.472 . . . . 72.12 107.026 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -158.0 132.17 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.215 -1.031 . . . . 72.43 108.215 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -142.95 22.43 1.93 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.266 0.626 . . . . 64.33 111.769 -159.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -120.77 91.55 3.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.737 0.78 . . . . 75.24 110.628 -174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.09 97.04 3.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.836 1.655 . . . . 72.13 109.438 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -73.96 178.42 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.284 1.033 . . . . 74.33 111.285 166.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.43 -90.04 0.11 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 108.808 -1.717 . . . . 61.11 108.808 154.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.24 131.93 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.638 -1.986 . . . . 71.22 105.638 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -126.69 157.16 39.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.568 -1.271 . . . . 73.12 107.568 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -148.94 151.33 34.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.317 1.047 . . . . 72.43 108.257 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.34 134.94 52.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.858 -1.905 . . . . 74.34 105.858 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.54 131.26 50.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.711 -1.589 . . . . 70.05 106.711 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.3 mt -135.2 143.09 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.475 -0.935 . . . . 70.31 108.475 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -134.47 161.75 34.15 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.381 1.072 . . . . 75.21 110.3 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.23 141.86 29.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.33 2.652 . . . . 71.14 109.961 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -141.83 172.49 12.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.56 1.544 . . . . 60.22 107.343 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.33 -155.63 24.4 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.886 -1.286 . . . . 74.55 109.886 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.21 33.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.548 2.339 . . . . 74.15 111.106 -173.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 t -65.04 8.29 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.163 2.185 . . . . 73.54 113.798 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -17.83 64.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.841 1.656 . . . . 72.51 111.149 162.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.7 m -130.95 16.33 5.18 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.937 1.295 . . . . 73.53 113.019 -163.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -126.26 116.02 20.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.352 1.061 . . . . 72.43 109.261 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.22 127.08 31.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.28 -1.378 . . . . 74.45 107.28 166.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 t -136.74 106.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 105.557 -2.016 . . . . 74.14 105.557 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -114.87 145.86 41.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.768 1.167 . . . . 65.44 110.082 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.77 139.19 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.363 1.065 . . . . 64.42 109.595 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -66.84 139.39 57.76 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.768 -1.567 . . . . 71.33 106.768 161.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -132.9 124.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.591 -2.003 . . . . 62.11 105.591 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.98 176.97 47.8 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.702 -1.359 . . . . 64.2 109.702 -171.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.44 172.76 43.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.337 -1.905 . . . . 64.41 108.337 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.8 163.61 27.85 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.783 0.833 . . . . 63.4 109.863 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.39 -170.82 2.68 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.215 1.006 . . . . 74.2 112.039 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -74.94 67.47 1.68 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.317 1.047 . . . . 74.13 110.674 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.36 -32.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.533 -0.593 . . . . 53.14 112.729 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.93 -156.71 15.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 119.907 -1.139 . . . . 70.32 114.627 -162.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.18 139.44 9.38 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.927 3.084 . . . . 65.4 110.567 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.14 117.95 23.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.081 1.352 . . . . 73.4 110.576 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -60.21 117.61 5.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.661 1.119 . . . . 74.43 110.482 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 159.16 16.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.004 1.321 . . . . 74.12 109.401 171.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -128.16 143.88 51.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.0 1.32 . . . . 74.21 109.306 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.75 165.87 20.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.182 -0.917 . . . . 71.22 109.864 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -74.45 19.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.654 1.582 . . . . 73.44 113.457 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -100.76 -10.95 20.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.159 1.383 . . . . 71.33 110.9 163.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.59 56.54 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.001 1.762 . . . . 73.13 113.339 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.19 160.88 14.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.553 1.141 . . . . 74.03 109.429 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -74.96 157.7 34.53 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.815 -0.553 . . . . 74.41 109.923 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.22 6.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.127 0.788 . . . . 72.44 113.127 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.18 -172.45 24.18 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.186 -1.565 . . . . 70.23 109.186 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -125.03 8.73 8.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.037 1.335 . . . . 72.04 111.943 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -170.85 124.48 0.65 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.477 3.111 . . . . 74.3 106.864 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -163.18 -173.39 3.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.238 1.015 . . . . 74.33 110.211 171.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -121.11 157.46 30.06 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.261 1.024 . . . . 73.22 109.249 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.55 142.27 50.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.923 -1.139 . . . . 74.01 107.923 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -96.29 132.71 41.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.554 -1.647 . . . . 72.35 106.554 170.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -74.99 100.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.673 -1.603 . . . . 71.34 106.673 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -127.09 35.1 4.63 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.87 1.668 . . . . 72.14 109.875 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -134.31 169.01 17.85 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.117 -1.068 . . . . 73.34 108.117 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.33 9.95 34.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 118.643 -0.694 . . . . 54.45 111.443 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -178.51 159.85 1.2 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.901 2.48 . . . . 71.34 107.485 145.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 mmm -125.42 165.13 18.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.173 2.189 . . . . 73.41 109.572 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.4 p -159.56 163.07 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.238 -0.892 . . . . 72.34 111.317 158.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.4 m -147.87 163.09 37.86 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.469 2.308 . . . . 73.23 106.624 162.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.35 -176.81 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.23 1.812 . . . . 61.11 108.789 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.27 156.42 47.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.565 1.946 . . . . 73.4 107.362 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -82.4 179.61 7.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.217 0.207 . . . . 65.22 110.699 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.07 32.56 0.52 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.784 1.659 . . . . 73.32 115.752 -171.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -128.2 80.74 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.705 -2.331 . . . . 72.13 104.705 168.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.76 18.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.123 1.329 . . . . 65.34 107.546 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -128.62 -13.89 4.71 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.363 1.065 . . . . 70.44 112.955 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -164.11 167.88 19.71 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.407 1.883 . . . . 73.02 107.5 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 ttt -130.87 145.5 52.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.225 -2.139 . . . . 72.01 105.225 169.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 t -111.85 161.98 15.78 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.57 0.7 . . . . 71.21 109.981 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.42 40.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.312 1.445 . . . . 74.04 110.284 170.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.64 58.28 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 121.439 -0.788 . . . . 73.24 108.993 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.47 -174.95 38.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.747 -0.941 . . . . 74.23 110.747 -173.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.8 p -134.9 168.42 19.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.722 0.772 . . . . 72.41 110.892 -173.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.69 147.14 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.046 1.738 . . . . 73.21 106.731 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 t -152.09 164.5 37.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.092 -0.707 . . . . 44.35 109.092 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.12 155.64 43.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.667 -1.235 . . . . 72.35 107.667 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.82 22.39 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.421 1.488 . . . . 72.43 109.343 167.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.36 173.75 12.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.498 1.919 . . . . 73.51 110.368 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 176.39 8.18 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.687 1.195 . . . . 71.22 112.474 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.98 153.92 42.71 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 113.652 -1.613 . . . . 63.55 112.959 -173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.65 -10.51 44.89 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.663 1.125 . . . . 54.31 114.278 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -64.6 117.34 7.26 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 106.622 -1.621 . . . . 74.41 106.622 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -102.4 168.37 9.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.155 0.582 . . . . 75.24 110.074 -168.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.6 tp -157.53 150.19 23.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.41 -1.7 . . . . 73.34 106.41 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -141.04 132.92 27.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 105.814 -1.921 . . . . 71.15 105.814 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 mm -127.64 133.81 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.767 -1.568 . . . . 73.13 106.767 -172.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.81 129.03 41.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.882 -1.525 . . . . 70.12 106.882 -168.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.17 121.05 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.315 1.046 . . . . 75.05 108.399 -173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.51 141.54 45.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.013 -1.477 . . . . 73.31 107.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.97 144.35 15.93 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 124.76 1.171 . . . . 73.12 111.155 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -131.63 151.39 51.65 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.67 1.588 . . . . 74.15 111.303 -165.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.5 mt -137.92 140.96 39.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.109 -1.812 . . . . 74.3 106.109 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t0 61.02 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.678 1.991 . . . . 74.11 110.829 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.67 20.82 1.31 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.52 1.528 . . . . 74.03 111.076 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -143.94 158.01 43.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 120.55 -1.344 . . . . 75.42 111.954 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -80.82 156.1 26.3 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.249 -1.019 . . . . 75.32 108.249 168.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.88 -5.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.01 0.524 . . . . 73.35 112.181 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -151.8 130.15 12.08 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.802 -1.186 . . . . 74.14 109.226 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.53 142.88 18.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.642 0.777 . . . . 74.44 110.153 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.48 169.21 21.43 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.896 -0.779 . . . . 72.15 108.896 159.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.98 135.73 37.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.617 -1.623 . . . . 73.25 106.617 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.72 167.35 17.37 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 123.83 0.852 . . . . 74.23 109.547 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.56 131.22 7.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.774 -1.103 . . . . 75.54 108.143 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -145.16 146.97 31.99 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.849 -0.797 . . . . 72.44 108.849 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.25 147.02 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.716 -1.216 . . . . 71.53 107.716 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -77.07 138.66 39.68 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.627 2.371 . . . . 74.45 111.172 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -125.88 55.11 1.47 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.467 1.107 . . . . 73.13 109.281 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.59 3.96 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.047 1.308 . . . . 73.52 112.558 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.07 -174.97 5.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.505 1.522 . . . . 72.52 113.967 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.0 142.4 58.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.098 1.359 . . . . 72.35 109.161 165.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 tt -108.05 143.08 37.26 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.743 -0.836 . . . . 74.15 108.743 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mm -143.21 158.83 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 128.929 2.891 . . . . 73.45 106.017 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -172.82 170.61 4.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.606 2.362 . . . . 63.45 109.074 158.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.5 p -143.13 150.69 39.79 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 72.34 110.179 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -147.04 168.73 20.82 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.617 0.767 . . . . 72.11 110.689 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 p -158.39 111.58 2.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.102 -0.374 . . . . 74.21 111.185 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.62 88.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.189 -1.411 . . . . 74.14 107.189 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 155.52 19.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.449 -1.315 . . . . 63.41 107.449 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.9 p -91.78 30.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.725 -1.234 . . . . 70.2 109.727 174.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -170.51 145.27 2.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.605 -1.31 . . . . 74.42 108.517 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -166.34 -171.57 1.98 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 129.313 3.045 . . . . 63.23 104.792 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 pt . . . . . 0 C--O 1.255 1.359 0 N-CA-C 108.363 -0.977 . . . . 73.05 108.363 162.925 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.158 0 N-CA-C 111.16 -0.776 . . . . 70.44 111.16 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.99 30.32 0.59 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.61 1.564 . . . . 70.31 112.865 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -91.23 176.56 6.53 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.52 1.128 . . . . 65.2 108.141 161.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -134.18 111.71 10.51 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.798 1.639 . . . . 73.21 107.082 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -147.26 105.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.355 1.062 . . . . 61.42 109.914 -158.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -121.82 115.24 22.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.064 1.345 . . . . 74.43 107.403 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 p -118.05 170.44 8.84 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.717 1.207 . . . . 74.14 109.249 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.22 -115.42 0.65 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.929 -2.068 . . . . 71.33 107.929 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.52 82.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.621 -0.881 . . . . 74.11 108.621 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -64.16 153.33 38.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.864 -0.791 . . . . 73.04 108.864 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -138.33 153.01 48.99 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.367 -1.345 . . . . 74.42 107.367 167.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -122.28 140.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.982 -2.599 . . . . 74.34 103.982 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.37 133.7 61.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 105.753 -1.943 . . . . 74.3 105.753 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -138.57 129.06 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.65 -0.87 . . . . 74.34 108.65 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -117.05 161.72 18.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.014 0.526 . . . . 74.42 110.517 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -147.77 146.35 29.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.784 0.834 . . . . 72.24 109.766 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.78 -177.16 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.111 0.964 . . . . 72.22 109.713 166.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.64 -95.49 0.7 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.714 -1.355 . . . . 74.43 109.714 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -122.81 122.62 39.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.175 -2.528 . . . . 62.0 104.175 157.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 p -118.66 9.54 12.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.361 0.665 . . . . 73.41 111.274 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -88.48 -33.62 17.75 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.827 1.651 . . . . 71.3 110.032 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.87 26.15 6.68 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.921 1.688 . . . . 72.14 110.049 -167.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.93 148.06 50.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.929 0.891 . . . . 73.43 109.504 165.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.04 154.38 19.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.262 1.825 . . . . 65.1 108.748 163.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.76 102.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.413 -2.439 . . . . 74.3 104.413 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 p -97.44 148.15 23.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.419 -0.956 . . . . 73.31 108.419 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.62 120.42 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.234 1.014 . . . . 73.13 110.667 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 t -59.58 136.04 57.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.359 -1.349 . . . . 71.24 107.359 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mt -130.43 116.37 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 105.124 -2.176 . . . . 64.3 105.124 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.12 174.57 36.08 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.01 0.814 . . . . 72.13 111.5 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.34 172.17 35.75 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.139 1.828 . . . . 72.43 110.219 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.07 168.94 18.55 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.108 0.963 . . . . 70.32 111.439 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.06 179.31 7.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.316 1.446 . . . . 73.22 113.987 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.69 71.81 1.01 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 74.21 109.946 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.24 -0.5 3.22 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 117.73 -1.594 . . . . 74.11 115.336 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.91 -166.78 39.46 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 120.509 2.154 . . . . 71.2 115.037 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.07 135.97 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.186 3.257 . . . . 70.42 109.102 163.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.77 102.78 12.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.954 -1.022 . . . . 70.14 108.864 -172.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -46.22 118.02 1.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.204 1.001 . . . . 74.44 110.898 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.42 154.67 26.27 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 120.254 1.388 . . . . 73.4 108.953 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -123.6 141.15 52.29 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.819 1.247 . . . . 74.43 110.346 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.9 173.36 12.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.799 -1.091 . . . . 65.34 110.9 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -80.48 8.36 7.88 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.44 0.904 . . . . 73.11 113.44 -170.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -105.43 -1.87 24.46 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.8 1.64 . . . . 73.1 111.266 165.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.81 55.51 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 118.766 -1.019 . . . . 74.04 114.656 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -107.28 150.79 26.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.15 1.475 . . . . 74.31 111.393 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -70.49 152.63 43.8 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.472 -0.566 . . . . 64.4 109.472 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.88 2.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 114.034 1.124 . . . . 74.13 114.034 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.25 -173.63 35.41 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 108.429 -1.868 . . . . 53.51 108.429 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -124.76 0.21 8.06 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.915 1.358 . . . . 74.33 113.451 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -151.3 150.72 30.87 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.938 2.495 . . . . 71.4 105.979 158.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -171.68 -178.08 2.16 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.397 1.879 . . . . 74.14 107.552 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -135.73 103.97 5.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.631 0.772 . . . . 73.41 109.434 172.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.44 154.52 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.528 0.604 . . . . 70.23 109.801 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.885 -1.524 . . . . 74.23 106.885 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -71.45 96.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.415 -1.328 . . . . 74.0 107.415 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -109.04 22.92 15.27 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.691 -1.256 . . . . 74.42 110.067 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -137.16 154.54 50.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.478 1.111 . . . . 65.13 108.69 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.3 67.22 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.605 0.595 . . . . 74.32 112.605 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -151.54 173.66 14.35 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.484 -0.76 . . . . 74.31 109.644 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.425 ' C ' ' HG ' ' A' ' 62' ' ' SER . 3.2 tmm? -152.6 163.29 39.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 129.388 3.075 . . . . 72.12 108.801 -170.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.425 ' HG ' ' C ' ' A' ' 61' ' ' MET . 4.1 m -158.8 157.82 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.383 1.473 . . . . 74.41 109.564 159.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.31 144.81 33.41 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.285 1.834 . . . . 64.43 106.804 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 p -127.77 -172.78 2.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.801 1.24 . . . . 62.43 110.044 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 p -125.01 -179.47 4.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.642 1.177 . . . . 64.14 109.2 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -74.22 -177.25 2.91 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.84 -0.8 . . . . 72.3 108.84 153.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.58 44.58 1.83 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.405 1.002 . . . . 71.03 110.896 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -142.92 89.4 2.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.878 -1.527 . . . . 72.03 106.878 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.07 179.83 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.895 1.678 . . . . 71.03 109.991 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -132.36 -16.0 2.78 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.888 1.07 . . . . 73.24 113.888 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -161.36 169.57 21.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.577 -1.268 . . . . 72.43 107.577 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.0 ttt -136.98 158.7 43.87 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 105.607 -1.997 . . . . 73.23 105.607 164.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -135.26 161.52 35.15 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.657 0.783 . . . . 73.11 109.935 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 104.48 3.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.798 1.239 . . . . 73.23 108.592 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.84 140.21 42.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.425 -1.324 . . . . 63.0 107.425 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.96 -150.73 5.83 Favored Glycine 0 C--N 1.331 0.269 0 O-C-N 121.186 -0.946 . . . . 65.01 113.176 -159.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -148.85 171.04 16.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 61.03 110.325 159.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.31 147.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.301 1.841 . . . . 70.12 106.472 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -155.02 167.59 29.86 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.09 -1.006 . . . . 71.03 111.655 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -139.42 148.98 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.237 1.815 . . . . 72.44 107.54 166.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.77 32.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.376 1.871 . . . . 62.42 107.737 170.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.16 -175.08 2.7 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.836 1.254 . . . . 74.12 110.522 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.34 163.31 23.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.402 1.881 . . . . 73.2 110.123 176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.59 163.05 2.63 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.321 1.848 . . . . 70.22 111.965 165.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.93 36.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 118.422 -1.21 . . . . 62.14 114.23 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -64.14 154.3 35.09 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.674 1.737 . . . . 74.12 108.066 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -136.98 161.72 35.27 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.043 0.937 . . . . 72.42 109.001 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 tp -155.8 133.69 11.27 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.982 -1.118 . . . . 74.41 107.982 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -132.26 88.76 2.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.196 1.398 . . . . 63.31 109.068 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.31 138.12 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.076 2.15 . . . . 73.04 108.441 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.9 m -126.14 140.3 52.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.161 -1.422 . . . . 74.43 107.161 169.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.64 124.58 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.468 1.507 . . . . 73.32 107.565 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mt -133.38 147.7 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.472 1.509 . . . . 72.31 107.532 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.5 141.8 11.42 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 124.458 1.028 . . . . 61.4 113.067 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.66 153.31 47.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.722 1.609 . . . . 74.01 110.896 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mt -121.24 107.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 N-CA-C 106.47 -1.678 . . . . 73.24 106.47 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t0 73.36 -64.7 0.39 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.864 2.066 . . . . 61.33 110.62 172.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 -7.66 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.311 2.244 . . . . 71.02 111.78 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.5 129.93 56.17 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 114.075 1.139 . . . . 74.12 114.075 -163.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.39 121.73 26.6 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 -1.53 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.698 . . . . 71.01 112.886 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -149.0 139.5 22.52 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.606 1.094 . . . . 65.14 108.225 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -157.42 149.21 22.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.578 -0.897 . . . . 70.33 108.578 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.72 164.06 36.27 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.474 -0.565 . . . . 74.24 109.474 160.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -137.03 147.55 46.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.987 1.315 . . . . 71.42 108.129 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -142.85 169.15 18.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.703 0.683 . . . . 73.21 110.391 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -139.91 139.86 36.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.376 -1.713 . . . . 63.21 106.376 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.93 153.26 51.89 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.55 1.14 . . . . 72.44 108.375 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -141.29 138.23 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.754 -1.573 . . . . 74.14 106.754 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 p -81.01 147.67 30.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.173 0.897 . . . . 73.34 110.214 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -136.62 28.85 2.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.712 0.805 . . . . 74.0 111.46 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.45 -26.33 13.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.132 1.349 . . . . 73.44 112.601 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -77.34 168.31 20.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.562 1.545 . . . . 74.43 109.278 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 m -67.12 112.34 4.37 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.847 -1.168 . . . . 74.42 107.847 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.07 135.65 44.85 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.782 -1.192 . . . . 74.04 107.782 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -146.64 153.64 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.274 -2.491 . . . . 72.41 104.274 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.33 169.63 15.59 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.023 0.929 . . . . 63.23 110.697 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.3 p -138.25 148.64 44.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.408 0.623 . . . . 73.22 109.453 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.01 173.89 11.15 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.404 1.882 . . . . 70.0 109.09 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -168.61 119.78 0.77 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.855 -0.528 . . . . 62.21 111.026 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.06 92.27 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.089 1.356 . . . . 71.44 108.335 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 m -88.27 159.82 17.94 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 71.12 108.878 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.15 -2.81 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.634 -1.291 . . . . 70.33 112.608 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -158.69 127.33 5.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.95 -1.5 . . . . 71.43 106.95 -166.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -172.55 126.46 0.51 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.379 1.072 . . . . 73.24 109.753 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.253 1.258 0 CA-C-O 116.987 -1.483 . . . . 74.13 108.966 171.357 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.617 0 N-CA-C 110.165 -1.174 . . . . 52.11 110.165 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.64 168.6 19.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.861 0.864 . . . . 74.14 109.354 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 t -149.39 13.03 0.84 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.966 0.728 . . . . 55.24 112.966 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -93.84 85.09 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.232 1.413 . . . . 73.3 112.297 -162.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -129.03 104.27 7.48 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.474 1.109 . . . . 72.43 109.367 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.94 107.68 18.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.851 2.061 . . . . 73.0 107.87 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.61 170.68 18.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.342 2.257 . . . . 72.3 110.24 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 -114.93 0.84 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 106.132 -2.787 . . . . 55.22 106.132 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.3 mt -130.24 110.15 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.359 1.064 . . . . 75.41 108.265 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -68.76 148.81 49.79 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.767 -0.583 . . . . 74.02 109.779 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -135.41 154.61 51.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.552 1.541 . . . . 72.34 107.414 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mm -130.87 148.92 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.312 -2.106 . . . . 64.22 105.312 170.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.32 140.79 45.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.974 -1.861 . . . . 75.33 105.974 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -139.2 134.52 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.247 -1.02 . . . . 75.51 108.247 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -137.1 161.7 35.4 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.146 -0.687 . . . . 74.33 109.146 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -136.47 155.05 50.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.332 1.053 . . . . 75.51 110.739 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.5 m -140.58 166.27 25.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.688 -1.227 . . . . 55.23 107.688 150.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.08 -161.48 19.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 124.717 1.151 . . . . 75.22 111.539 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.06 61.87 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.397 2.279 . . . . 73.53 107.909 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -66.82 11.26 0.1 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.635 2.774 . . . . 75.32 114.343 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -8.22 46.16 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.1 -1.625 . . . . 72.11 112.31 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.57 25.86 2.85 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.639 1.976 . . . . 73.45 111.853 -160.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.0 166.59 21.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.151 -0.968 . . . . 72.12 112.265 -170.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -134.65 126.79 29.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 127.657 2.383 . . . . 73.51 105.46 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.93 110.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.155 -1.054 . . . . 74.11 108.155 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -125.26 121.3 33.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.867 -0.79 . . . . 62.41 108.867 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 m -110.96 126.39 68.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.324 1.449 . . . . 75.1 109.806 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 t -72.01 130.25 40.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.623 -1.991 . . . . 74.2 105.623 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.18 110.41 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.392 -2.077 . . . . 64.54 105.392 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.11 177.26 30.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.602 -0.727 . . . . 64.4 111.351 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.63 170.11 38.79 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 127.337 2.399 . . . . 74.31 107.568 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.48 161.89 32.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.531 0.666 . . . . 73.24 110.601 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -140.5 178.27 7.43 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.474 2.31 . . . . 74.24 110.426 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -78.62 81.18 4.95 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.82 -1.178 . . . . 73.01 107.82 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.65 -31.6 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-O 118.68 -1.067 . . . . 51.53 111.607 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.14 26.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.722 1.761 . . . . 64.54 111.488 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.36 141.54 56.7 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.034 2.489 . . . . 52.2 110.254 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.14 118.79 15.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.96 1.304 . . . . 53.22 110.469 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -57.23 109.83 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.969 1.258 . . . . 74.12 110.717 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.63 162.93 16.07 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.41 1.484 . . . . 74.3 110.77 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -131.94 138.73 48.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.035 1.734 . . . . 74.14 107.863 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -77.67 173.41 12.08 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.364 -0.835 . . . . 60.21 110.402 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.07 -8.87 33.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.344 1.458 . . . . 73.22 114.435 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -88.59 -14.79 36.71 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.842 1.657 . . . . 73.21 111.631 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.58 19.16 30.51 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.994 1.283 . . . . 72.43 114.1 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -109.59 147.25 33.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.619 1.709 . . . . 75.24 111.715 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.81 131.7 44.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.542 1.537 . . . . 74.1 110.163 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -130.63 4.32 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.781 1.233 . . . . 73.34 112.926 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.25 169.26 11.78 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 109.945 -1.262 . . . . 74.32 109.945 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -101.14 10.7 40.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.42 1.088 . . . . 73.42 111.426 172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 139.01 1.07 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.394 1.877 . . . . 70.32 108.24 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -175.82 -173.33 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.406 1.482 . . . . 74.41 108.65 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -134.79 122.13 21.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.788 1.235 . . . . 65.21 108.722 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.59 147.82 22.58 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.13 -1.063 . . . . 73.34 108.13 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -95.61 148.57 22.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.193 -1.04 . . . . 74.4 108.193 166.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mm -86.38 118.05 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.874 -1.158 . . . . 75.21 107.874 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.44 18.29 6.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.599 1.16 . . . . 74.43 110.954 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 p -134.26 153.98 51.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.719 0.808 . . . . 72.13 110.157 -163.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.64 -53.66 55.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.636 -0.505 . . . . 62.42 109.636 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 p -140.31 120.36 13.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.485 0.66 . . . . 71.31 110.636 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 mmm -110.69 165.01 12.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.281 1.832 . . . . 72.0 111.013 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 p -157.06 166.16 34.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.679 -1.146 . . . . 75.42 110.536 160.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 61.3 m -144.03 163.47 33.41 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.005 2.122 . . . . 73.0 106.419 165.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 13.9 p -142.51 -172.06 3.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.978 -0.749 . . . . 74.04 108.978 168.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.76 176.73 5.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.473 1.909 . . . . 75.03 107.092 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -77.27 169.78 17.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 155.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.83 78.63 1.99 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.567 -1.013 . . . . 75.44 110.567 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -151.44 -17.16 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.674 0.789 . . . . 73.23 112.602 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 167.02 16.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.188 1.395 . . . . 64.02 111.581 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -124.39 -7.22 7.56 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.083 1.353 . . . . 75.41 113.223 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -162.05 170.95 18.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.631 1.572 . . . . 75.52 107.408 168.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.4 ttt -143.44 138.75 29.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.412 -2.07 . . . . 75.22 105.412 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.9 t -126.57 143.92 51.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.297 0.953 . . . . 75.53 110.438 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.7 t -129.3 46.23 2.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.409 3.083 . . . . 74.31 108.527 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.91 35.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.178 0.991 . . . . 73.52 109.562 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.41 -151.71 6.03 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 120.44 1.473 . . . . 63.13 113.297 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 100.0 p -153.86 171.34 19.11 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.888 0.475 . . . . 75.33 112.263 160.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.5 150.66 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.597 1.959 . . . . 75.32 107.661 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -152.62 165.79 34.13 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.509 -0.744 . . . . 74.45 111.236 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.6 t -144.44 158.75 43.6 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.926 2.09 . . . . 74.21 106.265 159.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.07 13.45 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.068 2.147 . . . . 73.15 108.472 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -73.64 -177.35 2.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 73.31 108.805 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.84 167.71 21.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.627 -1.17 . . . . 62.45 110.85 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.47 168.32 2.18 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.937 1.295 . . . . 63.14 112.247 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.19 -0.78 78.45 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.479 1.038 . . . . 75.42 114.288 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -88.75 114.33 25.26 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.2 1.4 . . . . 75.55 108.663 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 159.92 15.62 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.339 1.056 . . . . 75.25 108.385 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.19 135.76 14.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.013 -1.477 . . . . 74.14 107.013 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -132.9 127.79 35.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.409 -1.33 . . . . 75.42 107.409 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.0 140.11 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 124.982 1.313 . . . . 74.54 107.629 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.9 m -127.25 131.15 50.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.214 -1.772 . . . . 72.21 106.214 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 112.71 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.463 1.505 . . . . 75.44 108.658 -169.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.91 152.99 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.18 1.392 . . . . 71.21 108.594 -169.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.64 144.75 12.83 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.761 1.172 . . . . 61.04 113.531 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.64 159.78 35.36 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.235 1.814 . . . . 71.1 110.993 -168.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.22 111.99 18.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.149 -2.167 . . . . 74.43 105.149 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.6 t0 60.93 -72.84 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.898 2.479 . . . . 60.04 113.292 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.77 15.07 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.177 2.191 . . . . 73.04 110.942 -173.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -128.11 153.16 47.15 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.003 -1.686 . . . . 73.43 109.987 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -93.9 139.53 30.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.113 -1.069 . . . . 71.3 108.113 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.94 -26.23 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.958 1.095 . . . . 71.24 113.958 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -118.75 135.34 54.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.615 2.007 . . . . 72.31 107.568 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -154.25 145.76 23.15 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.183 0.516 . . . . 75.51 112.009 159.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -141.92 174.37 10.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.917 -1.038 . . . . 75.15 111.145 152.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -130.59 165.66 22.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.763 1.625 . . . . 74.25 107.418 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 162.77 39.78 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.677 -0.64 . . . . 64.43 109.481 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -142.29 146.51 35.15 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.07 0.948 . . . . 74.13 109.587 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -148.88 153.62 38.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.021 1.328 . . . . 72.24 108.959 -173.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.59 134.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.54 -1.282 . . . . 74.54 107.54 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -62.47 128.69 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.621 1.168 . . . . 74.55 108.543 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -116.45 -5.12 11.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.418 1.487 . . . . 71.25 112.073 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.29 8.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.093 2.283 . . . . 73.41 110.981 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -76.61 170.45 16.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.293 1.047 . . . . 71.41 108.649 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -72.37 113.15 9.09 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.205 -0.934 . . . . 73.33 108.816 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.18 113.95 5.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.117 -1.438 . . . . 74.15 107.117 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.52 141.06 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 104.433 -2.432 . . . . 73.23 104.433 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.95 166.77 31.05 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.638 1.175 . . . . 75.12 109.223 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -139.61 155.23 47.57 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.757 1.623 . . . . 75.31 106.743 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -154.76 164.03 39.4 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.76 1.224 . . . . 74.51 108.616 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -166.45 146.78 6.1 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 123.185 1.469 . . . . 64.34 113.576 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.67 134.27 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 112.177 -2.283 . . . . 74.1 109.428 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.23 135.27 35.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.638 -1.616 . . . . 73.21 106.638 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.25 -10.74 51.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.098 0.863 . . . . 75.24 113.139 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 123.11 13.29 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 106.61 -1.626 . . . . 75.33 106.61 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -136.34 44.77 2.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.845 1.258 . . . . 72.14 108.197 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.25 1.1 0 C-N-CA 129.232 3.013 . . . . 72.24 107.168 -168.645 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.667 0 CA-C-O 119.803 -0.443 . . . . 62.1 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.02 158.05 38.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.083 0.941 . . . . 75.21 108.733 171.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -9.3 28.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.356 1.063 . . . . 64.04 112.343 168.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -68.2 94.73 0.53 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.103 1.361 . . . . 71.44 110.196 -171.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -126.91 16.27 7.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 74.43 111.943 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -116.95 138.81 51.3 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.12 2.168 . . . . 64.33 107.333 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -149.8 -164.19 1.96 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 130.484 3.514 . . . . 75.12 106.445 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.83 -109.49 0.54 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 107.153 -2.379 . . . . 51.23 107.153 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -140.65 110.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 129.665 3.186 . . . . 75.31 103.638 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -74.2 158.75 33.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.258 -1.016 . . . . 62.23 108.258 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 153.42 34.11 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.008 1.323 . . . . 63.11 108.789 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mm -141.54 149.78 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 106.238 -1.764 . . . . 72.33 106.238 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.64 135.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.323 -2.217 . . . . 71.42 106.626 -164.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.55 144.1 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 107.382 -1.34 . . . . 74.31 107.382 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -129.95 165.45 22.07 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.422 0.689 . . . . 73.05 109.437 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -139.47 169.88 16.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 71.42 108.283 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.21 168.42 25.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.62 -1.622 . . . . 73.03 106.62 161.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.62 -144.37 18.22 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 119.579 1.081 . . . . 51.54 112.607 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -78.44 74.01 4.98 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 123.724 1.726 . . . . 42.25 108.276 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -73.76 15.05 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.935 1.294 . . . . 74.11 113.372 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.37 16.79 4.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.046 1.738 . . . . 72.05 111.951 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -145.41 7.6 1.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.543 1.537 . . . . 72.42 112.48 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.78 112.17 13.35 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.813 1.245 . . . . 72.45 109.1 -159.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.64 126.01 28.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.185 1.394 . . . . 63.34 108.51 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.8 113.57 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.397 -1.705 . . . . 73.01 106.397 164.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -112.33 148.57 33.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.79 0.805 . . . . 73.05 109.732 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.81 118.19 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.704 1.602 . . . . 74.04 108.65 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -77.94 129.86 35.85 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.344 -1.725 . . . . 72.03 106.344 166.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -126.86 149.32 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.732 -1.21 . . . . 74.12 107.732 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.21 174.46 46.76 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.711 -0.956 . . . . 73.41 110.711 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 169.45 42.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.125 -1.99 . . . . 43.1 108.125 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 126.28 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.947 1.699 . . . . 74.31 109.679 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.6 -171.14 1.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.332 1.053 . . . . 72.34 110.759 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -72.28 79.35 0.99 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 73.31 109.079 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.21 61.57 0.93 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.436 -1.466 . . . . 72.14 109.436 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.43 -176.48 30.64 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-O 119.566 -0.574 . . . . 74.14 113.199 158.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.78 135.78 24.24 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.986 2.457 . . . . 73.1 108.827 155.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.14 115.61 24.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 117.884 -1.055 . . . . 71.14 109.173 -170.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -47.72 111.58 0.44 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.824 1.193 . . . . 65.42 112.123 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.73 168.71 19.34 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.768 0.827 . . . . 74.42 109.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -135.33 163.11 30.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.637 1.975 . . . . 72.2 109.824 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -111.7 -176.96 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.008 1.723 . . . . 74.14 110.827 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.89 -16.26 60.67 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.504 0.927 . . . . 74.31 113.504 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -71.37 -24.06 62.02 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.984 -1.073 . . . . 74.22 109.375 168.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.21 27.56 25.25 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 125.684 1.611 . . . . 43.24 112.118 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.75 152.37 20.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.257 -1.386 . . . . 74.4 107.257 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.43 35.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.639 1.109 . . . . 74.01 108.066 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 pt -138.21 37.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 174.48 40.27 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.465 -1.454 . . . . 63.42 109.465 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.95 0.58 18.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.757 1.223 . . . . 74.34 112.563 -173.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.7 p -170.55 165.7 8.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.383 1.473 . . . . 54.21 109.536 152.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -179.52 -179.25 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.966 1.706 . . . . 73.22 107.853 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m -116.11 154.44 29.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.237 -1.394 . . . . 73.23 107.237 155.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.28 172.44 11.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.206 1.403 . . . . 72.0 108.018 171.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.14 129.01 37.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.71 0.804 . . . . 73.44 109.205 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -74.74 104.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.178 -1.416 . . . . 71.43 107.178 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 38.35 3.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.909 1.284 . . . . 73.22 109.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -147.92 169.76 19.16 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.704 0.802 . . . . 74.01 109.017 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.41 -43.33 77.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.101 -0.999 . . . . 72.15 110.327 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 p -137.64 147.44 44.95 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.277 1.431 . . . . 74.14 109.019 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mmm -140.12 165.96 25.95 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.163 1.785 . . . . 74.04 110.008 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.6 p -171.4 162.54 6.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.768 -1.56 . . . . 52.11 111.016 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.08 163.53 32.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.657 1.983 . . . . 74.31 107.339 160.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.6 p -140.09 -166.9 2.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.655 1.182 . . . . 71.42 109.902 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.02 156.96 43.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.405 1.082 . . . . 71.24 109.222 -168.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.91 159.27 28.99 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.012 0.911 . . . . 71.24 109.464 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.58 66.9 3.82 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 114.95 -1.023 . . . . 74.21 111.006 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -140.67 -12.68 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.611 1.565 . . . . 70.24 110.25 162.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.11 166.4 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.529 1.132 . . . . 65.1 112.31 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -127.61 -0.8 6.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.744 2.018 . . . . 74.12 113.152 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.31 -179.07 4.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.187 2.595 . . . . 74.1 107.99 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttt -154.28 146.24 23.56 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.009 -1.848 . . . . 71.24 106.009 160.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -124.36 170.41 10.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.503 0.721 . . . . 74.32 110.751 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.63 21.09 0.71 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.461 1.504 . . . . 74.42 111.944 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 115.3 2.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 127.017 2.127 . . . . 70.14 109.78 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.25 -179.62 30.53 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 109.638 -1.385 . . . . 65.25 109.638 -156.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 34.4 p -149.15 158.53 44.26 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.905 -0.647 . . . . 74.44 110.772 -165.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.8 146.62 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 105.216 -2.142 . . . . 73.22 105.216 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.5 m -152.32 170.55 19.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.444 -1.41 . . . . 74.31 110.932 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.78 165.98 27.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.427 1.491 . . . . 63.15 109.071 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.5 pt -155.73 10.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 127.564 2.345 . . . . 74.32 110.993 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -99.39 -170.6 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.045 0.926 . . . . 70.44 109.964 -167.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.32 163.07 8.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.41 1.084 . . . . 70.41 109.339 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.55 158.88 9.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.086 . . . . 51.45 111.318 165.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.01 1.5 59.66 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.708 1.147 . . . . 74.55 113.989 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -72.93 114.82 11.51 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.446 -1.687 . . . . 73.43 106.446 167.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -83.65 163.13 20.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.484 0.714 . . . . 74.32 109.864 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.41 136.65 10.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.588 -1.634 . . . . 64.23 106.588 171.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -129.28 143.98 51.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.219 -1.771 . . . . 75.32 106.219 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 mm -128.74 144.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 126.068 1.747 . . . . 63.31 108.25 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -146.88 133.83 20.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.602 -1.629 . . . . 75.25 106.602 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.42 120.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 107.211 -1.403 . . . . 75.04 107.211 -168.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.5 mt -133.06 156.3 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 107.965 -1.124 . . . . 73.12 107.965 -168.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.05 138.2 8.69 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.257 1.408 . . . . 72.14 111.11 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -132.45 147.64 52.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.733 2.013 . . . . 75.34 109.83 -162.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.02 114.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.953 1.701 . . . . 75.25 108.281 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.261 7.1 t0 49.51 -64.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 131.475 3.91 . . . . 73.13 114.267 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.38 39.43 0.66 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.939 1.245 . . . . 75.14 112.984 166.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.21 148.65 49.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.807 1.243 . . . . 72.44 111.184 177.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -79.4 143.7 34.81 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.225 -1.769 . . . . 63.41 106.225 161.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.91 -28.08 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.052 1.13 . . . . 71.12 114.052 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -148.11 142.32 26.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.391 1.45 . . . . 75.43 108.255 -163.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -172.13 155.91 3.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.264 1.026 . . . . 75.24 111.105 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -150.1 173.48 13.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.532 0.606 . . . . 61.43 109.782 161.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -134.75 152.9 52.12 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.432 -0.951 . . . . 75.45 108.432 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.1 170.55 15.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.415 0.686 . . . . 74.43 110.383 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.64 153.08 41.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.289 -1.745 . . . . 61.21 106.289 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.402 ' HH ' ' HG3' ' A' ' 117' ' ' GLU . 55.5 m-85 -142.58 154.57 44.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.242 2.217 . . . . 74.31 106.977 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.64 134.13 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.222 -2.881 . . . . 63.54 103.222 162.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -70.88 148.54 47.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.81 10.19 3.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.671 0.388 . . . . 74.12 111.07 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.59 -9.93 16.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.828 2.156 . . . . 65.53 112.152 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -85.06 168.51 14.82 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.355 -1.085 . . . . 74.34 109.873 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -59.94 160.99 7.07 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.648 -0.501 . . . . 64.15 109.648 154.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.19 129.96 36.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.306 -0.998 . . . . 74.15 108.306 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -152.98 141.14 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.292 1.837 . . . . 72.44 106.501 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG3' ' HH ' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -161.78 168.11 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.389 1.875 . . . . 74.55 109.319 177.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 64.7 p -130.97 172.9 11.54 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.76 1.624 . . . . 74.54 108.764 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -151.55 166.9 29.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.158 0.583 . . . . 72.04 110.519 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -152.5 132.07 13.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 122.508 1.147 . . . . 74.21 111.532 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -141.85 96.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 130.415 3.486 . . . . 74.04 103.759 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.5 t -81.5 -179.13 7.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.836 -1.542 . . . . 71.03 106.836 157.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.0 p -130.04 14.42 5.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.385 1.074 . . . . 71.23 111.055 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.16 113.16 3.68 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.449 -1.407 . . . . 73.33 107.62 166.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.94 139.14 22.29 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 128.432 2.693 . . . . 75.44 104.892 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 C--O 1.25 1.106 0 N-CA-C 104.195 -2.52 . . . . 75.32 104.195 -179.515 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.661 0 N-CA-C 110.978 -0.849 . . . . 72.31 110.978 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.07 110.62 23.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.948 1.299 . . . . 74.4 109.213 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 m -149.93 162.85 39.53 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.561 -1.274 . . . . 52.2 107.561 165.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.24 136.47 57.22 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.631 0.772 . . . . 71.42 109.944 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -139.68 15.62 2.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.91 1.448 . . . . 75.43 114.91 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -133.86 113.56 12.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.813 2.445 . . . . 75.31 108.24 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -171.42 -173.77 1.3 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.035 2.134 . . . . 64.24 106.511 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.74 -100.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 125.122 1.344 . . . . 74.4 109.906 168.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.2 mt -108.63 97.49 5.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.255 -2.128 . . . . 73.11 105.255 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.73 154.13 22.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.87 -1.159 . . . . 75.41 107.87 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.04 150.41 41.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.224 -1.398 . . . . 62.04 107.224 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 mm -120.92 150.44 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.56 -2.015 . . . . 75.25 105.56 165.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.88 133.37 64.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.047 -2.205 . . . . 75.35 105.047 171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.97 140.88 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 108.399 -0.963 . . . . 74.43 108.399 -171.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -147.58 156.02 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.105 0.866 . . . . 75.12 111.798 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -139.72 154.03 47.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.652 1.581 . . . . 73.23 110.637 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 m -150.03 156.14 41.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.674 2.79 . . . . 71.43 106.712 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.88 -112.71 2.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.373 -1.491 . . . . 72.54 109.373 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -117.1 99.09 6.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.352 1.461 . . . . 75.13 107.381 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 p -74.78 -1.03 20.23 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.571 0.952 . . . . 71.01 113.571 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.1 -19.86 13.21 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.851 1.26 . . . . 73.44 110.32 -166.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.3 m -120.15 37.44 4.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.641 1.976 . . . . 75.21 110.888 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -150.23 122.93 8.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.544 1.164 . . . . 73.21 109.16 171.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.23 90.87 6.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.433 -1.692 . . . . 74.34 106.433 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 23' ' ' PHE . 4.8 t -81.16 113.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.939 2.096 . . . . 63.44 108.042 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -114.63 144.57 43.2 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.485 1.039 . . . . 63.31 109.231 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 m -137.65 122.87 24.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.393 -1.276 . . . . 75.25 110.328 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -68.98 141.66 54.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.677 -1.601 . . . . 71.43 106.677 160.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.4 mt -130.7 107.41 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 103.916 -2.624 . . . . 73.43 103.916 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.1 30.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.367 0.508 . . . . 72.13 111.907 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.82 172.01 43.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.429 1.966 . . . . 61.24 109.483 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.86 163.28 16.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 121.599 -0.942 . . . . 72.41 110.759 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -138.88 -172.76 3.39 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.933 2.493 . . . . 74.11 109.502 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -71.65 -19.48 62.09 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 55.34 113.014 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 -31.52 10.74 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.446 -1.062 . . . . 75.43 110.446 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.41 -95.69 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.522 2.011 . . . . 73.41 108.416 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.68 135.2 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.695 2.263 . . . . 75.35 111.532 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.93 122.99 28.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.588 0.755 . . . . 73.32 109.103 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -61.13 121.34 12.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.044 0.538 . . . . 74.04 110.26 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.0 165.89 14.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.945 0.898 . . . . 75.22 109.526 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -129.98 157.37 42.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.803 1.241 . . . . 75.14 109.103 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.43 171.17 9.93 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.726 0.81 . . . . 72.22 109.487 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.05 -25.34 66.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.975 0.731 . . . . 75.31 112.975 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -71.63 -25.18 62.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.081 1.353 . . . . 74.33 110.668 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.35 17.73 9.74 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 125.085 1.326 . . . . 74.35 113.612 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -94.53 145.95 24.45 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.771 1.786 . . . . 73.14 110.253 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.16 146.64 54.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.553 -0.906 . . . . 73.14 108.553 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.09 -16.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.998 1.481 . . . . 75.45 114.998 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.65 164.17 29.07 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 120.062 1.301 . . . . 55.24 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.7 5.68 23.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.381 1.091 . . . . 74.22 112.445 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -166.29 145.55 5.87 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.503 2.321 . . . . 74.05 107.055 156.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -168.59 -179.76 3.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.96 1.304 . . . . 75.01 108.433 168.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -120.11 161.52 20.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.924 0.89 . . . . 60.45 108.94 160.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 120.79 14.07 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.129 -1.434 . . . . 72.33 107.129 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.39 134.33 45.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.197 -1.038 . . . . 73.04 108.197 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.13 91.35 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.315 -1.735 . . . . 75.41 106.315 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -100.58 46.08 0.96 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.136 0.974 . . . . 75.23 109.591 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -150.35 163.39 38.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.536 1.134 . . . . 75.33 108.411 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.7 -35.92 73.0 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.191 -0.943 . . . . 74.15 110.802 169.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.2 p -140.23 152.3 45.84 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.071 0.948 . . . . 72.43 110.951 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mmm -153.08 172.46 16.84 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 126.571 1.948 . . . . 63.32 111.326 -168.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -167.4 166.09 14.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.418 1.887 . . . . 63.43 111.163 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -156.98 160.87 39.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.921 2.888 . . . . 60.42 106.983 160.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.82 -179.78 6.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.478 0.656 . . . . 73.33 111.658 165.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -123.85 -176.87 3.58 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.784 1.634 . . . . 72.22 110.148 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.17 157.49 26.86 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.657 0.741 . . . . 75.25 111.735 173.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.69 96.53 0.1 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.015 2.245 . . . . 72.44 108.607 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 178.78 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 130.874 3.67 . . . . 75.11 105.731 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.4 173.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.648 1.979 . . . . 63.13 114.857 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -134.88 -12.47 2.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.711 2.005 . . . . 75.2 113.757 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -158.21 174.41 15.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.43 1.014 . . . . 73.14 108.887 166.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.3 ttt -137.81 155.13 49.34 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.635 1.974 . . . . 74.34 106.65 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -143.94 167.03 23.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.875 0.761 . . . . 73.02 110.72 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.0 t -143.9 29.61 1.35 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.614 2.766 . . . . 72.03 109.351 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.08 113.14 3.72 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 72.21 109.209 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.49 -154.13 8.08 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 110.367 -1.093 . . . . 62.21 110.367 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -154.51 171.73 18.93 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.702 0.763 . . . . 60.12 111.477 155.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG13 ' CE1' ' A' ' 23' ' ' PHE . 93.9 t -120.97 145.58 27.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 125.932 1.693 . . . . 74.22 107.983 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.1 t -151.87 160.67 43.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.506 0.594 . . . . 75.41 111.173 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 t -140.69 158.77 43.5 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.927 1.691 . . . . 71.43 109.057 166.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.85 24.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 126.69 1.996 . . . . 73.25 110.032 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -97.08 -176.48 3.56 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.494 1.043 . . . . 73.11 110.595 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.32 167.73 3.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.238 1.415 . . . . 72.43 110.276 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.92 167.16 1.26 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.958 1.303 . . . . 74.02 112.937 159.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 -13.07 52.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 117.753 -1.582 . . . . 72.13 114.776 168.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -57.11 161.13 3.28 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 119.432 1.616 . . . . 64.42 108.413 159.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -140.16 162.0 36.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.627 -1.249 . . . . 74.41 107.627 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.34 145.57 22.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.596 -1.261 . . . . 60.25 107.596 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -140.69 117.99 11.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.65 -1.982 . . . . 60.15 105.65 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mm -96.52 151.22 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 72.32 108.508 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -139.11 131.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.648 -1.612 . . . . 71.14 106.648 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.3 126.38 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.399 1.479 . . . . 73.45 109.114 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.88 140.32 46.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.597 -1.631 . . . . 75.34 106.597 -173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.75 133.13 6.9 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.224 -1.15 . . . . 72.22 110.224 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -120.24 154.59 34.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.286 1.834 . . . . 75.34 109.973 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.8 mt -148.62 137.19 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.803 2.041 . . . . 72.3 105.693 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t0 44.52 53.88 6.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.19 1.796 . . . . 75.3 111.982 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.27 23.87 14.05 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.038 1.735 . . . . 72.34 113.969 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -132.52 153.78 50.61 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 120.751 -1.218 . . . . 71.42 111.923 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.78 145.6 46.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.95 -1.5 . . . . 74.03 106.95 164.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.43 -6.14 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.618 -0.706 . . . . 60.12 112.847 161.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -159.77 143.47 14.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.542 1.519 . . . . 75.4 110.046 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -165.45 124.47 1.7 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.511 -0.922 . . . . 74.03 108.511 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -138.57 169.14 18.32 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.106 0.879 . . . . 75.12 110.932 172.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -126.59 171.61 10.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.274 . . . . 73.44 108.703 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 161.13 43.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.303 -0.629 . . . . 75.15 109.303 166.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -127.37 135.89 51.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.26 151.77 48.89 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.509 1.124 . . . . 73.41 108.581 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -143.62 124.46 10.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.361 -2.089 . . . . 75.34 105.361 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -64.13 130.41 43.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.329 -0.619 . . . . 73.14 109.329 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -105.4 -1.18 25.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.081 1.352 . . . . 74.32 111.863 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.33 -24.65 10.38 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.46 1.505 . . . . 74.23 111.129 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -82.22 163.63 21.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.009 0.923 . . . . 75.35 109.531 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.13 106.18 1.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.426 1.09 . . . . 74.32 110.296 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 131.55 46.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.618 -0.882 . . . . 73.41 108.618 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 mt -148.87 138.36 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.708 1.603 . . . . 73.21 107.715 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.8 170.13 4.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.051 1.74 . . . . 64.02 110.164 -171.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.4 p -141.55 170.41 15.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.471 2.308 . . . . 75.05 108.161 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.8 164.88 38.18 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.097 1.759 . . . . 75.12 107.61 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.4 p -152.64 123.73 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.186 -0.946 . . . . 72.23 110.475 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.7 t -135.67 92.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.755 -2.313 . . . . 74.24 104.755 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.53 148.59 24.05 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.342 -1.725 . . . . 74.23 106.342 163.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.1 p -110.71 29.39 7.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.089 0.956 . . . . 74.0 110.113 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -156.68 117.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.8 -1.926 . . . . 75.21 105.8 166.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.23 89.33 3.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.39 -1.337 . . . . 75.41 107.39 176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.593 -1.194 . . . . 63.14 109.241 164.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.654 0 N-CA-C 108.373 -1.891 . . . . 75.54 108.373 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.06 177.04 9.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.525 -1.287 . . . . 75.43 107.525 152.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -163.75 175.71 10.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.0 0.92 . . . . 64.45 108.767 163.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.3 93.04 4.12 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.264 1.026 . . . . 75.11 109.762 -160.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -141.96 118.47 10.94 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.074 2.15 . . . . 75.15 109.946 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -127.06 140.76 52.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.663 1.585 . . . . 64.14 107.041 159.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t -135.66 172.95 12.27 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 128.47 2.708 . . . . 74.43 107.712 161.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.29 -98.24 0.3 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 106.777 -2.529 . . . . 73.32 106.777 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.89 159.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.337 1.855 . . . . 73.34 107.093 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -125.57 137.5 53.92 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.446 1.899 . . . . 74.45 107.579 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.93 150.52 44.64 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.251 -0.906 . . . . 75.33 108.887 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mm -140.74 150.34 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 105.748 -1.945 . . . . 75.33 105.748 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.26 132.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 127.221 2.209 . . . . 71.35 106.861 -165.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.33 153.13 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 107.699 -1.223 . . . . 73.21 107.699 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -141.49 163.48 32.83 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.067 0.947 . . . . 75.23 109.53 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.28 156.15 39.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.86 1.264 . . . . 60.43 108.824 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -159.17 147.88 18.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.498 1.519 . . . . 61.44 109.92 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.89 -131.39 6.61 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.783 -0.927 . . . . 73.03 110.783 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -71.94 50.5 0.2 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.845 2.858 . . . . 74.32 113.577 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -63.22 7.19 0.1 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 74.14 114.552 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.08 -18.01 12.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.779 2.032 . . . . 75.02 112.062 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.34 36.64 3.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.755 2.022 . . . . 75.12 112.111 -169.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -123.42 155.47 37.36 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.466 1.106 . . . . 71.03 108.689 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.51 121.0 29.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.93 -1.878 . . . . 73.5 105.93 171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.4 t -137.84 106.84 4.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.081 -1.822 . . . . 75.45 106.081 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 112.32 20.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.015 -1.476 . . . . 75.11 107.015 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.34 135.09 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.285 -1.746 . . . . 74.25 106.285 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -90.82 139.14 31.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.952 2.101 . . . . 75.24 107.778 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.42 133.1 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.293 -2.114 . . . . 75.45 105.293 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.16 168.18 41.12 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.965 2.221 . . . . 63.43 108.976 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.68 175.74 39.85 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.074 -2.01 . . . . 73.21 108.074 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.25 157.32 31.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.403 1.101 . . . . 53.21 109.487 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.59 -171.13 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.956 1.702 . . . . 74.25 111.852 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -78.06 64.01 3.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.713 1.205 . . . . 74.15 110.101 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.21 3.1 1.97 Allowed Glycine 0 CA--C 1.517 0.172 0 CA-C-O 118.0 -1.444 . . . . 53.04 113.798 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.26 35.16 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 119.709 1.754 . . . . 74.34 112.588 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.86 144.3 24.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.467 2.778 . . . . 74.21 109.14 162.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.42 115.42 16.15 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.502 1.121 . . . . 72.55 109.699 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.31 128.7 36.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.382 0.992 . . . . 75.51 108.543 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 166.49 11.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.008 0.923 . . . . 73.44 109.732 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.7 155.73 42.22 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.758 1.623 . . . . 73.21 111.07 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.93 169.16 9.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.57 -1.65 . . . . 64.54 110.238 166.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.13 5.57 2.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.726 1.611 . . . . 73.52 112.908 -170.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -90.4 -8.88 49.5 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.488 1.515 . . . . 74.43 111.133 168.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.17 17.37 69.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.961 -0.911 . . . . 60.35 112.974 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.35 147.0 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.126 1.463 . . . . 62.54 108.522 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -75.0 159.58 31.6 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.03 -0.73 . . . . 73.24 109.03 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -144.88 23.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.73 0.812 . . . . 71.53 112.799 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.92 -176.99 16.51 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.41 -1.476 . . . . 64.41 109.41 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -121.15 11.51 10.9 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.538 1.135 . . . . 73.42 111.876 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -169.39 150.65 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.902 1.281 . . . . 75.54 110.459 165.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -176.19 -175.15 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.454 1.502 . . . . 63.45 109.218 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -141.21 102.84 4.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.113 0.965 . . . . 64.25 109.689 172.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.24 115.4 21.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.766 -0.828 . . . . 73.55 108.766 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -66.23 142.39 57.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.844 -1.169 . . . . 72.41 107.844 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -82.8 120.96 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.065 -1.828 . . . . 75.42 106.065 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -142.51 43.55 1.62 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.573 1.549 . . . . 74.42 108.961 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p -146.24 168.72 20.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.986 -1.116 . . . . 73.3 107.986 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.09 72.09 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.624 -0.672 . . . . 73.14 111.661 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -154.26 162.14 41.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.37 1.068 . . . . 74.23 108.971 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 mmm -143.38 171.72 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.75 2.82 . . . . 74.23 110.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.17 166.63 23.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.291 1.436 . . . . 61.12 110.928 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.3 m -149.9 167.64 26.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.999 2.519 . . . . 74.55 107.963 160.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.67 -174.89 4.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.853 1.261 . . . . 52.32 111.007 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.8 p -128.43 175.77 8.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.278 1.831 . . . . 74.34 109.748 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.85 -169.48 2.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.55 -0.908 . . . . 73.15 108.55 159.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 37.54 0.54 Allowed Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.833 -1.167 . . . . 61.42 113.976 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -140.73 78.14 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.158 1.383 . . . . 63.53 107.572 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.55 34.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.525 1.53 . . . . 74.14 109.954 159.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.46 -9.13 9.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.037 1.735 . . . . 75.31 111.693 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -161.49 172.37 16.54 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.608 -1.256 . . . . 75.44 107.608 167.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.9 ttt -152.59 111.67 3.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.462 -2.051 . . . . 75.45 105.462 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -95.51 154.62 17.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.53 110.026 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.556 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.6 OUTLIER -137.18 90.92 2.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.962 2.105 . . . . 63.24 105.498 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.79 46.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.93 -152.79 6.49 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 109.935 -1.266 . . . . 71.14 109.935 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.38 168.13 23.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.163 -1.051 . . . . 73.45 108.163 156.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.63 148.08 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.988 1.315 . . . . 75.32 108.844 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.88 171.32 14.99 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.296 -0.631 . . . . 63.11 109.296 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.8 t -151.38 149.44 29.31 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.374 -1.713 . . . . 75.41 106.374 163.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.44 10.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 124.526 1.131 . . . . 74.12 110.031 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -80.48 -173.54 4.15 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.034 0.934 . . . . 63.41 111.321 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -72.08 163.44 27.89 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.983 -0.448 . . . . 74.41 111.387 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 162.27 3.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.701 1.6 . . . . 72.2 113.539 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.33 4.33 90.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.431 1.015 . . . . 62.1 114.36 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -83.63 163.91 20.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.349 -1.352 . . . . 74.4 107.349 168.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -153.35 153.24 32.2 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.307 -0.854 . . . . 75.02 110.812 -163.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.9 tp -154.95 136.43 14.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.843 -1.54 . . . . 74.44 106.843 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -136.93 97.8 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.453 1.501 . . . . 74.34 108.775 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.43 132.42 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.916 1.286 . . . . 74.24 108.176 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.0 m -110.2 147.55 33.54 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.269 -1.012 . . . . 60.41 108.269 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.76 103.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.064 1.746 . . . . 74.53 110.201 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.4 mt -112.59 157.43 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 107.472 -1.307 . . . . 63.31 107.472 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.71 132.81 4.56 Favored Glycine 0 C--N 1.336 0.529 0 O-C-N 120.454 -1.404 . . . . 53.05 111.324 -170.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.01 147.83 48.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.44 1.496 . . . . 75.24 111.455 -170.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 128.939 2.895 . . . . 74.35 105.161 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.63 63.49 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.771 1.229 . . . . 51.43 111.749 164.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.42 18.75 5.85 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.414 2.286 . . . . 72.32 116.101 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.11 151.77 46.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.316 -1.49 . . . . 74.34 112.552 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -86.81 136.46 32.97 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.433 -1.321 . . . . 75.13 107.433 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.42 -10.51 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 73.33 113.12 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -144.9 141.02 28.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.737 1.153 . . . . 73.53 107.907 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.94 132.04 9.99 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.602 -0.518 . . . . 73.33 109.602 167.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.16 -175.8 4.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.575 0.702 . . . . 64.45 109.861 160.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.8 179.87 7.52 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.832 2.053 . . . . 74.34 108.399 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 176.22 12.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.05 -1.463 . . . . 63.42 107.05 171.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -147.29 137.88 23.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.391 -1.337 . . . . 75.25 107.391 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.22 157.45 46.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.571 0.748 . . . . 61.41 110.213 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mt -147.02 142.95 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.221 -1.77 . . . . 72.04 106.221 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -82.48 147.3 28.78 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 118.92 0.782 . . . . 73.43 110.394 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.57 26.25 2.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.923 0.868 . . . . 74.41 112.235 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.9 -16.02 61.36 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.196 1.855 . . . . 74.11 111.883 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -83.17 171.68 13.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.076 1.35 . . . . 75.11 109.463 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.69 111.09 2.25 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.855 -1.153 . . . . 72.11 109.425 162.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -73.12 132.23 43.03 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.808 -1.923 . . . . 75.31 105.808 163.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.3 mt -154.31 148.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.375 -2.454 . . . . 61.23 104.375 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.16 173.17 10.49 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.849 1.66 . . . . 71.53 109.357 168.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.0 p -129.33 172.95 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.234 1.492 . . . . 74.41 108.09 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.87 154.41 29.76 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 126.675 1.99 . . . . 72.25 106.103 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.4 p -155.97 127.13 7.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.228 0.537 . . . . 75.15 110.222 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 15.0 p -133.03 152.35 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.317 1.447 . . . . 74.34 107.874 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.6 t -134.82 -175.75 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.996 -1.113 . . . . 35.22 107.996 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.0 p -134.05 38.74 3.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.571 1.149 . . . . 75.45 109.061 167.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.72 122.6 0.51 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.532 -1.284 . . . . 75.43 107.532 166.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -116.04 112.91 22.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.336 -1.357 . . . . 75.22 107.336 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.079 -2.563 . . . . 74.55 104.079 178.238 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.519 0 N-CA-C 111.533 -0.627 . . . . 72.01 111.533 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.42 157.2 38.47 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.224 -1.399 . . . . 71.14 107.224 147.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -163.15 61.88 0.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.571 0.749 . . . . 71.3 110.038 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.02 88.18 1.38 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.928 -0.767 . . . . 72.0 108.928 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -140.76 103.5 4.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.36 1.464 . . . . 72.33 107.157 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.48 107.48 4.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.725 2.01 . . . . 72.41 106.531 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p -130.12 172.7 11.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.716 1.606 . . . . 70.23 107.703 169.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.76 -106.23 0.24 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 107.684 -2.166 . . . . 72.13 107.684 -172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.38 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 N-CA-C 106.129 -1.804 . . . . 72.4 106.129 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.99 143.44 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.497 -0.927 . . . . 74.02 108.497 171.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 162.84 34.39 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.171 0.588 . . . . 74.52 109.98 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 mm -129.66 153.24 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.065 1.746 . . . . 72.43 107.322 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 t -124.66 134.57 66.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 104.128 -2.545 . . . . 74.44 104.128 163.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 105.972 -1.862 . . . . 74.35 105.972 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.15 165.85 17.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.671 -0.492 . . . . 72.45 109.671 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.03 155.56 40.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.692 0.62 . . . . 73.34 111.623 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.0 m -145.1 142.94 30.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.578 1.151 . . . . 62.52 108.328 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.52 -150.71 23.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.29 -0.881 . . . . 74.42 111.545 -169.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.4 68.82 9.87 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.781 2.032 . . . . 72.12 107.258 170.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -78.79 24.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.174 1.546 . . . . 74.42 115.174 -158.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -135.33 12.82 3.53 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.47 1.108 . . . . 61.25 110.427 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -131.81 17.44 4.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 62.55 111.87 -168.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -133.25 130.19 38.67 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.366 0.985 . . . . 73.43 109.433 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -89.73 68.29 7.51 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.256 1.822 . . . . 74.41 109.069 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.31 92.08 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 127.518 2.327 . . . . 65.32 113.173 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -89.57 139.62 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.745 1.157 . . . . 73.34 109.519 165.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.56 164.5 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.345 -0.983 . . . . 74.14 108.345 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -127.23 129.83 48.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.868 2.867 . . . . 73.44 105.499 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.53 121.27 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.54 -1.652 . . . . 72.03 106.54 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.18 172.44 38.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.63 1.11 . . . . 51.11 110.392 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.2 176.26 43.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.11 1.338 . . . . 73.35 110.01 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.01 46.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.262 0.625 . . . . 70.05 111.884 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' CG ' HD21 ' A' ' 68' ' ' ASN . 2.7 p30 -130.92 139.35 50.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.945 2.098 . . . . 63.0 110.865 162.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.308 16.1 ttpp 43.16 32.93 0.5 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.521 1.929 . . . . 63.44 114.308 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 33.98 23.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.529 -0.732 . . . . 71.44 111.86 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.69 175.23 36.57 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.314 1.911 . . . . 74.13 109.856 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 152.04 45.59 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 74.23 112.492 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.09 130.61 56.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.44 1.096 . . . . 74.33 110.627 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -64.06 116.68 6.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.087 0.858 . . . . 72.23 110.612 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -96.05 158.58 15.38 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.921 2.088 . . . . 70.31 109.51 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.84 139.83 50.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.021 1.328 . . . . 73.21 110.988 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -78.35 177.19 8.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 113.748 -1.569 . . . . 74.15 110.777 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.11 -5.62 18.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.535 1.534 . . . . 74.34 114.51 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -114.19 20.63 15.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.122 1.769 . . . . 74.33 110.938 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.41 8.24 87.06 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 124.306 0.955 . . . . 72.23 114.379 162.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.52 149.45 26.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.826 2.45 . . . . 74.53 108.849 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -76.1 161.46 28.83 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.421 -0.585 . . . . 74.25 109.421 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.36 -11.83 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.787 0.835 . . . . 72.11 112.359 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.36 -171.39 35.83 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 109.055 -1.618 . . . . 70.34 109.055 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -110.05 3.02 19.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.143 1.777 . . . . 70.11 111.181 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 p -173.36 117.11 0.27 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.53 1.132 . . . . 65.15 109.292 -166.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -171.48 -178.27 2.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.291 0.95 . . . . 73.23 111.177 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.93 161.78 18.8 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.702 1.601 . . . . 72.43 109.593 166.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.7 29.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.319 1.448 . . . . 70.32 107.586 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -111.81 141.19 45.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.926 2.09 . . . . 73.04 110.299 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.79 86.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 121.035 1.743 . . . . 72.25 110.317 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.66 18.63 20.63 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.889 0.876 . . . . 74.35 112.363 175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -117.32 158.98 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.92 1.288 . . . . 61.31 108.782 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -49.94 62.07 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.543 -0.723 . . . . 75.45 109.125 168.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.5 p -141.29 113.77 8.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.398 0.679 . . . . 74.35 110.736 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mmm -115.18 167.98 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.113 2.165 . . . . 71.43 111.145 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.1 p -150.96 165.65 33.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.03 0.932 . . . . 71.14 110.524 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 m -143.88 159.14 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.594 -1.632 . . . . 73.54 106.594 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.5 p -148.09 -168.2 3.01 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.816 0.735 . . . . 64.32 109.792 166.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 t -124.7 179.25 5.05 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.893 1.677 . . . . 71.43 106.971 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.53 -176.39 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.831 0.853 . . . . 65.03 109.427 163.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.09 23.75 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.157 -0.802 . . . . 72.41 113.324 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.413 HD21 ' CG ' ' A' ' 33' ' ' ASP . 6.0 t30 -135.23 94.68 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.598 -1.63 . . . . 72.14 106.598 -175.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.32 158.99 16.77 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.957 1.303 . . . . 71.04 110.02 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -114.12 -28.06 7.45 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.453 1.501 . . . . 74.02 112.214 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.75 170.49 19.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.512 -1.292 . . . . 74.13 107.512 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 ttt -146.93 154.09 40.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 102.935 -2.987 . . . . 74.35 102.935 171.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.0 t -140.78 149.02 41.55 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.234 -0.916 . . . . 70.02 110.421 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -125.6 66.09 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.119 -1.808 . . . . 72.23 106.119 -177.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.86 143.73 55.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.974 -1.491 . . . . 74.21 106.974 167.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.28 178.73 43.5 Favored Glycine 0 CA--C 1.509 -0.309 0 CA-C-N 119.999 1.272 . . . . 65.25 111.987 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -142.5 159.21 42.67 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.556 1.142 . . . . 74.05 110.38 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.81 131.59 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.232 -1.395 . . . . 73.15 107.232 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -137.92 169.3 18.02 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.931 -0.557 . . . . 64.12 110.379 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -142.09 169.88 16.75 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.539 1.136 . . . . 65.35 109.921 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.96 0.55 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.358 2.663 . . . . 64.43 111.244 167.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -73.81 177.47 5.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.682 1.193 . . . . 61.32 109.866 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -68.79 174.14 4.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.897 0.879 . . . . 53.41 111.817 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.32 158.52 23.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.785 2.034 . . . . 71.11 112.763 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.36 -0.4 41.19 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.605 1.098 . . . . 42.14 114.337 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -70.58 131.25 43.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 104.916 -2.253 . . . . 70.25 104.916 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -111.39 162.02 15.49 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.412 0.685 . . . . 75.41 109.47 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.17 121.43 1.43 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 105.905 -1.887 . . . . 65.42 105.905 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -111.3 137.06 49.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.311 -1.737 . . . . 74.34 106.311 169.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 mm -117.73 121.63 67.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.702 -1.592 . . . . 74.34 106.702 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -95.09 131.03 41.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.896 -1.891 . . . . 75.53 105.896 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.11 104.05 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.939 1.296 . . . . 73.33 110.176 -174.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.26 152.71 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 75.51 108.338 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.61 152.88 22.27 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 124.456 1.027 . . . . 71.22 112.403 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -136.45 155.25 50.26 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.953 1.301 . . . . 75.24 110.826 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -130.32 83.24 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.104 -1.813 . . . . 74.33 106.104 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.285 3.0 p-10 49.64 7.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 1 C-N-CA 132.126 4.17 . . . . 73.11 117.369 162.02 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.86 -41.34 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.767 2.027 . . . . 72.14 109.644 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 158.66 44.13 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.595 1.158 . . . . 71.43 110.603 -167.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.44 146.79 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.444 -2.428 . . . . 71.5 104.444 163.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.68 -3.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 123.448 0.699 . . . . 73.31 110.836 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -156.77 141.06 16.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.047 -1.033 . . . . 72.24 108.496 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.95 129.27 12.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.995 -1.113 . . . . 70.24 107.995 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -132.49 160.58 36.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.286 -1.005 . . . . 71.45 108.286 163.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -145.39 121.79 10.97 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.126 -1.805 . . . . 72.22 106.126 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -131.31 161.56 32.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.658 0.663 . . . . 72.25 109.892 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.82 156.17 47.55 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 126.625 1.97 . . . . 74.54 110.839 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -151.63 124.79 8.72 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.891 1.677 . . . . 71.31 107.092 -165.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -135.7 130.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.536 -1.283 . . . . 74.14 107.536 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -72.26 152.96 41.83 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.437 1.095 . . . . 72.22 110.0 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -148.31 28.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.38 -0.825 . . . . 73.33 111.966 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.94 -48.63 0.92 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.517 1.532 . . . . 71.33 109.793 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -74.76 173.42 10.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.915 1.286 . . . . 71.05 112.441 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -72.43 100.46 2.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.34 -1.355 . . . . 71.33 107.34 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.68 134.58 57.22 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.157 -0.925 . . . . 72.21 108.824 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 mt -152.57 133.5 4.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.526 1.53 . . . . 74.12 107.881 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 74.02 112.071 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 p -144.12 150.72 38.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.115 0.966 . . . . 73.23 112.196 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -133.3 173.85 11.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.595 1.558 . . . . 72.31 110.191 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 p -156.39 119.73 4.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.253 1.021 . . . . 72.42 108.611 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.497 ' CG1' ' HB3' ' A' ' 74' ' ' CYS 0.313 10.4 p -121.88 86.42 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.964 1.364 . . . . 64.04 109.106 174.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 p -70.21 173.4 6.73 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.216 1.406 . . . . 63.25 110.127 164.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 p -130.55 9.69 5.11 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.316 -0.865 . . . . 70.23 112.877 166.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -146.86 125.7 12.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.852 -1.907 . . . . 74.14 105.852 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -142.13 155.85 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.807 0.843 . . . . 74.04 108.792 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.251 1.183 0 C-N-CA 129.533 3.133 . . . . 70.12 110.087 -167.451 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 110.135 -1.186 . . . . 63.34 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.03 121.02 26.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.974 0.91 . . . . 64.13 108.84 167.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.4 m -143.43 174.35 10.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.263 1.425 . . . . 62.54 107.562 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -132.3 146.58 52.09 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.186 -1.042 . . . . 73.32 108.186 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.92 84.99 2.04 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.478 1.511 . . . . 73.13 108.622 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -120.4 104.42 10.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.263 2.225 . . . . 73.3 107.677 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.4 p -140.47 175.6 9.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.564 1.146 . . . . 73.51 110.446 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.57 -116.82 1.98 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 106.572 -2.611 . . . . 74.22 106.572 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.93 128.99 68.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.535 -1.283 . . . . 74.24 107.535 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -97.85 157.96 15.79 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.541 -0.911 . . . . 65.2 108.541 171.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -143.1 150.42 39.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.815 -1.55 . . . . 74.33 106.815 167.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.58 155.45 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 106.197 -1.779 . . . . 73.44 106.197 165.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.59 126.17 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.434 -2.432 . . . . 74.11 104.434 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.1 mt -121.93 154.27 26.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.582 -1.636 . . . . 73.13 106.582 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.12 168.22 20.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.457 0.572 . . . . 70.12 110.331 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -148.25 158.87 44.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.939 1.296 . . . . 74.33 109.193 164.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.175 1.39 . . . . 72.13 107.509 163.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.87 -120.04 4.12 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.463 -1.455 . . . . 54.23 109.463 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -96.22 118.09 32.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.275 -1.38 . . . . 70.44 107.275 159.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.5 p -100.54 -5.78 26.37 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.139 0.975 . . . . 74.12 112.108 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -37.32 38.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.07 0.948 . . . . 75.23 110.133 -169.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.33 18.74 13.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.533 1.133 . . . . 73.21 112.754 -161.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -121.44 113.4 19.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.693 0.797 . . . . 73.3 111.021 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.89 136.65 36.72 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.892 1.677 . . . . 72.04 108.112 168.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -148.77 106.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 105.497 -2.038 . . . . 74.01 105.497 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -114.96 123.51 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.421 1.009 . . . . 73.04 108.946 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.52 140.92 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.033 1.333 . . . . 74.23 110.036 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -76.12 145.41 40.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.857 -1.905 . . . . 73.44 105.857 157.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mt -127.57 110.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 104.962 -2.236 . . . . 72.43 104.962 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.67 172.41 35.54 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.91 -0.586 . . . . 65.51 111.774 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.35 41.74 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 128.014 2.721 . . . . 71.2 108.597 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.49 34.41 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.89 1.276 . . . . 72.24 109.792 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.07 -177.46 4.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.117 1.367 . . . . 74.5 112.501 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.98 79.25 0.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.708 -0.849 . . . . 72.11 108.708 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.12 -65.02 0.29 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.268 -1.933 . . . . 71.33 108.268 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.34 -154.32 6.87 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.849 1.214 . . . . 73.22 110.586 -156.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -67.04 142.25 60.97 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.526 2.151 . . . . 54.23 109.868 172.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.9 130.3 39.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.79 -1.189 . . . . 64.33 107.79 172.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -59.47 137.73 57.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.968 -0.539 . . . . 72.1 109.592 168.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.45 154.56 23.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.572 1.149 . . . . 73.51 109.081 170.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -132.65 154.19 50.35 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.136 1.374 . . . . 74.1 108.737 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -77.63 178.28 7.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.726 1.61 . . . . 75.11 110.721 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.18 8.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.092 1.357 . . . . 62.44 113.551 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -119.18 -6.02 10.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.549 2.74 . . . . 75.42 111.147 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 9.38 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.304 -1.276 . . . . 60.22 114.576 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.66 142.25 27.66 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.528 2.164 . . . . 74.12 110.142 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -62.07 136.58 58.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.744 1.618 . . . . 72.22 110.856 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.38 9.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.562 0.949 . . . . 74.42 113.562 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.17 171.25 12.24 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.665 -1.374 . . . . 62.22 109.665 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.1 p30 -103.11 1.56 33.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.231 1.012 . . . . 74.4 110.774 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -159.14 129.04 5.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.238 2.215 . . . . 61.5 107.671 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -161.87 -179.64 7.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.69 1.196 . . . . 74.22 109.216 161.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 p -117.13 161.68 19.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.143 1.377 . . . . 74.22 109.614 159.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.02 166.7 24.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.834 0.854 . . . . 74.31 109.175 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -114.9 139.91 49.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.621 1.168 . . . . 70.2 111.033 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mm -82.04 72.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 107.288 -1.375 . . . . 65.22 107.288 172.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 17.06 7.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.088 1.355 . . . . 75.42 111.527 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 p -137.65 147.07 44.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.998 -0.741 . . . . 73.14 108.998 -171.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.92 66.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.152 0.981 . . . . 74.41 110.633 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.6 p -135.05 162.56 32.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.153 -1.055 . . . . 71.31 108.153 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.9 169.46 24.53 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.095 1.758 . . . . 74.04 109.388 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.66 148.61 6.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.125 1.37 . . . . 75.44 110.671 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 64.7 m -134.99 150.8 50.4 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.55 -0.907 . . . . 74.34 108.55 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.2 p -142.9 -179.08 6.14 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.287 0.635 . . . . 73.14 112.09 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.3 p -132.26 -177.72 4.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.883 1.673 . . . . 73.31 109.438 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.76 -173.98 2.43 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.031 -1.1 . . . . 74.21 108.031 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.0 -13.43 26.8 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.697 -0.627 . . . . 53.12 114.362 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -88.23 83.75 6.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.458 1.129 . . . . 73.5 108.774 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.29 178.03 7.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.343 1.057 . . . . 73.21 110.961 157.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.75 -22.34 4.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.357 1.463 . . . . 74.32 112.81 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.48 177.21 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.353 1.461 . . . . 73.32 109.272 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.5 ttt -147.44 154.1 40.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.914 1.685 . . . . 73.2 106.589 163.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 t -128.34 155.55 44.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 74.43 109.905 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.518 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -140.51 42.37 1.88 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.629 2.371 . . . . 63.33 109.904 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 120' ' ' SER . . . -69.09 142.39 54.48 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.048 -1.032 . . . . 72.22 110.971 165.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.78 -176.03 39.81 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.852 -0.899 . . . . 73.44 110.852 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 86.7 p -131.81 167.53 19.4 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.076 0.95 . . . . 72.54 110.53 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.68 153.3 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.224 -1.399 . . . . 73.3 107.224 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p -159.79 142.89 14.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.254 0.934 . . . . 72.34 111.705 166.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -148.37 159.79 43.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.233 1.413 . . . . 64.13 108.509 173.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.86 25.75 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.267 1.827 . . . . 73.12 110.163 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -73.61 -159.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.075 1.35 . . . . 73.43 110.394 174.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -83.99 169.02 15.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.156 0.982 . . . . 72.42 110.136 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 162.47 7.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 73.34 112.028 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.83 -2.27 80.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.276 1.417 . . . . 54.5 113.891 174.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -72.79 115.62 12.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.617 1.709 . . . . 74.41 106.658 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -96.05 164.81 12.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.638 -0.875 . . . . 74.32 108.638 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.1 tp -155.78 147.59 23.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.963 0.801 . . . . 72.32 109.035 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -148.15 98.17 2.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.813 1.645 . . . . 71.33 108.255 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.74 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.997 2.119 . . . . 71.4 108.124 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -128.19 146.46 50.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.103 1.361 . . . . 72.41 108.383 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.34 105.97 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.573 1.949 . . . . 74.14 110.749 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.02 139.05 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.198 1.399 . . . . 45.33 108.995 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.31 146.21 17.91 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.658 1.123 . . . . 64.32 111.464 -166.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -131.85 157.62 43.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.252 1.421 . . . . 73.34 110.2 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -131.41 130.76 63.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.949 -2.241 . . . . 73.44 104.949 167.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.65 -76.44 0.06 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.6 2.36 . . . . 70.23 111.031 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -149.37 1.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.519 1.928 . . . . 71.13 112.664 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.88 145.63 50.17 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.621 1.1 . . . . 71.42 111.412 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.81 126.08 33.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.353 1.461 . . . . 73.13 109.883 -172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.43 -1.44 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.687 0.995 . . . . 74.32 113.687 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -154.51 128.01 8.56 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 74.22 108.184 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.42 123.73 18.07 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.127 0.876 . . . . 71.43 110.204 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.43 175.11 9.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.562 0.696 . . . . 74.22 110.47 160.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.25 173.88 15.0 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.836 2.854 . . . . 71.04 107.104 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.48 176.0 9.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.062 0.945 . . . . 74.42 108.76 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -139.17 137.98 36.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.68 -1.23 . . . . 74.03 107.68 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.602 ' HH ' ' CD ' ' A' ' 117' ' ' GLU . 2.1 m-85 -132.43 160.88 35.12 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.138 -1.06 . . . . 73.23 108.138 170.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -143.51 148.11 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.646 -1.983 . . . . 74.43 105.646 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.4 p -76.32 139.35 41.0 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.038 -1.097 . . . . 73.33 108.038 164.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.91 2.9 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.194 1.398 . . . . 70.11 111.124 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.28 38.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.866 1.698 . . . . 53.35 111.366 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -90.6 159.99 16.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.682 1.241 . . . . 71.4 107.687 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.1 113.14 1.77 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.975 0.91 . . . . 74.33 109.775 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.82 130.24 41.75 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.55 -1.278 . . . . 72.22 107.55 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -162.18 153.73 3.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 103.901 -2.629 . . . . 73.23 103.901 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.602 ' CD ' ' HH ' ' A' ' 108' ' ' TYR . 1.3 pp20? -165.58 176.15 8.35 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.004 2.121 . . . . 74.22 106.512 160.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.2 p -141.87 142.24 33.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.067 -0.716 . . . . 54.22 109.067 167.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -125.92 169.02 13.1 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.512 1.525 . . . . 73.22 109.865 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 10.5 p -170.23 143.11 2.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.362 1.065 . . . . 70.43 108.731 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 6.3 p -162.77 128.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 102.641 -3.096 . . . . 74.34 102.641 -167.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 m -134.85 143.42 47.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.686 -1.227 . . . . 74.23 107.686 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.84 -16.71 58.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.325 -0.55 . . . . 64.1 111.28 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -132.44 137.09 47.15 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 105.888 -1.893 . . . . 71.41 105.888 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -167.23 123.96 1.18 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 102.432 -3.173 . . . . 74.52 102.432 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.25 1.104 0 CA-C-N 119.035 0.834 . . . . 73.53 110.028 179.596 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 110.014 -1.234 . . . . 61.14 110.014 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.33 155.61 32.54 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.474 1.11 . . . . 70.34 108.331 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 p -154.36 152.95 30.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.726 -1.212 . . . . 73.24 107.726 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -167.33 122.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.157 -1.794 . . . . 72.11 106.157 -170.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -149.45 103.91 3.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.898 2.079 . . . . 72.31 110.553 -169.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -127.99 109.21 11.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.659 1.584 . . . . 64.12 109.894 -166.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -132.64 177.46 7.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.599 1.96 . . . . 72.1 110.496 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.98 -129.15 6.91 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.642 -2.183 . . . . 64.23 107.642 -162.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.0 123.08 50.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.904 1.682 . . . . 73.54 110.427 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -95.11 147.06 23.84 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.504 1.122 . . . . 73.5 109.426 170.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -148.88 151.81 35.34 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.113 0.965 . . . . 72.2 109.044 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.25 149.46 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.702 2.401 . . . . 74.23 106.572 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.19 131.76 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.345 -2.094 . . . . 74.44 105.345 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.7 mt -127.96 149.01 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.877 -1.527 . . . . 74.11 106.877 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -145.58 161.72 39.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.536 -0.542 . . . . 72.41 109.536 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -153.32 159.86 42.59 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.756 0.788 . . . . 65.03 112.627 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -145.48 174.39 11.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.635 1.574 . . . . 72.13 108.882 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.12 -154.92 19.54 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.885 1.231 . . . . 75.03 110.538 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.12 50.67 0.15 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.09 2.156 . . . . 65.12 111.191 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -54.48 -36.22 63.92 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 129.454 3.102 . . . . 74.23 111.662 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.87 -28.68 64.38 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.645 1.178 . . . . 63.43 111.223 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.7 m -93.33 -0.48 56.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.809 1.644 . . . . 73.23 113.432 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE1' HG13 ' A' ' 78' ' ' VAL . 1.2 t80 -119.77 123.06 42.79 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 123.525 1.631 . . . . 73.42 110.964 -169.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.72 79.48 8.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.001 2.921 . . . . 72.14 110.697 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.467 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 4.0 t -75.88 91.83 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.331 1.453 . . . . 72.03 107.774 176.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -94.98 129.94 41.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.132 -1.433 . . . . 73.23 107.132 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.79 154.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.645 -1.613 . . . . 74.21 106.645 174.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -112.07 152.08 28.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.365 1.066 . . . . 65.41 109.172 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.3 mt -122.15 157.39 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.035 -1.098 . . . . 63.12 108.035 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.96 179.54 48.05 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.824 1.202 . . . . 64.12 110.515 172.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.78 166.89 35.08 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 127.053 2.263 . . . . 65.3 108.438 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.46 165.51 27.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.959 1.379 . . . . 73.03 111.418 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 34' ' ' LYS . 31.7 t70 -140.07 179.24 6.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.498 . . . . 73.24 110.587 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' H ' ' CG ' ' A' ' 33' ' ' ASP . 20.1 ttpp -75.5 72.01 2.47 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.534 1.534 . . . . 70.02 109.536 170.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.46 -5.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 118.459 -1.189 . . . . 63.12 114.333 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.41 -159.0 27.68 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.27 1.535 . . . . 63.31 110.872 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.35 161.72 41.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.605 2.87 . . . . 65.01 111.856 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.51 121.52 31.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.211 1.404 . . . . 70.44 109.29 166.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -62.4 153.77 30.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.163 0.892 . . . . 74.14 109.929 168.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -133.26 160.55 36.97 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.702 1.201 . . . . 72.1 109.711 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -138.01 160.55 39.05 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.81 0.844 . . . . 75.53 110.077 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -94.85 -179.4 4.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.156 -0.929 . . . . 61.25 111.399 178.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.35 1.95 3.41 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.826 2.451 . . . . 61.43 113.709 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -112.11 -3.34 14.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.409 1.884 . . . . 74.21 112.908 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 6.19 85.3 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.279 0.942 . . . . 74.31 113.691 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -76.06 144.85 40.54 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.628 1.214 . . . . 73.24 107.856 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 122.96 20.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.362 2.265 . . . . 71.43 109.665 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.9 pt -132.86 9.79 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 115.251 1.575 . . . . 74.22 115.251 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.77 -158.77 23.65 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.302 -1.119 . . . . 71.42 110.302 167.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -128.18 -2.66 5.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.338 1.055 . . . . 74.41 111.911 162.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -151.84 123.06 7.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.601 0.76 . . . . 72.43 109.901 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -173.93 -179.46 1.73 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.678 0.791 . . . . 72.24 109.55 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.7 p -137.19 119.43 15.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.264 1.426 . . . . 61.11 108.012 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.81 111.12 23.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.771 1.629 . . . . 74.12 108.128 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.17 147.9 49.57 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.351 -0.981 . . . . 73.12 108.351 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mm -97.05 125.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.188 -0.671 . . . . 72.12 109.188 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 27.3 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.65 1.98 . . . . 73.21 111.777 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 p -124.8 175.47 7.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.206 1.002 . . . . 73.04 109.033 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.71 66.35 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 64.33 110.182 163.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -137.88 155.62 48.76 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.238 1.015 . . . . 63.03 111.404 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.9 mmm -139.26 167.98 20.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.826 2.051 . . . . 72.11 111.518 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 p -151.56 152.63 33.18 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.122 0.969 . . . . 72.34 110.161 168.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.6 m -145.69 148.63 33.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.208 1.403 . . . . 71.03 108.349 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.4 p -137.98 174.83 10.15 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.419 0.554 . . . . 73.44 111.295 167.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 p -108.09 168.25 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.535 -0.913 . . . . 73.1 108.535 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.5 169.77 3.6 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.32 108.795 159.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.01 -26.1 67.47 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.08 -0.844 . . . . 72.24 112.302 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.72 90.39 3.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.604 1.702 . . . . 74.43 108.09 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.89 173.35 14.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.038 1.335 . . . . 72.41 110.413 159.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -131.25 -12.79 3.54 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.539 2.336 . . . . 74.12 113.198 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -159.08 170.19 22.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.214 -1.402 . . . . 64.33 107.214 167.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.1 ttt -133.55 155.41 49.65 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 105.452 -2.055 . . . . 74.33 105.452 167.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -130.06 161.2 31.56 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.129 0.572 . . . . 63.04 109.505 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.85 41.64 0.85 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.734 1.214 . . . . 74.21 110.705 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 134.41 56.09 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.327 -0.858 . . . . 64.41 110.284 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.43 179.19 26.42 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.481 -0.648 . . . . 71.21 111.481 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.91 130.93 34.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.917 -1.142 . . . . 65.15 107.917 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 23' ' ' PHE . 90.6 t -90.06 146.66 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.205 -1.035 . . . . 72.41 108.205 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.1 t -150.79 159.36 44.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 118.501 -1.279 . . . . 63.41 110.328 155.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 t -147.88 143.97 27.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.614 -0.884 . . . . 71.23 108.614 164.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 pt -117.84 19.48 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.581 1.952 . . . . 74.21 109.404 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.8 p -79.45 175.69 10.38 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.719 1.208 . . . . 72.11 111.593 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -70.22 167.03 18.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.155 -0.93 . . . . 72.02 110.741 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.63 158.11 10.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.745 2.018 . . . . 70.12 113.055 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.73 -10.2 57.25 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.514 1.53 . . . . 74.14 114.046 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -67.09 159.31 29.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.744 1.617 . . . . 73.05 108.335 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -144.6 170.97 15.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.764 0.826 . . . . 73.11 111.06 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 tp -159.97 162.29 34.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.638 -1.245 . . . . 74.44 107.638 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -145.16 116.69 8.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.595 -1.261 . . . . 70.01 107.595 164.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.14 147.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 124.978 1.311 . . . . 74.01 107.624 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 m -127.7 138.64 52.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.304 -1.739 . . . . 73.35 106.304 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.2 112.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.527 1.931 . . . . 74.22 108.459 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -129.08 150.8 34.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.43 -1.693 . . . . 70.14 106.43 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.62 152.06 22.76 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.182 0.896 . . . . 70.44 111.245 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.54 150.23 46.15 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.795 0.838 . . . . 74.3 111.388 -164.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.8 mt -146.08 136.0 17.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 104.774 -2.306 . . . . 74.4 104.774 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.0 t70 44.5 52.68 7.42 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.744 2.018 . . . . 63.34 113.683 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t0 60.25 25.12 14.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.115 0.966 . . . . 71.13 112.795 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -126.75 156.92 40.4 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.326 -1.484 . . . . 75.12 111.308 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -97.49 119.58 36.29 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.97 1.708 . . . . 74.4 107.267 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.8 m -124.97 -2.6 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.647 0.98 . . . . 73.4 113.647 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -162.36 133.73 5.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.372 -1.344 . . . . 73.22 107.372 -172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.37 118.43 2.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.723 0.692 . . . . 74.33 111.703 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.06 168.83 18.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.59 0.709 . . . . 72.05 110.826 166.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.82 166.47 20.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.589 2.355 . . . . 74.35 108.423 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -149.14 162.33 40.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.835 -0.802 . . . . 74.31 108.835 171.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -147.94 118.37 7.41 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.008 -1.849 . . . . 72.42 106.008 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -118.35 152.9 34.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.661 -0.866 . . . . 72.43 108.661 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.1 mt -138.36 153.77 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.281 1.432 . . . . 74.01 107.32 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -99.45 150.86 21.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.138 0.975 . . . . 72.34 110.214 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -130.45 15.1 5.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.908 1.683 . . . . 71.11 110.9 169.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.04 -24.44 18.81 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.549 1.547 . . . . 61.41 111.635 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 162.86 28.51 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.92 1.288 . . . . 73.32 109.345 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 106.73 2.68 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.254 0.622 . . . . 70.13 110.113 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.85 136.28 58.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.46 -0.941 . . . . 72.05 108.46 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.4 mt -152.68 147.49 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 104.83 -2.285 . . . . 72.33 104.83 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.83 176.49 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.59 1.156 . . . . 71.14 109.467 163.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -131.15 160.87 33.49 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.307 1.043 . . . . 74.11 108.735 163.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -149.16 165.49 31.66 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.207 1.003 . . . . 74.22 108.704 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -165.74 142.07 5.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.447 0.641 . . . . 53.53 111.413 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.4 t -143.89 109.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.049 2.54 . . . . 73.32 104.825 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.1 144.91 29.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.983 -1.488 . . . . 70.11 106.983 169.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.0 p -92.36 44.2 1.15 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.598 1.09 . . . . 74.11 109.011 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -171.07 146.4 2.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.795 1.238 . . . . 74.32 108.034 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -101.48 138.97 37.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.566 -1.642 . . . . 73.22 106.566 157.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.417 1.887 . . . . 61.0 106.595 -177.013 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.062 -1.215 . . . . 72.32 110.062 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.12 168.78 21.52 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.63 1.572 . . . . 63.41 110.811 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.4 m -137.1 46.42 2.18 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.307 2.243 . . . . 63.43 109.51 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -137.64 41.67 2.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.561 1.172 . . . . 73.41 113.196 -143.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.8 24.27 3.24 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 119.842 -1.787 . . . . 71.23 111.756 -152.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -112.3 112.53 24.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 130.339 3.456 . . . . 75.41 107.748 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -132.56 -163.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 128.123 2.569 . . . . 75.01 106.934 172.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.64 -91.1 0.14 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.444 -1.462 . . . . 53.23 109.444 163.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -139.78 110.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 105.824 -1.917 . . . . 74.42 105.824 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -78.23 140.97 38.89 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.544 -1.28 . . . . 74.14 107.544 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -135.74 157.47 46.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.55 -1.648 . . . . 74.34 106.55 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.1 tt -135.41 153.94 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.69 125.91 26.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 105.713 -1.958 . . . . 73.3 105.713 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.0 133.79 63.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 105.529 -2.026 . . . . 72.23 105.529 -170.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -140.68 159.97 41.05 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 119.562 1.074 . . . . 72.33 109.103 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -140.27 150.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.051 0.453 . . . . 75.44 110.76 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -134.34 163.24 30.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.388 -1.338 . . . . 64.41 107.388 158.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -152.15 18.81 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.752 0.691 . . . . 72.44 111.719 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.22 72.07 9.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.399 1.095 . . . . 75.45 109.209 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -70.93 17.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.883 2.073 . . . . 74.53 115.099 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.87 -3.89 5.81 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.866 1.061 . . . . 64.41 113.866 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 t -101.22 1.32 38.83 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.945 0.793 . . . . 74.33 112.942 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -117.81 148.47 42.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.137 0.975 . . . . 74.23 112.112 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -92.29 141.55 28.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.799 -1.926 . . . . 64.31 105.799 163.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.45 81.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 63.31 111.714 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 109.36 21.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.557 0.694 . . . . 75.32 110.366 -167.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 m -91.76 122.29 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.246 1.019 . . . . 73.45 109.695 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -66.77 133.72 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.175 -1.787 . . . . 72.11 106.175 160.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.38 126.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.733 -1.951 . . . . 72.21 105.733 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.22 177.86 38.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.022 0.82 . . . . 63.34 111.896 -171.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.85 167.16 29.08 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.039 2.257 . . . . 62.11 110.179 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.86 162.66 32.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.131 0.972 . . . . 75.24 111.637 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.99 -171.2 2.62 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.766 2.026 . . . . 75.14 112.332 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -78.62 65.74 3.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.586 0.755 . . . . 64.12 111.415 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.85 43.77 0.29 Allowed Glycine 0 C--N 1.323 -0.169 0 O-C-N 121.88 -0.512 . . . . 73.44 111.976 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.54 -154.9 22.75 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.053 -0.859 . . . . 74.23 111.961 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.03 159.78 37.31 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 124.267 3.311 . . . . 73.41 110.721 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.983 -1.118 . . . . 75.34 107.983 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -72.21 141.67 49.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.427 -0.953 . . . . 75.4 108.427 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.63 150.42 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.088 -1.449 . . . . 73.43 107.088 -171.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -131.46 134.22 45.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.542 1.137 . . . . 71.22 108.16 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -77.07 175.78 9.29 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.398 -0.819 . . . . 74.21 109.787 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -5.87 48.13 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 62.04 113.825 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.08 -5.21 50.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.277 1.431 . . . . 75.42 110.445 165.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.51 84.14 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.72 2.105 . . . . 73.32 113.131 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -101.96 142.42 33.27 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.045 1.338 . . . . 71.14 110.24 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -67.54 128.13 35.29 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.55 1.54 . . . . 75.3 109.159 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.57 20.57 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.544 0.738 . . . . 63.44 112.0 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -172.71 14.35 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.336 0.969 . . . . 65.4 110.958 174.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -118.68 9.25 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.957 1.303 . . . . 73.42 112.109 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -156.93 159.22 37.9 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.448 0.699 . . . . 71.43 110.196 150.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 p90 179.37 -175.39 0.24 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.988 1.715 . . . . 73.11 107.683 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 p -127.43 161.79 27.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.795 0.807 . . . . 73.32 109.333 157.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.77 155.23 50.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.244 -1.762 . . . . 75.04 106.244 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.77 144.79 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.412 -0.959 . . . . 72.53 108.412 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.78 83.17 2.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 N-CA-C 107.338 -1.356 . . . . 74.41 107.338 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -113.63 34.23 4.7 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 123.912 0.885 . . . . 74.51 111.546 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 p -140.92 146.95 38.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.637 -1.616 . . . . 72.04 106.637 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.78 -37.47 63.49 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.491 1.116 . . . . 71.03 110.171 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.0 p -140.94 142.62 34.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.543 1.537 . . . . 54.25 107.88 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.21 169.8 17.02 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.543 2.337 . . . . 71.41 109.485 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.9 p -167.43 161.95 14.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.993 2.117 . . . . 73.04 108.792 172.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.1 m -144.41 165.24 28.48 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.417 -1.697 . . . . 75.4 106.417 157.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.16 -178.73 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.537 0.735 . . . . 75.41 110.256 172.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.2 p -125.84 177.18 6.45 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.632 1.173 . . . . 75.0 108.79 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -87.49 178.96 6.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.298 -1.001 . . . . 72.04 108.298 162.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.23 17.74 3.82 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.382 -0.824 . . . . 63.1 114.647 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -105.25 85.87 2.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.094 -1.817 . . . . 61.34 106.094 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.05 172.62 18.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.563 1.074 . . . . 75.33 111.509 165.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -122.95 -17.96 6.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.2 -1.363 . . . . 75.43 111.652 164.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -157.12 173.72 16.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.999 0.92 . . . . 75.21 110.267 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.1 ttt -140.59 161.79 36.91 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.104 2.161 . . . . 74.12 105.86 165.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -140.35 160.23 40.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.478 1.111 . . . . 73.02 110.178 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.7 39.25 0.86 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.037 2.535 . . . . 74.12 108.94 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 123.53 22.25 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.231 1.012 . . . . 73.31 109.973 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.92 29.03 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.8 -0.92 . . . . 63.35 110.8 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 95.1 p -127.24 167.43 16.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.905 0.482 . . . . 75.44 111.448 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.32 132.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 126.744 2.018 . . . . 75.41 105.952 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -144.5 162.66 35.99 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.456 0.571 . . . . 75.42 111.575 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.13 159.76 38.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.135 0.974 . . . . 60.35 110.531 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -139.48 32.03 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.204 1.802 . . . . 73.21 110.91 -169.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -132.78 176.34 8.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.921 1.289 . . . . 63.52 110.742 -167.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -45.35 160.72 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.877 2.471 . . . . 75.54 116.096 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.72 157.21 21.57 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.09 -1.868 . . . . 62.32 113.002 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.1 -0.64 82.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.389 -0.673 . . . . 62.55 113.795 172.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -75.16 114.64 13.89 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.408 1.604 . . . . 72.52 106.739 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -95.88 158.66 15.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.704 -0.851 . . . . 72.43 108.704 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.7 103.0 1.53 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.502 -1.666 . . . . 75.11 106.502 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -105.07 118.53 36.76 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.881 -1.137 . . . . 75.32 109.207 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mm -107.56 134.82 48.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.759 -1.2 . . . . 75.23 107.759 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.9 m -113.13 126.53 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.77 -1.937 . . . . 74.22 105.77 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.4 127.67 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 106.976 -1.49 . . . . 74.15 106.976 175.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.8 mt -137.55 134.42 46.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.535 -1.654 . . . . 73.45 106.535 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.13 124.13 5.75 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 109.861 -1.295 . . . . 63.01 109.861 -169.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -113.95 144.22 43.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.788 1.235 . . . . 74.13 112.192 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.8 mt -135.22 107.85 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 104.475 -2.417 . . . . 74.34 104.475 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t0 44.44 66.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.275 1.03 . . . . 73.34 111.317 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 74.79 0.78 3.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.93 2.492 . . . . 75.02 116.069 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -117.38 163.25 16.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 120.665 1.575 . . . . 74.32 113.46 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -98.91 153.86 18.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.613 -1.254 . . . . 63.33 107.613 165.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.77 3.93 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.091 0.404 . . . . 73.42 112.091 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -165.18 132.96 3.1 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.515 -1.291 . . . . 73.05 107.515 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -158.61 130.25 6.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.199 0.6 . . . . 74.04 110.083 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.41 108.05 5.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.313 1.054 . . . . 74.43 110.863 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.61 156.92 34.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.341 -1.355 . . . . 75.55 107.341 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 119' ' ' PHE . 22.4 mtmm -142.72 170.21 16.12 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.113 -1.44 . . . . 74.55 107.113 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -145.6 145.31 30.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.093 -1.817 . . . . 71.33 106.093 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.26 153.42 46.51 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.523 -1.288 . . . . 71.32 107.523 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.0 mt -144.31 140.15 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.301 -1.37 . . . . 75.52 107.301 166.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -66.15 145.7 55.5 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.939 1.296 . . . . 72.15 111.168 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.8 63.77 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.667 1.222 . . . . 74.14 111.125 163.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.05 -32.13 4.16 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.821 2.153 . . . . 53.21 112.634 168.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.73 174.33 10.58 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.557 1.943 . . . . 75.22 110.065 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.4 168.7 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.391 -0.596 . . . . 71.32 109.391 159.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.71 134.0 44.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.902 -1.147 . . . . 75.11 107.902 168.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.4 mt -150.9 133.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.148 -1.427 . . . . 75.34 107.148 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -152.5 169.35 22.83 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.034 1.734 . . . . 72.21 109.876 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 53.6 p -134.74 167.84 20.11 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.755 0.822 . . . . 75.15 109.514 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.458 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 22.9 p90 -156.04 168.62 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.398 -0.819 . . . . 71.51 109.836 172.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -161.12 138.85 9.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.878 0.847 . . . . 62.12 108.989 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -145.67 100.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 104.653 -2.351 . . . . 72.14 104.653 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.06 140.3 29.9 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.632 -1.618 . . . . 64.4 106.632 168.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 p -94.78 27.73 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.087 1.312 . . . . 63.13 111.007 170.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -161.68 118.92 2.2 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 120.049 -1.657 . . . . 73.43 108.53 161.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -147.89 115.34 6.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.343 -1.354 . . . . 64.14 107.343 170.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.257 1.464 0 C-N-CA 126.711 2.004 . . . . 74.04 109.93 167.581 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.608 -1.397 . . . . 64.42 109.608 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.98 119.93 8.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.981 -1.859 . . . . 73.33 105.981 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.3 m -131.69 88.27 2.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.475 -2.046 . . . . 64.43 105.475 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.65 108.77 2.49 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.32 -1.363 . . . . 63.4 107.32 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -132.7 91.32 2.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.639 1.209 . . . . 75.14 111.483 -168.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -83.59 98.56 9.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.137 -1.431 . . . . 74.41 107.137 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.92 159.94 31.7 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.485 -0.932 . . . . 74.13 108.485 153.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.57 -101.4 0.15 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.826 1.203 . . . . 64.11 110.88 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -134.14 117.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.202 -2.148 . . . . 75.53 105.202 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -84.38 151.16 24.87 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.759 -1.213 . . . . 74.25 109.236 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -137.67 158.43 44.39 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.387 1.075 . . . . 75.23 108.125 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.1 mm -139.3 129.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 105.315 -2.106 . . . . 72.54 105.315 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.0 t -113.11 140.17 34.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.927 1.691 . . . . 74.54 106.459 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mt -130.55 144.27 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.471 -1.677 . . . . 72.11 106.471 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.13 162.4 35.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.589 -0.893 . . . . 75.44 108.589 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -153.25 173.76 15.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.165 0.507 . . . . 73.23 112.192 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.24 150.85 20.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.052 0.941 . . . . 72.21 108.621 161.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.2 -108.38 0.37 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.145 -0.782 . . . . 61.24 111.145 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -130.34 54.88 1.84 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.547 1.539 . . . . 73.54 108.917 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.7 p -54.92 -4.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 130.938 3.695 . . . . 73.32 116.586 -165.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -95.26 -11.94 27.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.359 1.064 . . . . 73.33 111.877 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.57 33.78 4.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.545 2.338 . . . . 73.45 110.366 -170.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -133.14 143.61 49.36 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.086 0.954 . . . . 73.13 110.098 171.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.14 58.38 0.6 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.595 1.558 . . . . 75.42 108.629 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.13 125.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 124.759 1.223 . . . . 74.35 108.377 165.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.29 121.98 18.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.245 -1.02 . . . . 74.32 108.245 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.8 120.83 55.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.603 1.161 . . . . 74.23 110.004 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 t -66.1 134.63 53.21 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.54 -1.652 . . . . 75.24 106.54 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.82 112.95 27.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.589 -2.004 . . . . 72.32 105.589 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.9 35.29 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.531 -1.028 . . . . 64.32 110.531 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 168.81 38.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.638 -1.385 . . . . 72.01 109.638 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.21 153.41 31.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.275 1.43 . . . . 75.22 110.331 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.08 170.83 14.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.302 1.441 . . . . 62.21 111.219 174.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -66.58 73.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.397 1.879 . . . . 74.42 110.195 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.47 6.18 2.74 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.332 -1.815 . . . . 64.03 113.992 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.49 -156.41 27.25 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 120.99 2.395 . . . . 74.04 115.427 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.67 125.79 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.698 2.932 . . . . 73.15 110.022 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.81 120.13 14.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.267 -1.333 . . . . 75.22 108.832 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 144.89 55.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.678 0.217 . . . . 74.23 111.057 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 145.41 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.716 2.006 . . . . 75.22 108.62 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.848 1.259 . . . . 74.44 110.945 -170.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -82.12 175.67 10.14 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.311 0.645 . . . . 64.22 110.651 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.09 -12.73 61.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.736 1.013 . . . . 52.32 113.736 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -87.35 -7.54 57.65 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.058 -1.026 . . . . 74.31 110.928 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.66 56.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.449 1.976 . . . . 75.32 113.596 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.25 148.99 21.71 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.892 1.346 . . . . 72.31 109.855 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.54 144.83 56.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.426 -1.324 . . . . 73.51 107.426 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.73 5.8 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.411 0.685 . . . . 72.22 112.397 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.08 -175.3 36.89 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.001 0.818 . . . . 63.13 111.495 166.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -121.0 0.29 10.2 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.911 1.284 . . . . 74.32 112.183 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.7 m -165.84 115.6 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.217 1.807 . . . . 73.31 108.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -153.49 -178.84 7.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.745 1.157 . . . . 75.44 111.958 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.3 155.59 39.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.648 0.779 . . . . 75.23 109.488 163.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.54 171.61 10.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.945 1.698 . . . . 71.32 107.683 171.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -124.05 139.15 54.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 128.062 2.545 . . . . 74.45 109.269 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mm -90.65 98.88 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 119.262 -0.975 . . . . 74.55 110.102 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.47 14.35 13.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.948 1.092 . . . . 73.52 113.948 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.7 p -128.69 173.89 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.713 0.688 . . . . 62.11 109.837 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.78 90.52 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.736 0.415 . . . . 74.21 110.597 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.6 p -145.7 143.46 29.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.001 0.429 . . . . 71.52 110.465 -166.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -138.22 163.48 31.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.843 2.057 . . . . 61.21 109.754 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.64 152.53 6.9 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.042 1.337 . . . . 75.22 108.849 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 53.0 m -147.36 160.36 42.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.506 1.923 . . . . 75.43 109.409 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.2 p -152.42 173.39 15.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.486 0.714 . . . . 53.42 111.834 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -109.29 -174.98 2.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.56 1.144 . . . . 75.44 109.694 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -91.97 -171.65 2.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.544 -0.91 . . . . 63.44 108.544 151.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.56 -17.72 79.17 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.54 -0.725 . . . . 74.21 114.068 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -78.17 89.65 4.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.383 1.092 . . . . 72.24 108.207 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.38 15.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.662 0.785 . . . . 75.45 109.758 154.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -123.7 -10.28 7.83 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.191 0.811 . . . . 75.23 113.191 172.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.573 ' CB ' ' HE3' ' A' ' 124' ' ' LYS . 52.5 p90 -152.2 -170.64 3.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.011 1.324 . . . . 74.32 108.84 172.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.1 ttt -142.37 162.4 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 104.561 -2.385 . . . . 72.55 104.561 146.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -133.74 158.66 42.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.301 1.048 . . . . 74.44 108.874 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -134.13 99.11 4.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 102.089 -3.3 . . . . 61.15 102.089 166.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.14 113.45 14.5 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.519 -1.66 . . . . 73.22 106.519 168.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.8 -151.22 6.81 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.72 -1.752 . . . . 60.34 108.72 -161.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.8 p -149.28 -179.2 6.87 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.707 -0.479 . . . . 73.14 109.707 151.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.38 157.27 21.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.955 1.302 . . . . 75.03 109.434 170.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.02 171.72 14.07 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.924 0.89 . . . . 64.14 109.358 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.8 t -159.26 162.46 36.12 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.267 1.027 . . . . 74.13 108.534 162.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.26 12.36 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.359 1.864 . . . . 73.45 111.597 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 p -83.88 176.64 8.76 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.254 1.022 . . . . 74.11 111.002 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -59.55 164.5 3.46 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.731 -0.668 . . . . 74.04 110.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 166.6 4.17 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.44 1.114 . . . . 75.01 112.938 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.09 -8.71 50.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.041 1.781 . . . . 75.31 114.348 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -62.62 158.85 17.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.532 1.166 . . . . 62.22 108.886 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -135.65 156.6 48.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.459 -0.571 . . . . 74.13 109.459 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.71 109.41 1.23 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.549 -2.019 . . . . 74.25 105.549 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -101.11 137.44 39.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.196 -1.779 . . . . 75.21 106.196 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.17 129.14 74.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.023 -1.103 . . . . 74.34 108.023 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -106.97 126.09 51.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.126 2.17 . . . . 73.33 106.008 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.39 109.84 16.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 125.297 1.439 . . . . 71.5 110.857 -165.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 mp -128.67 138.63 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.354 1.862 . . . . 73.21 106.747 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.49 177.07 21.24 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.167 -1.173 . . . . 71.31 110.167 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -156.26 153.95 29.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 118.674 1.237 . . . . 75.5 109.742 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.9 mt -129.16 110.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 108.239 -1.023 . . . . 73.54 108.239 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.0 -74.21 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.885 2.474 . . . . 71.14 110.107 -171.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.7 -1.41 2.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.717 1.006 . . . . 75.1 113.717 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -105.8 156.9 17.87 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.104 -0.997 . . . . 75.34 113.459 -171.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -118.22 103.8 10.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.817 1.247 . . . . 61.44 109.161 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.37 -6.92 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 115.022 1.49 . . . . 75.43 115.022 -168.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.85 99.49 1.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.382 -1.34 . . . . 73.33 107.382 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.89 123.11 11.54 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.347 1.059 . . . . 71.1 110.915 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.43 176.63 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 73.44 110.487 171.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -136.55 158.01 45.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.113 2.165 . . . . 74.5 107.97 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -160.51 166.86 28.35 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.349 0.66 . . . . 73.3 109.61 169.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -140.05 147.42 40.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.264 1.826 . . . . 75.32 111.322 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -139.08 134.44 32.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.948 1.699 . . . . 75.41 108.251 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.0 mt -144.59 126.96 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.494 -1.669 . . . . 75.42 106.494 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 134.34 48.43 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.814 -0.439 . . . . 74.43 109.814 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.45 -17.04 33.1 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.564 1.146 . . . . 75.13 112.576 168.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.21 10.23 11.0 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.085 0.85 . . . . 63.33 112.486 -172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.34 -177.39 4.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.347 1.859 . . . . 74.21 108.989 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.55 111.85 2.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.598 1.159 . . . . 74.14 112.593 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 tp -81.13 135.63 35.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 124.528 1.131 . . . . 74.45 108.304 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.4 mt -150.2 132.22 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.999 2.52 . . . . 74.25 106.04 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.38 171.25 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.779 0.832 . . . . 71.32 111.279 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -142.71 160.96 39.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.194 1.397 . . . . 73.41 110.159 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -148.01 163.32 37.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.731 -1.122 . . . . 75.1 108.997 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.6 p -152.93 135.23 15.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.629 -0.67 . . . . 75.4 112.671 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 74' ' ' CYS . 7.6 p -135.5 103.64 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 128.207 2.603 . . . . 74.33 105.495 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.57 -158.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.454 -0.943 . . . . 75.21 108.454 170.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 82.8 p -134.24 -3.88 2.73 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 161.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.573 ' HE3' ' CB ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -97.13 73.05 2.49 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.565 2.126 . . . . 74.41 112.793 -154.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.69 143.47 48.72 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.281 -2.236 . . . . 72.24 111.712 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . 0.286 66.9 mt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 129.807 3.243 . . . . 74.43 109.981 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 108.945 -1.662 . . . . 64.53 108.945 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.95 132.49 42.49 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.023 -1.103 . . . . 75.13 108.023 168.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 p -159.14 143.79 15.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.922 0.889 . . . . 75.21 108.931 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.21 113.06 12.24 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.387 1.075 . . . . 75.11 110.146 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -131.68 113.57 13.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.48 2.312 . . . . 75.21 104.928 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -139.67 104.58 4.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.43 1.492 . . . . 72.13 109.273 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -159.58 171.12 20.21 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.497 1.919 . . . . 73.33 108.229 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.49 -96.88 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.653 -2.179 . . . . 63.44 107.653 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.76 118.38 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.775 1.23 . . . . 74.31 108.264 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -80.88 141.02 35.01 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.475 -0.784 . . . . 71.12 109.951 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.39 144.63 42.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.637 2.375 . . . . 74.43 108.829 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.95 156.2 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.475 -1.676 . . . . 74.13 106.475 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.02 138.89 45.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.918 -1.882 . . . . 74.43 105.918 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.0 142.42 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.591 -1.263 . . . . 64.13 107.591 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.35 173.27 11.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.377 1.071 . . . . 63.22 109.41 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -152.17 170.93 18.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.407 0.683 . . . . 73.14 111.79 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p -158.99 136.88 10.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.948 0.499 . . . . 73.33 111.523 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.88 -128.81 5.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.086 1.327 . . . . 55.15 111.722 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 61.41 3.58 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.402 1.881 . . . . 75.14 110.642 -166.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 p -75.91 48.11 0.47 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.32 1.848 . . . . 73.3 111.452 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.62 -20.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.0 0.92 . . . . 73.52 112.733 -172.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -142.19 42.06 1.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.205 2.202 . . . . 72.42 109.735 -170.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.53 160.04 36.4 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.371 2.269 . . . . 71.32 109.359 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -133.87 107.91 8.13 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.16 1.784 . . . . 74.53 108.319 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -125.1 80.7 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 125.438 1.495 . . . . 75.23 113.386 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.42 117.61 30.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.109 -0.7 . . . . 71.12 109.109 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.59 133.53 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.854 -0.795 . . . . 75.34 108.854 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -66.08 151.28 47.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.579 -0.897 . . . . 51.3 108.579 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.51 117.52 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.231 -2.137 . . . . 72.53 105.231 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 173.47 35.99 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.786 -0.926 . . . . 64.34 110.786 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.64 179.67 44.88 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.086 -2.806 . . . . 75.42 106.086 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.2 163.47 28.48 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.296 0.569 . . . . 74.25 109.498 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -174.32 3.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.963 1.705 . . . . 75.24 110.055 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -64.22 -28.81 69.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.741 1.015 . . . . 75.24 113.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.68 -52.67 11.54 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.203 -1.959 . . . . 64.54 108.203 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.96 -80.32 0.19 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.284 -1.526 . . . . 74.3 109.284 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.48 131.72 15.29 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.207 2.004 . . . . 73.32 111.751 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.63 134.77 34.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.809 -1.091 . . . . 74.33 108.885 165.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -83.95 128.59 34.65 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.339 0.972 . . . . 72.33 109.243 159.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -100.3 152.58 20.15 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.877 1.271 . . . . 74.02 108.314 175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -124.36 155.06 39.41 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.05 0.928 . . . . 74.32 110.594 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.67 160.76 14.63 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.494 1.518 . . . . 72.1 109.795 168.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.83 0.93 9.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.649 1.98 . . . . 70.3 113.803 -171.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -77.23 -24.73 51.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.795 2.838 . . . . 73.21 110.743 165.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 4.35 50.32 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.22 1.867 . . . . 64.24 112.808 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -89.07 165.74 14.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.001 1.401 . . . . 73.03 108.183 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -84.77 151.94 24.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.861 -0.792 . . . . 65.4 108.861 165.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.29 -5.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.942 0.897 . . . . 70.44 112.659 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.81 40.69 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 119.708 1.14 . . . . 65.21 110.613 169.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.328 0.8 OUTLIER -121.87 14.96 10.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.289 2.235 . . . . 71.33 110.438 169.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 149.09 9.59 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 127.724 2.41 . . . . 70.14 106.947 151.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -169.23 179.86 3.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.146 0.979 . . . . 74.3 109.921 157.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -140.04 106.26 5.25 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 126.155 1.782 . . . . 74.52 107.185 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.12 150.26 20.39 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.483 -0.932 . . . . 71.12 108.483 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.27 147.33 26.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.502 1.121 . . . . 72.31 109.251 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -85.32 71.16 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.977 -1.12 . . . . 71.4 107.977 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -92.59 38.09 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.416 -1.427 . . . . 74.02 113.195 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 p -147.29 128.34 14.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.126 -1.435 . . . . 74.11 107.126 -165.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.95 65.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.549 0.613 . . . . 62.22 110.447 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 p -140.7 134.3 30.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.946 1.298 . . . . 72.24 107.95 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.488 ' HE1' ' H ' ' A' ' 62' ' ' SER . 6.0 tpt -125.26 159.93 30.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.469 2.308 . . . . 74.11 106.999 176.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.488 ' H ' ' HE1' ' A' ' 61' ' ' MET . 11.9 p -164.62 143.82 7.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.679 1.592 . . . . 74.03 107.409 168.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 12.6 m -136.86 147.63 46.62 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.417 -1.327 . . . . 75.01 107.417 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 p -146.56 -173.43 4.2 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.039 0.381 . . . . 64.22 110.735 170.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 p -135.49 172.92 12.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.705 1.202 . . . . 75.42 111.436 -162.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.99 170.2 11.32 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.569 -0.9 . . . . 64.14 108.569 163.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.96 60.96 3.78 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.124 0.869 . . . . 71.32 111.641 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.83 89.84 1.72 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.824 -2.658 . . . . 75.04 103.824 169.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.83 23.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.232 -0.413 . . . . 62.11 111.272 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.4 -8.18 2.92 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.04 0.756 . . . . 64.54 113.04 166.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -163.01 169.31 19.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.879 1.272 . . . . 73.52 107.736 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.3 ttt -138.74 151.47 47.14 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 104.382 -2.451 . . . . 75.42 104.382 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.0 t -138.53 157.84 45.4 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.615 0.766 . . . . 75.42 108.999 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.58 45.85 1.03 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.089 0.956 . . . . 64.31 111.244 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.59 141.29 58.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.787 0.835 . . . . 75.24 110.037 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.13 -149.13 4.9 Favored Glycine 0 C--N 1.336 0.532 0 O-C-N 121.427 -0.795 . . . . 71.22 111.201 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.6 p -142.85 178.52 7.6 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.217 -1.031 . . . . 62.42 108.217 149.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.67 149.71 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.988 0.915 . . . . 72.55 109.045 160.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.4 t -152.51 161.77 42.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.32 -0.622 . . . . 74.52 109.32 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -157.25 153.51 27.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.3 1.84 . . . . 75.33 106.323 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 26.8 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 127.07 2.148 . . . . 74.44 108.0 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -90.44 173.52 8.05 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.823 -1.173 . . . . 71.13 109.021 169.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.12 169.29 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.141 -1.845 . . . . 74.5 110.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.62 162.63 6.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.429 0.692 . . . . 75.43 112.243 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.95 71.53 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.71 0.672 . . . . 73.25 113.309 172.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -111.97 136.39 51.37 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.214 1.806 . . . . 75.54 106.846 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -125.6 159.38 32.28 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.581 -0.699 . . . . 72.51 110.605 -166.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.87 102.5 2.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.516 -2.402 . . . . 72.43 104.516 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.22 149.04 22.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.267 -1.753 . . . . 64.35 106.267 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.99 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.227 -1.768 . . . . 71.41 106.227 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -119.17 135.97 54.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 74.15 106.172 163.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.52 119.55 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.895 -1.521 . . . . 75.32 106.895 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 mt -135.06 134.68 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 107.358 -1.349 . . . . 55.54 107.358 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -119.98 132.44 9.41 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.701 -1.359 . . . . 75.35 109.701 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -126.44 152.94 45.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.145 1.378 . . . . 72.42 110.055 -170.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.2 mt -136.85 112.4 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.536 -2.394 . . . . 75.25 104.536 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 74.38 -54.12 0.67 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 127.726 2.411 . . . . 74.03 112.962 163.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.34 6.57 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.183 1.793 . . . . 75.04 112.947 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.98 155.65 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.239 -2.163 . . . . 75.13 109.996 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -72.11 159.0 34.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.955 -1.128 . . . . 64.02 107.955 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.11 -6.02 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.377 0.51 . . . . 71.44 112.377 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.1 136.64 12.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.846 -1.168 . . . . 73.43 107.846 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.49 158.36 26.42 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 119.308 0.958 . . . . 73.51 111.432 168.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.43 171.41 14.67 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.302 1.049 . . . . 64.34 108.692 155.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.72 161.56 24.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.091 -1.818 . . . . 75.21 106.091 160.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.63 169.21 24.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.633 -0.877 . . . . 74.55 108.633 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -155.48 149.06 25.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.05 -0.352 . . . . 75.32 110.05 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -148.29 138.4 22.55 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.774 1.23 . . . . 63.32 108.864 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.81 137.67 53.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.452 -0.944 . . . . 75.41 108.452 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -74.42 133.79 42.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.694 -0.854 . . . . 73.14 108.694 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.24 57.43 1.13 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.252 1.025 . . . . 75.53 108.921 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.67 -38.15 1.68 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.799 2.142 . . . . 62.15 111.774 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -62.8 152.43 35.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.363 1.065 . . . . 75.33 108.991 172.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 m -74.29 113.94 12.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.021 1.329 . . . . 74.52 109.044 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.03 115.14 6.41 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.8 mt -149.71 138.53 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 103.043 -2.947 . . . . 75.45 103.043 170.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 170.58 21.01 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.965 1.416 . . . . 73.13 108.846 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -138.29 153.83 49.03 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.316 -0.994 . . . . 74.15 108.316 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.71 161.71 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.718 1.207 . . . . 75.22 108.165 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.6 t -160.2 144.37 14.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.853 -1.165 . . . . 75.42 107.853 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.32 118.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.1 -2.556 . . . . 73.15 104.1 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 132.5 51.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.335 1.054 . . . . 73.52 108.249 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -95.14 14.13 23.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.484 -0.76 . . . . 73.15 112.17 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 118.66 6.19 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.217 -2.142 . . . . 74.43 105.217 162.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.42 71.4 1.43 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 105.395 -2.076 . . . . 74.15 105.395 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . 0.254 12.3 mm . . . . . 0 C--O 1.244 0.803 0 C-N-CA 126.555 1.942 . . . . 62.51 109.742 -165.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.545 0 N-CA-C 111.363 -0.695 . . . . 72.53 111.363 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.23 104.86 4.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.159 1.384 . . . . 71.35 107.976 163.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.1 p -158.82 159.4 35.05 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.001 -1.481 . . . . 74.55 107.001 160.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.49 121.99 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.115 -1.068 . . . . 64.34 108.115 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -142.33 105.93 4.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.363 1.465 . . . . 74.24 109.993 168.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -119.29 124.82 47.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.105 2.562 . . . . 74.11 104.484 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.48 154.14 51.51 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.327 0.651 . . . . 74.35 111.689 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.58 -105.94 0.44 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.174 -1.57 . . . . 74.43 109.174 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.87 83.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.43 106.172 -162.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -84.04 122.97 29.52 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.847 -1.538 . . . . 54.23 106.847 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.05 151.43 49.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.755 1.161 . . . . 74.53 110.574 -167.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 mm -135.01 146.38 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.357 1.463 . . . . 74.11 107.696 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 t -141.84 133.62 27.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.912 -1.514 . . . . 71.34 106.912 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mt -130.5 149.67 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.067 0.947 . . . . 70.11 109.214 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -135.84 167.34 21.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.677 0.672 . . . . 74.35 111.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -140.7 139.88 34.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.776 1.231 . . . . 72.21 109.239 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -149.82 152.9 35.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.484 2.313 . . . . 72.31 108.147 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.7 -145.33 18.68 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.55 -1.42 . . . . 63.43 109.55 -168.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -85.57 75.41 10.15 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.038 -1.467 . . . . 61.55 107.038 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.1 p -75.16 71.02 2.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.395 -1.706 . . . . 72.32 106.395 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.72 -48.31 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.506 1.122 . . . . 71.43 108.71 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.93 67.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 124.002 1.858 . . . . 72.42 109.462 -163.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 1.1 p90 -148.27 166.69 27.24 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 128.251 2.62 . . . . 73.52 108.22 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.79 150.52 49.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.556 1.943 . . . . 74.15 108.423 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.13 85.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.576 -0.898 . . . . 74.31 108.576 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -86.63 136.04 33.19 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.809 0.814 . . . . 73.15 108.874 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.519 ' CG1' ' HG ' ' A' ' 74' ' ' CYS . 1.6 t -136.09 132.91 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.836 -1.913 . . . . 73.22 105.836 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -85.34 140.8 30.5 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.778 1.631 . . . . 74.55 106.926 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.7 mt -124.64 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.409 -1.7 . . . . 74.34 106.409 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.56 172.88 42.57 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.193 -0.763 . . . . 65.33 111.193 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.46 175.29 40.51 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 127.176 2.322 . . . . 71.35 108.25 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.45 46.47 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.857 -0.79 . . . . 73.31 109.031 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -136.85 -178.55 5.24 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 125.835 1.654 . . . . 71.52 110.688 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -80.25 70.33 6.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.081 0.553 . . . . 74.14 110.29 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.68 -34.74 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.228 0.918 . . . . 73.34 111.652 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.24 -164.89 26.72 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 117.698 0.749 . . . . 63.34 113.273 -164.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.42 140.02 26.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.906 3.071 . . . . 72.31 109.337 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.62 26.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.293 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -54.49 120.1 6.17 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.039 0.935 . . . . 73.25 109.701 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.67 168.6 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.497 -0.927 . . . . 71.44 108.497 169.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.74 142.09 46.65 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.837 0.855 . . . . 74.43 109.079 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.34 170.81 16.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.552 1.141 . . . . 73.25 109.773 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -74.93 15.28 0.41 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 73.42 113.877 -169.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -100.37 -16.56 17.6 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.315 . . . . 72.51 111.559 162.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.48 67.36 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.37 0.986 . . . . 72.15 113.124 -168.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -79.97 161.52 25.44 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 1.116 . . . . 70.43 109.626 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.02 137.59 34.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.812 -0.81 . . . . 74.43 108.812 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.33 16.72 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.012 1.325 . . . . 72.35 112.944 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.17 172.21 14.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.867 1.222 . . . . 73.11 110.462 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -112.17 9.83 20.17 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.227 1.411 . . . . 62.34 111.159 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -167.05 148.78 5.96 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.071 2.148 . . . . 72.15 108.097 165.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -179.96 179.34 0.55 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.141 2.576 . . . . 74.43 109.186 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.4 p -129.39 159.09 37.32 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.33 1.052 . . . . 73.11 109.426 163.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.45 114.72 7.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.1 -1.074 . . . . 72.25 108.1 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -71.69 128.18 34.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.967 -1.123 . . . . 73.42 107.967 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.36 117.05 3.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.417 -1.327 . . . . 73.43 107.417 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -137.51 35.95 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.861 0.839 . . . . 74.33 110.856 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.21 147.71 26.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.456 -1.683 . . . . 73.12 106.456 -161.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.75 -37.47 71.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.95 0.5 . . . . 74.13 111.771 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 t -149.72 161.99 41.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.228 -1.027 . . . . 74.33 108.228 167.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 mmm -134.75 165.93 24.13 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 128.632 2.773 . . . . 71.22 108.883 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.5 p -164.94 162.28 20.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.507 -1.224 . . . . 74.33 110.058 171.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.2 m -150.94 166.02 31.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.046 2.138 . . . . 70.12 107.261 165.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.05 -178.68 6.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.934 0.894 . . . . 62.25 111.839 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 p -129.07 175.6 8.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.649 1.979 . . . . 74.23 108.987 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.2 172.32 7.66 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.398 -0.814 . . . . 74.25 109.162 159.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 55.01 4.99 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.092 0.853 . . . . 63.12 113.06 -169.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -133.38 -8.79 2.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.586 1.154 . . . . 63.51 111.215 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.59 165.12 23.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.834 0.826 . . . . 73.55 111.121 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -119.72 -1.8 10.51 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.906 1.682 . . . . 73.23 112.065 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -177.12 172.03 2.0 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.289 1.835 . . . . 71.41 108.022 171.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ttt -132.66 163.64 28.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.832 -2.284 . . . . 65.41 104.832 161.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -146.94 166.59 26.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.277 0.561 . . . . 63.25 110.253 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.519 ' HG ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -151.11 65.18 0.9 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.595 2.358 . . . . 72.12 107.711 179.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.39 41.03 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.742 0.817 . . . . 74.52 108.95 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.65 179.74 32.25 Favored Glycine 0 CA--C 1.502 -0.731 0 CA-C-N 119.082 0.856 . . . . 70.23 111.9 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 90.3 p -135.34 169.37 17.58 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.377 -1.411 . . . . 73.45 109.535 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.54 153.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.422 1.489 . . . . 70.25 107.254 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.0 164.0 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.914 -0.772 . . . . 71.41 108.914 166.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.7 p -145.65 162.45 37.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.612 -0.514 . . . . 71.32 109.612 154.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 pt -133.63 15.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 128.653 2.781 . . . . 63.33 109.313 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -81.02 174.55 11.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.015 1.726 . . . . 74.13 111.28 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.3 163.83 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.227 -2.261 . . . . 71.21 110.626 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.89 160.16 15.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.203 1.401 . . . . 72.11 113.289 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.42 87.0 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.907 1.241 . . . . 61.13 114.164 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -66.66 167.47 11.05 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.564 1.182 . . . . 65.53 108.273 167.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -149.5 160.05 43.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 121.572 -0.705 . . . . 74.44 110.083 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.3 tp -152.87 130.45 11.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.591 -1.633 . . . . 74.24 106.591 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -129.16 109.25 11.0 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.389 1.876 . . . . 72.34 106.185 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.83 134.18 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.053 -2.203 . . . . 72.33 105.053 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 m -112.06 137.49 50.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.142 -1.799 . . . . 74.55 106.142 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.16 113.31 3.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.583 1.553 . . . . 74.33 109.194 -171.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.84 141.09 45.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.727 -1.583 . . . . 74.23 106.727 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.82 155.85 25.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 123.869 0.747 . . . . 61.21 111.483 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.13 154.46 42.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.051 0.94 . . . . 73.23 110.366 -165.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.9 mt -122.89 117.89 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.824 -1.176 . . . . 73.34 107.824 163.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 t70 69.28 -58.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 129.06 2.944 . . . . 74.21 111.666 165.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.68 8.5 0.51 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.043 1.497 . . . . 74.45 115.043 158.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.44 143.51 32.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.992 1.317 . . . . 74.35 111.267 -170.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.16 118.2 12.68 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.043 1.737 . . . . 64.12 107.203 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.31 -8.31 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.735 0.779 . . . . 74.12 109.825 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -162.44 130.85 4.05 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.215 -1.402 . . . . 73.21 107.215 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -153.65 110.79 3.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.188 -0.671 . . . . 73.12 109.188 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 pp -142.25 179.51 6.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.783 -1.099 . . . . 73.43 111.296 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -145.9 171.27 15.07 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.171 2.589 . . . . 74.54 106.301 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -146.99 160.42 42.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.687 -0.857 . . . . 71.11 108.687 170.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -128.25 136.16 50.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.437 1.495 . . . . 72.33 107.057 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.16 152.8 51.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.141 0.977 . . . . 71.33 109.055 168.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.0 mt -144.21 154.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.219 1.808 . . . . 74.24 107.424 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -95.79 141.17 29.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.928 0.891 . . . . 72.12 110.223 176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -121.67 4.99 10.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.343 1.857 . . . . 73.23 110.489 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 113.61 -34.91 4.78 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.715 2.102 . . . . 51.43 110.309 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -79.42 161.67 25.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.939 1.296 . . . . 74.42 110.622 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.36 105.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.765 0.826 . . . . 74.13 110.126 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.8 tt -68.02 134.61 50.96 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.392 -0.966 . . . . 74.42 108.392 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -150.61 133.97 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.026 -1.842 . . . . 70.54 106.026 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.17 174.55 14.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.958 0.786 . . . . 52.35 111.608 171.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 73.9 p -139.65 161.64 37.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.81 1.644 . . . . 72.42 110.797 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -151.2 176.7 10.95 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.309 1.444 . . . . 74.45 109.606 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -160.74 147.48 15.34 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.561 -0.903 . . . . 62.23 108.561 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.2 t -146.31 88.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.236 -1.765 . . . . 72.31 106.236 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.5 m -77.82 166.78 22.49 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.06 -0.718 . . . . 70.52 109.06 165.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.1 p -135.17 58.3 1.77 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.11 -1.07 . . . . 71.53 108.11 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 72.14 1.01 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 124.507 2.098 . . . . 73.21 110.724 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -154.98 135.52 13.43 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 126.59 1.956 . . . . 74.35 108.533 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.243 0.749 0 C-N-CA 128.551 2.74 . . . . 63.42 111.573 167.494 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 72.54 110.005 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.42 -95.08 0.29 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.458 -1.057 . . . . 64.54 110.458 156.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.34 126.95 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 104.667 -2.345 . . . . 74.43 104.667 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -108.87 142.14 39.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.432 -1.692 . . . . 73.2 106.432 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -137.23 152.74 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.658 -1.238 . . . . 52.42 107.658 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.29 154.38 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.695 -1.224 . . . . 62.41 107.695 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 t -136.67 142.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.272 -1.751 . . . . 71.45 106.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.84 148.58 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.309 -1.737 . . . . 63.35 106.309 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -135.51 153.46 51.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.302 -1.37 . . . . 74.12 107.302 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -140.87 154.0 45.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.769 0.795 . . . . 70.24 109.888 166.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 p -151.64 173.09 15.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.712 -0.676 . . . . 72.34 109.333 171.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.68 -143.13 16.55 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.537 -1.425 . . . . 61.11 109.537 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.34 65.59 0.88 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.783 1.233 . . . . 75.02 112.17 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -64.21 -30.48 71.53 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.466 -1.396 . . . . 64.44 110.517 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.25 -30.82 64.97 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.783 1.233 . . . . 73.23 111.52 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.47 23.48 5.12 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 71.32 112.644 -168.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -124.88 118.49 26.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.273 1.029 . . . . 73.32 108.72 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -78.69 136.92 37.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.44 -1.319 . . . . 72.21 107.44 163.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -141.98 111.21 2.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.1 -1.815 . . . . 63.31 106.1 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -125.61 126.77 45.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.648 1.567 . . . . 65.01 110.662 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.53 130.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.025 1.33 . . . . 52.5 109.696 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -78.13 127.43 32.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.595 -1.632 . . . . 72.24 106.595 165.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 57.6 mt -113.47 138.83 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.689 -1.967 . . . . 71.13 105.689 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.32 179.82 46.98 Favored Glycine 0 C--N 1.334 0.451 0 O-C-N 121.356 -0.84 . . . . 74.5 112.661 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.76 -176.63 48.02 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.185 1.374 . . . . 73.53 110.437 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.31 159.83 40.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.905 0.882 . . . . 31.24 110.295 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.74 -177.34 5.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.431 1.093 . . . . 74.3 111.116 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.78 59.28 0.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.756 2.022 . . . . 54.31 108.909 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.74 21.87 0.02 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.582 -0.566 . . . . 61.3 112.665 -160.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.98 -154.0 20.15 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.459 1.129 . . . . 74.34 111.439 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -62.58 142.81 91.3 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.83 1.686 . . . . 61.33 109.191 166.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.52 149.07 31.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.997 -0.742 . . . . 63.42 108.997 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -69.32 146.94 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.764 0.711 . . . . 75.12 109.781 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 2.3 mm? -113.84 154.81 26.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 126.119 1.768 . . . . 73.11 108.59 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.33 151.29 50.99 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.404 2.281 . . . . 75.4 107.902 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -95.04 173.97 7.32 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.848 1.259 . . . . 74.42 110.4 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.99 21.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.229 1.411 . . . . 71.03 113.903 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -109.83 6.54 23.51 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.678 1.991 . . . . 75.32 110.102 163.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.92 7.05 80.66 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.335 -1.258 . . . . 41.41 112.87 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -103.18 143.77 32.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.888 1.844 . . . . 73.5 109.895 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -65.26 151.38 46.34 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.83 -0.804 . . . . 75.3 108.83 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.17 1.03 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.005 0.743 . . . . 63.11 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.29 -174.06 33.45 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 120.288 1.404 . . . . 63.13 110.328 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -121.18 -2.88 9.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.017 2.127 . . . . 74.5 112.165 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -153.17 142.38 21.48 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.692 1.597 . . . . 34.51 108.822 161.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -173.0 176.78 2.93 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.578 1.951 . . . . 73.42 108.038 164.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.0 p -122.17 159.25 27.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.508 1.123 . . . . 63.12 109.057 165.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.97 130.48 29.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.088 -1.078 . . . . 62.42 108.088 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.85 140.08 40.51 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.066 -1.087 . . . . 64.2 108.066 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -73.99 94.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 104.51 -2.404 . . . . 75.23 104.51 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -120.23 44.29 2.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.852 -1.166 . . . . 73.22 107.852 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -141.71 166.43 24.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.221 -1.399 . . . . 75.32 107.221 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.49 78.79 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.136 0.974 . . . . 63.22 110.391 170.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.7 p -130.32 156.86 43.98 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.367 -0.975 . . . . 75.34 108.367 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -146.66 159.63 43.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.023 1.329 . . . . 75.24 109.52 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 p -165.31 155.55 13.41 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.412 1.085 . . . . 74.14 108.453 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.6 m -143.0 157.67 44.33 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.072 -1.455 . . . . 74.41 107.072 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.9 p -144.1 169.23 18.25 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.685 -0.635 . . . . 75.54 110.839 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 p -105.82 -170.25 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.121 -1.437 . . . . 73.21 107.121 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.75 -167.91 1.41 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.51 -0.922 . . . . 74.53 108.51 148.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.36 172.57 7.41 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.89 -0.884 . . . . 70.4 110.89 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.96 84.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.596 1.159 . . . . 72.51 108.861 -164.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.69 165.58 35.84 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.53 1.132 . . . . 64.23 108.305 156.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -132.91 -0.45 3.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.326 1.05 . . . . 73.22 113.404 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -166.88 175.59 7.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.964 -2.236 . . . . 65.33 104.964 162.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ttt -140.55 145.48 36.84 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.705 -2.702 . . . . 70.3 103.705 157.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -116.58 150.9 37.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.003 -1.11 . . . . 53.42 108.003 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.5 t -147.91 89.54 1.75 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.564 -2.013 . . . . 65.32 105.564 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.25 135.15 55.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.94 -1.133 . . . . 74.15 107.94 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.09 32.8 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 118.724 0.693 . . . . 62.01 112.011 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.4 p -139.41 167.28 22.44 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.331 -0.934 . . . . 73.11 110.336 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.67 148.21 31.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.2 1.8 . . . . 73.05 106.736 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 p -142.97 160.89 39.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.173 0.442 . . . . 62.45 111.139 155.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.81 156.17 41.97 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.745 1.218 . . . . 54.34 108.173 164.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.22 49.81 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 126.26 1.824 . . . . 73.31 109.463 -172.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.0 p -129.07 -173.9 3.12 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.196 0.999 . . . . 51.34 111.809 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -66.71 165.33 15.18 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.118 0.967 . . . . 73.02 112.118 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 161.04 14.62 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 112.998 -1.91 . . . . 73.21 113.514 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.99 2.32 81.95 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.861 -1.522 . . . . 24.41 114.431 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -70.12 114.82 8.64 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 120.1 1.95 . . . . 73.11 106.001 165.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -104.4 155.9 18.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.313 -0.995 . . . . 72.11 108.313 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 tp -143.16 159.13 42.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.543 -2.021 . . . . 65.25 105.543 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -143.97 145.97 32.6 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.946 -1.501 . . . . 73.43 106.946 165.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mm -134.37 140.59 45.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.677 -1.971 . . . . 64.33 105.677 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.495 HG22 HD11 ' A' ' 93' ' ' ILE . 6.3 m -131.43 125.83 33.56 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.89 -2.263 . . . . 73.33 104.89 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.24 116.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.737 1.215 . . . . 73.41 107.93 -170.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 91' ' ' THR . 2.1 mp -138.62 131.22 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.066 0.946 . . . . 72.32 108.719 -162.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.79 141.44 16.39 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.792 1.187 . . . . 62.34 111.4 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -131.45 153.94 49.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.122 2.169 . . . . 72.24 108.72 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.72 139.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.179 -2.526 . . . . 73.41 104.179 167.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 t0 49.82 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.121 2.968 . . . . 71.52 110.954 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -133.75 15.49 3.97 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 120.599 1.545 . . . . 72.34 113.948 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.85 155.71 42.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.529 -1.357 . . . . 65.41 111.467 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -84.82 135.32 34.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.907 2.083 . . . . 72.03 106.341 165.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.09 -1.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.831 0.678 . . . . 61.14 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -155.94 145.61 21.11 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.771 -1.206 . . . . 64.34 109.769 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -158.3 142.79 16.03 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 124.073 0.949 . . . . 71.25 109.973 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.07 170.55 15.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.872 0.844 . . . . 73.02 108.935 155.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -129.23 155.71 45.12 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.615 -1.624 . . . . 74.13 106.615 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 160.34 43.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.727 -0.842 . . . . 52.33 108.727 173.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.15 138.29 28.06 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 106.345 -1.724 . . . . 71.42 106.345 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' HD11 ' A' ' 115' ' ' LEU . 21.2 m-85 -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 123.544 0.527 . . . . 72.43 109.661 176.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.56 136.35 21.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.159 -1.423 . . . . 73.11 107.159 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 p -67.33 136.84 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.301 0.64 . . . . 71.25 110.255 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -109.19 -5.9 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.736 1.214 . . . . 74.41 112.615 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.59 -29.97 5.05 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.132 1.825 . . . . 65.31 110.913 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -82.68 170.52 15.02 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.035 0.934 . . . . 64.21 110.554 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -54.26 136.63 42.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.412 -0.959 . . . . 65.33 108.412 164.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.0 tt -93.21 135.6 34.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.057 -1.09 . . . . 63.15 108.057 168.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.7 mt -149.05 142.35 18.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.151 -2.166 . . . . 53.12 105.151 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.28 171.09 17.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.888 1.275 . . . . 74.45 109.339 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.1 p -140.06 157.68 45.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.736 1.214 . . . . 63.22 109.859 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 169.75 22.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.482 0.713 . . . . 73.42 110.638 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.89 134.57 1.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.72 0.808 . . . . 71.33 110.364 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.9 t -142.64 100.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.374 1.87 . . . . 71.11 106.112 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.45 139.49 41.86 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 72.14 109.762 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.7 p -92.73 26.69 2.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.232 -0.917 . . . . 71.42 112.551 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.426 0 N-CA-C 107.345 -1.354 . . . . 70.1 107.345 161.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.134 0.492 . . . . 73.32 109.796 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.66 -133.56 5.8 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.04 -2.424 . . . . 43.34 107.04 -166.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.03 136.91 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.045 -1.465 . . . . 73.34 107.045 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -113.69 158.05 21.39 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.724 -1.213 . . . . 74.52 107.724 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -154.11 147.27 24.71 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.798 -0.815 . . . . 74.05 108.798 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mm -135.53 120.45 28.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.909 -1.886 . . . . 65.03 105.909 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.41 153.44 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.688 -1.967 . . . . 74.11 105.688 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 74' ' ' CYS . 2.9 mt -130.53 155.2 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.304 -0.999 . . . . 62.0 108.304 165.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.519 ' HG3' HG22 ' A' ' 60' ' ' THR . 23.8 mp0 -138.46 164.17 30.05 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.367 0.667 . . . . 72.43 110.747 163.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -142.39 156.29 45.2 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.624 0.77 . . . . 71.12 109.553 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.93 161.47 40.69 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.123 1.369 . . . . 65.23 108.059 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.5 -117.66 4.41 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.857 1.218 . . . . 72.42 110.685 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.37 104.11 16.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.36 1.064 . . . . 65.03 109.222 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.4 p -115.26 16.84 16.82 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.829 0.451 . . . . 72.12 111.23 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.99 -13.05 15.59 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.405 0.682 . . . . 54.51 110.48 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.81 23.69 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.462 1.105 . . . . 70.02 113.131 -164.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.865 ' CE2' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.97 119.33 20.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.022 0.915 . . . . 70.41 110.274 172.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.53 81.25 7.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.937 2.095 . . . . 72.21 109.141 174.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.865 HG22 ' CE2' ' A' ' 23' ' ' PHE . 3.0 t -72.88 106.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.947 -1.501 . . . . 70.3 106.947 171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -98.14 146.05 25.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.799 -1.556 . . . . 70.3 106.799 161.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.77 152.22 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.043 -0.98 . . . . 71.43 108.67 156.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.3 t -97.25 148.25 23.3 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.11 -1.811 . . . . 71.01 106.11 159.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.455 HG22 ' HG ' ' A' ' 40' ' ' LEU . 82.5 mt -128.07 145.74 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.309 -1.738 . . . . 70.43 106.309 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.55 176.42 47.85 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.517 -1.033 . . . . 50.22 110.517 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.61 173.1 43.84 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.771 2.129 . . . . 61.52 107.925 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.26 159.73 41.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.548 1.174 . . . . 52.32 111.116 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -137.22 -173.29 3.42 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.42 2.288 . . . . 71.22 110.013 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -65.62 -10.73 38.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.673 1.189 . . . . 65.13 113.624 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.87 36.53 1.97 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.676 1.131 . . . . 52.43 113.316 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.88 -160.16 13.35 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.693 1.246 . . . . 74.24 111.752 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.08 156.2 67.39 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.033 1.822 . . . . 71.41 110.065 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.4 144.8 25.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.502 1.121 . . . . 72.43 109.942 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -69.51 139.78 53.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.05 0.841 . . . . 72.1 109.745 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -102.63 157.46 16.92 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.611 1.164 . . . . 74.34 108.413 171.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.2 146.81 52.27 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.703 1.201 . . . . 72.1 109.837 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -82.11 179.62 7.74 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.633 1.573 . . . . 70.12 111.109 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.49 1.43 6.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.128 1.529 . . . . 71.1 115.128 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -101.01 -9.57 21.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.595 1.089 . . . . 73.01 111.007 165.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.77 13.92 76.79 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.654 -1.081 . . . . 12.34 112.426 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.48 148.24 27.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.556 1.942 . . . . 65.12 106.69 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.96 152.83 26.56 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.111 -0.7 . . . . 74.1 109.111 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -144.08 12.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 114.442 1.275 . . . . 72.21 114.442 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 -173.74 22.16 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.345 -1.102 . . . . 74.53 110.345 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.266 21.3 p30 -125.29 2.51 7.8 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.928 1.291 . . . . 74.32 112.856 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 m -153.63 140.5 19.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.525 1.93 . . . . 51.01 108.41 162.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -168.85 171.71 8.27 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.281 1.032 . . . . 74.3 110.594 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 m -118.28 145.99 44.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.96 1.704 . . . . 73.4 108.163 167.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.54 157.06 46.64 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.564 1.946 . . . . 52.22 107.939 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -109.49 135.68 50.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.648 1.579 . . . . 64.13 108.465 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.23 87.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.445 -1.317 . . . . 74.11 107.445 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 35.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.873 1.269 . . . . 74.21 110.303 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -146.2 160.05 42.5 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.178 -0.464 . . . . 71.44 110.756 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.99 -37.85 75.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.815 0.446 . . . . 72.34 111.341 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 15' ' ' GLN . 7.5 p -135.07 142.74 46.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.78 1.632 . . . . 72.21 108.516 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -135.54 163.33 30.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.626 2.37 . . . . 63.04 109.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.9 p -165.62 130.44 2.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.987 0.915 . . . . 71.24 110.456 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.8 m -139.53 154.4 47.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.905 1.282 . . . . 64.34 108.947 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -146.75 -179.81 7.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.209 1.004 . . . . 74.02 111.243 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -124.81 178.92 5.22 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.912 1.285 . . . . 71.44 110.695 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -91.56 -178.29 5.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.455 1.102 . . . . 74.12 108.691 162.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.24 10.74 52.99 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.37 0.986 . . . . 73.12 113.694 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -98.82 69.65 1.82 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.797 -1.927 . . . . 65.11 105.797 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -170.08 172.28 6.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.043 1.337 . . . . 52.31 110.638 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -130.36 -13.01 3.94 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.084 1.754 . . . . 72.55 112.782 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -159.86 174.66 14.1 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.052 0.941 . . . . 70.33 108.754 170.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.2 ttt -136.89 155.21 50.05 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.465 1.906 . . . . 70.01 106.21 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.8 p -113.14 177.5 4.61 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.706 1.203 . . . . 73.22 108.841 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 14' ' ' ILE . 1.9 t -157.84 33.24 0.26 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.104 -1.039 . . . . 72.04 113.157 150.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.51 132.53 53.43 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.488 -0.758 . . . . 73.01 110.746 -172.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.69 175.65 29.6 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 109.711 -1.356 . . . . 71.2 109.711 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.6 p -136.79 160.12 39.81 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.908 0.861 . . . . 74.13 110.721 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 69.1 t -117.52 135.36 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 106.678 -1.601 . . . . 72.43 106.678 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.35 124.85 10.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.114 -0.699 . . . . 74.14 109.114 167.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -119.2 142.98 47.52 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.232 -1.395 . . . . 74.01 107.232 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.86 17.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.179 2.192 . . . . 63.01 109.315 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -88.3 179.33 6.37 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.706 1.241 . . . . 64.33 110.733 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.2 165.48 18.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 113.258 -1.792 . . . . 74.41 112.369 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.94 155.09 20.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.608 -1.178 . . . . 71.24 113.293 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.86 79.68 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.386 -0.674 . . . . 72.33 113.486 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -67.85 156.91 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.306 -1.739 . . . . 73.42 106.306 155.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -139.51 158.35 44.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.359 -1.719 . . . . 73.12 106.359 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tp -156.15 157.25 35.63 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.438 -0.949 . . . . 74.42 108.438 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -147.32 111.71 5.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.172 -1.788 . . . . 70.34 106.172 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mm -101.66 143.44 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.777 -1.564 . . . . 73.14 106.777 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.2 m -119.34 136.21 54.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.023 -1.843 . . . . 71.04 106.023 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 108.47 3.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.481 1.512 . . . . 64.41 109.696 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.0 mt -123.66 140.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.796 -1.187 . . . . 61.32 107.796 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.9 154.18 20.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 124.569 1.081 . . . . 44.45 111.531 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -142.84 152.12 41.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.183 -1.008 . . . . 70.35 110.265 -161.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.1 125.88 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 104.798 -2.297 . . . . 62.13 104.798 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 44.95 55.89 5.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.584 1.154 . . . . 72.11 112.19 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 67.31 26.85 8.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.036 2.134 . . . . 70.31 114.43 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -134.94 161.6 34.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 120.15 -1.594 . . . . 74.22 110.196 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -97.25 127.68 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.032 -1.84 . . . . 70.43 106.032 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.15 -2.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.33 0.863 . . . . 50.15 113.33 -172.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.32 138.56 13.65 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.576 -1.639 . . . . 72.34 106.576 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.17 128.87 8.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.163 0.438 . . . . 72.41 110.839 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -142.61 171.49 13.98 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.934 0.873 . . . . 63.32 110.897 166.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -137.95 165.87 25.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.001 1.72 . . . . 74.24 106.386 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -146.46 166.57 26.01 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.422 -0.584 . . . . 74.22 109.422 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.44 132.59 33.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.126 1.37 . . . . 70.11 107.838 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.543 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 34.1 m-85 -127.43 154.15 45.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.442 -0.948 . . . . 74.4 108.442 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.3 mt -147.03 139.91 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.355 -2.091 . . . . 72.41 105.355 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -86.54 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.448 -0.783 . . . . 74.01 110.224 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -123.75 8.83 8.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.219 . . . . 72.02 111.564 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.78 -6.85 41.32 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.328 1.442 . . . . 62.33 111.505 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -102.22 174.85 5.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.84 1.256 . . . . 71.04 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.09 111.75 6.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.402 -1.333 . . . . 71.23 107.402 169.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.94 138.0 49.69 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.756 -1.201 . . . . 74.43 107.756 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -153.58 131.16 2.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.901 -1.518 . . . . 73.33 106.901 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -158.07 175.66 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.453 1.501 . . . . 70.42 111.87 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -146.64 152.29 38.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.139 1.776 . . . . 73.43 110.059 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -147.43 168.45 21.84 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.739 1.215 . . . . 73.22 109.318 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 p -168.89 128.11 1.08 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.543 0.687 . . . . 74.21 111.897 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.09 113.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.664 1.986 . . . . 73.31 106.1 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 m -97.25 158.35 15.5 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.575 -1.269 . . . . 50.52 107.575 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -107.39 38.48 2.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.705 0.684 . . . . 61.33 109.165 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptp . . . . . 0 C--O 1.235 0.296 0 C-N-CA 125.555 1.542 . . . . 73.43 107.561 172.856 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 108.699 -0.852 . . . . 72.13 108.699 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.68 -98.41 0.11 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 127.62 2.533 . . . . 53.14 107.106 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.23 135.66 61.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 125.502 1.521 . . . . 73.33 107.093 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -97.58 145.15 26.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.55 1.14 . . . . 72.51 108.7 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -141.05 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.901 0.88 . . . . 70.23 111.678 166.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.9 mm -130.86 152.16 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.035 1.734 . . . . 74.52 106.59 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.63 141.31 46.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.714 1.606 . . . . 70.11 106.942 166.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 56' ' ' ILE . 53.0 mt -131.62 151.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.028 -1.101 . . . . 74.53 108.028 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -142.72 164.63 29.59 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.723 0.809 . . . . 65.34 110.992 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -156.65 139.89 15.6 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.515 1.126 . . . . 51.31 109.687 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -152.9 147.72 26.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 128.313 2.645 . . . . 70.24 107.647 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.83 -134.8 11.29 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.323 -1.111 . . . . 50.33 110.323 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.19 58.75 0.72 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.022 1.729 . . . . 42.3 111.428 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.8 p -76.13 63.22 1.8 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.365 -1.46 . . . . 72.32 109.031 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -148.93 -40.06 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.858 1.263 . . . . 63.51 110.653 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.84 60.88 1.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 124.268 1.985 . . . . 72.43 110.114 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 0.2 OUTLIER -141.53 160.18 40.69 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.582 2.753 . . . . 71.51 108.449 176.127 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.69 107.17 3.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.17 0.895 . . . . 74.12 108.806 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.46 92.84 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.419 1.887 . . . . 43.41 109.568 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.92 113.74 27.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 75.24 109.414 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.03 149.12 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.537 1.062 . . . . 72.24 110.078 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t -82.52 150.32 27.03 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.278 1.431 . . . . 75.14 109.413 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 HD22 ' A' ' 40' ' ' LEU . 47.6 mt -130.61 116.01 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.56 -2.015 . . . . 75.14 105.56 165.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 173.53 35.15 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.811 -0.516 . . . . 54.44 111.811 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.34 169.49 36.49 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.582 2.039 . . . . 71.11 111.039 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.83 39.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.577 1.151 . . . . 74.2 111.026 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.48 -168.39 1.77 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.711 2.004 . . . . 74.43 113.258 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -77.74 77.62 4.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.146 -0.687 . . . . 64.1 109.146 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.04 49.56 0.72 Allowed Glycine 0 N--CA 1.453 -0.231 0 O-C-N 124.609 1.193 . . . . 75.53 111.768 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.79 -164.07 28.83 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 120.12 -0.267 . . . . 61.12 112.923 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.27 173.09 13.74 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.921 3.747 . . . . 72.51 110.56 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.39 117.82 35.72 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.477 1.111 . . . . 75.42 109.46 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -60.02 124.14 19.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.285 0.948 . . . . 73.44 110.396 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 65' ' ' THR . 0.8 OUTLIER -113.02 162.83 15.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.163 1.385 . . . . 75.23 109.455 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -131.03 152.76 49.99 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.358 -0.979 . . . . 62.52 108.358 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.287 1.5 p30 -79.05 -152.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.596 1.558 . . . . 61.21 110.228 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.86 2.32 32.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 119.727 -1.858 . . . . 75.11 113.231 174.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -106.2 -2.52 22.38 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.838 2.055 . . . . 71.43 111.63 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.46 56.87 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.46 1.505 . . . . 44.11 113.262 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -113.99 141.2 47.71 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.874 1.337 . . . . 63.53 109.86 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -66.94 135.06 53.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.208 1.803 . . . . 74.33 109.309 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.68 32.1 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.205 1.002 . . . . 74.5 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.1 176.18 27.81 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-O 122.432 1.018 . . . . 71.54 110.702 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.22 6.53 35.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.872 1.269 . . . . 62.42 112.524 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 p -167.48 125.62 1.26 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.908 0.883 . . . . 62.4 112.139 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -167.86 -175.43 2.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.561 0.744 . . . . 73.1 111.007 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -122.84 160.74 25.42 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.068 1.347 . . . . 72.43 108.571 162.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.16 127.83 17.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.83 -1.545 . . . . 61.53 106.83 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -78.69 149.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.921 -1.14 . . . . 63.23 107.921 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 14' ' ' ILE . 5.3 mm -86.42 112.75 23.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.108 -1.071 . . . . 65.34 108.108 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.26 37.77 3.69 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.861 1.265 . . . . 64.44 108.902 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -142.0 160.44 40.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.722 -1.214 . . . . 73.54 107.722 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 -16.92 62.69 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.277 -0.889 . . . . 33.23 113.235 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 p -145.22 150.85 37.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.703 1.601 . . . . 53.14 107.506 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmm -142.69 166.96 23.24 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.783 1.633 . . . . 74.21 110.641 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.6 p -162.26 151.89 16.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.251 1.42 . . . . 61.32 109.566 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.9 m -143.25 145.66 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.363 1.865 . . . . 64.32 107.665 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.8 p -143.82 -179.86 6.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.492 0.587 . . . . 54.3 111.254 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.543 HG22 HD23 ' A' ' 40' ' ' LEU . 26.1 p -129.34 -171.24 2.45 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.462 1.105 . . . . 71.52 110.633 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.6 -154.47 0.46 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.17 -1.048 . . . . 73.33 108.17 165.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.38 35.83 4.63 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.914 1.245 . . . . 72.1 112.526 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -135.86 87.95 2.36 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.694 -1.595 . . . . 74.2 106.694 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -171.2 166.17 7.23 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.33 1.452 . . . . 74.11 111.025 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.81 -16.11 7.23 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.476 1.51 . . . . 74.2 112.815 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.78 165.19 36.15 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.892 -1.151 . . . . 74.1 107.892 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 ttt -131.1 156.38 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 104.569 -2.382 . . . . 61.4 104.569 164.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -130.94 152.4 50.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.682 -0.859 . . . . 72.54 108.682 167.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.17 87.78 2.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.381 -2.081 . . . . 71.12 105.381 167.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.4 136.77 53.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.15 1.78 . . . . 71.23 107.123 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.98 -148.65 5.06 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 121.564 -0.71 . . . . 73.12 111.477 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -150.25 171.49 16.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.388 1.475 . . . . 64.13 109.427 161.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.53 143.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.058 1.343 . . . . 65.4 108.1 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -142.18 163.05 33.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.267 0.354 . . . . 62.52 110.777 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 t -135.68 160.01 39.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.946 1.698 . . . . 75.2 107.885 165.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 pt -133.95 21.08 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 128.233 2.613 . . . . 73.41 108.987 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -81.19 -177.75 6.6 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 123.145 1.45 . . . . 55.3 109.881 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -73.99 170.62 15.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.029 -1.896 . . . . 64.2 109.275 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 165.29 3.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.669 1.188 . . . . 70.43 112.514 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.64 71.77 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.579 1.561 . . . . 61.3 114.111 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.45 134.94 36.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.736 1.768 . . . . 74.4 108.269 -176.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -125.99 129.16 48.66 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.745 1.157 . . . . 70.32 111.124 -169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.29 158.95 25.05 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.285 2.234 . . . . 74.21 105.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -161.14 101.38 1.24 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.146 -1.798 . . . . 64.33 106.146 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.71 143.78 21.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.258 -1.756 . . . . 72.34 106.258 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m -131.46 144.74 51.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.716 -1.587 . . . . 73.54 106.716 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -147.24 112.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 125.702 1.601 . . . . 53.2 109.231 -164.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.22 143.96 39.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.395 1.478 . . . . 74.21 107.046 -170.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.67 140.49 11.84 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.897 -0.881 . . . . 61.22 110.897 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -134.64 144.91 48.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.158 1.383 . . . . 73.53 110.099 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.65 118.6 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 105.193 -2.151 . . . . 65.34 105.193 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 t70 43.91 71.32 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.64 1.576 . . . . 61.34 112.153 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.08 27.29 3.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.251 2.221 . . . . 70.33 113.694 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -129.8 158.56 39.11 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 120.799 -1.188 . . . . 65.54 110.94 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.82 134.87 40.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.228 1.411 . . . . 72.15 107.456 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.51 -0.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.852 0.861 . . . . 65.32 112.101 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -161.87 153.52 18.8 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.399 -0.963 . . . . 73.51 108.399 165.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.62 122.86 3.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.691 -1.596 . . . . 73.15 106.691 170.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.49 171.25 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.895 0.747 . . . . 71.22 110.753 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.05 168.8 14.81 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.614 1.966 . . . . 74.44 109.376 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -150.86 170.6 18.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.585 -1.265 . . . . 70.32 107.585 162.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.55 154.91 51.23 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 127.852 2.461 . . . . 71.12 107.727 169.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.571 ' HB3' HD11 ' A' ' 115' ' ' LEU . 22.8 m-85 -137.79 154.83 49.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.987 -0.746 . . . . 71.14 108.987 164.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -145.27 134.16 17.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.707 -1.22 . . . . 74.1 107.707 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 p -75.58 131.81 40.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.687 0.795 . . . . 74.14 109.929 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -128.64 66.26 1.41 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.06 0.933 . . . . 71.12 108.793 161.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.21 15.71 79.78 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.703 -0.68 . . . . 63.53 114.26 163.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.55 162.97 32.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.58 1.552 . . . . 74.21 110.273 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 105.69 1.35 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.342 -0.844 . . . . 52.12 109.896 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -66.08 133.14 50.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.335 -0.987 . . . . 61.33 108.335 175.106 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -149.37 138.62 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.854 -2.276 . . . . 71.13 104.854 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.58 166.92 32.01 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.66 1.184 . . . . 63.12 111.484 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.1 p -136.81 153.7 50.74 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.143 0.977 . . . . 74.44 111.182 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -142.97 174.47 10.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.005 1.722 . . . . 73.53 108.943 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 t -164.38 144.08 7.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.503 -0.748 . . . . 52.0 109.621 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 92' ' ' VAL . 48.0 t -143.19 109.61 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.134 -2.173 . . . . 70.53 105.134 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 128.1 55.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.172 1.389 . . . . 65.5 107.574 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 5.4 44.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.924 1.083 . . . . 72.42 113.924 -172.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.292 0 O-C-N 120.116 -1.615 . . . . 73.34 106.775 171.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 108.777 -0.823 . . . . 53.25 108.777 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.49 -97.72 0.11 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 106.859 -2.496 . . . . 53.21 106.859 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.49 147.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.624 -2.362 . . . . 71.23 104.624 167.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -107.12 146.73 30.91 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.725 -1.583 . . . . 75.14 106.725 166.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -142.66 145.36 33.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.932 -1.507 . . . . 72.4 106.932 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 94' ' ' GLY . 2.5 tp -119.95 152.28 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.792 -1.558 . . . . 61.51 106.792 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.2 t -126.82 137.43 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.561 -2.385 . . . . 73.4 104.561 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 74' ' ' CYS . 53.2 mt -122.1 151.6 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.358 -2.09 . . . . 54.43 105.358 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.62 166.35 24.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.29 -1.004 . . . . 72.51 108.29 170.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -138.4 171.63 14.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.413 0.685 . . . . 63.42 109.426 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -161.78 174.14 13.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.053 2.141 . . . . 50.44 107.686 164.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.82 -147.68 18.58 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.317 -1.513 . . . . 65.33 109.317 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.88 78.67 3.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.056 0.931 . . . . 72.1 111.197 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -73.29 39.63 0.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.676 1.59 . . . . 73.33 112.534 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -142.49 -11.38 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.439 1.496 . . . . 74.23 113.239 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 14.05 1.04 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.579 1.081 . . . . 73.22 113.134 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.49 167.19 18.65 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.008 0.923 . . . . 73.13 110.061 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.3 111.62 6.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.264 -1.754 . . . . 70.3 106.264 163.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 90' ' ' ILE . 62.1 t -125.01 112.83 33.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.801 -1.926 . . . . 65.4 105.801 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -110.03 121.71 45.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.783 -1.192 . . . . 53.44 107.783 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 m -95.26 137.53 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.368 -1.345 . . . . 72.22 107.368 163.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.94 145.36 34.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.161 -1.422 . . . . 73.24 107.161 155.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -130.08 123.26 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.041 -2.207 . . . . 62.1 105.041 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.81 167.78 37.38 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.913 0.768 . . . . 50.02 111.487 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.72 39.38 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.972 1.748 . . . . 44.21 109.003 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.96 164.32 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.654 1.227 . . . . 71.21 111.425 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.18 175.85 9.25 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.923 1.689 . . . . 74.34 112.722 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -74.71 78.54 2.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.526 -0.916 . . . . 74.02 108.526 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.54 35.82 1.38 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-O 118.572 -1.127 . . . . 74.2 113.554 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.21 -172.12 30.8 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.918 1.859 . . . . 72.32 112.692 162.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.06 134.28 21.09 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.423 2.082 . . . . 70.33 107.662 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.91 131.06 42.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.406 1.082 . . . . 45.4 109.625 -167.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -61.68 122.24 14.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.433 -0.58 . . . . 70.22 109.433 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD23 HG22 ' A' ' 65' ' ' THR . 2.4 mt -97.09 154.97 17.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.177 1.791 . . . . 71.34 107.768 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -133.84 141.96 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.718 -1.586 . . . . 65.31 106.718 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.604 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -73.58 -154.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.439 1.896 . . . . 61.34 111.457 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -100.14 -3.17 32.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.02 1.728 . . . . 64.12 112.773 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -111.48 17.37 20.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.198 2.199 . . . . 54.41 110.109 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.09 19.06 69.71 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.634 1.588 . . . . 50.21 114.234 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.604 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -102.58 156.52 17.56 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 119.694 1.747 . . . . 71.22 107.958 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -85.43 150.48 24.68 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.47 -1.307 . . . . 72.2 107.47 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.2 pt -150.67 23.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.876 0.87 . . . . 74.31 112.927 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.32 -172.18 14.08 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.578 -1.326 . . . . 54.13 111.955 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -119.18 -4.99 10.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.843 2.057 . . . . 73.43 112.544 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -164.38 134.87 4.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.208 -1.405 . . . . 73.34 107.208 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -168.4 -173.86 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.013 1.725 . . . . 72.42 108.651 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.44 165.58 14.75 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.206 1.002 . . . . 74.33 110.17 159.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.84 133.06 26.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.963 1.305 . . . . 73.32 107.985 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -78.95 136.46 37.25 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.605 -0.517 . . . . 71.2 109.605 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 mm -78.86 74.43 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.778 0.831 . . . . 72.52 109.516 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -89.38 13.78 12.8 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.178 1.177 . . . . 65.34 114.178 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.4 p -118.52 161.11 20.56 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.989 0.916 . . . . 63.4 109.386 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.7 92.57 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 73.13 109.29 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.4 p -132.82 140.23 47.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.721 1.208 . . . . 64.14 108.671 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.05 168.42 19.64 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.325 1.85 . . . . 73.53 110.956 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.5 p -165.92 144.18 5.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.396 0.678 . . . . 45.12 110.885 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.3 m -127.1 157.77 38.78 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.487 -1.301 . . . . 64.41 107.487 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -146.86 -176.92 5.39 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.152 0.887 . . . . 72.3 110.611 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.496 HG22 HD23 ' A' ' 40' ' ' LEU . 20.0 p -134.91 177.75 7.55 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.353 0.661 . . . . 74.32 110.571 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -73.45 -172.53 1.2 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.074 1.35 . . . . 64.43 112.0 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.42 -5.54 72.98 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.783 -1.198 . . . . 72.21 115.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -130.82 109.25 10.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.767 2.027 . . . . 73.0 107.99 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.2 165.56 24.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.178 2.191 . . . . 74.5 110.103 166.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -117.55 -19.29 9.48 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.203 1.401 . . . . 74.52 113.268 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -159.86 172.51 17.5 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.89 0.768 . . . . 73.3 109.327 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.3 ttt -141.17 155.83 46.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.529 -2.026 . . . . 65.12 105.529 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -139.3 156.95 46.69 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.966 0.906 . . . . 51.23 108.911 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.637 ' HB3' HG12 ' A' ' 121' ' ' VAL . 2.1 t -123.94 16.27 9.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.727 1.611 . . . . 71.52 111.798 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.4 129.14 21.36 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 125.752 1.621 . . . . 73.3 110.632 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.7 -179.83 31.09 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 42.22 111.263 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.89 150.73 43.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.246 2.218 . . . . 61.54 107.809 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.67 HG13 ' CG ' ' A' ' 117' ' ' GLU 0.295 1.6 p -138.04 155.89 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 50.42 110.552 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -151.73 179.18 8.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.214 -1.402 . . . . 72.4 107.214 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.5 t -161.91 164.69 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.218 1.407 . . . . 65.52 108.417 165.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.11 -0.11 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.914 1.286 . . . . 71.24 112.115 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.84 -176.5 1.69 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.752 1.263 . . . . 72.22 109.253 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -72.51 175.59 6.15 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 73.11 111.107 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 166.88 8.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.693 1.597 . . . . 74.53 113.169 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.43 37.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.312 1.911 . . . . 51.02 114.805 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -87.67 115.34 25.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.382 1.873 . . . . 51.2 106.987 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 167.59 9.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.573 1.149 . . . . 74.44 109.776 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -157.87 97.15 1.54 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.757 -1.201 . . . . 74.3 107.757 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -87.86 138.9 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.621 -1.622 . . . . 75.33 106.621 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 25' ' ' VAL . 6.2 mm -128.28 140.05 50.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 106.157 -1.794 . . . . 74.22 106.157 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m -124.03 135.72 53.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.156 -1.794 . . . . 74.34 106.156 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -137.59 110.94 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 108.126 -1.065 . . . . 61.23 108.126 -172.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.55 141.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.929 1.292 . . . . 75.21 108.497 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' CA ' HD12 ' A' ' 12' ' ' ILE . . . -138.58 144.56 15.69 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.361 0.981 . . . . 75.13 113.3 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -128.82 158.58 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.049 1.74 . . . . 74.33 110.82 -169.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.72 110.35 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.454 -2.054 . . . . 73.54 105.454 168.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 t0 72.6 -67.41 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.924 2.489 . . . . 72.45 110.012 168.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -153.97 10.45 0.4 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.784 1.634 . . . . 74.21 112.971 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -123.15 152.38 41.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.571 1.078 . . . . 55.22 111.486 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.46 121.51 39.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.537 1.535 . . . . 73.31 108.091 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.09 -15.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 62.24 112.881 -169.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.38 141.63 25.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.545 1.066 . . . . 75.51 108.689 -170.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.61 158.08 3.3 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.661 0.784 . . . . 72.52 111.469 173.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -152.14 172.62 16.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.119 1.512 . . . . 74.55 108.432 156.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.21 163.96 16.97 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.789 -1.189 . . . . 63.22 107.789 169.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -143.68 165.95 26.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.043 1.337 . . . . 64.21 109.409 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -162.53 120.95 2.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.439 -2.164 . . . . 75.31 109.507 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 117' ' ' GLU . 26.8 m-85 -131.5 149.43 52.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.077 0.861 . . . . 75.51 110.316 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mt -144.73 118.32 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.81 -1.552 . . . . 61.32 106.81 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 p -64.6 142.43 58.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.925 1.29 . . . . 71.42 110.993 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.56 51.73 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.313 2.245 . . . . 73.3 107.675 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.5 7.21 85.27 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.927 1.251 . . . . 73.42 114.338 167.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -127.68 179.59 5.44 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.295 2.238 . . . . 62.51 108.98 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -63.5 134.7 56.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.164 -0.68 . . . . 70.3 109.164 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.5 tp -95.39 135.36 37.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.7 2.0 . . . . 64.52 107.563 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.7 mt -164.76 133.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 128.68 2.792 . . . . 73.32 110.643 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.67 ' CG ' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -159.55 167.03 29.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.268 2.627 . . . . 74.52 112.838 -176.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -136.33 158.57 44.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.554 1.541 . . . . 71.44 110.42 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.11 164.92 28.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.365 1.866 . . . . 74.41 108.512 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -150.89 129.54 12.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.089 0.471 . . . . 75.4 110.081 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 74' ' ' CYS . 8.8 p -129.9 131.06 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.274 -1.75 . . . . 63.15 106.274 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.9 m -128.69 -179.61 5.16 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.517 -1.29 . . . . 71.34 107.517 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.3 p -135.28 33.84 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.566 -0.709 . . . . 52.12 109.103 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tptp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 106.585 -1.635 . . . . 75.42 106.585 174.995 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 107.185 -1.413 . . . . 73.11 107.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.42 -90.76 0.08 OUTLIER Glycine 0 C--N 1.338 0.64 0 O-C-N 121.032 -1.043 . . . . 54.14 110.706 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.8 145.68 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 104.965 -2.235 . . . . 74.41 104.965 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 23.6 m-70 -120.73 148.97 43.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.912 1.233 . . . . 63.43 108.601 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 161.22 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.832 . . . . 74.15 109.714 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mm -140.35 136.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.25 -1.759 . . . . 65.22 106.25 170.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.5 t -113.95 144.87 20.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.17 2.188 . . . . 42.23 107.031 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.22 154.13 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.84 -1.541 . . . . 70.42 106.84 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -144.73 168.35 20.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.696 -1.224 . . . . 65.22 107.696 172.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -146.72 164.53 32.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.301 0.572 . . . . 72.44 111.358 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 m -157.05 172.14 19.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.159 2.584 . . . . 65.22 108.291 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.46 -151.56 19.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.026 -1.23 . . . . 61.03 110.026 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -76.04 64.86 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 123.444 1.592 . . . . 75.25 110.423 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -61.57 -14.28 28.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.495 . . . . 72.41 113.151 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.82 -30.64 62.82 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.397 0.679 . . . . 73.34 112.146 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.0 1.14 11.42 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.122 0.786 . . . . 60.23 113.122 -162.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.17 111.46 21.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.751 -1.574 . . . . 73.35 106.751 -173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 150.88 38.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.138 -0.69 . . . . 54.23 109.138 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.04 111.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 106.899 -1.519 . . . . 74.14 106.899 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -112.73 127.69 56.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.946 -1.131 . . . . 73.54 107.946 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.26 147.96 32.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.777 0.831 . . . . 53.35 109.361 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 t -117.92 120.68 38.6 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.201 2.201 . . . . 74.53 107.739 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.3 mt -120.35 125.31 74.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 74.54 108.39 -156.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.01 169.1 35.87 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 121.267 0.37 . . . . 72.22 113.099 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.05 174.21 39.34 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 127.303 2.383 . . . . 73.21 108.239 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.43 147.23 50.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 119.898 1.849 . . . . 54.01 110.227 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.07 179.49 4.03 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.752 2.421 . . . . 44.1 111.383 -172.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.37 76.2 0.16 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.825 0.85 . . . . 50.2 110.561 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.42 34.0 4.32 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.775 1.178 . . . . 74.34 111.734 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.9 175.42 47.5 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.637 1.218 . . . . 72.32 112.759 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.48 134.16 34.78 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.66 2.24 . . . . 72.32 108.921 159.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.87 128.23 34.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.831 -0.804 . . . . 73.14 108.831 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -56.0 123.25 13.75 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.271 -0.64 . . . . 72.44 109.271 169.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -92.69 164.6 13.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 124.222 0.951 . . . . 74.51 109.16 169.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -137.38 143.36 41.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.417 1.887 . . . . 72.12 107.926 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -69.59 -152.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.267 2.627 . . . . 75.23 110.944 174.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -99.91 -3.64 31.97 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.403 -1.435 . . . . 74.32 114.322 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -98.74 -3.5 35.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.321 -1.487 . . . . 75.3 111.6 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.99 9.49 56.01 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 127.356 2.407 . . . . 55.5 112.396 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -110.32 142.39 42.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 120.589 2.195 . . . . 75.12 108.334 -165.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -64.32 131.32 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.439 1.496 . . . . 74.13 108.704 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.54 9.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.063 0.945 . . . . 73.33 111.81 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.87 175.62 22.99 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.441 -1.063 . . . . 73.51 110.441 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.98 11.62 17.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.075 0.95 . . . . 75.33 110.727 166.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -162.3 157.13 22.36 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 126.791 2.036 . . . . 52.12 106.415 151.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 40' ' ' LEU . 17.5 p90 -176.99 -174.99 0.56 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.493 1.917 . . . . 75.14 110.878 171.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.7 p -122.38 158.3 29.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.613 2.365 . . . . 71.52 108.369 161.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.96 106.06 3.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.299 -0.63 . . . . 72.1 109.299 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.43 145.09 52.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.598 0.714 . . . . 75.53 110.049 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mm -75.68 135.58 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.058 -1.46 . . . . 75.23 107.058 167.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.1 7.74 3.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.356 1.062 . . . . 61.43 110.816 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -139.51 152.39 46.91 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.073 -1.017 . . . . 72.32 108.874 -148.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -31.22 64.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.99 0.359 . . . . 64.35 111.937 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -134.99 164.18 28.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.827 1.251 . . . . 71.25 109.328 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.28 171.2 15.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.814 2.045 . . . . 62.33 109.912 170.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 p -173.46 156.78 3.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.668 1.587 . . . . 74.44 111.17 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.6 m -150.06 165.81 31.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.482 2.713 . . . . 62.23 107.416 162.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 p -147.88 -179.85 7.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.125 0.97 . . . . 54.01 111.28 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.8 p -102.9 164.91 11.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.662 1.185 . . . . 74.41 109.334 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.42 169.42 4.75 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.235 -0.586 . . . . 62.32 109.608 152.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.36 36.94 1.78 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.072 0.844 . . . . 65.54 113.123 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -146.33 90.17 1.93 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.237 -2.134 . . . . 65.43 105.237 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.6 141.94 17.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.319 1.847 . . . . 74.35 106.977 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -86.09 -22.43 27.15 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.446 1.098 . . . . 73.44 111.832 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 25.6 p90 -157.38 167.33 30.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.697 1.199 . . . . 74.21 108.481 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.57 148.86 49.24 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.302 -2.11 . . . . 74.25 105.302 159.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.6 t -140.55 157.83 44.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.302 -0.999 . . . . 54.34 108.302 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.47 79.06 1.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.923 1.289 . . . . 73.11 109.157 -169.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.43 156.33 31.19 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.222 -0.659 . . . . 64.43 109.222 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.4 174.49 41.21 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 121.947 0.748 . . . . 72.45 112.662 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.6 t -146.33 148.59 32.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 126.337 1.855 . . . . 74.51 107.724 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.05 136.41 53.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 126.097 1.759 . . . . 72.44 106.718 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -148.57 151.86 35.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.698 0.799 . . . . 74.45 110.906 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -150.15 151.08 32.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.126 0.97 . . . . 72.32 108.462 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 5.15 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.367 2.267 . . . . 72.12 110.827 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 p -63.01 169.46 3.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.185 0.994 . . . . 50.31 110.322 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 168.18 9.68 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.319 1.057 . . . . 73.05 112.252 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.4 19.14 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.561 -1.654 . . . . 70.12 112.854 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.85 57.88 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.873 1.225 . . . . 73.13 114.014 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -75.19 167.07 22.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.21 1.505 . . . . 74.14 107.313 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -153.87 174.03 15.14 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.952 -1.093 . . . . 74.32 111.118 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tp -158.46 152.78 24.21 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.338 -0.986 . . . . 45.23 108.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -140.57 131.38 25.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.409 -1.7 . . . . 73.14 106.409 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.51 116.97 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 106.429 -1.693 . . . . 72.44 106.429 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -96.99 139.33 33.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.24 -1.763 . . . . 73.13 106.24 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.36 132.07 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.004 -2.221 . . . . 73.13 105.004 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.1 mt -142.58 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 107.727 -1.212 . . . . 74.25 107.727 -172.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.27 143.95 17.97 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 109.002 -1.639 . . . . 42.03 109.002 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -132.88 152.59 51.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.239 1.015 . . . . 72.55 110.333 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.1 mt -132.52 124.26 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.609 -2.367 . . . . 73.14 104.609 167.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 44.77 68.4 0.56 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.198 1.799 . . . . 70.54 110.804 163.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.6 1.83 3.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.148 1.536 . . . . 43.45 115.148 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -132.11 153.11 50.82 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.072 1.306 . . . . 74.22 111.227 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -86.02 148.23 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.113 0.482 . . . . 73.54 110.034 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 m -135.27 1.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.938 1.295 . . . . 65.11 111.657 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.56 140.68 8.53 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 120.908 -1.12 . . . . 74.13 108.605 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -158.54 144.47 16.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.999 0.919 . . . . 70.41 109.311 162.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.18 108.02 2.53 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.829 0.823 . . . . 71.33 109.435 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.64 157.76 37.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.621 -1.299 . . . . 53.23 108.997 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 173.69 7.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.823 -1.547 . . . . 72.33 106.823 159.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -145.94 132.29 19.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 74.33 106.301 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 115' ' ' LEU . 8.4 m-85 -128.5 165.62 20.36 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.898 0.772 . . . . 72.35 110.246 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.9 mt -150.47 137.03 12.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.968 2.507 . . . . 73.24 105.783 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.2 144.72 30.49 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.993 0.917 . . . . 63.03 108.875 170.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -129.68 13.5 5.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 64.02 111.599 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.5 55.36 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 121.314 -0.866 . . . . 71.23 112.94 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -90.17 170.27 10.44 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.559 1.544 . . . . 65.32 107.892 160.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.59 139.66 58.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.808 -1.182 . . . . 62.25 107.808 161.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.1 tt -97.65 134.22 41.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.699 -1.223 . . . . 74.13 107.699 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.8 mt -145.5 141.93 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.251 -2.129 . . . . 71.55 105.251 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.74 168.23 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.632 1.573 . . . . 65.41 109.318 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.2 p -140.91 157.61 45.11 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.687 1.195 . . . . 73.43 109.152 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.25 171.88 18.51 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.394 -0.821 . . . . 70.52 109.129 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -151.93 142.83 23.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.421 1.088 . . . . 61.22 108.419 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.87 85.78 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.767 -1.938 . . . . 73.31 105.767 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -64.88 170.02 4.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.59 -0.893 . . . . 71.13 108.59 160.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 p -127.87 -12.13 5.36 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.549 -0.719 . . . . 72.11 111.444 159.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 106.413 -1.699 . . . . 74.45 106.413 -169.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.815 0.817 . . . . 52.11 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.02 -119.8 0.93 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.799 3.095 . . . . 50.43 106.311 -166.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.01 103.93 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 53.34 108.456 -167.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.453 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 50.1 m-70 -74.38 154.86 38.64 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.962 -0.461 . . . . 71.34 109.771 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -145.86 152.26 39.19 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.817 1.247 . . . . 61.42 107.905 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -127.24 152.43 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.294 2.238 . . . . 71.11 105.489 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.83 136.04 54.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.396 -2.076 . . . . 72.23 105.396 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.4 mt -122.91 150.82 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 105.959 -1.867 . . . . 62.14 105.959 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -142.9 163.36 33.01 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.053 -1.462 . . . . 64.21 107.053 166.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -136.93 154.45 50.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.625 -1.25 . . . . 72.25 107.625 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -145.36 171.01 15.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.29 -137.47 14.22 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.023 -1.631 . . . . 32.02 109.023 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -89.98 65.42 6.58 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.521 1.529 . . . . 40.12 109.79 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.8 p -75.42 35.5 0.12 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.161 2.184 . . . . 72.04 113.338 -164.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -142.6 8.48 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.244 1.417 . . . . 72.44 111.644 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 m -149.19 7.64 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.106 1.762 . . . . 60.01 111.412 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.75 141.91 50.03 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.074 -1.016 . . . . 73.43 109.103 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -116.1 116.56 28.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.229 -1.767 . . . . 74.22 106.229 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.75 90.14 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.462 -0.94 . . . . 72.34 108.462 -171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -86.89 145.23 26.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.046 -1.033 . . . . 71.44 108.298 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.14 129.12 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.316 1.046 . . . . 65.33 109.469 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -64.59 138.12 58.22 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.723 -1.584 . . . . 74.44 106.723 160.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 122.27 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.129 -2.175 . . . . 73.31 105.129 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.69 167.38 35.22 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.048 -0.821 . . . . 41.42 111.048 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.04 170.95 44.13 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.388 1.947 . . . . 73.2 109.065 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.69 164.78 21.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.852 0.861 . . . . 62.01 109.999 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -131.24 -164.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.255 1.822 . . . . 74.42 111.074 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -79.82 71.59 6.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.845 -0.428 . . . . 71.42 109.845 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.58 -22.6 2.01 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-O 119.035 -0.869 . . . . 50.23 114.2 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.69 -154.8 8.09 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.102 -1.199 . . . . 74.14 110.102 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.1 154.92 42.4 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.726 2.284 . . . . 72.33 110.515 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 110.79 20.77 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.214 1.406 . . . . 74.41 108.993 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -45.46 116.25 1.11 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.988 1.715 . . . . 61.44 111.531 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.71 160.2 15.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.956 0.884 . . . . 71.13 110.09 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -129.09 152.09 49.06 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.677 1.591 . . . . 75.42 107.897 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -96.5 172.75 7.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 73.3 110.424 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -65.47 -9.47 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.096 1.758 . . . . 73.43 113.978 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -87.52 -8.52 56.28 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.652 1.581 . . . . 61.43 111.152 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.1 59.09 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.921 1.724 . . . . 71.14 113.741 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -104.7 147.15 27.99 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.698 1.249 . . . . 74.02 109.251 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -66.29 135.76 54.87 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.003 -1.11 . . . . 61.23 108.003 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -136.63 28.83 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.713 0.805 . . . . 60.43 111.509 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.06 18.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.4 -1.08 . . . . 73.0 110.4 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.04 2.95 55.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.134 1.773 . . . . 70.24 113.246 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -165.77 157.38 14.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.565 1.546 . . . . 72.23 108.375 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.3 p90 177.92 -173.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.578 2.351 . . . . 74.23 109.726 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 m -119.28 153.0 35.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.648 1.179 . . . . 62.31 108.246 154.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.79 110.29 7.02 Favored 'General case' 0 CA--C 1.523 -0.086 0 C-N-CA 124.328 1.051 . . . . 64.04 108.332 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -73.19 145.1 46.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.096 0.958 . . . . 64.32 110.383 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -80.51 118.78 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.734 -1.58 . . . . 75.22 106.734 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.55 29.37 2.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.037 1.335 . . . . 73.1 108.604 167.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 p -135.51 157.25 47.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.446 1.098 . . . . 54.32 108.862 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.52 -40.66 79.22 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.28 0.632 . . . . 63.24 110.408 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.5 p -133.76 163.67 28.96 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.74 0.816 . . . . 44.13 110.878 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 mmm -142.43 170.62 15.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.297 1.839 . . . . 74.03 111.563 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 p -160.9 154.76 22.49 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.22 1.808 . . . . 72.34 108.641 165.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.8 m -143.91 150.43 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.203 1.801 . . . . 64.01 107.851 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.6 p -149.15 179.74 7.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.164 0.983 . . . . 62.43 110.529 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -119.29 -174.65 2.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.28 -1.748 . . . . 64.2 106.28 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -92.37 -176.57 4.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.533 -1.284 . . . . 75.02 107.533 158.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.76 64.33 2.63 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.961 -1.087 . . . . 34.43 111.684 173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.94 71.75 1.35 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 103.883 -2.636 . . . . 71.4 103.883 169.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.89 32.94 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.134 -0.978 . . . . 63.14 111.247 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.09 -7.13 2.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.172 1.789 . . . . 74.1 112.552 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 29.6 p90 -157.29 170.66 21.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.36 -1.348 . . . . 73.24 107.36 163.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.7 ttt -146.29 147.66 31.61 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 105.136 -2.172 . . . . 74.43 105.136 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.5 t -135.36 164.97 26.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.82 0.819 . . . . 63.44 110.002 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.32 106.91 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.703 -2.332 . . . . 74.22 104.703 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 142.97 41.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.906 -1.887 . . . . 70.02 105.906 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.54 -151.05 5.55 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 120.94 -0.648 . . . . 34.13 111.813 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.24 175.49 10.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.137 -0.69 . . . . 74.24 109.137 147.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -137.15 147.46 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.661 1.584 . . . . 73.15 109.273 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.5 m -149.32 167.71 25.35 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.43 -0.794 . . . . 73.04 112.743 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 t -143.47 151.61 40.51 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.771 2.029 . . . . 65.24 107.05 158.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.02 48.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.839 . . . . 73.23 107.616 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.1 m -127.72 174.62 8.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.292 1.037 . . . . 70.15 112.499 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -55.14 158.53 2.91 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.631 1.972 . . . . 63.05 110.817 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.8 167.14 1.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.196 1.398 . . . . 52.22 112.974 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.52 -13.65 33.75 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.043 1.306 . . . . 50.54 114.157 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -67.43 132.45 47.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.119 1.46 . . . . 74.22 108.215 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.0 mtt85 -110.38 159.78 17.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.711 -1.218 . . . . 70.25 107.711 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -146.67 141.42 26.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.87 -1.529 . . . . 71.33 106.87 177.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -145.79 92.92 2.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.993 -1.484 . . . . 73.25 106.993 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.61 143.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.442 -1.688 . . . . 73.14 106.442 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -119.28 136.47 54.22 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.493 -1.669 . . . . 65.23 106.493 165.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.51 115.07 12.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 125.655 1.582 . . . . 71.04 108.842 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.67 153.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.348 -1.723 . . . . 65.33 106.348 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.16 158.18 27.61 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.695 -0.962 . . . . 71.45 110.695 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -143.35 152.92 42.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.947 0.899 . . . . 74.24 110.369 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.8 mt -121.81 120.76 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.288 -2.115 . . . . 73.24 105.288 165.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.5 t0 72.39 -83.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.122 2.969 . . . . 73.02 110.197 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.73 24.73 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.58 1.952 . . . . 64.41 108.702 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -135.74 132.85 37.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.266 -0.896 . . . . 75.42 110.746 -166.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.31 136.17 57.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.992 -0.744 . . . . 70.12 108.992 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.59 -25.55 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.16 0.984 . . . . 52.35 108.823 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -145.89 142.92 29.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.512 1.525 . . . . 74.23 107.768 -168.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -167.23 112.0 0.72 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.642 1.177 . . . . 74.43 109.095 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.07 173.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.551 0.532 . . . . 50.11 109.893 162.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -128.3 172.76 10.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 72.21 108.068 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 147.12 33.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.704 -0.85 . . . . 71.13 108.704 164.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -120.61 136.11 54.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.655 -0.869 . . . . 65.41 108.655 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -138.65 155.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.044 0.938 . . . . 72.21 108.849 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.88 135.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.17 -1.419 . . . . 64.34 107.17 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -65.86 144.23 56.95 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.076 0.95 . . . . 53.55 109.328 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -137.0 21.34 3.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.97 0.804 . . . . 73.34 112.546 164.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.12 -24.1 31.62 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.15 1.833 . . . . 72.12 111.336 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.47 159.08 27.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.789 -0.819 . . . . 63.33 108.789 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.42 120.64 21.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.759 -1.571 . . . . 63.44 106.759 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.1 21.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.42 -1.696 . . . . 70.42 106.42 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.03 142.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 105.699 -1.963 . . . . 73.12 105.699 166.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.59 179.1 8.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.835 0.826 . . . . 72.11 109.555 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -135.68 173.01 12.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.387 1.875 . . . . 62.34 107.692 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -164.81 165.62 20.44 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.245 2.218 . . . . 74.32 108.621 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.5 149.82 27.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.558 0.617 . . . . 73.04 110.717 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 t -145.28 84.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.943 -1.502 . . . . 70.45 106.943 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.62 129.2 37.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.177 -1.786 . . . . 44.23 106.177 175.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.0 p -85.72 5.84 30.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.38 0.991 . . . . 74.13 112.049 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.239 0.515 0 N-CA-C 107.563 -1.273 . . . . 74.14 107.563 177.284 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.139 -1.43 . . . . 75.33 107.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.0 -90.52 0.08 OUTLIER Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.85 2.166 . . . . 64.11 109.437 -163.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -139.36 135.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 127.468 2.307 . . . . 62.32 107.378 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -103.71 152.6 21.63 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.529 -0.732 . . . . 72.24 109.725 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -142.68 147.37 35.59 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.841 -1.17 . . . . 72.12 107.841 169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.9 mm -119.16 151.08 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.349 1.86 . . . . 75.43 106.267 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.93 139.13 46.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.118 -1.808 . . . . 73.44 106.118 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.67 154.36 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.325 -1.361 . . . . 73.1 107.325 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -142.8 168.9 18.64 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.52 1.128 . . . . 75.44 109.106 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -136.39 150.38 48.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.674 1.59 . . . . 74.41 108.355 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -154.25 162.39 41.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.303 1.841 . . . . 61.54 108.107 167.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.11 -163.69 31.84 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.329 -1.508 . . . . 75.4 109.329 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.1 99.13 3.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.953 1.701 . . . . 62.11 109.049 -169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.9 p -85.76 -10.24 55.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.836 1.254 . . . . 73.12 114.259 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.1 -12.66 46.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.709 -1.244 . . . . 71.24 111.661 -171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.59 30.84 1.88 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.221 1.408 . . . . 71.34 112.613 -169.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.618 ' CD2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -126.83 155.23 43.23 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.794 -1.192 . . . . 71.12 108.443 170.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.06 121.68 18.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.369 -1.345 . . . . 72.3 107.369 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.97 105.08 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 123.908 0.883 . . . . 54.44 109.079 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 145.98 25.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.694 -0.854 . . . . 64.43 108.694 162.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.45 131.59 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.605 1.562 . . . . 73.33 108.996 163.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 t -68.39 140.08 55.82 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.257 -1.386 . . . . 62.24 107.257 161.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.5 mt -130.43 108.54 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 104.297 -2.482 . . . . 71.3 104.297 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -143.39 166.43 26.82 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 109.382 -1.487 . . . . 52.44 109.382 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 172.04 44.96 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 108.314 -1.915 . . . . 71.34 108.314 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 164.75 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.521 1.129 . . . . 75.14 108.773 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -144.08 145.46 32.17 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.196 0.998 . . . . 64.04 109.306 156.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 45.2 -8.15 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 130.525 3.53 . . . . 60.21 117.829 -160.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 33' ' ' ASP . . . 138.51 -19.47 3.19 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 126.408 1.956 . . . . 63.1 110.796 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.96 -171.5 32.69 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.213 2.34 . . . . 41.41 111.711 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.7 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.281 2.654 . . . . 75.54 110.688 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.84 138.73 47.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.103 0.478 . . . . 62.24 111.902 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -65.14 110.59 2.59 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.749 1.62 . . . . 72.02 110.485 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 30' ' ' GLY . 2.8 mt -89.14 160.93 16.76 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.439 1.018 . . . . 74.33 108.745 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -130.4 144.29 51.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.335 1.054 . . . . 74.2 109.797 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.03 176.99 6.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.816 1.246 . . . . 64.1 110.808 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -72.03 -13.25 61.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.83 0.852 . . . . 63.21 112.86 -169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.82 -13.85 62.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.814 1.246 . . . . 64.03 110.635 168.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 14.27 72.69 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 126.542 2.02 . . . . 71.01 112.544 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -106.64 154.81 20.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.697 1.599 . . . . 73.32 110.337 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -76.03 152.02 37.01 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.211 -0.663 . . . . 74.43 109.211 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 pt -153.49 10.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.877 1.066 . . . . 63.11 113.877 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.19 167.09 11.13 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.814 -1.179 . . . . 53.44 110.574 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -111.66 -0.65 15.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.805 1.242 . . . . 73.3 112.443 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 m -148.34 141.85 25.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.068 -1.827 . . . . 74.33 106.068 159.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.06 -173.63 2.4 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.422 1.089 . . . . 73.13 108.578 166.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.3 m -130.23 153.87 48.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.493 1.117 . . . . 72.2 108.116 161.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.68 160.71 38.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.322 1.049 . . . . 61.52 108.827 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.196 0.598 . . . . 72.24 110.565 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.96 81.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.859 1.264 . . . . 63.52 108.417 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 29.42 7.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.623 1.169 . . . . 75.31 110.359 172.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -141.89 138.61 32.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.991 -1.115 . . . . 72.12 107.991 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.86 49.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.687 0.795 . . . . 60.11 111.94 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.9 p -141.6 159.87 41.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.931 1.292 . . . . 52.03 107.515 166.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -145.23 163.67 33.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.028 1.331 . . . . 73.34 109.897 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -172.59 153.82 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.365 1.466 . . . . 75.23 110.912 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.1 m -143.73 152.66 41.56 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.375 1.87 . . . . 73.21 107.292 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.4 p -142.35 177.62 8.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.842 0.857 . . . . 71.41 110.589 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.4 p -101.08 171.21 7.76 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.837 1.255 . . . . 63.0 109.923 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.48 177.2 1.6 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.269 -1.011 . . . . 71.32 108.269 152.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.01 34.69 0.9 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.73 -1.039 . . . . 32.12 113.13 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.11 131.35 11.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.778 1.789 . . . . 75.22 107.769 164.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -174.2 152.31 1.81 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.814 2.446 . . . . 64.31 108.315 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.23 -18.11 12.61 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.571 1.548 . . . . 73.42 112.856 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.39 177.35 11.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.688 2.395 . . . . 73.52 107.072 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 ttt -150.93 150.15 30.49 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 104.803 -2.295 . . . . 72.34 104.803 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 t -122.41 155.44 36.07 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.204 -1.406 . . . . 74.32 107.204 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 t -155.19 98.45 2.0 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.19 -2.152 . . . . 72.11 105.19 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -129.84 144.3 51.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.048 -1.464 . . . . 23.53 107.048 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.98 -149.74 5.08 Favored Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.577 -0.609 . . . . 63.44 111.577 -164.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.06 175.46 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.901 -0.777 . . . . 63.12 108.901 145.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -122.34 156.08 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.753 1.621 . . . . 72.5 107.674 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t -151.38 163.8 38.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.836 1.254 . . . . 61.51 109.289 161.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -151.44 134.84 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.47 2.308 . . . . 73.33 105.392 168.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.68 12.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.242 -1.022 . . . . 75.22 108.242 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -75.0 -176.66 3.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.796 -1.187 . . . . 72.1 107.796 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -62.38 167.3 4.32 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.368 1.08 . . . . 75.4 112.254 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.45 153.03 16.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.312 -1.767 . . . . 64.13 113.3 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.78 6.35 85.46 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.403 -1.221 . . . . 51.31 113.574 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -76.11 172.51 12.67 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.604 1.702 . . . . 54.44 108.599 160.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -147.47 150.86 35.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.591 -1.263 . . . . 75.15 107.591 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.618 HD21 ' CD2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -154.69 115.34 3.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.088 -0.708 . . . . 61.4 109.088 -175.119 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -118.89 124.66 47.66 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.982 1.713 . . . . 75.55 108.401 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.3 mm -113.75 142.88 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.526 -1.287 . . . . 52.3 107.526 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -122.87 133.66 54.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.21 -1.774 . . . . 75.15 106.21 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -139.59 132.23 35.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 125.73 1.612 . . . . 73.52 109.517 -173.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mt -143.76 152.31 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.54 108.333 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.2 151.24 23.51 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.554 1.074 . . . . 54.21 111.553 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -136.19 155.79 49.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.327 1.851 . . . . 73.32 110.372 -166.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mt -141.89 138.12 31.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 127.003 2.121 . . . . 71.3 105.395 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.75 -85.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.739 3.616 . . . . 64.44 109.955 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -152.27 37.2 0.54 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.444 1.498 . . . . 75.0 110.593 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -141.49 153.43 44.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.623 1.169 . . . . 75.33 110.975 171.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.54 148.36 42.39 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.041 0.936 . . . . 64.14 108.906 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.39 -18.38 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 54.43 112.685 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -136.6 137.69 40.42 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.23 1.377 . . . . 74.22 108.765 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -151.8 138.4 18.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.544 1.138 . . . . 74.51 109.751 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -143.8 168.95 18.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.648 0.737 . . . . 74.25 110.498 155.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.06 156.12 43.28 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.414 -1.698 . . . . 72.42 106.414 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 164.14 34.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.684 -0.858 . . . . 75.32 108.684 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -153.5 148.45 26.62 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.276 -0.268 . . . . 73.13 110.276 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.443 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.6 m-85 -148.44 137.69 21.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.582 1.153 . . . . 74.31 110.358 -167.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.2 mt -124.85 135.92 62.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.007 -1.479 . . . . 62.53 107.007 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.54 137.91 38.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.634 1.973 . . . . 63.33 108.634 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -141.75 31.16 1.65 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.777 0.798 . . . . 74.14 112.02 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.39 -3.92 86.3 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.368 0.985 . . . . 64.41 112.607 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.63 -155.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.497 1.919 . . . . 71.32 108.512 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -118.9 110.82 17.62 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.188 -1.782 . . . . 71.2 106.188 166.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 108' ' ' TYR . 1.4 tm? -62.13 120.28 10.58 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.426 -1.324 . . . . 63.55 107.426 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -148.19 144.11 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 103.976 -2.602 . . . . 75.44 103.976 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.48 169.72 18.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.991 -0.744 . . . . 74.53 108.991 169.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 p -134.85 162.47 32.31 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.797 1.239 . . . . 75.42 108.361 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -151.8 175.78 12.09 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.036 1.334 . . . . 75.32 108.68 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 t -160.58 148.52 16.19 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.716 0.769 . . . . 72.12 109.445 168.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.6 107.16 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 127.314 2.246 . . . . 61.21 106.393 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.24 118.47 30.54 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.084 1.354 . . . . 72.4 108.437 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.1 p -86.43 33.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.92 0.888 . . . . 71.23 111.847 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tptp . . . . . 0 C--O 1.235 0.33 0 N-CA-C 107.199 -1.408 . . . . 74.44 107.199 167.52 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 111.285 0.106 . . . . 74.2 111.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.43 -90.04 0.11 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 108.808 -1.717 . . . . 53.51 108.808 154.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.24 131.93 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.638 -1.986 . . . . 71.22 105.638 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -126.69 157.16 39.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.568 -1.271 . . . . 73.12 107.568 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -148.94 151.33 34.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.317 1.047 . . . . 62.04 108.257 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.34 134.94 52.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.858 -1.905 . . . . 74.34 105.858 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.54 131.26 50.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.711 -1.589 . . . . 70.05 106.711 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.3 mt -135.2 143.09 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.475 -0.935 . . . . 64.12 108.475 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -134.47 161.75 34.15 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.381 1.072 . . . . 75.21 110.3 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.23 141.86 29.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.33 2.652 . . . . 63.35 109.961 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -141.83 172.49 12.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.56 1.544 . . . . 60.22 107.343 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.33 -155.63 24.4 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.886 -1.286 . . . . 73.45 109.886 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.21 33.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.548 2.339 . . . . 61.25 111.106 -173.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 t -65.04 8.29 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.163 2.185 . . . . 73.54 113.798 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -17.83 64.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.841 1.656 . . . . 72.51 111.149 162.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.7 m -130.95 16.33 5.18 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.937 1.295 . . . . 72.45 113.019 -163.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 88' ' ' LEU . 53.1 m-85 -126.26 116.02 20.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.352 1.061 . . . . 70.14 109.261 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.22 127.08 31.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.28 -1.378 . . . . 71.11 107.28 166.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 t -136.74 106.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 105.557 -2.016 . . . . 61.54 105.557 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -114.87 145.86 41.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.768 1.167 . . . . 53.43 110.082 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.77 139.19 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.363 1.065 . . . . 63.43 109.595 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -66.84 139.39 57.76 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.768 -1.567 . . . . 64.44 106.768 161.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -132.9 124.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.591 -2.003 . . . . 44.41 105.591 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . -179.98 176.97 47.8 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.702 -1.359 . . . . 52.41 109.702 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.44 172.76 43.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.337 -1.905 . . . . 64.41 108.337 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.8 163.61 27.85 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.783 0.833 . . . . 54.14 109.863 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.39 -170.82 2.68 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.215 1.006 . . . . 74.2 112.039 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -74.94 67.47 1.68 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.317 1.047 . . . . 74.13 110.674 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.36 -32.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.533 -0.593 . . . . 53.14 112.729 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.93 -156.71 15.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 119.907 -1.139 . . . . 70.32 114.627 -162.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.18 139.44 9.38 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.927 3.084 . . . . 65.4 110.567 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.14 117.95 23.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.081 1.352 . . . . 73.4 110.576 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -60.21 117.61 5.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.661 1.119 . . . . 74.43 110.482 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD21 ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -91.39 159.16 16.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.004 1.321 . . . . 74.12 109.401 171.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -128.16 143.88 51.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.0 1.32 . . . . 74.21 109.306 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -81.75 165.87 20.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.182 -0.917 . . . . 53.42 109.864 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -74.45 19.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.654 1.582 . . . . 73.13 113.457 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -100.76 -10.95 20.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.159 1.383 . . . . 70.22 110.9 163.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.59 56.54 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.001 1.762 . . . . 73.13 113.339 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.19 160.88 14.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.553 1.141 . . . . 72.1 109.429 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -74.96 157.7 34.53 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.815 -0.553 . . . . 74.41 109.923 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.22 6.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.127 0.788 . . . . 43.52 113.127 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.18 -172.45 24.18 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.186 -1.565 . . . . 63.0 109.186 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 40' ' ' LEU . 14.6 p30 -125.03 8.73 8.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.037 1.335 . . . . 72.04 111.943 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -170.85 124.48 0.65 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.477 3.111 . . . . 74.3 106.864 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -163.18 -173.39 3.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.238 1.015 . . . . 73.24 110.211 171.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -121.11 157.46 30.06 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.261 1.024 . . . . 64.11 109.249 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.55 142.27 50.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.923 -1.139 . . . . 62.45 107.923 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -96.29 132.71 41.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.554 -1.647 . . . . 72.35 106.554 170.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -74.99 100.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.673 -1.603 . . . . 64.43 106.673 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -127.09 35.1 4.63 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.87 1.668 . . . . 65.24 109.875 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -134.31 169.01 17.85 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.117 -1.068 . . . . 63.41 108.117 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.33 9.95 34.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 118.643 -0.694 . . . . 54.45 111.443 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -178.51 159.85 1.2 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.901 2.48 . . . . 71.34 107.485 145.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 mmm -125.42 165.13 18.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.173 2.189 . . . . 73.41 109.572 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.4 p -159.56 163.07 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.238 -0.892 . . . . 61.05 111.317 158.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.4 m -147.87 163.09 37.86 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.469 2.308 . . . . 73.23 106.624 162.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.35 -176.81 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.23 1.812 . . . . 61.11 108.789 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.27 156.42 47.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.565 1.946 . . . . 73.4 107.362 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -82.4 179.61 7.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.217 0.207 . . . . 65.22 110.699 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.07 32.56 0.52 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.784 1.659 . . . . 73.32 115.752 -171.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -128.2 80.74 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.705 -2.331 . . . . 72.13 104.705 168.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.76 18.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.123 1.329 . . . . 65.34 107.546 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -128.62 -13.89 4.71 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.363 1.065 . . . . 70.3 112.955 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -164.11 167.88 19.71 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.407 1.883 . . . . 65.22 107.5 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 ttt -130.87 145.5 52.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.225 -2.139 . . . . 72.01 105.225 169.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 t -111.85 161.98 15.78 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.57 0.7 . . . . 65.01 109.981 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.42 40.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.312 1.445 . . . . 74.04 110.284 170.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.64 58.28 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 121.439 -0.788 . . . . 63.25 108.993 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.47 -174.95 38.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.747 -0.941 . . . . 74.23 110.747 -173.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.8 p -134.9 168.42 19.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.722 0.772 . . . . 72.41 110.892 -173.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.69 147.14 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.046 1.738 . . . . 71.44 106.731 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 t -152.09 164.5 37.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.092 -0.707 . . . . 44.35 109.092 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.12 155.64 43.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.667 -1.235 . . . . 72.35 107.667 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.82 22.39 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.421 1.488 . . . . 71.21 109.343 167.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.36 173.75 12.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.498 1.919 . . . . 54.05 110.368 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 176.39 8.18 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.687 1.195 . . . . 71.22 112.474 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.98 153.92 42.71 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 113.652 -1.613 . . . . 61.12 112.959 -173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.65 -10.51 44.89 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.663 1.125 . . . . 43.13 114.278 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -64.6 117.34 7.26 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 106.622 -1.621 . . . . 71.32 106.622 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -102.4 168.37 9.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.155 0.582 . . . . 72.14 110.074 -168.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 23' ' ' PHE . 12.6 tp -157.53 150.19 23.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.41 -1.7 . . . . 73.34 106.41 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -141.04 132.92 27.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 105.814 -1.921 . . . . 71.15 105.814 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 mm -127.64 133.81 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.767 -1.568 . . . . 72.15 106.767 -172.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.81 129.03 41.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.882 -1.525 . . . . 70.12 106.882 -168.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.17 121.05 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.315 1.046 . . . . 75.05 108.399 -173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.51 141.54 45.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.013 -1.477 . . . . 72.15 107.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.97 144.35 15.93 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 124.76 1.171 . . . . 73.12 111.155 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 100' ' ' GLU . 88.1 m-85 -131.63 151.39 51.65 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.67 1.588 . . . . 74.15 111.303 -165.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.5 mt -137.92 140.96 39.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.109 -1.812 . . . . 60.03 106.109 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t0 61.02 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.678 1.991 . . . . 74.11 110.829 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.67 20.82 1.31 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.52 1.528 . . . . 74.03 111.076 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -143.94 158.01 43.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 120.55 -1.344 . . . . 60.14 111.954 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 5.9 pm0 -80.82 156.1 26.3 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.249 -1.019 . . . . 63.05 108.249 168.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.88 -5.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.01 0.524 . . . . 73.35 112.181 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -151.8 130.15 12.08 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.802 -1.186 . . . . 74.14 109.226 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.53 142.88 18.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.642 0.777 . . . . 74.44 110.153 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.48 169.21 21.43 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.896 -0.779 . . . . 72.15 108.896 159.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.98 135.73 37.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.617 -1.623 . . . . 73.25 106.617 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.72 167.35 17.37 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 123.83 0.852 . . . . 73.21 109.547 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.56 131.22 7.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.774 -1.103 . . . . 74.34 108.143 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 16.5 m-85 -145.16 146.97 31.99 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.849 -0.797 . . . . 72.43 108.849 -171.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.25 147.02 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.716 -1.216 . . . . 71.53 107.716 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -77.07 138.66 39.68 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.627 2.371 . . . . 65.53 111.172 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -125.88 55.11 1.47 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.467 1.107 . . . . 73.13 109.281 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.59 3.96 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.047 1.308 . . . . 73.52 112.558 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.07 -174.97 5.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.505 1.522 . . . . 72.52 113.967 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.0 142.4 58.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.098 1.359 . . . . 64.12 109.161 165.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.6 tt -108.05 143.08 37.26 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.743 -0.836 . . . . 63.22 108.743 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mm -143.21 158.83 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 128.929 2.891 . . . . 73.45 106.017 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -172.82 170.61 4.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.606 2.362 . . . . 63.45 109.074 158.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.5 p -143.13 150.69 39.79 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 72.34 110.179 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -147.04 168.73 20.82 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.617 0.767 . . . . 51.14 110.689 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 p -158.39 111.58 2.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.102 -0.374 . . . . 74.21 111.185 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.62 88.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.189 -1.411 . . . . 74.14 107.189 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 155.52 19.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.449 -1.315 . . . . 63.41 107.449 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.9 p -91.78 30.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.725 -1.234 . . . . 70.2 109.727 174.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptm . . . . . 0 N--CA 1.452 -0.343 0 O-C-N 120.605 -1.31 . . . . 74.14 108.517 -179.025 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.239 0.537 0 N-CA-C 109.249 -0.648 . . . . 74.14 109.249 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.22 -115.42 0.65 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.929 -2.068 . . . . 54.24 107.929 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.52 82.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.621 -0.881 . . . . 74.11 108.621 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -64.16 153.33 38.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.864 -0.791 . . . . 73.04 108.864 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -138.33 153.01 48.99 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.367 -1.345 . . . . 74.42 107.367 167.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -122.28 140.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.982 -2.599 . . . . 73.12 103.982 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.37 133.7 61.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 105.753 -1.943 . . . . 74.3 105.753 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -138.57 129.06 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.65 -0.87 . . . . 63.14 108.65 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -117.05 161.72 18.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.014 0.526 . . . . 73.21 110.517 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -147.77 146.35 29.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.784 0.834 . . . . 61.13 109.766 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.78 -177.16 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.111 0.964 . . . . 64.13 109.713 166.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.64 -95.49 0.7 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.714 -1.355 . . . . 50.44 109.714 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -122.81 122.62 39.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.175 -2.528 . . . . 62.0 104.175 157.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 p -118.66 9.54 12.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.361 0.665 . . . . 73.41 111.274 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -88.48 -33.62 17.75 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.827 1.651 . . . . 71.3 110.032 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.87 26.15 6.68 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.921 1.688 . . . . 70.41 110.049 -167.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 80' ' ' SER . 81.2 m-85 -128.93 148.06 50.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.929 0.891 . . . . 73.43 109.504 165.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.04 154.38 19.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.262 1.825 . . . . 64.34 108.748 163.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.76 102.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.413 -2.439 . . . . 74.3 104.413 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 p -97.44 148.15 23.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.419 -0.956 . . . . 73.31 108.419 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.62 120.42 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.234 1.014 . . . . 62.23 110.667 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 t -59.58 136.04 57.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.359 -1.349 . . . . 63.2 107.359 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 40' ' ' LEU . 41.7 mt -130.43 116.37 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 105.124 -2.176 . . . . 64.3 105.124 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.12 174.57 36.08 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.01 0.814 . . . . 64.44 111.5 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.34 172.17 35.75 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.139 1.828 . . . . 72.43 110.219 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.07 168.94 18.55 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.108 0.963 . . . . 70.32 111.439 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.06 179.31 7.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.316 1.446 . . . . 73.22 113.987 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.69 71.81 1.01 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 74.21 109.946 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.24 -0.5 3.22 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 117.73 -1.594 . . . . 65.4 115.336 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.91 -166.78 39.46 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 120.509 2.154 . . . . 61.3 115.037 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.07 135.97 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.186 3.257 . . . . 65.51 109.102 163.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.77 102.78 12.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.954 -1.022 . . . . 70.14 108.864 -172.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -46.22 118.02 1.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.204 1.001 . . . . 65.04 110.898 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.2 mm? -81.42 154.67 26.27 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 120.254 1.388 . . . . 71.02 108.953 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -123.6 141.15 52.29 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.819 1.247 . . . . 74.43 110.346 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.9 173.36 12.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.799 -1.091 . . . . 65.13 110.9 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -80.48 8.36 7.88 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.44 0.904 . . . . 73.11 113.44 -170.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -105.43 -1.87 24.46 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.8 1.64 . . . . 73.1 111.266 165.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.81 55.51 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 118.766 -1.019 . . . . 74.04 114.656 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -107.28 150.79 26.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.15 1.475 . . . . 74.31 111.393 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -70.49 152.63 43.8 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.472 -0.566 . . . . 61.34 109.472 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.88 2.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 114.034 1.124 . . . . 74.13 114.034 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.25 -173.63 35.41 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 108.429 -1.868 . . . . 53.51 108.429 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -124.76 0.21 8.06 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.915 1.358 . . . . 74.33 113.451 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -151.3 150.72 30.87 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.938 2.495 . . . . 71.4 105.979 158.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -171.68 -178.08 2.16 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.397 1.879 . . . . 74.14 107.552 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -135.73 103.97 5.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.631 0.772 . . . . 73.41 109.434 172.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.44 154.52 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.528 0.604 . . . . 70.23 109.801 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.885 -1.524 . . . . 51.42 106.885 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -71.45 96.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.415 -1.328 . . . . 64.41 107.415 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -109.04 22.92 15.27 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.691 -1.256 . . . . 72.4 110.067 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -137.16 154.54 50.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.478 1.111 . . . . 63.22 108.69 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.3 67.22 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.605 0.595 . . . . 73.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -151.54 173.66 14.35 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.484 -0.76 . . . . 74.31 109.644 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -152.6 163.29 39.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 129.388 3.075 . . . . 70.34 108.801 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -158.8 157.82 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.383 1.473 . . . . 74.41 109.564 159.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.31 144.81 33.41 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.285 1.834 . . . . 64.43 106.804 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 p -127.77 -172.78 2.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.801 1.24 . . . . 53.22 110.044 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 p -125.01 -179.47 4.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.642 1.177 . . . . 64.14 109.2 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -74.22 -177.25 2.91 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.84 -0.8 . . . . 72.3 108.84 153.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.58 44.58 1.83 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.405 1.002 . . . . 54.5 110.896 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -142.92 89.4 2.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.878 -1.527 . . . . 72.02 106.878 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.07 179.83 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.895 1.678 . . . . 61.02 109.991 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -132.36 -16.0 2.78 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.888 1.07 . . . . 73.24 113.888 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -161.36 169.57 21.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.577 -1.268 . . . . 72.43 107.577 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.0 ttt -136.98 158.7 43.87 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 105.607 -1.997 . . . . 73.23 105.607 164.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -135.26 161.52 35.15 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.657 0.783 . . . . 70.24 109.935 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 104.48 3.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.798 1.239 . . . . 73.23 108.592 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.84 140.21 42.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.425 -1.324 . . . . 41.23 107.425 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.96 -150.73 5.83 Favored Glycine 0 C--N 1.331 0.269 0 O-C-N 121.186 -0.946 . . . . 65.01 113.176 -159.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -148.85 171.04 16.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 41.23 110.325 159.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.31 147.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.301 1.841 . . . . 70.12 106.472 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -155.02 167.59 29.86 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.09 -1.006 . . . . 61.43 111.655 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 10.2 t -139.42 148.98 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.237 1.815 . . . . 64.01 107.54 166.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.77 32.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.376 1.871 . . . . 62.42 107.737 170.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.16 -175.08 2.7 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.836 1.254 . . . . 74.12 110.522 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.34 163.31 23.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.402 1.881 . . . . 73.2 110.123 176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.59 163.05 2.63 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.321 1.848 . . . . 50.41 111.965 165.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.93 36.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 118.422 -1.21 . . . . 62.14 114.23 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -64.14 154.3 35.09 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.674 1.737 . . . . 74.03 108.066 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -136.98 161.72 35.27 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.043 0.937 . . . . 72.42 109.001 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 tp -155.8 133.69 11.27 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.982 -1.118 . . . . 74.03 107.982 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -132.26 88.76 2.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.196 1.398 . . . . 63.31 109.068 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.31 138.12 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.076 2.15 . . . . 63.22 108.441 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.9 m -126.14 140.3 52.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.161 -1.422 . . . . 74.43 107.161 169.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.515 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -135.64 124.58 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.468 1.507 . . . . 72.13 107.565 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mt -133.38 147.7 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.472 1.509 . . . . 72.31 107.532 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.5 141.8 11.42 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 124.458 1.028 . . . . 61.4 113.067 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.66 153.31 47.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.722 1.609 . . . . 74.01 110.896 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mt -121.24 107.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 N-CA-C 106.47 -1.678 . . . . 72.41 106.47 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t0 73.36 -64.7 0.39 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.864 2.066 . . . . 61.33 110.62 172.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 -7.66 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.311 2.244 . . . . 71.02 111.78 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.5 129.93 56.17 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 114.075 1.139 . . . . 65.33 114.075 -163.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.39 121.73 26.6 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 -1.53 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.698 . . . . 64.13 112.886 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -149.0 139.5 22.52 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.606 1.094 . . . . 65.14 108.225 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -157.42 149.21 22.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.578 -0.897 . . . . 63.32 108.578 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -149.72 164.06 36.27 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.474 -0.565 . . . . 74.24 109.474 160.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -137.03 147.55 46.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.987 1.315 . . . . 70.24 108.129 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -142.85 169.15 18.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.703 0.683 . . . . 61.33 110.391 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -139.91 139.86 36.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.376 -1.713 . . . . 63.21 106.376 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.93 153.26 51.89 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.55 1.14 . . . . 72.44 108.375 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -141.29 138.23 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.754 -1.573 . . . . 74.14 106.754 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 p -81.01 147.67 30.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.173 0.897 . . . . 44.52 110.214 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -136.62 28.85 2.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.712 0.805 . . . . 74.0 111.46 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.45 -26.33 13.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.132 1.349 . . . . 31.34 112.601 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -77.34 168.31 20.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.562 1.545 . . . . 74.43 109.278 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 m -67.12 112.34 4.37 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.847 -1.168 . . . . 74.42 107.847 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.07 135.65 44.85 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.782 -1.192 . . . . 74.04 107.782 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -146.64 153.64 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.274 -2.491 . . . . 70.12 104.274 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.33 169.63 15.59 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.023 0.929 . . . . 63.23 110.697 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.3 p -138.25 148.64 44.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.408 0.623 . . . . 73.22 109.453 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.01 173.89 11.15 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.404 1.882 . . . . 70.0 109.09 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -168.61 119.78 0.77 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.855 -0.528 . . . . 62.21 111.026 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.06 92.27 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.089 1.356 . . . . 71.44 108.335 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 m -88.27 159.82 17.94 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 71.12 108.878 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.15 -2.81 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.634 -1.291 . . . . 53.33 112.608 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? . . . . . 0 CA--C 1.521 -0.17 0 N-CA-C 106.95 -1.5 . . . . 71.43 106.95 -166.477 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 110.24 -0.281 . . . . 72.3 110.24 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 -114.93 0.84 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 106.132 -2.787 . . . . 32.23 106.132 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.3 mt -130.24 110.15 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.359 1.064 . . . . 73.33 108.265 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -68.76 148.81 49.79 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.767 -0.583 . . . . 72.24 109.779 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -135.41 154.61 51.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.552 1.541 . . . . 64.14 107.414 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mm -130.87 148.92 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.312 -2.106 . . . . 63.42 105.312 170.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.32 140.79 45.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.974 -1.861 . . . . 75.33 105.974 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -139.2 134.52 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.247 -1.02 . . . . 72.52 108.247 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -137.1 161.7 35.4 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.146 -0.687 . . . . 74.33 109.146 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -136.47 155.05 50.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.332 1.053 . . . . 75.51 110.739 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.5 m -140.58 166.27 25.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.688 -1.227 . . . . 55.23 107.688 150.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.08 -161.48 19.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 124.717 1.151 . . . . 75.22 111.539 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.06 61.87 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.397 2.279 . . . . 73.53 107.909 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -66.82 11.26 0.1 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.635 2.774 . . . . 75.32 114.343 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -8.22 46.16 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.1 -1.625 . . . . 72.11 112.31 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.57 25.86 2.85 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.639 1.976 . . . . 73.45 111.853 -160.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.0 166.59 21.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.151 -0.968 . . . . 71.11 112.265 -170.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -134.65 126.79 29.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 127.657 2.383 . . . . 73.51 105.46 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 78' ' ' VAL . 22.4 t -140.93 110.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.155 -1.054 . . . . 74.11 108.155 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -125.26 121.3 33.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.867 -0.79 . . . . 62.41 108.867 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 m -110.96 126.39 68.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.324 1.449 . . . . 62.22 109.806 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 t -72.01 130.25 40.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.623 -1.991 . . . . 65.32 105.623 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.18 110.41 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.392 -2.077 . . . . 54.1 105.392 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.11 177.26 30.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.602 -0.727 . . . . 64.4 111.351 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.63 170.11 38.79 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 127.337 2.399 . . . . 74.31 107.568 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.48 161.89 32.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.531 0.666 . . . . 73.24 110.601 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -140.5 178.27 7.43 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.474 2.31 . . . . 73.22 110.426 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -78.62 81.18 4.95 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.82 -1.178 . . . . 72.33 107.82 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.65 -31.6 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-O 118.68 -1.067 . . . . 51.53 111.607 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.14 26.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.722 1.761 . . . . 64.54 111.488 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.36 141.54 56.7 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.034 2.489 . . . . 33.15 110.254 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.14 118.79 15.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.96 1.304 . . . . 53.22 110.469 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -57.23 109.83 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.969 1.258 . . . . 74.12 110.717 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.63 162.93 16.07 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.41 1.484 . . . . 74.3 110.77 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -131.94 138.73 48.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.035 1.734 . . . . 72.23 107.863 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -77.67 173.41 12.08 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.364 -0.835 . . . . 60.21 110.402 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.07 -8.87 33.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.344 1.458 . . . . 73.22 114.435 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -88.59 -14.79 36.71 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.842 1.657 . . . . 61.13 111.631 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.58 19.16 30.51 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.994 1.283 . . . . 61.33 114.1 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -109.59 147.25 33.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.619 1.709 . . . . 75.24 111.715 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.81 131.7 44.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.542 1.537 . . . . 64.41 110.163 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -130.63 4.32 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.781 1.233 . . . . 73.34 112.926 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.25 169.26 11.78 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 109.945 -1.262 . . . . 71.0 109.945 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -101.14 10.7 40.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.42 1.088 . . . . 73.42 111.426 172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 139.01 1.07 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.394 1.877 . . . . 70.32 108.24 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -175.82 -173.33 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.406 1.482 . . . . 74.41 108.65 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -134.79 122.13 21.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.788 1.235 . . . . 65.21 108.722 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.59 147.82 22.58 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.13 -1.063 . . . . 72.34 108.13 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -95.61 148.57 22.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.193 -1.04 . . . . 74.4 108.193 166.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mm -86.38 118.05 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.874 -1.158 . . . . 71.4 107.874 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.44 18.29 6.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.599 1.16 . . . . 74.43 110.954 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 p -134.26 153.98 51.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.719 0.808 . . . . 72.13 110.157 -163.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.64 -53.66 55.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.636 -0.505 . . . . 62.42 109.636 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 p -140.31 120.36 13.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.485 0.66 . . . . 71.31 110.636 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 mmm -110.69 165.01 12.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.281 1.832 . . . . 72.0 111.013 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 p -157.06 166.16 34.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.679 -1.146 . . . . 75.42 110.536 160.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 61.3 m -144.03 163.47 33.41 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.005 2.122 . . . . 55.31 106.419 165.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 13.9 p -142.51 -172.06 3.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.978 -0.749 . . . . 55.53 108.978 168.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.76 176.73 5.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.473 1.909 . . . . 74.4 107.092 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.27 169.78 17.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 155.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.83 78.63 1.99 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.567 -1.013 . . . . 54.43 110.567 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -151.44 -17.16 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.674 0.789 . . . . 73.23 112.602 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 167.02 16.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.188 1.395 . . . . 64.02 111.581 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -124.39 -7.22 7.56 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.083 1.353 . . . . 75.41 113.223 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -162.05 170.95 18.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.631 1.572 . . . . 75.52 107.408 168.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.4 ttt -143.44 138.75 29.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.412 -2.07 . . . . 64.1 105.412 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.9 t -126.57 143.92 51.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.297 0.953 . . . . 72.34 110.438 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.701 ' HB3' HG22 ' A' ' 121' ' ' VAL . 22.7 t -129.3 46.23 2.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.409 3.083 . . . . 74.31 108.527 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.91 35.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.178 0.991 . . . . 63.13 109.562 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.41 -151.71 6.03 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 120.44 1.473 . . . . 63.13 113.297 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 100.0 p -153.86 171.34 19.11 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.888 0.475 . . . . 75.33 112.263 160.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' VAL . 98.9 t -129.5 150.66 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.597 1.959 . . . . 73.54 107.661 170.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -152.62 165.79 34.13 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.509 -0.744 . . . . 74.45 111.236 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.6 t -144.44 158.75 43.6 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.926 2.09 . . . . 74.21 106.265 159.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.07 13.45 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.068 2.147 . . . . 71.33 108.472 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -73.64 -177.35 2.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 73.31 108.805 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.84 167.71 21.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.627 -1.17 . . . . 62.45 110.85 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.47 168.32 2.18 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.937 1.295 . . . . 54.21 112.247 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.19 -0.78 78.45 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.479 1.038 . . . . 75.42 114.288 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -88.75 114.33 25.26 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.2 1.4 . . . . 72.52 108.663 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 159.92 15.62 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.339 1.056 . . . . 74.22 108.385 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -154.19 135.76 14.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.013 -1.477 . . . . 53.42 107.013 175.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -132.9 127.79 35.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.409 -1.33 . . . . 75.42 107.409 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.0 140.11 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 124.982 1.313 . . . . 74.54 107.629 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.9 m -127.25 131.15 50.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.214 -1.772 . . . . 61.34 106.214 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 112.71 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.463 1.505 . . . . 75.44 108.658 -169.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.91 152.99 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.18 1.392 . . . . 71.21 108.594 -169.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.64 144.75 12.83 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.761 1.172 . . . . 61.04 113.531 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.64 159.78 35.36 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.235 1.814 . . . . 71.1 110.993 -168.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.22 111.99 18.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.149 -2.167 . . . . 63.4 105.149 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.6 t0 60.93 -72.84 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.898 2.479 . . . . 60.02 113.292 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.77 15.07 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.177 2.191 . . . . 73.04 110.942 -173.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -128.11 153.16 47.15 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.003 -1.686 . . . . 53.34 109.987 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -93.9 139.53 30.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.113 -1.069 . . . . 54.43 108.113 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.94 -26.23 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.958 1.095 . . . . 53.1 113.958 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -118.75 135.34 54.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.615 2.007 . . . . 72.31 107.568 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -154.25 145.76 23.15 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.183 0.516 . . . . 75.51 112.009 159.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -141.92 174.37 10.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.917 -1.038 . . . . 73.12 111.145 152.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -130.59 165.66 22.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.763 1.625 . . . . 74.25 107.418 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 162.77 39.78 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.677 -0.64 . . . . 64.33 109.481 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -142.29 146.51 35.15 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.07 0.948 . . . . 74.13 109.587 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -148.88 153.62 38.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.021 1.328 . . . . 61.33 108.959 -173.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.59 134.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.54 -1.282 . . . . 74.54 107.54 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -62.47 128.69 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.621 1.168 . . . . 74.55 108.543 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -116.45 -5.12 11.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.418 1.487 . . . . 64.24 112.073 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.29 8.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.093 2.283 . . . . 31.52 110.981 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -76.61 170.45 16.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.293 1.047 . . . . 71.41 108.649 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -72.37 113.15 9.09 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.205 -0.934 . . . . 73.33 108.816 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.18 113.95 5.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.117 -1.438 . . . . 74.15 107.117 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.52 141.06 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 104.433 -2.432 . . . . 60.41 104.433 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.95 166.77 31.05 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.638 1.175 . . . . 75.12 109.223 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -139.61 155.23 47.57 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.757 1.623 . . . . 75.31 106.743 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -154.76 164.03 39.4 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.76 1.224 . . . . 74.51 108.616 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -166.45 146.78 6.1 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 123.185 1.469 . . . . 64.34 113.576 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 74' ' ' CYS . 3.5 m -141.67 134.27 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 112.177 -2.283 . . . . 74.1 109.428 -174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.23 135.27 35.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.638 -1.616 . . . . 41.33 106.638 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.25 -10.74 51.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.098 0.863 . . . . 71.11 113.139 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 106.61 -1.626 . . . . 72.42 106.61 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 106.445 -1.687 . . . . 74.23 106.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.83 -109.49 0.54 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 107.153 -2.379 . . . . 33.41 107.153 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -140.65 110.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 129.665 3.186 . . . . 63.21 103.638 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -74.2 158.75 33.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.258 -1.016 . . . . 62.23 108.258 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 153.42 34.11 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.008 1.323 . . . . 54.33 108.789 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mm -141.54 149.78 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 106.238 -1.764 . . . . 72.33 106.238 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.5 OUTLIER -142.64 135.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.323 -2.217 . . . . 71.42 106.626 -164.163 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.55 144.1 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 107.382 -1.34 . . . . 74.31 107.382 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -129.95 165.45 22.07 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.422 0.689 . . . . 73.05 109.437 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -139.47 169.88 16.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 71.42 108.283 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.21 168.42 25.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.62 -1.622 . . . . 63.34 106.62 161.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.62 -144.37 18.22 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 119.579 1.081 . . . . 51.43 112.607 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -78.44 74.01 4.98 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 123.724 1.726 . . . . 42.25 108.276 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -73.76 15.05 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.935 1.294 . . . . 72.12 113.372 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.37 16.79 4.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.046 1.738 . . . . 72.05 111.951 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -145.41 7.6 1.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.543 1.537 . . . . 72.42 112.48 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.78 112.17 13.35 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.813 1.245 . . . . 72.45 109.1 -159.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.64 126.01 28.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.185 1.394 . . . . 42.24 108.51 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.8 113.57 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.397 -1.705 . . . . 73.01 106.397 164.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -112.33 148.57 33.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.79 0.805 . . . . 65.43 109.732 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.81 118.19 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.704 1.602 . . . . 74.04 108.65 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -77.94 129.86 35.85 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.344 -1.725 . . . . 72.03 106.344 166.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -126.86 149.32 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.732 -1.21 . . . . 74.12 107.732 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.21 174.46 46.76 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.711 -0.956 . . . . 73.41 110.711 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 169.45 42.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.125 -1.99 . . . . 43.1 108.125 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 126.28 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.947 1.699 . . . . 44.12 109.679 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.6 -171.14 1.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.332 1.053 . . . . 72.34 110.759 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -72.28 79.35 0.99 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 73.31 109.079 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.21 61.57 0.93 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.436 -1.466 . . . . 53.21 109.436 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.43 -176.48 30.64 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-O 119.566 -0.574 . . . . 71.42 113.199 158.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.78 135.78 24.24 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.986 2.457 . . . . 73.1 108.827 155.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.14 115.61 24.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 117.884 -1.055 . . . . 41.42 109.173 -170.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -47.72 111.58 0.44 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.824 1.193 . . . . 44.11 112.123 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.73 168.71 19.34 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.768 0.827 . . . . 74.42 109.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -135.33 163.11 30.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.637 1.975 . . . . 70.23 109.824 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -111.7 -176.96 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.008 1.723 . . . . 72.4 110.827 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.89 -16.26 60.67 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.504 0.927 . . . . 74.3 113.504 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -71.37 -24.06 62.02 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.984 -1.073 . . . . 73.21 109.375 168.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.21 27.56 25.25 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 125.684 1.611 . . . . 43.24 112.118 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.75 152.37 20.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.257 -1.386 . . . . 74.4 107.257 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.43 35.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.639 1.109 . . . . 74.01 108.066 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 pt -138.21 37.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 174.48 40.27 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.465 -1.454 . . . . 63.42 109.465 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.95 0.58 18.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.757 1.223 . . . . 72.2 112.563 -173.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.7 p -170.55 165.7 8.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.383 1.473 . . . . 54.21 109.536 152.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -179.52 -179.25 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.966 1.706 . . . . 73.22 107.853 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m -116.11 154.44 29.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.237 -1.394 . . . . 73.23 107.237 155.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.28 172.44 11.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.206 1.403 . . . . 72.0 108.018 171.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.14 129.01 37.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.71 0.804 . . . . 63.42 109.205 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -74.74 104.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.178 -1.416 . . . . 71.43 107.178 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 38.35 3.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.909 1.284 . . . . 63.32 109.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -147.92 169.76 19.16 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.704 0.802 . . . . 74.01 109.017 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.41 -43.33 77.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.101 -0.999 . . . . 63.34 110.327 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 p -137.64 147.44 44.95 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.277 1.431 . . . . 54.34 109.019 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mmm -140.12 165.96 25.95 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.163 1.785 . . . . 51.12 110.008 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.6 p -171.4 162.54 6.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.768 -1.56 . . . . 51.22 111.016 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.08 163.53 32.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.657 1.983 . . . . 74.31 107.339 160.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.6 p -140.09 -166.9 2.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.655 1.182 . . . . 71.42 109.902 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.02 156.96 43.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.405 1.082 . . . . 71.24 109.222 -168.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.91 159.27 28.99 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.012 0.911 . . . . 44.41 109.464 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.58 66.9 3.82 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 114.95 -1.023 . . . . 51.1 111.006 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -140.67 -12.68 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.611 1.565 . . . . 70.24 110.25 162.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.11 166.4 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.529 1.132 . . . . 52.4 112.31 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -127.61 -0.8 6.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.744 2.018 . . . . 74.12 113.152 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.31 -179.07 4.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.187 2.595 . . . . 74.1 107.99 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttt -154.28 146.24 23.56 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.009 -1.848 . . . . 64.0 106.009 160.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -124.36 170.41 10.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.503 0.721 . . . . 74.32 110.751 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.63 21.09 0.71 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.461 1.504 . . . . 74.42 111.944 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 115.3 2.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 127.017 2.127 . . . . 44.12 109.78 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.25 -179.62 30.53 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 109.638 -1.385 . . . . 52.51 109.638 -156.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 34.4 p -149.15 158.53 44.26 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.905 -0.647 . . . . 63.33 110.772 -165.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.8 146.62 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 105.216 -2.142 . . . . 45.11 105.216 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.5 m -152.32 170.55 19.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.444 -1.41 . . . . 74.31 110.932 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.78 165.98 27.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.427 1.491 . . . . 61.44 109.071 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.5 pt -155.73 10.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 127.564 2.345 . . . . 64.25 110.993 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -99.39 -170.6 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.045 0.926 . . . . 62.45 109.964 -167.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.32 163.07 8.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.41 1.084 . . . . 70.41 109.339 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.55 158.88 9.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.086 . . . . 51.45 111.318 165.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.01 1.5 59.66 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.708 1.147 . . . . 74.55 113.989 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -72.93 114.82 11.51 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.446 -1.687 . . . . 73.42 106.446 167.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -83.65 163.13 20.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.484 0.714 . . . . 72.52 109.864 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.41 136.65 10.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.588 -1.634 . . . . 64.23 106.588 171.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -129.28 143.98 51.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.219 -1.771 . . . . 60.12 106.219 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 mm -128.74 144.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 126.068 1.747 . . . . 44.42 108.25 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -146.88 133.83 20.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.602 -1.629 . . . . 73.43 106.602 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.42 120.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 107.211 -1.403 . . . . 75.04 107.211 -168.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.542 ' HB ' HG23 ' A' ' 13' ' ' VAL . 51.5 mt -133.06 156.3 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 107.965 -1.124 . . . . 63.42 107.965 -168.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.05 138.2 8.69 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.257 1.408 . . . . 72.14 111.11 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HE2' HG21 ' A' ' 13' ' ' VAL . 43.0 m-85 -132.45 147.64 52.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.733 2.013 . . . . 73.44 109.83 -162.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.02 114.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.953 1.701 . . . . 75.0 108.281 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.261 7.1 t0 49.51 -64.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 131.475 3.91 . . . . 63.23 114.267 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.38 39.43 0.66 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.939 1.245 . . . . 75.14 112.984 166.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.21 148.65 49.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.807 1.243 . . . . 64.01 111.184 177.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -79.4 143.7 34.81 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.225 -1.769 . . . . 63.41 106.225 161.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.91 -28.08 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.052 1.13 . . . . 41.21 114.052 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -148.11 142.32 26.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.391 1.45 . . . . 54.45 108.255 -163.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -172.13 155.91 3.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.264 1.026 . . . . 74.31 111.105 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -150.1 173.48 13.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.532 0.606 . . . . 61.43 109.782 161.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -134.75 152.9 52.12 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.432 -0.951 . . . . 75.35 108.432 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.1 170.55 15.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.415 0.686 . . . . 73.44 110.383 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.64 153.08 41.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.289 -1.745 . . . . 61.21 106.289 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.401 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 55.5 m-85 -142.58 154.57 44.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.242 2.217 . . . . 74.31 106.977 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.64 134.13 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.222 -2.881 . . . . 61.44 103.222 162.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -70.88 148.54 47.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.81 10.19 3.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.671 0.388 . . . . 53.11 111.07 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.59 -9.93 16.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.828 2.156 . . . . 65.53 112.152 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -85.06 168.51 14.82 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.355 -1.085 . . . . 74.11 109.873 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -59.94 160.99 7.07 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.648 -0.501 . . . . 61.44 109.648 154.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.19 129.96 36.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.306 -0.998 . . . . 65.55 108.306 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -152.98 141.14 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.292 1.837 . . . . 65.12 106.501 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -161.78 168.11 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.389 1.875 . . . . 74.55 109.319 177.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 64.7 p -130.97 172.9 11.54 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.76 1.624 . . . . 74.15 108.764 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -151.55 166.9 29.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.158 0.583 . . . . 72.04 110.519 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -152.5 132.07 13.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 122.508 1.147 . . . . 74.21 111.532 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -141.85 96.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 130.415 3.486 . . . . 54.24 103.759 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.5 t -81.5 -179.13 7.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.836 -1.542 . . . . 71.03 106.836 157.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.0 p -130.04 14.42 5.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.385 1.074 . . . . 71.23 111.055 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.188 0 O-C-N 120.449 -1.407 . . . . 62.03 107.62 166.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 106.511 -1.663 . . . . 62.44 106.511 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.74 -100.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 125.122 1.344 . . . . 64.24 109.906 168.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.2 mt -108.63 97.49 5.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.255 -2.128 . . . . 60.21 105.255 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.73 154.13 22.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.87 -1.159 . . . . 74.3 107.87 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.04 150.41 41.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.224 -1.398 . . . . 55.15 107.224 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 mm -120.92 150.44 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.56 -2.015 . . . . 75.25 105.56 165.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.88 133.37 64.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.047 -2.205 . . . . 75.35 105.047 171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.97 140.88 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 108.399 -0.963 . . . . 74.43 108.399 -171.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -147.58 156.02 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.105 0.866 . . . . 74.23 111.798 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -139.72 154.03 47.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.652 1.581 . . . . 73.23 110.637 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 m -150.03 156.14 41.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.674 2.79 . . . . 64.13 106.712 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.88 -112.71 2.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.373 -1.491 . . . . 72.54 109.373 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -117.1 99.09 6.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.352 1.461 . . . . 74.42 107.381 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 p -74.78 -1.03 20.23 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.571 0.952 . . . . 53.02 113.571 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.1 -19.86 13.21 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.851 1.26 . . . . 53.01 110.32 -166.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.3 m -120.15 37.44 4.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.641 1.976 . . . . 75.21 110.888 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.898 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -150.23 122.93 8.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.544 1.164 . . . . 73.21 109.16 171.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.23 90.87 6.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.433 -1.692 . . . . 73.14 106.433 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.829 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.8 t -81.16 113.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.939 2.096 . . . . 52.32 108.042 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -114.63 144.57 43.2 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.485 1.039 . . . . 63.31 109.231 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 m -137.65 122.87 24.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.393 -1.276 . . . . 74.33 110.328 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -68.98 141.66 54.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.677 -1.601 . . . . 71.43 106.677 160.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.4 mt -130.7 107.41 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 103.916 -2.624 . . . . 63.15 103.916 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.1 30.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.367 0.508 . . . . 60.04 111.907 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.82 172.01 43.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.429 1.966 . . . . 61.24 109.483 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.86 163.28 16.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 121.599 -0.942 . . . . 71.01 110.759 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -138.88 -172.76 3.39 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.933 2.493 . . . . 61.13 109.502 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -71.65 -19.48 62.09 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 55.22 113.014 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 -31.52 10.74 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.446 -1.062 . . . . 75.43 110.446 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.41 -95.69 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.522 2.011 . . . . 72.12 108.416 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.68 135.2 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.695 2.263 . . . . 75.35 111.532 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.93 122.99 28.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.588 0.755 . . . . 73.32 109.103 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -61.13 121.34 12.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.044 0.538 . . . . 63.33 110.26 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.0 165.89 14.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.945 0.898 . . . . 75.22 109.526 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -129.98 157.37 42.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.803 1.241 . . . . 75.14 109.103 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.43 171.17 9.93 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.726 0.81 . . . . 72.22 109.487 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.05 -25.34 66.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.975 0.731 . . . . 75.31 112.975 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -71.63 -25.18 62.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.081 1.353 . . . . 74.33 110.668 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.35 17.73 9.74 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 125.085 1.326 . . . . 74.35 113.612 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -94.53 145.95 24.45 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.771 1.786 . . . . 73.14 110.253 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.16 146.64 54.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.553 -0.906 . . . . 71.02 108.553 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.09 -16.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.998 1.481 . . . . 75.45 114.998 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.65 164.17 29.07 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 120.062 1.301 . . . . 54.55 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.7 5.68 23.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.381 1.091 . . . . 64.01 112.445 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -166.29 145.55 5.87 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.503 2.321 . . . . 74.05 107.055 156.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -168.59 -179.76 3.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.96 1.304 . . . . 75.01 108.433 168.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -120.11 161.52 20.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.924 0.89 . . . . 60.45 108.94 160.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 120.79 14.07 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.129 -1.434 . . . . 40.22 107.129 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.39 134.33 45.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.197 -1.038 . . . . 73.04 108.197 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.13 91.35 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.315 -1.735 . . . . 64.45 106.315 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -100.58 46.08 0.96 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.136 0.974 . . . . 75.23 109.591 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -150.35 163.39 38.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.536 1.134 . . . . 75.33 108.411 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.7 -35.92 73.0 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.191 -0.943 . . . . 74.15 110.802 169.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.2 p -140.23 152.3 45.84 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.071 0.948 . . . . 64.25 110.951 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mmm -153.08 172.46 16.84 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 126.571 1.948 . . . . 63.32 111.326 -168.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -167.4 166.09 14.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.418 1.887 . . . . 63.43 111.163 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -156.98 160.87 39.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.921 2.888 . . . . 60.42 106.983 160.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.82 -179.78 6.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.478 0.656 . . . . 63.01 111.658 165.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -123.85 -176.87 3.58 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.784 1.634 . . . . 64.02 110.148 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.17 157.49 26.86 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.657 0.741 . . . . 75.22 111.735 173.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.69 96.53 0.1 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.015 2.245 . . . . 64.24 108.607 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 178.78 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 130.874 3.67 . . . . 75.1 105.731 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.4 173.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.648 1.979 . . . . 63.13 114.857 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -134.88 -12.47 2.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.711 2.005 . . . . 60.34 113.757 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -158.21 174.41 15.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.43 1.014 . . . . 73.14 108.887 166.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.3 ttt -137.81 155.13 49.34 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.635 1.974 . . . . 74.34 106.65 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -143.94 167.03 23.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.875 0.761 . . . . 73.02 110.72 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.0 t -143.9 29.61 1.35 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.614 2.766 . . . . 72.03 109.351 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.08 113.14 3.72 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 72.21 109.209 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.49 -154.13 8.08 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 110.367 -1.093 . . . . 54.43 110.367 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -154.51 171.73 18.93 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.702 0.763 . . . . 52.31 111.477 155.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.898 HG13 ' CE1' ' A' ' 23' ' ' PHE . 93.9 t -120.97 145.58 27.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 125.932 1.693 . . . . 72.33 107.983 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.1 t -151.87 160.67 43.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.506 0.594 . . . . 61.24 111.173 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 t -140.69 158.77 43.5 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.927 1.691 . . . . 64.24 109.057 166.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.85 24.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 126.69 1.996 . . . . 72.41 110.032 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -97.08 -176.48 3.56 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.494 1.043 . . . . 64.31 110.595 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.32 167.73 3.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.238 1.415 . . . . 72.43 110.276 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.92 167.16 1.26 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.958 1.303 . . . . 74.02 112.937 159.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 -13.07 52.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 117.753 -1.582 . . . . 40.44 114.776 168.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -57.11 161.13 3.28 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 119.432 1.616 . . . . 51.55 108.413 159.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -140.16 162.0 36.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.627 -1.249 . . . . 74.41 107.627 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.34 145.57 22.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.596 -1.261 . . . . 60.25 107.596 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -140.69 117.99 11.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.65 -1.982 . . . . 60.15 105.65 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 23' ' ' PHE . 13.5 mm -96.52 151.22 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 72.32 108.508 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -139.11 131.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.648 -1.612 . . . . 71.05 106.648 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -132.3 126.38 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.399 1.479 . . . . 40.31 109.114 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.88 140.32 46.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.597 -1.631 . . . . 63.42 106.597 -173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.75 133.13 6.9 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.224 -1.15 . . . . 72.22 110.224 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -120.24 154.59 34.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.286 1.834 . . . . 75.34 109.973 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.8 mt -148.62 137.19 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.803 2.041 . . . . 72.3 105.693 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t0 44.52 53.88 6.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.19 1.796 . . . . 75.3 111.982 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.27 23.87 14.05 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.038 1.735 . . . . 72.34 113.969 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 45.5 mtpt -132.52 153.78 50.61 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 120.751 -1.218 . . . . 71.42 111.923 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.78 145.6 46.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.95 -1.5 . . . . 64.2 106.95 164.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.43 -6.14 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.618 -0.706 . . . . 52.5 112.847 161.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -159.77 143.47 14.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.542 1.519 . . . . 75.4 110.046 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -165.45 124.47 1.7 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.511 -0.922 . . . . 74.03 108.511 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.7 pp -138.57 169.14 18.32 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.106 0.879 . . . . 75.12 110.932 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -126.59 171.61 10.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.274 . . . . 62.15 108.703 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 161.13 43.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.303 -0.629 . . . . 75.15 109.303 166.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -127.37 135.89 51.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.26 151.77 48.89 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.509 1.124 . . . . 71.44 108.581 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -143.62 124.46 10.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.361 -2.089 . . . . 55.11 105.361 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -64.13 130.41 43.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.329 -0.619 . . . . 62.02 109.329 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -105.4 -1.18 25.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.081 1.352 . . . . 64.44 111.863 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.33 -24.65 10.38 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.46 1.505 . . . . 74.23 111.129 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -82.22 163.63 21.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.009 0.923 . . . . 75.35 109.531 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.13 106.18 1.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.426 1.09 . . . . 62.23 110.296 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 131.55 46.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.618 -0.882 . . . . 60.21 108.618 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 mt -148.87 138.36 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.708 1.603 . . . . 63.33 107.715 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.8 170.13 4.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.051 1.74 . . . . 64.02 110.164 -171.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.4 p -141.55 170.41 15.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.471 2.308 . . . . 74.11 108.161 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.8 164.88 38.18 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.097 1.759 . . . . 75.12 107.61 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.4 p -152.64 123.73 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.186 -0.946 . . . . 72.23 110.475 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.7 t -135.67 92.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.755 -2.313 . . . . 60.12 104.755 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.53 148.59 24.05 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.342 -1.725 . . . . 74.23 106.342 163.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.1 p -110.71 29.39 7.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.089 0.956 . . . . 54.41 110.113 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 105.8 -1.926 . . . . 74.24 105.8 166.5 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.712 -1.218 . . . . 63.41 107.712 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.29 -98.24 0.3 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 106.777 -2.529 . . . . 73.32 106.777 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.89 159.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.337 1.855 . . . . 63.33 107.093 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -125.57 137.5 53.92 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.446 1.899 . . . . 74.45 107.579 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.93 150.52 44.64 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.251 -0.906 . . . . 63.22 108.887 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mm -140.74 150.34 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 105.748 -1.945 . . . . 75.33 105.748 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 93' ' ' ILE . 1.3 m -143.26 132.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 127.221 2.209 . . . . 44.03 106.861 -165.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.33 153.13 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 107.699 -1.223 . . . . 61.35 107.699 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -141.49 163.48 32.83 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.067 0.947 . . . . 75.23 109.53 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.28 156.15 39.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.86 1.264 . . . . 55.11 108.824 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -159.17 147.88 18.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.498 1.519 . . . . 61.44 109.92 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.89 -131.39 6.61 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.783 -0.927 . . . . 73.03 110.783 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.415 ' OD1' HD13 ' A' ' 88' ' ' LEU . 1.7 p-10 -71.94 50.5 0.2 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.845 2.858 . . . . 72.12 113.577 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -63.22 7.19 0.1 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 74.14 114.552 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.08 -18.01 12.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.779 2.032 . . . . 74.0 112.062 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.34 36.64 3.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.755 2.022 . . . . 75.12 112.111 -169.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CD2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -123.42 155.47 37.36 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.466 1.106 . . . . 71.03 108.689 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.51 121.0 29.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.93 -1.878 . . . . 73.5 105.93 171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' CD2' ' A' ' 23' ' ' PHE . 90.4 t -137.84 106.84 4.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.081 -1.822 . . . . 60.13 106.081 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 112.32 20.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.015 -1.476 . . . . 75.11 107.015 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.34 135.09 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.285 -1.746 . . . . 64.12 106.285 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -90.82 139.14 31.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.952 2.101 . . . . 75.24 107.778 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.42 133.1 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.293 -2.114 . . . . 75.45 105.293 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.16 168.18 41.12 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.965 2.221 . . . . 63.43 108.976 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.68 175.74 39.85 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.074 -2.01 . . . . 73.21 108.074 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.25 157.32 31.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.403 1.101 . . . . 53.21 109.487 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.59 -171.13 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.956 1.702 . . . . 74.12 111.852 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -78.06 64.01 3.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.713 1.205 . . . . 73.54 110.101 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.21 3.1 1.97 Allowed Glycine 0 CA--C 1.517 0.172 0 CA-C-O 118.0 -1.444 . . . . 53.04 113.798 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.26 35.16 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 119.709 1.754 . . . . 74.34 112.588 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.86 144.3 24.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.467 2.778 . . . . 74.21 109.14 162.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.42 115.42 16.15 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.502 1.121 . . . . 61.12 109.699 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.31 128.7 36.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.382 0.992 . . . . 75.13 108.543 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 166.49 11.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.008 0.923 . . . . 73.44 109.732 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.7 155.73 42.22 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.758 1.623 . . . . 73.21 111.07 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.93 169.16 9.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.57 -1.65 . . . . 64.54 110.238 166.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.13 5.57 2.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.726 1.611 . . . . 73.52 112.908 -170.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -90.4 -8.88 49.5 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.488 1.515 . . . . 74.13 111.133 168.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.17 17.37 69.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.961 -0.911 . . . . 60.35 112.974 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.35 147.0 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.126 1.463 . . . . 62.13 108.522 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -75.0 159.58 31.6 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.03 -0.73 . . . . 73.24 109.03 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -144.88 23.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.73 0.812 . . . . 63.14 112.799 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.92 -176.99 16.51 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.41 -1.476 . . . . 40.02 109.41 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -121.15 11.51 10.9 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.538 1.135 . . . . 73.42 111.876 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -169.39 150.65 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.902 1.281 . . . . 75.54 110.459 165.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -176.19 -175.15 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.454 1.502 . . . . 63.45 109.218 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -141.21 102.84 4.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.113 0.965 . . . . 63.41 109.689 172.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.24 115.4 21.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.766 -0.828 . . . . 73.55 108.766 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -66.23 142.39 57.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.844 -1.169 . . . . 72.41 107.844 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -82.8 120.96 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.065 -1.828 . . . . 75.42 106.065 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -142.51 43.55 1.62 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.573 1.549 . . . . 74.42 108.961 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p -146.24 168.72 20.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.986 -1.116 . . . . 55.51 107.986 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.09 72.09 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.624 -0.672 . . . . 55.13 111.661 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -154.26 162.14 41.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.37 1.068 . . . . 64.35 108.971 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 mmm -143.38 171.72 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.75 2.82 . . . . 62.43 110.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.17 166.63 23.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.291 1.436 . . . . 61.12 110.928 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.3 m -149.9 167.64 26.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.999 2.519 . . . . 71.44 107.963 160.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.67 -174.89 4.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.853 1.261 . . . . 51.23 111.007 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.8 p -128.43 175.77 8.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.278 1.831 . . . . 74.34 109.748 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.85 -169.48 2.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.55 -0.908 . . . . 73.15 108.55 159.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 37.54 0.54 Allowed Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.833 -1.167 . . . . 61.42 113.976 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -140.73 78.14 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.158 1.383 . . . . 63.53 107.572 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.55 34.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.525 1.53 . . . . 74.14 109.954 159.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.46 -9.13 9.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.037 1.735 . . . . 75.31 111.693 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -161.49 172.37 16.54 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.608 -1.256 . . . . 75.44 107.608 167.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.9 ttt -152.59 111.67 3.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.462 -2.051 . . . . 75.45 105.462 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -95.51 154.62 17.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.53 110.026 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.593 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -137.18 90.92 2.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.962 2.105 . . . . 63.24 105.498 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.79 46.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.93 -152.79 6.49 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 109.935 -1.266 . . . . 62.53 109.935 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.38 168.13 23.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.163 -1.051 . . . . 73.45 108.163 156.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.63 148.08 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.988 1.315 . . . . 75.32 108.844 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.88 171.32 14.99 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.296 -0.631 . . . . 41.34 109.296 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.613 ' CB ' HD23 ' A' ' 115' ' ' LEU . 20.8 t -151.38 149.44 29.31 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.374 -1.713 . . . . 75.04 106.374 163.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.44 10.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 124.526 1.131 . . . . 74.02 110.031 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -80.48 -173.54 4.15 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.034 0.934 . . . . 62.14 111.321 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -72.08 163.44 27.89 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.983 -0.448 . . . . 72.31 111.387 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 162.27 3.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.701 1.6 . . . . 72.2 113.539 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.33 4.33 90.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.431 1.015 . . . . 62.1 114.36 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -83.63 163.91 20.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.349 -1.352 . . . . 63.41 107.349 168.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -153.35 153.24 32.2 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.307 -0.854 . . . . 74.43 110.812 -163.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.415 HD13 ' OD1' ' A' ' 19' ' ' ASP . 11.9 tp -154.95 136.43 14.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.843 -1.54 . . . . 74.44 106.843 -172.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -136.93 97.8 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.453 1.501 . . . . 74.34 108.775 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.43 132.42 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.916 1.286 . . . . 61.12 108.176 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.0 m -110.2 147.55 33.54 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.269 -1.012 . . . . 41.25 108.269 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.76 103.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.064 1.746 . . . . 74.53 110.201 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 13' ' ' VAL . 24.4 mt -112.59 157.43 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 107.472 -1.307 . . . . 63.31 107.472 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.71 132.81 4.56 Favored Glycine 0 C--N 1.336 0.529 0 O-C-N 120.454 -1.404 . . . . 41.33 111.324 -170.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.443 ' HE2' HG21 ' A' ' 13' ' ' VAL . 83.9 m-85 -125.01 147.83 48.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.44 1.496 . . . . 75.24 111.455 -170.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 123' ' ' THR . 33.0 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 128.939 2.895 . . . . 64.35 105.161 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.63 63.49 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.771 1.229 . . . . 43.03 111.749 164.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.42 18.75 5.85 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.414 2.286 . . . . 71.51 116.101 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.11 151.77 46.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.316 -1.49 . . . . 72.51 112.552 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -86.81 136.46 32.97 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.433 -1.321 . . . . 75.13 107.433 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 96' ' ' ILE . 23.0 m -130.42 -10.51 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 62.52 113.12 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -144.9 141.02 28.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.737 1.153 . . . . 73.53 107.907 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.94 132.04 9.99 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.602 -0.518 . . . . 71.22 109.602 167.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.16 -175.8 4.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.575 0.702 . . . . 63.42 109.861 160.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.8 179.87 7.52 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.832 2.053 . . . . 71.52 108.399 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 176.22 12.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.05 -1.463 . . . . 60.54 107.05 171.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -147.29 137.88 23.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.391 -1.337 . . . . 55.41 107.391 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.22 157.45 46.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.571 0.748 . . . . 53.44 110.213 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mt -147.02 142.95 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.221 -1.77 . . . . 72.04 106.221 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -82.48 147.3 28.78 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 118.92 0.782 . . . . 73.43 110.394 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.57 26.25 2.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.923 0.868 . . . . 74.41 112.235 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.9 -16.02 61.36 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.196 1.855 . . . . 61.0 111.883 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -83.17 171.68 13.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.076 1.35 . . . . 75.11 109.463 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.69 111.09 2.25 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.855 -1.153 . . . . 41.13 109.425 162.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.613 HD23 ' CB ' ' A' ' 80' ' ' SER . 13.1 tp -73.12 132.23 43.03 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.808 -1.923 . . . . 72.22 105.808 163.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.3 mt -154.31 148.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.375 -2.454 . . . . 60.3 104.375 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.16 173.17 10.49 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.849 1.66 . . . . 54.35 109.357 168.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.0 p -129.33 172.95 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.234 1.492 . . . . 74.41 108.09 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.87 154.41 29.76 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 126.675 1.99 . . . . 71.42 106.103 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.4 p -155.97 127.13 7.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.228 0.537 . . . . 75.15 110.222 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' A' ' 74' ' ' CYS . 15.0 p -133.03 152.35 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.317 1.447 . . . . 74.34 107.874 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.6 t -134.82 -175.75 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.996 -1.113 . . . . 35.22 107.996 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.506 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.0 p -134.05 38.74 3.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.571 1.149 . . . . 75.45 109.061 167.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 107.532 -1.284 . . . . 63.33 107.532 166.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 107.703 -1.221 . . . . 65.34 107.703 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.76 -106.23 0.24 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 107.684 -2.166 . . . . 72.13 107.684 -172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.38 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 N-CA-C 106.129 -1.804 . . . . 71.14 106.129 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.99 143.44 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.497 -0.927 . . . . 74.02 108.497 171.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 162.84 34.39 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.171 0.588 . . . . 72.21 109.98 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 mm -129.66 153.24 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.065 1.746 . . . . 72.43 107.322 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 t -124.66 134.57 66.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 104.128 -2.545 . . . . 71.42 104.128 163.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 105.972 -1.862 . . . . 74.35 105.972 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.15 165.85 17.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.671 -0.492 . . . . 62.55 109.671 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.03 155.56 40.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.692 0.62 . . . . 73.34 111.623 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.0 m -145.1 142.94 30.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.578 1.151 . . . . 53.42 108.328 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.52 -150.71 23.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.29 -0.881 . . . . 74.42 111.545 -169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.4 68.82 9.87 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.781 2.032 . . . . 72.12 107.258 170.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -78.79 24.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.174 1.546 . . . . 61.41 115.174 -158.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -135.33 12.82 3.53 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.47 1.108 . . . . 61.25 110.427 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -131.81 17.44 4.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 62.55 111.87 -168.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -133.25 130.19 38.67 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.366 0.985 . . . . 73.24 109.433 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -89.73 68.29 7.51 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.256 1.822 . . . . 74.41 109.069 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.31 92.08 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 127.518 2.327 . . . . 62.15 113.173 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -89.57 139.62 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.745 1.157 . . . . 73.34 109.519 165.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.56 164.5 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.345 -0.983 . . . . 71.45 108.345 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -127.23 129.83 48.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.868 2.867 . . . . 72.15 105.499 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.53 121.27 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.54 -1.652 . . . . 65.21 106.54 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -162.18 172.44 38.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.63 1.11 . . . . 24.14 110.392 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.2 176.26 43.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.11 1.338 . . . . 73.35 110.01 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.01 46.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.262 0.625 . . . . 70.05 111.884 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.92 139.35 50.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.945 2.098 . . . . 61.03 110.865 162.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.308 16.1 ttpp 43.16 32.93 0.5 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.521 1.929 . . . . 63.13 114.308 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 33.98 23.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.529 -0.732 . . . . 71.44 111.86 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.69 175.23 36.57 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.314 1.911 . . . . 74.13 109.856 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 152.04 45.59 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 74.23 112.492 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.09 130.61 56.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.44 1.096 . . . . 73.43 110.627 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -64.06 116.68 6.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.087 0.858 . . . . 72.23 110.612 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.446 HD11 ' HA2' ' A' ' 30' ' ' GLY . 1.1 mt -96.05 158.58 15.38 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.921 2.088 . . . . 61.12 109.51 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 11.6 m-85 -130.84 139.83 50.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.021 1.328 . . . . 70.13 110.988 -170.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -78.35 177.19 8.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 113.748 -1.569 . . . . 74.15 110.777 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.11 -5.62 18.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.535 1.534 . . . . 74.34 114.51 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -114.19 20.63 15.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.122 1.769 . . . . 74.33 110.938 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.41 8.24 87.06 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 124.306 0.955 . . . . 54.41 114.379 162.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.52 149.45 26.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.826 2.45 . . . . 74.53 108.849 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 23.6 p90 -76.1 161.46 28.83 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.36 -11.83 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.787 0.835 . . . . 63.43 112.359 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.36 -171.39 35.83 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 109.055 -1.618 . . . . 41.32 109.055 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -110.05 3.02 19.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.143 1.777 . . . . 70.11 111.181 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 p -173.36 117.11 0.27 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.53 1.132 . . . . 42.43 109.292 -166.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -171.48 -178.27 2.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.291 0.95 . . . . 73.23 111.177 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.93 161.78 18.8 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.702 1.601 . . . . 72.23 109.593 166.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.7 29.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.319 1.448 . . . . 32.44 107.586 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -111.81 141.19 45.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.926 2.09 . . . . 73.04 110.299 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.79 86.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 121.035 1.743 . . . . 72.25 110.317 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -108.66 18.63 20.63 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.889 0.876 . . . . 73.14 112.363 175.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -117.32 158.98 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.92 1.288 . . . . 53.14 108.782 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -49.94 62.07 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.543 -0.723 . . . . 61.53 109.125 168.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.5 p -141.29 113.77 8.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.398 0.679 . . . . 74.35 110.736 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mmm -115.18 167.98 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.113 2.165 . . . . 45.45 111.145 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.1 p -150.96 165.65 33.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.03 0.932 . . . . 61.52 110.524 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 m -143.88 159.14 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.594 -1.632 . . . . 53.41 106.594 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.5 p -148.09 -168.2 3.01 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.816 0.735 . . . . 64.05 109.792 166.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 t -124.7 179.25 5.05 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.893 1.677 . . . . 71.43 106.971 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.53 -176.39 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.831 0.853 . . . . 50.41 109.427 163.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.09 23.75 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.157 -0.802 . . . . 54.54 113.324 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -135.23 94.68 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.598 -1.63 . . . . 72.14 106.598 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.32 158.99 16.77 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.957 1.303 . . . . 63.24 110.02 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -114.12 -28.06 7.45 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.453 1.501 . . . . 64.41 112.214 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.75 170.49 19.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.512 -1.292 . . . . 61.33 107.512 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 ttt -146.93 154.09 40.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 102.935 -2.987 . . . . 73.44 102.935 171.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.0 t -140.78 149.02 41.55 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.234 -0.916 . . . . 52.44 110.421 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.606 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -125.6 66.09 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.119 -1.808 . . . . 65.22 106.119 -177.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.86 143.73 55.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.974 -1.491 . . . . 63.35 106.974 167.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.28 178.73 43.5 Favored Glycine 0 CA--C 1.509 -0.309 0 CA-C-N 119.999 1.272 . . . . 65.25 111.987 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -142.5 159.21 42.67 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.556 1.142 . . . . 50.22 110.38 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.81 131.59 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.232 -1.395 . . . . 62.45 107.232 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -137.92 169.3 18.02 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.931 -0.557 . . . . 61.21 110.379 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -142.09 169.88 16.75 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.539 1.136 . . . . 65.35 109.921 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.96 0.55 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.358 2.663 . . . . 64.43 111.244 167.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -73.81 177.47 5.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.682 1.193 . . . . 44.22 109.866 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -68.79 174.14 4.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.897 0.879 . . . . 53.41 111.817 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.32 158.52 23.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.785 2.034 . . . . 62.41 112.763 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.36 -0.4 41.19 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.605 1.098 . . . . 34.53 114.337 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -70.58 131.25 43.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 104.916 -2.253 . . . . 70.25 104.916 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -111.39 162.02 15.49 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.412 0.685 . . . . 61.45 109.47 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -165.17 121.43 1.43 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 105.905 -1.887 . . . . 65.42 105.905 176.28 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -111.3 137.06 49.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.311 -1.737 . . . . 74.34 106.311 169.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 mm -117.73 121.63 67.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.702 -1.592 . . . . 65.43 106.702 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -95.09 131.03 41.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.896 -1.891 . . . . 75.53 105.896 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.11 104.05 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.939 1.296 . . . . 73.33 110.176 -174.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.26 152.71 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 75.51 108.338 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.61 152.88 22.27 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 124.456 1.027 . . . . 64.15 112.403 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -136.45 155.25 50.26 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.953 1.301 . . . . 70.2 110.826 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -130.32 83.24 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.104 -1.813 . . . . 74.33 106.104 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.285 3.0 p-10 49.64 7.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 1 C-N-CA 132.126 4.17 . . . . 73.11 117.369 162.02 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.86 -41.34 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.767 2.027 . . . . 72.14 109.644 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 158.66 44.13 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.595 1.158 . . . . 64.4 110.603 -167.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.44 146.79 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.444 -2.428 . . . . 71.5 104.444 163.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.68 -3.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 123.448 0.699 . . . . 72.43 110.836 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -156.77 141.06 16.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.047 -1.033 . . . . 72.24 108.496 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.95 129.27 12.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.995 -1.113 . . . . 65.23 107.995 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -132.49 160.58 36.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.286 -1.005 . . . . 71.45 108.286 163.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -145.39 121.79 10.97 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.126 -1.805 . . . . 72.22 106.126 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -131.31 161.56 32.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.658 0.663 . . . . 72.25 109.892 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.82 156.17 47.55 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 126.625 1.97 . . . . 74.54 110.839 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 115' ' ' LEU . 39.1 m-85 -151.63 124.79 8.72 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.891 1.677 . . . . 71.31 107.092 -165.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -135.7 130.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.536 -1.283 . . . . 74.14 107.536 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -72.26 152.96 41.83 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.437 1.095 . . . . 65.11 110.0 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -148.31 28.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.38 -0.825 . . . . 73.33 111.966 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.94 -48.63 0.92 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.517 1.532 . . . . 71.33 109.793 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -74.76 173.42 10.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.915 1.286 . . . . 71.05 112.441 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -72.43 100.46 2.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.34 -1.355 . . . . 70.14 107.34 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 108' ' ' TYR . 8.3 tt -60.68 134.58 57.22 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.157 -0.925 . . . . 72.21 108.824 171.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 mt -152.57 133.5 4.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.526 1.53 . . . . 74.12 107.881 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 74.02 112.071 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 p -144.12 150.72 38.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.115 0.966 . . . . 64.11 112.196 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -133.3 173.85 11.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.595 1.558 . . . . 72.31 110.191 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 p -156.39 119.73 4.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.253 1.021 . . . . 70.05 108.611 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 74' ' ' CYS 0.313 10.4 p -121.88 86.42 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.964 1.364 . . . . 64.04 109.106 174.202 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 p -70.21 173.4 6.73 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.216 1.406 . . . . 62.23 110.127 164.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 p -130.55 9.69 5.11 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.316 -0.865 . . . . 64.42 112.877 166.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 tptt . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 105.852 -1.907 . . . . 74.14 105.852 177.181 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.4 p . . . . . 0 C--O 1.237 0.433 0 N-CA-C 110.446 -0.205 . . . . 52.34 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.57 -116.82 1.98 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 106.572 -2.611 . . . . 73.22 106.572 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.93 128.99 68.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.535 -1.283 . . . . 64.42 107.535 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -97.85 157.96 15.79 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.541 -0.911 . . . . 54.34 108.541 171.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -143.1 150.42 39.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.815 -1.55 . . . . 74.33 106.815 167.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.58 155.45 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 106.197 -1.779 . . . . 64.44 106.197 165.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.59 126.17 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.434 -2.432 . . . . 54.33 104.434 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.1 mt -121.93 154.27 26.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.582 -1.636 . . . . 73.13 106.582 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.12 168.22 20.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.457 0.572 . . . . 54.3 110.331 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -148.25 158.87 44.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.939 1.296 . . . . 74.33 109.193 164.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.175 1.39 . . . . 72.13 107.509 163.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.87 -120.04 4.12 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.463 -1.455 . . . . 51.33 109.463 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -96.22 118.09 32.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.275 -1.38 . . . . 63.1 107.275 159.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.5 p -100.54 -5.78 26.37 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.139 0.975 . . . . 74.12 112.108 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -37.32 38.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.07 0.948 . . . . 75.23 110.133 -169.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.33 18.74 13.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.533 1.133 . . . . 61.04 112.754 -161.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -121.44 113.4 19.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.693 0.797 . . . . 73.3 111.021 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.89 136.65 36.72 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.892 1.677 . . . . 72.04 108.112 168.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -148.77 106.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 105.497 -2.038 . . . . 73.4 105.497 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -114.96 123.51 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.421 1.009 . . . . 73.04 108.946 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.52 140.92 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.033 1.333 . . . . 53.32 110.036 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -76.12 145.41 40.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.857 -1.905 . . . . 73.44 105.857 157.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HG ' ' A' ' 40' ' ' LEU . 22.1 mt -127.57 110.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 104.962 -2.236 . . . . 71.11 104.962 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.67 172.41 35.54 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.91 -0.586 . . . . 65.51 111.774 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.35 41.74 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 128.014 2.721 . . . . 64.52 108.597 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.49 34.41 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.89 1.276 . . . . 24.15 109.792 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.07 -177.46 4.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.117 1.367 . . . . 72.33 112.501 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.98 79.25 0.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.708 -0.849 . . . . 61.2 108.708 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.12 -65.02 0.29 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.268 -1.933 . . . . 71.33 108.268 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.34 -154.32 6.87 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.849 1.214 . . . . 73.22 110.586 -156.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -67.04 142.25 60.97 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.526 2.151 . . . . 54.23 109.868 172.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.9 130.3 39.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.79 -1.189 . . . . 63.32 107.79 172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -59.47 137.73 57.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.968 -0.539 . . . . 65.33 109.592 168.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -110.45 154.56 23.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.572 1.149 . . . . 62.31 109.081 170.602 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -132.65 154.19 50.35 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.136 1.374 . . . . 63.43 108.737 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -77.63 178.28 7.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.726 1.61 . . . . 75.11 110.721 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.18 8.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.092 1.357 . . . . 62.44 113.551 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -119.18 -6.02 10.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.549 2.74 . . . . 75.42 111.147 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 9.38 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.304 -1.276 . . . . 60.22 114.576 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.66 142.25 27.66 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.528 2.164 . . . . 74.12 110.142 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -62.07 136.58 58.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.744 1.618 . . . . 60.12 110.856 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.38 9.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.562 0.949 . . . . 55.41 113.562 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.17 171.25 12.24 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.665 -1.374 . . . . 43.24 109.665 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.1 p30 -103.11 1.56 33.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.231 1.012 . . . . 52.33 110.774 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -159.14 129.04 5.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.238 2.215 . . . . 31.33 107.671 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -161.87 -179.64 7.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.69 1.196 . . . . 74.22 109.216 161.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 p -117.13 161.68 19.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.143 1.377 . . . . 53.14 109.614 159.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.02 166.7 24.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.834 0.854 . . . . 74.31 109.175 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -114.9 139.91 49.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.621 1.168 . . . . 62.04 111.033 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mm -82.04 72.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 107.288 -1.375 . . . . 65.03 107.288 172.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 17.06 7.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.088 1.355 . . . . 72.34 111.527 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 p -137.65 147.07 44.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.998 -0.741 . . . . 62.1 108.998 -171.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.92 66.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.152 0.981 . . . . 73.12 110.633 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.6 p -135.05 162.56 32.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.153 -1.055 . . . . 71.31 108.153 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.9 169.46 24.53 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.095 1.758 . . . . 71.11 109.388 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.66 148.61 6.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.125 1.37 . . . . 75.44 110.671 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 64.7 m -134.99 150.8 50.4 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.55 -0.907 . . . . 74.34 108.55 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.2 p -142.9 -179.08 6.14 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.287 0.635 . . . . 73.14 112.09 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.3 p -132.26 -177.72 4.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.883 1.673 . . . . 73.31 109.438 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.76 -173.98 2.43 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.031 -1.1 . . . . 74.21 108.031 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.0 -13.43 26.8 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.697 -0.627 . . . . 53.12 114.362 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -88.23 83.75 6.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.458 1.129 . . . . 73.24 108.774 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.29 178.03 7.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.343 1.057 . . . . 73.21 110.961 157.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.75 -22.34 4.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.357 1.463 . . . . 74.32 112.81 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.48 177.21 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.353 1.461 . . . . 72.11 109.272 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.5 ttt -147.44 154.1 40.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.914 1.685 . . . . 73.2 106.589 163.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 t -128.34 155.55 44.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 72.31 109.905 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -140.51 42.37 1.88 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.629 2.371 . . . . 63.33 109.904 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 120' ' ' SER . . . -69.09 142.39 54.48 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.048 -1.032 . . . . 72.22 110.971 165.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.78 -176.03 39.81 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.852 -0.899 . . . . 64.53 110.852 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 86.7 p -131.81 167.53 19.4 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.076 0.95 . . . . 72.54 110.53 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.68 153.3 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.224 -1.399 . . . . 62.31 107.224 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p -159.79 142.89 14.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.254 0.934 . . . . 72.34 111.705 166.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -148.37 159.79 43.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.233 1.413 . . . . 64.13 108.509 173.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.86 25.75 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.267 1.827 . . . . 73.12 110.163 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -73.61 -159.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.075 1.35 . . . . 64.0 110.394 174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -83.99 169.02 15.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.156 0.982 . . . . 65.31 110.136 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 162.47 7.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 73.34 112.028 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.83 -2.27 80.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.276 1.417 . . . . 54.5 113.891 174.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -72.79 115.62 12.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.617 1.709 . . . . 72.33 106.658 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -96.05 164.81 12.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.638 -0.875 . . . . 62.11 108.638 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.1 tp -155.78 147.59 23.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.963 0.801 . . . . 72.32 109.035 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -148.15 98.17 2.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.813 1.645 . . . . 71.33 108.255 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.74 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.997 2.119 . . . . 71.4 108.124 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -128.19 146.46 50.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.103 1.361 . . . . 72.41 108.383 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.34 105.97 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.573 1.949 . . . . 54.23 110.749 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.02 139.05 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.198 1.399 . . . . 21.21 108.995 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.31 146.21 17.91 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.658 1.123 . . . . 61.13 111.464 -166.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -131.85 157.62 43.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.252 1.421 . . . . 73.34 110.2 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -131.41 130.76 63.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.949 -2.241 . . . . 73.33 104.949 167.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.65 -76.44 0.06 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.6 2.36 . . . . 70.23 111.031 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -149.37 1.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.519 1.928 . . . . 70.11 112.664 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.88 145.63 50.17 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.621 1.1 . . . . 70.31 111.412 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.81 126.08 33.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.353 1.461 . . . . 71.4 109.883 -172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.43 -1.44 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.687 0.995 . . . . 65.41 113.687 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -154.51 128.01 8.56 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 72.3 108.184 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.42 123.73 18.07 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.127 0.876 . . . . 70.24 110.204 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.43 175.11 9.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.562 0.696 . . . . 64.1 110.47 160.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.25 173.88 15.0 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.836 2.854 . . . . 71.04 107.104 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.48 176.0 9.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.062 0.945 . . . . 74.42 108.76 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -139.17 137.98 36.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.68 -1.23 . . . . 74.03 107.68 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.639 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 2.1 m-85 -132.43 160.88 35.12 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.138 -1.06 . . . . 73.23 108.138 170.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -143.51 148.11 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.646 -1.983 . . . . 74.43 105.646 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.4 p -76.32 139.35 41.0 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.038 -1.097 . . . . 73.32 108.038 164.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.91 2.9 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.194 1.398 . . . . 51.24 111.124 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.28 38.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.866 1.698 . . . . 41.1 111.366 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -90.6 159.99 16.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.682 1.241 . . . . 71.4 107.687 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.1 113.14 1.77 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.975 0.91 . . . . 73.32 109.775 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.82 130.24 41.75 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.55 -1.278 . . . . 72.22 107.55 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -162.18 153.73 3.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 103.901 -2.629 . . . . 62.3 103.901 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.639 ' HG2' ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp20? -165.58 176.15 8.35 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.004 2.121 . . . . 74.22 106.512 160.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.2 p -141.87 142.24 33.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.067 -0.716 . . . . 52.23 109.067 167.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -125.92 169.02 13.1 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.512 1.525 . . . . 73.22 109.865 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 10.5 p -170.23 143.11 2.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.362 1.065 . . . . 54.4 108.731 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 74' ' ' CYS . 6.3 p -162.77 128.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 102.641 -3.096 . . . . 62.41 102.641 -167.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 m -134.85 143.42 47.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.686 -1.227 . . . . 62.54 107.686 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.84 -16.71 58.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.325 -0.55 . . . . 64.1 111.28 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.7 tptm . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 105.888 -1.893 . . . . 71.41 105.888 171.462 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.745 0.307 . . . . 61.52 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.98 -129.15 6.91 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.642 -2.183 . . . . 64.23 107.642 -162.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.0 123.08 50.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.904 1.682 . . . . 73.54 110.427 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -95.11 147.06 23.84 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.504 1.122 . . . . 73.5 109.426 170.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 62' ' ' SER . 34.2 tttt -148.88 151.81 35.34 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.113 0.965 . . . . 72.2 109.044 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.25 149.46 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.702 2.401 . . . . 74.23 106.572 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.19 131.76 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.345 -2.094 . . . . 74.44 105.345 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 74' ' ' CYS . 51.7 mt -127.96 149.01 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.877 -1.527 . . . . 63.42 106.877 -173.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -145.58 161.72 39.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.536 -0.542 . . . . 72.41 109.536 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -153.32 159.86 42.59 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.756 0.788 . . . . 65.03 112.627 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -145.48 174.39 11.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.635 1.574 . . . . 52.15 108.882 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.12 -154.92 19.54 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.885 1.231 . . . . 75.03 110.538 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.12 50.67 0.15 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.09 2.156 . . . . 65.12 111.191 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -54.48 -36.22 63.92 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 129.454 3.102 . . . . 74.23 111.662 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.87 -28.68 64.38 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.645 1.178 . . . . 63.43 111.223 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.7 m -93.33 -0.48 56.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.809 1.644 . . . . 63.35 113.432 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.813 ' CE2' HG22 ' A' ' 25' ' ' VAL . 1.2 t80 -119.77 123.06 42.79 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 123.525 1.631 . . . . 73.42 110.964 -169.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.72 79.48 8.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.001 2.921 . . . . 72.14 110.697 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.813 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.0 t -75.88 91.83 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.331 1.453 . . . . 61.03 107.774 176.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -94.98 129.94 41.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.132 -1.433 . . . . 73.23 107.132 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.79 154.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.645 -1.613 . . . . 70.05 106.645 174.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 49.9 m -112.07 152.08 28.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.365 1.066 . . . . 65.41 109.172 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 40' ' ' LEU . 58.3 mt -122.15 157.39 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.035 -1.098 . . . . 53.3 108.035 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.96 179.54 48.05 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.824 1.202 . . . . 64.12 110.515 172.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.78 166.89 35.08 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 127.053 2.263 . . . . 65.3 108.438 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.46 165.51 27.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.959 1.379 . . . . 73.03 111.418 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -140.07 179.24 6.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.498 . . . . 73.24 110.587 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -75.5 72.01 2.47 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.534 1.534 . . . . 65.34 109.536 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.46 -5.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 118.459 -1.189 . . . . 63.12 114.333 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.41 -159.0 27.68 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.27 1.535 . . . . 54.52 110.872 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.35 161.72 41.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.605 2.87 . . . . 65.01 111.856 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -89.51 121.52 31.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.211 1.404 . . . . 70.44 109.29 166.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -62.4 153.77 30.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.163 0.892 . . . . 72.12 109.929 168.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD13 HG22 ' A' ' 29' ' ' ILE . 9.9 mt -133.26 160.55 36.97 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.702 1.201 . . . . 72.1 109.711 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -138.01 160.55 39.05 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.81 0.844 . . . . 75.53 110.077 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -94.85 -179.4 4.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.156 -0.929 . . . . 53.23 111.399 178.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.35 1.95 3.41 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.826 2.451 . . . . 61.43 113.709 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.516 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 31.5 mttt -112.11 -3.34 14.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.409 1.884 . . . . 72.23 112.908 166.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 6.19 85.3 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.279 0.942 . . . . 74.31 113.691 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.06 144.85 40.54 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.628 1.214 . . . . 73.24 107.856 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 122.96 20.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.362 2.265 . . . . 63.24 109.665 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.9 pt -132.86 9.79 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 115.251 1.575 . . . . 45.14 115.251 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.77 -158.77 23.65 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.302 -1.119 . . . . 71.42 110.302 167.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -128.18 -2.66 5.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.338 1.055 . . . . 74.41 111.911 162.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -151.84 123.06 7.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.601 0.76 . . . . 72.43 109.901 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -173.93 -179.46 1.73 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.678 0.791 . . . . 63.42 109.55 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 27.7 p -137.19 119.43 15.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.264 1.426 . . . . 51.33 108.012 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.81 111.12 23.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.771 1.629 . . . . 74.12 108.128 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.17 147.9 49.57 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.351 -0.981 . . . . 61.02 108.351 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mm -97.05 125.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.188 -0.671 . . . . 71.02 109.188 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 27.3 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.65 1.98 . . . . 71.25 111.777 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 p -124.8 175.47 7.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.206 1.002 . . . . 72.44 109.033 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.71 66.35 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 55.33 110.182 163.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -137.88 155.62 48.76 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.238 1.015 . . . . 35.01 111.404 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.9 mmm -139.26 167.98 20.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.826 2.051 . . . . 72.11 111.518 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' ' HE3' ' A' ' 11' ' ' LYS . 22.6 p -151.56 152.63 33.18 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.122 0.969 . . . . 71.43 110.161 168.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.6 m -145.69 148.63 33.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.208 1.403 . . . . 52.52 108.349 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.4 p -137.98 174.83 10.15 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.419 0.554 . . . . 73.44 111.295 167.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 p -108.09 168.25 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.535 -0.913 . . . . 73.1 108.535 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.5 169.77 3.6 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.32 108.795 159.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.01 -26.1 67.47 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.08 -0.844 . . . . 72.24 112.302 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.72 90.39 3.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.604 1.702 . . . . 74.43 108.09 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB2' ' CB ' ' A' ' 38' ' ' ALA . . . -161.89 173.35 14.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.038 1.335 . . . . 54.12 110.413 159.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -131.25 -12.79 3.54 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.539 2.336 . . . . 74.12 113.198 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -159.08 170.19 22.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.214 -1.402 . . . . 64.21 107.214 167.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.1 ttt -133.55 155.41 49.65 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 105.452 -2.055 . . . . 74.33 105.452 167.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -130.06 161.2 31.56 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.129 0.572 . . . . 63.04 109.505 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -149.85 41.64 0.85 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.734 1.214 . . . . 45.44 110.705 174.037 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 134.41 56.09 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.327 -0.858 . . . . 64.41 110.284 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.43 179.19 26.42 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.481 -0.648 . . . . 70.23 111.481 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.91 130.93 34.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.917 -1.142 . . . . 65.15 107.917 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.641 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 90.6 t -90.06 146.66 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.205 -1.035 . . . . 72.41 108.205 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.1 t -150.79 159.36 44.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 118.501 -1.279 . . . . 43.24 110.328 155.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 115' ' ' LEU . 12.5 t -147.88 143.97 27.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.614 -0.884 . . . . 65.25 108.614 164.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 pt -117.84 19.48 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.581 1.952 . . . . 73.15 109.404 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.8 p -79.45 175.69 10.38 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.719 1.208 . . . . 72.11 111.593 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -70.22 167.03 18.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.155 -0.93 . . . . 72.02 110.741 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.63 158.11 10.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.745 2.018 . . . . 64.03 113.055 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.73 -10.2 57.25 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.514 1.53 . . . . 71.34 114.046 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -67.09 159.31 29.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.744 1.617 . . . . 73.05 108.335 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -144.6 170.97 15.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.764 0.826 . . . . 70.42 111.06 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 tp -159.97 162.29 34.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.638 -1.245 . . . . 74.44 107.638 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -145.16 116.69 8.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.595 -1.261 . . . . 65.15 107.595 164.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.14 147.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 124.978 1.311 . . . . 74.01 107.624 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 m -127.7 138.64 52.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.304 -1.739 . . . . 73.35 106.304 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.2 112.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.527 1.931 . . . . 42.13 108.459 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -129.08 150.8 34.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.43 -1.693 . . . . 63.41 106.43 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.62 152.06 22.76 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.182 0.896 . . . . 70.44 111.245 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.54 150.23 46.15 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.795 0.838 . . . . 74.3 111.388 -164.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.8 mt -146.08 136.0 17.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 104.774 -2.306 . . . . 71.53 104.774 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.0 t70 44.5 52.68 7.42 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.744 2.018 . . . . 63.34 113.683 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t0 60.25 25.12 14.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.115 0.966 . . . . 71.13 112.795 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -126.75 156.92 40.4 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.326 -1.484 . . . . 74.13 111.308 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -97.49 119.58 36.29 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.97 1.708 . . . . 74.4 107.267 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.8 m -124.97 -2.6 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.647 0.98 . . . . 73.4 113.647 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -162.36 133.73 5.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.372 -1.344 . . . . 73.22 107.372 -172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.37 118.43 2.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.723 0.692 . . . . 74.33 111.703 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.06 168.83 18.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.59 0.709 . . . . 63.42 110.826 166.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.82 166.47 20.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.589 2.355 . . . . 74.01 108.423 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -149.14 162.33 40.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.835 -0.802 . . . . 74.31 108.835 171.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -147.94 118.37 7.41 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.008 -1.849 . . . . 72.42 106.008 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.641 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 30.6 m-85 -118.35 152.9 34.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.661 -0.866 . . . . 72.43 108.661 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.1 mt -138.36 153.77 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.281 1.432 . . . . 65.34 107.32 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -99.45 150.86 21.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.138 0.975 . . . . 62.03 110.214 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -130.45 15.1 5.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.908 1.683 . . . . 65.35 110.9 169.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.04 -24.44 18.81 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.549 1.547 . . . . 61.41 111.635 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 162.86 28.51 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.92 1.288 . . . . 73.32 109.345 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 106.73 2.68 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.254 0.622 . . . . 70.13 110.113 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 80' ' ' SER . 11.0 tp -60.85 136.28 58.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.46 -0.941 . . . . 72.05 108.46 174.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.4 mt -152.68 147.49 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 104.83 -2.285 . . . . 70.04 104.83 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.83 176.49 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.59 1.156 . . . . 71.14 109.467 163.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -131.15 160.87 33.49 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.307 1.043 . . . . 74.11 108.735 163.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -149.16 165.49 31.66 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.207 1.003 . . . . 73.03 108.704 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -165.74 142.07 5.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.447 0.641 . . . . 53.53 111.413 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.4 t -143.89 109.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.049 2.54 . . . . 63.2 104.825 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.1 144.91 29.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.983 -1.488 . . . . 70.11 106.983 169.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.0 p -92.36 44.2 1.15 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.598 1.09 . . . . 54.54 109.011 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.7 tttm . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.795 1.238 . . . . 74.32 108.034 171.54 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 106.934 -1.506 . . . . 75.01 106.934 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.64 -91.1 0.14 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.444 -1.462 . . . . 53.23 109.444 163.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -139.78 110.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 105.824 -1.917 . . . . 63.41 105.824 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -78.23 140.97 38.89 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.544 -1.28 . . . . 72.41 107.544 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -135.74 157.47 46.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.55 -1.648 . . . . 74.34 106.55 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 74' ' ' CYS . 1.1 tt -135.41 153.94 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 106.266 -1.753 . . . . 74.12 106.266 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.69 125.91 26.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 105.713 -1.958 . . . . 51.24 105.713 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.0 133.79 63.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 105.529 -2.026 . . . . 72.23 105.529 -170.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -140.68 159.97 41.05 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 119.562 1.074 . . . . 72.33 109.103 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -140.27 150.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.051 0.453 . . . . 42.14 110.76 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -134.34 163.24 30.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.388 -1.338 . . . . 54.32 107.388 158.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -152.15 18.81 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.752 0.691 . . . . 72.44 111.719 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.22 72.07 9.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.399 1.095 . . . . 75.45 109.209 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -70.93 17.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.883 2.073 . . . . 74.53 115.099 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.87 -3.89 5.81 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.866 1.061 . . . . 64.41 113.866 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 t -101.22 1.32 38.83 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.945 0.793 . . . . 74.33 112.942 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -117.81 148.47 42.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.137 0.975 . . . . 74.23 112.112 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -92.29 141.55 28.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.799 -1.926 . . . . 64.31 105.799 163.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 56' ' ' ILE . 1.4 p -153.45 81.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 63.31 111.714 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 109.36 21.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.557 0.694 . . . . 75.32 110.366 -167.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 m -91.76 122.29 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.246 1.019 . . . . 62.12 109.695 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -66.77 133.72 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.175 -1.787 . . . . 35.52 106.175 160.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.38 126.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.733 -1.951 . . . . 63.33 105.733 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.22 177.86 38.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.022 0.82 . . . . 63.34 111.896 -171.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.85 167.16 29.08 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.039 2.257 . . . . 62.11 110.179 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.86 162.66 32.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.131 0.972 . . . . 75.24 111.637 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.99 -171.2 2.62 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.766 2.026 . . . . 75.14 112.332 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -78.62 65.74 3.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.586 0.755 . . . . 64.12 111.415 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.85 43.77 0.29 Allowed Glycine 0 C--N 1.323 -0.169 0 O-C-N 121.88 -0.512 . . . . 73.44 111.976 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.54 -154.9 22.75 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.053 -0.859 . . . . 74.23 111.961 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.03 159.78 37.31 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 124.267 3.311 . . . . 73.41 110.721 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.983 -1.118 . . . . 75.14 107.983 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -72.21 141.67 49.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.427 -0.953 . . . . 61.43 108.427 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 HG22 ' A' ' 65' ' ' THR . 5.0 mt -121.63 150.42 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.088 -1.449 . . . . 73.43 107.088 -171.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -131.46 134.22 45.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.542 1.137 . . . . 71.14 108.16 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -77.07 175.78 9.29 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.398 -0.819 . . . . 63.31 109.787 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -5.87 48.13 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 62.04 113.825 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.08 -5.21 50.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.277 1.431 . . . . 72.02 110.445 165.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.51 84.14 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.72 2.105 . . . . 73.32 113.131 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -101.96 142.42 33.27 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.045 1.338 . . . . 55.32 110.24 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -67.54 128.13 35.29 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.55 1.54 . . . . 75.3 109.159 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.57 20.57 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.544 0.738 . . . . 63.44 112.0 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -172.71 14.35 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.336 0.969 . . . . 65.4 110.958 174.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -118.68 9.25 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.957 1.303 . . . . 73.42 112.109 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -156.93 159.22 37.9 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.448 0.699 . . . . 71.43 110.196 150.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 p90 179.37 -175.39 0.24 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.988 1.715 . . . . 55.42 107.683 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 p -127.43 161.79 27.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.795 0.807 . . . . 62.5 109.333 157.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.77 155.23 50.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.244 -1.762 . . . . 75.04 106.244 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 20.0 tt0 -105.77 144.79 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.412 -0.959 . . . . 72.53 108.412 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 25' ' ' VAL . 38.4 mm -86.78 83.17 2.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 N-CA-C 107.338 -1.356 . . . . 74.41 107.338 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 44.4 mmm-85 -113.63 34.23 4.7 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 123.912 0.885 . . . . 73.31 111.546 176.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 p -140.92 146.95 38.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.637 -1.616 . . . . 52.35 106.637 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.78 -37.47 63.49 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.491 1.116 . . . . 71.03 110.171 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.0 p -140.94 142.62 34.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.543 1.537 . . . . 51.45 107.88 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.21 169.8 17.02 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.543 2.337 . . . . 71.41 109.485 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.9 p -167.43 161.95 14.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.993 2.117 . . . . 73.04 108.792 172.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.1 m -144.41 165.24 28.48 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.417 -1.697 . . . . 74.4 106.417 157.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.16 -178.73 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.537 0.735 . . . . 55.42 110.256 172.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.434 HG22 HD23 ' A' ' 40' ' ' LEU . 69.2 p -125.84 177.18 6.45 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.632 1.173 . . . . 73.34 108.79 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -87.49 178.96 6.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.298 -1.001 . . . . 72.04 108.298 162.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.23 17.74 3.82 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.382 -0.824 . . . . 63.1 114.647 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -105.25 85.87 2.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.094 -1.817 . . . . 61.03 106.094 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.05 172.62 18.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.563 1.074 . . . . 75.33 111.509 165.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -122.95 -17.96 6.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.2 -1.363 . . . . 75.43 111.652 164.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -157.12 173.72 16.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.999 0.92 . . . . 75.21 110.267 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.1 ttt -140.59 161.79 36.91 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.104 2.161 . . . . 74.12 105.86 165.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -140.35 160.23 40.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.478 1.111 . . . . 42.14 110.178 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HB2' HD13 ' A' ' 12' ' ' ILE . 43.9 t -148.7 39.25 0.86 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.037 2.535 . . . . 60.13 108.94 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 123.53 22.25 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.231 1.012 . . . . 73.1 109.973 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.92 29.03 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.8 -0.92 . . . . 63.35 110.8 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 95.1 p -127.24 167.43 16.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.905 0.482 . . . . 75.44 111.448 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.32 132.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 126.744 2.018 . . . . 75.41 105.952 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -144.5 162.66 35.99 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.456 0.571 . . . . 73.33 111.575 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.13 159.76 38.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.135 0.974 . . . . 60.35 110.531 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.48 32.03 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.204 1.802 . . . . 73.21 110.91 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -132.78 176.34 8.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.921 1.289 . . . . 52.23 110.742 -167.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -45.35 160.72 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.877 2.471 . . . . 75.54 116.096 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.72 157.21 21.57 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.09 -1.868 . . . . 62.32 113.002 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.1 -0.64 82.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.389 -0.673 . . . . 55.21 113.795 172.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -75.16 114.64 13.89 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.408 1.604 . . . . 55.22 106.739 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -95.88 158.66 15.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.704 -0.851 . . . . 72.43 108.704 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.7 103.0 1.53 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.502 -1.666 . . . . 75.11 106.502 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -105.07 118.53 36.76 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.881 -1.137 . . . . 75.32 109.207 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mm -107.56 134.82 48.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.759 -1.2 . . . . 73.43 107.759 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.9 m -113.13 126.53 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.77 -1.937 . . . . 73.31 105.77 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.4 127.67 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 106.976 -1.49 . . . . 74.15 106.976 175.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.8 mt -137.55 134.42 46.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.535 -1.654 . . . . 52.22 106.535 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.13 124.13 5.75 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 109.861 -1.295 . . . . 52.22 109.861 -169.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -113.95 144.22 43.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.788 1.235 . . . . 64.44 112.192 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 101' ' ' VAL . 22.8 mt -135.22 107.85 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 104.475 -2.417 . . . . 74.34 104.475 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t0 44.44 66.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.275 1.03 . . . . 64.4 111.317 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 74.79 0.78 3.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.93 2.492 . . . . 75.02 116.069 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -117.38 163.25 16.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 120.665 1.575 . . . . 71.34 113.46 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -98.91 153.86 18.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.613 -1.254 . . . . 63.33 107.613 165.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 96' ' ' ILE . 33.1 m -137.77 3.93 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.091 0.404 . . . . 54.53 112.091 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -165.18 132.96 3.1 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.515 -1.291 . . . . 73.04 107.515 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -158.61 130.25 6.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.199 0.6 . . . . 74.04 110.083 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.41 108.05 5.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.313 1.054 . . . . 64.52 110.863 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.61 156.92 34.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.341 -1.355 . . . . 73.33 107.341 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 119' ' ' PHE . 22.4 mtmm -142.72 170.21 16.12 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.113 -1.44 . . . . 74.55 107.113 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -145.6 145.31 30.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.093 -1.817 . . . . 71.33 106.093 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.26 153.42 46.51 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.523 -1.288 . . . . 71.32 107.523 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.0 mt -144.31 140.15 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.301 -1.37 . . . . 74.35 107.301 166.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -66.15 145.7 55.5 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.939 1.296 . . . . 72.15 111.168 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.8 63.77 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.667 1.222 . . . . 61.32 111.125 163.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.05 -32.13 4.16 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.821 2.153 . . . . 53.21 112.634 168.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.73 174.33 10.58 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.557 1.943 . . . . 74.42 110.065 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.4 168.7 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.391 -0.596 . . . . 60.45 109.391 159.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.71 134.0 44.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.902 -1.147 . . . . 75.11 107.902 168.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.4 mt -150.9 133.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.148 -1.427 . . . . 75.34 107.148 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -152.5 169.35 22.83 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.034 1.734 . . . . 72.21 109.876 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 53.6 p -134.74 167.84 20.11 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.755 0.822 . . . . 75.15 109.514 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.501 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 22.9 p90 -156.04 168.62 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.398 -0.819 . . . . 61.53 109.836 172.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -161.12 138.85 9.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.878 0.847 . . . . 62.12 108.989 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -145.67 100.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 104.653 -2.351 . . . . 63.15 104.653 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.06 140.3 29.9 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.632 -1.618 . . . . 64.4 106.632 168.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.449 ' O ' HD11 ' A' ' 96' ' ' ILE . 2.8 p -94.78 27.73 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.087 1.312 . . . . 44.54 111.007 170.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 tptm . . . . . 0 CA--C 1.512 -0.488 0 O-C-N 120.049 -1.657 . . . . 72.22 108.53 161.506 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.936 0 N-CA-C 108.485 -0.932 . . . . 64.54 108.485 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.57 -101.4 0.15 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.826 1.203 . . . . 64.11 110.88 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -134.14 117.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.202 -2.148 . . . . 75.53 105.202 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -84.38 151.16 24.87 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.759 -1.213 . . . . 74.25 109.236 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -137.67 158.43 44.39 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.387 1.075 . . . . 75.23 108.125 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.548 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.1 mm -139.3 129.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 105.315 -2.106 . . . . 63.45 105.315 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.0 t -113.11 140.17 34.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.927 1.691 . . . . 74.54 106.459 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mt -130.55 144.27 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.471 -1.677 . . . . 55.05 106.471 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.13 162.4 35.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.589 -0.893 . . . . 75.44 108.589 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -153.25 173.76 15.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.165 0.507 . . . . 72.45 112.192 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.24 150.85 20.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.052 0.941 . . . . 44.13 108.621 161.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.2 -108.38 0.37 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.145 -0.782 . . . . 61.24 111.145 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -130.34 54.88 1.84 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.547 1.539 . . . . 71.35 108.917 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.7 p -54.92 -4.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 130.938 3.695 . . . . 55.05 116.586 -165.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -95.26 -11.94 27.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.359 1.064 . . . . 71.25 111.877 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.57 33.78 4.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.545 2.338 . . . . 55.13 110.366 -170.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 88.7 m-85 -133.14 143.61 49.36 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.086 0.954 . . . . 73.13 110.098 171.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.14 58.38 0.6 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.595 1.558 . . . . 75.42 108.629 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 25' ' ' VAL . 1.5 p -62.13 125.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 124.759 1.223 . . . . 73.35 108.377 165.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.29 121.98 18.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.245 -1.02 . . . . 51.12 108.245 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.8 120.83 55.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.603 1.161 . . . . 74.23 110.004 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 t -66.1 134.63 53.21 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.54 -1.652 . . . . 73.45 106.54 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.82 112.95 27.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.589 -2.004 . . . . 63.12 105.589 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.9 35.29 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.531 -1.028 . . . . 64.32 110.531 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 168.81 38.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.638 -1.385 . . . . 72.01 109.638 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.21 153.41 31.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.275 1.43 . . . . 75.22 110.331 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.08 170.83 14.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.302 1.441 . . . . 62.21 111.219 174.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -66.58 73.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.397 1.879 . . . . 74.42 110.195 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.47 6.18 2.74 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.332 -1.815 . . . . 64.03 113.992 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.49 -156.41 27.25 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 120.99 2.395 . . . . 60.05 115.427 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.67 125.79 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.698 2.932 . . . . 73.15 110.022 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.81 120.13 14.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.267 -1.333 . . . . 75.22 108.832 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 144.89 55.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.678 0.217 . . . . 74.23 111.057 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 145.41 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.716 2.006 . . . . 75.22 108.62 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.848 1.259 . . . . 74.44 110.945 -170.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -82.12 175.67 10.14 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.311 0.645 . . . . 64.22 110.651 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.09 -12.73 61.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.736 1.013 . . . . 52.32 113.736 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -87.35 -7.54 57.65 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.058 -1.026 . . . . 73.43 110.928 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.66 56.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.449 1.976 . . . . 75.32 113.596 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.25 148.99 21.71 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.892 1.346 . . . . 72.31 109.855 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.54 144.83 56.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.426 -1.324 . . . . 73.51 107.426 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.73 5.8 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.411 0.685 . . . . 64.22 112.397 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.08 -175.3 36.89 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.001 0.818 . . . . 44.15 111.495 166.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -121.0 0.29 10.2 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.911 1.284 . . . . 74.32 112.183 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.7 m -165.84 115.6 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.217 1.807 . . . . 73.31 108.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -153.49 -178.84 7.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.745 1.157 . . . . 75.44 111.958 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.3 155.59 39.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.648 0.779 . . . . 75.23 109.488 163.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.54 171.61 10.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.945 1.698 . . . . 33.21 107.683 171.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -124.05 139.15 54.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 128.062 2.545 . . . . 74.45 109.269 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mm -90.65 98.88 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 119.262 -0.975 . . . . 74.55 110.102 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.47 14.35 13.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.948 1.092 . . . . 73.52 113.948 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.7 p -128.69 173.89 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.713 0.688 . . . . 62.11 109.837 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.78 90.52 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.736 0.415 . . . . 61.31 110.597 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.6 p -145.7 143.46 29.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.001 0.429 . . . . 71.23 110.465 -166.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -138.22 163.48 31.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.843 2.057 . . . . 61.21 109.754 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.64 152.53 6.9 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.042 1.337 . . . . 75.22 108.849 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 53.0 m -147.36 160.36 42.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.506 1.923 . . . . 75.43 109.409 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.2 p -152.42 173.39 15.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.486 0.714 . . . . 53.42 111.834 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -109.29 -174.98 2.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.56 1.144 . . . . 61.23 109.694 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -91.97 -171.65 2.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.544 -0.91 . . . . 63.44 108.544 151.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.56 -17.72 79.17 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.54 -0.725 . . . . 74.21 114.068 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -78.17 89.65 4.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.383 1.092 . . . . 64.51 108.207 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.38 15.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.662 0.785 . . . . 55.04 109.758 154.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -123.7 -10.28 7.83 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.191 0.811 . . . . 75.23 113.191 172.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.62 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 52.5 p90 -152.2 -170.64 3.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.011 1.324 . . . . 74.32 108.84 172.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.1 ttt -142.37 162.4 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 104.561 -2.385 . . . . 72.34 104.561 146.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -133.74 158.66 42.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.301 1.048 . . . . 61.23 108.874 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.542 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -134.13 99.11 4.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 102.089 -3.3 . . . . 53.42 102.089 166.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.14 113.45 14.5 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.519 -1.66 . . . . 71.42 106.519 168.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.8 -151.22 6.81 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.72 -1.752 . . . . 60.34 108.72 -161.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.8 p -149.28 -179.2 6.87 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.707 -0.479 . . . . 73.14 109.707 151.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.38 157.27 21.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.955 1.302 . . . . 75.03 109.434 170.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.02 171.72 14.07 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.924 0.89 . . . . 64.14 109.358 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HD23 ' A' ' 115' ' ' LEU . 36.8 t -159.26 162.46 36.12 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.267 1.027 . . . . 60.33 108.534 162.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.26 12.36 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.359 1.864 . . . . 63.31 111.597 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 p -83.88 176.64 8.76 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.254 1.022 . . . . 73.25 111.002 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -59.55 164.5 3.46 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.731 -0.668 . . . . 74.04 110.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 166.6 4.17 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.44 1.114 . . . . 72.41 112.938 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.09 -8.71 50.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.041 1.781 . . . . 71.44 114.348 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -62.62 158.85 17.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.532 1.166 . . . . 51.24 108.886 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -135.65 156.6 48.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.459 -0.571 . . . . 72.42 109.459 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -162.71 109.41 1.23 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.549 -2.019 . . . . 72.42 105.549 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -101.11 137.44 39.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.196 -1.779 . . . . 74.21 106.196 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.17 129.14 74.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.023 -1.103 . . . . 72.45 108.023 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -106.97 126.09 51.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.126 2.17 . . . . 73.33 106.008 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.39 109.84 16.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 125.297 1.439 . . . . 71.5 110.857 -165.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 mp -128.67 138.63 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.354 1.862 . . . . 73.21 106.747 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 12' ' ' ILE . . . -107.49 177.07 21.24 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.167 -1.173 . . . . 62.12 110.167 166.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -156.26 153.95 29.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 118.674 1.237 . . . . 75.5 109.742 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' HE2' ' A' ' 99' ' ' LYS . 11.9 mt -129.16 110.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 108.239 -1.023 . . . . 72.34 108.239 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.0 -74.21 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.885 2.474 . . . . 71.14 110.107 -171.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.7 -1.41 2.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.717 1.006 . . . . 75.1 113.717 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE2' ' HB ' ' A' ' 96' ' ' ILE . 12.9 pttt -105.8 156.9 17.87 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.104 -0.997 . . . . 72.42 113.459 -171.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -118.22 103.8 10.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.817 1.247 . . . . 61.31 109.161 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.37 -6.92 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 115.022 1.49 . . . . 72.44 115.022 -168.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.85 99.49 1.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.382 -1.34 . . . . 73.33 107.382 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.89 123.11 11.54 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.347 1.059 . . . . 71.1 110.915 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.43 176.63 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 73.44 110.487 171.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -136.55 158.01 45.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.113 2.165 . . . . 54.23 107.97 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -160.51 166.86 28.35 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.349 0.66 . . . . 72.2 109.61 169.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -140.05 147.42 40.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.264 1.826 . . . . 73.21 111.322 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -139.08 134.44 32.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.948 1.699 . . . . 63.3 108.251 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.0 mt -144.59 126.96 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.494 -1.669 . . . . 74.42 106.494 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 134.34 48.43 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.814 -0.439 . . . . 74.43 109.814 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.45 -17.04 33.1 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.564 1.146 . . . . 75.13 112.576 168.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.21 10.23 11.0 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.085 0.85 . . . . 63.33 112.486 -172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.34 -177.39 4.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.347 1.859 . . . . 53.32 108.989 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.55 111.85 2.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.598 1.159 . . . . 72.31 112.593 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 116' ' ' ILE . 4.3 tp -81.13 135.63 35.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 124.528 1.131 . . . . 74.45 108.304 170.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 115' ' ' LEU . 22.4 mt -150.2 132.22 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.999 2.52 . . . . 74.25 106.04 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.38 171.25 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.779 0.832 . . . . 71.32 111.279 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -142.71 160.96 39.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.194 1.397 . . . . 72.32 110.159 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -148.01 163.32 37.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.731 -1.122 . . . . 73.11 108.997 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.6 p -152.93 135.23 15.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.629 -0.67 . . . . 75.4 112.671 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 74' ' ' CYS . 7.6 p -135.5 103.64 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 128.207 2.603 . . . . 60.34 105.495 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.57 -158.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.454 -0.943 . . . . 74.4 108.454 170.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 82.8 p -134.24 -3.88 2.73 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 161.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HE3' ' CG ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 124.565 2.126 . . . . 74.41 112.793 -154.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.238 0.462 0 N-CA-C 108.229 -1.026 . . . . 73.33 108.229 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.49 -96.88 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.653 -2.179 . . . . 63.44 107.653 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.76 118.38 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.775 1.23 . . . . 71.03 108.264 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -80.88 141.02 35.01 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.475 -0.784 . . . . 64.25 109.951 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.39 144.63 42.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.637 2.375 . . . . 53.31 108.829 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.95 156.2 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.475 -1.676 . . . . 74.13 106.475 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.02 138.89 45.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.918 -1.882 . . . . 54.23 105.918 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.0 142.42 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.591 -1.263 . . . . 63.55 107.591 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.35 173.27 11.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.377 1.071 . . . . 62.05 109.41 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -152.17 170.93 18.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.407 0.683 . . . . 73.14 111.79 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p -158.99 136.88 10.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.948 0.499 . . . . 73.33 111.523 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.88 -128.81 5.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.086 1.327 . . . . 55.15 111.722 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 61.41 3.58 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.402 1.881 . . . . 71.42 110.642 -166.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 p -75.91 48.11 0.47 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.32 1.848 . . . . 71.52 111.452 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.62 -20.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.0 0.92 . . . . 73.52 112.733 -172.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -142.19 42.06 1.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.205 2.202 . . . . 72.42 109.735 -170.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.53 160.04 36.4 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.371 2.269 . . . . 71.32 109.359 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -133.87 107.91 8.13 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.16 1.784 . . . . 74.5 108.319 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 1.3 p -125.1 80.7 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 125.438 1.495 . . . . 75.23 113.386 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.42 117.61 30.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.109 -0.7 . . . . 64.5 109.109 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 76' ' ' GLY . 35.5 m -115.59 133.53 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.854 -0.795 . . . . 75.34 108.854 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -66.08 151.28 47.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.579 -0.897 . . . . 51.3 108.579 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 95.9 mt -129.51 117.52 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.231 -2.137 . . . . 71.4 105.231 169.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 173.47 35.99 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.786 -0.926 . . . . 62.34 110.786 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.64 179.67 44.88 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.086 -2.806 . . . . 75.42 106.086 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.2 163.47 28.48 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.296 0.569 . . . . 72.42 109.498 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -174.32 3.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.963 1.705 . . . . 75.24 110.055 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -64.22 -28.81 69.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.741 1.015 . . . . 75.24 113.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.68 -52.67 11.54 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.203 -1.959 . . . . 64.33 108.203 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.96 -80.32 0.19 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.284 -1.526 . . . . 74.3 109.284 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.48 131.72 15.29 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.207 2.004 . . . . 73.32 111.751 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.63 134.77 34.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.809 -1.091 . . . . 64.32 108.885 165.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -83.95 128.59 34.65 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.339 0.972 . . . . 72.33 109.243 159.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.3 mm? -100.3 152.58 20.15 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.877 1.271 . . . . 52.32 108.314 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -124.36 155.06 39.41 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.05 0.928 . . . . 73.1 110.594 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.67 160.76 14.63 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.494 1.518 . . . . 72.1 109.795 168.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.83 0.93 9.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.649 1.98 . . . . 64.21 113.803 -171.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -77.23 -24.73 51.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.795 2.838 . . . . 65.13 110.743 165.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 4.35 50.32 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.22 1.867 . . . . 64.24 112.808 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -89.07 165.74 14.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.001 1.401 . . . . 70.43 108.183 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -84.77 151.94 24.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.861 -0.792 . . . . 65.4 108.861 165.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.29 -5.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.942 0.897 . . . . 63.24 112.659 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.81 40.69 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 119.708 1.14 . . . . 63.43 110.613 169.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.328 0.8 OUTLIER -121.87 14.96 10.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.289 2.235 . . . . 71.33 110.438 169.111 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 149.09 9.59 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 127.724 2.41 . . . . 70.14 106.947 151.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -169.23 179.86 3.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.146 0.979 . . . . 74.3 109.921 157.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -140.04 106.26 5.25 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 126.155 1.782 . . . . 74.52 107.185 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.12 150.26 20.39 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.483 -0.932 . . . . 62.31 108.483 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 9.6 tt0 -85.27 147.33 26.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.502 1.121 . . . . 72.22 109.251 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 15.1 mm -85.32 71.16 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.977 -1.12 . . . . 64.33 107.977 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -92.59 38.09 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.416 -1.427 . . . . 62.21 113.195 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 p -147.29 128.34 14.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.126 -1.435 . . . . 73.02 107.126 -165.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.95 65.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.549 0.613 . . . . 62.22 110.447 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 p -140.7 134.3 30.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.946 1.298 . . . . 72.24 107.95 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE2' ' H ' ' A' ' 62' ' ' SER . 6.0 tpt -125.26 159.93 30.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.469 2.308 . . . . 74.11 106.999 176.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 61' ' ' MET . 11.9 p -164.62 143.82 7.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.679 1.592 . . . . 74.03 107.409 168.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' A' ' 29' ' ' ILE . 12.6 m -136.86 147.63 46.62 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.417 -1.327 . . . . 75.01 107.417 176.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 p -146.56 -173.43 4.2 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.039 0.381 . . . . 63.0 110.735 170.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 p -135.49 172.92 12.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.705 1.202 . . . . 72.24 111.436 -162.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.99 170.2 11.32 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.569 -0.9 . . . . 51.12 108.569 163.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.96 60.96 3.78 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.124 0.869 . . . . 71.32 111.641 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.83 89.84 1.72 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.824 -2.658 . . . . 75.04 103.824 169.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.83 23.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.232 -0.413 . . . . 60.45 111.272 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.4 -8.18 2.92 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.04 0.756 . . . . 64.54 113.04 166.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -163.01 169.31 19.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.879 1.272 . . . . 73.52 107.736 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.3 ttt -138.74 151.47 47.14 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 104.382 -2.451 . . . . 64.54 104.382 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.0 t -138.53 157.84 45.4 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.615 0.766 . . . . 74.22 108.999 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.58 45.85 1.03 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.089 0.956 . . . . 62.35 111.244 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.59 141.29 58.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.787 0.835 . . . . 75.24 110.037 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 27' ' ' VAL . . . -149.13 -149.13 4.9 Favored Glycine 0 C--N 1.336 0.532 0 O-C-N 121.427 -0.795 . . . . 64.14 111.201 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.6 p -142.85 178.52 7.6 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.217 -1.031 . . . . 43.32 108.217 149.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.67 149.71 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.988 0.915 . . . . 72.55 109.045 160.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.4 t -152.51 161.77 42.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.32 -0.622 . . . . 73.32 109.32 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -157.25 153.51 27.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.3 1.84 . . . . 75.33 106.323 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 26.8 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 127.07 2.148 . . . . 73.44 108.0 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -90.44 173.52 8.05 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.823 -1.173 . . . . 71.13 109.021 169.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.12 169.29 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.141 -1.845 . . . . 74.5 110.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.62 162.63 6.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.429 0.692 . . . . 75.43 112.243 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.95 71.53 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.71 0.672 . . . . 73.25 113.309 172.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -111.97 136.39 51.37 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.214 1.806 . . . . 75.54 106.846 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -125.6 159.38 32.28 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.581 -0.699 . . . . 61.15 110.605 -166.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 tm? -154.87 102.5 2.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.516 -2.402 . . . . 44.34 104.516 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.22 149.04 22.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.267 -1.753 . . . . 64.35 106.267 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.99 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.227 -1.768 . . . . 55.33 106.227 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -119.17 135.97 54.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.45 106.172 163.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -138.52 119.55 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.895 -1.521 . . . . 75.32 106.895 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 mt -135.06 134.68 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 107.358 -1.349 . . . . 51.14 107.358 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -119.98 132.44 9.41 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.701 -1.359 . . . . 75.35 109.701 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -126.44 152.94 45.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.145 1.378 . . . . 72.42 110.055 -170.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.429 HD11 ' O ' ' A' ' 123' ' ' THR . 26.2 mt -136.85 112.4 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.536 -2.394 . . . . 72.43 104.536 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 74.38 -54.12 0.67 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 127.726 2.411 . . . . 73.14 112.962 163.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.34 6.57 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.183 1.793 . . . . 75.04 112.947 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.98 155.65 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.239 -2.163 . . . . 74.03 109.996 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -72.11 159.0 34.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.955 -1.128 . . . . 64.02 107.955 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.11 -6.02 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.377 0.51 . . . . 71.44 112.377 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.1 136.64 12.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.846 -1.168 . . . . 64.32 107.846 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.49 158.36 26.42 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 119.308 0.958 . . . . 73.51 111.432 168.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.43 171.41 14.67 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.302 1.049 . . . . 64.34 108.692 155.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.72 161.56 24.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.091 -1.818 . . . . 75.21 106.091 160.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.63 169.21 24.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.633 -0.877 . . . . 62.21 108.633 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -155.48 149.06 25.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.05 -0.352 . . . . 73.55 110.05 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.502 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.5 m-85 -148.29 138.4 22.55 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.774 1.23 . . . . 61.25 108.864 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.81 137.67 53.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.452 -0.944 . . . . 75.41 108.452 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -74.42 133.79 42.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.694 -0.854 . . . . 71.25 108.694 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.24 57.43 1.13 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.252 1.025 . . . . 75.53 108.921 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.67 -38.15 1.68 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.799 2.142 . . . . 62.15 111.774 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -62.8 152.43 35.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.363 1.065 . . . . 75.33 108.991 172.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 m -74.29 113.94 12.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.021 1.329 . . . . 52.11 109.044 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -67.03 115.14 6.41 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.712 -1.588 . . . . 73.33 106.712 175.13 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.8 mt -149.71 138.53 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 103.043 -2.947 . . . . 74.52 103.043 170.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 170.58 21.01 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.965 1.416 . . . . 73.13 108.846 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -138.29 153.83 49.03 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.316 -0.994 . . . . 73.34 108.316 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.71 161.71 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.718 1.207 . . . . 71.34 108.165 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.6 t -160.2 144.37 14.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.853 -1.165 . . . . 75.42 107.853 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.469 HG21 ' HB ' ' A' ' 92' ' ' VAL . 40.5 t -146.32 118.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.1 -2.556 . . . . 71.22 104.1 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 132.5 51.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.335 1.054 . . . . 73.52 108.249 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.429 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.8 p -95.14 14.13 23.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.484 -0.76 . . . . 72.42 112.17 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.46 0 N-CA-C 105.217 -2.142 . . . . 74.43 105.217 162.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.731 0.301 . . . . 64.34 111.689 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.58 -105.94 0.44 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.174 -1.57 . . . . 74.43 109.174 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.87 83.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.43 106.172 -162.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -84.04 122.97 29.52 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.847 -1.538 . . . . 54.23 106.847 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.05 151.43 49.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.755 1.161 . . . . 63.44 110.574 -167.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 mm -135.01 146.38 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.357 1.463 . . . . 52.24 107.696 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 t -141.84 133.62 27.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.912 -1.514 . . . . 71.34 106.912 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mt -130.5 149.67 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.067 0.947 . . . . 70.11 109.214 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -135.84 167.34 21.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.677 0.672 . . . . 74.35 111.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -140.7 139.88 34.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.776 1.231 . . . . 72.21 109.239 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -149.82 152.9 35.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.484 2.313 . . . . 72.31 108.147 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.7 -145.33 18.68 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.55 -1.42 . . . . 63.43 109.55 -168.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -85.57 75.41 10.15 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.038 -1.467 . . . . 50.35 107.038 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.1 p -75.16 71.02 2.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.395 -1.706 . . . . 72.11 106.395 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.72 -48.31 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.506 1.122 . . . . 71.43 108.71 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.93 67.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 124.002 1.858 . . . . 72.42 109.462 -163.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 1.1 p90 -148.27 166.69 27.24 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 128.251 2.62 . . . . 70.43 108.22 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.79 150.52 49.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.556 1.943 . . . . 74.15 108.423 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.13 85.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.576 -0.898 . . . . 74.31 108.576 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -86.63 136.04 33.19 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.809 0.814 . . . . 73.15 108.874 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.09 132.91 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.836 -1.913 . . . . 71.43 105.836 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -85.34 140.8 30.5 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.778 1.631 . . . . 74.55 106.926 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.434 HG22 ' HG ' ' A' ' 40' ' ' LEU . 94.7 mt -124.64 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.409 -1.7 . . . . 74.34 106.409 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.56 172.88 42.57 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.193 -0.763 . . . . 61.45 111.193 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.46 175.29 40.51 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 127.176 2.322 . . . . 43.12 108.25 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.45 46.47 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.857 -0.79 . . . . 73.31 109.031 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -136.85 -178.55 5.24 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 125.835 1.654 . . . . 71.52 110.688 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -80.25 70.33 6.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.081 0.553 . . . . 64.55 110.29 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.68 -34.74 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.228 0.918 . . . . 73.34 111.652 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.24 -164.89 26.72 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 117.698 0.749 . . . . 63.34 113.273 -164.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.42 140.02 26.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.906 3.071 . . . . 72.31 109.337 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.62 26.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.293 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -54.49 120.1 6.17 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.039 0.935 . . . . 73.25 109.701 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.5 mm? -82.67 168.6 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.497 -0.927 . . . . 71.44 108.497 169.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.74 142.09 46.65 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.837 0.855 . . . . 74.43 109.079 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.34 170.81 16.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.552 1.141 . . . . 73.25 109.773 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -74.93 15.28 0.41 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 63.52 113.877 -169.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -100.37 -16.56 17.6 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.315 . . . . 72.51 111.559 162.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.48 67.36 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.37 0.986 . . . . 54.23 113.124 -168.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -79.97 161.52 25.44 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 1.116 . . . . 70.43 109.626 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.02 137.59 34.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.812 -0.81 . . . . 54.12 108.812 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.33 16.72 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.012 1.325 . . . . 71.43 112.944 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.17 172.21 14.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.867 1.222 . . . . 73.11 110.462 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -112.17 9.83 20.17 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.227 1.411 . . . . 62.34 111.159 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -167.05 148.78 5.96 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.071 2.148 . . . . 72.15 108.097 165.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -179.96 179.34 0.55 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.141 2.576 . . . . 74.43 109.186 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.4 p -129.39 159.09 37.32 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.33 1.052 . . . . 73.11 109.426 163.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.45 114.72 7.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.1 -1.074 . . . . 64.32 108.1 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -71.69 128.18 34.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.967 -1.123 . . . . 64.22 107.967 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.36 117.05 3.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.417 -1.327 . . . . 63.31 107.417 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 2.4 mmm180 -137.51 35.95 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.861 0.839 . . . . 74.33 110.856 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.21 147.71 26.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.456 -1.683 . . . . 73.12 106.456 -161.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.75 -37.47 71.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.95 0.5 . . . . 65.42 111.771 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 t -149.72 161.99 41.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.228 -1.027 . . . . 74.31 108.228 167.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 mmm -134.75 165.93 24.13 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 128.632 2.773 . . . . 71.22 108.883 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.5 p -164.94 162.28 20.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.507 -1.224 . . . . 64.12 110.058 171.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.2 m -150.94 166.02 31.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.046 2.138 . . . . 70.12 107.261 165.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.05 -178.68 6.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.934 0.894 . . . . 62.25 111.839 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 p -129.07 175.6 8.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.649 1.979 . . . . 64.25 108.987 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.2 172.32 7.66 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.398 -0.814 . . . . 74.25 109.162 159.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 55.01 4.99 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.092 0.853 . . . . 53.21 113.06 -169.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -133.38 -8.79 2.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.586 1.154 . . . . 63.51 111.215 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.59 165.12 23.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.834 0.826 . . . . 73.55 111.121 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -119.72 -1.8 10.51 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.906 1.682 . . . . 70.45 112.065 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -177.12 172.03 2.0 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.289 1.835 . . . . 71.41 108.022 171.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ttt -132.66 163.64 28.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.832 -2.284 . . . . 53.41 104.832 161.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -146.94 166.59 26.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.277 0.561 . . . . 62.25 110.253 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.11 65.18 0.9 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.595 2.358 . . . . 61.12 107.711 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.39 41.03 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.742 0.817 . . . . 74.52 108.95 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.65 179.74 32.25 Favored Glycine 0 CA--C 1.502 -0.731 0 CA-C-N 119.082 0.856 . . . . 70.23 111.9 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 90.3 p -135.34 169.37 17.58 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.377 -1.411 . . . . 54.25 109.535 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.54 153.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.422 1.489 . . . . 45.04 107.254 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.0 164.0 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.914 -0.772 . . . . 71.34 108.914 166.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.7 p -145.65 162.45 37.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.612 -0.514 . . . . 71.32 109.612 154.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 pt -133.63 15.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 128.653 2.781 . . . . 62.21 109.313 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -81.02 174.55 11.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.015 1.726 . . . . 74.12 111.28 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.3 163.83 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.227 -2.261 . . . . 71.21 110.626 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.89 160.16 15.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.203 1.401 . . . . 71.15 113.289 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.42 87.0 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.907 1.241 . . . . 61.13 114.164 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -66.66 167.47 11.05 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.564 1.182 . . . . 53.33 108.273 167.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -149.5 160.05 43.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 121.572 -0.705 . . . . 74.44 110.083 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.3 tp -152.87 130.45 11.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.591 -1.633 . . . . 74.24 106.591 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -129.16 109.25 11.0 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.389 1.876 . . . . 72.34 106.185 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.83 134.18 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.053 -2.203 . . . . 54.41 105.053 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 m -112.06 137.49 50.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.142 -1.799 . . . . 70.31 106.142 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.16 113.31 3.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.583 1.553 . . . . 74.33 109.194 -171.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.84 141.09 45.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.727 -1.583 . . . . 74.13 106.727 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.82 155.85 25.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 123.869 0.747 . . . . 61.21 111.483 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.13 154.46 42.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.051 0.94 . . . . 73.23 110.366 -165.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG13 HG11 ' A' ' 101' ' ' VAL . 39.9 mt -122.89 117.89 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.824 -1.176 . . . . 73.34 107.824 163.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 t70 69.28 -58.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 129.06 2.944 . . . . 74.21 111.666 165.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.68 8.5 0.51 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.043 1.497 . . . . 74.45 115.043 158.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.44 143.51 32.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.992 1.317 . . . . 74.35 111.267 -170.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.16 118.2 12.68 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.043 1.737 . . . . 64.12 107.203 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.42 HG11 HG13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -129.31 -8.31 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.735 0.779 . . . . 65.14 109.825 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -162.44 130.85 4.05 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.215 -1.402 . . . . 73.21 107.215 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -153.65 110.79 3.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.188 -0.671 . . . . 73.12 109.188 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 pp -142.25 179.51 6.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.783 -1.099 . . . . 73.43 111.296 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -145.9 171.27 15.07 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.171 2.589 . . . . 74.54 106.301 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -146.99 160.42 42.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.687 -0.857 . . . . 53.25 108.687 170.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -128.25 136.16 50.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.437 1.495 . . . . 72.33 107.057 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.655 ' HB3' HD11 ' A' ' 115' ' ' LEU . 9.3 m-85 -136.16 152.8 51.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.141 0.977 . . . . 62.41 109.055 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.0 mt -144.21 154.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.219 1.808 . . . . 74.21 107.424 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -95.79 141.17 29.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.928 0.891 . . . . 72.12 110.223 176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -121.67 4.99 10.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.343 1.857 . . . . 73.23 110.489 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 113.61 -34.91 4.78 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.715 2.102 . . . . 51.43 110.309 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -79.42 161.67 25.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.939 1.296 . . . . 73.41 110.622 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.36 105.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.765 0.826 . . . . 74.13 110.126 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 108' ' ' TYR . 7.8 tt -68.02 134.61 50.96 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.392 -0.966 . . . . 70.45 108.392 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -150.61 133.97 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.026 -1.842 . . . . 70.54 106.026 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.17 174.55 14.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.958 0.786 . . . . 52.35 111.608 171.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 73.9 p -139.65 161.64 37.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.81 1.644 . . . . 72.41 110.797 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -151.2 176.7 10.95 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.309 1.444 . . . . 74.24 109.606 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -160.74 147.48 15.34 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.561 -0.903 . . . . 54.02 108.561 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.2 t -146.31 88.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.236 -1.765 . . . . 63.32 106.236 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.5 m -77.82 166.78 22.49 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.06 -0.718 . . . . 53.21 109.06 165.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.1 p -135.17 58.3 1.77 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.11 -1.07 . . . . 43.44 108.11 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 124.507 2.098 . . . . 73.21 110.724 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 109.81 -1.316 . . . . 52.03 109.81 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.19 73.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.134 -1.802 . . . . 70.52 106.134 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -160.03 -165.98 1.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.864 2.466 . . . . 73.24 107.435 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.86 83.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.367 2.667 . . . . 52.4 114.216 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.72 104.32 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.16 -1.422 . . . . 73.1 107.16 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.92 127.65 18.15 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 126.223 1.809 . . . . 72.13 106.733 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -133.98 179.66 6.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.337 2.255 . . . . 72.54 110.005 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.42 -95.08 0.29 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.458 -1.057 . . . . 64.54 110.458 156.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.34 126.95 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 104.667 -2.345 . . . . 74.43 104.667 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -108.87 142.14 39.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.432 -1.692 . . . . 73.2 106.432 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -137.23 152.74 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.658 -1.238 . . . . 52.42 107.658 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.29 154.38 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.695 -1.224 . . . . 62.41 107.695 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 t -136.67 142.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.272 -1.751 . . . . 71.45 106.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.84 148.58 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.309 -1.737 . . . . 63.35 106.309 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -135.51 153.46 51.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.302 -1.37 . . . . 74.12 107.302 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -140.87 154.0 45.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.769 0.795 . . . . 70.24 109.888 166.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 p -151.64 173.09 15.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.712 -0.676 . . . . 72.34 109.333 171.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.68 -143.13 16.55 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.537 -1.425 . . . . 61.11 109.537 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.34 65.59 0.88 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.783 1.233 . . . . 75.02 112.17 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -64.21 -30.48 71.53 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.466 -1.396 . . . . 64.44 110.517 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.25 -30.82 64.97 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.783 1.233 . . . . 73.23 111.52 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.47 23.48 5.12 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 71.32 112.644 -168.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -124.88 118.49 26.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.273 1.029 . . . . 73.32 108.72 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -78.69 136.92 37.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.44 -1.319 . . . . 72.21 107.44 163.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -141.98 111.21 2.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.1 -1.815 . . . . 63.31 106.1 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -125.61 126.77 45.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.648 1.567 . . . . 65.01 110.662 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.53 130.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.025 1.33 . . . . 52.5 109.696 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -78.13 127.43 32.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.595 -1.632 . . . . 72.24 106.595 165.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 57.6 mt -113.47 138.83 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.689 -1.967 . . . . 71.13 105.689 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.32 179.82 46.98 Favored Glycine 0 C--N 1.334 0.451 0 O-C-N 121.356 -0.84 . . . . 74.5 112.661 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.76 -176.63 48.02 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.185 1.374 . . . . 73.53 110.437 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.31 159.83 40.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.905 0.882 . . . . 31.24 110.295 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.74 -177.34 5.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.431 1.093 . . . . 74.3 111.116 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.78 59.28 0.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.756 2.022 . . . . 54.31 108.909 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.74 21.87 0.02 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.582 -0.566 . . . . 61.3 112.665 -160.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.98 -154.0 20.15 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.459 1.129 . . . . 74.34 111.439 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -62.58 142.81 91.3 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.83 1.686 . . . . 61.33 109.191 166.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.52 149.07 31.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.997 -0.742 . . . . 63.42 108.997 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -69.32 146.94 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.764 0.711 . . . . 75.12 109.781 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 2.3 mm? -113.84 154.81 26.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 126.119 1.768 . . . . 73.11 108.59 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.33 151.29 50.99 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.404 2.281 . . . . 75.4 107.902 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -95.04 173.97 7.32 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.848 1.259 . . . . 74.42 110.4 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.99 21.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.229 1.411 . . . . 71.03 113.903 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -109.83 6.54 23.51 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.678 1.991 . . . . 75.32 110.102 163.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.92 7.05 80.66 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.335 -1.258 . . . . 41.41 112.87 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -103.18 143.77 32.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.888 1.844 . . . . 73.5 109.895 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -65.26 151.38 46.34 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.83 -0.804 . . . . 75.3 108.83 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.17 1.03 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.005 0.743 . . . . 63.11 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.29 -174.06 33.45 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 120.288 1.404 . . . . 63.13 110.328 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -121.18 -2.88 9.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.017 2.127 . . . . 74.5 112.165 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -153.17 142.38 21.48 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.692 1.597 . . . . 34.51 108.822 161.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -173.0 176.78 2.93 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.578 1.951 . . . . 73.42 108.038 164.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.0 p -122.17 159.25 27.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.508 1.123 . . . . 63.12 109.057 165.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.97 130.48 29.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.088 -1.078 . . . . 62.42 108.088 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.85 140.08 40.51 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.066 -1.087 . . . . 64.2 108.066 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -73.99 94.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 104.51 -2.404 . . . . 75.23 104.51 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -120.23 44.29 2.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.852 -1.166 . . . . 73.22 107.852 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -141.71 166.43 24.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.221 -1.399 . . . . 75.32 107.221 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.49 78.79 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.136 0.974 . . . . 63.22 110.391 170.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.7 p -130.32 156.86 43.98 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.367 -0.975 . . . . 75.34 108.367 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -146.66 159.63 43.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.023 1.329 . . . . 75.24 109.52 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 p -165.31 155.55 13.41 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.412 1.085 . . . . 74.14 108.453 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.6 m -143.0 157.67 44.33 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.072 -1.455 . . . . 74.41 107.072 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.9 p -144.1 169.23 18.25 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.685 -0.635 . . . . 75.54 110.839 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 p -105.82 -170.25 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.121 -1.437 . . . . 73.21 107.121 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.75 -167.91 1.41 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.51 -0.922 . . . . 74.53 108.51 148.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.36 172.57 7.41 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.89 -0.884 . . . . 70.4 110.89 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.96 84.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.596 1.159 . . . . 72.51 108.861 -164.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.69 165.58 35.84 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.53 1.132 . . . . 64.23 108.305 156.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -132.91 -0.45 3.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.326 1.05 . . . . 73.22 113.404 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -166.88 175.59 7.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.964 -2.236 . . . . 65.33 104.964 162.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ttt -140.55 145.48 36.84 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.705 -2.702 . . . . 70.3 103.705 157.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -116.58 150.9 37.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.003 -1.11 . . . . 53.42 108.003 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.5 t -147.91 89.54 1.75 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.564 -2.013 . . . . 65.32 105.564 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.25 135.15 55.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.94 -1.133 . . . . 74.15 107.94 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.09 32.8 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 118.724 0.693 . . . . 62.01 112.011 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.4 p -139.41 167.28 22.44 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.331 -0.934 . . . . 73.11 110.336 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.67 148.21 31.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.2 1.8 . . . . 73.05 106.736 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 p -142.97 160.89 39.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.173 0.442 . . . . 62.45 111.139 155.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.81 156.17 41.97 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.745 1.218 . . . . 54.34 108.173 164.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.22 49.81 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 126.26 1.824 . . . . 73.31 109.463 -172.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.0 p -129.07 -173.9 3.12 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.196 0.999 . . . . 51.34 111.809 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -66.71 165.33 15.18 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.118 0.967 . . . . 73.02 112.118 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 161.04 14.62 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 112.998 -1.91 . . . . 73.21 113.514 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.99 2.32 81.95 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.861 -1.522 . . . . 24.41 114.431 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -70.12 114.82 8.64 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 120.1 1.95 . . . . 73.11 106.001 165.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -104.4 155.9 18.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.313 -0.995 . . . . 72.11 108.313 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 tp -143.16 159.13 42.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.543 -2.021 . . . . 65.25 105.543 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -143.97 145.97 32.6 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.946 -1.501 . . . . 73.43 106.946 165.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mm -134.37 140.59 45.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.677 -1.971 . . . . 64.33 105.677 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.495 HG22 HD11 ' A' ' 93' ' ' ILE . 6.3 m -131.43 125.83 33.56 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.89 -2.263 . . . . 73.33 104.89 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.24 116.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.737 1.215 . . . . 73.41 107.93 -170.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 91' ' ' THR . 2.1 mp -138.62 131.22 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.066 0.946 . . . . 72.32 108.719 -162.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.79 141.44 16.39 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.792 1.187 . . . . 62.34 111.4 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -131.45 153.94 49.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.122 2.169 . . . . 72.24 108.72 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.72 139.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.179 -2.526 . . . . 73.41 104.179 167.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 t0 49.82 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.121 2.968 . . . . 71.52 110.954 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -133.75 15.49 3.97 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 120.599 1.545 . . . . 72.34 113.948 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.85 155.71 42.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.529 -1.357 . . . . 65.41 111.467 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -84.82 135.32 34.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.907 2.083 . . . . 72.03 106.341 165.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.09 -1.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.831 0.678 . . . . 61.14 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -155.94 145.61 21.11 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.771 -1.206 . . . . 64.34 109.769 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -158.3 142.79 16.03 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 124.073 0.949 . . . . 71.25 109.973 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.07 170.55 15.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.872 0.844 . . . . 73.02 108.935 155.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -129.23 155.71 45.12 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.615 -1.624 . . . . 74.13 106.615 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 160.34 43.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.727 -0.842 . . . . 52.33 108.727 173.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.15 138.29 28.06 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 106.345 -1.724 . . . . 71.42 106.345 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' HD11 ' A' ' 115' ' ' LEU . 21.2 m-85 -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 123.544 0.527 . . . . 72.43 109.661 176.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.56 136.35 21.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.159 -1.423 . . . . 73.11 107.159 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 p -67.33 136.84 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.301 0.64 . . . . 71.25 110.255 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -109.19 -5.9 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.736 1.214 . . . . 74.41 112.615 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.59 -29.97 5.05 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.132 1.825 . . . . 65.31 110.913 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -82.68 170.52 15.02 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.035 0.934 . . . . 64.21 110.554 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -54.26 136.63 42.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.412 -0.959 . . . . 65.33 108.412 164.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.0 tt -93.21 135.6 34.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.057 -1.09 . . . . 63.15 108.057 168.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.7 mt -149.05 142.35 18.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.151 -2.166 . . . . 53.12 105.151 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.28 171.09 17.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.888 1.275 . . . . 74.45 109.339 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.1 p -140.06 157.68 45.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.736 1.214 . . . . 63.22 109.859 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 169.75 22.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.482 0.713 . . . . 73.42 110.638 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.89 134.57 1.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.72 0.808 . . . . 71.33 110.364 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.9 t -142.64 100.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.374 1.87 . . . . 71.11 106.112 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.45 139.49 41.86 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 72.14 109.762 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.7 p -92.73 26.69 2.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.232 -0.917 . . . . 71.42 112.551 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.37 144.85 5.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.345 -1.354 . . . . 70.1 107.345 161.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -128.67 164.3 23.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 127.407 2.283 . . . . 70.34 108.386 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.024 0 C-N-CA 127.293 2.237 . . . . 52.0 106.117 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 109.259 -1.536 . . . . 51.44 109.259 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.01 92.92 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.61 -1.256 . . . . 64.53 107.61 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t -174.74 108.29 0.11 Allowed 'General case' 0 C--O 1.237 0.427 0 N-CA-C 104.324 -2.472 . . . . 52.02 104.324 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.12 133.3 37.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.571 -1.27 . . . . 70.44 107.571 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -144.41 91.39 2.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.483 1.913 . . . . 70.51 108.346 -165.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -117.22 123.15 45.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.072 1.749 . . . . 62.42 108.467 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -129.77 176.1 8.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.895 2.078 . . . . 73.32 109.796 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.66 -133.56 5.8 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.04 -2.424 . . . . 43.34 107.04 -166.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.03 136.91 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.045 -1.465 . . . . 73.34 107.045 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -113.69 158.05 21.39 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.724 -1.213 . . . . 74.52 107.724 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -154.11 147.27 24.71 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.798 -0.815 . . . . 74.05 108.798 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mm -135.53 120.45 28.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.909 -1.886 . . . . 65.03 105.909 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.41 153.44 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.688 -1.967 . . . . 74.11 105.688 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 74' ' ' CYS . 2.9 mt -130.53 155.2 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.304 -0.999 . . . . 62.0 108.304 165.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.519 ' HG3' HG22 ' A' ' 60' ' ' THR . 23.8 mp0 -138.46 164.17 30.05 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.367 0.667 . . . . 72.43 110.747 163.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -142.39 156.29 45.2 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.624 0.77 . . . . 71.12 109.553 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.93 161.47 40.69 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.123 1.369 . . . . 65.23 108.059 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.5 -117.66 4.41 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.857 1.218 . . . . 72.42 110.685 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.37 104.11 16.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.36 1.064 . . . . 65.03 109.222 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.4 p -115.26 16.84 16.82 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.829 0.451 . . . . 72.12 111.23 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.99 -13.05 15.59 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.405 0.682 . . . . 54.51 110.48 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.81 23.69 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.462 1.105 . . . . 70.02 113.131 -164.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.865 ' CE2' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.97 119.33 20.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.022 0.915 . . . . 70.41 110.274 172.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.53 81.25 7.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.937 2.095 . . . . 72.21 109.141 174.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.865 HG22 ' CE2' ' A' ' 23' ' ' PHE . 3.0 t -72.88 106.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.947 -1.501 . . . . 70.3 106.947 171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -98.14 146.05 25.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.799 -1.556 . . . . 70.3 106.799 161.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.77 152.22 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.043 -0.98 . . . . 71.43 108.67 156.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.3 t -97.25 148.25 23.3 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.11 -1.811 . . . . 71.01 106.11 159.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.455 HG22 ' HG ' ' A' ' 40' ' ' LEU . 82.5 mt -128.07 145.74 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.309 -1.738 . . . . 70.43 106.309 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.55 176.42 47.85 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.517 -1.033 . . . . 50.22 110.517 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.61 173.1 43.84 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.771 2.129 . . . . 61.52 107.925 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.26 159.73 41.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.548 1.174 . . . . 52.32 111.116 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -137.22 -173.29 3.42 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.42 2.288 . . . . 71.22 110.013 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -65.62 -10.73 38.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.673 1.189 . . . . 65.13 113.624 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.87 36.53 1.97 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.676 1.131 . . . . 52.43 113.316 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.88 -160.16 13.35 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.693 1.246 . . . . 74.24 111.752 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.08 156.2 67.39 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.033 1.822 . . . . 71.41 110.065 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.4 144.8 25.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.502 1.121 . . . . 72.43 109.942 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -69.51 139.78 53.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.05 0.841 . . . . 72.1 109.745 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -102.63 157.46 16.92 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.611 1.164 . . . . 74.34 108.413 171.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.2 146.81 52.27 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.703 1.201 . . . . 72.1 109.837 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -82.11 179.62 7.74 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.633 1.573 . . . . 70.12 111.109 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.49 1.43 6.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.128 1.529 . . . . 71.1 115.128 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -101.01 -9.57 21.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.595 1.089 . . . . 73.01 111.007 165.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.77 13.92 76.79 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.654 -1.081 . . . . 12.34 112.426 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.48 148.24 27.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.556 1.942 . . . . 65.12 106.69 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.96 152.83 26.56 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.111 -0.7 . . . . 74.1 109.111 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -144.08 12.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 114.442 1.275 . . . . 72.21 114.442 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 -173.74 22.16 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.345 -1.102 . . . . 74.53 110.345 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.266 21.3 p30 -125.29 2.51 7.8 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.928 1.291 . . . . 74.32 112.856 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 m -153.63 140.5 19.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.525 1.93 . . . . 51.01 108.41 162.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -168.85 171.71 8.27 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.281 1.032 . . . . 74.3 110.594 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 m -118.28 145.99 44.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.96 1.704 . . . . 73.4 108.163 167.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.54 157.06 46.64 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.564 1.946 . . . . 52.22 107.939 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -109.49 135.68 50.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.648 1.579 . . . . 64.13 108.465 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.23 87.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.445 -1.317 . . . . 74.11 107.445 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 35.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.873 1.269 . . . . 74.21 110.303 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -146.2 160.05 42.5 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.178 -0.464 . . . . 71.44 110.756 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.99 -37.85 75.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.815 0.446 . . . . 72.34 111.341 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 15' ' ' GLN . 7.5 p -135.07 142.74 46.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.78 1.632 . . . . 72.21 108.516 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -135.54 163.33 30.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.626 2.37 . . . . 63.04 109.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.9 p -165.62 130.44 2.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.987 0.915 . . . . 71.24 110.456 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.8 m -139.53 154.4 47.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.905 1.282 . . . . 64.34 108.947 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -146.75 -179.81 7.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.209 1.004 . . . . 74.02 111.243 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -124.81 178.92 5.22 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.912 1.285 . . . . 71.44 110.695 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -91.56 -178.29 5.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.455 1.102 . . . . 74.12 108.691 162.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.24 10.74 52.99 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.37 0.986 . . . . 73.12 113.694 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -98.82 69.65 1.82 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.797 -1.927 . . . . 65.11 105.797 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -170.08 172.28 6.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.043 1.337 . . . . 52.31 110.638 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -130.36 -13.01 3.94 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.084 1.754 . . . . 72.55 112.782 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -159.86 174.66 14.1 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.052 0.941 . . . . 70.33 108.754 170.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.2 ttt -136.89 155.21 50.05 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.465 1.906 . . . . 70.01 106.21 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.8 p -113.14 177.5 4.61 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.706 1.203 . . . . 73.22 108.841 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 14' ' ' ILE . 1.9 t -157.84 33.24 0.26 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.104 -1.039 . . . . 72.04 113.157 150.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.51 132.53 53.43 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.488 -0.758 . . . . 73.01 110.746 -172.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.69 175.65 29.6 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 109.711 -1.356 . . . . 71.2 109.711 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.6 p -136.79 160.12 39.81 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.908 0.861 . . . . 74.13 110.721 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 69.1 t -117.52 135.36 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 106.678 -1.601 . . . . 72.43 106.678 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.35 124.85 10.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.114 -0.699 . . . . 74.14 109.114 167.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -119.2 142.98 47.52 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.232 -1.395 . . . . 74.01 107.232 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.86 17.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.179 2.192 . . . . 63.01 109.315 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -88.3 179.33 6.37 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.706 1.241 . . . . 64.33 110.733 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.2 165.48 18.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 113.258 -1.792 . . . . 74.41 112.369 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.94 155.09 20.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.608 -1.178 . . . . 71.24 113.293 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.86 79.68 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.386 -0.674 . . . . 72.33 113.486 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -67.85 156.91 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.306 -1.739 . . . . 73.42 106.306 155.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -139.51 158.35 44.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.359 -1.719 . . . . 73.12 106.359 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tp -156.15 157.25 35.63 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.438 -0.949 . . . . 74.42 108.438 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -147.32 111.71 5.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.172 -1.788 . . . . 70.34 106.172 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mm -101.66 143.44 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.777 -1.564 . . . . 73.14 106.777 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.2 m -119.34 136.21 54.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.023 -1.843 . . . . 71.04 106.023 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 108.47 3.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.481 1.512 . . . . 64.41 109.696 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.0 mt -123.66 140.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.796 -1.187 . . . . 61.32 107.796 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.9 154.18 20.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 124.569 1.081 . . . . 44.45 111.531 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -142.84 152.12 41.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.183 -1.008 . . . . 70.35 110.265 -161.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.1 125.88 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 104.798 -2.297 . . . . 62.13 104.798 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 44.95 55.89 5.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.584 1.154 . . . . 72.11 112.19 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 67.31 26.85 8.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.036 2.134 . . . . 70.31 114.43 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -134.94 161.6 34.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 120.15 -1.594 . . . . 74.22 110.196 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -97.25 127.68 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.032 -1.84 . . . . 70.43 106.032 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.15 -2.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.33 0.863 . . . . 50.15 113.33 -172.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.32 138.56 13.65 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.576 -1.639 . . . . 72.34 106.576 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.17 128.87 8.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.163 0.438 . . . . 72.41 110.839 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -142.61 171.49 13.98 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.934 0.873 . . . . 63.32 110.897 166.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -137.95 165.87 25.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.001 1.72 . . . . 74.24 106.386 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -146.46 166.57 26.01 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.422 -0.584 . . . . 74.22 109.422 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.44 132.59 33.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.126 1.37 . . . . 70.11 107.838 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.543 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 34.1 m-85 -127.43 154.15 45.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.442 -0.948 . . . . 74.4 108.442 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.3 mt -147.03 139.91 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.355 -2.091 . . . . 72.41 105.355 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -86.54 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.448 -0.783 . . . . 74.01 110.224 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -123.75 8.83 8.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.219 . . . . 72.02 111.564 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.78 -6.85 41.32 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.328 1.442 . . . . 62.33 111.505 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -102.22 174.85 5.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.84 1.256 . . . . 71.04 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.09 111.75 6.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.402 -1.333 . . . . 71.23 107.402 169.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.94 138.0 49.69 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.756 -1.201 . . . . 74.43 107.756 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -153.58 131.16 2.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.901 -1.518 . . . . 73.33 106.901 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -158.07 175.66 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.453 1.501 . . . . 70.42 111.87 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -146.64 152.29 38.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.139 1.776 . . . . 73.43 110.059 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -147.43 168.45 21.84 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.739 1.215 . . . . 73.22 109.318 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 p -168.89 128.11 1.08 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.543 0.687 . . . . 74.21 111.897 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.09 113.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.664 1.986 . . . . 73.31 106.1 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 m -97.25 158.35 15.5 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.575 -1.269 . . . . 50.52 107.575 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -107.39 38.48 2.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.705 0.684 . . . . 61.33 109.165 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -174.1 145.04 1.03 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.555 1.542 . . . . 73.43 107.561 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -147.76 131.3 16.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.723 2.809 . . . . 70.41 104.15 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.109 1.363 . . . . 72.33 110.536 -167.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 109.398 -1.481 . . . . 73.52 109.398 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.25 166.0 15.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.818 0.847 . . . . 54.04 109.65 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 p -162.14 177.3 9.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.49 1.116 . . . . 62.54 109.226 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -66.35 160.63 24.24 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.797 -0.565 . . . . 70.12 109.652 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -148.78 103.5 3.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.276 -1.75 . . . . 65.35 106.276 161.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.09 103.64 9.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.999 -1.482 . . . . 73.24 106.999 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -160.7 173.47 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.152 1.381 . . . . 72.13 108.699 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.68 -98.41 0.11 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 127.62 2.533 . . . . 53.14 107.106 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.23 135.66 61.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 125.502 1.521 . . . . 73.33 107.093 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -97.58 145.15 26.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.55 1.14 . . . . 72.51 108.7 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -141.05 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.901 0.88 . . . . 70.23 111.678 166.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.9 mm -130.86 152.16 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.035 1.734 . . . . 74.52 106.59 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.63 141.31 46.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.714 1.606 . . . . 70.11 106.942 166.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 56' ' ' ILE . 53.0 mt -131.62 151.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.028 -1.101 . . . . 74.53 108.028 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -142.72 164.63 29.59 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.723 0.809 . . . . 65.34 110.992 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -156.65 139.89 15.6 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.515 1.126 . . . . 51.31 109.687 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -152.9 147.72 26.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 128.313 2.645 . . . . 70.24 107.647 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.83 -134.8 11.29 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.323 -1.111 . . . . 50.33 110.323 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.19 58.75 0.72 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.022 1.729 . . . . 42.3 111.428 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.8 p -76.13 63.22 1.8 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.365 -1.46 . . . . 72.32 109.031 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -148.93 -40.06 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.858 1.263 . . . . 63.51 110.653 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.84 60.88 1.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 124.268 1.985 . . . . 72.43 110.114 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 0.2 OUTLIER -141.53 160.18 40.69 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.582 2.753 . . . . 71.51 108.449 176.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.69 107.17 3.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.17 0.895 . . . . 74.12 108.806 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.46 92.84 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.419 1.887 . . . . 43.41 109.568 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.92 113.74 27.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 75.24 109.414 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.03 149.12 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.537 1.062 . . . . 72.24 110.078 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t -82.52 150.32 27.03 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.278 1.431 . . . . 75.14 109.413 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 HD22 ' A' ' 40' ' ' LEU . 47.6 mt -130.61 116.01 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.56 -2.015 . . . . 75.14 105.56 165.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 173.53 35.15 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.811 -0.516 . . . . 54.44 111.811 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.34 169.49 36.49 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.582 2.039 . . . . 71.11 111.039 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.83 39.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.577 1.151 . . . . 74.2 111.026 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.48 -168.39 1.77 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.711 2.004 . . . . 74.43 113.258 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -77.74 77.62 4.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.146 -0.687 . . . . 64.1 109.146 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.04 49.56 0.72 Allowed Glycine 0 N--CA 1.453 -0.231 0 O-C-N 124.609 1.193 . . . . 75.53 111.768 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.79 -164.07 28.83 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 120.12 -0.267 . . . . 61.12 112.923 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.27 173.09 13.74 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.921 3.747 . . . . 72.51 110.56 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.39 117.82 35.72 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.477 1.111 . . . . 75.42 109.46 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -60.02 124.14 19.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.285 0.948 . . . . 73.44 110.396 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 65' ' ' THR . 0.8 OUTLIER -113.02 162.83 15.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.163 1.385 . . . . 75.23 109.455 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -131.03 152.76 49.99 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.358 -0.979 . . . . 62.52 108.358 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.287 1.5 p30 -79.05 -152.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.596 1.558 . . . . 61.21 110.228 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.86 2.32 32.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 119.727 -1.858 . . . . 75.11 113.231 174.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -106.2 -2.52 22.38 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.838 2.055 . . . . 71.43 111.63 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.46 56.87 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.46 1.505 . . . . 44.11 113.262 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -113.99 141.2 47.71 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.874 1.337 . . . . 63.53 109.86 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -66.94 135.06 53.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.208 1.803 . . . . 74.33 109.309 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.68 32.1 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.205 1.002 . . . . 74.5 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.1 176.18 27.81 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-O 122.432 1.018 . . . . 71.54 110.702 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.22 6.53 35.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.872 1.269 . . . . 62.42 112.524 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 p -167.48 125.62 1.26 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.908 0.883 . . . . 62.4 112.139 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -167.86 -175.43 2.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.561 0.744 . . . . 73.1 111.007 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -122.84 160.74 25.42 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.068 1.347 . . . . 72.43 108.571 162.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.16 127.83 17.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.83 -1.545 . . . . 61.53 106.83 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -78.69 149.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.921 -1.14 . . . . 63.23 107.921 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 14' ' ' ILE . 5.3 mm -86.42 112.75 23.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.108 -1.071 . . . . 65.34 108.108 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.26 37.77 3.69 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.861 1.265 . . . . 64.44 108.902 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -142.0 160.44 40.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.722 -1.214 . . . . 73.54 107.722 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 -16.92 62.69 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.277 -0.889 . . . . 33.23 113.235 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 p -145.22 150.85 37.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.703 1.601 . . . . 53.14 107.506 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmm -142.69 166.96 23.24 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.783 1.633 . . . . 74.21 110.641 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.6 p -162.26 151.89 16.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.251 1.42 . . . . 61.32 109.566 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.9 m -143.25 145.66 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.363 1.865 . . . . 64.32 107.665 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.8 p -143.82 -179.86 6.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.492 0.587 . . . . 54.3 111.254 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.543 HG22 HD23 ' A' ' 40' ' ' LEU . 26.1 p -129.34 -171.24 2.45 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.462 1.105 . . . . 71.52 110.633 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.6 -154.47 0.46 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.17 -1.048 . . . . 73.33 108.17 165.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.38 35.83 4.63 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.914 1.245 . . . . 72.1 112.526 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -135.86 87.95 2.36 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.694 -1.595 . . . . 74.2 106.694 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -171.2 166.17 7.23 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.33 1.452 . . . . 74.11 111.025 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.81 -16.11 7.23 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.476 1.51 . . . . 74.2 112.815 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.78 165.19 36.15 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.892 -1.151 . . . . 74.1 107.892 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 ttt -131.1 156.38 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 104.569 -2.382 . . . . 61.4 104.569 164.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -130.94 152.4 50.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.682 -0.859 . . . . 72.54 108.682 167.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.17 87.78 2.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.381 -2.081 . . . . 71.12 105.381 167.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.4 136.77 53.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.15 1.78 . . . . 71.23 107.123 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.98 -148.65 5.06 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 121.564 -0.71 . . . . 73.12 111.477 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -150.25 171.49 16.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.388 1.475 . . . . 64.13 109.427 161.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.53 143.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.058 1.343 . . . . 65.4 108.1 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -142.18 163.05 33.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.267 0.354 . . . . 62.52 110.777 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 t -135.68 160.01 39.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.946 1.698 . . . . 75.2 107.885 165.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 pt -133.95 21.08 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 128.233 2.613 . . . . 73.41 108.987 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -81.19 -177.75 6.6 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 123.145 1.45 . . . . 55.3 109.881 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -73.99 170.62 15.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.029 -1.896 . . . . 64.2 109.275 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 165.29 3.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.669 1.188 . . . . 70.43 112.514 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.64 71.77 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.579 1.561 . . . . 61.3 114.111 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.45 134.94 36.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.736 1.768 . . . . 74.4 108.269 -176.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -125.99 129.16 48.66 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.745 1.157 . . . . 70.32 111.124 -169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.29 158.95 25.05 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.285 2.234 . . . . 74.21 105.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -161.14 101.38 1.24 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.146 -1.798 . . . . 64.33 106.146 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.71 143.78 21.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.258 -1.756 . . . . 72.34 106.258 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m -131.46 144.74 51.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.716 -1.587 . . . . 73.54 106.716 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -147.24 112.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 125.702 1.601 . . . . 53.2 109.231 -164.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.22 143.96 39.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.395 1.478 . . . . 74.21 107.046 -170.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.67 140.49 11.84 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.897 -0.881 . . . . 61.22 110.897 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -134.64 144.91 48.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.158 1.383 . . . . 73.53 110.099 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.65 118.6 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 105.193 -2.151 . . . . 65.34 105.193 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 t70 43.91 71.32 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.64 1.576 . . . . 61.34 112.153 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.08 27.29 3.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.251 2.221 . . . . 70.33 113.694 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -129.8 158.56 39.11 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 120.799 -1.188 . . . . 65.54 110.94 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.82 134.87 40.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.228 1.411 . . . . 72.15 107.456 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.51 -0.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.852 0.861 . . . . 65.32 112.101 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -161.87 153.52 18.8 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.399 -0.963 . . . . 73.51 108.399 165.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.62 122.86 3.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.691 -1.596 . . . . 73.15 106.691 170.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.49 171.25 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.895 0.747 . . . . 71.22 110.753 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.05 168.8 14.81 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.614 1.966 . . . . 74.44 109.376 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -150.86 170.6 18.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.585 -1.265 . . . . 70.32 107.585 162.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.55 154.91 51.23 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 127.852 2.461 . . . . 71.12 107.727 169.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.571 ' HB3' HD11 ' A' ' 115' ' ' LEU . 22.8 m-85 -137.79 154.83 49.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.987 -0.746 . . . . 71.14 108.987 164.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -145.27 134.16 17.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.707 -1.22 . . . . 74.1 107.707 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 p -75.58 131.81 40.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.687 0.795 . . . . 74.14 109.929 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -128.64 66.26 1.41 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.06 0.933 . . . . 71.12 108.793 161.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.21 15.71 79.78 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.703 -0.68 . . . . 63.53 114.26 163.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.55 162.97 32.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.58 1.552 . . . . 74.21 110.273 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 105.69 1.35 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.342 -0.844 . . . . 52.12 109.896 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -66.08 133.14 50.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.335 -0.987 . . . . 61.33 108.335 175.106 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -149.37 138.62 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.854 -2.276 . . . . 71.13 104.854 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.58 166.92 32.01 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.66 1.184 . . . . 63.12 111.484 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.1 p -136.81 153.7 50.74 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.143 0.977 . . . . 74.44 111.182 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -142.97 174.47 10.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.005 1.722 . . . . 73.53 108.943 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 t -164.38 144.08 7.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.503 -0.748 . . . . 52.0 109.621 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 92' ' ' VAL . 48.0 t -143.19 109.61 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.134 -2.173 . . . . 70.53 105.134 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 128.1 55.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.172 1.389 . . . . 65.5 107.574 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 5.4 44.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.924 1.083 . . . . 72.42 113.924 -172.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.3 116.52 6.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.116 -1.615 . . . . 73.34 106.775 171.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -133.65 168.34 18.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.125 1.37 . . . . 64.42 107.951 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--O 1.251 1.149 0 N-CA-C 105.153 -2.166 . . . . 74.11 105.153 -175.897 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 108.889 -1.684 . . . . 54.52 108.889 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.63 167.51 12.94 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.109 0.954 . . . . 60.45 109.357 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -153.89 72.92 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.66 1.184 . . . . 74.41 107.942 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.98 136.29 36.58 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.502 -0.925 . . . . 72.15 108.502 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -151.51 119.92 6.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.076 1.751 . . . . 75.44 108.789 167.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -119.37 99.8 6.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.39 1.876 . . . . 75.05 108.091 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -135.65 -174.36 3.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 128.415 2.686 . . . . 53.25 108.777 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.49 -97.72 0.11 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 106.859 -2.496 . . . . 53.21 106.859 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.49 147.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.624 -2.362 . . . . 71.23 104.624 167.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -107.12 146.73 30.91 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.725 -1.583 . . . . 75.14 106.725 166.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -142.66 145.36 33.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.932 -1.507 . . . . 72.4 106.932 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 94' ' ' GLY . 2.5 tp -119.95 152.28 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.792 -1.558 . . . . 61.51 106.792 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.2 t -126.82 137.43 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.561 -2.385 . . . . 73.4 104.561 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 74' ' ' CYS . 53.2 mt -122.1 151.6 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.358 -2.09 . . . . 54.43 105.358 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.62 166.35 24.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.29 -1.004 . . . . 72.51 108.29 170.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -138.4 171.63 14.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.413 0.685 . . . . 63.42 109.426 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -161.78 174.14 13.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.053 2.141 . . . . 50.44 107.686 164.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.82 -147.68 18.58 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.317 -1.513 . . . . 65.33 109.317 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.88 78.67 3.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.056 0.931 . . . . 72.1 111.197 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -73.29 39.63 0.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.676 1.59 . . . . 73.33 112.534 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -142.49 -11.38 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.439 1.496 . . . . 74.23 113.239 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 14.05 1.04 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.579 1.081 . . . . 73.22 113.134 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.49 167.19 18.65 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.008 0.923 . . . . 73.13 110.061 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.3 111.62 6.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.264 -1.754 . . . . 70.3 106.264 163.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 90' ' ' ILE . 62.1 t -125.01 112.83 33.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.801 -1.926 . . . . 65.4 105.801 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -110.03 121.71 45.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.783 -1.192 . . . . 53.44 107.783 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 m -95.26 137.53 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.368 -1.345 . . . . 72.22 107.368 163.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.94 145.36 34.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.161 -1.422 . . . . 73.24 107.161 155.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -130.08 123.26 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.041 -2.207 . . . . 62.1 105.041 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.81 167.78 37.38 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.913 0.768 . . . . 50.02 111.487 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.72 39.38 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.972 1.748 . . . . 44.21 109.003 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.96 164.32 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.654 1.227 . . . . 71.21 111.425 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.18 175.85 9.25 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.923 1.689 . . . . 74.34 112.722 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -74.71 78.54 2.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.526 -0.916 . . . . 74.02 108.526 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.54 35.82 1.38 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-O 118.572 -1.127 . . . . 74.2 113.554 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.21 -172.12 30.8 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.918 1.859 . . . . 72.32 112.692 162.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.06 134.28 21.09 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.423 2.082 . . . . 70.33 107.662 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.91 131.06 42.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.406 1.082 . . . . 45.4 109.625 -167.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -61.68 122.24 14.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.433 -0.58 . . . . 70.22 109.433 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD23 HG22 ' A' ' 65' ' ' THR . 2.4 mt -97.09 154.97 17.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.177 1.791 . . . . 71.34 107.768 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -133.84 141.96 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.718 -1.586 . . . . 65.31 106.718 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.604 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -73.58 -154.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.439 1.896 . . . . 61.34 111.457 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -100.14 -3.17 32.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.02 1.728 . . . . 64.12 112.773 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -111.48 17.37 20.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.198 2.199 . . . . 54.41 110.109 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.09 19.06 69.71 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.634 1.588 . . . . 50.21 114.234 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.604 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -102.58 156.52 17.56 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 119.694 1.747 . . . . 71.22 107.958 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -85.43 150.48 24.68 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.47 -1.307 . . . . 72.2 107.47 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.2 pt -150.67 23.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.876 0.87 . . . . 74.31 112.927 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.32 -172.18 14.08 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.578 -1.326 . . . . 54.13 111.955 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -119.18 -4.99 10.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.843 2.057 . . . . 73.43 112.544 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -164.38 134.87 4.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.208 -1.405 . . . . 73.34 107.208 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -168.4 -173.86 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.013 1.725 . . . . 72.42 108.651 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.44 165.58 14.75 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.206 1.002 . . . . 74.33 110.17 159.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.84 133.06 26.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.963 1.305 . . . . 73.32 107.985 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -78.95 136.46 37.25 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.605 -0.517 . . . . 71.2 109.605 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 mm -78.86 74.43 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.778 0.831 . . . . 72.52 109.516 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -89.38 13.78 12.8 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.178 1.177 . . . . 65.34 114.178 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.4 p -118.52 161.11 20.56 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.989 0.916 . . . . 63.4 109.386 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.7 92.57 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 73.13 109.29 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.4 p -132.82 140.23 47.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.721 1.208 . . . . 64.14 108.671 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.05 168.42 19.64 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.325 1.85 . . . . 73.53 110.956 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.5 p -165.92 144.18 5.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.396 0.678 . . . . 45.12 110.885 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.3 m -127.1 157.77 38.78 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.487 -1.301 . . . . 64.41 107.487 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -146.86 -176.92 5.39 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.152 0.887 . . . . 72.3 110.611 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.496 HG22 HD23 ' A' ' 40' ' ' LEU . 20.0 p -134.91 177.75 7.55 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.353 0.661 . . . . 74.32 110.571 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -73.45 -172.53 1.2 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.074 1.35 . . . . 64.43 112.0 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.42 -5.54 72.98 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.783 -1.198 . . . . 72.21 115.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -130.82 109.25 10.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.767 2.027 . . . . 73.0 107.99 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.2 165.56 24.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.178 2.191 . . . . 74.5 110.103 166.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -117.55 -19.29 9.48 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.203 1.401 . . . . 74.52 113.268 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -159.86 172.51 17.5 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.89 0.768 . . . . 73.3 109.327 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.3 ttt -141.17 155.83 46.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.529 -2.026 . . . . 65.12 105.529 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -139.3 156.95 46.69 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.966 0.906 . . . . 51.23 108.911 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.637 ' HB3' HG12 ' A' ' 121' ' ' VAL . 2.1 t -123.94 16.27 9.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.727 1.611 . . . . 71.52 111.798 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.4 129.14 21.36 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 125.752 1.621 . . . . 73.3 110.632 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.7 -179.83 31.09 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 42.22 111.263 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.89 150.73 43.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.246 2.218 . . . . 61.54 107.809 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.67 HG13 ' CG ' ' A' ' 117' ' ' GLU 0.295 1.6 p -138.04 155.89 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 50.42 110.552 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -151.73 179.18 8.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.214 -1.402 . . . . 72.4 107.214 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.5 t -161.91 164.69 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.218 1.407 . . . . 65.52 108.417 165.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.11 -0.11 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.914 1.286 . . . . 71.24 112.115 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.84 -176.5 1.69 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.752 1.263 . . . . 72.22 109.253 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -72.51 175.59 6.15 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 73.11 111.107 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 166.88 8.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.693 1.597 . . . . 74.53 113.169 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.43 37.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.312 1.911 . . . . 51.02 114.805 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -87.67 115.34 25.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.382 1.873 . . . . 51.2 106.987 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 167.59 9.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.573 1.149 . . . . 74.44 109.776 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -157.87 97.15 1.54 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.757 -1.201 . . . . 74.3 107.757 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -87.86 138.9 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.621 -1.622 . . . . 75.33 106.621 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 25' ' ' VAL . 6.2 mm -128.28 140.05 50.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 106.157 -1.794 . . . . 74.22 106.157 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m -124.03 135.72 53.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.156 -1.794 . . . . 74.34 106.156 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -137.59 110.94 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 108.126 -1.065 . . . . 61.23 108.126 -172.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.55 141.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.929 1.292 . . . . 75.21 108.497 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' CA ' HD12 ' A' ' 12' ' ' ILE . . . -138.58 144.56 15.69 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.361 0.981 . . . . 75.13 113.3 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -128.82 158.58 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.049 1.74 . . . . 74.33 110.82 -169.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.72 110.35 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.454 -2.054 . . . . 73.54 105.454 168.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 t0 72.6 -67.41 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.924 2.489 . . . . 72.45 110.012 168.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -153.97 10.45 0.4 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.784 1.634 . . . . 74.21 112.971 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -123.15 152.38 41.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.571 1.078 . . . . 55.22 111.486 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.46 121.51 39.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.537 1.535 . . . . 73.31 108.091 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.09 -15.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 62.24 112.881 -169.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.38 141.63 25.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.545 1.066 . . . . 75.51 108.689 -170.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.61 158.08 3.3 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.661 0.784 . . . . 72.52 111.469 173.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -152.14 172.62 16.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.119 1.512 . . . . 74.55 108.432 156.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.21 163.96 16.97 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.789 -1.189 . . . . 63.22 107.789 169.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -143.68 165.95 26.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.043 1.337 . . . . 64.21 109.409 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -162.53 120.95 2.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.439 -2.164 . . . . 75.31 109.507 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 117' ' ' GLU . 26.8 m-85 -131.5 149.43 52.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.077 0.861 . . . . 75.51 110.316 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mt -144.73 118.32 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.81 -1.552 . . . . 61.32 106.81 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 p -64.6 142.43 58.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.925 1.29 . . . . 71.42 110.993 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.56 51.73 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.313 2.245 . . . . 73.3 107.675 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.5 7.21 85.27 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.927 1.251 . . . . 73.42 114.338 167.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -127.68 179.59 5.44 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.295 2.238 . . . . 62.51 108.98 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -63.5 134.7 56.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.164 -0.68 . . . . 70.3 109.164 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.5 tp -95.39 135.36 37.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.7 2.0 . . . . 64.52 107.563 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.7 mt -164.76 133.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 128.68 2.792 . . . . 73.32 110.643 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.67 ' CG ' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -159.55 167.03 29.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.268 2.627 . . . . 74.52 112.838 -176.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -136.33 158.57 44.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.554 1.541 . . . . 71.44 110.42 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.11 164.92 28.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.365 1.866 . . . . 74.41 108.512 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -150.89 129.54 12.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.089 0.471 . . . . 75.4 110.081 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 74' ' ' CYS . 8.8 p -129.9 131.06 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.274 -1.75 . . . . 63.15 106.274 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.9 m -128.69 -179.61 5.16 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.517 -1.29 . . . . 71.34 107.517 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.3 p -135.28 33.84 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.566 -0.709 . . . . 52.12 109.103 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -173.74 117.74 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.585 -1.635 . . . . 75.42 106.585 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -134.3 169.31 17.41 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.753 1.221 . . . . 73.31 108.111 163.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.382 1.473 . . . . 62.23 107.904 -175.913 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 108.982 -1.647 . . . . 74.33 108.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.72 86.89 2.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 103.068 -2.938 . . . . 74.25 103.068 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -163.02 151.92 14.67 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.63 -1.618 . . . . 73.13 106.63 -162.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.82 87.74 1.64 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.432 -0.951 . . . . 45.42 108.432 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -136.2 98.93 3.98 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.007 0.923 . . . . 64.42 108.869 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -110.94 106.09 15.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.969 1.708 . . . . 64.53 108.114 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 p -147.72 172.42 14.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.726 2.41 . . . . 73.11 107.185 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.42 -90.76 0.08 OUTLIER Glycine 0 C--N 1.338 0.64 0 O-C-N 121.032 -1.043 . . . . 54.14 110.706 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.8 145.68 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 104.965 -2.235 . . . . 74.41 104.965 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 23.6 m-70 -120.73 148.97 43.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.912 1.233 . . . . 63.43 108.601 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 161.22 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.832 . . . . 74.15 109.714 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mm -140.35 136.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.25 -1.759 . . . . 65.22 106.25 170.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.5 t -113.95 144.87 20.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.17 2.188 . . . . 42.23 107.031 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.22 154.13 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.84 -1.541 . . . . 70.42 106.84 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -144.73 168.35 20.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.696 -1.224 . . . . 65.22 107.696 172.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -146.72 164.53 32.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.301 0.572 . . . . 72.44 111.358 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 m -157.05 172.14 19.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.159 2.584 . . . . 65.22 108.291 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.46 -151.56 19.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.026 -1.23 . . . . 61.03 110.026 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -76.04 64.86 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 123.444 1.592 . . . . 75.25 110.423 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -61.57 -14.28 28.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.495 . . . . 72.41 113.151 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.82 -30.64 62.82 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.397 0.679 . . . . 73.34 112.146 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.0 1.14 11.42 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.122 0.786 . . . . 60.23 113.122 -162.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.17 111.46 21.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.751 -1.574 . . . . 73.35 106.751 -173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 150.88 38.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.138 -0.69 . . . . 54.23 109.138 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.04 111.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 106.899 -1.519 . . . . 74.14 106.899 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -112.73 127.69 56.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.946 -1.131 . . . . 73.54 107.946 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.26 147.96 32.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.777 0.831 . . . . 53.35 109.361 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 t -117.92 120.68 38.6 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.201 2.201 . . . . 74.53 107.739 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.3 mt -120.35 125.31 74.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 74.54 108.39 -156.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.01 169.1 35.87 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 121.267 0.37 . . . . 72.22 113.099 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.05 174.21 39.34 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 127.303 2.383 . . . . 73.21 108.239 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.43 147.23 50.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 119.898 1.849 . . . . 54.01 110.227 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.07 179.49 4.03 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.752 2.421 . . . . 44.1 111.383 -172.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.37 76.2 0.16 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.825 0.85 . . . . 50.2 110.561 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.42 34.0 4.32 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.775 1.178 . . . . 74.34 111.734 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.9 175.42 47.5 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.637 1.218 . . . . 72.32 112.759 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.48 134.16 34.78 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.66 2.24 . . . . 72.32 108.921 159.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.87 128.23 34.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.831 -0.804 . . . . 73.14 108.831 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -56.0 123.25 13.75 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.271 -0.64 . . . . 72.44 109.271 169.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -92.69 164.6 13.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 124.222 0.951 . . . . 74.51 109.16 169.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -137.38 143.36 41.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.417 1.887 . . . . 72.12 107.926 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -69.59 -152.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.267 2.627 . . . . 75.23 110.944 174.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -99.91 -3.64 31.97 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.403 -1.435 . . . . 74.32 114.322 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -98.74 -3.5 35.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.321 -1.487 . . . . 75.3 111.6 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.99 9.49 56.01 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 127.356 2.407 . . . . 55.5 112.396 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -110.32 142.39 42.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 120.589 2.195 . . . . 75.12 108.334 -165.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -64.32 131.32 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.439 1.496 . . . . 74.13 108.704 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.54 9.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.063 0.945 . . . . 73.33 111.81 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.87 175.62 22.99 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.441 -1.063 . . . . 73.51 110.441 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.98 11.62 17.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.075 0.95 . . . . 75.33 110.727 166.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -162.3 157.13 22.36 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 126.791 2.036 . . . . 52.12 106.415 151.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 40' ' ' LEU . 17.5 p90 -176.99 -174.99 0.56 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.493 1.917 . . . . 75.14 110.878 171.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.7 p -122.38 158.3 29.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.613 2.365 . . . . 71.52 108.369 161.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.96 106.06 3.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.299 -0.63 . . . . 72.1 109.299 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.43 145.09 52.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.598 0.714 . . . . 75.53 110.049 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mm -75.68 135.58 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.058 -1.46 . . . . 75.23 107.058 167.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.1 7.74 3.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.356 1.062 . . . . 61.43 110.816 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -139.51 152.39 46.91 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.073 -1.017 . . . . 72.32 108.874 -148.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -31.22 64.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.99 0.359 . . . . 64.35 111.937 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -134.99 164.18 28.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.827 1.251 . . . . 71.25 109.328 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.28 171.2 15.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.814 2.045 . . . . 62.33 109.912 170.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 p -173.46 156.78 3.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.668 1.587 . . . . 74.44 111.17 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.6 m -150.06 165.81 31.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.482 2.713 . . . . 62.23 107.416 162.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 p -147.88 -179.85 7.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.125 0.97 . . . . 54.01 111.28 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.8 p -102.9 164.91 11.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.662 1.185 . . . . 74.41 109.334 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.42 169.42 4.75 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.235 -0.586 . . . . 62.32 109.608 152.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.36 36.94 1.78 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.072 0.844 . . . . 65.54 113.123 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -146.33 90.17 1.93 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.237 -2.134 . . . . 65.43 105.237 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.6 141.94 17.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.319 1.847 . . . . 74.35 106.977 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -86.09 -22.43 27.15 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.446 1.098 . . . . 73.44 111.832 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 25.6 p90 -157.38 167.33 30.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.697 1.199 . . . . 74.21 108.481 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.57 148.86 49.24 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.302 -2.11 . . . . 74.25 105.302 159.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.6 t -140.55 157.83 44.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.302 -0.999 . . . . 54.34 108.302 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.47 79.06 1.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.923 1.289 . . . . 73.11 109.157 -169.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.43 156.33 31.19 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.222 -0.659 . . . . 64.43 109.222 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.4 174.49 41.21 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 121.947 0.748 . . . . 72.45 112.662 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.6 t -146.33 148.59 32.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 126.337 1.855 . . . . 74.51 107.724 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.05 136.41 53.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 126.097 1.759 . . . . 72.44 106.718 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -148.57 151.86 35.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.698 0.799 . . . . 74.45 110.906 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -150.15 151.08 32.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.126 0.97 . . . . 72.32 108.462 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 5.15 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.367 2.267 . . . . 72.12 110.827 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 p -63.01 169.46 3.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.185 0.994 . . . . 50.31 110.322 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 168.18 9.68 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.319 1.057 . . . . 73.05 112.252 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.4 19.14 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.561 -1.654 . . . . 70.12 112.854 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.85 57.88 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.873 1.225 . . . . 73.13 114.014 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -75.19 167.07 22.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.21 1.505 . . . . 74.14 107.313 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -153.87 174.03 15.14 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.952 -1.093 . . . . 74.32 111.118 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tp -158.46 152.78 24.21 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.338 -0.986 . . . . 45.23 108.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -140.57 131.38 25.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.409 -1.7 . . . . 73.14 106.409 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.51 116.97 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 106.429 -1.693 . . . . 72.44 106.429 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -96.99 139.33 33.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.24 -1.763 . . . . 73.13 106.24 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.36 132.07 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.004 -2.221 . . . . 73.13 105.004 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.1 mt -142.58 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 107.727 -1.212 . . . . 74.25 107.727 -172.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.27 143.95 17.97 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 109.002 -1.639 . . . . 42.03 109.002 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -132.88 152.59 51.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.239 1.015 . . . . 72.55 110.333 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.1 mt -132.52 124.26 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.609 -2.367 . . . . 73.14 104.609 167.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 44.77 68.4 0.56 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.198 1.799 . . . . 70.54 110.804 163.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.6 1.83 3.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.148 1.536 . . . . 43.45 115.148 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -132.11 153.11 50.82 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.072 1.306 . . . . 74.22 111.227 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -86.02 148.23 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.113 0.482 . . . . 73.54 110.034 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 m -135.27 1.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.938 1.295 . . . . 65.11 111.657 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.56 140.68 8.53 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 120.908 -1.12 . . . . 74.13 108.605 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -158.54 144.47 16.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.999 0.919 . . . . 70.41 109.311 162.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.18 108.02 2.53 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.829 0.823 . . . . 71.33 109.435 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.64 157.76 37.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.621 -1.299 . . . . 53.23 108.997 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 173.69 7.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.823 -1.547 . . . . 72.33 106.823 159.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -145.94 132.29 19.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 74.33 106.301 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 115' ' ' LEU . 8.4 m-85 -128.5 165.62 20.36 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.898 0.772 . . . . 72.35 110.246 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.9 mt -150.47 137.03 12.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.968 2.507 . . . . 73.24 105.783 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.2 144.72 30.49 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.993 0.917 . . . . 63.03 108.875 170.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -129.68 13.5 5.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 64.02 111.599 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.5 55.36 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 121.314 -0.866 . . . . 71.23 112.94 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -90.17 170.27 10.44 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.559 1.544 . . . . 65.32 107.892 160.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.59 139.66 58.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.808 -1.182 . . . . 62.25 107.808 161.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.1 tt -97.65 134.22 41.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.699 -1.223 . . . . 74.13 107.699 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.8 mt -145.5 141.93 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.251 -2.129 . . . . 71.55 105.251 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.74 168.23 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.632 1.573 . . . . 65.41 109.318 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.2 p -140.91 157.61 45.11 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.687 1.195 . . . . 73.43 109.152 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.25 171.88 18.51 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.394 -0.821 . . . . 70.52 109.129 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -151.93 142.83 23.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.421 1.088 . . . . 61.22 108.419 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.87 85.78 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.767 -1.938 . . . . 73.31 105.767 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -64.88 170.02 4.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.59 -0.893 . . . . 71.13 108.59 160.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 p -127.87 -12.13 5.36 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.549 -0.719 . . . . 72.11 111.444 159.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.13 112.76 5.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.413 -1.699 . . . . 74.45 106.413 -169.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -151.23 -172.56 4.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.741 -1.207 . . . . 73.35 107.741 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.31 -1.329 . . . . 74.42 108.436 165.47 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.242 -2.343 . . . . 72.35 107.242 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.27 58.85 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.036 -1.098 . . . . 70.23 108.036 162.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -136.23 155.96 49.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.833 -1.543 . . . . 62.21 106.833 163.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.25 113.2 16.66 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.082 -0.386 . . . . 43.21 110.474 -153.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -126.26 94.39 4.07 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.13 0.972 . . . . 70.34 110.022 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -115.59 102.03 9.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.537 1.935 . . . . 74.41 106.846 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -153.78 -178.32 6.97 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.815 0.817 . . . . 52.11 111.338 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.02 -119.8 0.93 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.799 3.095 . . . . 50.43 106.311 -166.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.01 103.93 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 53.34 108.456 -167.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.453 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 50.1 m-70 -74.38 154.86 38.64 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.962 -0.461 . . . . 71.34 109.771 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -145.86 152.26 39.19 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.817 1.247 . . . . 61.42 107.905 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -127.24 152.43 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.294 2.238 . . . . 71.11 105.489 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.83 136.04 54.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.396 -2.076 . . . . 72.23 105.396 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.4 mt -122.91 150.82 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 105.959 -1.867 . . . . 62.14 105.959 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -142.9 163.36 33.01 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.053 -1.462 . . . . 64.21 107.053 166.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -136.93 154.45 50.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.625 -1.25 . . . . 72.25 107.625 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -145.36 171.01 15.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.29 -137.47 14.22 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.023 -1.631 . . . . 32.02 109.023 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -89.98 65.42 6.58 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.521 1.529 . . . . 40.12 109.79 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.8 p -75.42 35.5 0.12 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.161 2.184 . . . . 72.04 113.338 -164.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -142.6 8.48 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.244 1.417 . . . . 72.44 111.644 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 m -149.19 7.64 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.106 1.762 . . . . 60.01 111.412 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.75 141.91 50.03 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.074 -1.016 . . . . 73.43 109.103 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -116.1 116.56 28.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.229 -1.767 . . . . 74.22 106.229 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.75 90.14 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.462 -0.94 . . . . 72.34 108.462 -171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -86.89 145.23 26.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.046 -1.033 . . . . 71.44 108.298 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.14 129.12 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.316 1.046 . . . . 65.33 109.469 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -64.59 138.12 58.22 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.723 -1.584 . . . . 74.44 106.723 160.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 122.27 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.129 -2.175 . . . . 73.31 105.129 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.69 167.38 35.22 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.048 -0.821 . . . . 41.42 111.048 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.04 170.95 44.13 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.388 1.947 . . . . 73.2 109.065 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.69 164.78 21.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.852 0.861 . . . . 62.01 109.999 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -131.24 -164.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.255 1.822 . . . . 74.42 111.074 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -79.82 71.59 6.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.845 -0.428 . . . . 71.42 109.845 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.58 -22.6 2.01 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-O 119.035 -0.869 . . . . 50.23 114.2 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.69 -154.8 8.09 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.102 -1.199 . . . . 74.14 110.102 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.1 154.92 42.4 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.726 2.284 . . . . 72.33 110.515 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 110.79 20.77 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.214 1.406 . . . . 74.41 108.993 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -45.46 116.25 1.11 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.988 1.715 . . . . 61.44 111.531 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.71 160.2 15.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.956 0.884 . . . . 71.13 110.09 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -129.09 152.09 49.06 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.677 1.591 . . . . 75.42 107.897 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -96.5 172.75 7.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 73.3 110.424 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -65.47 -9.47 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.096 1.758 . . . . 73.43 113.978 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -87.52 -8.52 56.28 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.652 1.581 . . . . 61.43 111.152 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.1 59.09 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.921 1.724 . . . . 71.14 113.741 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -104.7 147.15 27.99 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.698 1.249 . . . . 74.02 109.251 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -66.29 135.76 54.87 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.003 -1.11 . . . . 61.23 108.003 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -136.63 28.83 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.713 0.805 . . . . 60.43 111.509 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.06 18.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.4 -1.08 . . . . 73.0 110.4 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.04 2.95 55.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.134 1.773 . . . . 70.24 113.246 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -165.77 157.38 14.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.565 1.546 . . . . 72.23 108.375 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.3 p90 177.92 -173.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.578 2.351 . . . . 74.23 109.726 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 m -119.28 153.0 35.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.648 1.179 . . . . 62.31 108.246 154.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.79 110.29 7.02 Favored 'General case' 0 CA--C 1.523 -0.086 0 C-N-CA 124.328 1.051 . . . . 64.04 108.332 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -73.19 145.1 46.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.096 0.958 . . . . 64.32 110.383 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -80.51 118.78 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.734 -1.58 . . . . 75.22 106.734 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.55 29.37 2.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.037 1.335 . . . . 73.1 108.604 167.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 p -135.51 157.25 47.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.446 1.098 . . . . 54.32 108.862 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.52 -40.66 79.22 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.28 0.632 . . . . 63.24 110.408 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.5 p -133.76 163.67 28.96 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.74 0.816 . . . . 44.13 110.878 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 mmm -142.43 170.62 15.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.297 1.839 . . . . 74.03 111.563 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 p -160.9 154.76 22.49 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.22 1.808 . . . . 72.34 108.641 165.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.8 m -143.91 150.43 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.203 1.801 . . . . 64.01 107.851 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.6 p -149.15 179.74 7.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.164 0.983 . . . . 62.43 110.529 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -119.29 -174.65 2.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.28 -1.748 . . . . 64.2 106.28 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -92.37 -176.57 4.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.533 -1.284 . . . . 75.02 107.533 158.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.76 64.33 2.63 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.961 -1.087 . . . . 34.43 111.684 173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.94 71.75 1.35 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 103.883 -2.636 . . . . 71.4 103.883 169.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.89 32.94 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.134 -0.978 . . . . 63.14 111.247 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.09 -7.13 2.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.172 1.789 . . . . 74.1 112.552 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 29.6 p90 -157.29 170.66 21.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.36 -1.348 . . . . 73.24 107.36 163.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.7 ttt -146.29 147.66 31.61 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 105.136 -2.172 . . . . 74.43 105.136 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.5 t -135.36 164.97 26.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.82 0.819 . . . . 63.44 110.002 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.32 106.91 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.703 -2.332 . . . . 74.22 104.703 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 142.97 41.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.906 -1.887 . . . . 70.02 105.906 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.54 -151.05 5.55 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 120.94 -0.648 . . . . 34.13 111.813 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.24 175.49 10.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.137 -0.69 . . . . 74.24 109.137 147.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -137.15 147.46 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.661 1.584 . . . . 73.15 109.273 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.5 m -149.32 167.71 25.35 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.43 -0.794 . . . . 73.04 112.743 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 t -143.47 151.61 40.51 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.771 2.029 . . . . 65.24 107.05 158.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.02 48.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.839 . . . . 73.23 107.616 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.1 m -127.72 174.62 8.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.292 1.037 . . . . 70.15 112.499 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -55.14 158.53 2.91 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.631 1.972 . . . . 63.05 110.817 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.8 167.14 1.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.196 1.398 . . . . 52.22 112.974 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.52 -13.65 33.75 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.043 1.306 . . . . 50.54 114.157 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -67.43 132.45 47.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.119 1.46 . . . . 74.22 108.215 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.0 mtt85 -110.38 159.78 17.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.711 -1.218 . . . . 70.25 107.711 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -146.67 141.42 26.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.87 -1.529 . . . . 71.33 106.87 177.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -145.79 92.92 2.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.993 -1.484 . . . . 73.25 106.993 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.61 143.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.442 -1.688 . . . . 73.14 106.442 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -119.28 136.47 54.22 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.493 -1.669 . . . . 65.23 106.493 165.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.51 115.07 12.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 125.655 1.582 . . . . 71.04 108.842 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.67 153.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.348 -1.723 . . . . 65.33 106.348 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.16 158.18 27.61 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.695 -0.962 . . . . 71.45 110.695 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -143.35 152.92 42.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.947 0.899 . . . . 74.24 110.369 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.8 mt -121.81 120.76 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.288 -2.115 . . . . 73.24 105.288 165.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.5 t0 72.39 -83.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.122 2.969 . . . . 73.02 110.197 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.73 24.73 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.58 1.952 . . . . 64.41 108.702 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -135.74 132.85 37.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.266 -0.896 . . . . 75.42 110.746 -166.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.31 136.17 57.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.992 -0.744 . . . . 70.12 108.992 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.59 -25.55 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.16 0.984 . . . . 52.35 108.823 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -145.89 142.92 29.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.512 1.525 . . . . 74.23 107.768 -168.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -167.23 112.0 0.72 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.642 1.177 . . . . 74.43 109.095 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.07 173.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.551 0.532 . . . . 50.11 109.893 162.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -128.3 172.76 10.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 72.21 108.068 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 147.12 33.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.704 -0.85 . . . . 71.13 108.704 164.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -120.61 136.11 54.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.655 -0.869 . . . . 65.41 108.655 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -138.65 155.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.044 0.938 . . . . 72.21 108.849 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.88 135.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.17 -1.419 . . . . 64.34 107.17 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -65.86 144.23 56.95 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.076 0.95 . . . . 53.55 109.328 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -137.0 21.34 3.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.97 0.804 . . . . 73.34 112.546 164.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.12 -24.1 31.62 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.15 1.833 . . . . 72.12 111.336 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.47 159.08 27.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.789 -0.819 . . . . 63.33 108.789 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.42 120.64 21.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.759 -1.571 . . . . 63.44 106.759 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.1 21.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.42 -1.696 . . . . 70.42 106.42 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.03 142.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 105.699 -1.963 . . . . 73.12 105.699 166.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.59 179.1 8.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.835 0.826 . . . . 72.11 109.555 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -135.68 173.01 12.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.387 1.875 . . . . 62.34 107.692 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -164.81 165.62 20.44 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.245 2.218 . . . . 74.32 108.621 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.5 149.82 27.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.558 0.617 . . . . 73.04 110.717 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 t -145.28 84.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.943 -1.502 . . . . 70.45 106.943 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.62 129.2 37.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.177 -1.786 . . . . 44.23 106.177 175.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.0 p -85.72 5.84 30.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.38 0.991 . . . . 74.13 112.049 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -143.17 133.69 24.93 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.563 -1.273 . . . . 74.14 107.563 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.29 134.98 33.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 105.709 -1.96 . . . . 62.31 105.709 162.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.248 1.017 0 CA-C-O 115.803 -2.046 . . . . 73.22 109.619 178.076 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.702 -0.959 . . . . 64.11 110.702 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.18 169.38 24.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.298 2.239 . . . . 35.55 108.129 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 p -89.64 -21.99 22.52 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.001 1.111 . . . . 62.12 114.001 -168.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -106.52 118.26 36.21 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.656 1.182 . . . . 75.31 111.503 -166.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.93 96.83 5.01 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.878 1.271 . . . . 71.01 110.185 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -136.91 110.78 8.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.452 1.901 . . . . 64.03 108.982 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -165.58 -178.55 4.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.139 -1.43 . . . . 75.33 107.139 165.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.0 -90.52 0.08 OUTLIER Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.85 2.166 . . . . 64.11 109.437 -163.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -139.36 135.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 127.468 2.307 . . . . 62.32 107.378 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -103.71 152.6 21.63 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.529 -0.732 . . . . 72.24 109.725 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -142.68 147.37 35.59 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.841 -1.17 . . . . 72.12 107.841 169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.9 mm -119.16 151.08 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.349 1.86 . . . . 75.43 106.267 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.93 139.13 46.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.118 -1.808 . . . . 73.44 106.118 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.67 154.36 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.325 -1.361 . . . . 73.1 107.325 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -142.8 168.9 18.64 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.52 1.128 . . . . 75.44 109.106 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -136.39 150.38 48.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.674 1.59 . . . . 74.41 108.355 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -154.25 162.39 41.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.303 1.841 . . . . 61.54 108.107 167.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.11 -163.69 31.84 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.329 -1.508 . . . . 75.4 109.329 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.1 99.13 3.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.953 1.701 . . . . 62.11 109.049 -169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.9 p -85.76 -10.24 55.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.836 1.254 . . . . 73.12 114.259 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.1 -12.66 46.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.709 -1.244 . . . . 71.24 111.661 -171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.59 30.84 1.88 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.221 1.408 . . . . 71.34 112.613 -169.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.618 ' CD2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -126.83 155.23 43.23 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.794 -1.192 . . . . 71.12 108.443 170.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.06 121.68 18.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.369 -1.345 . . . . 72.3 107.369 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.97 105.08 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 123.908 0.883 . . . . 54.44 109.079 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 145.98 25.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.694 -0.854 . . . . 64.43 108.694 162.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.45 131.59 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.605 1.562 . . . . 73.33 108.996 163.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 t -68.39 140.08 55.82 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.257 -1.386 . . . . 62.24 107.257 161.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.5 mt -130.43 108.54 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 104.297 -2.482 . . . . 71.3 104.297 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -143.39 166.43 26.82 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 109.382 -1.487 . . . . 52.44 109.382 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 172.04 44.96 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 108.314 -1.915 . . . . 71.34 108.314 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 164.75 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.521 1.129 . . . . 75.14 108.773 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -144.08 145.46 32.17 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.196 0.998 . . . . 64.04 109.306 156.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 45.2 -8.15 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 130.525 3.53 . . . . 60.21 117.829 -160.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 33' ' ' ASP . . . 138.51 -19.47 3.19 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 126.408 1.956 . . . . 63.1 110.796 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.96 -171.5 32.69 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.213 2.34 . . . . 41.41 111.711 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.7 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.281 2.654 . . . . 75.54 110.688 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.84 138.73 47.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.103 0.478 . . . . 62.24 111.902 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -65.14 110.59 2.59 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.749 1.62 . . . . 72.02 110.485 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 30' ' ' GLY . 2.8 mt -89.14 160.93 16.76 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.439 1.018 . . . . 74.33 108.745 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -130.4 144.29 51.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.335 1.054 . . . . 74.2 109.797 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.03 176.99 6.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.816 1.246 . . . . 64.1 110.808 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -72.03 -13.25 61.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.83 0.852 . . . . 63.21 112.86 -169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.82 -13.85 62.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.814 1.246 . . . . 64.03 110.635 168.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 14.27 72.69 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 126.542 2.02 . . . . 71.01 112.544 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -106.64 154.81 20.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.697 1.599 . . . . 73.32 110.337 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -76.03 152.02 37.01 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.211 -0.663 . . . . 74.43 109.211 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 pt -153.49 10.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.877 1.066 . . . . 63.11 113.877 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.19 167.09 11.13 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.814 -1.179 . . . . 53.44 110.574 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -111.66 -0.65 15.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.805 1.242 . . . . 73.3 112.443 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 m -148.34 141.85 25.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.068 -1.827 . . . . 74.33 106.068 159.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.06 -173.63 2.4 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.422 1.089 . . . . 73.13 108.578 166.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.3 m -130.23 153.87 48.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.493 1.117 . . . . 72.2 108.116 161.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.68 160.71 38.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.322 1.049 . . . . 61.52 108.827 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.196 0.598 . . . . 72.24 110.565 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.96 81.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.859 1.264 . . . . 63.52 108.417 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 29.42 7.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.623 1.169 . . . . 75.31 110.359 172.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -141.89 138.61 32.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.991 -1.115 . . . . 72.12 107.991 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.86 49.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.687 0.795 . . . . 60.11 111.94 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.9 p -141.6 159.87 41.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.931 1.292 . . . . 52.03 107.515 166.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -145.23 163.67 33.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.028 1.331 . . . . 73.34 109.897 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -172.59 153.82 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.365 1.466 . . . . 75.23 110.912 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.1 m -143.73 152.66 41.56 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.375 1.87 . . . . 73.21 107.292 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.4 p -142.35 177.62 8.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.842 0.857 . . . . 71.41 110.589 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.4 p -101.08 171.21 7.76 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.837 1.255 . . . . 63.0 109.923 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.48 177.2 1.6 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.269 -1.011 . . . . 71.32 108.269 152.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.01 34.69 0.9 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.73 -1.039 . . . . 32.12 113.13 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.11 131.35 11.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.778 1.789 . . . . 75.22 107.769 164.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -174.2 152.31 1.81 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.814 2.446 . . . . 64.31 108.315 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.23 -18.11 12.61 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.571 1.548 . . . . 73.42 112.856 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.39 177.35 11.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.688 2.395 . . . . 73.52 107.072 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 ttt -150.93 150.15 30.49 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 104.803 -2.295 . . . . 72.34 104.803 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 t -122.41 155.44 36.07 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.204 -1.406 . . . . 74.32 107.204 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 t -155.19 98.45 2.0 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.19 -2.152 . . . . 72.11 105.19 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -129.84 144.3 51.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.048 -1.464 . . . . 23.53 107.048 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.98 -149.74 5.08 Favored Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.577 -0.609 . . . . 63.44 111.577 -164.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.06 175.46 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.901 -0.777 . . . . 63.12 108.901 145.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -122.34 156.08 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.753 1.621 . . . . 72.5 107.674 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t -151.38 163.8 38.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.836 1.254 . . . . 61.51 109.289 161.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -151.44 134.84 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.47 2.308 . . . . 73.33 105.392 168.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.68 12.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.242 -1.022 . . . . 75.22 108.242 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -75.0 -176.66 3.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.796 -1.187 . . . . 72.1 107.796 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -62.38 167.3 4.32 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.368 1.08 . . . . 75.4 112.254 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.45 153.03 16.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.312 -1.767 . . . . 64.13 113.3 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.78 6.35 85.46 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.403 -1.221 . . . . 51.31 113.574 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -76.11 172.51 12.67 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.604 1.702 . . . . 54.44 108.599 160.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -147.47 150.86 35.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.591 -1.263 . . . . 75.15 107.591 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.618 HD21 ' CD2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -154.69 115.34 3.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.088 -0.708 . . . . 61.4 109.088 -175.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -118.89 124.66 47.66 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.982 1.713 . . . . 75.55 108.401 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.3 mm -113.75 142.88 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.526 -1.287 . . . . 52.3 107.526 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -122.87 133.66 54.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.21 -1.774 . . . . 75.15 106.21 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -139.59 132.23 35.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 125.73 1.612 . . . . 73.52 109.517 -173.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mt -143.76 152.31 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.54 108.333 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.2 151.24 23.51 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.554 1.074 . . . . 54.21 111.553 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -136.19 155.79 49.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.327 1.851 . . . . 73.32 110.372 -166.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mt -141.89 138.12 31.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 127.003 2.121 . . . . 71.3 105.395 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.75 -85.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.739 3.616 . . . . 64.44 109.955 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -152.27 37.2 0.54 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.444 1.498 . . . . 75.0 110.593 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -141.49 153.43 44.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.623 1.169 . . . . 75.33 110.975 171.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.54 148.36 42.39 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.041 0.936 . . . . 64.14 108.906 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.39 -18.38 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 54.43 112.685 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -136.6 137.69 40.42 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.23 1.377 . . . . 74.22 108.765 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -151.8 138.4 18.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.544 1.138 . . . . 74.51 109.751 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -143.8 168.95 18.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.648 0.737 . . . . 74.25 110.498 155.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.06 156.12 43.28 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.414 -1.698 . . . . 72.42 106.414 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 164.14 34.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.684 -0.858 . . . . 75.32 108.684 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -153.5 148.45 26.62 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.276 -0.268 . . . . 73.13 110.276 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.443 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.6 m-85 -148.44 137.69 21.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.582 1.153 . . . . 74.31 110.358 -167.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.2 mt -124.85 135.92 62.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.007 -1.479 . . . . 62.53 107.007 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.54 137.91 38.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.634 1.973 . . . . 63.33 108.634 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -141.75 31.16 1.65 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.777 0.798 . . . . 74.14 112.02 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.39 -3.92 86.3 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.368 0.985 . . . . 64.41 112.607 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.63 -155.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.497 1.919 . . . . 71.32 108.512 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -118.9 110.82 17.62 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.188 -1.782 . . . . 71.2 106.188 166.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 108' ' ' TYR . 1.4 tm? -62.13 120.28 10.58 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.426 -1.324 . . . . 63.55 107.426 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -148.19 144.11 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 103.976 -2.602 . . . . 75.44 103.976 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.48 169.72 18.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.991 -0.744 . . . . 74.53 108.991 169.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 p -134.85 162.47 32.31 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.797 1.239 . . . . 75.42 108.361 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -151.8 175.78 12.09 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.036 1.334 . . . . 75.32 108.68 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 t -160.58 148.52 16.19 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.716 0.769 . . . . 72.12 109.445 168.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.6 107.16 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 127.314 2.246 . . . . 61.21 106.393 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.24 118.47 30.54 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.084 1.354 . . . . 72.4 108.437 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.1 p -86.43 33.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.92 0.888 . . . . 71.23 111.847 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -169.47 114.68 0.55 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.199 -1.408 . . . . 74.44 107.199 167.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -130.53 -165.0 1.49 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.034 0.933 . . . . 71.13 109.373 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--O 1.248 0.984 0 CA-C-O 117.024 -1.465 . . . . 52.34 111.944 171.558 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 N-CA-C 110.742 -0.943 . . . . 43.24 110.742 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.7 94.68 2.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.026 -1.472 . . . . 72.12 107.026 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -158.0 132.17 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.215 -1.031 . . . . 71.43 108.215 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -142.95 22.43 1.93 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.266 0.626 . . . . 64.33 111.769 -159.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -120.77 91.55 3.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.737 0.78 . . . . 73.42 110.628 -174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.09 97.04 3.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.836 1.655 . . . . 72.13 109.438 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -73.96 178.42 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.284 1.033 . . . . 74.2 111.285 166.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.43 -90.04 0.11 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 108.808 -1.717 . . . . 53.51 108.808 154.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.24 131.93 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.638 -1.986 . . . . 71.22 105.638 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -126.69 157.16 39.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.568 -1.271 . . . . 73.12 107.568 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -148.94 151.33 34.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.317 1.047 . . . . 62.04 108.257 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.34 134.94 52.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.858 -1.905 . . . . 74.34 105.858 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.54 131.26 50.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.711 -1.589 . . . . 70.05 106.711 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.3 mt -135.2 143.09 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.475 -0.935 . . . . 64.12 108.475 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -134.47 161.75 34.15 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.381 1.072 . . . . 75.21 110.3 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.23 141.86 29.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.33 2.652 . . . . 63.35 109.961 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -141.83 172.49 12.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.56 1.544 . . . . 60.22 107.343 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.33 -155.63 24.4 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.886 -1.286 . . . . 73.45 109.886 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.21 33.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.548 2.339 . . . . 61.25 111.106 -173.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 t -65.04 8.29 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.163 2.185 . . . . 73.54 113.798 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -17.83 64.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.841 1.656 . . . . 72.51 111.149 162.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.7 m -130.95 16.33 5.18 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.937 1.295 . . . . 72.45 113.019 -163.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 88' ' ' LEU . 53.1 m-85 -126.26 116.02 20.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.352 1.061 . . . . 70.14 109.261 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.22 127.08 31.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.28 -1.378 . . . . 71.11 107.28 166.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 t -136.74 106.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 105.557 -2.016 . . . . 61.54 105.557 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -114.87 145.86 41.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.768 1.167 . . . . 53.43 110.082 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.77 139.19 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.363 1.065 . . . . 63.43 109.595 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -66.84 139.39 57.76 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.768 -1.567 . . . . 64.44 106.768 161.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -132.9 124.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.591 -2.003 . . . . 44.41 105.591 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . -179.98 176.97 47.8 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.702 -1.359 . . . . 52.41 109.702 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.44 172.76 43.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.337 -1.905 . . . . 64.41 108.337 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.8 163.61 27.85 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.783 0.833 . . . . 54.14 109.863 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.39 -170.82 2.68 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.215 1.006 . . . . 74.2 112.039 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -74.94 67.47 1.68 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.317 1.047 . . . . 74.13 110.674 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.36 -32.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.533 -0.593 . . . . 53.14 112.729 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.93 -156.71 15.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 119.907 -1.139 . . . . 70.32 114.627 -162.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.18 139.44 9.38 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.927 3.084 . . . . 65.4 110.567 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.14 117.95 23.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.081 1.352 . . . . 73.4 110.576 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -60.21 117.61 5.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.661 1.119 . . . . 74.43 110.482 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD21 ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -91.39 159.16 16.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.004 1.321 . . . . 74.12 109.401 171.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -128.16 143.88 51.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.0 1.32 . . . . 74.21 109.306 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -81.75 165.87 20.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.182 -0.917 . . . . 53.42 109.864 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -74.45 19.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.654 1.582 . . . . 73.13 113.457 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -100.76 -10.95 20.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.159 1.383 . . . . 70.22 110.9 163.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.59 56.54 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.001 1.762 . . . . 73.13 113.339 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.19 160.88 14.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.553 1.141 . . . . 72.1 109.429 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -74.96 157.7 34.53 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.815 -0.553 . . . . 74.41 109.923 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.22 6.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.127 0.788 . . . . 43.52 113.127 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.18 -172.45 24.18 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.186 -1.565 . . . . 63.0 109.186 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 40' ' ' LEU . 14.6 p30 -125.03 8.73 8.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.037 1.335 . . . . 72.04 111.943 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -170.85 124.48 0.65 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.477 3.111 . . . . 74.3 106.864 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -163.18 -173.39 3.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.238 1.015 . . . . 73.24 110.211 171.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -121.11 157.46 30.06 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.261 1.024 . . . . 64.11 109.249 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.55 142.27 50.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.923 -1.139 . . . . 62.45 107.923 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -96.29 132.71 41.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.554 -1.647 . . . . 72.35 106.554 170.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -74.99 100.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.673 -1.603 . . . . 64.43 106.673 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -127.09 35.1 4.63 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.87 1.668 . . . . 65.24 109.875 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -134.31 169.01 17.85 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.117 -1.068 . . . . 63.41 108.117 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.33 9.95 34.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 118.643 -0.694 . . . . 54.45 111.443 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -178.51 159.85 1.2 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.901 2.48 . . . . 71.34 107.485 145.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 mmm -125.42 165.13 18.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.173 2.189 . . . . 73.41 109.572 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.4 p -159.56 163.07 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.238 -0.892 . . . . 61.05 111.317 158.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.4 m -147.87 163.09 37.86 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.469 2.308 . . . . 73.23 106.624 162.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.35 -176.81 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.23 1.812 . . . . 61.11 108.789 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.27 156.42 47.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.565 1.946 . . . . 73.4 107.362 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -82.4 179.61 7.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.217 0.207 . . . . 65.22 110.699 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.07 32.56 0.52 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.784 1.659 . . . . 73.32 115.752 -171.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -128.2 80.74 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.705 -2.331 . . . . 72.13 104.705 168.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.76 18.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.123 1.329 . . . . 65.34 107.546 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -128.62 -13.89 4.71 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.363 1.065 . . . . 70.3 112.955 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -164.11 167.88 19.71 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.407 1.883 . . . . 65.22 107.5 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 ttt -130.87 145.5 52.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.225 -2.139 . . . . 72.01 105.225 169.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 t -111.85 161.98 15.78 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.57 0.7 . . . . 65.01 109.981 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.42 40.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.312 1.445 . . . . 74.04 110.284 170.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.64 58.28 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 121.439 -0.788 . . . . 63.25 108.993 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.47 -174.95 38.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.747 -0.941 . . . . 74.23 110.747 -173.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.8 p -134.9 168.42 19.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.722 0.772 . . . . 72.41 110.892 -173.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.69 147.14 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.046 1.738 . . . . 71.44 106.731 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 t -152.09 164.5 37.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.092 -0.707 . . . . 44.35 109.092 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.12 155.64 43.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.667 -1.235 . . . . 72.35 107.667 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.82 22.39 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.421 1.488 . . . . 71.21 109.343 167.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.36 173.75 12.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.498 1.919 . . . . 54.05 110.368 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 176.39 8.18 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.687 1.195 . . . . 71.22 112.474 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.98 153.92 42.71 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 113.652 -1.613 . . . . 61.12 112.959 -173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.65 -10.51 44.89 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.663 1.125 . . . . 43.13 114.278 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -64.6 117.34 7.26 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 106.622 -1.621 . . . . 71.32 106.622 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -102.4 168.37 9.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.155 0.582 . . . . 72.14 110.074 -168.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 23' ' ' PHE . 12.6 tp -157.53 150.19 23.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.41 -1.7 . . . . 73.34 106.41 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -141.04 132.92 27.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 105.814 -1.921 . . . . 71.15 105.814 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 mm -127.64 133.81 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.767 -1.568 . . . . 72.15 106.767 -172.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.81 129.03 41.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.882 -1.525 . . . . 70.12 106.882 -168.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.17 121.05 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.315 1.046 . . . . 75.05 108.399 -173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.51 141.54 45.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.013 -1.477 . . . . 72.15 107.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.97 144.35 15.93 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 124.76 1.171 . . . . 73.12 111.155 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 100' ' ' GLU . 88.1 m-85 -131.63 151.39 51.65 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.67 1.588 . . . . 74.15 111.303 -165.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.5 mt -137.92 140.96 39.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.109 -1.812 . . . . 60.03 106.109 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t0 61.02 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.678 1.991 . . . . 74.11 110.829 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.67 20.82 1.31 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.52 1.528 . . . . 74.03 111.076 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -143.94 158.01 43.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 120.55 -1.344 . . . . 60.14 111.954 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 5.9 pm0 -80.82 156.1 26.3 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.249 -1.019 . . . . 63.05 108.249 168.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.88 -5.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.01 0.524 . . . . 73.35 112.181 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -151.8 130.15 12.08 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.802 -1.186 . . . . 74.14 109.226 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.53 142.88 18.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.642 0.777 . . . . 74.44 110.153 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.48 169.21 21.43 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.896 -0.779 . . . . 72.15 108.896 159.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.98 135.73 37.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.617 -1.623 . . . . 73.25 106.617 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.72 167.35 17.37 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 123.83 0.852 . . . . 73.21 109.547 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.56 131.22 7.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.774 -1.103 . . . . 74.34 108.143 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 16.5 m-85 -145.16 146.97 31.99 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.849 -0.797 . . . . 72.43 108.849 -171.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.25 147.02 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.716 -1.216 . . . . 71.53 107.716 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -77.07 138.66 39.68 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.627 2.371 . . . . 65.53 111.172 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -125.88 55.11 1.47 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.467 1.107 . . . . 73.13 109.281 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.59 3.96 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.047 1.308 . . . . 73.52 112.558 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.07 -174.97 5.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.505 1.522 . . . . 72.52 113.967 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.0 142.4 58.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.098 1.359 . . . . 64.12 109.161 165.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.6 tt -108.05 143.08 37.26 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.743 -0.836 . . . . 63.22 108.743 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mm -143.21 158.83 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 128.929 2.891 . . . . 73.45 106.017 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -172.82 170.61 4.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.606 2.362 . . . . 63.45 109.074 158.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.5 p -143.13 150.69 39.79 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 72.34 110.179 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -147.04 168.73 20.82 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.617 0.767 . . . . 51.14 110.689 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 p -158.39 111.58 2.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.102 -0.374 . . . . 74.21 111.185 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.62 88.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.189 -1.411 . . . . 74.14 107.189 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 155.52 19.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.449 -1.315 . . . . 63.41 107.449 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.9 p -91.78 30.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.725 -1.234 . . . . 70.2 109.727 174.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -170.51 145.27 2.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.605 -1.31 . . . . 74.14 108.517 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -166.34 -171.57 1.98 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 129.313 3.045 . . . . 63.23 104.792 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 pt . . . . . 0 C--O 1.255 1.359 0 N-CA-C 108.363 -0.977 . . . . 60.11 108.363 162.925 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.158 0 N-CA-C 111.16 -0.776 . . . . 70.44 111.16 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.99 30.32 0.59 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.61 1.564 . . . . 70.11 112.865 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -91.23 176.56 6.53 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.52 1.128 . . . . 65.2 108.141 161.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -134.18 111.71 10.51 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.798 1.639 . . . . 73.21 107.082 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -147.26 105.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.355 1.062 . . . . 52.41 109.914 -158.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -121.82 115.24 22.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.064 1.345 . . . . 74.43 107.403 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 p -118.05 170.44 8.84 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.717 1.207 . . . . 74.14 109.249 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.22 -115.42 0.65 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.929 -2.068 . . . . 54.24 107.929 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.52 82.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.621 -0.881 . . . . 74.11 108.621 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -64.16 153.33 38.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.864 -0.791 . . . . 73.04 108.864 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -138.33 153.01 48.99 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.367 -1.345 . . . . 74.42 107.367 167.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -122.28 140.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.982 -2.599 . . . . 73.12 103.982 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.37 133.7 61.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 105.753 -1.943 . . . . 74.3 105.753 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -138.57 129.06 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.65 -0.87 . . . . 63.14 108.65 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -117.05 161.72 18.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.014 0.526 . . . . 73.21 110.517 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -147.77 146.35 29.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.784 0.834 . . . . 61.13 109.766 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.78 -177.16 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.111 0.964 . . . . 64.13 109.713 166.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.64 -95.49 0.7 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.714 -1.355 . . . . 50.44 109.714 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -122.81 122.62 39.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.175 -2.528 . . . . 62.0 104.175 157.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 p -118.66 9.54 12.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.361 0.665 . . . . 73.41 111.274 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -88.48 -33.62 17.75 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.827 1.651 . . . . 71.3 110.032 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.87 26.15 6.68 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.921 1.688 . . . . 70.41 110.049 -167.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 80' ' ' SER . 81.2 m-85 -128.93 148.06 50.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.929 0.891 . . . . 73.43 109.504 165.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.04 154.38 19.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.262 1.825 . . . . 64.34 108.748 163.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.76 102.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.413 -2.439 . . . . 74.3 104.413 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 p -97.44 148.15 23.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.419 -0.956 . . . . 73.31 108.419 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.62 120.42 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.234 1.014 . . . . 62.23 110.667 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 t -59.58 136.04 57.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.359 -1.349 . . . . 63.2 107.359 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 40' ' ' LEU . 41.7 mt -130.43 116.37 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 105.124 -2.176 . . . . 64.3 105.124 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.12 174.57 36.08 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.01 0.814 . . . . 64.44 111.5 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.34 172.17 35.75 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.139 1.828 . . . . 72.43 110.219 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.07 168.94 18.55 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.108 0.963 . . . . 70.32 111.439 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.06 179.31 7.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.316 1.446 . . . . 73.22 113.987 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.69 71.81 1.01 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 74.21 109.946 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.24 -0.5 3.22 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 117.73 -1.594 . . . . 65.4 115.336 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.91 -166.78 39.46 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 120.509 2.154 . . . . 61.3 115.037 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.07 135.97 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.186 3.257 . . . . 65.51 109.102 163.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.77 102.78 12.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.954 -1.022 . . . . 70.14 108.864 -172.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -46.22 118.02 1.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.204 1.001 . . . . 65.04 110.898 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.2 mm? -81.42 154.67 26.27 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 120.254 1.388 . . . . 71.02 108.953 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -123.6 141.15 52.29 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.819 1.247 . . . . 74.43 110.346 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.9 173.36 12.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.799 -1.091 . . . . 65.13 110.9 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -80.48 8.36 7.88 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.44 0.904 . . . . 73.11 113.44 -170.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -105.43 -1.87 24.46 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.8 1.64 . . . . 73.1 111.266 165.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.81 55.51 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 118.766 -1.019 . . . . 74.04 114.656 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -107.28 150.79 26.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.15 1.475 . . . . 74.31 111.393 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -70.49 152.63 43.8 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.472 -0.566 . . . . 61.34 109.472 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.88 2.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 114.034 1.124 . . . . 74.13 114.034 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.25 -173.63 35.41 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 108.429 -1.868 . . . . 53.51 108.429 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -124.76 0.21 8.06 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.915 1.358 . . . . 74.33 113.451 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -151.3 150.72 30.87 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.938 2.495 . . . . 71.4 105.979 158.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -171.68 -178.08 2.16 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.397 1.879 . . . . 74.14 107.552 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -135.73 103.97 5.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.631 0.772 . . . . 73.41 109.434 172.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.44 154.52 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.528 0.604 . . . . 70.23 109.801 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.885 -1.524 . . . . 51.42 106.885 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -71.45 96.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.415 -1.328 . . . . 64.41 107.415 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -109.04 22.92 15.27 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.691 -1.256 . . . . 72.4 110.067 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -137.16 154.54 50.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.478 1.111 . . . . 63.22 108.69 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.3 67.22 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.605 0.595 . . . . 73.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -151.54 173.66 14.35 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.484 -0.76 . . . . 74.31 109.644 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -152.6 163.29 39.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 129.388 3.075 . . . . 70.34 108.801 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -158.8 157.82 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.383 1.473 . . . . 74.41 109.564 159.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.31 144.81 33.41 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.285 1.834 . . . . 64.43 106.804 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 p -127.77 -172.78 2.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.801 1.24 . . . . 53.22 110.044 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 p -125.01 -179.47 4.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.642 1.177 . . . . 64.14 109.2 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -74.22 -177.25 2.91 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.84 -0.8 . . . . 72.3 108.84 153.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.58 44.58 1.83 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.405 1.002 . . . . 54.5 110.896 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -142.92 89.4 2.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.878 -1.527 . . . . 72.02 106.878 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.07 179.83 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.895 1.678 . . . . 61.02 109.991 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -132.36 -16.0 2.78 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.888 1.07 . . . . 73.24 113.888 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -161.36 169.57 21.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.577 -1.268 . . . . 72.43 107.577 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.0 ttt -136.98 158.7 43.87 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 105.607 -1.997 . . . . 73.23 105.607 164.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -135.26 161.52 35.15 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.657 0.783 . . . . 70.24 109.935 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 104.48 3.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.798 1.239 . . . . 73.23 108.592 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.84 140.21 42.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.425 -1.324 . . . . 41.23 107.425 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.96 -150.73 5.83 Favored Glycine 0 C--N 1.331 0.269 0 O-C-N 121.186 -0.946 . . . . 65.01 113.176 -159.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -148.85 171.04 16.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 41.23 110.325 159.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.31 147.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.301 1.841 . . . . 70.12 106.472 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -155.02 167.59 29.86 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.09 -1.006 . . . . 61.43 111.655 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 10.2 t -139.42 148.98 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.237 1.815 . . . . 64.01 107.54 166.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.77 32.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.376 1.871 . . . . 62.42 107.737 170.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.16 -175.08 2.7 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.836 1.254 . . . . 74.12 110.522 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.34 163.31 23.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.402 1.881 . . . . 73.2 110.123 176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.59 163.05 2.63 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.321 1.848 . . . . 50.41 111.965 165.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.93 36.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 118.422 -1.21 . . . . 62.14 114.23 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -64.14 154.3 35.09 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.674 1.737 . . . . 74.03 108.066 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -136.98 161.72 35.27 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.043 0.937 . . . . 72.42 109.001 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 tp -155.8 133.69 11.27 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.982 -1.118 . . . . 74.03 107.982 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -132.26 88.76 2.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.196 1.398 . . . . 63.31 109.068 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.31 138.12 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.076 2.15 . . . . 63.22 108.441 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.9 m -126.14 140.3 52.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.161 -1.422 . . . . 74.43 107.161 169.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.515 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -135.64 124.58 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.468 1.507 . . . . 72.13 107.565 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mt -133.38 147.7 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.472 1.509 . . . . 72.31 107.532 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.5 141.8 11.42 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 124.458 1.028 . . . . 61.4 113.067 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.66 153.31 47.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.722 1.609 . . . . 74.01 110.896 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mt -121.24 107.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 N-CA-C 106.47 -1.678 . . . . 72.41 106.47 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t0 73.36 -64.7 0.39 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.864 2.066 . . . . 61.33 110.62 172.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 -7.66 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.311 2.244 . . . . 71.02 111.78 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.5 129.93 56.17 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 114.075 1.139 . . . . 65.33 114.075 -163.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.39 121.73 26.6 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 -1.53 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.698 . . . . 64.13 112.886 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -149.0 139.5 22.52 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.606 1.094 . . . . 65.14 108.225 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -157.42 149.21 22.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.578 -0.897 . . . . 63.32 108.578 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -149.72 164.06 36.27 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.474 -0.565 . . . . 74.24 109.474 160.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -137.03 147.55 46.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.987 1.315 . . . . 70.24 108.129 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -142.85 169.15 18.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.703 0.683 . . . . 61.33 110.391 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -139.91 139.86 36.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.376 -1.713 . . . . 63.21 106.376 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.93 153.26 51.89 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.55 1.14 . . . . 72.44 108.375 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -141.29 138.23 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.754 -1.573 . . . . 74.14 106.754 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 p -81.01 147.67 30.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.173 0.897 . . . . 44.52 110.214 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -136.62 28.85 2.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.712 0.805 . . . . 74.0 111.46 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.45 -26.33 13.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.132 1.349 . . . . 31.34 112.601 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -77.34 168.31 20.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.562 1.545 . . . . 74.43 109.278 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 m -67.12 112.34 4.37 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.847 -1.168 . . . . 74.42 107.847 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.07 135.65 44.85 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.782 -1.192 . . . . 74.04 107.782 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -146.64 153.64 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.274 -2.491 . . . . 70.12 104.274 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.33 169.63 15.59 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.023 0.929 . . . . 63.23 110.697 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.3 p -138.25 148.64 44.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.408 0.623 . . . . 73.22 109.453 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.01 173.89 11.15 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.404 1.882 . . . . 70.0 109.09 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -168.61 119.78 0.77 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.855 -0.528 . . . . 62.21 111.026 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.06 92.27 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.089 1.356 . . . . 71.44 108.335 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 m -88.27 159.82 17.94 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 71.12 108.878 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.15 -2.81 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.634 -1.291 . . . . 53.33 112.608 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -158.69 127.33 5.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.95 -1.5 . . . . 71.43 106.95 -166.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -172.55 126.46 0.51 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.379 1.072 . . . . 73.24 109.753 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.253 1.258 0 CA-C-O 116.987 -1.483 . . . . 53.2 108.966 171.357 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.617 0 N-CA-C 110.165 -1.174 . . . . 52.11 110.165 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.64 168.6 19.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.861 0.864 . . . . 71.04 109.354 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 t -149.39 13.03 0.84 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.966 0.728 . . . . 55.24 112.966 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -93.84 85.09 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.232 1.413 . . . . 73.3 112.297 -162.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -129.03 104.27 7.48 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.474 1.109 . . . . 64.22 109.367 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.94 107.68 18.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.851 2.061 . . . . 73.0 107.87 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.61 170.68 18.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.342 2.257 . . . . 72.3 110.24 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 -114.93 0.84 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 106.132 -2.787 . . . . 32.23 106.132 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.3 mt -130.24 110.15 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.359 1.064 . . . . 73.33 108.265 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -68.76 148.81 49.79 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.767 -0.583 . . . . 72.24 109.779 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -135.41 154.61 51.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.552 1.541 . . . . 64.14 107.414 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mm -130.87 148.92 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.312 -2.106 . . . . 63.42 105.312 170.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.32 140.79 45.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.974 -1.861 . . . . 75.33 105.974 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -139.2 134.52 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.247 -1.02 . . . . 72.52 108.247 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -137.1 161.7 35.4 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.146 -0.687 . . . . 74.33 109.146 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -136.47 155.05 50.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.332 1.053 . . . . 75.51 110.739 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.5 m -140.58 166.27 25.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.688 -1.227 . . . . 55.23 107.688 150.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.08 -161.48 19.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 124.717 1.151 . . . . 75.22 111.539 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.06 61.87 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.397 2.279 . . . . 73.53 107.909 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -66.82 11.26 0.1 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.635 2.774 . . . . 75.32 114.343 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -8.22 46.16 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.1 -1.625 . . . . 72.11 112.31 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.57 25.86 2.85 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.639 1.976 . . . . 73.45 111.853 -160.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.0 166.59 21.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.151 -0.968 . . . . 71.11 112.265 -170.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -134.65 126.79 29.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 127.657 2.383 . . . . 73.51 105.46 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 78' ' ' VAL . 22.4 t -140.93 110.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.155 -1.054 . . . . 74.11 108.155 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -125.26 121.3 33.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.867 -0.79 . . . . 62.41 108.867 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 m -110.96 126.39 68.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.324 1.449 . . . . 62.22 109.806 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 t -72.01 130.25 40.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.623 -1.991 . . . . 65.32 105.623 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.18 110.41 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.392 -2.077 . . . . 54.1 105.392 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.11 177.26 30.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.602 -0.727 . . . . 64.4 111.351 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.63 170.11 38.79 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 127.337 2.399 . . . . 74.31 107.568 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.48 161.89 32.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.531 0.666 . . . . 73.24 110.601 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -140.5 178.27 7.43 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.474 2.31 . . . . 73.22 110.426 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -78.62 81.18 4.95 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.82 -1.178 . . . . 72.33 107.82 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.65 -31.6 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-O 118.68 -1.067 . . . . 51.53 111.607 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.14 26.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.722 1.761 . . . . 64.54 111.488 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.36 141.54 56.7 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.034 2.489 . . . . 33.15 110.254 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.14 118.79 15.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.96 1.304 . . . . 53.22 110.469 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -57.23 109.83 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.969 1.258 . . . . 74.12 110.717 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.63 162.93 16.07 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.41 1.484 . . . . 74.3 110.77 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -131.94 138.73 48.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.035 1.734 . . . . 72.23 107.863 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -77.67 173.41 12.08 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.364 -0.835 . . . . 60.21 110.402 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.07 -8.87 33.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.344 1.458 . . . . 73.22 114.435 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -88.59 -14.79 36.71 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.842 1.657 . . . . 61.13 111.631 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.58 19.16 30.51 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.994 1.283 . . . . 61.33 114.1 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -109.59 147.25 33.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.619 1.709 . . . . 75.24 111.715 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.81 131.7 44.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.542 1.537 . . . . 64.41 110.163 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -130.63 4.32 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.781 1.233 . . . . 73.34 112.926 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.25 169.26 11.78 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 109.945 -1.262 . . . . 71.0 109.945 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -101.14 10.7 40.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.42 1.088 . . . . 73.42 111.426 172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 139.01 1.07 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.394 1.877 . . . . 70.32 108.24 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -175.82 -173.33 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.406 1.482 . . . . 74.41 108.65 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -134.79 122.13 21.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.788 1.235 . . . . 65.21 108.722 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.59 147.82 22.58 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.13 -1.063 . . . . 72.34 108.13 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -95.61 148.57 22.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.193 -1.04 . . . . 74.4 108.193 166.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mm -86.38 118.05 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.874 -1.158 . . . . 71.4 107.874 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.44 18.29 6.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.599 1.16 . . . . 74.43 110.954 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 p -134.26 153.98 51.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.719 0.808 . . . . 72.13 110.157 -163.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.64 -53.66 55.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.636 -0.505 . . . . 62.42 109.636 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 p -140.31 120.36 13.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.485 0.66 . . . . 71.31 110.636 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 mmm -110.69 165.01 12.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.281 1.832 . . . . 72.0 111.013 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 p -157.06 166.16 34.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.679 -1.146 . . . . 75.42 110.536 160.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 61.3 m -144.03 163.47 33.41 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.005 2.122 . . . . 55.31 106.419 165.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 13.9 p -142.51 -172.06 3.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.978 -0.749 . . . . 55.53 108.978 168.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.76 176.73 5.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.473 1.909 . . . . 74.4 107.092 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -77.27 169.78 17.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 155.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.83 78.63 1.99 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.567 -1.013 . . . . 54.43 110.567 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -151.44 -17.16 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.674 0.789 . . . . 73.23 112.602 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 167.02 16.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.188 1.395 . . . . 64.02 111.581 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -124.39 -7.22 7.56 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.083 1.353 . . . . 75.41 113.223 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -162.05 170.95 18.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.631 1.572 . . . . 75.52 107.408 168.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.4 ttt -143.44 138.75 29.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.412 -2.07 . . . . 64.1 105.412 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.9 t -126.57 143.92 51.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.297 0.953 . . . . 72.34 110.438 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.701 ' HB3' HG22 ' A' ' 121' ' ' VAL . 22.7 t -129.3 46.23 2.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.409 3.083 . . . . 74.31 108.527 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.91 35.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.178 0.991 . . . . 63.13 109.562 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.41 -151.71 6.03 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 120.44 1.473 . . . . 63.13 113.297 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 100.0 p -153.86 171.34 19.11 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.888 0.475 . . . . 75.33 112.263 160.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' VAL . 98.9 t -129.5 150.66 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.597 1.959 . . . . 73.54 107.661 170.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -152.62 165.79 34.13 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.509 -0.744 . . . . 74.45 111.236 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.6 t -144.44 158.75 43.6 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.926 2.09 . . . . 74.21 106.265 159.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.07 13.45 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.068 2.147 . . . . 71.33 108.472 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -73.64 -177.35 2.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 73.31 108.805 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.84 167.71 21.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.627 -1.17 . . . . 62.45 110.85 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.47 168.32 2.18 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.937 1.295 . . . . 54.21 112.247 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.19 -0.78 78.45 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.479 1.038 . . . . 75.42 114.288 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -88.75 114.33 25.26 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.2 1.4 . . . . 72.52 108.663 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 159.92 15.62 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.339 1.056 . . . . 74.22 108.385 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -154.19 135.76 14.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.013 -1.477 . . . . 53.42 107.013 175.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -132.9 127.79 35.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.409 -1.33 . . . . 75.42 107.409 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.0 140.11 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 124.982 1.313 . . . . 74.54 107.629 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.9 m -127.25 131.15 50.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.214 -1.772 . . . . 61.34 106.214 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 112.71 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.463 1.505 . . . . 75.44 108.658 -169.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.91 152.99 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.18 1.392 . . . . 71.21 108.594 -169.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.64 144.75 12.83 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.761 1.172 . . . . 61.04 113.531 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.64 159.78 35.36 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.235 1.814 . . . . 71.1 110.993 -168.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.22 111.99 18.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.149 -2.167 . . . . 63.4 105.149 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.6 t0 60.93 -72.84 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.898 2.479 . . . . 60.02 113.292 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.77 15.07 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.177 2.191 . . . . 73.04 110.942 -173.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -128.11 153.16 47.15 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.003 -1.686 . . . . 53.34 109.987 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -93.9 139.53 30.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.113 -1.069 . . . . 54.43 108.113 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.94 -26.23 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.958 1.095 . . . . 53.1 113.958 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -118.75 135.34 54.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.615 2.007 . . . . 72.31 107.568 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -154.25 145.76 23.15 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.183 0.516 . . . . 75.51 112.009 159.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -141.92 174.37 10.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.917 -1.038 . . . . 73.12 111.145 152.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -130.59 165.66 22.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.763 1.625 . . . . 74.25 107.418 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 162.77 39.78 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.677 -0.64 . . . . 64.33 109.481 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -142.29 146.51 35.15 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.07 0.948 . . . . 74.13 109.587 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -148.88 153.62 38.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.021 1.328 . . . . 61.33 108.959 -173.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.59 134.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.54 -1.282 . . . . 74.54 107.54 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -62.47 128.69 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.621 1.168 . . . . 74.55 108.543 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -116.45 -5.12 11.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.418 1.487 . . . . 64.24 112.073 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.29 8.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.093 2.283 . . . . 31.52 110.981 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -76.61 170.45 16.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.293 1.047 . . . . 71.41 108.649 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -72.37 113.15 9.09 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.205 -0.934 . . . . 73.33 108.816 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.18 113.95 5.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.117 -1.438 . . . . 74.15 107.117 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.52 141.06 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 104.433 -2.432 . . . . 60.41 104.433 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.95 166.77 31.05 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.638 1.175 . . . . 75.12 109.223 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -139.61 155.23 47.57 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.757 1.623 . . . . 75.31 106.743 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -154.76 164.03 39.4 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.76 1.224 . . . . 74.51 108.616 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -166.45 146.78 6.1 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 123.185 1.469 . . . . 64.34 113.576 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 74' ' ' CYS . 3.5 m -141.67 134.27 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 112.177 -2.283 . . . . 74.1 109.428 -174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.23 135.27 35.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.638 -1.616 . . . . 41.33 106.638 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.25 -10.74 51.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.098 0.863 . . . . 71.11 113.139 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 123.11 13.29 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 106.61 -1.626 . . . . 72.42 106.61 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -136.34 44.77 2.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.845 1.258 . . . . 72.14 108.197 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.25 1.1 0 C-N-CA 129.232 3.013 . . . . 62.43 107.168 -168.645 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.667 0 CA-C-O 119.803 -0.443 . . . . 62.1 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.02 158.05 38.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.083 0.941 . . . . 72.33 108.733 171.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -9.3 28.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.356 1.063 . . . . 64.04 112.343 168.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -68.2 94.73 0.53 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.103 1.361 . . . . 71.44 110.196 -171.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -126.91 16.27 7.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 63.23 111.943 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -116.95 138.81 51.3 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.12 2.168 . . . . 64.33 107.333 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -149.8 -164.19 1.96 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 130.484 3.514 . . . . 74.23 106.445 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.83 -109.49 0.54 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 107.153 -2.379 . . . . 33.41 107.153 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -140.65 110.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 129.665 3.186 . . . . 63.21 103.638 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -74.2 158.75 33.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.258 -1.016 . . . . 62.23 108.258 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 153.42 34.11 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.008 1.323 . . . . 54.33 108.789 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mm -141.54 149.78 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 106.238 -1.764 . . . . 72.33 106.238 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.5 OUTLIER -142.64 135.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.323 -2.217 . . . . 71.42 106.626 -164.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.55 144.1 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 107.382 -1.34 . . . . 74.31 107.382 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -129.95 165.45 22.07 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.422 0.689 . . . . 73.05 109.437 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -139.47 169.88 16.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 71.42 108.283 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.21 168.42 25.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.62 -1.622 . . . . 63.34 106.62 161.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.62 -144.37 18.22 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 119.579 1.081 . . . . 51.43 112.607 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -78.44 74.01 4.98 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 123.724 1.726 . . . . 42.25 108.276 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -73.76 15.05 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.935 1.294 . . . . 72.12 113.372 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.37 16.79 4.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.046 1.738 . . . . 72.05 111.951 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -145.41 7.6 1.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.543 1.537 . . . . 72.42 112.48 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.78 112.17 13.35 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.813 1.245 . . . . 72.45 109.1 -159.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.64 126.01 28.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.185 1.394 . . . . 42.24 108.51 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.8 113.57 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.397 -1.705 . . . . 73.01 106.397 164.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -112.33 148.57 33.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.79 0.805 . . . . 65.43 109.732 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.81 118.19 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.704 1.602 . . . . 74.04 108.65 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -77.94 129.86 35.85 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.344 -1.725 . . . . 72.03 106.344 166.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -126.86 149.32 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.732 -1.21 . . . . 74.12 107.732 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.21 174.46 46.76 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.711 -0.956 . . . . 73.41 110.711 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 169.45 42.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.125 -1.99 . . . . 43.1 108.125 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 126.28 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.947 1.699 . . . . 44.12 109.679 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.6 -171.14 1.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.332 1.053 . . . . 72.34 110.759 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -72.28 79.35 0.99 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 73.31 109.079 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.21 61.57 0.93 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.436 -1.466 . . . . 53.21 109.436 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.43 -176.48 30.64 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-O 119.566 -0.574 . . . . 71.42 113.199 158.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.78 135.78 24.24 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.986 2.457 . . . . 73.1 108.827 155.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.14 115.61 24.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 117.884 -1.055 . . . . 41.42 109.173 -170.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -47.72 111.58 0.44 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.824 1.193 . . . . 44.11 112.123 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.73 168.71 19.34 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.768 0.827 . . . . 74.42 109.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -135.33 163.11 30.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.637 1.975 . . . . 70.23 109.824 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -111.7 -176.96 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.008 1.723 . . . . 72.4 110.827 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.89 -16.26 60.67 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.504 0.927 . . . . 74.3 113.504 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -71.37 -24.06 62.02 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.984 -1.073 . . . . 73.21 109.375 168.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.21 27.56 25.25 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 125.684 1.611 . . . . 43.24 112.118 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.75 152.37 20.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.257 -1.386 . . . . 74.4 107.257 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.43 35.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.639 1.109 . . . . 74.01 108.066 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 pt -138.21 37.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 174.48 40.27 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.465 -1.454 . . . . 63.42 109.465 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.95 0.58 18.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.757 1.223 . . . . 72.2 112.563 -173.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.7 p -170.55 165.7 8.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.383 1.473 . . . . 54.21 109.536 152.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -179.52 -179.25 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.966 1.706 . . . . 73.22 107.853 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m -116.11 154.44 29.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.237 -1.394 . . . . 73.23 107.237 155.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.28 172.44 11.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.206 1.403 . . . . 72.0 108.018 171.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.14 129.01 37.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.71 0.804 . . . . 63.42 109.205 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -74.74 104.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.178 -1.416 . . . . 71.43 107.178 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 38.35 3.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.909 1.284 . . . . 63.32 109.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -147.92 169.76 19.16 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.704 0.802 . . . . 74.01 109.017 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.41 -43.33 77.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.101 -0.999 . . . . 63.34 110.327 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 p -137.64 147.44 44.95 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.277 1.431 . . . . 54.34 109.019 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mmm -140.12 165.96 25.95 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.163 1.785 . . . . 51.12 110.008 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.6 p -171.4 162.54 6.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.768 -1.56 . . . . 51.22 111.016 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.08 163.53 32.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.657 1.983 . . . . 74.31 107.339 160.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.6 p -140.09 -166.9 2.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.655 1.182 . . . . 71.42 109.902 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.02 156.96 43.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.405 1.082 . . . . 71.24 109.222 -168.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.91 159.27 28.99 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.012 0.911 . . . . 44.41 109.464 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.58 66.9 3.82 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 114.95 -1.023 . . . . 51.1 111.006 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -140.67 -12.68 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.611 1.565 . . . . 70.24 110.25 162.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.11 166.4 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.529 1.132 . . . . 52.4 112.31 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -127.61 -0.8 6.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.744 2.018 . . . . 74.12 113.152 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.31 -179.07 4.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.187 2.595 . . . . 74.1 107.99 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttt -154.28 146.24 23.56 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.009 -1.848 . . . . 64.0 106.009 160.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -124.36 170.41 10.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.503 0.721 . . . . 74.32 110.751 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.63 21.09 0.71 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.461 1.504 . . . . 74.42 111.944 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 115.3 2.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 127.017 2.127 . . . . 44.12 109.78 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.25 -179.62 30.53 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 109.638 -1.385 . . . . 52.51 109.638 -156.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 34.4 p -149.15 158.53 44.26 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.905 -0.647 . . . . 63.33 110.772 -165.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.8 146.62 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 105.216 -2.142 . . . . 45.11 105.216 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.5 m -152.32 170.55 19.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.444 -1.41 . . . . 74.31 110.932 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.78 165.98 27.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.427 1.491 . . . . 61.44 109.071 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.5 pt -155.73 10.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 127.564 2.345 . . . . 64.25 110.993 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -99.39 -170.6 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.045 0.926 . . . . 62.45 109.964 -167.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.32 163.07 8.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.41 1.084 . . . . 70.41 109.339 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.55 158.88 9.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.086 . . . . 51.45 111.318 165.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.01 1.5 59.66 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.708 1.147 . . . . 74.55 113.989 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -72.93 114.82 11.51 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.446 -1.687 . . . . 73.42 106.446 167.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -83.65 163.13 20.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.484 0.714 . . . . 72.52 109.864 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.41 136.65 10.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.588 -1.634 . . . . 64.23 106.588 171.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -129.28 143.98 51.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.219 -1.771 . . . . 60.12 106.219 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 mm -128.74 144.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 126.068 1.747 . . . . 44.42 108.25 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -146.88 133.83 20.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.602 -1.629 . . . . 73.43 106.602 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.42 120.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 107.211 -1.403 . . . . 75.04 107.211 -168.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.542 ' HB ' HG23 ' A' ' 13' ' ' VAL . 51.5 mt -133.06 156.3 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 107.965 -1.124 . . . . 63.42 107.965 -168.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.05 138.2 8.69 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.257 1.408 . . . . 72.14 111.11 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HE2' HG21 ' A' ' 13' ' ' VAL . 43.0 m-85 -132.45 147.64 52.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.733 2.013 . . . . 73.44 109.83 -162.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.02 114.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.953 1.701 . . . . 75.0 108.281 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.261 7.1 t0 49.51 -64.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 131.475 3.91 . . . . 63.23 114.267 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.38 39.43 0.66 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.939 1.245 . . . . 75.14 112.984 166.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.21 148.65 49.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.807 1.243 . . . . 64.01 111.184 177.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -79.4 143.7 34.81 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.225 -1.769 . . . . 63.41 106.225 161.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.91 -28.08 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.052 1.13 . . . . 41.21 114.052 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -148.11 142.32 26.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.391 1.45 . . . . 54.45 108.255 -163.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -172.13 155.91 3.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.264 1.026 . . . . 74.31 111.105 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -150.1 173.48 13.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.532 0.606 . . . . 61.43 109.782 161.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -134.75 152.9 52.12 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.432 -0.951 . . . . 75.35 108.432 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.1 170.55 15.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.415 0.686 . . . . 73.44 110.383 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.64 153.08 41.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.289 -1.745 . . . . 61.21 106.289 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.401 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 55.5 m-85 -142.58 154.57 44.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.242 2.217 . . . . 74.31 106.977 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.64 134.13 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.222 -2.881 . . . . 61.44 103.222 162.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -70.88 148.54 47.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.81 10.19 3.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.671 0.388 . . . . 53.11 111.07 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.59 -9.93 16.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.828 2.156 . . . . 65.53 112.152 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -85.06 168.51 14.82 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.355 -1.085 . . . . 74.11 109.873 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -59.94 160.99 7.07 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.648 -0.501 . . . . 61.44 109.648 154.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.19 129.96 36.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.306 -0.998 . . . . 65.55 108.306 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -152.98 141.14 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.292 1.837 . . . . 65.12 106.501 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -161.78 168.11 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.389 1.875 . . . . 74.55 109.319 177.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 64.7 p -130.97 172.9 11.54 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.76 1.624 . . . . 74.15 108.764 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -151.55 166.9 29.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.158 0.583 . . . . 72.04 110.519 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -152.5 132.07 13.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 122.508 1.147 . . . . 74.21 111.532 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -141.85 96.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 130.415 3.486 . . . . 54.24 103.759 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.5 t -81.5 -179.13 7.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.836 -1.542 . . . . 71.03 106.836 157.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.0 p -130.04 14.42 5.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.385 1.074 . . . . 71.23 111.055 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.16 113.16 3.68 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.449 -1.407 . . . . 62.03 107.62 166.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.94 139.14 22.29 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 128.432 2.693 . . . . 75.44 104.892 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 C--O 1.25 1.106 0 N-CA-C 104.195 -2.52 . . . . 75.32 104.195 -179.515 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.661 0 N-CA-C 110.978 -0.849 . . . . 72.31 110.978 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.07 110.62 23.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.948 1.299 . . . . 74.14 109.213 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 m -149.93 162.85 39.53 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.561 -1.274 . . . . 43.33 107.561 165.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.24 136.47 57.22 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.631 0.772 . . . . 71.42 109.944 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -139.68 15.62 2.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.91 1.448 . . . . 75.43 114.91 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -133.86 113.56 12.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.813 2.445 . . . . 63.24 108.24 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -171.42 -173.77 1.3 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.035 2.134 . . . . 62.44 106.511 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.74 -100.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 125.122 1.344 . . . . 64.24 109.906 168.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.2 mt -108.63 97.49 5.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.255 -2.128 . . . . 60.21 105.255 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.73 154.13 22.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.87 -1.159 . . . . 74.3 107.87 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.04 150.41 41.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.224 -1.398 . . . . 55.15 107.224 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 mm -120.92 150.44 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.56 -2.015 . . . . 75.25 105.56 165.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.88 133.37 64.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.047 -2.205 . . . . 75.35 105.047 171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.97 140.88 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 108.399 -0.963 . . . . 74.43 108.399 -171.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -147.58 156.02 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.105 0.866 . . . . 74.23 111.798 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -139.72 154.03 47.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.652 1.581 . . . . 73.23 110.637 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 m -150.03 156.14 41.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.674 2.79 . . . . 64.13 106.712 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.88 -112.71 2.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.373 -1.491 . . . . 72.54 109.373 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -117.1 99.09 6.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.352 1.461 . . . . 74.42 107.381 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 p -74.78 -1.03 20.23 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.571 0.952 . . . . 53.02 113.571 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.1 -19.86 13.21 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.851 1.26 . . . . 53.01 110.32 -166.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.3 m -120.15 37.44 4.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.641 1.976 . . . . 75.21 110.888 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.898 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -150.23 122.93 8.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.544 1.164 . . . . 73.21 109.16 171.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.23 90.87 6.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.433 -1.692 . . . . 73.14 106.433 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.829 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.8 t -81.16 113.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.939 2.096 . . . . 52.32 108.042 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -114.63 144.57 43.2 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.485 1.039 . . . . 63.31 109.231 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 m -137.65 122.87 24.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.393 -1.276 . . . . 74.33 110.328 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -68.98 141.66 54.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.677 -1.601 . . . . 71.43 106.677 160.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.4 mt -130.7 107.41 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 103.916 -2.624 . . . . 63.15 103.916 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.1 30.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.367 0.508 . . . . 60.04 111.907 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.82 172.01 43.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.429 1.966 . . . . 61.24 109.483 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.86 163.28 16.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 121.599 -0.942 . . . . 71.01 110.759 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -138.88 -172.76 3.39 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.933 2.493 . . . . 61.13 109.502 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -71.65 -19.48 62.09 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 55.22 113.014 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 -31.52 10.74 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.446 -1.062 . . . . 75.43 110.446 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.41 -95.69 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.522 2.011 . . . . 72.12 108.416 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.68 135.2 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.695 2.263 . . . . 75.35 111.532 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.93 122.99 28.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.588 0.755 . . . . 73.32 109.103 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -61.13 121.34 12.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.044 0.538 . . . . 63.33 110.26 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.0 165.89 14.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.945 0.898 . . . . 75.22 109.526 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -129.98 157.37 42.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.803 1.241 . . . . 75.14 109.103 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.43 171.17 9.93 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.726 0.81 . . . . 72.22 109.487 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.05 -25.34 66.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.975 0.731 . . . . 75.31 112.975 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -71.63 -25.18 62.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.081 1.353 . . . . 74.33 110.668 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.35 17.73 9.74 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 125.085 1.326 . . . . 74.35 113.612 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -94.53 145.95 24.45 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.771 1.786 . . . . 73.14 110.253 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.16 146.64 54.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.553 -0.906 . . . . 71.02 108.553 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.09 -16.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.998 1.481 . . . . 75.45 114.998 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.65 164.17 29.07 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 120.062 1.301 . . . . 54.55 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.7 5.68 23.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.381 1.091 . . . . 64.01 112.445 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -166.29 145.55 5.87 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.503 2.321 . . . . 74.05 107.055 156.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -168.59 -179.76 3.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.96 1.304 . . . . 75.01 108.433 168.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -120.11 161.52 20.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.924 0.89 . . . . 60.45 108.94 160.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 120.79 14.07 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.129 -1.434 . . . . 40.22 107.129 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.39 134.33 45.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.197 -1.038 . . . . 73.04 108.197 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.13 91.35 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.315 -1.735 . . . . 64.45 106.315 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -100.58 46.08 0.96 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.136 0.974 . . . . 75.23 109.591 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -150.35 163.39 38.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.536 1.134 . . . . 75.33 108.411 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.7 -35.92 73.0 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.191 -0.943 . . . . 74.15 110.802 169.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.2 p -140.23 152.3 45.84 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.071 0.948 . . . . 64.25 110.951 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mmm -153.08 172.46 16.84 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 126.571 1.948 . . . . 63.32 111.326 -168.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -167.4 166.09 14.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.418 1.887 . . . . 63.43 111.163 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -156.98 160.87 39.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.921 2.888 . . . . 60.42 106.983 160.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.82 -179.78 6.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.478 0.656 . . . . 63.01 111.658 165.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -123.85 -176.87 3.58 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.784 1.634 . . . . 64.02 110.148 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.17 157.49 26.86 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.657 0.741 . . . . 75.22 111.735 173.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.69 96.53 0.1 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.015 2.245 . . . . 64.24 108.607 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 178.78 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 130.874 3.67 . . . . 75.1 105.731 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.4 173.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.648 1.979 . . . . 63.13 114.857 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -134.88 -12.47 2.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.711 2.005 . . . . 60.34 113.757 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -158.21 174.41 15.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.43 1.014 . . . . 73.14 108.887 166.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.3 ttt -137.81 155.13 49.34 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.635 1.974 . . . . 74.34 106.65 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -143.94 167.03 23.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.875 0.761 . . . . 73.02 110.72 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.0 t -143.9 29.61 1.35 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.614 2.766 . . . . 72.03 109.351 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.08 113.14 3.72 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 72.21 109.209 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.49 -154.13 8.08 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 110.367 -1.093 . . . . 54.43 110.367 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -154.51 171.73 18.93 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.702 0.763 . . . . 52.31 111.477 155.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.898 HG13 ' CE1' ' A' ' 23' ' ' PHE . 93.9 t -120.97 145.58 27.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 125.932 1.693 . . . . 72.33 107.983 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.1 t -151.87 160.67 43.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.506 0.594 . . . . 61.24 111.173 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 t -140.69 158.77 43.5 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.927 1.691 . . . . 64.24 109.057 166.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.85 24.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 126.69 1.996 . . . . 72.41 110.032 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -97.08 -176.48 3.56 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.494 1.043 . . . . 64.31 110.595 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.32 167.73 3.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.238 1.415 . . . . 72.43 110.276 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.92 167.16 1.26 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.958 1.303 . . . . 74.02 112.937 159.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 -13.07 52.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 117.753 -1.582 . . . . 40.44 114.776 168.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -57.11 161.13 3.28 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 119.432 1.616 . . . . 51.55 108.413 159.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -140.16 162.0 36.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.627 -1.249 . . . . 74.41 107.627 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.34 145.57 22.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.596 -1.261 . . . . 60.25 107.596 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -140.69 117.99 11.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.65 -1.982 . . . . 60.15 105.65 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 23' ' ' PHE . 13.5 mm -96.52 151.22 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 72.32 108.508 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -139.11 131.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.648 -1.612 . . . . 71.05 106.648 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -132.3 126.38 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.399 1.479 . . . . 40.31 109.114 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.88 140.32 46.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.597 -1.631 . . . . 63.42 106.597 -173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.75 133.13 6.9 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.224 -1.15 . . . . 72.22 110.224 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -120.24 154.59 34.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.286 1.834 . . . . 75.34 109.973 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.8 mt -148.62 137.19 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.803 2.041 . . . . 72.3 105.693 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t0 44.52 53.88 6.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.19 1.796 . . . . 75.3 111.982 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.27 23.87 14.05 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.038 1.735 . . . . 72.34 113.969 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 45.5 mtpt -132.52 153.78 50.61 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 120.751 -1.218 . . . . 71.42 111.923 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.78 145.6 46.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.95 -1.5 . . . . 64.2 106.95 164.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.43 -6.14 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.618 -0.706 . . . . 52.5 112.847 161.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -159.77 143.47 14.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.542 1.519 . . . . 75.4 110.046 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -165.45 124.47 1.7 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.511 -0.922 . . . . 74.03 108.511 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.7 pp -138.57 169.14 18.32 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.106 0.879 . . . . 75.12 110.932 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -126.59 171.61 10.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.274 . . . . 62.15 108.703 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 161.13 43.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.303 -0.629 . . . . 75.15 109.303 166.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -127.37 135.89 51.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.26 151.77 48.89 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.509 1.124 . . . . 71.44 108.581 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -143.62 124.46 10.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.361 -2.089 . . . . 55.11 105.361 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -64.13 130.41 43.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.329 -0.619 . . . . 62.02 109.329 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -105.4 -1.18 25.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.081 1.352 . . . . 64.44 111.863 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.33 -24.65 10.38 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.46 1.505 . . . . 74.23 111.129 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -82.22 163.63 21.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.009 0.923 . . . . 75.35 109.531 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.13 106.18 1.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.426 1.09 . . . . 62.23 110.296 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 131.55 46.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.618 -0.882 . . . . 60.21 108.618 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 mt -148.87 138.36 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.708 1.603 . . . . 63.33 107.715 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.8 170.13 4.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.051 1.74 . . . . 64.02 110.164 -171.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.4 p -141.55 170.41 15.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.471 2.308 . . . . 74.11 108.161 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.8 164.88 38.18 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.097 1.759 . . . . 75.12 107.61 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.4 p -152.64 123.73 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.186 -0.946 . . . . 72.23 110.475 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.7 t -135.67 92.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.755 -2.313 . . . . 60.12 104.755 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.53 148.59 24.05 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.342 -1.725 . . . . 74.23 106.342 163.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.1 p -110.71 29.39 7.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.089 0.956 . . . . 54.41 110.113 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -156.68 117.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.8 -1.926 . . . . 74.24 105.8 166.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.23 89.33 3.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.39 -1.337 . . . . 75.41 107.39 176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.593 -1.194 . . . . 63.14 109.241 164.924 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.654 0 N-CA-C 108.373 -1.891 . . . . 74.45 108.373 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.06 177.04 9.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.525 -1.287 . . . . 75.43 107.525 152.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -163.75 175.71 10.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.0 0.92 . . . . 64.45 108.767 163.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.3 93.04 4.12 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.264 1.026 . . . . 75.11 109.762 -160.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -141.96 118.47 10.94 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.074 2.15 . . . . 75.15 109.946 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -127.06 140.76 52.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.663 1.585 . . . . 64.14 107.041 159.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t -135.66 172.95 12.27 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 128.47 2.708 . . . . 63.41 107.712 161.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.29 -98.24 0.3 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 106.777 -2.529 . . . . 73.32 106.777 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.89 159.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.337 1.855 . . . . 63.33 107.093 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -125.57 137.5 53.92 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.446 1.899 . . . . 74.45 107.579 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.93 150.52 44.64 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.251 -0.906 . . . . 63.22 108.887 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mm -140.74 150.34 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 105.748 -1.945 . . . . 75.33 105.748 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 93' ' ' ILE . 1.3 m -143.26 132.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 127.221 2.209 . . . . 44.03 106.861 -165.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.33 153.13 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 107.699 -1.223 . . . . 61.35 107.699 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -141.49 163.48 32.83 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.067 0.947 . . . . 75.23 109.53 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.28 156.15 39.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.86 1.264 . . . . 55.11 108.824 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -159.17 147.88 18.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.498 1.519 . . . . 61.44 109.92 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.89 -131.39 6.61 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.783 -0.927 . . . . 73.03 110.783 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.415 ' OD1' HD13 ' A' ' 88' ' ' LEU . 1.7 p-10 -71.94 50.5 0.2 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.845 2.858 . . . . 72.12 113.577 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -63.22 7.19 0.1 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 74.14 114.552 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.08 -18.01 12.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.779 2.032 . . . . 74.0 112.062 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.34 36.64 3.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.755 2.022 . . . . 75.12 112.111 -169.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CD2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -123.42 155.47 37.36 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.466 1.106 . . . . 71.03 108.689 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.51 121.0 29.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.93 -1.878 . . . . 73.5 105.93 171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' CD2' ' A' ' 23' ' ' PHE . 90.4 t -137.84 106.84 4.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.081 -1.822 . . . . 60.13 106.081 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 112.32 20.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.015 -1.476 . . . . 75.11 107.015 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.34 135.09 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.285 -1.746 . . . . 64.12 106.285 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -90.82 139.14 31.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.952 2.101 . . . . 75.24 107.778 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.42 133.1 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.293 -2.114 . . . . 75.45 105.293 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.16 168.18 41.12 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.965 2.221 . . . . 63.43 108.976 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.68 175.74 39.85 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.074 -2.01 . . . . 73.21 108.074 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.25 157.32 31.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.403 1.101 . . . . 53.21 109.487 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.59 -171.13 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.956 1.702 . . . . 74.12 111.852 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -78.06 64.01 3.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.713 1.205 . . . . 73.54 110.101 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.21 3.1 1.97 Allowed Glycine 0 CA--C 1.517 0.172 0 CA-C-O 118.0 -1.444 . . . . 53.04 113.798 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.26 35.16 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 119.709 1.754 . . . . 74.34 112.588 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.86 144.3 24.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.467 2.778 . . . . 74.21 109.14 162.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.42 115.42 16.15 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.502 1.121 . . . . 61.12 109.699 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.31 128.7 36.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.382 0.992 . . . . 75.13 108.543 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 166.49 11.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.008 0.923 . . . . 73.44 109.732 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.7 155.73 42.22 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.758 1.623 . . . . 73.21 111.07 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.93 169.16 9.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.57 -1.65 . . . . 64.54 110.238 166.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.13 5.57 2.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.726 1.611 . . . . 73.52 112.908 -170.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -90.4 -8.88 49.5 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.488 1.515 . . . . 74.13 111.133 168.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.17 17.37 69.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.961 -0.911 . . . . 60.35 112.974 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.35 147.0 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.126 1.463 . . . . 62.13 108.522 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -75.0 159.58 31.6 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.03 -0.73 . . . . 73.24 109.03 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -144.88 23.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.73 0.812 . . . . 63.14 112.799 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.92 -176.99 16.51 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.41 -1.476 . . . . 40.02 109.41 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -121.15 11.51 10.9 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.538 1.135 . . . . 73.42 111.876 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -169.39 150.65 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.902 1.281 . . . . 75.54 110.459 165.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -176.19 -175.15 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.454 1.502 . . . . 63.45 109.218 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -141.21 102.84 4.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.113 0.965 . . . . 63.41 109.689 172.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.24 115.4 21.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.766 -0.828 . . . . 73.55 108.766 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -66.23 142.39 57.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.844 -1.169 . . . . 72.41 107.844 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -82.8 120.96 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.065 -1.828 . . . . 75.42 106.065 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -142.51 43.55 1.62 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.573 1.549 . . . . 74.42 108.961 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p -146.24 168.72 20.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.986 -1.116 . . . . 55.51 107.986 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.09 72.09 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.624 -0.672 . . . . 55.13 111.661 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -154.26 162.14 41.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.37 1.068 . . . . 64.35 108.971 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 mmm -143.38 171.72 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.75 2.82 . . . . 62.43 110.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.17 166.63 23.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.291 1.436 . . . . 61.12 110.928 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.3 m -149.9 167.64 26.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.999 2.519 . . . . 71.44 107.963 160.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.67 -174.89 4.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.853 1.261 . . . . 51.23 111.007 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.8 p -128.43 175.77 8.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.278 1.831 . . . . 74.34 109.748 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.85 -169.48 2.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.55 -0.908 . . . . 73.15 108.55 159.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 37.54 0.54 Allowed Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.833 -1.167 . . . . 61.42 113.976 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -140.73 78.14 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.158 1.383 . . . . 63.53 107.572 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.55 34.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.525 1.53 . . . . 74.14 109.954 159.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.46 -9.13 9.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.037 1.735 . . . . 75.31 111.693 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -161.49 172.37 16.54 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.608 -1.256 . . . . 75.44 107.608 167.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.9 ttt -152.59 111.67 3.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.462 -2.051 . . . . 75.45 105.462 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -95.51 154.62 17.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.53 110.026 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.593 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -137.18 90.92 2.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.962 2.105 . . . . 63.24 105.498 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.79 46.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.93 -152.79 6.49 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 109.935 -1.266 . . . . 62.53 109.935 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.38 168.13 23.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.163 -1.051 . . . . 73.45 108.163 156.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.63 148.08 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.988 1.315 . . . . 75.32 108.844 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.88 171.32 14.99 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.296 -0.631 . . . . 41.34 109.296 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.613 ' CB ' HD23 ' A' ' 115' ' ' LEU . 20.8 t -151.38 149.44 29.31 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.374 -1.713 . . . . 75.04 106.374 163.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.44 10.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 124.526 1.131 . . . . 74.02 110.031 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -80.48 -173.54 4.15 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.034 0.934 . . . . 62.14 111.321 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -72.08 163.44 27.89 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.983 -0.448 . . . . 72.31 111.387 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 162.27 3.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.701 1.6 . . . . 72.2 113.539 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.33 4.33 90.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.431 1.015 . . . . 62.1 114.36 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -83.63 163.91 20.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.349 -1.352 . . . . 63.41 107.349 168.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -153.35 153.24 32.2 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.307 -0.854 . . . . 74.43 110.812 -163.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD13 ' OD1' ' A' ' 19' ' ' ASP . 11.9 tp -154.95 136.43 14.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.843 -1.54 . . . . 74.44 106.843 -172.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -136.93 97.8 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.453 1.501 . . . . 74.34 108.775 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.43 132.42 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.916 1.286 . . . . 61.12 108.176 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.0 m -110.2 147.55 33.54 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.269 -1.012 . . . . 41.25 108.269 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.76 103.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.064 1.746 . . . . 74.53 110.201 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 13' ' ' VAL . 24.4 mt -112.59 157.43 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 107.472 -1.307 . . . . 63.31 107.472 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.71 132.81 4.56 Favored Glycine 0 C--N 1.336 0.529 0 O-C-N 120.454 -1.404 . . . . 41.33 111.324 -170.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.443 ' HE2' HG21 ' A' ' 13' ' ' VAL . 83.9 m-85 -125.01 147.83 48.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.44 1.496 . . . . 75.24 111.455 -170.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 123' ' ' THR . 33.0 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 128.939 2.895 . . . . 64.35 105.161 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.63 63.49 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.771 1.229 . . . . 43.03 111.749 164.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.42 18.75 5.85 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.414 2.286 . . . . 71.51 116.101 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.11 151.77 46.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.316 -1.49 . . . . 72.51 112.552 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -86.81 136.46 32.97 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.433 -1.321 . . . . 75.13 107.433 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 96' ' ' ILE . 23.0 m -130.42 -10.51 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 62.52 113.12 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -144.9 141.02 28.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.737 1.153 . . . . 73.53 107.907 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.94 132.04 9.99 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.602 -0.518 . . . . 71.22 109.602 167.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.16 -175.8 4.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.575 0.702 . . . . 63.42 109.861 160.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.8 179.87 7.52 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.832 2.053 . . . . 71.52 108.399 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 176.22 12.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.05 -1.463 . . . . 60.54 107.05 171.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -147.29 137.88 23.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.391 -1.337 . . . . 55.41 107.391 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.22 157.45 46.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.571 0.748 . . . . 53.44 110.213 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mt -147.02 142.95 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.221 -1.77 . . . . 72.04 106.221 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -82.48 147.3 28.78 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 118.92 0.782 . . . . 73.43 110.394 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.57 26.25 2.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.923 0.868 . . . . 74.41 112.235 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.9 -16.02 61.36 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.196 1.855 . . . . 61.0 111.883 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -83.17 171.68 13.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.076 1.35 . . . . 75.11 109.463 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.69 111.09 2.25 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.855 -1.153 . . . . 41.13 109.425 162.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.613 HD23 ' CB ' ' A' ' 80' ' ' SER . 13.1 tp -73.12 132.23 43.03 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.808 -1.923 . . . . 72.22 105.808 163.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.3 mt -154.31 148.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.375 -2.454 . . . . 60.3 104.375 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.16 173.17 10.49 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.849 1.66 . . . . 54.35 109.357 168.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.0 p -129.33 172.95 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.234 1.492 . . . . 74.41 108.09 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.87 154.41 29.76 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 126.675 1.99 . . . . 71.42 106.103 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.4 p -155.97 127.13 7.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.228 0.537 . . . . 75.15 110.222 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' A' ' 74' ' ' CYS . 15.0 p -133.03 152.35 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.317 1.447 . . . . 74.34 107.874 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.6 t -134.82 -175.75 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.996 -1.113 . . . . 35.22 107.996 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.506 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.0 p -134.05 38.74 3.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.571 1.149 . . . . 75.45 109.061 167.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.72 122.6 0.51 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.532 -1.284 . . . . 63.33 107.532 166.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -116.04 112.91 22.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.336 -1.357 . . . . 75.22 107.336 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.079 -2.563 . . . . 74.55 104.079 178.238 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.519 0 N-CA-C 111.533 -0.627 . . . . 72.01 111.533 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.42 157.2 38.47 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.224 -1.399 . . . . 70.04 107.224 147.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -163.15 61.88 0.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.571 0.749 . . . . 71.3 110.038 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.02 88.18 1.38 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.928 -0.767 . . . . 72.0 108.928 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -140.76 103.5 4.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.36 1.464 . . . . 72.33 107.157 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.48 107.48 4.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.725 2.01 . . . . 72.41 106.531 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p -130.12 172.7 11.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.716 1.606 . . . . 65.34 107.703 169.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.76 -106.23 0.24 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 107.684 -2.166 . . . . 72.13 107.684 -172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.38 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 N-CA-C 106.129 -1.804 . . . . 71.14 106.129 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.99 143.44 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.497 -0.927 . . . . 74.02 108.497 171.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 162.84 34.39 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.171 0.588 . . . . 72.21 109.98 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 mm -129.66 153.24 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.065 1.746 . . . . 72.43 107.322 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 t -124.66 134.57 66.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 104.128 -2.545 . . . . 71.42 104.128 163.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 105.972 -1.862 . . . . 74.35 105.972 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.15 165.85 17.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.671 -0.492 . . . . 62.55 109.671 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.03 155.56 40.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.692 0.62 . . . . 73.34 111.623 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.0 m -145.1 142.94 30.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.578 1.151 . . . . 53.42 108.328 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.52 -150.71 23.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.29 -0.881 . . . . 74.42 111.545 -169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.4 68.82 9.87 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.781 2.032 . . . . 72.12 107.258 170.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -78.79 24.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.174 1.546 . . . . 61.41 115.174 -158.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -135.33 12.82 3.53 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.47 1.108 . . . . 61.25 110.427 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -131.81 17.44 4.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 62.55 111.87 -168.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -133.25 130.19 38.67 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.366 0.985 . . . . 73.24 109.433 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -89.73 68.29 7.51 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.256 1.822 . . . . 74.41 109.069 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.31 92.08 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 127.518 2.327 . . . . 62.15 113.173 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -89.57 139.62 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.745 1.157 . . . . 73.34 109.519 165.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.56 164.5 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.345 -0.983 . . . . 71.45 108.345 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -127.23 129.83 48.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.868 2.867 . . . . 72.15 105.499 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.53 121.27 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.54 -1.652 . . . . 65.21 106.54 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -162.18 172.44 38.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.63 1.11 . . . . 24.14 110.392 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.2 176.26 43.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.11 1.338 . . . . 73.35 110.01 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.01 46.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.262 0.625 . . . . 70.05 111.884 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.92 139.35 50.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.945 2.098 . . . . 61.03 110.865 162.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.308 16.1 ttpp 43.16 32.93 0.5 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.521 1.929 . . . . 63.13 114.308 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 33.98 23.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.529 -0.732 . . . . 71.44 111.86 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.69 175.23 36.57 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.314 1.911 . . . . 74.13 109.856 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 152.04 45.59 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 74.23 112.492 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.09 130.61 56.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.44 1.096 . . . . 73.43 110.627 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -64.06 116.68 6.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.087 0.858 . . . . 72.23 110.612 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD11 ' HA2' ' A' ' 30' ' ' GLY . 1.1 mt -96.05 158.58 15.38 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.921 2.088 . . . . 61.12 109.51 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 11.6 m-85 -130.84 139.83 50.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.021 1.328 . . . . 70.13 110.988 -170.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -78.35 177.19 8.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 113.748 -1.569 . . . . 74.15 110.777 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.11 -5.62 18.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.535 1.534 . . . . 74.34 114.51 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -114.19 20.63 15.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.122 1.769 . . . . 74.33 110.938 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.41 8.24 87.06 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 124.306 0.955 . . . . 54.41 114.379 162.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.52 149.45 26.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.826 2.45 . . . . 74.53 108.849 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 23.6 p90 -76.1 161.46 28.83 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.36 -11.83 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.787 0.835 . . . . 63.43 112.359 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.36 -171.39 35.83 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 109.055 -1.618 . . . . 41.32 109.055 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -110.05 3.02 19.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.143 1.777 . . . . 70.11 111.181 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 p -173.36 117.11 0.27 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.53 1.132 . . . . 42.43 109.292 -166.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -171.48 -178.27 2.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.291 0.95 . . . . 73.23 111.177 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.93 161.78 18.8 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.702 1.601 . . . . 72.23 109.593 166.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.7 29.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.319 1.448 . . . . 32.44 107.586 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -111.81 141.19 45.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.926 2.09 . . . . 73.04 110.299 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.79 86.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 121.035 1.743 . . . . 72.25 110.317 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -108.66 18.63 20.63 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.889 0.876 . . . . 73.14 112.363 175.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -117.32 158.98 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.92 1.288 . . . . 53.14 108.782 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -49.94 62.07 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.543 -0.723 . . . . 61.53 109.125 168.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.5 p -141.29 113.77 8.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.398 0.679 . . . . 74.35 110.736 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mmm -115.18 167.98 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.113 2.165 . . . . 45.45 111.145 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.1 p -150.96 165.65 33.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.03 0.932 . . . . 61.52 110.524 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 m -143.88 159.14 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.594 -1.632 . . . . 53.41 106.594 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.5 p -148.09 -168.2 3.01 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.816 0.735 . . . . 64.05 109.792 166.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 t -124.7 179.25 5.05 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.893 1.677 . . . . 71.43 106.971 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.53 -176.39 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.831 0.853 . . . . 50.41 109.427 163.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.09 23.75 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.157 -0.802 . . . . 54.54 113.324 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -135.23 94.68 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.598 -1.63 . . . . 72.14 106.598 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.32 158.99 16.77 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.957 1.303 . . . . 63.24 110.02 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -114.12 -28.06 7.45 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.453 1.501 . . . . 64.41 112.214 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.75 170.49 19.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.512 -1.292 . . . . 61.33 107.512 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 ttt -146.93 154.09 40.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 102.935 -2.987 . . . . 73.44 102.935 171.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.0 t -140.78 149.02 41.55 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.234 -0.916 . . . . 52.44 110.421 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.606 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -125.6 66.09 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.119 -1.808 . . . . 65.22 106.119 -177.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.86 143.73 55.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.974 -1.491 . . . . 63.35 106.974 167.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.28 178.73 43.5 Favored Glycine 0 CA--C 1.509 -0.309 0 CA-C-N 119.999 1.272 . . . . 65.25 111.987 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -142.5 159.21 42.67 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.556 1.142 . . . . 50.22 110.38 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.81 131.59 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.232 -1.395 . . . . 62.45 107.232 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -137.92 169.3 18.02 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.931 -0.557 . . . . 61.21 110.379 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -142.09 169.88 16.75 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.539 1.136 . . . . 65.35 109.921 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.96 0.55 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.358 2.663 . . . . 64.43 111.244 167.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -73.81 177.47 5.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.682 1.193 . . . . 44.22 109.866 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -68.79 174.14 4.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.897 0.879 . . . . 53.41 111.817 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.32 158.52 23.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.785 2.034 . . . . 62.41 112.763 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.36 -0.4 41.19 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.605 1.098 . . . . 34.53 114.337 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -70.58 131.25 43.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 104.916 -2.253 . . . . 70.25 104.916 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -111.39 162.02 15.49 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.412 0.685 . . . . 61.45 109.47 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -165.17 121.43 1.43 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 105.905 -1.887 . . . . 65.42 105.905 176.28 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -111.3 137.06 49.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.311 -1.737 . . . . 74.34 106.311 169.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 mm -117.73 121.63 67.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.702 -1.592 . . . . 65.43 106.702 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -95.09 131.03 41.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.896 -1.891 . . . . 75.53 105.896 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.11 104.05 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.939 1.296 . . . . 73.33 110.176 -174.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.26 152.71 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 75.51 108.338 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.61 152.88 22.27 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 124.456 1.027 . . . . 64.15 112.403 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -136.45 155.25 50.26 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.953 1.301 . . . . 70.2 110.826 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -130.32 83.24 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.104 -1.813 . . . . 74.33 106.104 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.285 3.0 p-10 49.64 7.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 1 C-N-CA 132.126 4.17 . . . . 73.11 117.369 162.02 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.86 -41.34 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.767 2.027 . . . . 72.14 109.644 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 158.66 44.13 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.595 1.158 . . . . 64.4 110.603 -167.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.44 146.79 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.444 -2.428 . . . . 71.5 104.444 163.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.68 -3.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 123.448 0.699 . . . . 72.43 110.836 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -156.77 141.06 16.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.047 -1.033 . . . . 72.24 108.496 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.95 129.27 12.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.995 -1.113 . . . . 65.23 107.995 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -132.49 160.58 36.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.286 -1.005 . . . . 71.45 108.286 163.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -145.39 121.79 10.97 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.126 -1.805 . . . . 72.22 106.126 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -131.31 161.56 32.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.658 0.663 . . . . 72.25 109.892 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.82 156.17 47.55 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 126.625 1.97 . . . . 74.54 110.839 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 115' ' ' LEU . 39.1 m-85 -151.63 124.79 8.72 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.891 1.677 . . . . 71.31 107.092 -165.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -135.7 130.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.536 -1.283 . . . . 74.14 107.536 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -72.26 152.96 41.83 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.437 1.095 . . . . 65.11 110.0 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -148.31 28.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.38 -0.825 . . . . 73.33 111.966 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.94 -48.63 0.92 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.517 1.532 . . . . 71.33 109.793 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -74.76 173.42 10.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.915 1.286 . . . . 71.05 112.441 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -72.43 100.46 2.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.34 -1.355 . . . . 70.14 107.34 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 108' ' ' TYR . 8.3 tt -60.68 134.58 57.22 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.157 -0.925 . . . . 72.21 108.824 171.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 mt -152.57 133.5 4.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.526 1.53 . . . . 74.12 107.881 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 74.02 112.071 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 p -144.12 150.72 38.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.115 0.966 . . . . 64.11 112.196 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -133.3 173.85 11.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.595 1.558 . . . . 72.31 110.191 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 p -156.39 119.73 4.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.253 1.021 . . . . 70.05 108.611 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 74' ' ' CYS 0.313 10.4 p -121.88 86.42 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.964 1.364 . . . . 64.04 109.106 174.202 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 p -70.21 173.4 6.73 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.216 1.406 . . . . 62.23 110.127 164.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 p -130.55 9.69 5.11 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.316 -0.865 . . . . 64.42 112.877 166.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -146.86 125.7 12.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.852 -1.907 . . . . 74.14 105.852 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -142.13 155.85 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.807 0.843 . . . . 74.04 108.792 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.251 1.183 0 C-N-CA 129.533 3.133 . . . . 70.12 110.087 -167.451 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 110.135 -1.186 . . . . 63.34 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.03 121.02 26.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.974 0.91 . . . . 43.43 108.84 167.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.4 m -143.43 174.35 10.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.263 1.425 . . . . 62.54 107.562 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -132.3 146.58 52.09 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.186 -1.042 . . . . 73.32 108.186 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.92 84.99 2.04 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.478 1.511 . . . . 64.31 108.622 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -120.4 104.42 10.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.263 2.225 . . . . 72.32 107.677 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.4 p -140.47 175.6 9.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.564 1.146 . . . . 52.34 110.446 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.57 -116.82 1.98 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 106.572 -2.611 . . . . 73.22 106.572 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.93 128.99 68.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.535 -1.283 . . . . 64.42 107.535 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -97.85 157.96 15.79 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.541 -0.911 . . . . 54.34 108.541 171.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -143.1 150.42 39.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.815 -1.55 . . . . 74.33 106.815 167.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.58 155.45 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 106.197 -1.779 . . . . 64.44 106.197 165.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.59 126.17 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.434 -2.432 . . . . 54.33 104.434 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.1 mt -121.93 154.27 26.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.582 -1.636 . . . . 73.13 106.582 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.12 168.22 20.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.457 0.572 . . . . 54.3 110.331 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -148.25 158.87 44.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.939 1.296 . . . . 74.33 109.193 164.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.175 1.39 . . . . 72.13 107.509 163.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.87 -120.04 4.12 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.463 -1.455 . . . . 51.33 109.463 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -96.22 118.09 32.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.275 -1.38 . . . . 63.1 107.275 159.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.5 p -100.54 -5.78 26.37 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.139 0.975 . . . . 74.12 112.108 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -37.32 38.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.07 0.948 . . . . 75.23 110.133 -169.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.33 18.74 13.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.533 1.133 . . . . 61.04 112.754 -161.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -121.44 113.4 19.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.693 0.797 . . . . 73.3 111.021 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.89 136.65 36.72 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.892 1.677 . . . . 72.04 108.112 168.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -148.77 106.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 105.497 -2.038 . . . . 73.4 105.497 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -114.96 123.51 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.421 1.009 . . . . 73.04 108.946 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.52 140.92 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.033 1.333 . . . . 53.32 110.036 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -76.12 145.41 40.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.857 -1.905 . . . . 73.44 105.857 157.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HG ' ' A' ' 40' ' ' LEU . 22.1 mt -127.57 110.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 104.962 -2.236 . . . . 71.11 104.962 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.67 172.41 35.54 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.91 -0.586 . . . . 65.51 111.774 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.35 41.74 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 128.014 2.721 . . . . 64.52 108.597 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.49 34.41 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.89 1.276 . . . . 24.15 109.792 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.07 -177.46 4.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.117 1.367 . . . . 72.33 112.501 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.98 79.25 0.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.708 -0.849 . . . . 61.2 108.708 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.12 -65.02 0.29 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.268 -1.933 . . . . 71.33 108.268 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.34 -154.32 6.87 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.849 1.214 . . . . 73.22 110.586 -156.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -67.04 142.25 60.97 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.526 2.151 . . . . 54.23 109.868 172.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.9 130.3 39.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.79 -1.189 . . . . 63.32 107.79 172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -59.47 137.73 57.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.968 -0.539 . . . . 65.33 109.592 168.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -110.45 154.56 23.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.572 1.149 . . . . 62.31 109.081 170.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -132.65 154.19 50.35 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.136 1.374 . . . . 63.43 108.737 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -77.63 178.28 7.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.726 1.61 . . . . 75.11 110.721 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.18 8.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.092 1.357 . . . . 62.44 113.551 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -119.18 -6.02 10.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.549 2.74 . . . . 75.42 111.147 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 9.38 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.304 -1.276 . . . . 60.22 114.576 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.66 142.25 27.66 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.528 2.164 . . . . 74.12 110.142 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -62.07 136.58 58.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.744 1.618 . . . . 60.12 110.856 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.38 9.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.562 0.949 . . . . 55.41 113.562 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.17 171.25 12.24 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.665 -1.374 . . . . 43.24 109.665 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.1 p30 -103.11 1.56 33.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.231 1.012 . . . . 52.33 110.774 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -159.14 129.04 5.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.238 2.215 . . . . 31.33 107.671 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -161.87 -179.64 7.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.69 1.196 . . . . 74.22 109.216 161.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 p -117.13 161.68 19.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.143 1.377 . . . . 53.14 109.614 159.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.02 166.7 24.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.834 0.854 . . . . 74.31 109.175 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -114.9 139.91 49.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.621 1.168 . . . . 62.04 111.033 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mm -82.04 72.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 107.288 -1.375 . . . . 65.03 107.288 172.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 17.06 7.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.088 1.355 . . . . 72.34 111.527 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 p -137.65 147.07 44.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.998 -0.741 . . . . 62.1 108.998 -171.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.92 66.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.152 0.981 . . . . 73.12 110.633 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.6 p -135.05 162.56 32.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.153 -1.055 . . . . 71.31 108.153 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.9 169.46 24.53 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.095 1.758 . . . . 71.11 109.388 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.66 148.61 6.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.125 1.37 . . . . 75.44 110.671 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 64.7 m -134.99 150.8 50.4 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.55 -0.907 . . . . 74.34 108.55 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.2 p -142.9 -179.08 6.14 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.287 0.635 . . . . 73.14 112.09 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.3 p -132.26 -177.72 4.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.883 1.673 . . . . 73.31 109.438 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.76 -173.98 2.43 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.031 -1.1 . . . . 74.21 108.031 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.0 -13.43 26.8 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.697 -0.627 . . . . 53.12 114.362 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -88.23 83.75 6.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.458 1.129 . . . . 73.24 108.774 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.29 178.03 7.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.343 1.057 . . . . 73.21 110.961 157.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.75 -22.34 4.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.357 1.463 . . . . 74.32 112.81 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.48 177.21 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.353 1.461 . . . . 72.11 109.272 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.5 ttt -147.44 154.1 40.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.914 1.685 . . . . 73.2 106.589 163.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 t -128.34 155.55 44.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 72.31 109.905 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -140.51 42.37 1.88 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.629 2.371 . . . . 63.33 109.904 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 120' ' ' SER . . . -69.09 142.39 54.48 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.048 -1.032 . . . . 72.22 110.971 165.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.78 -176.03 39.81 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.852 -0.899 . . . . 64.53 110.852 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 86.7 p -131.81 167.53 19.4 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.076 0.95 . . . . 72.54 110.53 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.68 153.3 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.224 -1.399 . . . . 62.31 107.224 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p -159.79 142.89 14.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.254 0.934 . . . . 72.34 111.705 166.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -148.37 159.79 43.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.233 1.413 . . . . 64.13 108.509 173.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.86 25.75 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.267 1.827 . . . . 73.12 110.163 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -73.61 -159.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.075 1.35 . . . . 64.0 110.394 174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -83.99 169.02 15.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.156 0.982 . . . . 65.31 110.136 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 162.47 7.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 73.34 112.028 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.83 -2.27 80.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.276 1.417 . . . . 54.5 113.891 174.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -72.79 115.62 12.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.617 1.709 . . . . 72.33 106.658 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -96.05 164.81 12.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.638 -0.875 . . . . 62.11 108.638 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.1 tp -155.78 147.59 23.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.963 0.801 . . . . 72.32 109.035 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -148.15 98.17 2.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.813 1.645 . . . . 71.33 108.255 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.74 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.997 2.119 . . . . 71.4 108.124 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -128.19 146.46 50.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.103 1.361 . . . . 72.41 108.383 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.34 105.97 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.573 1.949 . . . . 54.23 110.749 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.02 139.05 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.198 1.399 . . . . 21.21 108.995 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.31 146.21 17.91 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.658 1.123 . . . . 61.13 111.464 -166.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -131.85 157.62 43.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.252 1.421 . . . . 73.34 110.2 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -131.41 130.76 63.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.949 -2.241 . . . . 73.33 104.949 167.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.65 -76.44 0.06 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.6 2.36 . . . . 70.23 111.031 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -149.37 1.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.519 1.928 . . . . 70.11 112.664 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.88 145.63 50.17 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.621 1.1 . . . . 70.31 111.412 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.81 126.08 33.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.353 1.461 . . . . 71.4 109.883 -172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.43 -1.44 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.687 0.995 . . . . 65.41 113.687 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -154.51 128.01 8.56 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 72.3 108.184 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.42 123.73 18.07 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.127 0.876 . . . . 70.24 110.204 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.43 175.11 9.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.562 0.696 . . . . 64.1 110.47 160.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.25 173.88 15.0 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.836 2.854 . . . . 71.04 107.104 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.48 176.0 9.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.062 0.945 . . . . 74.42 108.76 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -139.17 137.98 36.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.68 -1.23 . . . . 74.03 107.68 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.639 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 2.1 m-85 -132.43 160.88 35.12 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.138 -1.06 . . . . 73.23 108.138 170.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -143.51 148.11 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.646 -1.983 . . . . 74.43 105.646 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.4 p -76.32 139.35 41.0 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.038 -1.097 . . . . 73.32 108.038 164.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.91 2.9 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.194 1.398 . . . . 51.24 111.124 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.28 38.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.866 1.698 . . . . 41.1 111.366 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -90.6 159.99 16.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.682 1.241 . . . . 71.4 107.687 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.1 113.14 1.77 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.975 0.91 . . . . 73.32 109.775 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.82 130.24 41.75 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.55 -1.278 . . . . 72.22 107.55 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -162.18 153.73 3.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 103.901 -2.629 . . . . 62.3 103.901 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.639 ' HG2' ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp20? -165.58 176.15 8.35 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.004 2.121 . . . . 74.22 106.512 160.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.2 p -141.87 142.24 33.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.067 -0.716 . . . . 52.23 109.067 167.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -125.92 169.02 13.1 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.512 1.525 . . . . 73.22 109.865 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 10.5 p -170.23 143.11 2.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.362 1.065 . . . . 54.4 108.731 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 74' ' ' CYS . 6.3 p -162.77 128.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 102.641 -3.096 . . . . 62.41 102.641 -167.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 m -134.85 143.42 47.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.686 -1.227 . . . . 62.54 107.686 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.84 -16.71 58.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.325 -0.55 . . . . 64.1 111.28 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -132.44 137.09 47.15 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 105.888 -1.893 . . . . 71.41 105.888 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -167.23 123.96 1.18 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 102.432 -3.173 . . . . 53.23 102.432 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.25 1.104 0 CA-C-N 119.035 0.834 . . . . 73.53 110.028 179.596 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 110.014 -1.234 . . . . 61.14 110.014 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.33 155.61 32.54 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.474 1.11 . . . . 51.31 108.331 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 p -154.36 152.95 30.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.726 -1.212 . . . . 73.24 107.726 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -167.33 122.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.157 -1.794 . . . . 72.11 106.157 -170.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -149.45 103.91 3.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.898 2.079 . . . . 70.11 110.553 -169.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -127.99 109.21 11.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.659 1.584 . . . . 64.12 109.894 -166.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -132.64 177.46 7.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.599 1.96 . . . . 61.52 110.496 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.98 -129.15 6.91 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.642 -2.183 . . . . 64.23 107.642 -162.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.0 123.08 50.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.904 1.682 . . . . 73.54 110.427 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -95.11 147.06 23.84 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.504 1.122 . . . . 73.5 109.426 170.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 62' ' ' SER . 34.2 tttt -148.88 151.81 35.34 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.113 0.965 . . . . 72.2 109.044 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.25 149.46 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.702 2.401 . . . . 74.23 106.572 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.19 131.76 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.345 -2.094 . . . . 74.44 105.345 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 74' ' ' CYS . 51.7 mt -127.96 149.01 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.877 -1.527 . . . . 63.42 106.877 -173.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -145.58 161.72 39.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.536 -0.542 . . . . 72.41 109.536 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -153.32 159.86 42.59 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.756 0.788 . . . . 65.03 112.627 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -145.48 174.39 11.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.635 1.574 . . . . 52.15 108.882 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.12 -154.92 19.54 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.885 1.231 . . . . 75.03 110.538 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.12 50.67 0.15 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.09 2.156 . . . . 65.12 111.191 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -54.48 -36.22 63.92 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 129.454 3.102 . . . . 74.23 111.662 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.87 -28.68 64.38 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.645 1.178 . . . . 63.43 111.223 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.7 m -93.33 -0.48 56.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.809 1.644 . . . . 63.35 113.432 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.813 ' CE2' HG22 ' A' ' 25' ' ' VAL . 1.2 t80 -119.77 123.06 42.79 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 123.525 1.631 . . . . 73.42 110.964 -169.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.72 79.48 8.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.001 2.921 . . . . 72.14 110.697 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.813 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.0 t -75.88 91.83 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.331 1.453 . . . . 61.03 107.774 176.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -94.98 129.94 41.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.132 -1.433 . . . . 73.23 107.132 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.79 154.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.645 -1.613 . . . . 70.05 106.645 174.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 49.9 m -112.07 152.08 28.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.365 1.066 . . . . 65.41 109.172 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 40' ' ' LEU . 58.3 mt -122.15 157.39 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.035 -1.098 . . . . 53.3 108.035 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.96 179.54 48.05 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.824 1.202 . . . . 64.12 110.515 172.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.78 166.89 35.08 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 127.053 2.263 . . . . 65.3 108.438 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.46 165.51 27.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.959 1.379 . . . . 73.03 111.418 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -140.07 179.24 6.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.498 . . . . 73.24 110.587 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -75.5 72.01 2.47 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.534 1.534 . . . . 65.34 109.536 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.46 -5.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 118.459 -1.189 . . . . 63.12 114.333 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.41 -159.0 27.68 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.27 1.535 . . . . 54.52 110.872 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.35 161.72 41.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.605 2.87 . . . . 65.01 111.856 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -89.51 121.52 31.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.211 1.404 . . . . 70.44 109.29 166.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -62.4 153.77 30.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.163 0.892 . . . . 72.12 109.929 168.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD13 HG22 ' A' ' 29' ' ' ILE . 9.9 mt -133.26 160.55 36.97 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.702 1.201 . . . . 72.1 109.711 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -138.01 160.55 39.05 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.81 0.844 . . . . 75.53 110.077 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -94.85 -179.4 4.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.156 -0.929 . . . . 53.23 111.399 178.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.35 1.95 3.41 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.826 2.451 . . . . 61.43 113.709 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.516 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 31.5 mttt -112.11 -3.34 14.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.409 1.884 . . . . 72.23 112.908 166.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 6.19 85.3 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.279 0.942 . . . . 74.31 113.691 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.06 144.85 40.54 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.628 1.214 . . . . 73.24 107.856 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 122.96 20.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.362 2.265 . . . . 63.24 109.665 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.9 pt -132.86 9.79 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 115.251 1.575 . . . . 45.14 115.251 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.77 -158.77 23.65 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.302 -1.119 . . . . 71.42 110.302 167.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -128.18 -2.66 5.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.338 1.055 . . . . 74.41 111.911 162.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -151.84 123.06 7.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.601 0.76 . . . . 72.43 109.901 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -173.93 -179.46 1.73 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.678 0.791 . . . . 63.42 109.55 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 27.7 p -137.19 119.43 15.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.264 1.426 . . . . 51.33 108.012 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.81 111.12 23.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.771 1.629 . . . . 74.12 108.128 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.17 147.9 49.57 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.351 -0.981 . . . . 61.02 108.351 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mm -97.05 125.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.188 -0.671 . . . . 71.02 109.188 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 27.3 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.65 1.98 . . . . 71.25 111.777 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 p -124.8 175.47 7.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.206 1.002 . . . . 72.44 109.033 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.71 66.35 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 55.33 110.182 163.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -137.88 155.62 48.76 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.238 1.015 . . . . 35.01 111.404 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.9 mmm -139.26 167.98 20.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.826 2.051 . . . . 72.11 111.518 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' ' HE3' ' A' ' 11' ' ' LYS . 22.6 p -151.56 152.63 33.18 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.122 0.969 . . . . 71.43 110.161 168.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.6 m -145.69 148.63 33.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.208 1.403 . . . . 52.52 108.349 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.4 p -137.98 174.83 10.15 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.419 0.554 . . . . 73.44 111.295 167.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 p -108.09 168.25 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.535 -0.913 . . . . 73.1 108.535 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.5 169.77 3.6 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.32 108.795 159.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.01 -26.1 67.47 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.08 -0.844 . . . . 72.24 112.302 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.72 90.39 3.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.604 1.702 . . . . 74.43 108.09 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB2' ' CB ' ' A' ' 38' ' ' ALA . . . -161.89 173.35 14.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.038 1.335 . . . . 54.12 110.413 159.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -131.25 -12.79 3.54 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.539 2.336 . . . . 74.12 113.198 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -159.08 170.19 22.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.214 -1.402 . . . . 64.21 107.214 167.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.1 ttt -133.55 155.41 49.65 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 105.452 -2.055 . . . . 74.33 105.452 167.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -130.06 161.2 31.56 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.129 0.572 . . . . 63.04 109.505 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -149.85 41.64 0.85 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.734 1.214 . . . . 45.44 110.705 174.037 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 134.41 56.09 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.327 -0.858 . . . . 64.41 110.284 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.43 179.19 26.42 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.481 -0.648 . . . . 70.23 111.481 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.91 130.93 34.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.917 -1.142 . . . . 65.15 107.917 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.641 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 90.6 t -90.06 146.66 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.205 -1.035 . . . . 72.41 108.205 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.1 t -150.79 159.36 44.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 118.501 -1.279 . . . . 43.24 110.328 155.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 115' ' ' LEU . 12.5 t -147.88 143.97 27.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.614 -0.884 . . . . 65.25 108.614 164.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 pt -117.84 19.48 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.581 1.952 . . . . 73.15 109.404 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.8 p -79.45 175.69 10.38 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.719 1.208 . . . . 72.11 111.593 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -70.22 167.03 18.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.155 -0.93 . . . . 72.02 110.741 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.63 158.11 10.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.745 2.018 . . . . 64.03 113.055 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.73 -10.2 57.25 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.514 1.53 . . . . 71.34 114.046 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -67.09 159.31 29.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.744 1.617 . . . . 73.05 108.335 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -144.6 170.97 15.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.764 0.826 . . . . 70.42 111.06 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 tp -159.97 162.29 34.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.638 -1.245 . . . . 74.44 107.638 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -145.16 116.69 8.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.595 -1.261 . . . . 65.15 107.595 164.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.14 147.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 124.978 1.311 . . . . 74.01 107.624 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 m -127.7 138.64 52.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.304 -1.739 . . . . 73.35 106.304 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.2 112.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.527 1.931 . . . . 42.13 108.459 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -129.08 150.8 34.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.43 -1.693 . . . . 63.41 106.43 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.62 152.06 22.76 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.182 0.896 . . . . 70.44 111.245 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.54 150.23 46.15 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.795 0.838 . . . . 74.3 111.388 -164.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.8 mt -146.08 136.0 17.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 104.774 -2.306 . . . . 71.53 104.774 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.0 t70 44.5 52.68 7.42 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.744 2.018 . . . . 63.34 113.683 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t0 60.25 25.12 14.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.115 0.966 . . . . 71.13 112.795 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -126.75 156.92 40.4 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.326 -1.484 . . . . 74.13 111.308 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -97.49 119.58 36.29 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.97 1.708 . . . . 74.4 107.267 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.8 m -124.97 -2.6 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.647 0.98 . . . . 73.4 113.647 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -162.36 133.73 5.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.372 -1.344 . . . . 73.22 107.372 -172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.37 118.43 2.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.723 0.692 . . . . 74.33 111.703 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.06 168.83 18.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.59 0.709 . . . . 63.42 110.826 166.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.82 166.47 20.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.589 2.355 . . . . 74.01 108.423 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -149.14 162.33 40.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.835 -0.802 . . . . 74.31 108.835 171.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -147.94 118.37 7.41 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.008 -1.849 . . . . 72.42 106.008 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.641 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 30.6 m-85 -118.35 152.9 34.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.661 -0.866 . . . . 72.43 108.661 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.1 mt -138.36 153.77 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.281 1.432 . . . . 65.34 107.32 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -99.45 150.86 21.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.138 0.975 . . . . 62.03 110.214 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -130.45 15.1 5.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.908 1.683 . . . . 65.35 110.9 169.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.04 -24.44 18.81 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.549 1.547 . . . . 61.41 111.635 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 162.86 28.51 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.92 1.288 . . . . 73.32 109.345 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 106.73 2.68 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.254 0.622 . . . . 70.13 110.113 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 80' ' ' SER . 11.0 tp -60.85 136.28 58.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.46 -0.941 . . . . 72.05 108.46 174.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.4 mt -152.68 147.49 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 104.83 -2.285 . . . . 70.04 104.83 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.83 176.49 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.59 1.156 . . . . 71.14 109.467 163.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -131.15 160.87 33.49 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.307 1.043 . . . . 74.11 108.735 163.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -149.16 165.49 31.66 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.207 1.003 . . . . 73.03 108.704 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -165.74 142.07 5.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.447 0.641 . . . . 53.53 111.413 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.4 t -143.89 109.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.049 2.54 . . . . 63.2 104.825 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.1 144.91 29.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.983 -1.488 . . . . 70.11 106.983 169.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.0 p -92.36 44.2 1.15 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.598 1.09 . . . . 54.54 109.011 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -171.07 146.4 2.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.795 1.238 . . . . 74.32 108.034 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -101.48 138.97 37.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.566 -1.642 . . . . 73.22 106.566 157.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 126' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.417 1.887 . . . . 50.22 106.595 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.062 -1.215 . . . . 72.32 110.062 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.12 168.78 21.52 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.63 1.572 . . . . 35.22 110.811 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.4 m -137.1 46.42 2.18 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.307 2.243 . . . . 62.13 109.51 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -137.64 41.67 2.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.561 1.172 . . . . 73.0 113.196 -143.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.8 24.27 3.24 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 119.842 -1.787 . . . . 71.23 111.756 -152.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -112.3 112.53 24.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 130.339 3.456 . . . . 51.11 107.748 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -132.56 -163.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 128.123 2.569 . . . . 75.01 106.934 172.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.64 -91.1 0.14 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.444 -1.462 . . . . 53.23 109.444 163.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -139.78 110.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 105.824 -1.917 . . . . 63.41 105.824 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -78.23 140.97 38.89 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.544 -1.28 . . . . 72.41 107.544 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -135.74 157.47 46.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.55 -1.648 . . . . 74.34 106.55 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 74' ' ' CYS . 1.1 tt -135.41 153.94 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 106.266 -1.753 . . . . 74.12 106.266 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.69 125.91 26.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 105.713 -1.958 . . . . 51.24 105.713 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.0 133.79 63.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 105.529 -2.026 . . . . 72.23 105.529 -170.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -140.68 159.97 41.05 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 119.562 1.074 . . . . 72.33 109.103 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -140.27 150.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.051 0.453 . . . . 42.14 110.76 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -134.34 163.24 30.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.388 -1.338 . . . . 54.32 107.388 158.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -152.15 18.81 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.752 0.691 . . . . 72.44 111.719 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.22 72.07 9.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.399 1.095 . . . . 75.45 109.209 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -70.93 17.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.883 2.073 . . . . 74.53 115.099 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.87 -3.89 5.81 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.866 1.061 . . . . 64.41 113.866 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 t -101.22 1.32 38.83 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.945 0.793 . . . . 74.33 112.942 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -117.81 148.47 42.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.137 0.975 . . . . 74.23 112.112 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -92.29 141.55 28.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.799 -1.926 . . . . 64.31 105.799 163.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 56' ' ' ILE . 1.4 p -153.45 81.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 63.31 111.714 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 109.36 21.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.557 0.694 . . . . 75.32 110.366 -167.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 m -91.76 122.29 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.246 1.019 . . . . 62.12 109.695 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -66.77 133.72 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.175 -1.787 . . . . 35.52 106.175 160.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.38 126.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.733 -1.951 . . . . 63.33 105.733 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.22 177.86 38.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.022 0.82 . . . . 63.34 111.896 -171.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.85 167.16 29.08 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.039 2.257 . . . . 62.11 110.179 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.86 162.66 32.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.131 0.972 . . . . 75.24 111.637 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.99 -171.2 2.62 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.766 2.026 . . . . 75.14 112.332 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -78.62 65.74 3.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.586 0.755 . . . . 64.12 111.415 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.85 43.77 0.29 Allowed Glycine 0 C--N 1.323 -0.169 0 O-C-N 121.88 -0.512 . . . . 73.44 111.976 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.54 -154.9 22.75 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.053 -0.859 . . . . 74.23 111.961 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.03 159.78 37.31 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 124.267 3.311 . . . . 73.41 110.721 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.983 -1.118 . . . . 75.14 107.983 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -72.21 141.67 49.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.427 -0.953 . . . . 61.43 108.427 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 HG22 ' A' ' 65' ' ' THR . 5.0 mt -121.63 150.42 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.088 -1.449 . . . . 73.43 107.088 -171.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -131.46 134.22 45.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.542 1.137 . . . . 71.14 108.16 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -77.07 175.78 9.29 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.398 -0.819 . . . . 63.31 109.787 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -5.87 48.13 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 62.04 113.825 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.08 -5.21 50.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.277 1.431 . . . . 72.02 110.445 165.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.51 84.14 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.72 2.105 . . . . 73.32 113.131 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -101.96 142.42 33.27 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.045 1.338 . . . . 55.32 110.24 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -67.54 128.13 35.29 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.55 1.54 . . . . 75.3 109.159 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.57 20.57 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.544 0.738 . . . . 63.44 112.0 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -172.71 14.35 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.336 0.969 . . . . 65.4 110.958 174.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -118.68 9.25 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.957 1.303 . . . . 73.42 112.109 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -156.93 159.22 37.9 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.448 0.699 . . . . 71.43 110.196 150.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 p90 179.37 -175.39 0.24 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.988 1.715 . . . . 55.42 107.683 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 p -127.43 161.79 27.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.795 0.807 . . . . 62.5 109.333 157.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.77 155.23 50.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.244 -1.762 . . . . 75.04 106.244 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 20.0 tt0 -105.77 144.79 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.412 -0.959 . . . . 72.53 108.412 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 25' ' ' VAL . 38.4 mm -86.78 83.17 2.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 N-CA-C 107.338 -1.356 . . . . 74.41 107.338 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 44.4 mmm-85 -113.63 34.23 4.7 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 123.912 0.885 . . . . 73.31 111.546 176.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 p -140.92 146.95 38.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.637 -1.616 . . . . 52.35 106.637 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.78 -37.47 63.49 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.491 1.116 . . . . 71.03 110.171 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.0 p -140.94 142.62 34.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.543 1.537 . . . . 51.45 107.88 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.21 169.8 17.02 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.543 2.337 . . . . 71.41 109.485 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.9 p -167.43 161.95 14.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.993 2.117 . . . . 73.04 108.792 172.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.1 m -144.41 165.24 28.48 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.417 -1.697 . . . . 74.4 106.417 157.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.16 -178.73 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.537 0.735 . . . . 55.42 110.256 172.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.434 HG22 HD23 ' A' ' 40' ' ' LEU . 69.2 p -125.84 177.18 6.45 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.632 1.173 . . . . 73.34 108.79 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -87.49 178.96 6.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.298 -1.001 . . . . 72.04 108.298 162.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.23 17.74 3.82 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.382 -0.824 . . . . 63.1 114.647 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -105.25 85.87 2.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.094 -1.817 . . . . 61.03 106.094 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.05 172.62 18.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.563 1.074 . . . . 75.33 111.509 165.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -122.95 -17.96 6.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.2 -1.363 . . . . 75.43 111.652 164.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -157.12 173.72 16.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.999 0.92 . . . . 75.21 110.267 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.1 ttt -140.59 161.79 36.91 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.104 2.161 . . . . 74.12 105.86 165.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -140.35 160.23 40.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.478 1.111 . . . . 42.14 110.178 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HB2' HD13 ' A' ' 12' ' ' ILE . 43.9 t -148.7 39.25 0.86 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.037 2.535 . . . . 60.13 108.94 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 123.53 22.25 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.231 1.012 . . . . 73.1 109.973 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.92 29.03 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.8 -0.92 . . . . 63.35 110.8 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 95.1 p -127.24 167.43 16.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.905 0.482 . . . . 75.44 111.448 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.32 132.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 126.744 2.018 . . . . 75.41 105.952 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -144.5 162.66 35.99 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.456 0.571 . . . . 73.33 111.575 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.13 159.76 38.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.135 0.974 . . . . 60.35 110.531 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.48 32.03 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.204 1.802 . . . . 73.21 110.91 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -132.78 176.34 8.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.921 1.289 . . . . 52.23 110.742 -167.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -45.35 160.72 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.877 2.471 . . . . 75.54 116.096 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.72 157.21 21.57 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.09 -1.868 . . . . 62.32 113.002 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.1 -0.64 82.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.389 -0.673 . . . . 55.21 113.795 172.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -75.16 114.64 13.89 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.408 1.604 . . . . 55.22 106.739 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -95.88 158.66 15.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.704 -0.851 . . . . 72.43 108.704 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.7 103.0 1.53 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.502 -1.666 . . . . 75.11 106.502 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -105.07 118.53 36.76 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.881 -1.137 . . . . 75.32 109.207 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mm -107.56 134.82 48.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.759 -1.2 . . . . 73.43 107.759 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.9 m -113.13 126.53 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.77 -1.937 . . . . 73.31 105.77 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.4 127.67 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 106.976 -1.49 . . . . 74.15 106.976 175.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.8 mt -137.55 134.42 46.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.535 -1.654 . . . . 52.22 106.535 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.13 124.13 5.75 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 109.861 -1.295 . . . . 52.22 109.861 -169.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -113.95 144.22 43.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.788 1.235 . . . . 64.44 112.192 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 101' ' ' VAL . 22.8 mt -135.22 107.85 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 104.475 -2.417 . . . . 74.34 104.475 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t0 44.44 66.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.275 1.03 . . . . 64.4 111.317 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 74.79 0.78 3.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.93 2.492 . . . . 75.02 116.069 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -117.38 163.25 16.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 120.665 1.575 . . . . 71.34 113.46 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -98.91 153.86 18.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.613 -1.254 . . . . 63.33 107.613 165.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 96' ' ' ILE . 33.1 m -137.77 3.93 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.091 0.404 . . . . 54.53 112.091 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -165.18 132.96 3.1 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.515 -1.291 . . . . 73.04 107.515 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -158.61 130.25 6.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.199 0.6 . . . . 74.04 110.083 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.41 108.05 5.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.313 1.054 . . . . 64.52 110.863 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.61 156.92 34.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.341 -1.355 . . . . 73.33 107.341 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 119' ' ' PHE . 22.4 mtmm -142.72 170.21 16.12 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.113 -1.44 . . . . 74.55 107.113 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -145.6 145.31 30.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.093 -1.817 . . . . 71.33 106.093 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.26 153.42 46.51 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.523 -1.288 . . . . 71.32 107.523 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.0 mt -144.31 140.15 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.301 -1.37 . . . . 74.35 107.301 166.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -66.15 145.7 55.5 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.939 1.296 . . . . 72.15 111.168 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.8 63.77 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.667 1.222 . . . . 61.32 111.125 163.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.05 -32.13 4.16 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.821 2.153 . . . . 53.21 112.634 168.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.73 174.33 10.58 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.557 1.943 . . . . 74.42 110.065 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.4 168.7 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.391 -0.596 . . . . 60.45 109.391 159.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.71 134.0 44.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.902 -1.147 . . . . 75.11 107.902 168.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.4 mt -150.9 133.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.148 -1.427 . . . . 75.34 107.148 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -152.5 169.35 22.83 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.034 1.734 . . . . 72.21 109.876 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 53.6 p -134.74 167.84 20.11 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.755 0.822 . . . . 75.15 109.514 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.501 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 22.9 p90 -156.04 168.62 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.398 -0.819 . . . . 61.53 109.836 172.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -161.12 138.85 9.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.878 0.847 . . . . 62.12 108.989 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -145.67 100.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 104.653 -2.351 . . . . 63.15 104.653 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.06 140.3 29.9 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.632 -1.618 . . . . 64.4 106.632 168.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.449 ' O ' HD11 ' A' ' 96' ' ' ILE . 2.8 p -94.78 27.73 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.087 1.312 . . . . 44.54 111.007 170.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -161.68 118.92 2.2 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 120.049 -1.657 . . . . 72.22 108.53 161.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -147.89 115.34 6.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.343 -1.354 . . . . 62.44 107.343 170.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.257 1.464 0 C-N-CA 126.711 2.004 . . . . 61.32 109.93 167.581 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.608 -1.397 . . . . 64.42 109.608 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.98 119.93 8.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.981 -1.859 . . . . 73.33 105.981 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.3 m -131.69 88.27 2.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.475 -2.046 . . . . 64.43 105.475 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.65 108.77 2.49 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.32 -1.363 . . . . 63.22 107.32 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -132.7 91.32 2.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.639 1.209 . . . . 75.14 111.483 -168.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -83.59 98.56 9.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.137 -1.431 . . . . 74.41 107.137 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.92 159.94 31.7 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.485 -0.932 . . . . 64.54 108.485 153.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.57 -101.4 0.15 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.826 1.203 . . . . 64.11 110.88 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -134.14 117.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.202 -2.148 . . . . 75.53 105.202 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -84.38 151.16 24.87 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.759 -1.213 . . . . 74.25 109.236 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -137.67 158.43 44.39 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.387 1.075 . . . . 75.23 108.125 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.548 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.1 mm -139.3 129.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 105.315 -2.106 . . . . 63.45 105.315 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.0 t -113.11 140.17 34.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.927 1.691 . . . . 74.54 106.459 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mt -130.55 144.27 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.471 -1.677 . . . . 55.05 106.471 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.13 162.4 35.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.589 -0.893 . . . . 75.44 108.589 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -153.25 173.76 15.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.165 0.507 . . . . 72.45 112.192 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.24 150.85 20.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.052 0.941 . . . . 44.13 108.621 161.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.2 -108.38 0.37 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.145 -0.782 . . . . 61.24 111.145 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -130.34 54.88 1.84 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.547 1.539 . . . . 71.35 108.917 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.7 p -54.92 -4.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 130.938 3.695 . . . . 55.05 116.586 -165.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -95.26 -11.94 27.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.359 1.064 . . . . 71.25 111.877 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.57 33.78 4.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.545 2.338 . . . . 55.13 110.366 -170.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 88.7 m-85 -133.14 143.61 49.36 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.086 0.954 . . . . 73.13 110.098 171.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.14 58.38 0.6 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.595 1.558 . . . . 75.42 108.629 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 25' ' ' VAL . 1.5 p -62.13 125.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 124.759 1.223 . . . . 73.35 108.377 165.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.29 121.98 18.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.245 -1.02 . . . . 51.12 108.245 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.8 120.83 55.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.603 1.161 . . . . 74.23 110.004 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 t -66.1 134.63 53.21 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.54 -1.652 . . . . 73.45 106.54 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.82 112.95 27.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.589 -2.004 . . . . 63.12 105.589 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.9 35.29 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.531 -1.028 . . . . 64.32 110.531 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 168.81 38.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.638 -1.385 . . . . 72.01 109.638 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.21 153.41 31.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.275 1.43 . . . . 75.22 110.331 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.08 170.83 14.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.302 1.441 . . . . 62.21 111.219 174.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -66.58 73.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.397 1.879 . . . . 74.42 110.195 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.47 6.18 2.74 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.332 -1.815 . . . . 64.03 113.992 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.49 -156.41 27.25 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 120.99 2.395 . . . . 60.05 115.427 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.67 125.79 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.698 2.932 . . . . 73.15 110.022 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.81 120.13 14.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.267 -1.333 . . . . 75.22 108.832 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 144.89 55.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.678 0.217 . . . . 74.23 111.057 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 145.41 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.716 2.006 . . . . 75.22 108.62 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.848 1.259 . . . . 74.44 110.945 -170.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -82.12 175.67 10.14 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.311 0.645 . . . . 64.22 110.651 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.09 -12.73 61.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.736 1.013 . . . . 52.32 113.736 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -87.35 -7.54 57.65 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.058 -1.026 . . . . 73.43 110.928 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.66 56.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.449 1.976 . . . . 75.32 113.596 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.25 148.99 21.71 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.892 1.346 . . . . 72.31 109.855 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.54 144.83 56.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.426 -1.324 . . . . 73.51 107.426 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.73 5.8 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.411 0.685 . . . . 64.22 112.397 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.08 -175.3 36.89 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.001 0.818 . . . . 44.15 111.495 166.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -121.0 0.29 10.2 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.911 1.284 . . . . 74.32 112.183 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.7 m -165.84 115.6 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.217 1.807 . . . . 73.31 108.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -153.49 -178.84 7.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.745 1.157 . . . . 75.44 111.958 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.3 155.59 39.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.648 0.779 . . . . 75.23 109.488 163.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.54 171.61 10.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.945 1.698 . . . . 33.21 107.683 171.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -124.05 139.15 54.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 128.062 2.545 . . . . 74.45 109.269 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mm -90.65 98.88 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 119.262 -0.975 . . . . 74.55 110.102 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.47 14.35 13.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.948 1.092 . . . . 73.52 113.948 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.7 p -128.69 173.89 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.713 0.688 . . . . 62.11 109.837 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.78 90.52 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.736 0.415 . . . . 61.31 110.597 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.6 p -145.7 143.46 29.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.001 0.429 . . . . 71.23 110.465 -166.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -138.22 163.48 31.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.843 2.057 . . . . 61.21 109.754 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.64 152.53 6.9 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.042 1.337 . . . . 75.22 108.849 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 53.0 m -147.36 160.36 42.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.506 1.923 . . . . 75.43 109.409 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.2 p -152.42 173.39 15.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.486 0.714 . . . . 53.42 111.834 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -109.29 -174.98 2.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.56 1.144 . . . . 61.23 109.694 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -91.97 -171.65 2.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.544 -0.91 . . . . 63.44 108.544 151.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.56 -17.72 79.17 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.54 -0.725 . . . . 74.21 114.068 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -78.17 89.65 4.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.383 1.092 . . . . 64.51 108.207 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.38 15.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.662 0.785 . . . . 55.04 109.758 154.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -123.7 -10.28 7.83 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.191 0.811 . . . . 75.23 113.191 172.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.62 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 52.5 p90 -152.2 -170.64 3.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.011 1.324 . . . . 74.32 108.84 172.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.1 ttt -142.37 162.4 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 104.561 -2.385 . . . . 72.34 104.561 146.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -133.74 158.66 42.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.301 1.048 . . . . 61.23 108.874 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.542 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -134.13 99.11 4.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 102.089 -3.3 . . . . 53.42 102.089 166.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.14 113.45 14.5 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.519 -1.66 . . . . 71.42 106.519 168.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.8 -151.22 6.81 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.72 -1.752 . . . . 60.34 108.72 -161.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.8 p -149.28 -179.2 6.87 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.707 -0.479 . . . . 73.14 109.707 151.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.38 157.27 21.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.955 1.302 . . . . 75.03 109.434 170.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.02 171.72 14.07 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.924 0.89 . . . . 64.14 109.358 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HD23 ' A' ' 115' ' ' LEU . 36.8 t -159.26 162.46 36.12 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.267 1.027 . . . . 60.33 108.534 162.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.26 12.36 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.359 1.864 . . . . 63.31 111.597 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 p -83.88 176.64 8.76 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.254 1.022 . . . . 73.25 111.002 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -59.55 164.5 3.46 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.731 -0.668 . . . . 74.04 110.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 166.6 4.17 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.44 1.114 . . . . 72.41 112.938 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.09 -8.71 50.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.041 1.781 . . . . 71.44 114.348 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -62.62 158.85 17.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.532 1.166 . . . . 51.24 108.886 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -135.65 156.6 48.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.459 -0.571 . . . . 72.42 109.459 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -162.71 109.41 1.23 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.549 -2.019 . . . . 72.42 105.549 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -101.11 137.44 39.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.196 -1.779 . . . . 74.21 106.196 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.17 129.14 74.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.023 -1.103 . . . . 72.45 108.023 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -106.97 126.09 51.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.126 2.17 . . . . 73.33 106.008 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.39 109.84 16.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 125.297 1.439 . . . . 71.5 110.857 -165.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 mp -128.67 138.63 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.354 1.862 . . . . 73.21 106.747 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 12' ' ' ILE . . . -107.49 177.07 21.24 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.167 -1.173 . . . . 62.12 110.167 166.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -156.26 153.95 29.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 118.674 1.237 . . . . 75.5 109.742 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' HE2' ' A' ' 99' ' ' LYS . 11.9 mt -129.16 110.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 108.239 -1.023 . . . . 72.34 108.239 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.0 -74.21 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.885 2.474 . . . . 71.14 110.107 -171.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.7 -1.41 2.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.717 1.006 . . . . 75.1 113.717 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE2' ' HB ' ' A' ' 96' ' ' ILE . 12.9 pttt -105.8 156.9 17.87 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.104 -0.997 . . . . 72.42 113.459 -171.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -118.22 103.8 10.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.817 1.247 . . . . 61.31 109.161 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.37 -6.92 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 115.022 1.49 . . . . 72.44 115.022 -168.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.85 99.49 1.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.382 -1.34 . . . . 73.33 107.382 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.89 123.11 11.54 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.347 1.059 . . . . 71.1 110.915 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.43 176.63 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 73.44 110.487 171.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -136.55 158.01 45.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.113 2.165 . . . . 54.23 107.97 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -160.51 166.86 28.35 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.349 0.66 . . . . 72.2 109.61 169.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -140.05 147.42 40.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.264 1.826 . . . . 73.21 111.322 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -139.08 134.44 32.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.948 1.699 . . . . 63.3 108.251 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.0 mt -144.59 126.96 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.494 -1.669 . . . . 74.42 106.494 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 134.34 48.43 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.814 -0.439 . . . . 74.43 109.814 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.45 -17.04 33.1 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.564 1.146 . . . . 75.13 112.576 168.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.21 10.23 11.0 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.085 0.85 . . . . 63.33 112.486 -172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.34 -177.39 4.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.347 1.859 . . . . 53.32 108.989 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.55 111.85 2.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.598 1.159 . . . . 72.31 112.593 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 116' ' ' ILE . 4.3 tp -81.13 135.63 35.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 124.528 1.131 . . . . 74.45 108.304 170.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 115' ' ' LEU . 22.4 mt -150.2 132.22 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.999 2.52 . . . . 74.25 106.04 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.38 171.25 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.779 0.832 . . . . 71.32 111.279 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -142.71 160.96 39.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.194 1.397 . . . . 72.32 110.159 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -148.01 163.32 37.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.731 -1.122 . . . . 73.11 108.997 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.6 p -152.93 135.23 15.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.629 -0.67 . . . . 75.4 112.671 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 74' ' ' CYS . 7.6 p -135.5 103.64 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 128.207 2.603 . . . . 60.34 105.495 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.57 -158.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.454 -0.943 . . . . 74.4 108.454 170.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 82.8 p -134.24 -3.88 2.73 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.831 1.048 . . . . 74.32 113.831 161.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HE3' ' CG ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -97.13 73.05 2.49 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.565 2.126 . . . . 74.41 112.793 -154.209 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.69 143.47 48.72 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.281 -2.236 . . . . 72.24 111.712 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . 0.286 66.9 mt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 129.807 3.243 . . . . 74.43 109.981 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 108.945 -1.662 . . . . 55.43 108.945 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.95 132.49 42.49 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.023 -1.103 . . . . 75.13 108.023 168.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 p -159.14 143.79 15.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.922 0.889 . . . . 75.21 108.931 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.21 113.06 12.24 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.387 1.075 . . . . 75.11 110.146 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -131.68 113.57 13.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.48 2.312 . . . . 61.25 104.928 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -139.67 104.58 4.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.43 1.492 . . . . 72.13 109.273 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -159.58 171.12 20.21 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.497 1.919 . . . . 73.33 108.229 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.49 -96.88 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.653 -2.179 . . . . 63.44 107.653 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.76 118.38 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.775 1.23 . . . . 71.03 108.264 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -80.88 141.02 35.01 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.475 -0.784 . . . . 64.25 109.951 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.39 144.63 42.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.637 2.375 . . . . 53.31 108.829 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.95 156.2 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.475 -1.676 . . . . 74.13 106.475 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.02 138.89 45.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.918 -1.882 . . . . 54.23 105.918 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.0 142.42 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.591 -1.263 . . . . 63.55 107.591 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.35 173.27 11.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.377 1.071 . . . . 62.05 109.41 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -152.17 170.93 18.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.407 0.683 . . . . 73.14 111.79 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p -158.99 136.88 10.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.948 0.499 . . . . 73.33 111.523 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.88 -128.81 5.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.086 1.327 . . . . 55.15 111.722 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 61.41 3.58 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.402 1.881 . . . . 71.42 110.642 -166.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 p -75.91 48.11 0.47 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.32 1.848 . . . . 71.52 111.452 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.62 -20.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.0 0.92 . . . . 73.52 112.733 -172.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -142.19 42.06 1.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.205 2.202 . . . . 72.42 109.735 -170.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.53 160.04 36.4 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.371 2.269 . . . . 71.32 109.359 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -133.87 107.91 8.13 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.16 1.784 . . . . 74.5 108.319 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 1.3 p -125.1 80.7 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 125.438 1.495 . . . . 75.23 113.386 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.42 117.61 30.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.109 -0.7 . . . . 64.5 109.109 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 76' ' ' GLY . 35.5 m -115.59 133.53 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.854 -0.795 . . . . 75.34 108.854 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -66.08 151.28 47.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.579 -0.897 . . . . 51.3 108.579 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 95.9 mt -129.51 117.52 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.231 -2.137 . . . . 71.4 105.231 169.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 173.47 35.99 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.786 -0.926 . . . . 62.34 110.786 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.64 179.67 44.88 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.086 -2.806 . . . . 75.42 106.086 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.2 163.47 28.48 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.296 0.569 . . . . 72.42 109.498 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -174.32 3.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.963 1.705 . . . . 75.24 110.055 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -64.22 -28.81 69.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.741 1.015 . . . . 75.24 113.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.68 -52.67 11.54 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.203 -1.959 . . . . 64.33 108.203 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.96 -80.32 0.19 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.284 -1.526 . . . . 74.3 109.284 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.48 131.72 15.29 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.207 2.004 . . . . 73.32 111.751 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.63 134.77 34.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.809 -1.091 . . . . 64.32 108.885 165.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -83.95 128.59 34.65 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.339 0.972 . . . . 72.33 109.243 159.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.3 mm? -100.3 152.58 20.15 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.877 1.271 . . . . 52.32 108.314 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -124.36 155.06 39.41 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.05 0.928 . . . . 73.1 110.594 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.67 160.76 14.63 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.494 1.518 . . . . 72.1 109.795 168.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.83 0.93 9.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.649 1.98 . . . . 64.21 113.803 -171.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -77.23 -24.73 51.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.795 2.838 . . . . 65.13 110.743 165.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 4.35 50.32 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.22 1.867 . . . . 64.24 112.808 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -89.07 165.74 14.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.001 1.401 . . . . 70.43 108.183 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -84.77 151.94 24.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.861 -0.792 . . . . 65.4 108.861 165.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.29 -5.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.942 0.897 . . . . 63.24 112.659 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.81 40.69 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 119.708 1.14 . . . . 63.43 110.613 169.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.328 0.8 OUTLIER -121.87 14.96 10.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.289 2.235 . . . . 71.33 110.438 169.111 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 149.09 9.59 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 127.724 2.41 . . . . 70.14 106.947 151.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -169.23 179.86 3.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.146 0.979 . . . . 74.3 109.921 157.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -140.04 106.26 5.25 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 126.155 1.782 . . . . 74.52 107.185 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.12 150.26 20.39 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.483 -0.932 . . . . 62.31 108.483 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 9.6 tt0 -85.27 147.33 26.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.502 1.121 . . . . 72.22 109.251 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 15.1 mm -85.32 71.16 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.977 -1.12 . . . . 64.33 107.977 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -92.59 38.09 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.416 -1.427 . . . . 62.21 113.195 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 p -147.29 128.34 14.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.126 -1.435 . . . . 73.02 107.126 -165.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.95 65.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.549 0.613 . . . . 62.22 110.447 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 p -140.7 134.3 30.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.946 1.298 . . . . 72.24 107.95 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE2' ' H ' ' A' ' 62' ' ' SER . 6.0 tpt -125.26 159.93 30.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.469 2.308 . . . . 74.11 106.999 176.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 61' ' ' MET . 11.9 p -164.62 143.82 7.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.679 1.592 . . . . 74.03 107.409 168.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' A' ' 29' ' ' ILE . 12.6 m -136.86 147.63 46.62 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.417 -1.327 . . . . 75.01 107.417 176.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 p -146.56 -173.43 4.2 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.039 0.381 . . . . 63.0 110.735 170.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 p -135.49 172.92 12.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.705 1.202 . . . . 72.24 111.436 -162.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.99 170.2 11.32 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.569 -0.9 . . . . 51.12 108.569 163.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.96 60.96 3.78 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.124 0.869 . . . . 71.32 111.641 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.83 89.84 1.72 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.824 -2.658 . . . . 75.04 103.824 169.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.83 23.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.232 -0.413 . . . . 60.45 111.272 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.4 -8.18 2.92 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.04 0.756 . . . . 64.54 113.04 166.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -163.01 169.31 19.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.879 1.272 . . . . 73.52 107.736 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.3 ttt -138.74 151.47 47.14 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 104.382 -2.451 . . . . 64.54 104.382 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.0 t -138.53 157.84 45.4 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.615 0.766 . . . . 74.22 108.999 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.58 45.85 1.03 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.089 0.956 . . . . 62.35 111.244 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.59 141.29 58.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.787 0.835 . . . . 75.24 110.037 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 27' ' ' VAL . . . -149.13 -149.13 4.9 Favored Glycine 0 C--N 1.336 0.532 0 O-C-N 121.427 -0.795 . . . . 64.14 111.201 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.6 p -142.85 178.52 7.6 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.217 -1.031 . . . . 43.32 108.217 149.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.67 149.71 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.988 0.915 . . . . 72.55 109.045 160.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.4 t -152.51 161.77 42.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.32 -0.622 . . . . 73.32 109.32 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -157.25 153.51 27.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.3 1.84 . . . . 75.33 106.323 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 26.8 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 127.07 2.148 . . . . 73.44 108.0 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -90.44 173.52 8.05 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.823 -1.173 . . . . 71.13 109.021 169.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.12 169.29 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.141 -1.845 . . . . 74.5 110.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.62 162.63 6.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.429 0.692 . . . . 75.43 112.243 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.95 71.53 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.71 0.672 . . . . 73.25 113.309 172.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -111.97 136.39 51.37 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.214 1.806 . . . . 75.54 106.846 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -125.6 159.38 32.28 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.581 -0.699 . . . . 61.15 110.605 -166.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 tm? -154.87 102.5 2.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.516 -2.402 . . . . 44.34 104.516 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.22 149.04 22.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.267 -1.753 . . . . 64.35 106.267 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.99 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.227 -1.768 . . . . 55.33 106.227 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -119.17 135.97 54.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.45 106.172 163.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -138.52 119.55 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.895 -1.521 . . . . 75.32 106.895 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 mt -135.06 134.68 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 107.358 -1.349 . . . . 51.14 107.358 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -119.98 132.44 9.41 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.701 -1.359 . . . . 75.35 109.701 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -126.44 152.94 45.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.145 1.378 . . . . 72.42 110.055 -170.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 HD11 ' O ' ' A' ' 123' ' ' THR . 26.2 mt -136.85 112.4 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.536 -2.394 . . . . 72.43 104.536 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 74.38 -54.12 0.67 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 127.726 2.411 . . . . 73.14 112.962 163.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.34 6.57 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.183 1.793 . . . . 75.04 112.947 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.98 155.65 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.239 -2.163 . . . . 74.03 109.996 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -72.11 159.0 34.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.955 -1.128 . . . . 64.02 107.955 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.11 -6.02 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.377 0.51 . . . . 71.44 112.377 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.1 136.64 12.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.846 -1.168 . . . . 64.32 107.846 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.49 158.36 26.42 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 119.308 0.958 . . . . 73.51 111.432 168.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.43 171.41 14.67 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.302 1.049 . . . . 64.34 108.692 155.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.72 161.56 24.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.091 -1.818 . . . . 75.21 106.091 160.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.63 169.21 24.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.633 -0.877 . . . . 62.21 108.633 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -155.48 149.06 25.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.05 -0.352 . . . . 73.55 110.05 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.502 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.5 m-85 -148.29 138.4 22.55 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.774 1.23 . . . . 61.25 108.864 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.81 137.67 53.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.452 -0.944 . . . . 75.41 108.452 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -74.42 133.79 42.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.694 -0.854 . . . . 71.25 108.694 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.24 57.43 1.13 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.252 1.025 . . . . 75.53 108.921 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.67 -38.15 1.68 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.799 2.142 . . . . 62.15 111.774 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -62.8 152.43 35.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.363 1.065 . . . . 75.33 108.991 172.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 m -74.29 113.94 12.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.021 1.329 . . . . 52.11 109.044 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -67.03 115.14 6.41 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.712 -1.588 . . . . 73.33 106.712 175.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.8 mt -149.71 138.53 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 103.043 -2.947 . . . . 74.52 103.043 170.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 170.58 21.01 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.965 1.416 . . . . 73.13 108.846 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -138.29 153.83 49.03 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.316 -0.994 . . . . 73.34 108.316 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.71 161.71 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.718 1.207 . . . . 71.34 108.165 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.6 t -160.2 144.37 14.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.853 -1.165 . . . . 75.42 107.853 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.469 HG21 ' HB ' ' A' ' 92' ' ' VAL . 40.5 t -146.32 118.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.1 -2.556 . . . . 71.22 104.1 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 132.5 51.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.335 1.054 . . . . 73.52 108.249 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.429 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.8 p -95.14 14.13 23.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.484 -0.76 . . . . 72.42 112.17 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 118.66 6.19 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.217 -2.142 . . . . 74.43 105.217 162.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.42 71.4 1.43 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 105.395 -2.076 . . . . 74.15 105.395 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . 0.254 12.3 mm . . . . . 0 C--O 1.244 0.803 0 C-N-CA 126.555 1.942 . . . . 62.51 109.742 -165.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.545 0 N-CA-C 111.363 -0.695 . . . . 72.53 111.363 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.23 104.86 4.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.159 1.384 . . . . 70.24 107.976 163.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.1 p -158.82 159.4 35.05 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.001 -1.481 . . . . 74.55 107.001 160.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.49 121.99 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.115 -1.068 . . . . 64.34 108.115 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -142.33 105.93 4.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.363 1.465 . . . . 74.24 109.993 168.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -119.29 124.82 47.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.105 2.562 . . . . 72.14 104.484 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.48 154.14 51.51 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.327 0.651 . . . . 64.34 111.689 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.58 -105.94 0.44 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.174 -1.57 . . . . 74.43 109.174 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.87 83.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.43 106.172 -162.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -84.04 122.97 29.52 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.847 -1.538 . . . . 54.23 106.847 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.05 151.43 49.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.755 1.161 . . . . 63.44 110.574 -167.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 mm -135.01 146.38 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.357 1.463 . . . . 52.24 107.696 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 t -141.84 133.62 27.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.912 -1.514 . . . . 71.34 106.912 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mt -130.5 149.67 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.067 0.947 . . . . 70.11 109.214 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -135.84 167.34 21.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.677 0.672 . . . . 74.35 111.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -140.7 139.88 34.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.776 1.231 . . . . 72.21 109.239 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -149.82 152.9 35.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.484 2.313 . . . . 72.31 108.147 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.7 -145.33 18.68 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.55 -1.42 . . . . 63.43 109.55 -168.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -85.57 75.41 10.15 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.038 -1.467 . . . . 50.35 107.038 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.1 p -75.16 71.02 2.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.395 -1.706 . . . . 72.11 106.395 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.72 -48.31 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.506 1.122 . . . . 71.43 108.71 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.93 67.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 124.002 1.858 . . . . 72.42 109.462 -163.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 1.1 p90 -148.27 166.69 27.24 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 128.251 2.62 . . . . 70.43 108.22 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.79 150.52 49.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.556 1.943 . . . . 74.15 108.423 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.13 85.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.576 -0.898 . . . . 74.31 108.576 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -86.63 136.04 33.19 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.809 0.814 . . . . 73.15 108.874 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.09 132.91 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.836 -1.913 . . . . 71.43 105.836 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -85.34 140.8 30.5 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.778 1.631 . . . . 74.55 106.926 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.434 HG22 ' HG ' ' A' ' 40' ' ' LEU . 94.7 mt -124.64 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.409 -1.7 . . . . 74.34 106.409 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.56 172.88 42.57 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.193 -0.763 . . . . 61.45 111.193 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.46 175.29 40.51 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 127.176 2.322 . . . . 43.12 108.25 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.45 46.47 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.857 -0.79 . . . . 73.31 109.031 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -136.85 -178.55 5.24 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 125.835 1.654 . . . . 71.52 110.688 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -80.25 70.33 6.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.081 0.553 . . . . 64.55 110.29 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.68 -34.74 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.228 0.918 . . . . 73.34 111.652 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.24 -164.89 26.72 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 117.698 0.749 . . . . 63.34 113.273 -164.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.42 140.02 26.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.906 3.071 . . . . 72.31 109.337 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.62 26.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.293 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -54.49 120.1 6.17 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.039 0.935 . . . . 73.25 109.701 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.5 mm? -82.67 168.6 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.497 -0.927 . . . . 71.44 108.497 169.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.74 142.09 46.65 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.837 0.855 . . . . 74.43 109.079 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.34 170.81 16.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.552 1.141 . . . . 73.25 109.773 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -74.93 15.28 0.41 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 63.52 113.877 -169.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -100.37 -16.56 17.6 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.315 . . . . 72.51 111.559 162.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.48 67.36 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.37 0.986 . . . . 54.23 113.124 -168.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -79.97 161.52 25.44 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 1.116 . . . . 70.43 109.626 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.02 137.59 34.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.812 -0.81 . . . . 54.12 108.812 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.33 16.72 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.012 1.325 . . . . 71.43 112.944 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.17 172.21 14.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.867 1.222 . . . . 73.11 110.462 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -112.17 9.83 20.17 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.227 1.411 . . . . 62.34 111.159 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -167.05 148.78 5.96 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.071 2.148 . . . . 72.15 108.097 165.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -179.96 179.34 0.55 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.141 2.576 . . . . 74.43 109.186 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.4 p -129.39 159.09 37.32 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.33 1.052 . . . . 73.11 109.426 163.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.45 114.72 7.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.1 -1.074 . . . . 64.32 108.1 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -71.69 128.18 34.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.967 -1.123 . . . . 64.22 107.967 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.36 117.05 3.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.417 -1.327 . . . . 63.31 107.417 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 2.4 mmm180 -137.51 35.95 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.861 0.839 . . . . 74.33 110.856 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.21 147.71 26.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.456 -1.683 . . . . 73.12 106.456 -161.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.75 -37.47 71.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.95 0.5 . . . . 65.42 111.771 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 t -149.72 161.99 41.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.228 -1.027 . . . . 74.31 108.228 167.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 mmm -134.75 165.93 24.13 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 128.632 2.773 . . . . 71.22 108.883 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.5 p -164.94 162.28 20.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.507 -1.224 . . . . 64.12 110.058 171.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.2 m -150.94 166.02 31.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.046 2.138 . . . . 70.12 107.261 165.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.05 -178.68 6.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.934 0.894 . . . . 62.25 111.839 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 p -129.07 175.6 8.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.649 1.979 . . . . 64.25 108.987 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.2 172.32 7.66 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.398 -0.814 . . . . 74.25 109.162 159.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 55.01 4.99 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.092 0.853 . . . . 53.21 113.06 -169.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -133.38 -8.79 2.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.586 1.154 . . . . 63.51 111.215 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.59 165.12 23.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.834 0.826 . . . . 73.55 111.121 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -119.72 -1.8 10.51 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.906 1.682 . . . . 70.45 112.065 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -177.12 172.03 2.0 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.289 1.835 . . . . 71.41 108.022 171.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ttt -132.66 163.64 28.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.832 -2.284 . . . . 53.41 104.832 161.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -146.94 166.59 26.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.277 0.561 . . . . 62.25 110.253 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.11 65.18 0.9 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.595 2.358 . . . . 61.12 107.711 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.39 41.03 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.742 0.817 . . . . 74.52 108.95 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.65 179.74 32.25 Favored Glycine 0 CA--C 1.502 -0.731 0 CA-C-N 119.082 0.856 . . . . 70.23 111.9 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 90.3 p -135.34 169.37 17.58 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.377 -1.411 . . . . 54.25 109.535 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.54 153.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.422 1.489 . . . . 45.04 107.254 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.0 164.0 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.914 -0.772 . . . . 71.34 108.914 166.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.7 p -145.65 162.45 37.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.612 -0.514 . . . . 71.32 109.612 154.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 pt -133.63 15.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 128.653 2.781 . . . . 62.21 109.313 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -81.02 174.55 11.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.015 1.726 . . . . 74.12 111.28 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.3 163.83 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.227 -2.261 . . . . 71.21 110.626 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.89 160.16 15.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.203 1.401 . . . . 71.15 113.289 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.42 87.0 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.907 1.241 . . . . 61.13 114.164 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -66.66 167.47 11.05 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.564 1.182 . . . . 53.33 108.273 167.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -149.5 160.05 43.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 121.572 -0.705 . . . . 74.44 110.083 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.3 tp -152.87 130.45 11.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.591 -1.633 . . . . 74.24 106.591 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -129.16 109.25 11.0 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.389 1.876 . . . . 72.34 106.185 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.83 134.18 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.053 -2.203 . . . . 54.41 105.053 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 m -112.06 137.49 50.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.142 -1.799 . . . . 70.31 106.142 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.16 113.31 3.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.583 1.553 . . . . 74.33 109.194 -171.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.84 141.09 45.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.727 -1.583 . . . . 74.13 106.727 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.82 155.85 25.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 123.869 0.747 . . . . 61.21 111.483 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.13 154.46 42.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.051 0.94 . . . . 73.23 110.366 -165.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG13 HG11 ' A' ' 101' ' ' VAL . 39.9 mt -122.89 117.89 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.824 -1.176 . . . . 73.34 107.824 163.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 t70 69.28 -58.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 129.06 2.944 . . . . 74.21 111.666 165.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.68 8.5 0.51 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.043 1.497 . . . . 74.45 115.043 158.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.44 143.51 32.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.992 1.317 . . . . 74.35 111.267 -170.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.16 118.2 12.68 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.043 1.737 . . . . 64.12 107.203 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.42 HG11 HG13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -129.31 -8.31 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.735 0.779 . . . . 65.14 109.825 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -162.44 130.85 4.05 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.215 -1.402 . . . . 73.21 107.215 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -153.65 110.79 3.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.188 -0.671 . . . . 73.12 109.188 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 pp -142.25 179.51 6.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.783 -1.099 . . . . 73.43 111.296 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -145.9 171.27 15.07 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.171 2.589 . . . . 74.54 106.301 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -146.99 160.42 42.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.687 -0.857 . . . . 53.25 108.687 170.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -128.25 136.16 50.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.437 1.495 . . . . 72.33 107.057 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.655 ' HB3' HD11 ' A' ' 115' ' ' LEU . 9.3 m-85 -136.16 152.8 51.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.141 0.977 . . . . 62.41 109.055 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.0 mt -144.21 154.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.219 1.808 . . . . 74.21 107.424 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -95.79 141.17 29.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.928 0.891 . . . . 72.12 110.223 176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -121.67 4.99 10.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.343 1.857 . . . . 73.23 110.489 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 113.61 -34.91 4.78 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.715 2.102 . . . . 51.43 110.309 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -79.42 161.67 25.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.939 1.296 . . . . 73.41 110.622 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.36 105.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.765 0.826 . . . . 74.13 110.126 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 108' ' ' TYR . 7.8 tt -68.02 134.61 50.96 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.392 -0.966 . . . . 70.45 108.392 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -150.61 133.97 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.026 -1.842 . . . . 70.54 106.026 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.17 174.55 14.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.958 0.786 . . . . 52.35 111.608 171.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 73.9 p -139.65 161.64 37.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.81 1.644 . . . . 72.41 110.797 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -151.2 176.7 10.95 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.309 1.444 . . . . 74.24 109.606 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -160.74 147.48 15.34 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.561 -0.903 . . . . 54.02 108.561 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.2 t -146.31 88.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.236 -1.765 . . . . 63.32 106.236 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.5 m -77.82 166.78 22.49 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.06 -0.718 . . . . 53.21 109.06 165.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.1 p -135.17 58.3 1.77 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.11 -1.07 . . . . 43.44 108.11 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 72.14 1.01 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 124.507 2.098 . . . . 73.21 110.724 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -154.98 135.52 13.43 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 126.59 1.956 . . . . 74.35 108.533 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.243 0.749 0 C-N-CA 128.551 2.74 . . . . 61.53 111.573 167.494 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 72.540000000000006 110.005 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.42 -95.08 0.29 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.458 -1.057 . . . . 64.540000000000006 110.458 156.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.34 126.95 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 104.667 -2.345 . . . . 74.430000000000007 104.667 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -108.87 142.14 39.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.432 -1.692 . . . . 73.200000000000003 106.432 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -137.23 152.74 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.658 -1.238 . . . . 52.420000000000002 107.658 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.29 154.38 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.695 -1.224 . . . . 62.409999999999997 107.695 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 t -136.67 142.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.272 -1.751 . . . . 71.450000000000003 106.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.84 148.58 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.309 -1.737 . . . . 63.350000000000001 106.309 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -135.51 153.46 51.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.302 -1.37 . . . . 74.120000000000005 107.302 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -140.87 154.0 45.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.769 0.795 . . . . 70.239999999999995 109.888 166.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 p -151.64 173.09 15.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.712 -0.676 . . . . 72.340000000000003 109.333 171.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.68 -143.13 16.55 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.537 -1.425 . . . . 61.109999999999999 109.537 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.34 65.59 0.88 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.783 1.233 . . . . 75.019999999999996 112.17 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -64.21 -30.48 71.53 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.466 -1.396 . . . . 64.439999999999998 110.517 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.25 -30.82 64.97 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.783 1.233 . . . . 73.230000000000004 111.52 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.47 23.48 5.12 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 71.319999999999993 112.644 -168.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -124.88 118.49 26.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.273 1.029 . . . . 73.319999999999993 108.72 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -78.69 136.92 37.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.44 -1.319 . . . . 72.209999999999994 107.44 163.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -141.98 111.21 2.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.1 -1.815 . . . . 63.310000000000002 106.1 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -125.61 126.77 45.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.648 1.567 . . . . 65.010000000000005 110.662 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.53 130.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.025 1.33 . . . . 52.5 109.696 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -78.13 127.43 32.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.595 -1.632 . . . . 72.239999999999995 106.595 165.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 57.6 mt -113.47 138.83 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.689 -1.967 . . . . 71.129999999999995 105.689 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.32 179.82 46.98 Favored Glycine 0 C--N 1.334 0.451 0 O-C-N 121.356 -0.84 . . . . 74.5 112.661 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.76 -176.63 48.02 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.185 1.374 . . . . 73.530000000000001 110.437 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.31 159.83 40.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.905 0.882 . . . . 31.239999999999998 110.295 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.74 -177.34 5.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.431 1.093 . . . . 74.299999999999997 111.116 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.78 59.28 0.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.756 2.022 . . . . 54.310000000000002 108.909 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.74 21.87 0.02 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.582 -0.566 . . . . 61.299999999999997 112.665 -160.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.98 -154.0 20.15 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.459 1.129 . . . . 74.340000000000003 111.439 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -62.58 142.81 91.3 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.83 1.686 . . . . 61.329999999999998 109.191 166.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.52 149.07 31.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.997 -0.742 . . . . 63.420000000000002 108.997 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -69.32 146.94 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.764 0.711 . . . . 75.120000000000005 109.781 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 2.3 mm? -113.84 154.81 26.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 126.119 1.768 . . . . 73.109999999999999 108.59 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.33 151.29 50.99 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.404 2.281 . . . . 75.400000000000006 107.902 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -95.04 173.97 7.32 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.848 1.259 . . . . 74.420000000000002 110.4 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.99 21.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.229 1.411 . . . . 71.030000000000001 113.903 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -109.83 6.54 23.51 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.678 1.991 . . . . 75.319999999999993 110.102 163.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.92 7.05 80.66 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.335 -1.258 . . . . 41.409999999999997 112.87 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -103.18 143.77 32.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.888 1.844 . . . . 73.5 109.895 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -65.26 151.38 46.34 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.83 -0.804 . . . . 75.299999999999997 108.83 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.17 1.03 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.005 0.743 . . . . 63.109999999999999 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.29 -174.06 33.45 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 120.288 1.404 . . . . 63.130000000000003 110.328 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -121.18 -2.88 9.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.017 2.127 . . . . 74.5 112.165 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -153.17 142.38 21.48 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.692 1.597 . . . . 34.509999999999998 108.822 161.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -173.0 176.78 2.93 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.578 1.951 . . . . 73.420000000000002 108.038 164.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.0 p -122.17 159.25 27.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.508 1.123 . . . . 63.119999999999997 109.057 165.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.97 130.48 29.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.088 -1.078 . . . . 62.420000000000002 108.088 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.85 140.08 40.51 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.066 -1.087 . . . . 64.200000000000003 108.066 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -73.99 94.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 104.51 -2.404 . . . . 75.230000000000004 104.51 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -120.23 44.29 2.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.852 -1.166 . . . . 73.219999999999999 107.852 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -141.71 166.43 24.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.221 -1.399 . . . . 75.319999999999993 107.221 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.49 78.79 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.136 0.974 . . . . 63.219999999999999 110.391 170.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.7 p -130.32 156.86 43.98 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.367 -0.975 . . . . 75.340000000000003 108.367 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -146.66 159.63 43.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.023 1.329 . . . . 75.239999999999995 109.52 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 p -165.31 155.55 13.41 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.412 1.085 . . . . 74.140000000000001 108.453 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.6 m -143.0 157.67 44.33 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.072 -1.455 . . . . 74.409999999999997 107.072 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.9 p -144.1 169.23 18.25 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.685 -0.635 . . . . 75.540000000000006 110.839 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 p -105.82 -170.25 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.121 -1.437 . . . . 73.209999999999994 107.121 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.75 -167.91 1.41 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.51 -0.922 . . . . 74.530000000000001 108.51 148.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.36 172.57 7.41 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.89 -0.884 . . . . 70.400000000000006 110.89 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.96 84.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.596 1.159 . . . . 72.510000000000005 108.861 -164.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.69 165.58 35.84 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.53 1.132 . . . . 64.230000000000004 108.305 156.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -132.91 -0.45 3.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.326 1.05 . . . . 73.219999999999999 113.404 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -166.88 175.59 7.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.964 -2.236 . . . . 65.329999999999998 104.964 162.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ttt -140.55 145.48 36.84 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.705 -2.702 . . . . 70.299999999999997 103.705 157.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -116.58 150.9 37.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.003 -1.11 . . . . 53.420000000000002 108.003 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.5 t -147.91 89.54 1.75 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.564 -2.013 . . . . 65.319999999999993 105.564 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.25 135.15 55.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.94 -1.133 . . . . 74.150000000000006 107.94 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.09 32.8 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 118.724 0.693 . . . . 62.009999999999998 112.011 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.4 p -139.41 167.28 22.44 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.331 -0.934 . . . . 73.109999999999999 110.336 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.67 148.21 31.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.2 1.8 . . . . 73.049999999999997 106.736 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 p -142.97 160.89 39.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.173 0.442 . . . . 62.450000000000003 111.139 155.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.81 156.17 41.97 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.745 1.218 . . . . 54.340000000000003 108.173 164.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.22 49.81 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 126.26 1.824 . . . . 73.310000000000002 109.463 -172.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.0 p -129.07 -173.9 3.12 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.196 0.999 . . . . 51.340000000000003 111.809 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -66.71 165.33 15.18 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.118 0.967 . . . . 73.019999999999996 112.118 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 161.04 14.62 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 112.998 -1.91 . . . . 73.209999999999994 113.514 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.99 2.32 81.95 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.861 -1.522 . . . . 24.41 114.431 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -70.12 114.82 8.64 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 120.1 1.95 . . . . 73.109999999999999 106.001 165.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -104.4 155.9 18.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.313 -0.995 . . . . 72.109999999999999 108.313 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 tp -143.16 159.13 42.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.543 -2.021 . . . . 65.25 105.543 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -143.97 145.97 32.6 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.946 -1.501 . . . . 73.430000000000007 106.946 165.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mm -134.37 140.59 45.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.677 -1.971 . . . . 64.329999999999998 105.677 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.495 HG22 HD11 ' A' ' 93' ' ' ILE . 6.3 m -131.43 125.83 33.56 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.89 -2.263 . . . . 73.329999999999998 104.89 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.24 116.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.737 1.215 . . . . 73.409999999999997 107.93 -170.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 91' ' ' THR . 2.1 mp -138.62 131.22 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.066 0.946 . . . . 72.319999999999993 108.719 -162.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.79 141.44 16.39 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.792 1.187 . . . . 62.340000000000003 111.4 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -131.45 153.94 49.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.122 2.169 . . . . 72.239999999999995 108.72 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.72 139.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.179 -2.526 . . . . 73.409999999999997 104.179 167.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 t0 49.82 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.121 2.968 . . . . 71.519999999999996 110.954 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -133.75 15.49 3.97 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 120.599 1.545 . . . . 72.340000000000003 113.948 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.85 155.71 42.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.529 -1.357 . . . . 65.409999999999997 111.467 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -84.82 135.32 34.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.907 2.083 . . . . 72.030000000000001 106.341 165.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.09 -1.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.831 0.678 . . . . 61.140000000000001 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -155.94 145.61 21.11 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.771 -1.206 . . . . 64.340000000000003 109.769 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -158.3 142.79 16.03 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 124.073 0.949 . . . . 71.25 109.973 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.07 170.55 15.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.872 0.844 . . . . 73.019999999999996 108.935 155.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -129.23 155.71 45.12 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.615 -1.624 . . . . 74.129999999999995 106.615 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 160.34 43.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.727 -0.842 . . . . 52.329999999999998 108.727 173.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.15 138.29 28.06 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 106.345 -1.724 . . . . 71.420000000000002 106.345 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' HD11 ' A' ' 115' ' ' LEU . 21.2 m-85 -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 123.544 0.527 . . . . 72.430000000000007 109.661 176.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.56 136.35 21.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.159 -1.423 . . . . 73.109999999999999 107.159 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 p -67.33 136.84 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.301 0.64 . . . . 71.25 110.255 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -109.19 -5.9 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.736 1.214 . . . . 74.409999999999997 112.615 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.59 -29.97 5.05 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.132 1.825 . . . . 65.310000000000002 110.913 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -82.68 170.52 15.02 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.035 0.934 . . . . 64.209999999999994 110.554 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -54.26 136.63 42.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.412 -0.959 . . . . 65.329999999999998 108.412 164.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.0 tt -93.21 135.6 34.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.057 -1.09 . . . . 63.149999999999999 108.057 168.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.7 mt -149.05 142.35 18.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.151 -2.166 . . . . 53.119999999999997 105.151 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.28 171.09 17.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.888 1.275 . . . . 74.450000000000003 109.339 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.1 p -140.06 157.68 45.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.736 1.214 . . . . 63.219999999999999 109.859 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 169.75 22.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.482 0.713 . . . . 73.420000000000002 110.638 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.89 134.57 1.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.72 0.808 . . . . 71.329999999999998 110.364 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.9 t -142.64 100.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.374 1.87 . . . . 71.109999999999999 106.112 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.45 139.49 41.86 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 72.140000000000001 109.762 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.7 p -92.73 26.69 2.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.232 -0.917 . . . . 71.420000000000002 112.551 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.426 0 N-CA-C 107.345 -1.354 . . . . 70.099999999999994 107.345 161.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.134 0.492 . . . . 73.319999999999993 109.796 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.66 -133.56 5.8 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.04 -2.424 . . . . 43.340000000000003 107.04 -166.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.03 136.91 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.045 -1.465 . . . . 73.340000000000003 107.045 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -113.69 158.05 21.39 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.724 -1.213 . . . . 74.519999999999996 107.724 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -154.11 147.27 24.71 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.798 -0.815 . . . . 74.049999999999997 108.798 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mm -135.53 120.45 28.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.909 -1.886 . . . . 65.030000000000001 105.909 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.41 153.44 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.688 -1.967 . . . . 74.109999999999999 105.688 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 74' ' ' CYS . 2.9 mt -130.53 155.2 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.304 -0.999 . . . . 62.0 108.304 165.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.519 ' HG3' HG22 ' A' ' 60' ' ' THR . 23.8 mp0 -138.46 164.17 30.05 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.367 0.667 . . . . 72.430000000000007 110.747 163.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -142.39 156.29 45.2 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.624 0.77 . . . . 71.120000000000005 109.553 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.93 161.47 40.69 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.123 1.369 . . . . 65.230000000000004 108.059 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.5 -117.66 4.41 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.857 1.218 . . . . 72.420000000000002 110.685 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.37 104.11 16.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.36 1.064 . . . . 65.030000000000001 109.222 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.4 p -115.26 16.84 16.82 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.829 0.451 . . . . 72.120000000000005 111.23 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.99 -13.05 15.59 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.405 0.682 . . . . 54.509999999999998 110.48 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.81 23.69 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.462 1.105 . . . . 70.019999999999996 113.131 -164.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.865 ' CE2' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.97 119.33 20.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.022 0.915 . . . . 70.409999999999997 110.274 172.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.53 81.25 7.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.937 2.095 . . . . 72.209999999999994 109.141 174.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.865 HG22 ' CE2' ' A' ' 23' ' ' PHE . 3.0 t -72.88 106.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.947 -1.501 . . . . 70.299999999999997 106.947 171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -98.14 146.05 25.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.799 -1.556 . . . . 70.299999999999997 106.799 161.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.77 152.22 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.043 -0.98 . . . . 71.430000000000007 108.67 156.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.3 t -97.25 148.25 23.3 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.11 -1.811 . . . . 71.010000000000005 106.11 159.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.455 HG22 ' HG ' ' A' ' 40' ' ' LEU . 82.5 mt -128.07 145.74 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.309 -1.738 . . . . 70.430000000000007 106.309 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.55 176.42 47.85 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.517 -1.033 . . . . 50.219999999999999 110.517 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.61 173.1 43.84 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.771 2.129 . . . . 61.520000000000003 107.925 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.26 159.73 41.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.548 1.174 . . . . 52.32 111.116 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -137.22 -173.29 3.42 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.42 2.288 . . . . 71.219999999999999 110.013 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -65.62 -10.73 38.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.673 1.189 . . . . 65.129999999999995 113.624 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.87 36.53 1.97 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.676 1.131 . . . . 52.43 113.316 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.88 -160.16 13.35 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.693 1.246 . . . . 74.239999999999995 111.752 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.08 156.2 67.39 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.033 1.822 . . . . 71.409999999999997 110.065 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.4 144.8 25.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.502 1.121 . . . . 72.430000000000007 109.942 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -69.51 139.78 53.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.05 0.841 . . . . 72.099999999999994 109.745 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -102.63 157.46 16.92 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.611 1.164 . . . . 74.340000000000003 108.413 171.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.2 146.81 52.27 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.703 1.201 . . . . 72.099999999999994 109.837 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -82.11 179.62 7.74 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.633 1.573 . . . . 70.120000000000005 111.109 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.49 1.43 6.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.128 1.529 . . . . 71.099999999999994 115.128 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -101.01 -9.57 21.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.595 1.089 . . . . 73.010000000000005 111.007 165.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.77 13.92 76.79 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.654 -1.081 . . . . 12.34 112.426 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.48 148.24 27.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.556 1.942 . . . . 65.120000000000005 106.69 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.96 152.83 26.56 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.111 -0.7 . . . . 74.099999999999994 109.111 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -144.08 12.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 114.442 1.275 . . . . 72.209999999999994 114.442 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 -173.74 22.16 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.345 -1.102 . . . . 74.530000000000001 110.345 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.266 21.3 p30 -125.29 2.51 7.8 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.928 1.291 . . . . 74.319999999999993 112.856 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 m -153.63 140.5 19.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.525 1.93 . . . . 51.009999999999998 108.41 162.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -168.85 171.71 8.27 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.281 1.032 . . . . 74.299999999999997 110.594 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 m -118.28 145.99 44.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.96 1.704 . . . . 73.400000000000006 108.163 167.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.54 157.06 46.64 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.564 1.946 . . . . 52.219999999999999 107.939 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -109.49 135.68 50.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.648 1.579 . . . . 64.129999999999995 108.465 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.23 87.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.445 -1.317 . . . . 74.109999999999999 107.445 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 35.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.873 1.269 . . . . 74.209999999999994 110.303 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -146.2 160.05 42.5 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.178 -0.464 . . . . 71.439999999999998 110.756 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.99 -37.85 75.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.815 0.446 . . . . 72.340000000000003 111.341 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 15' ' ' GLN . 7.5 p -135.07 142.74 46.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.78 1.632 . . . . 72.209999999999994 108.516 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -135.54 163.33 30.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.626 2.37 . . . . 63.039999999999999 109.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.9 p -165.62 130.44 2.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.987 0.915 . . . . 71.239999999999995 110.456 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.8 m -139.53 154.4 47.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.905 1.282 . . . . 64.340000000000003 108.947 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -146.75 -179.81 7.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.209 1.004 . . . . 74.019999999999996 111.243 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -124.81 178.92 5.22 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.912 1.285 . . . . 71.439999999999998 110.695 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -91.56 -178.29 5.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.455 1.102 . . . . 74.120000000000005 108.691 162.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.24 10.74 52.99 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.37 0.986 . . . . 73.120000000000005 113.694 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -98.82 69.65 1.82 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.797 -1.927 . . . . 65.109999999999999 105.797 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -170.08 172.28 6.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.043 1.337 . . . . 52.310000000000002 110.638 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -130.36 -13.01 3.94 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.084 1.754 . . . . 72.549999999999997 112.782 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -159.86 174.66 14.1 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.052 0.941 . . . . 70.329999999999998 108.754 170.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.2 ttt -136.89 155.21 50.05 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.465 1.906 . . . . 70.010000000000005 106.21 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.8 p -113.14 177.5 4.61 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.706 1.203 . . . . 73.219999999999999 108.841 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 14' ' ' ILE . 1.9 t -157.84 33.24 0.26 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.104 -1.039 . . . . 72.040000000000006 113.157 150.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.51 132.53 53.43 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.488 -0.758 . . . . 73.010000000000005 110.746 -172.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.69 175.65 29.6 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 109.711 -1.356 . . . . 71.200000000000003 109.711 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.6 p -136.79 160.12 39.81 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.908 0.861 . . . . 74.129999999999995 110.721 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 69.1 t -117.52 135.36 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 106.678 -1.601 . . . . 72.430000000000007 106.678 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.35 124.85 10.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.114 -0.699 . . . . 74.140000000000001 109.114 167.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -119.2 142.98 47.52 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.232 -1.395 . . . . 74.010000000000005 107.232 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.86 17.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.179 2.192 . . . . 63.009999999999998 109.315 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -88.3 179.33 6.37 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.706 1.241 . . . . 64.329999999999998 110.733 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.2 165.48 18.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 113.258 -1.792 . . . . 74.409999999999997 112.369 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.94 155.09 20.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.608 -1.178 . . . . 71.239999999999995 113.293 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.86 79.68 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.386 -0.674 . . . . 72.329999999999998 113.486 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -67.85 156.91 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.306 -1.739 . . . . 73.420000000000002 106.306 155.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -139.51 158.35 44.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.359 -1.719 . . . . 73.120000000000005 106.359 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tp -156.15 157.25 35.63 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.438 -0.949 . . . . 74.420000000000002 108.438 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -147.32 111.71 5.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.172 -1.788 . . . . 70.340000000000003 106.172 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mm -101.66 143.44 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.777 -1.564 . . . . 73.140000000000001 106.777 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.2 m -119.34 136.21 54.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.023 -1.843 . . . . 71.040000000000006 106.023 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 108.47 3.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.481 1.512 . . . . 64.409999999999997 109.696 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.0 mt -123.66 140.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.796 -1.187 . . . . 61.32 107.796 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.9 154.18 20.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 124.569 1.081 . . . . 44.450000000000003 111.531 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -142.84 152.12 41.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.183 -1.008 . . . . 70.349999999999994 110.265 -161.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.1 125.88 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 104.798 -2.297 . . . . 62.130000000000003 104.798 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 44.95 55.89 5.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.584 1.154 . . . . 72.109999999999999 112.19 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 67.31 26.85 8.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.036 2.134 . . . . 70.310000000000002 114.43 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -134.94 161.6 34.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 120.15 -1.594 . . . . 74.219999999999999 110.196 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -97.25 127.68 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.032 -1.84 . . . . 70.430000000000007 106.032 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.15 -2.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.33 0.863 . . . . 50.149999999999999 113.33 -172.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.32 138.56 13.65 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.576 -1.639 . . . . 72.340000000000003 106.576 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.17 128.87 8.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.163 0.438 . . . . 72.409999999999997 110.839 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -142.61 171.49 13.98 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.934 0.873 . . . . 63.32 110.897 166.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -137.95 165.87 25.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.001 1.72 . . . . 74.239999999999995 106.386 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -146.46 166.57 26.01 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.422 -0.584 . . . . 74.219999999999999 109.422 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.44 132.59 33.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.126 1.37 . . . . 70.109999999999999 107.838 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.543 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 34.1 m-85 -127.43 154.15 45.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.442 -0.948 . . . . 74.400000000000006 108.442 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.3 mt -147.03 139.91 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.355 -2.091 . . . . 72.409999999999997 105.355 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -86.54 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.448 -0.783 . . . . 74.010000000000005 110.224 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -123.75 8.83 8.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.219 . . . . 72.019999999999996 111.564 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.78 -6.85 41.32 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.328 1.442 . . . . 62.329999999999998 111.505 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -102.22 174.85 5.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.84 1.256 . . . . 71.040000000000006 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.09 111.75 6.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.402 -1.333 . . . . 71.230000000000004 107.402 169.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.94 138.0 49.69 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.756 -1.201 . . . . 74.430000000000007 107.756 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -153.58 131.16 2.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.901 -1.518 . . . . 73.329999999999998 106.901 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -158.07 175.66 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.453 1.501 . . . . 70.420000000000002 111.87 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -146.64 152.29 38.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.139 1.776 . . . . 73.430000000000007 110.059 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -147.43 168.45 21.84 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.739 1.215 . . . . 73.219999999999999 109.318 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 p -168.89 128.11 1.08 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.543 0.687 . . . . 74.209999999999994 111.897 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.09 113.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.664 1.986 . . . . 73.310000000000002 106.1 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 m -97.25 158.35 15.5 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.575 -1.269 . . . . 50.520000000000003 107.575 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -107.39 38.48 2.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.705 0.684 . . . . 61.329999999999998 109.165 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptp . . . . . 0 C--O 1.235 0.296 0 C-N-CA 125.555 1.542 . . . . 73.430000000000007 107.561 172.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 108.699 -0.852 . . . . 72.129999999999995 108.699 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.68 -98.41 0.11 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 127.62 2.533 . . . . 53.140000000000001 107.106 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.23 135.66 61.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 125.502 1.521 . . . . 73.329999999999998 107.093 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -97.58 145.15 26.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.55 1.14 . . . . 72.510000000000005 108.7 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -141.05 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.901 0.88 . . . . 70.230000000000004 111.678 166.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.9 mm -130.86 152.16 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.035 1.734 . . . . 74.519999999999996 106.59 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.63 141.31 46.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.714 1.606 . . . . 70.109999999999999 106.942 166.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 56' ' ' ILE . 53.0 mt -131.62 151.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -142.72 164.63 29.59 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.723 0.809 . . . . 65.340000000000003 110.992 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -156.65 139.89 15.6 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.515 1.126 . . . . 51.310000000000002 109.687 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -152.9 147.72 26.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 128.313 2.645 . . . . 70.239999999999995 107.647 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.83 -134.8 11.29 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.323 -1.111 . . . . 50.329999999999998 110.323 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.19 58.75 0.72 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.022 1.729 . . . . 42.299999999999997 111.428 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.8 p -76.13 63.22 1.8 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.365 -1.46 . . . . 72.319999999999993 109.031 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -148.93 -40.06 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.858 1.263 . . . . 63.509999999999998 110.653 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.84 60.88 1.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 124.268 1.985 . . . . 72.430000000000007 110.114 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 0.2 OUTLIER -141.53 160.18 40.69 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.582 2.753 . . . . 71.510000000000005 108.449 176.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.69 107.17 3.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.17 0.895 . . . . 74.120000000000005 108.806 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.46 92.84 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.419 1.887 . . . . 43.409999999999997 109.568 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.92 113.74 27.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 75.239999999999995 109.414 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.03 149.12 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.537 1.062 . . . . 72.239999999999995 110.078 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t -82.52 150.32 27.03 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.278 1.431 . . . . 75.140000000000001 109.413 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 HD22 ' A' ' 40' ' ' LEU . 47.6 mt -130.61 116.01 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.56 -2.015 . . . . 75.140000000000001 105.56 165.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 173.53 35.15 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.811 -0.516 . . . . 54.439999999999998 111.811 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.34 169.49 36.49 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.582 2.039 . . . . 71.109999999999999 111.039 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.83 39.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.577 1.151 . . . . 74.200000000000003 111.026 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.48 -168.39 1.77 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.711 2.004 . . . . 74.430000000000007 113.258 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -77.74 77.62 4.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.146 -0.687 . . . . 64.099999999999994 109.146 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.04 49.56 0.72 Allowed Glycine 0 N--CA 1.453 -0.231 0 O-C-N 124.609 1.193 . . . . 75.530000000000001 111.768 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.79 -164.07 28.83 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 120.12 -0.267 . . . . 61.119999999999997 112.923 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.27 173.09 13.74 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.921 3.747 . . . . 72.510000000000005 110.56 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.39 117.82 35.72 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.477 1.111 . . . . 75.420000000000002 109.46 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -60.02 124.14 19.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.285 0.948 . . . . 73.439999999999998 110.396 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 65' ' ' THR . 0.8 OUTLIER -113.02 162.83 15.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.163 1.385 . . . . 75.230000000000004 109.455 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -131.03 152.76 49.99 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.358 -0.979 . . . . 62.520000000000003 108.358 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.287 1.5 p30 -79.05 -152.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.596 1.558 . . . . 61.210000000000001 110.228 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.86 2.32 32.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 119.727 -1.858 . . . . 75.109999999999999 113.231 174.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -106.2 -2.52 22.38 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.838 2.055 . . . . 71.430000000000007 111.63 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.46 56.87 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.46 1.505 . . . . 44.109999999999999 113.262 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -113.99 141.2 47.71 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.874 1.337 . . . . 63.530000000000001 109.86 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -66.94 135.06 53.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.208 1.803 . . . . 74.329999999999998 109.309 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.68 32.1 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.205 1.002 . . . . 74.5 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.1 176.18 27.81 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-O 122.432 1.018 . . . . 71.540000000000006 110.702 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.22 6.53 35.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.872 1.269 . . . . 62.420000000000002 112.524 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 p -167.48 125.62 1.26 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.908 0.883 . . . . 62.399999999999999 112.139 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -167.86 -175.43 2.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.561 0.744 . . . . 73.099999999999994 111.007 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -122.84 160.74 25.42 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.068 1.347 . . . . 72.430000000000007 108.571 162.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.16 127.83 17.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.83 -1.545 . . . . 61.530000000000001 106.83 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -78.69 149.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.921 -1.14 . . . . 63.229999999999997 107.921 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 14' ' ' ILE . 5.3 mm -86.42 112.75 23.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.108 -1.071 . . . . 65.340000000000003 108.108 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.26 37.77 3.69 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.861 1.265 . . . . 64.439999999999998 108.902 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -142.0 160.44 40.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.722 -1.214 . . . . 73.540000000000006 107.722 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 -16.92 62.69 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.277 -0.889 . . . . 33.229999999999997 113.235 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 p -145.22 150.85 37.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.703 1.601 . . . . 53.140000000000001 107.506 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmm -142.69 166.96 23.24 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.783 1.633 . . . . 74.209999999999994 110.641 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.6 p -162.26 151.89 16.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.251 1.42 . . . . 61.32 109.566 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.9 m -143.25 145.66 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.363 1.865 . . . . 64.319999999999993 107.665 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.8 p -143.82 -179.86 6.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.492 0.587 . . . . 54.299999999999997 111.254 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.543 HG22 HD23 ' A' ' 40' ' ' LEU . 26.1 p -129.34 -171.24 2.45 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.462 1.105 . . . . 71.519999999999996 110.633 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.6 -154.47 0.46 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.17 -1.048 . . . . 73.329999999999998 108.17 165.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.38 35.83 4.63 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.914 1.245 . . . . 72.099999999999994 112.526 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -135.86 87.95 2.36 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.694 -1.595 . . . . 74.200000000000003 106.694 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -171.2 166.17 7.23 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.33 1.452 . . . . 74.109999999999999 111.025 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.81 -16.11 7.23 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.476 1.51 . . . . 74.200000000000003 112.815 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.78 165.19 36.15 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.892 -1.151 . . . . 74.099999999999994 107.892 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 ttt -131.1 156.38 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 104.569 -2.382 . . . . 61.399999999999999 104.569 164.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -130.94 152.4 50.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.682 -0.859 . . . . 72.540000000000006 108.682 167.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.17 87.78 2.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.381 -2.081 . . . . 71.120000000000005 105.381 167.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.4 136.77 53.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.15 1.78 . . . . 71.230000000000004 107.123 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.98 -148.65 5.06 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 121.564 -0.71 . . . . 73.120000000000005 111.477 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -150.25 171.49 16.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.388 1.475 . . . . 64.129999999999995 109.427 161.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.53 143.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.058 1.343 . . . . 65.400000000000006 108.1 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -142.18 163.05 33.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.267 0.354 . . . . 62.520000000000003 110.777 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 t -135.68 160.01 39.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.946 1.698 . . . . 75.200000000000003 107.885 165.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 pt -133.95 21.08 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 128.233 2.613 . . . . 73.409999999999997 108.987 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -81.19 -177.75 6.6 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 123.145 1.45 . . . . 55.299999999999997 109.881 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -73.99 170.62 15.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.029 -1.896 . . . . 64.200000000000003 109.275 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 165.29 3.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.669 1.188 . . . . 70.430000000000007 112.514 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.64 71.77 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.579 1.561 . . . . 61.299999999999997 114.111 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.45 134.94 36.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.736 1.768 . . . . 74.400000000000006 108.269 -176.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -125.99 129.16 48.66 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.745 1.157 . . . . 70.319999999999993 111.124 -169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.29 158.95 25.05 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.285 2.234 . . . . 74.209999999999994 105.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -161.14 101.38 1.24 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.146 -1.798 . . . . 64.329999999999998 106.146 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.71 143.78 21.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.258 -1.756 . . . . 72.340000000000003 106.258 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m -131.46 144.74 51.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.716 -1.587 . . . . 73.540000000000006 106.716 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -147.24 112.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 125.702 1.601 . . . . 53.200000000000003 109.231 -164.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.22 143.96 39.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.395 1.478 . . . . 74.209999999999994 107.046 -170.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.67 140.49 11.84 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.897 -0.881 . . . . 61.219999999999999 110.897 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -134.64 144.91 48.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.158 1.383 . . . . 73.530000000000001 110.099 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.65 118.6 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 105.193 -2.151 . . . . 65.340000000000003 105.193 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 t70 43.91 71.32 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.64 1.576 . . . . 61.340000000000003 112.153 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.08 27.29 3.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.251 2.221 . . . . 70.329999999999998 113.694 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -129.8 158.56 39.11 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 120.799 -1.188 . . . . 65.540000000000006 110.94 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.82 134.87 40.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.228 1.411 . . . . 72.150000000000006 107.456 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.51 -0.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.852 0.861 . . . . 65.319999999999993 112.101 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -161.87 153.52 18.8 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.399 -0.963 . . . . 73.510000000000005 108.399 165.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.62 122.86 3.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.691 -1.596 . . . . 73.150000000000006 106.691 170.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.49 171.25 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.895 0.747 . . . . 71.219999999999999 110.753 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.05 168.8 14.81 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.614 1.966 . . . . 74.439999999999998 109.376 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -150.86 170.6 18.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.585 -1.265 . . . . 70.319999999999993 107.585 162.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.55 154.91 51.23 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 127.852 2.461 . . . . 71.120000000000005 107.727 169.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.571 ' HB3' HD11 ' A' ' 115' ' ' LEU . 22.8 m-85 -137.79 154.83 49.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.987 -0.746 . . . . 71.140000000000001 108.987 164.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -145.27 134.16 17.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.707 -1.22 . . . . 74.099999999999994 107.707 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 p -75.58 131.81 40.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.687 0.795 . . . . 74.140000000000001 109.929 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -128.64 66.26 1.41 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.06 0.933 . . . . 71.120000000000005 108.793 161.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.21 15.71 79.78 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.703 -0.68 . . . . 63.530000000000001 114.26 163.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.55 162.97 32.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.58 1.552 . . . . 74.209999999999994 110.273 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 105.69 1.35 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.342 -0.844 . . . . 52.119999999999997 109.896 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -66.08 133.14 50.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.335 -0.987 . . . . 61.329999999999998 108.335 175.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -149.37 138.62 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.854 -2.276 . . . . 71.129999999999995 104.854 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.58 166.92 32.01 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.66 1.184 . . . . 63.119999999999997 111.484 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.1 p -136.81 153.7 50.74 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.143 0.977 . . . . 74.439999999999998 111.182 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -142.97 174.47 10.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.005 1.722 . . . . 73.530000000000001 108.943 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 t -164.38 144.08 7.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.503 -0.748 . . . . 52.0 109.621 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 92' ' ' VAL . 48.0 t -143.19 109.61 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.134 -2.173 . . . . 70.530000000000001 105.134 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 128.1 55.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.172 1.389 . . . . 65.5 107.574 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 5.4 44.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.924 1.083 . . . . 72.420000000000002 113.924 -172.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.292 0 O-C-N 120.116 -1.615 . . . . 73.340000000000003 106.775 171.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 108.777 -0.823 . . . . 53.25 108.777 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.49 -97.72 0.11 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 106.859 -2.496 . . . . 53.210000000000001 106.859 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.49 147.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.624 -2.362 . . . . 71.230000000000004 104.624 167.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -107.12 146.73 30.91 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.725 -1.583 . . . . 75.140000000000001 106.725 166.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -142.66 145.36 33.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.932 -1.507 . . . . 72.400000000000006 106.932 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 94' ' ' GLY . 2.5 tp -119.95 152.28 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.792 -1.558 . . . . 61.509999999999998 106.792 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.2 t -126.82 137.43 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.561 -2.385 . . . . 73.400000000000006 104.561 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 74' ' ' CYS . 53.2 mt -122.1 151.6 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.358 -2.09 . . . . 54.43 105.358 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.62 166.35 24.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.29 -1.004 . . . . 72.510000000000005 108.29 170.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -138.4 171.63 14.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.413 0.685 . . . . 63.420000000000002 109.426 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -161.78 174.14 13.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.053 2.141 . . . . 50.439999999999998 107.686 164.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.82 -147.68 18.58 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.317 -1.513 . . . . 65.329999999999998 109.317 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.88 78.67 3.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.056 0.931 . . . . 72.099999999999994 111.197 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -73.29 39.63 0.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.676 1.59 . . . . 73.329999999999998 112.534 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -142.49 -11.38 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.439 1.496 . . . . 74.230000000000004 113.239 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 14.05 1.04 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.579 1.081 . . . . 73.219999999999999 113.134 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.49 167.19 18.65 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.008 0.923 . . . . 73.129999999999995 110.061 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.3 111.62 6.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.264 -1.754 . . . . 70.299999999999997 106.264 163.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 90' ' ' ILE . 62.1 t -125.01 112.83 33.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.801 -1.926 . . . . 65.400000000000006 105.801 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -110.03 121.71 45.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.783 -1.192 . . . . 53.439999999999998 107.783 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 m -95.26 137.53 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.368 -1.345 . . . . 72.219999999999999 107.368 163.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.94 145.36 34.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.161 -1.422 . . . . 73.239999999999995 107.161 155.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -130.08 123.26 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.041 -2.207 . . . . 62.100000000000001 105.041 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.81 167.78 37.38 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.913 0.768 . . . . 50.020000000000003 111.487 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.72 39.38 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.972 1.748 . . . . 44.210000000000001 109.003 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.96 164.32 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.654 1.227 . . . . 71.209999999999994 111.425 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.18 175.85 9.25 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.923 1.689 . . . . 74.340000000000003 112.722 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -74.71 78.54 2.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.526 -0.916 . . . . 74.019999999999996 108.526 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.54 35.82 1.38 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-O 118.572 -1.127 . . . . 74.200000000000003 113.554 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.21 -172.12 30.8 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.918 1.859 . . . . 72.319999999999993 112.692 162.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.06 134.28 21.09 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.423 2.082 . . . . 70.329999999999998 107.662 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.91 131.06 42.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.406 1.082 . . . . 45.399999999999999 109.625 -167.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -61.68 122.24 14.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.433 -0.58 . . . . 70.219999999999999 109.433 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD23 HG22 ' A' ' 65' ' ' THR . 2.4 mt -97.09 154.97 17.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.177 1.791 . . . . 71.340000000000003 107.768 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -133.84 141.96 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.718 -1.586 . . . . 65.310000000000002 106.718 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.604 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -73.58 -154.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.439 1.896 . . . . 61.340000000000003 111.457 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -100.14 -3.17 32.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.02 1.728 . . . . 64.120000000000005 112.773 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -111.48 17.37 20.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.198 2.199 . . . . 54.409999999999997 110.109 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.09 19.06 69.71 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.634 1.588 . . . . 50.210000000000001 114.234 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.604 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -102.58 156.52 17.56 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 119.694 1.747 . . . . 71.219999999999999 107.958 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -85.43 150.48 24.68 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.47 -1.307 . . . . 72.200000000000003 107.47 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.2 pt -150.67 23.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.876 0.87 . . . . 74.310000000000002 112.927 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.32 -172.18 14.08 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.578 -1.326 . . . . 54.130000000000003 111.955 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -119.18 -4.99 10.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.843 2.057 . . . . 73.430000000000007 112.544 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -164.38 134.87 4.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.208 -1.405 . . . . 73.340000000000003 107.208 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -168.4 -173.86 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.013 1.725 . . . . 72.420000000000002 108.651 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.44 165.58 14.75 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.206 1.002 . . . . 74.329999999999998 110.17 159.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.84 133.06 26.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.963 1.305 . . . . 73.319999999999993 107.985 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -78.95 136.46 37.25 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.605 -0.517 . . . . 71.200000000000003 109.605 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 mm -78.86 74.43 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.778 0.831 . . . . 72.519999999999996 109.516 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -89.38 13.78 12.8 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.178 1.177 . . . . 65.340000000000003 114.178 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.4 p -118.52 161.11 20.56 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.989 0.916 . . . . 63.399999999999999 109.386 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.7 92.57 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 73.129999999999995 109.29 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.4 p -132.82 140.23 47.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.721 1.208 . . . . 64.140000000000001 108.671 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.05 168.42 19.64 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.325 1.85 . . . . 73.530000000000001 110.956 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.5 p -165.92 144.18 5.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.396 0.678 . . . . 45.119999999999997 110.885 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.3 m -127.1 157.77 38.78 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.487 -1.301 . . . . 64.409999999999997 107.487 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -146.86 -176.92 5.39 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.152 0.887 . . . . 72.299999999999997 110.611 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.496 HG22 HD23 ' A' ' 40' ' ' LEU . 20.0 p -134.91 177.75 7.55 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.353 0.661 . . . . 74.319999999999993 110.571 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -73.45 -172.53 1.2 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.074 1.35 . . . . 64.430000000000007 112.0 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.42 -5.54 72.98 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.783 -1.198 . . . . 72.209999999999994 115.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -130.82 109.25 10.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.767 2.027 . . . . 73.0 107.99 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.2 165.56 24.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.178 2.191 . . . . 74.5 110.103 166.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -117.55 -19.29 9.48 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.203 1.401 . . . . 74.519999999999996 113.268 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -159.86 172.51 17.5 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.89 0.768 . . . . 73.299999999999997 109.327 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.3 ttt -141.17 155.83 46.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.529 -2.026 . . . . 65.120000000000005 105.529 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -139.3 156.95 46.69 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.966 0.906 . . . . 51.229999999999997 108.911 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.637 ' HB3' HG12 ' A' ' 121' ' ' VAL . 2.1 t -123.94 16.27 9.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.727 1.611 . . . . 71.519999999999996 111.798 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.4 129.14 21.36 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 125.752 1.621 . . . . 73.299999999999997 110.632 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.7 -179.83 31.09 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 42.219999999999999 111.263 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.89 150.73 43.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.246 2.218 . . . . 61.539999999999999 107.809 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.67 HG13 ' CG ' ' A' ' 117' ' ' GLU 0.295 1.6 p -138.04 155.89 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 50.420000000000002 110.552 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -151.73 179.18 8.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.214 -1.402 . . . . 72.400000000000006 107.214 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.5 t -161.91 164.69 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.218 1.407 . . . . 65.519999999999996 108.417 165.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.11 -0.11 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.914 1.286 . . . . 71.239999999999995 112.115 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.84 -176.5 1.69 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.752 1.263 . . . . 72.219999999999999 109.253 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -72.51 175.59 6.15 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 73.109999999999999 111.107 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 166.88 8.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.693 1.597 . . . . 74.530000000000001 113.169 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.43 37.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.312 1.911 . . . . 51.020000000000003 114.805 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -87.67 115.34 25.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.382 1.873 . . . . 51.200000000000003 106.987 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 167.59 9.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.573 1.149 . . . . 74.439999999999998 109.776 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -157.87 97.15 1.54 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.757 -1.201 . . . . 74.299999999999997 107.757 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -87.86 138.9 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.621 -1.622 . . . . 75.329999999999998 106.621 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 25' ' ' VAL . 6.2 mm -128.28 140.05 50.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 106.157 -1.794 . . . . 74.219999999999999 106.157 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m -124.03 135.72 53.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.156 -1.794 . . . . 74.340000000000003 106.156 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -137.59 110.94 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 108.126 -1.065 . . . . 61.229999999999997 108.126 -172.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.55 141.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.929 1.292 . . . . 75.209999999999994 108.497 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' CA ' HD12 ' A' ' 12' ' ' ILE . . . -138.58 144.56 15.69 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.361 0.981 . . . . 75.129999999999995 113.3 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -128.82 158.58 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.049 1.74 . . . . 74.329999999999998 110.82 -169.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.72 110.35 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.454 -2.054 . . . . 73.540000000000006 105.454 168.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 t0 72.6 -67.41 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.924 2.489 . . . . 72.450000000000003 110.012 168.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -153.97 10.45 0.4 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.784 1.634 . . . . 74.209999999999994 112.971 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -123.15 152.38 41.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.571 1.078 . . . . 55.219999999999999 111.486 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.46 121.51 39.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.537 1.535 . . . . 73.310000000000002 108.091 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.09 -15.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 62.240000000000002 112.881 -169.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.38 141.63 25.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.545 1.066 . . . . 75.510000000000005 108.689 -170.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.61 158.08 3.3 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.661 0.784 . . . . 72.519999999999996 111.469 173.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -152.14 172.62 16.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.119 1.512 . . . . 74.549999999999997 108.432 156.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.21 163.96 16.97 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.789 -1.189 . . . . 63.219999999999999 107.789 169.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -143.68 165.95 26.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.043 1.337 . . . . 64.209999999999994 109.409 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -162.53 120.95 2.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.439 -2.164 . . . . 75.310000000000002 109.507 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 117' ' ' GLU . 26.8 m-85 -131.5 149.43 52.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.077 0.861 . . . . 75.510000000000005 110.316 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mt -144.73 118.32 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.81 -1.552 . . . . 61.32 106.81 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 p -64.6 142.43 58.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.925 1.29 . . . . 71.420000000000002 110.993 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.56 51.73 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.313 2.245 . . . . 73.299999999999997 107.675 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.5 7.21 85.27 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.927 1.251 . . . . 73.420000000000002 114.338 167.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -127.68 179.59 5.44 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.295 2.238 . . . . 62.509999999999998 108.98 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -63.5 134.7 56.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.164 -0.68 . . . . 70.299999999999997 109.164 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.5 tp -95.39 135.36 37.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.7 2.0 . . . . 64.519999999999996 107.563 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.7 mt -164.76 133.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 128.68 2.792 . . . . 73.319999999999993 110.643 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.67 ' CG ' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -159.55 167.03 29.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.268 2.627 . . . . 74.519999999999996 112.838 -176.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -136.33 158.57 44.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.554 1.541 . . . . 71.439999999999998 110.42 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.11 164.92 28.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.365 1.866 . . . . 74.409999999999997 108.512 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -150.89 129.54 12.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.089 0.471 . . . . 75.400000000000006 110.081 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 74' ' ' CYS . 8.8 p -129.9 131.06 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.274 -1.75 . . . . 63.149999999999999 106.274 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.9 m -128.69 -179.61 5.16 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.517 -1.29 . . . . 71.340000000000003 107.517 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.3 p -135.28 33.84 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.566 -0.709 . . . . 52.119999999999997 109.103 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tptp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 106.585 -1.635 . . . . 75.420000000000002 106.585 174.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 107.185 -1.413 . . . . 73.109999999999999 107.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.42 -90.76 0.08 OUTLIER Glycine 0 C--N 1.338 0.64 0 O-C-N 121.032 -1.043 . . . . 54.140000000000001 110.706 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.8 145.68 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 104.965 -2.235 . . . . 74.409999999999997 104.965 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 23.6 m-70 -120.73 148.97 43.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.912 1.233 . . . . 63.43 108.601 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 161.22 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.832 . . . . 74.150000000000006 109.714 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mm -140.35 136.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.25 -1.759 . . . . 65.219999999999999 106.25 170.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.5 t -113.95 144.87 20.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.17 2.188 . . . . 42.229999999999997 107.031 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.22 154.13 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.84 -1.541 . . . . 70.420000000000002 106.84 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -144.73 168.35 20.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.696 -1.224 . . . . 65.219999999999999 107.696 172.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -146.72 164.53 32.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.301 0.572 . . . . 72.439999999999998 111.358 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 m -157.05 172.14 19.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.159 2.584 . . . . 65.219999999999999 108.291 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.46 -151.56 19.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.026 -1.23 . . . . 61.030000000000001 110.026 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -76.04 64.86 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 123.444 1.592 . . . . 75.25 110.423 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -61.57 -14.28 28.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.495 . . . . 72.409999999999997 113.151 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.82 -30.64 62.82 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.397 0.679 . . . . 73.340000000000003 112.146 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.0 1.14 11.42 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.122 0.786 . . . . 60.229999999999997 113.122 -162.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.17 111.46 21.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.751 -1.574 . . . . 73.349999999999994 106.751 -173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 150.88 38.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.138 -0.69 . . . . 54.229999999999997 109.138 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.04 111.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 106.899 -1.519 . . . . 74.140000000000001 106.899 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -112.73 127.69 56.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.946 -1.131 . . . . 73.540000000000006 107.946 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.26 147.96 32.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.777 0.831 . . . . 53.350000000000001 109.361 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 t -117.92 120.68 38.6 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.201 2.201 . . . . 74.530000000000001 107.739 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.3 mt -120.35 125.31 74.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 74.540000000000006 108.39 -156.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.01 169.1 35.87 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 121.267 0.37 . . . . 72.219999999999999 113.099 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.05 174.21 39.34 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 127.303 2.383 . . . . 73.209999999999994 108.239 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.43 147.23 50.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 119.898 1.849 . . . . 54.009999999999998 110.227 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.07 179.49 4.03 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.752 2.421 . . . . 44.100000000000001 111.383 -172.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.37 76.2 0.16 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.825 0.85 . . . . 50.200000000000003 110.561 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.42 34.0 4.32 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.775 1.178 . . . . 74.340000000000003 111.734 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.9 175.42 47.5 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.637 1.218 . . . . 72.319999999999993 112.759 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.48 134.16 34.78 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.66 2.24 . . . . 72.319999999999993 108.921 159.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.87 128.23 34.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.831 -0.804 . . . . 73.140000000000001 108.831 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -56.0 123.25 13.75 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.271 -0.64 . . . . 72.439999999999998 109.271 169.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -92.69 164.6 13.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 124.222 0.951 . . . . 74.510000000000005 109.16 169.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -137.38 143.36 41.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.417 1.887 . . . . 72.120000000000005 107.926 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -69.59 -152.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.267 2.627 . . . . 75.230000000000004 110.944 174.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -99.91 -3.64 31.97 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.403 -1.435 . . . . 74.319999999999993 114.322 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -98.74 -3.5 35.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.321 -1.487 . . . . 75.299999999999997 111.6 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.99 9.49 56.01 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 127.356 2.407 . . . . 55.5 112.396 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -110.32 142.39 42.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 120.589 2.195 . . . . 75.120000000000005 108.334 -165.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -64.32 131.32 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.439 1.496 . . . . 74.129999999999995 108.704 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.54 9.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.063 0.945 . . . . 73.329999999999998 111.81 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.87 175.62 22.99 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.441 -1.063 . . . . 73.510000000000005 110.441 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.98 11.62 17.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.075 0.95 . . . . 75.329999999999998 110.727 166.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -162.3 157.13 22.36 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 126.791 2.036 . . . . 52.119999999999997 106.415 151.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 40' ' ' LEU . 17.5 p90 -176.99 -174.99 0.56 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.493 1.917 . . . . 75.140000000000001 110.878 171.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.7 p -122.38 158.3 29.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.613 2.365 . . . . 71.519999999999996 108.369 161.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.96 106.06 3.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.299 -0.63 . . . . 72.099999999999994 109.299 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.43 145.09 52.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.598 0.714 . . . . 75.530000000000001 110.049 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mm -75.68 135.58 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.058 -1.46 . . . . 75.230000000000004 107.058 167.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.1 7.74 3.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.356 1.062 . . . . 61.43 110.816 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -139.51 152.39 46.91 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.073 -1.017 . . . . 72.319999999999993 108.874 -148.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -31.22 64.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.99 0.359 . . . . 64.349999999999994 111.937 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -134.99 164.18 28.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.827 1.251 . . . . 71.25 109.328 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.28 171.2 15.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.814 2.045 . . . . 62.329999999999998 109.912 170.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 p -173.46 156.78 3.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.668 1.587 . . . . 74.439999999999998 111.17 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.6 m -150.06 165.81 31.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.482 2.713 . . . . 62.229999999999997 107.416 162.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 p -147.88 -179.85 7.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.125 0.97 . . . . 54.009999999999998 111.28 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.8 p -102.9 164.91 11.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.662 1.185 . . . . 74.409999999999997 109.334 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.42 169.42 4.75 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.235 -0.586 . . . . 62.32 109.608 152.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.36 36.94 1.78 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.072 0.844 . . . . 65.540000000000006 113.123 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -146.33 90.17 1.93 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.237 -2.134 . . . . 65.430000000000007 105.237 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.6 141.94 17.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.319 1.847 . . . . 74.349999999999994 106.977 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -86.09 -22.43 27.15 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.446 1.098 . . . . 73.439999999999998 111.832 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 25.6 p90 -157.38 167.33 30.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.697 1.199 . . . . 74.209999999999994 108.481 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.57 148.86 49.24 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.302 -2.11 . . . . 74.25 105.302 159.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.6 t -140.55 157.83 44.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.302 -0.999 . . . . 54.340000000000003 108.302 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.47 79.06 1.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.923 1.289 . . . . 73.109999999999999 109.157 -169.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.43 156.33 31.19 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.222 -0.659 . . . . 64.430000000000007 109.222 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.4 174.49 41.21 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 121.947 0.748 . . . . 72.450000000000003 112.662 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.6 t -146.33 148.59 32.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 126.337 1.855 . . . . 74.510000000000005 107.724 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.05 136.41 53.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 126.097 1.759 . . . . 72.439999999999998 106.718 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -148.57 151.86 35.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.698 0.799 . . . . 74.450000000000003 110.906 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -150.15 151.08 32.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.126 0.97 . . . . 72.319999999999993 108.462 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 5.15 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.367 2.267 . . . . 72.120000000000005 110.827 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 p -63.01 169.46 3.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.185 0.994 . . . . 50.310000000000002 110.322 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 168.18 9.68 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.319 1.057 . . . . 73.049999999999997 112.252 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.4 19.14 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.561 -1.654 . . . . 70.120000000000005 112.854 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.85 57.88 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.873 1.225 . . . . 73.129999999999995 114.014 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -75.19 167.07 22.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.21 1.505 . . . . 74.140000000000001 107.313 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -153.87 174.03 15.14 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.952 -1.093 . . . . 74.319999999999993 111.118 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tp -158.46 152.78 24.21 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.338 -0.986 . . . . 45.229999999999997 108.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -140.57 131.38 25.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.409 -1.7 . . . . 73.140000000000001 106.409 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.51 116.97 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 106.429 -1.693 . . . . 72.439999999999998 106.429 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -96.99 139.33 33.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.24 -1.763 . . . . 73.129999999999995 106.24 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.36 132.07 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.004 -2.221 . . . . 73.129999999999995 105.004 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.1 mt -142.58 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 107.727 -1.212 . . . . 74.25 107.727 -172.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.27 143.95 17.97 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 109.002 -1.639 . . . . 42.030000000000001 109.002 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -132.88 152.59 51.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.239 1.015 . . . . 72.549999999999997 110.333 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.1 mt -132.52 124.26 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.609 -2.367 . . . . 73.140000000000001 104.609 167.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 44.77 68.4 0.56 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.198 1.799 . . . . 70.540000000000006 110.804 163.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.6 1.83 3.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.148 1.536 . . . . 43.450000000000003 115.148 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -132.11 153.11 50.82 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.072 1.306 . . . . 74.219999999999999 111.227 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -86.02 148.23 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.113 0.482 . . . . 73.540000000000006 110.034 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 m -135.27 1.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.938 1.295 . . . . 65.109999999999999 111.657 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.56 140.68 8.53 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 120.908 -1.12 . . . . 74.129999999999995 108.605 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -158.54 144.47 16.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.999 0.919 . . . . 70.409999999999997 109.311 162.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.18 108.02 2.53 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.829 0.823 . . . . 71.329999999999998 109.435 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.64 157.76 37.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.621 -1.299 . . . . 53.229999999999997 108.997 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 173.69 7.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.823 -1.547 . . . . 72.329999999999998 106.823 159.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -145.94 132.29 19.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 74.329999999999998 106.301 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 115' ' ' LEU . 8.4 m-85 -128.5 165.62 20.36 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.898 0.772 . . . . 72.349999999999994 110.246 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.9 mt -150.47 137.03 12.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.968 2.507 . . . . 73.239999999999995 105.783 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.2 144.72 30.49 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.993 0.917 . . . . 63.030000000000001 108.875 170.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -129.68 13.5 5.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 64.019999999999996 111.599 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.5 55.36 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 121.314 -0.866 . . . . 71.230000000000004 112.94 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -90.17 170.27 10.44 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.559 1.544 . . . . 65.319999999999993 107.892 160.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.59 139.66 58.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.808 -1.182 . . . . 62.25 107.808 161.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.1 tt -97.65 134.22 41.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.699 -1.223 . . . . 74.129999999999995 107.699 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.8 mt -145.5 141.93 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.251 -2.129 . . . . 71.549999999999997 105.251 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.74 168.23 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.632 1.573 . . . . 65.409999999999997 109.318 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.2 p -140.91 157.61 45.11 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.687 1.195 . . . . 73.430000000000007 109.152 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.25 171.88 18.51 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.394 -0.821 . . . . 70.519999999999996 109.129 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -151.93 142.83 23.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.421 1.088 . . . . 61.219999999999999 108.419 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.87 85.78 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.767 -1.938 . . . . 73.310000000000002 105.767 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -64.88 170.02 4.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.59 -0.893 . . . . 71.129999999999995 108.59 160.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 p -127.87 -12.13 5.36 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.549 -0.719 . . . . 72.109999999999999 111.444 159.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 106.413 -1.699 . . . . 74.450000000000003 106.413 -169.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.815 0.817 . . . . 52.109999999999999 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.02 -119.8 0.93 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.799 3.095 . . . . 50.43 106.311 -166.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.01 103.93 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 53.340000000000003 108.456 -167.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.453 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 50.1 m-70 -74.38 154.86 38.64 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.962 -0.461 . . . . 71.340000000000003 109.771 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -145.86 152.26 39.19 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.817 1.247 . . . . 61.420000000000002 107.905 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -127.24 152.43 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.294 2.238 . . . . 71.109999999999999 105.489 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.83 136.04 54.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.396 -2.076 . . . . 72.230000000000004 105.396 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.4 mt -122.91 150.82 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 105.959 -1.867 . . . . 62.140000000000001 105.959 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -142.9 163.36 33.01 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.053 -1.462 . . . . 64.209999999999994 107.053 166.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -136.93 154.45 50.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.625 -1.25 . . . . 72.25 107.625 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -145.36 171.01 15.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.29 -137.47 14.22 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.023 -1.631 . . . . 32.020000000000003 109.023 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -89.98 65.42 6.58 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.521 1.529 . . . . 40.119999999999997 109.79 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.8 p -75.42 35.5 0.12 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.161 2.184 . . . . 72.040000000000006 113.338 -164.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -142.6 8.48 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.244 1.417 . . . . 72.439999999999998 111.644 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 m -149.19 7.64 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.106 1.762 . . . . 60.009999999999998 111.412 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.75 141.91 50.03 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.074 -1.016 . . . . 73.430000000000007 109.103 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -116.1 116.56 28.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.229 -1.767 . . . . 74.219999999999999 106.229 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.75 90.14 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.462 -0.94 . . . . 72.340000000000003 108.462 -171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -86.89 145.23 26.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.046 -1.033 . . . . 71.439999999999998 108.298 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.14 129.12 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.316 1.046 . . . . 65.329999999999998 109.469 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -64.59 138.12 58.22 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.723 -1.584 . . . . 74.439999999999998 106.723 160.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 122.27 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.129 -2.175 . . . . 73.310000000000002 105.129 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.69 167.38 35.22 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.048 -0.821 . . . . 41.420000000000002 111.048 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.04 170.95 44.13 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.388 1.947 . . . . 73.200000000000003 109.065 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.69 164.78 21.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.852 0.861 . . . . 62.009999999999998 109.999 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -131.24 -164.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.255 1.822 . . . . 74.420000000000002 111.074 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -79.82 71.59 6.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.845 -0.428 . . . . 71.420000000000002 109.845 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.58 -22.6 2.01 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-O 119.035 -0.869 . . . . 50.229999999999997 114.2 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.69 -154.8 8.09 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.102 -1.199 . . . . 74.140000000000001 110.102 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.1 154.92 42.4 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.726 2.284 . . . . 72.329999999999998 110.515 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 110.79 20.77 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.214 1.406 . . . . 74.409999999999997 108.993 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -45.46 116.25 1.11 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.988 1.715 . . . . 61.439999999999998 111.531 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.71 160.2 15.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.956 0.884 . . . . 71.129999999999995 110.09 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -129.09 152.09 49.06 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.677 1.591 . . . . 75.420000000000002 107.897 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -96.5 172.75 7.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 73.299999999999997 110.424 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -65.47 -9.47 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.096 1.758 . . . . 73.430000000000007 113.978 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -87.52 -8.52 56.28 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.652 1.581 . . . . 61.43 111.152 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.1 59.09 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.921 1.724 . . . . 71.140000000000001 113.741 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -104.7 147.15 27.99 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.698 1.249 . . . . 74.019999999999996 109.251 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -66.29 135.76 54.87 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.003 -1.11 . . . . 61.229999999999997 108.003 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -136.63 28.83 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.713 0.805 . . . . 60.43 111.509 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.06 18.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.4 -1.08 . . . . 73.0 110.4 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.04 2.95 55.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.134 1.773 . . . . 70.239999999999995 113.246 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -165.77 157.38 14.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.565 1.546 . . . . 72.230000000000004 108.375 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.3 p90 177.92 -173.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.578 2.351 . . . . 74.230000000000004 109.726 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 m -119.28 153.0 35.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.648 1.179 . . . . 62.310000000000002 108.246 154.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.79 110.29 7.02 Favored 'General case' 0 CA--C 1.523 -0.086 0 C-N-CA 124.328 1.051 . . . . 64.040000000000006 108.332 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -73.19 145.1 46.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.096 0.958 . . . . 64.319999999999993 110.383 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -80.51 118.78 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.734 -1.58 . . . . 75.219999999999999 106.734 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.55 29.37 2.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.037 1.335 . . . . 73.099999999999994 108.604 167.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 p -135.51 157.25 47.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.446 1.098 . . . . 54.32 108.862 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.52 -40.66 79.22 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.28 0.632 . . . . 63.240000000000002 110.408 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.5 p -133.76 163.67 28.96 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.74 0.816 . . . . 44.130000000000003 110.878 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 mmm -142.43 170.62 15.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.297 1.839 . . . . 74.030000000000001 111.563 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 p -160.9 154.76 22.49 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.22 1.808 . . . . 72.340000000000003 108.641 165.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.8 m -143.91 150.43 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.203 1.801 . . . . 64.010000000000005 107.851 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.6 p -149.15 179.74 7.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.164 0.983 . . . . 62.43 110.529 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -119.29 -174.65 2.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.28 -1.748 . . . . 64.200000000000003 106.28 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -92.37 -176.57 4.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.533 -1.284 . . . . 75.019999999999996 107.533 158.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.76 64.33 2.63 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.961 -1.087 . . . . 34.43 111.684 173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.94 71.75 1.35 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 103.883 -2.636 . . . . 71.400000000000006 103.883 169.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.89 32.94 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.134 -0.978 . . . . 63.140000000000001 111.247 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.09 -7.13 2.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.172 1.789 . . . . 74.099999999999994 112.552 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 29.6 p90 -157.29 170.66 21.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.36 -1.348 . . . . 73.239999999999995 107.36 163.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.7 ttt -146.29 147.66 31.61 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 105.136 -2.172 . . . . 74.430000000000007 105.136 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.5 t -135.36 164.97 26.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.82 0.819 . . . . 63.439999999999998 110.002 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.32 106.91 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.703 -2.332 . . . . 74.219999999999999 104.703 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 142.97 41.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.906 -1.887 . . . . 70.019999999999996 105.906 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.54 -151.05 5.55 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 120.94 -0.648 . . . . 34.130000000000003 111.813 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.24 175.49 10.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.137 -0.69 . . . . 74.239999999999995 109.137 147.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -137.15 147.46 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.661 1.584 . . . . 73.150000000000006 109.273 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.5 m -149.32 167.71 25.35 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.43 -0.794 . . . . 73.040000000000006 112.743 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 t -143.47 151.61 40.51 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.771 2.029 . . . . 65.239999999999995 107.05 158.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.02 48.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.839 . . . . 73.230000000000004 107.616 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.1 m -127.72 174.62 8.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.292 1.037 . . . . 70.150000000000006 112.499 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -55.14 158.53 2.91 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.631 1.972 . . . . 63.049999999999997 110.817 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.8 167.14 1.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.196 1.398 . . . . 52.219999999999999 112.974 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.52 -13.65 33.75 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.043 1.306 . . . . 50.539999999999999 114.157 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -67.43 132.45 47.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.119 1.46 . . . . 74.219999999999999 108.215 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.0 mtt85 -110.38 159.78 17.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.711 -1.218 . . . . 70.25 107.711 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -146.67 141.42 26.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.87 -1.529 . . . . 71.329999999999998 106.87 177.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -145.79 92.92 2.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.993 -1.484 . . . . 73.25 106.993 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.61 143.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.442 -1.688 . . . . 73.140000000000001 106.442 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -119.28 136.47 54.22 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.493 -1.669 . . . . 65.230000000000004 106.493 165.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.51 115.07 12.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 125.655 1.582 . . . . 71.040000000000006 108.842 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.67 153.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.348 -1.723 . . . . 65.329999999999998 106.348 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.16 158.18 27.61 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.695 -0.962 . . . . 71.450000000000003 110.695 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -143.35 152.92 42.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.947 0.899 . . . . 74.239999999999995 110.369 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.8 mt -121.81 120.76 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.288 -2.115 . . . . 73.239999999999995 105.288 165.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.5 t0 72.39 -83.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.122 2.969 . . . . 73.019999999999996 110.197 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.73 24.73 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.58 1.952 . . . . 64.409999999999997 108.702 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -135.74 132.85 37.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.266 -0.896 . . . . 75.420000000000002 110.746 -166.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.31 136.17 57.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.992 -0.744 . . . . 70.120000000000005 108.992 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.59 -25.55 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.16 0.984 . . . . 52.350000000000001 108.823 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -145.89 142.92 29.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.512 1.525 . . . . 74.230000000000004 107.768 -168.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -167.23 112.0 0.72 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.642 1.177 . . . . 74.430000000000007 109.095 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.07 173.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.551 0.532 . . . . 50.109999999999999 109.893 162.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -128.3 172.76 10.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 72.209999999999994 108.068 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 147.12 33.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.704 -0.85 . . . . 71.129999999999995 108.704 164.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -120.61 136.11 54.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.655 -0.869 . . . . 65.409999999999997 108.655 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -138.65 155.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.044 0.938 . . . . 72.209999999999994 108.849 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.88 135.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.17 -1.419 . . . . 64.340000000000003 107.17 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -65.86 144.23 56.95 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.076 0.95 . . . . 53.549999999999997 109.328 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -137.0 21.34 3.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.97 0.804 . . . . 73.340000000000003 112.546 164.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.12 -24.1 31.62 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.15 1.833 . . . . 72.120000000000005 111.336 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.47 159.08 27.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.789 -0.819 . . . . 63.329999999999998 108.789 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.42 120.64 21.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.759 -1.571 . . . . 63.439999999999998 106.759 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.1 21.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.42 -1.696 . . . . 70.420000000000002 106.42 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.03 142.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 105.699 -1.963 . . . . 73.120000000000005 105.699 166.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.59 179.1 8.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.835 0.826 . . . . 72.109999999999999 109.555 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -135.68 173.01 12.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.387 1.875 . . . . 62.340000000000003 107.692 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -164.81 165.62 20.44 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.245 2.218 . . . . 74.319999999999993 108.621 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.5 149.82 27.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.558 0.617 . . . . 73.040000000000006 110.717 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 t -145.28 84.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.943 -1.502 . . . . 70.450000000000003 106.943 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.62 129.2 37.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.177 -1.786 . . . . 44.229999999999997 106.177 175.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.0 p -85.72 5.84 30.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.38 0.991 . . . . 74.129999999999995 112.049 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 tptp . . . . . 0 C--O 1.239 0.515 0 N-CA-C 107.563 -1.273 . . . . 74.140000000000001 107.563 177.284 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.139 -1.43 . . . . 75.329999999999998 107.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.0 -90.52 0.08 OUTLIER Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.85 2.166 . . . . 64.109999999999999 109.437 -163.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -139.36 135.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 127.468 2.307 . . . . 62.32 107.378 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -103.71 152.6 21.63 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.529 -0.732 . . . . 72.239999999999995 109.725 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -142.68 147.37 35.59 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.841 -1.17 . . . . 72.120000000000005 107.841 169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.9 mm -119.16 151.08 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.349 1.86 . . . . 75.430000000000007 106.267 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.93 139.13 46.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.118 -1.808 . . . . 73.439999999999998 106.118 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.67 154.36 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.325 -1.361 . . . . 73.099999999999994 107.325 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -142.8 168.9 18.64 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.52 1.128 . . . . 75.439999999999998 109.106 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -136.39 150.38 48.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.674 1.59 . . . . 74.409999999999997 108.355 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -154.25 162.39 41.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.303 1.841 . . . . 61.539999999999999 108.107 167.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.11 -163.69 31.84 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.329 -1.508 . . . . 75.400000000000006 109.329 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.1 99.13 3.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.953 1.701 . . . . 62.109999999999999 109.049 -169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.9 p -85.76 -10.24 55.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.836 1.254 . . . . 73.120000000000005 114.259 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.1 -12.66 46.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.709 -1.244 . . . . 71.239999999999995 111.661 -171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.59 30.84 1.88 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.221 1.408 . . . . 71.340000000000003 112.613 -169.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.618 ' CD2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -126.83 155.23 43.23 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.794 -1.192 . . . . 71.120000000000005 108.443 170.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.06 121.68 18.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.369 -1.345 . . . . 72.299999999999997 107.369 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.97 105.08 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 123.908 0.883 . . . . 54.439999999999998 109.079 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 145.98 25.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.694 -0.854 . . . . 64.430000000000007 108.694 162.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.45 131.59 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.605 1.562 . . . . 73.329999999999998 108.996 163.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 t -68.39 140.08 55.82 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.257 -1.386 . . . . 62.240000000000002 107.257 161.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.5 mt -130.43 108.54 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 104.297 -2.482 . . . . 71.299999999999997 104.297 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -143.39 166.43 26.82 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 109.382 -1.487 . . . . 52.439999999999998 109.382 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 172.04 44.96 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 108.314 -1.915 . . . . 71.340000000000003 108.314 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 164.75 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.521 1.129 . . . . 75.140000000000001 108.773 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -144.08 145.46 32.17 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.196 0.998 . . . . 64.040000000000006 109.306 156.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 45.2 -8.15 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 130.525 3.53 . . . . 60.210000000000001 117.829 -160.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 33' ' ' ASP . . . 138.51 -19.47 3.19 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 126.408 1.956 . . . . 63.100000000000001 110.796 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.96 -171.5 32.69 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.213 2.34 . . . . 41.409999999999997 111.711 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.7 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.281 2.654 . . . . 75.540000000000006 110.688 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.84 138.73 47.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.103 0.478 . . . . 62.240000000000002 111.902 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -65.14 110.59 2.59 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.749 1.62 . . . . 72.019999999999996 110.485 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 30' ' ' GLY . 2.8 mt -89.14 160.93 16.76 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.439 1.018 . . . . 74.329999999999998 108.745 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -130.4 144.29 51.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.335 1.054 . . . . 74.200000000000003 109.797 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.03 176.99 6.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.816 1.246 . . . . 64.099999999999994 110.808 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -72.03 -13.25 61.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.83 0.852 . . . . 63.210000000000001 112.86 -169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.82 -13.85 62.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.814 1.246 . . . . 64.030000000000001 110.635 168.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 14.27 72.69 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 126.542 2.02 . . . . 71.010000000000005 112.544 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -106.64 154.81 20.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.697 1.599 . . . . 73.319999999999993 110.337 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -76.03 152.02 37.01 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.211 -0.663 . . . . 74.430000000000007 109.211 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 pt -153.49 10.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.877 1.066 . . . . 63.109999999999999 113.877 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.19 167.09 11.13 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.814 -1.179 . . . . 53.439999999999998 110.574 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -111.66 -0.65 15.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.805 1.242 . . . . 73.299999999999997 112.443 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 m -148.34 141.85 25.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.068 -1.827 . . . . 74.329999999999998 106.068 159.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.06 -173.63 2.4 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.422 1.089 . . . . 73.129999999999995 108.578 166.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.3 m -130.23 153.87 48.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.493 1.117 . . . . 72.200000000000003 108.116 161.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.68 160.71 38.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.322 1.049 . . . . 61.520000000000003 108.827 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.196 0.598 . . . . 72.239999999999995 110.565 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.96 81.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.859 1.264 . . . . 63.520000000000003 108.417 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 29.42 7.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.623 1.169 . . . . 75.310000000000002 110.359 172.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -141.89 138.61 32.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.991 -1.115 . . . . 72.120000000000005 107.991 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.86 49.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.687 0.795 . . . . 60.109999999999999 111.94 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.9 p -141.6 159.87 41.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.931 1.292 . . . . 52.030000000000001 107.515 166.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -145.23 163.67 33.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.028 1.331 . . . . 73.340000000000003 109.897 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -172.59 153.82 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.365 1.466 . . . . 75.230000000000004 110.912 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.1 m -143.73 152.66 41.56 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.375 1.87 . . . . 73.209999999999994 107.292 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.4 p -142.35 177.62 8.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.842 0.857 . . . . 71.409999999999997 110.589 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.4 p -101.08 171.21 7.76 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.837 1.255 . . . . 63.0 109.923 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.48 177.2 1.6 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.269 -1.011 . . . . 71.319999999999993 108.269 152.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.01 34.69 0.9 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.73 -1.039 . . . . 32.119999999999997 113.13 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.11 131.35 11.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.778 1.789 . . . . 75.219999999999999 107.769 164.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -174.2 152.31 1.81 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.814 2.446 . . . . 64.310000000000002 108.315 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.23 -18.11 12.61 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.571 1.548 . . . . 73.420000000000002 112.856 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.39 177.35 11.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.688 2.395 . . . . 73.519999999999996 107.072 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 ttt -150.93 150.15 30.49 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 104.803 -2.295 . . . . 72.340000000000003 104.803 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 t -122.41 155.44 36.07 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.204 -1.406 . . . . 74.319999999999993 107.204 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 t -155.19 98.45 2.0 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.19 -2.152 . . . . 72.109999999999999 105.19 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -129.84 144.3 51.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.048 -1.464 . . . . 23.530000000000001 107.048 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.98 -149.74 5.08 Favored Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.577 -0.609 . . . . 63.439999999999998 111.577 -164.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.06 175.46 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.901 -0.777 . . . . 63.119999999999997 108.901 145.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -122.34 156.08 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.753 1.621 . . . . 72.5 107.674 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t -151.38 163.8 38.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.836 1.254 . . . . 61.509999999999998 109.289 161.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -151.44 134.84 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.47 2.308 . . . . 73.329999999999998 105.392 168.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.68 12.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.242 -1.022 . . . . 75.219999999999999 108.242 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -75.0 -176.66 3.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.796 -1.187 . . . . 72.099999999999994 107.796 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -62.38 167.3 4.32 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.368 1.08 . . . . 75.400000000000006 112.254 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.45 153.03 16.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.312 -1.767 . . . . 64.129999999999995 113.3 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.78 6.35 85.46 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.403 -1.221 . . . . 51.310000000000002 113.574 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -76.11 172.51 12.67 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.604 1.702 . . . . 54.439999999999998 108.599 160.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -147.47 150.86 35.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.591 -1.263 . . . . 75.150000000000006 107.591 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.618 HD21 ' CD2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -154.69 115.34 3.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.088 -0.708 . . . . 61.399999999999999 109.088 -175.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -118.89 124.66 47.66 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.982 1.713 . . . . 75.549999999999997 108.401 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.3 mm -113.75 142.88 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.526 -1.287 . . . . 52.299999999999997 107.526 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -122.87 133.66 54.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.21 -1.774 . . . . 75.150000000000006 106.21 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -139.59 132.23 35.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 125.73 1.612 . . . . 73.519999999999996 109.517 -173.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mt -143.76 152.31 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.540000000000006 108.333 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.2 151.24 23.51 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.554 1.074 . . . . 54.210000000000001 111.553 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -136.19 155.79 49.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.327 1.851 . . . . 73.319999999999993 110.372 -166.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mt -141.89 138.12 31.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 127.003 2.121 . . . . 71.299999999999997 105.395 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.75 -85.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.739 3.616 . . . . 64.439999999999998 109.955 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -152.27 37.2 0.54 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.444 1.498 . . . . 75.0 110.593 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -141.49 153.43 44.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.623 1.169 . . . . 75.329999999999998 110.975 171.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.54 148.36 42.39 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.041 0.936 . . . . 64.140000000000001 108.906 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.39 -18.38 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 54.43 112.685 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -136.6 137.69 40.42 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.23 1.377 . . . . 74.219999999999999 108.765 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -151.8 138.4 18.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.544 1.138 . . . . 74.510000000000005 109.751 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -143.8 168.95 18.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.648 0.737 . . . . 74.25 110.498 155.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.06 156.12 43.28 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.414 -1.698 . . . . 72.420000000000002 106.414 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 164.14 34.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.684 -0.858 . . . . 75.319999999999993 108.684 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -153.5 148.45 26.62 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.276 -0.268 . . . . 73.129999999999995 110.276 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.443 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.6 m-85 -148.44 137.69 21.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.582 1.153 . . . . 74.310000000000002 110.358 -167.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.2 mt -124.85 135.92 62.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.007 -1.479 . . . . 62.530000000000001 107.007 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.54 137.91 38.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.634 1.973 . . . . 63.329999999999998 108.634 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -141.75 31.16 1.65 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.777 0.798 . . . . 74.140000000000001 112.02 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.39 -3.92 86.3 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.368 0.985 . . . . 64.409999999999997 112.607 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.63 -155.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.497 1.919 . . . . 71.319999999999993 108.512 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -118.9 110.82 17.62 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.188 -1.782 . . . . 71.200000000000003 106.188 166.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 108' ' ' TYR . 1.4 tm? -62.13 120.28 10.58 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.426 -1.324 . . . . 63.549999999999997 107.426 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -148.19 144.11 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 103.976 -2.602 . . . . 75.439999999999998 103.976 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.48 169.72 18.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.991 -0.744 . . . . 74.530000000000001 108.991 169.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 p -134.85 162.47 32.31 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.797 1.239 . . . . 75.420000000000002 108.361 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -151.8 175.78 12.09 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.036 1.334 . . . . 75.319999999999993 108.68 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 t -160.58 148.52 16.19 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.716 0.769 . . . . 72.120000000000005 109.445 168.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.6 107.16 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 127.314 2.246 . . . . 61.210000000000001 106.393 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.24 118.47 30.54 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.084 1.354 . . . . 72.400000000000006 108.437 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.1 p -86.43 33.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.92 0.888 . . . . 71.230000000000004 111.847 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tptp . . . . . 0 C--O 1.235 0.33 0 N-CA-C 107.199 -1.408 . . . . 74.439999999999998 107.199 167.52 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 111.285 0.106 . . . . 74.200000000000003 111.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.43 -90.04 0.11 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 108.808 -1.717 . . . . 53.509999999999998 108.808 154.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.24 131.93 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.638 -1.986 . . . . 71.219999999999999 105.638 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -126.69 157.16 39.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.568 -1.271 . . . . 73.120000000000005 107.568 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -148.94 151.33 34.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.317 1.047 . . . . 62.039999999999999 108.257 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.34 134.94 52.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.858 -1.905 . . . . 74.340000000000003 105.858 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.54 131.26 50.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.711 -1.589 . . . . 70.049999999999997 106.711 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.3 mt -135.2 143.09 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.475 -0.935 . . . . 64.120000000000005 108.475 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -134.47 161.75 34.15 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.381 1.072 . . . . 75.209999999999994 110.3 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.23 141.86 29.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.33 2.652 . . . . 63.350000000000001 109.961 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -141.83 172.49 12.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.56 1.544 . . . . 60.219999999999999 107.343 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.33 -155.63 24.4 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.886 -1.286 . . . . 73.450000000000003 109.886 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.21 33.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.548 2.339 . . . . 61.25 111.106 -173.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 t -65.04 8.29 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.163 2.185 . . . . 73.540000000000006 113.798 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -17.83 64.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.841 1.656 . . . . 72.510000000000005 111.149 162.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.7 m -130.95 16.33 5.18 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.937 1.295 . . . . 72.450000000000003 113.019 -163.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 88' ' ' LEU . 53.1 m-85 -126.26 116.02 20.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.352 1.061 . . . . 70.140000000000001 109.261 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.22 127.08 31.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.28 -1.378 . . . . 71.109999999999999 107.28 166.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 t -136.74 106.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 105.557 -2.016 . . . . 61.539999999999999 105.557 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -114.87 145.86 41.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.768 1.167 . . . . 53.43 110.082 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.77 139.19 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.363 1.065 . . . . 63.43 109.595 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -66.84 139.39 57.76 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.768 -1.567 . . . . 64.439999999999998 106.768 161.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -132.9 124.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.591 -2.003 . . . . 44.409999999999997 105.591 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . -179.98 176.97 47.8 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.702 -1.359 . . . . 52.409999999999997 109.702 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.44 172.76 43.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.337 -1.905 . . . . 64.409999999999997 108.337 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.8 163.61 27.85 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.783 0.833 . . . . 54.140000000000001 109.863 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.39 -170.82 2.68 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.215 1.006 . . . . 74.200000000000003 112.039 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -74.94 67.47 1.68 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.317 1.047 . . . . 74.129999999999995 110.674 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.36 -32.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.533 -0.593 . . . . 53.140000000000001 112.729 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.93 -156.71 15.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 119.907 -1.139 . . . . 70.319999999999993 114.627 -162.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.18 139.44 9.38 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.927 3.084 . . . . 65.400000000000006 110.567 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.14 117.95 23.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.081 1.352 . . . . 73.400000000000006 110.576 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -60.21 117.61 5.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.661 1.119 . . . . 74.430000000000007 110.482 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD21 ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -91.39 159.16 16.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.004 1.321 . . . . 74.120000000000005 109.401 171.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -128.16 143.88 51.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.0 1.32 . . . . 74.209999999999994 109.306 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.75 165.87 20.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.182 -0.917 . . . . 53.420000000000002 109.864 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -74.45 19.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.654 1.582 . . . . 73.129999999999995 113.457 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -100.76 -10.95 20.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.159 1.383 . . . . 70.219999999999999 110.9 163.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.59 56.54 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.001 1.762 . . . . 73.129999999999995 113.339 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.19 160.88 14.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.553 1.141 . . . . 72.099999999999994 109.429 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -74.96 157.7 34.53 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.815 -0.553 . . . . 74.409999999999997 109.923 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.22 6.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.127 0.788 . . . . 43.520000000000003 113.127 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.18 -172.45 24.18 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.186 -1.565 . . . . 63.0 109.186 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 40' ' ' LEU . 14.6 p30 -125.03 8.73 8.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.037 1.335 . . . . 72.040000000000006 111.943 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -170.85 124.48 0.65 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.477 3.111 . . . . 74.299999999999997 106.864 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -163.18 -173.39 3.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.238 1.015 . . . . 73.239999999999995 110.211 171.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -121.11 157.46 30.06 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.261 1.024 . . . . 64.109999999999999 109.249 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.55 142.27 50.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.923 -1.139 . . . . 62.450000000000003 107.923 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -96.29 132.71 41.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.554 -1.647 . . . . 72.349999999999994 106.554 170.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -74.99 100.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.673 -1.603 . . . . 64.430000000000007 106.673 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -127.09 35.1 4.63 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.87 1.668 . . . . 65.239999999999995 109.875 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -134.31 169.01 17.85 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.117 -1.068 . . . . 63.409999999999997 108.117 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.33 9.95 34.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 118.643 -0.694 . . . . 54.450000000000003 111.443 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -178.51 159.85 1.2 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.901 2.48 . . . . 71.340000000000003 107.485 145.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 mmm -125.42 165.13 18.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.173 2.189 . . . . 73.409999999999997 109.572 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.4 p -159.56 163.07 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.238 -0.892 . . . . 61.049999999999997 111.317 158.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.4 m -147.87 163.09 37.86 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.469 2.308 . . . . 73.230000000000004 106.624 162.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.35 -176.81 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.23 1.812 . . . . 61.109999999999999 108.789 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.27 156.42 47.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.565 1.946 . . . . 73.400000000000006 107.362 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -82.4 179.61 7.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.217 0.207 . . . . 65.219999999999999 110.699 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.07 32.56 0.52 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.784 1.659 . . . . 73.319999999999993 115.752 -171.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -128.2 80.74 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.705 -2.331 . . . . 72.129999999999995 104.705 168.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.76 18.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.123 1.329 . . . . 65.340000000000003 107.546 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -128.62 -13.89 4.71 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.363 1.065 . . . . 70.299999999999997 112.955 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -164.11 167.88 19.71 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.407 1.883 . . . . 65.219999999999999 107.5 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 ttt -130.87 145.5 52.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.225 -2.139 . . . . 72.010000000000005 105.225 169.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 t -111.85 161.98 15.78 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.57 0.7 . . . . 65.010000000000005 109.981 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.42 40.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.312 1.445 . . . . 74.040000000000006 110.284 170.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.64 58.28 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 121.439 -0.788 . . . . 63.25 108.993 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.47 -174.95 38.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.747 -0.941 . . . . 74.230000000000004 110.747 -173.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.8 p -134.9 168.42 19.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.722 0.772 . . . . 72.409999999999997 110.892 -173.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.69 147.14 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.046 1.738 . . . . 71.439999999999998 106.731 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 t -152.09 164.5 37.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.092 -0.707 . . . . 44.350000000000001 109.092 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.12 155.64 43.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.667 -1.235 . . . . 72.349999999999994 107.667 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.82 22.39 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.421 1.488 . . . . 71.209999999999994 109.343 167.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.36 173.75 12.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.498 1.919 . . . . 54.049999999999997 110.368 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 176.39 8.18 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.687 1.195 . . . . 71.219999999999999 112.474 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.98 153.92 42.71 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 113.652 -1.613 . . . . 61.119999999999997 112.959 -173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.65 -10.51 44.89 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.663 1.125 . . . . 43.130000000000003 114.278 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -64.6 117.34 7.26 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 106.622 -1.621 . . . . 71.319999999999993 106.622 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -102.4 168.37 9.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.155 0.582 . . . . 72.140000000000001 110.074 -168.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 23' ' ' PHE . 12.6 tp -157.53 150.19 23.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.41 -1.7 . . . . 73.340000000000003 106.41 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -141.04 132.92 27.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 105.814 -1.921 . . . . 71.150000000000006 105.814 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 mm -127.64 133.81 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.767 -1.568 . . . . 72.150000000000006 106.767 -172.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.81 129.03 41.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.882 -1.525 . . . . 70.120000000000005 106.882 -168.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.17 121.05 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.315 1.046 . . . . 75.049999999999997 108.399 -173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.51 141.54 45.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.013 -1.477 . . . . 72.150000000000006 107.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.97 144.35 15.93 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 124.76 1.171 . . . . 73.120000000000005 111.155 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 100' ' ' GLU . 88.1 m-85 -131.63 151.39 51.65 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.67 1.588 . . . . 74.150000000000006 111.303 -165.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.5 mt -137.92 140.96 39.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.109 -1.812 . . . . 60.030000000000001 106.109 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t0 61.02 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.678 1.991 . . . . 74.109999999999999 110.829 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.67 20.82 1.31 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.52 1.528 . . . . 74.030000000000001 111.076 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -143.94 158.01 43.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 120.55 -1.344 . . . . 60.140000000000001 111.954 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 5.9 pm0 -80.82 156.1 26.3 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.249 -1.019 . . . . 63.049999999999997 108.249 168.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.88 -5.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.01 0.524 . . . . 73.349999999999994 112.181 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -151.8 130.15 12.08 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.802 -1.186 . . . . 74.140000000000001 109.226 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.53 142.88 18.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.642 0.777 . . . . 74.439999999999998 110.153 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.48 169.21 21.43 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.896 -0.779 . . . . 72.150000000000006 108.896 159.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.98 135.73 37.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.617 -1.623 . . . . 73.25 106.617 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.72 167.35 17.37 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 123.83 0.852 . . . . 73.209999999999994 109.547 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.56 131.22 7.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.774 -1.103 . . . . 74.340000000000003 108.143 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 16.5 m-85 -145.16 146.97 31.99 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.849 -0.797 . . . . 72.430000000000007 108.849 -171.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.25 147.02 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.716 -1.216 . . . . 71.530000000000001 107.716 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -77.07 138.66 39.68 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.627 2.371 . . . . 65.530000000000001 111.172 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -125.88 55.11 1.47 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.467 1.107 . . . . 73.129999999999995 109.281 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.59 3.96 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.047 1.308 . . . . 73.519999999999996 112.558 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.07 -174.97 5.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.505 1.522 . . . . 72.519999999999996 113.967 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.0 142.4 58.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.098 1.359 . . . . 64.120000000000005 109.161 165.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.6 tt -108.05 143.08 37.26 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.743 -0.836 . . . . 63.219999999999999 108.743 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mm -143.21 158.83 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 128.929 2.891 . . . . 73.450000000000003 106.017 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -172.82 170.61 4.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.606 2.362 . . . . 63.450000000000003 109.074 158.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.5 p -143.13 150.69 39.79 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 72.340000000000003 110.179 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -147.04 168.73 20.82 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.617 0.767 . . . . 51.140000000000001 110.689 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 p -158.39 111.58 2.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.102 -0.374 . . . . 74.209999999999994 111.185 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.62 88.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.189 -1.411 . . . . 74.140000000000001 107.189 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 155.52 19.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.449 -1.315 . . . . 63.409999999999997 107.449 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.9 p -91.78 30.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.725 -1.234 . . . . 70.200000000000003 109.727 174.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptm . . . . . 0 N--CA 1.452 -0.343 0 O-C-N 120.605 -1.31 . . . . 74.140000000000001 108.517 -179.025 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.239 0.537 0 N-CA-C 109.249 -0.648 . . . . 74.140000000000001 109.249 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.22 -115.42 0.65 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.929 -2.068 . . . . 54.240000000000002 107.929 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.52 82.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.621 -0.881 . . . . 74.109999999999999 108.621 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -64.16 153.33 38.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.864 -0.791 . . . . 73.040000000000006 108.864 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -138.33 153.01 48.99 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.367 -1.345 . . . . 74.420000000000002 107.367 167.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -122.28 140.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.982 -2.599 . . . . 73.120000000000005 103.982 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.37 133.7 61.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 105.753 -1.943 . . . . 74.299999999999997 105.753 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -138.57 129.06 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.65 -0.87 . . . . 63.140000000000001 108.65 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -117.05 161.72 18.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.014 0.526 . . . . 73.209999999999994 110.517 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -147.77 146.35 29.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.784 0.834 . . . . 61.130000000000003 109.766 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.78 -177.16 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.111 0.964 . . . . 64.129999999999995 109.713 166.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.64 -95.49 0.7 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.714 -1.355 . . . . 50.439999999999998 109.714 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -122.81 122.62 39.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.175 -2.528 . . . . 62.0 104.175 157.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 p -118.66 9.54 12.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.361 0.665 . . . . 73.409999999999997 111.274 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -88.48 -33.62 17.75 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.827 1.651 . . . . 71.299999999999997 110.032 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.87 26.15 6.68 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.921 1.688 . . . . 70.409999999999997 110.049 -167.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 80' ' ' SER . 81.2 m-85 -128.93 148.06 50.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.929 0.891 . . . . 73.430000000000007 109.504 165.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.04 154.38 19.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.262 1.825 . . . . 64.340000000000003 108.748 163.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.76 102.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.413 -2.439 . . . . 74.299999999999997 104.413 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 p -97.44 148.15 23.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.419 -0.956 . . . . 73.310000000000002 108.419 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.62 120.42 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.234 1.014 . . . . 62.229999999999997 110.667 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 t -59.58 136.04 57.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.359 -1.349 . . . . 63.200000000000003 107.359 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 40' ' ' LEU . 41.7 mt -130.43 116.37 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 105.124 -2.176 . . . . 64.299999999999997 105.124 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.12 174.57 36.08 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.01 0.814 . . . . 64.439999999999998 111.5 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.34 172.17 35.75 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.139 1.828 . . . . 72.430000000000007 110.219 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.07 168.94 18.55 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.108 0.963 . . . . 70.319999999999993 111.439 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.06 179.31 7.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.316 1.446 . . . . 73.219999999999999 113.987 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.69 71.81 1.01 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 74.209999999999994 109.946 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.24 -0.5 3.22 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 117.73 -1.594 . . . . 65.400000000000006 115.336 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.91 -166.78 39.46 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 120.509 2.154 . . . . 61.299999999999997 115.037 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.07 135.97 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.186 3.257 . . . . 65.510000000000005 109.102 163.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.77 102.78 12.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.954 -1.022 . . . . 70.140000000000001 108.864 -172.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -46.22 118.02 1.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.204 1.001 . . . . 65.040000000000006 110.898 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.2 mm? -81.42 154.67 26.27 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 120.254 1.388 . . . . 71.019999999999996 108.953 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -123.6 141.15 52.29 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.819 1.247 . . . . 74.430000000000007 110.346 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.9 173.36 12.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.799 -1.091 . . . . 65.129999999999995 110.9 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -80.48 8.36 7.88 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.44 0.904 . . . . 73.109999999999999 113.44 -170.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -105.43 -1.87 24.46 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.8 1.64 . . . . 73.099999999999994 111.266 165.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.81 55.51 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 118.766 -1.019 . . . . 74.040000000000006 114.656 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -107.28 150.79 26.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.15 1.475 . . . . 74.310000000000002 111.393 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -70.49 152.63 43.8 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.472 -0.566 . . . . 61.340000000000003 109.472 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.88 2.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 114.034 1.124 . . . . 74.129999999999995 114.034 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.25 -173.63 35.41 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 108.429 -1.868 . . . . 53.509999999999998 108.429 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -124.76 0.21 8.06 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.915 1.358 . . . . 74.329999999999998 113.451 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -151.3 150.72 30.87 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.938 2.495 . . . . 71.400000000000006 105.979 158.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -171.68 -178.08 2.16 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.397 1.879 . . . . 74.140000000000001 107.552 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -135.73 103.97 5.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.631 0.772 . . . . 73.409999999999997 109.434 172.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.44 154.52 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.528 0.604 . . . . 70.230000000000004 109.801 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.885 -1.524 . . . . 51.420000000000002 106.885 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -71.45 96.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.415 -1.328 . . . . 64.409999999999997 107.415 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -109.04 22.92 15.27 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.691 -1.256 . . . . 72.400000000000006 110.067 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -137.16 154.54 50.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.478 1.111 . . . . 63.219999999999999 108.69 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.3 67.22 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.605 0.595 . . . . 73.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -151.54 173.66 14.35 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.484 -0.76 . . . . 74.310000000000002 109.644 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -152.6 163.29 39.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 129.388 3.075 . . . . 70.340000000000003 108.801 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -158.8 157.82 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.383 1.473 . . . . 74.409999999999997 109.564 159.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.31 144.81 33.41 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.285 1.834 . . . . 64.430000000000007 106.804 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 p -127.77 -172.78 2.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.801 1.24 . . . . 53.219999999999999 110.044 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 p -125.01 -179.47 4.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.642 1.177 . . . . 64.140000000000001 109.2 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -74.22 -177.25 2.91 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.84 -0.8 . . . . 72.299999999999997 108.84 153.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.58 44.58 1.83 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.405 1.002 . . . . 54.5 110.896 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -142.92 89.4 2.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.878 -1.527 . . . . 72.019999999999996 106.878 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.07 179.83 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.895 1.678 . . . . 61.020000000000003 109.991 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -132.36 -16.0 2.78 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.888 1.07 . . . . 73.239999999999995 113.888 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -161.36 169.57 21.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.577 -1.268 . . . . 72.430000000000007 107.577 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.0 ttt -136.98 158.7 43.87 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 105.607 -1.997 . . . . 73.230000000000004 105.607 164.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -135.26 161.52 35.15 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.657 0.783 . . . . 70.239999999999995 109.935 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 104.48 3.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.798 1.239 . . . . 73.230000000000004 108.592 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.84 140.21 42.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.425 -1.324 . . . . 41.229999999999997 107.425 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.96 -150.73 5.83 Favored Glycine 0 C--N 1.331 0.269 0 O-C-N 121.186 -0.946 . . . . 65.010000000000005 113.176 -159.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -148.85 171.04 16.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 41.229999999999997 110.325 159.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.31 147.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.301 1.841 . . . . 70.120000000000005 106.472 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -155.02 167.59 29.86 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.09 -1.006 . . . . 61.43 111.655 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 10.2 t -139.42 148.98 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.237 1.815 . . . . 64.010000000000005 107.54 166.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.77 32.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.376 1.871 . . . . 62.420000000000002 107.737 170.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.16 -175.08 2.7 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.836 1.254 . . . . 74.120000000000005 110.522 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.34 163.31 23.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.402 1.881 . . . . 73.200000000000003 110.123 176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.59 163.05 2.63 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.321 1.848 . . . . 50.409999999999997 111.965 165.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.93 36.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 118.422 -1.21 . . . . 62.140000000000001 114.23 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -64.14 154.3 35.09 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.674 1.737 . . . . 74.030000000000001 108.066 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -136.98 161.72 35.27 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.043 0.937 . . . . 72.420000000000002 109.001 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 tp -155.8 133.69 11.27 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.982 -1.118 . . . . 74.030000000000001 107.982 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -132.26 88.76 2.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.196 1.398 . . . . 63.310000000000002 109.068 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.31 138.12 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.076 2.15 . . . . 63.219999999999999 108.441 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.9 m -126.14 140.3 52.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.161 -1.422 . . . . 74.430000000000007 107.161 169.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.515 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -135.64 124.58 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.468 1.507 . . . . 72.129999999999995 107.565 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mt -133.38 147.7 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.472 1.509 . . . . 72.310000000000002 107.532 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.5 141.8 11.42 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 124.458 1.028 . . . . 61.399999999999999 113.067 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.66 153.31 47.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.722 1.609 . . . . 74.010000000000005 110.896 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mt -121.24 107.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 N-CA-C 106.47 -1.678 . . . . 72.409999999999997 106.47 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t0 73.36 -64.7 0.39 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.864 2.066 . . . . 61.329999999999998 110.62 172.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 -7.66 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.311 2.244 . . . . 71.019999999999996 111.78 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.5 129.93 56.17 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 114.075 1.139 . . . . 65.329999999999998 114.075 -163.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.39 121.73 26.6 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.689 -0.856 . . . . 74.129999999999995 108.689 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 -1.53 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.698 . . . . 64.129999999999995 112.886 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -149.0 139.5 22.52 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.606 1.094 . . . . 65.140000000000001 108.225 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -157.42 149.21 22.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.578 -0.897 . . . . 63.32 108.578 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -149.72 164.06 36.27 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.474 -0.565 . . . . 74.239999999999995 109.474 160.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -137.03 147.55 46.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.987 1.315 . . . . 70.239999999999995 108.129 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -142.85 169.15 18.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.703 0.683 . . . . 61.329999999999998 110.391 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -139.91 139.86 36.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.376 -1.713 . . . . 63.210000000000001 106.376 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.93 153.26 51.89 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.55 1.14 . . . . 72.439999999999998 108.375 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -141.29 138.23 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.754 -1.573 . . . . 74.140000000000001 106.754 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 p -81.01 147.67 30.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.173 0.897 . . . . 44.520000000000003 110.214 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -136.62 28.85 2.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.712 0.805 . . . . 74.0 111.46 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.45 -26.33 13.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.132 1.349 . . . . 31.34 112.601 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -77.34 168.31 20.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.562 1.545 . . . . 74.430000000000007 109.278 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 m -67.12 112.34 4.37 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.847 -1.168 . . . . 74.420000000000002 107.847 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.07 135.65 44.85 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.782 -1.192 . . . . 74.040000000000006 107.782 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -146.64 153.64 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.274 -2.491 . . . . 70.120000000000005 104.274 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.33 169.63 15.59 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.023 0.929 . . . . 63.229999999999997 110.697 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.3 p -138.25 148.64 44.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.408 0.623 . . . . 73.219999999999999 109.453 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.01 173.89 11.15 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.404 1.882 . . . . 70.0 109.09 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -168.61 119.78 0.77 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.855 -0.528 . . . . 62.210000000000001 111.026 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.06 92.27 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.089 1.356 . . . . 71.439999999999998 108.335 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 m -88.27 159.82 17.94 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 71.120000000000005 108.878 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.15 -2.81 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.634 -1.291 . . . . 53.329999999999998 112.608 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? . . . . . 0 CA--C 1.521 -0.17 0 N-CA-C 106.95 -1.5 . . . . 71.430000000000007 106.95 -166.477 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 110.24 -0.281 . . . . 72.299999999999997 110.24 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 -114.93 0.84 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 106.132 -2.787 . . . . 32.229999999999997 106.132 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.3 mt -130.24 110.15 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.359 1.064 . . . . 73.329999999999998 108.265 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -68.76 148.81 49.79 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.767 -0.583 . . . . 72.239999999999995 109.779 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -135.41 154.61 51.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.552 1.541 . . . . 64.140000000000001 107.414 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mm -130.87 148.92 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.312 -2.106 . . . . 63.420000000000002 105.312 170.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.32 140.79 45.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.974 -1.861 . . . . 75.329999999999998 105.974 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -139.2 134.52 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.247 -1.02 . . . . 72.519999999999996 108.247 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -137.1 161.7 35.4 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.146 -0.687 . . . . 74.329999999999998 109.146 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -136.47 155.05 50.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.332 1.053 . . . . 75.510000000000005 110.739 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.5 m -140.58 166.27 25.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.688 -1.227 . . . . 55.229999999999997 107.688 150.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.08 -161.48 19.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 124.717 1.151 . . . . 75.219999999999999 111.539 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.06 61.87 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.397 2.279 . . . . 73.530000000000001 107.909 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -66.82 11.26 0.1 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.635 2.774 . . . . 75.319999999999993 114.343 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -8.22 46.16 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.1 -1.625 . . . . 72.109999999999999 112.31 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.57 25.86 2.85 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.639 1.976 . . . . 73.450000000000003 111.853 -160.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.0 166.59 21.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.151 -0.968 . . . . 71.109999999999999 112.265 -170.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -134.65 126.79 29.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 127.657 2.383 . . . . 73.510000000000005 105.46 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 78' ' ' VAL . 22.4 t -140.93 110.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.155 -1.054 . . . . 74.109999999999999 108.155 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -125.26 121.3 33.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.867 -0.79 . . . . 62.409999999999997 108.867 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 m -110.96 126.39 68.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.324 1.449 . . . . 62.219999999999999 109.806 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 t -72.01 130.25 40.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.623 -1.991 . . . . 65.319999999999993 105.623 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.18 110.41 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.392 -2.077 . . . . 54.100000000000001 105.392 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.11 177.26 30.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.602 -0.727 . . . . 64.400000000000006 111.351 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.63 170.11 38.79 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 127.337 2.399 . . . . 74.310000000000002 107.568 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.48 161.89 32.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.531 0.666 . . . . 73.239999999999995 110.601 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -140.5 178.27 7.43 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.474 2.31 . . . . 73.219999999999999 110.426 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -78.62 81.18 4.95 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.82 -1.178 . . . . 72.329999999999998 107.82 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.65 -31.6 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-O 118.68 -1.067 . . . . 51.530000000000001 111.607 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.14 26.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.722 1.761 . . . . 64.540000000000006 111.488 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.36 141.54 56.7 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.034 2.489 . . . . 33.149999999999999 110.254 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.14 118.79 15.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.96 1.304 . . . . 53.219999999999999 110.469 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -57.23 109.83 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.969 1.258 . . . . 74.120000000000005 110.717 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.63 162.93 16.07 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.41 1.484 . . . . 74.299999999999997 110.77 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -131.94 138.73 48.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.035 1.734 . . . . 72.230000000000004 107.863 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -77.67 173.41 12.08 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.364 -0.835 . . . . 60.210000000000001 110.402 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.07 -8.87 33.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.344 1.458 . . . . 73.219999999999999 114.435 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -88.59 -14.79 36.71 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.842 1.657 . . . . 61.130000000000003 111.631 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.58 19.16 30.51 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.994 1.283 . . . . 61.329999999999998 114.1 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -109.59 147.25 33.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.619 1.709 . . . . 75.239999999999995 111.715 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.81 131.7 44.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.542 1.537 . . . . 64.409999999999997 110.163 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -130.63 4.32 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.781 1.233 . . . . 73.340000000000003 112.926 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.25 169.26 11.78 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 109.945 -1.262 . . . . 71.0 109.945 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -101.14 10.7 40.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.42 1.088 . . . . 73.420000000000002 111.426 172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 139.01 1.07 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.394 1.877 . . . . 70.319999999999993 108.24 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -175.82 -173.33 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.406 1.482 . . . . 74.409999999999997 108.65 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -134.79 122.13 21.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.788 1.235 . . . . 65.209999999999994 108.722 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.59 147.82 22.58 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.13 -1.063 . . . . 72.340000000000003 108.13 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -95.61 148.57 22.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.193 -1.04 . . . . 74.400000000000006 108.193 166.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mm -86.38 118.05 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.874 -1.158 . . . . 71.400000000000006 107.874 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.44 18.29 6.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.599 1.16 . . . . 74.430000000000007 110.954 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 p -134.26 153.98 51.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.719 0.808 . . . . 72.129999999999995 110.157 -163.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.64 -53.66 55.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.636 -0.505 . . . . 62.420000000000002 109.636 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 p -140.31 120.36 13.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.485 0.66 . . . . 71.310000000000002 110.636 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 mmm -110.69 165.01 12.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.281 1.832 . . . . 72.0 111.013 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 p -157.06 166.16 34.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.679 -1.146 . . . . 75.420000000000002 110.536 160.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 61.3 m -144.03 163.47 33.41 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.005 2.122 . . . . 55.310000000000002 106.419 165.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 13.9 p -142.51 -172.06 3.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.978 -0.749 . . . . 55.530000000000001 108.978 168.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.76 176.73 5.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.473 1.909 . . . . 74.400000000000006 107.092 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -77.27 169.78 17.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.373 -0.973 . . . . 75.329999999999998 108.373 155.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.83 78.63 1.99 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.567 -1.013 . . . . 54.43 110.567 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -151.44 -17.16 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.674 0.789 . . . . 73.230000000000004 112.602 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 167.02 16.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.188 1.395 . . . . 64.019999999999996 111.581 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -124.39 -7.22 7.56 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.083 1.353 . . . . 75.409999999999997 113.223 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -162.05 170.95 18.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.631 1.572 . . . . 75.519999999999996 107.408 168.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.4 ttt -143.44 138.75 29.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.412 -2.07 . . . . 64.099999999999994 105.412 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.9 t -126.57 143.92 51.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.297 0.953 . . . . 72.340000000000003 110.438 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.701 ' HB3' HG22 ' A' ' 121' ' ' VAL . 22.7 t -129.3 46.23 2.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.409 3.083 . . . . 74.310000000000002 108.527 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.91 35.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.178 0.991 . . . . 63.130000000000003 109.562 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.41 -151.71 6.03 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 120.44 1.473 . . . . 63.130000000000003 113.297 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 100.0 p -153.86 171.34 19.11 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.888 0.475 . . . . 75.329999999999998 112.263 160.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' VAL . 98.9 t -129.5 150.66 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.597 1.959 . . . . 73.540000000000006 107.661 170.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -152.62 165.79 34.13 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.509 -0.744 . . . . 74.450000000000003 111.236 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.6 t -144.44 158.75 43.6 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.926 2.09 . . . . 74.209999999999994 106.265 159.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.07 13.45 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.068 2.147 . . . . 71.329999999999998 108.472 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -73.64 -177.35 2.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 73.310000000000002 108.805 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.84 167.71 21.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.627 -1.17 . . . . 62.450000000000003 110.85 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.47 168.32 2.18 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.937 1.295 . . . . 54.210000000000001 112.247 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.19 -0.78 78.45 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.479 1.038 . . . . 75.420000000000002 114.288 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -88.75 114.33 25.26 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.2 1.4 . . . . 72.519999999999996 108.663 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 159.92 15.62 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.339 1.056 . . . . 74.219999999999999 108.385 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -154.19 135.76 14.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.013 -1.477 . . . . 53.420000000000002 107.013 175.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -132.9 127.79 35.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.409 -1.33 . . . . 75.420000000000002 107.409 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.0 140.11 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 124.982 1.313 . . . . 74.540000000000006 107.629 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.9 m -127.25 131.15 50.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.214 -1.772 . . . . 61.340000000000003 106.214 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 112.71 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.463 1.505 . . . . 75.439999999999998 108.658 -169.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.91 152.99 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.18 1.392 . . . . 71.209999999999994 108.594 -169.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.64 144.75 12.83 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.761 1.172 . . . . 61.039999999999999 113.531 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.64 159.78 35.36 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.235 1.814 . . . . 71.099999999999994 110.993 -168.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.22 111.99 18.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.149 -2.167 . . . . 63.399999999999999 105.149 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.6 t0 60.93 -72.84 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.898 2.479 . . . . 60.020000000000003 113.292 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.77 15.07 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.177 2.191 . . . . 73.040000000000006 110.942 -173.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -128.11 153.16 47.15 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.003 -1.686 . . . . 53.340000000000003 109.987 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -93.9 139.53 30.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.113 -1.069 . . . . 54.43 108.113 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.94 -26.23 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.958 1.095 . . . . 53.100000000000001 113.958 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -118.75 135.34 54.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.615 2.007 . . . . 72.310000000000002 107.568 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -154.25 145.76 23.15 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.183 0.516 . . . . 75.510000000000005 112.009 159.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -141.92 174.37 10.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.917 -1.038 . . . . 73.120000000000005 111.145 152.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -130.59 165.66 22.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.763 1.625 . . . . 74.25 107.418 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 162.77 39.78 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.677 -0.64 . . . . 64.329999999999998 109.481 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -142.29 146.51 35.15 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.07 0.948 . . . . 74.129999999999995 109.587 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -148.88 153.62 38.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.021 1.328 . . . . 61.329999999999998 108.959 -173.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.59 134.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.54 -1.282 . . . . 74.540000000000006 107.54 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -62.47 128.69 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.621 1.168 . . . . 74.549999999999997 108.543 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -116.45 -5.12 11.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.418 1.487 . . . . 64.239999999999995 112.073 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.29 8.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.093 2.283 . . . . 31.52 110.981 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -76.61 170.45 16.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.293 1.047 . . . . 71.409999999999997 108.649 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -72.37 113.15 9.09 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.205 -0.934 . . . . 73.329999999999998 108.816 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.18 113.95 5.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.117 -1.438 . . . . 74.150000000000006 107.117 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.52 141.06 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 104.433 -2.432 . . . . 60.409999999999997 104.433 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.95 166.77 31.05 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.638 1.175 . . . . 75.120000000000005 109.223 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -139.61 155.23 47.57 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.757 1.623 . . . . 75.310000000000002 106.743 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -154.76 164.03 39.4 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.76 1.224 . . . . 74.510000000000005 108.616 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -166.45 146.78 6.1 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 123.185 1.469 . . . . 64.340000000000003 113.576 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 74' ' ' CYS . 3.5 m -141.67 134.27 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 112.177 -2.283 . . . . 74.099999999999994 109.428 -174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.23 135.27 35.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.638 -1.616 . . . . 41.329999999999998 106.638 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.25 -10.74 51.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.098 0.863 . . . . 71.109999999999999 113.139 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 106.61 -1.626 . . . . 72.420000000000002 106.61 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 106.445 -1.687 . . . . 74.230000000000004 106.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.83 -109.49 0.54 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 107.153 -2.379 . . . . 33.409999999999997 107.153 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -140.65 110.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 129.665 3.186 . . . . 63.210000000000001 103.638 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -74.2 158.75 33.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.258 -1.016 . . . . 62.229999999999997 108.258 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 153.42 34.11 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.008 1.323 . . . . 54.329999999999998 108.789 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mm -141.54 149.78 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 106.238 -1.764 . . . . 72.329999999999998 106.238 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.5 OUTLIER -142.64 135.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.323 -2.217 . . . . 71.420000000000002 106.626 -164.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.55 144.1 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 107.382 -1.34 . . . . 74.310000000000002 107.382 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -129.95 165.45 22.07 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.422 0.689 . . . . 73.049999999999997 109.437 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -139.47 169.88 16.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 71.420000000000002 108.283 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.21 168.42 25.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.62 -1.622 . . . . 63.340000000000003 106.62 161.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.62 -144.37 18.22 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 119.579 1.081 . . . . 51.43 112.607 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -78.44 74.01 4.98 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 123.724 1.726 . . . . 42.25 108.276 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -73.76 15.05 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.935 1.294 . . . . 72.120000000000005 113.372 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.37 16.79 4.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.046 1.738 . . . . 72.049999999999997 111.951 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -145.41 7.6 1.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.543 1.537 . . . . 72.420000000000002 112.48 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.78 112.17 13.35 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.813 1.245 . . . . 72.450000000000003 109.1 -159.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.64 126.01 28.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.185 1.394 . . . . 42.240000000000002 108.51 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.8 113.57 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.397 -1.705 . . . . 73.010000000000005 106.397 164.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -112.33 148.57 33.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.79 0.805 . . . . 65.430000000000007 109.732 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.81 118.19 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.704 1.602 . . . . 74.040000000000006 108.65 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -77.94 129.86 35.85 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.344 -1.725 . . . . 72.030000000000001 106.344 166.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -126.86 149.32 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.732 -1.21 . . . . 74.120000000000005 107.732 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.21 174.46 46.76 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.711 -0.956 . . . . 73.409999999999997 110.711 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 169.45 42.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.125 -1.99 . . . . 43.100000000000001 108.125 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 126.28 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.947 1.699 . . . . 44.119999999999997 109.679 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.6 -171.14 1.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.332 1.053 . . . . 72.340000000000003 110.759 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -72.28 79.35 0.99 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 73.310000000000002 109.079 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.21 61.57 0.93 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.436 -1.466 . . . . 53.210000000000001 109.436 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.43 -176.48 30.64 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-O 119.566 -0.574 . . . . 71.420000000000002 113.199 158.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.78 135.78 24.24 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.986 2.457 . . . . 73.099999999999994 108.827 155.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.14 115.61 24.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 117.884 -1.055 . . . . 41.420000000000002 109.173 -170.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -47.72 111.58 0.44 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.824 1.193 . . . . 44.109999999999999 112.123 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.73 168.71 19.34 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.768 0.827 . . . . 74.420000000000002 109.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -135.33 163.11 30.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.637 1.975 . . . . 70.230000000000004 109.824 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -111.7 -176.96 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.008 1.723 . . . . 72.400000000000006 110.827 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.89 -16.26 60.67 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.504 0.927 . . . . 74.299999999999997 113.504 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -71.37 -24.06 62.02 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.984 -1.073 . . . . 73.209999999999994 109.375 168.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.21 27.56 25.25 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 125.684 1.611 . . . . 43.240000000000002 112.118 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.75 152.37 20.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.257 -1.386 . . . . 74.400000000000006 107.257 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.43 35.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.639 1.109 . . . . 74.010000000000005 108.066 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 pt -138.21 37.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.105 0.78 . . . . 74.340000000000003 113.105 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 174.48 40.27 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.465 -1.454 . . . . 63.420000000000002 109.465 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.95 0.58 18.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.757 1.223 . . . . 72.200000000000003 112.563 -173.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.7 p -170.55 165.7 8.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.383 1.473 . . . . 54.210000000000001 109.536 152.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -179.52 -179.25 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.966 1.706 . . . . 73.219999999999999 107.853 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m -116.11 154.44 29.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.237 -1.394 . . . . 73.230000000000004 107.237 155.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.28 172.44 11.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.206 1.403 . . . . 72.0 108.018 171.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.14 129.01 37.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.71 0.804 . . . . 63.420000000000002 109.205 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -74.74 104.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.178 -1.416 . . . . 71.430000000000007 107.178 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 38.35 3.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.909 1.284 . . . . 63.32 109.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -147.92 169.76 19.16 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.704 0.802 . . . . 74.010000000000005 109.017 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.41 -43.33 77.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.101 -0.999 . . . . 63.340000000000003 110.327 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 p -137.64 147.44 44.95 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.277 1.431 . . . . 54.340000000000003 109.019 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mmm -140.12 165.96 25.95 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.163 1.785 . . . . 51.119999999999997 110.008 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.6 p -171.4 162.54 6.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.768 -1.56 . . . . 51.219999999999999 111.016 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.08 163.53 32.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.657 1.983 . . . . 74.310000000000002 107.339 160.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.6 p -140.09 -166.9 2.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.655 1.182 . . . . 71.420000000000002 109.902 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.02 156.96 43.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.405 1.082 . . . . 71.239999999999995 109.222 -168.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.91 159.27 28.99 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.012 0.911 . . . . 44.409999999999997 109.464 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.58 66.9 3.82 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 114.95 -1.023 . . . . 51.100000000000001 111.006 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -140.67 -12.68 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.611 1.565 . . . . 70.239999999999995 110.25 162.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.11 166.4 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.529 1.132 . . . . 52.399999999999999 112.31 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -127.61 -0.8 6.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.744 2.018 . . . . 74.120000000000005 113.152 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.31 -179.07 4.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.187 2.595 . . . . 74.099999999999994 107.99 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttt -154.28 146.24 23.56 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.009 -1.848 . . . . 64.0 106.009 160.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -124.36 170.41 10.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.503 0.721 . . . . 74.319999999999993 110.751 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.63 21.09 0.71 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.461 1.504 . . . . 74.420000000000002 111.944 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 115.3 2.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 127.017 2.127 . . . . 44.119999999999997 109.78 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.25 -179.62 30.53 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 109.638 -1.385 . . . . 52.509999999999998 109.638 -156.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 34.4 p -149.15 158.53 44.26 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.905 -0.647 . . . . 63.329999999999998 110.772 -165.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.8 146.62 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 105.216 -2.142 . . . . 45.109999999999999 105.216 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.5 m -152.32 170.55 19.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.444 -1.41 . . . . 74.310000000000002 110.932 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.78 165.98 27.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.427 1.491 . . . . 61.439999999999998 109.071 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.5 pt -155.73 10.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 127.564 2.345 . . . . 64.25 110.993 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -99.39 -170.6 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.045 0.926 . . . . 62.450000000000003 109.964 -167.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.32 163.07 8.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.41 1.084 . . . . 70.409999999999997 109.339 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.55 158.88 9.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.086 . . . . 51.450000000000003 111.318 165.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.01 1.5 59.66 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.708 1.147 . . . . 74.549999999999997 113.989 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -72.93 114.82 11.51 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.446 -1.687 . . . . 73.420000000000002 106.446 167.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -83.65 163.13 20.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.484 0.714 . . . . 72.519999999999996 109.864 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.41 136.65 10.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.588 -1.634 . . . . 64.230000000000004 106.588 171.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -129.28 143.98 51.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.219 -1.771 . . . . 60.119999999999997 106.219 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 mm -128.74 144.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 126.068 1.747 . . . . 44.420000000000002 108.25 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -146.88 133.83 20.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.602 -1.629 . . . . 73.430000000000007 106.602 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.42 120.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 107.211 -1.403 . . . . 75.040000000000006 107.211 -168.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.542 ' HB ' HG23 ' A' ' 13' ' ' VAL . 51.5 mt -133.06 156.3 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 107.965 -1.124 . . . . 63.420000000000002 107.965 -168.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.05 138.2 8.69 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.257 1.408 . . . . 72.140000000000001 111.11 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HE2' HG21 ' A' ' 13' ' ' VAL . 43.0 m-85 -132.45 147.64 52.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.733 2.013 . . . . 73.439999999999998 109.83 -162.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.02 114.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.953 1.701 . . . . 75.0 108.281 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.261 7.1 t0 49.51 -64.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 131.475 3.91 . . . . 63.229999999999997 114.267 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.38 39.43 0.66 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.939 1.245 . . . . 75.140000000000001 112.984 166.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.21 148.65 49.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.807 1.243 . . . . 64.010000000000005 111.184 177.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -79.4 143.7 34.81 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.225 -1.769 . . . . 63.409999999999997 106.225 161.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.91 -28.08 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.052 1.13 . . . . 41.210000000000001 114.052 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -148.11 142.32 26.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.391 1.45 . . . . 54.450000000000003 108.255 -163.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -172.13 155.91 3.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.264 1.026 . . . . 74.310000000000002 111.105 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -150.1 173.48 13.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.532 0.606 . . . . 61.43 109.782 161.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -134.75 152.9 52.12 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.432 -0.951 . . . . 75.349999999999994 108.432 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.1 170.55 15.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.415 0.686 . . . . 73.439999999999998 110.383 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.64 153.08 41.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.289 -1.745 . . . . 61.210000000000001 106.289 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.401 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 55.5 m-85 -142.58 154.57 44.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.242 2.217 . . . . 74.310000000000002 106.977 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.64 134.13 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.222 -2.881 . . . . 61.439999999999998 103.222 162.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -70.88 148.54 47.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.657 -1.238 . . . . 74.120000000000005 107.657 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.81 10.19 3.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.671 0.388 . . . . 53.109999999999999 111.07 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.59 -9.93 16.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.828 2.156 . . . . 65.530000000000001 112.152 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -85.06 168.51 14.82 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.355 -1.085 . . . . 74.109999999999999 109.873 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -59.94 160.99 7.07 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.648 -0.501 . . . . 61.439999999999998 109.648 154.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.19 129.96 36.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.306 -0.998 . . . . 65.549999999999997 108.306 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -152.98 141.14 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.292 1.837 . . . . 65.120000000000005 106.501 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -161.78 168.11 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.389 1.875 . . . . 74.549999999999997 109.319 177.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 64.7 p -130.97 172.9 11.54 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.76 1.624 . . . . 74.150000000000006 108.764 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -151.55 166.9 29.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.158 0.583 . . . . 72.040000000000006 110.519 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -152.5 132.07 13.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 122.508 1.147 . . . . 74.209999999999994 111.532 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -141.85 96.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 130.415 3.486 . . . . 54.240000000000002 103.759 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.5 t -81.5 -179.13 7.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.836 -1.542 . . . . 71.030000000000001 106.836 157.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.0 p -130.04 14.42 5.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.385 1.074 . . . . 71.230000000000004 111.055 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.188 0 O-C-N 120.449 -1.407 . . . . 62.030000000000001 107.62 166.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 106.511 -1.663 . . . . 62.439999999999998 106.511 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.74 -100.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 125.122 1.344 . . . . 64.239999999999995 109.906 168.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.2 mt -108.63 97.49 5.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.255 -2.128 . . . . 60.210000000000001 105.255 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.73 154.13 22.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.87 -1.159 . . . . 74.299999999999997 107.87 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.04 150.41 41.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.224 -1.398 . . . . 55.149999999999999 107.224 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 mm -120.92 150.44 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.56 -2.015 . . . . 75.25 105.56 165.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.88 133.37 64.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.047 -2.205 . . . . 75.349999999999994 105.047 171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.97 140.88 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 108.399 -0.963 . . . . 74.430000000000007 108.399 -171.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -147.58 156.02 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.105 0.866 . . . . 74.230000000000004 111.798 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -139.72 154.03 47.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.652 1.581 . . . . 73.230000000000004 110.637 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 m -150.03 156.14 41.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.674 2.79 . . . . 64.129999999999995 106.712 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.88 -112.71 2.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.373 -1.491 . . . . 72.540000000000006 109.373 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -117.1 99.09 6.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.352 1.461 . . . . 74.420000000000002 107.381 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 p -74.78 -1.03 20.23 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.571 0.952 . . . . 53.020000000000003 113.571 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.1 -19.86 13.21 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.851 1.26 . . . . 53.009999999999998 110.32 -166.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.3 m -120.15 37.44 4.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.641 1.976 . . . . 75.209999999999994 110.888 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.898 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -150.23 122.93 8.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.544 1.164 . . . . 73.209999999999994 109.16 171.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.23 90.87 6.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.433 -1.692 . . . . 73.140000000000001 106.433 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.829 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.8 t -81.16 113.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.939 2.096 . . . . 52.32 108.042 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -114.63 144.57 43.2 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.485 1.039 . . . . 63.310000000000002 109.231 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 m -137.65 122.87 24.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.393 -1.276 . . . . 74.329999999999998 110.328 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -68.98 141.66 54.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.677 -1.601 . . . . 71.430000000000007 106.677 160.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.4 mt -130.7 107.41 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 103.916 -2.624 . . . . 63.149999999999999 103.916 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.1 30.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.367 0.508 . . . . 60.039999999999999 111.907 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.82 172.01 43.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.429 1.966 . . . . 61.240000000000002 109.483 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.86 163.28 16.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 121.599 -0.942 . . . . 71.010000000000005 110.759 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -138.88 -172.76 3.39 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.933 2.493 . . . . 61.130000000000003 109.502 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -71.65 -19.48 62.09 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 55.219999999999999 113.014 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 -31.52 10.74 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.446 -1.062 . . . . 75.430000000000007 110.446 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.41 -95.69 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.522 2.011 . . . . 72.120000000000005 108.416 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.68 135.2 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.695 2.263 . . . . 75.349999999999994 111.532 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.93 122.99 28.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.588 0.755 . . . . 73.319999999999993 109.103 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -61.13 121.34 12.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.044 0.538 . . . . 63.329999999999998 110.26 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.0 165.89 14.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.945 0.898 . . . . 75.219999999999999 109.526 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -129.98 157.37 42.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.803 1.241 . . . . 75.140000000000001 109.103 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.43 171.17 9.93 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.726 0.81 . . . . 72.219999999999999 109.487 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.05 -25.34 66.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.975 0.731 . . . . 75.310000000000002 112.975 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -71.63 -25.18 62.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.081 1.353 . . . . 74.329999999999998 110.668 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.35 17.73 9.74 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 125.085 1.326 . . . . 74.349999999999994 113.612 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -94.53 145.95 24.45 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.771 1.786 . . . . 73.140000000000001 110.253 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.16 146.64 54.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.553 -0.906 . . . . 71.019999999999996 108.553 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.09 -16.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.998 1.481 . . . . 75.450000000000003 114.998 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.65 164.17 29.07 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 120.062 1.301 . . . . 54.549999999999997 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.7 5.68 23.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.381 1.091 . . . . 64.010000000000005 112.445 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -166.29 145.55 5.87 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.503 2.321 . . . . 74.049999999999997 107.055 156.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -168.59 -179.76 3.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.96 1.304 . . . . 75.010000000000005 108.433 168.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -120.11 161.52 20.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.924 0.89 . . . . 60.450000000000003 108.94 160.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 120.79 14.07 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.129 -1.434 . . . . 40.219999999999999 107.129 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.39 134.33 45.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.197 -1.038 . . . . 73.040000000000006 108.197 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.13 91.35 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.315 -1.735 . . . . 64.450000000000003 106.315 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -100.58 46.08 0.96 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.136 0.974 . . . . 75.230000000000004 109.591 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -150.35 163.39 38.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.536 1.134 . . . . 75.329999999999998 108.411 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.7 -35.92 73.0 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.191 -0.943 . . . . 74.150000000000006 110.802 169.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.2 p -140.23 152.3 45.84 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.071 0.948 . . . . 64.25 110.951 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mmm -153.08 172.46 16.84 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 126.571 1.948 . . . . 63.32 111.326 -168.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -167.4 166.09 14.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.418 1.887 . . . . 63.43 111.163 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -156.98 160.87 39.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.921 2.888 . . . . 60.420000000000002 106.983 160.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.82 -179.78 6.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.478 0.656 . . . . 63.009999999999998 111.658 165.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -123.85 -176.87 3.58 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.784 1.634 . . . . 64.019999999999996 110.148 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.17 157.49 26.86 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.657 0.741 . . . . 75.219999999999999 111.735 173.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.69 96.53 0.1 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.015 2.245 . . . . 64.239999999999995 108.607 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 178.78 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 130.874 3.67 . . . . 75.099999999999994 105.731 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.4 173.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.648 1.979 . . . . 63.130000000000003 114.857 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -134.88 -12.47 2.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.711 2.005 . . . . 60.340000000000003 113.757 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -158.21 174.41 15.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.43 1.014 . . . . 73.140000000000001 108.887 166.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.3 ttt -137.81 155.13 49.34 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.635 1.974 . . . . 74.340000000000003 106.65 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -143.94 167.03 23.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.875 0.761 . . . . 73.019999999999996 110.72 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.0 t -143.9 29.61 1.35 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.614 2.766 . . . . 72.030000000000001 109.351 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.08 113.14 3.72 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 72.209999999999994 109.209 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.49 -154.13 8.08 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 110.367 -1.093 . . . . 54.43 110.367 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -154.51 171.73 18.93 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.702 0.763 . . . . 52.310000000000002 111.477 155.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.898 HG13 ' CE1' ' A' ' 23' ' ' PHE . 93.9 t -120.97 145.58 27.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 125.932 1.693 . . . . 72.329999999999998 107.983 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.1 t -151.87 160.67 43.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.506 0.594 . . . . 61.240000000000002 111.173 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 t -140.69 158.77 43.5 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.927 1.691 . . . . 64.239999999999995 109.057 166.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.85 24.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 126.69 1.996 . . . . 72.409999999999997 110.032 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -97.08 -176.48 3.56 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.494 1.043 . . . . 64.310000000000002 110.595 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.32 167.73 3.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.238 1.415 . . . . 72.430000000000007 110.276 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.92 167.16 1.26 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.958 1.303 . . . . 74.019999999999996 112.937 159.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 -13.07 52.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 117.753 -1.582 . . . . 40.439999999999998 114.776 168.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -57.11 161.13 3.28 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 119.432 1.616 . . . . 51.549999999999997 108.413 159.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -140.16 162.0 36.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.627 -1.249 . . . . 74.409999999999997 107.627 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.34 145.57 22.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.596 -1.261 . . . . 60.25 107.596 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -140.69 117.99 11.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.65 -1.982 . . . . 60.149999999999999 105.65 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 23' ' ' PHE . 13.5 mm -96.52 151.22 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.508 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -139.11 131.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.648 -1.612 . . . . 71.049999999999997 106.648 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -132.3 126.38 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.399 1.479 . . . . 40.310000000000002 109.114 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.88 140.32 46.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.597 -1.631 . . . . 63.420000000000002 106.597 -173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.75 133.13 6.9 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.224 -1.15 . . . . 72.219999999999999 110.224 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -120.24 154.59 34.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.286 1.834 . . . . 75.340000000000003 109.973 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.8 mt -148.62 137.19 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.803 2.041 . . . . 72.299999999999997 105.693 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t0 44.52 53.88 6.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.19 1.796 . . . . 75.299999999999997 111.982 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.27 23.87 14.05 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.038 1.735 . . . . 72.340000000000003 113.969 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 45.5 mtpt -132.52 153.78 50.61 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 120.751 -1.218 . . . . 71.420000000000002 111.923 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.78 145.6 46.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.95 -1.5 . . . . 64.200000000000003 106.95 164.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.43 -6.14 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.618 -0.706 . . . . 52.5 112.847 161.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -159.77 143.47 14.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.542 1.519 . . . . 75.400000000000006 110.046 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -165.45 124.47 1.7 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.511 -0.922 . . . . 74.030000000000001 108.511 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.7 pp -138.57 169.14 18.32 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.106 0.879 . . . . 75.120000000000005 110.932 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -126.59 171.61 10.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.274 . . . . 62.149999999999999 108.703 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 161.13 43.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.303 -0.629 . . . . 75.150000000000006 109.303 166.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -127.37 135.89 51.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.179 -1.415 . . . . 73.040000000000006 107.179 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.26 151.77 48.89 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.509 1.124 . . . . 71.439999999999998 108.581 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -143.62 124.46 10.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.361 -2.089 . . . . 55.109999999999999 105.361 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -64.13 130.41 43.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.329 -0.619 . . . . 62.020000000000003 109.329 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -105.4 -1.18 25.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.081 1.352 . . . . 64.439999999999998 111.863 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.33 -24.65 10.38 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.46 1.505 . . . . 74.230000000000004 111.129 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -82.22 163.63 21.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.009 0.923 . . . . 75.349999999999994 109.531 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.13 106.18 1.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.426 1.09 . . . . 62.229999999999997 110.296 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 131.55 46.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.618 -0.882 . . . . 60.210000000000001 108.618 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 mt -148.87 138.36 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.708 1.603 . . . . 63.329999999999998 107.715 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.8 170.13 4.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.051 1.74 . . . . 64.019999999999996 110.164 -171.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.4 p -141.55 170.41 15.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.471 2.308 . . . . 74.109999999999999 108.161 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.8 164.88 38.18 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.097 1.759 . . . . 75.120000000000005 107.61 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.4 p -152.64 123.73 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.186 -0.946 . . . . 72.230000000000004 110.475 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.7 t -135.67 92.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.755 -2.313 . . . . 60.119999999999997 104.755 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.53 148.59 24.05 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.342 -1.725 . . . . 74.230000000000004 106.342 163.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.1 p -110.71 29.39 7.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.089 0.956 . . . . 54.409999999999997 110.113 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 105.8 -1.926 . . . . 74.239999999999995 105.8 166.5 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.712 -1.218 . . . . 63.409999999999997 107.712 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.29 -98.24 0.3 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 106.777 -2.529 . . . . 73.319999999999993 106.777 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.89 159.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.337 1.855 . . . . 63.329999999999998 107.093 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -125.57 137.5 53.92 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.446 1.899 . . . . 74.450000000000003 107.579 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.93 150.52 44.64 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.251 -0.906 . . . . 63.219999999999999 108.887 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mm -140.74 150.34 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 105.748 -1.945 . . . . 75.329999999999998 105.748 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 93' ' ' ILE . 1.3 m -143.26 132.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 127.221 2.209 . . . . 44.030000000000001 106.861 -165.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.33 153.13 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 107.699 -1.223 . . . . 61.350000000000001 107.699 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -141.49 163.48 32.83 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.067 0.947 . . . . 75.230000000000004 109.53 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.28 156.15 39.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.86 1.264 . . . . 55.109999999999999 108.824 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -159.17 147.88 18.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.498 1.519 . . . . 61.439999999999998 109.92 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.89 -131.39 6.61 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.783 -0.927 . . . . 73.030000000000001 110.783 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.415 ' OD1' HD13 ' A' ' 88' ' ' LEU . 1.7 p-10 -71.94 50.5 0.2 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.845 2.858 . . . . 72.120000000000005 113.577 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -63.22 7.19 0.1 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 74.140000000000001 114.552 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.08 -18.01 12.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.779 2.032 . . . . 74.0 112.062 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.34 36.64 3.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.755 2.022 . . . . 75.120000000000005 112.111 -169.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CD2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -123.42 155.47 37.36 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.466 1.106 . . . . 71.030000000000001 108.689 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.51 121.0 29.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.93 -1.878 . . . . 73.5 105.93 171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' CD2' ' A' ' 23' ' ' PHE . 90.4 t -137.84 106.84 4.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.081 -1.822 . . . . 60.130000000000003 106.081 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 112.32 20.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.015 -1.476 . . . . 75.109999999999999 107.015 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.34 135.09 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.285 -1.746 . . . . 64.120000000000005 106.285 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -90.82 139.14 31.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.952 2.101 . . . . 75.239999999999995 107.778 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.42 133.1 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.293 -2.114 . . . . 75.450000000000003 105.293 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.16 168.18 41.12 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.965 2.221 . . . . 63.43 108.976 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.68 175.74 39.85 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.074 -2.01 . . . . 73.209999999999994 108.074 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.25 157.32 31.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.403 1.101 . . . . 53.210000000000001 109.487 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.59 -171.13 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.956 1.702 . . . . 74.120000000000005 111.852 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -78.06 64.01 3.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.713 1.205 . . . . 73.540000000000006 110.101 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.21 3.1 1.97 Allowed Glycine 0 CA--C 1.517 0.172 0 CA-C-O 118.0 -1.444 . . . . 53.039999999999999 113.798 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.26 35.16 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 119.709 1.754 . . . . 74.340000000000003 112.588 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.86 144.3 24.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.467 2.778 . . . . 74.209999999999994 109.14 162.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.42 115.42 16.15 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.502 1.121 . . . . 61.119999999999997 109.699 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.31 128.7 36.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.382 0.992 . . . . 75.129999999999995 108.543 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 166.49 11.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.008 0.923 . . . . 73.439999999999998 109.732 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.7 155.73 42.22 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.758 1.623 . . . . 73.209999999999994 111.07 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.93 169.16 9.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.57 -1.65 . . . . 64.540000000000006 110.238 166.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.13 5.57 2.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.726 1.611 . . . . 73.519999999999996 112.908 -170.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -90.4 -8.88 49.5 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.488 1.515 . . . . 74.129999999999995 111.133 168.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.17 17.37 69.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.961 -0.911 . . . . 60.350000000000001 112.974 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.35 147.0 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.126 1.463 . . . . 62.130000000000003 108.522 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -75.0 159.58 31.6 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.03 -0.73 . . . . 73.239999999999995 109.03 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -144.88 23.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.73 0.812 . . . . 63.140000000000001 112.799 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.92 -176.99 16.51 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.41 -1.476 . . . . 40.020000000000003 109.41 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -121.15 11.51 10.9 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.538 1.135 . . . . 73.420000000000002 111.876 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -169.39 150.65 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.902 1.281 . . . . 75.540000000000006 110.459 165.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -176.19 -175.15 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.454 1.502 . . . . 63.450000000000003 109.218 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -141.21 102.84 4.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.113 0.965 . . . . 63.409999999999997 109.689 172.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.24 115.4 21.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.766 -0.828 . . . . 73.549999999999997 108.766 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -66.23 142.39 57.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.844 -1.169 . . . . 72.409999999999997 107.844 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -82.8 120.96 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.065 -1.828 . . . . 75.420000000000002 106.065 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -142.51 43.55 1.62 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.573 1.549 . . . . 74.420000000000002 108.961 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p -146.24 168.72 20.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.986 -1.116 . . . . 55.509999999999998 107.986 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.09 72.09 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.624 -0.672 . . . . 55.130000000000003 111.661 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -154.26 162.14 41.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.37 1.068 . . . . 64.349999999999994 108.971 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 mmm -143.38 171.72 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.75 2.82 . . . . 62.43 110.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.17 166.63 23.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.291 1.436 . . . . 61.119999999999997 110.928 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.3 m -149.9 167.64 26.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.999 2.519 . . . . 71.439999999999998 107.963 160.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.67 -174.89 4.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.853 1.261 . . . . 51.229999999999997 111.007 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.8 p -128.43 175.77 8.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.278 1.831 . . . . 74.340000000000003 109.748 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.85 -169.48 2.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.55 -0.908 . . . . 73.150000000000006 108.55 159.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 37.54 0.54 Allowed Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.833 -1.167 . . . . 61.420000000000002 113.976 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -140.73 78.14 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.158 1.383 . . . . 63.530000000000001 107.572 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.55 34.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.525 1.53 . . . . 74.140000000000001 109.954 159.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.46 -9.13 9.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.037 1.735 . . . . 75.310000000000002 111.693 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -161.49 172.37 16.54 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.608 -1.256 . . . . 75.439999999999998 107.608 167.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.9 ttt -152.59 111.67 3.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.462 -2.051 . . . . 75.450000000000003 105.462 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -95.51 154.62 17.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.530000000000001 110.026 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.593 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -137.18 90.92 2.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.962 2.105 . . . . 63.240000000000002 105.498 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.79 46.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.542 -0.91 . . . . 75.329999999999998 108.542 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.93 -152.79 6.49 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 109.935 -1.266 . . . . 62.530000000000001 109.935 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.38 168.13 23.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.163 -1.051 . . . . 73.450000000000003 108.163 156.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.63 148.08 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.988 1.315 . . . . 75.319999999999993 108.844 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.88 171.32 14.99 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.296 -0.631 . . . . 41.340000000000003 109.296 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.613 ' CB ' HD23 ' A' ' 115' ' ' LEU . 20.8 t -151.38 149.44 29.31 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.374 -1.713 . . . . 75.040000000000006 106.374 163.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.44 10.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 124.526 1.131 . . . . 74.019999999999996 110.031 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -80.48 -173.54 4.15 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.034 0.934 . . . . 62.140000000000001 111.321 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -72.08 163.44 27.89 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.983 -0.448 . . . . 72.310000000000002 111.387 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 162.27 3.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.701 1.6 . . . . 72.200000000000003 113.539 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.33 4.33 90.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.431 1.015 . . . . 62.100000000000001 114.36 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -83.63 163.91 20.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.349 -1.352 . . . . 63.409999999999997 107.349 168.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -153.35 153.24 32.2 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.307 -0.854 . . . . 74.430000000000007 110.812 -163.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.415 HD13 ' OD1' ' A' ' 19' ' ' ASP . 11.9 tp -154.95 136.43 14.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.843 -1.54 . . . . 74.439999999999998 106.843 -172.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -136.93 97.8 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.453 1.501 . . . . 74.340000000000003 108.775 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.43 132.42 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.916 1.286 . . . . 61.119999999999997 108.176 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.0 m -110.2 147.55 33.54 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.269 -1.012 . . . . 41.25 108.269 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.76 103.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.064 1.746 . . . . 74.530000000000001 110.201 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 13' ' ' VAL . 24.4 mt -112.59 157.43 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 107.472 -1.307 . . . . 63.310000000000002 107.472 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.71 132.81 4.56 Favored Glycine 0 C--N 1.336 0.529 0 O-C-N 120.454 -1.404 . . . . 41.329999999999998 111.324 -170.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.443 ' HE2' HG21 ' A' ' 13' ' ' VAL . 83.9 m-85 -125.01 147.83 48.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.44 1.496 . . . . 75.239999999999995 111.455 -170.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 123' ' ' THR . 33.0 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 128.939 2.895 . . . . 64.349999999999994 105.161 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.63 63.49 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.771 1.229 . . . . 43.030000000000001 111.749 164.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.42 18.75 5.85 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.414 2.286 . . . . 71.510000000000005 116.101 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.11 151.77 46.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.316 -1.49 . . . . 72.510000000000005 112.552 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -86.81 136.46 32.97 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.433 -1.321 . . . . 75.129999999999995 107.433 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 96' ' ' ILE . 23.0 m -130.42 -10.51 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 62.520000000000003 113.12 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -144.9 141.02 28.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.737 1.153 . . . . 73.530000000000001 107.907 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.94 132.04 9.99 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.602 -0.518 . . . . 71.219999999999999 109.602 167.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.16 -175.8 4.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.575 0.702 . . . . 63.420000000000002 109.861 160.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.8 179.87 7.52 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.832 2.053 . . . . 71.519999999999996 108.399 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 176.22 12.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.05 -1.463 . . . . 60.539999999999999 107.05 171.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -147.29 137.88 23.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.391 -1.337 . . . . 55.409999999999997 107.391 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.22 157.45 46.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.571 0.748 . . . . 53.439999999999998 110.213 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mt -147.02 142.95 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.221 -1.77 . . . . 72.040000000000006 106.221 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -82.48 147.3 28.78 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 118.92 0.782 . . . . 73.430000000000007 110.394 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.57 26.25 2.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.923 0.868 . . . . 74.409999999999997 112.235 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.9 -16.02 61.36 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.196 1.855 . . . . 61.0 111.883 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -83.17 171.68 13.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.076 1.35 . . . . 75.109999999999999 109.463 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.69 111.09 2.25 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.855 -1.153 . . . . 41.130000000000003 109.425 162.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.613 HD23 ' CB ' ' A' ' 80' ' ' SER . 13.1 tp -73.12 132.23 43.03 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.808 -1.923 . . . . 72.219999999999999 105.808 163.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.3 mt -154.31 148.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.375 -2.454 . . . . 60.299999999999997 104.375 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.16 173.17 10.49 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.849 1.66 . . . . 54.350000000000001 109.357 168.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.0 p -129.33 172.95 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.234 1.492 . . . . 74.409999999999997 108.09 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.87 154.41 29.76 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 126.675 1.99 . . . . 71.420000000000002 106.103 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.4 p -155.97 127.13 7.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.228 0.537 . . . . 75.150000000000006 110.222 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' A' ' 74' ' ' CYS . 15.0 p -133.03 152.35 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.317 1.447 . . . . 74.340000000000003 107.874 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.6 t -134.82 -175.75 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.996 -1.113 . . . . 35.219999999999999 107.996 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.506 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.0 p -134.05 38.74 3.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.571 1.149 . . . . 75.450000000000003 109.061 167.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 107.532 -1.284 . . . . 63.329999999999998 107.532 166.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 107.703 -1.221 . . . . 65.340000000000003 107.703 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.76 -106.23 0.24 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 107.684 -2.166 . . . . 72.129999999999995 107.684 -172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.38 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 N-CA-C 106.129 -1.804 . . . . 71.140000000000001 106.129 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.99 143.44 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.497 -0.927 . . . . 74.019999999999996 108.497 171.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 162.84 34.39 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.171 0.588 . . . . 72.209999999999994 109.98 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 mm -129.66 153.24 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.065 1.746 . . . . 72.430000000000007 107.322 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 t -124.66 134.57 66.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 104.128 -2.545 . . . . 71.420000000000002 104.128 163.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 105.972 -1.862 . . . . 74.349999999999994 105.972 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.15 165.85 17.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.671 -0.492 . . . . 62.549999999999997 109.671 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.03 155.56 40.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.692 0.62 . . . . 73.340000000000003 111.623 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.0 m -145.1 142.94 30.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.578 1.151 . . . . 53.420000000000002 108.328 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.52 -150.71 23.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.29 -0.881 . . . . 74.420000000000002 111.545 -169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.4 68.82 9.87 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.781 2.032 . . . . 72.120000000000005 107.258 170.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -78.79 24.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.174 1.546 . . . . 61.409999999999997 115.174 -158.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -135.33 12.82 3.53 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.47 1.108 . . . . 61.25 110.427 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -131.81 17.44 4.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 62.549999999999997 111.87 -168.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -133.25 130.19 38.67 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.366 0.985 . . . . 73.239999999999995 109.433 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -89.73 68.29 7.51 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.256 1.822 . . . . 74.409999999999997 109.069 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.31 92.08 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 127.518 2.327 . . . . 62.149999999999999 113.173 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -89.57 139.62 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.745 1.157 . . . . 73.340000000000003 109.519 165.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.56 164.5 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.345 -0.983 . . . . 71.450000000000003 108.345 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -127.23 129.83 48.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.868 2.867 . . . . 72.150000000000006 105.499 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.53 121.27 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.54 -1.652 . . . . 65.209999999999994 106.54 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -162.18 172.44 38.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.63 1.11 . . . . 24.140000000000001 110.392 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.2 176.26 43.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.11 1.338 . . . . 73.349999999999994 110.01 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.01 46.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.262 0.625 . . . . 70.049999999999997 111.884 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.92 139.35 50.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.945 2.098 . . . . 61.030000000000001 110.865 162.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.308 16.1 ttpp 43.16 32.93 0.5 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.521 1.929 . . . . 63.130000000000003 114.308 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 33.98 23.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.529 -0.732 . . . . 71.439999999999998 111.86 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.69 175.23 36.57 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.314 1.911 . . . . 74.129999999999995 109.856 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 152.04 45.59 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 74.230000000000004 112.492 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.09 130.61 56.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.44 1.096 . . . . 73.430000000000007 110.627 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -64.06 116.68 6.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.087 0.858 . . . . 72.230000000000004 110.612 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.446 HD11 ' HA2' ' A' ' 30' ' ' GLY . 1.1 mt -96.05 158.58 15.38 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.921 2.088 . . . . 61.119999999999997 109.51 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 11.6 m-85 -130.84 139.83 50.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.021 1.328 . . . . 70.129999999999995 110.988 -170.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -78.35 177.19 8.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 113.748 -1.569 . . . . 74.150000000000006 110.777 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.11 -5.62 18.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.535 1.534 . . . . 74.340000000000003 114.51 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -114.19 20.63 15.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.122 1.769 . . . . 74.329999999999998 110.938 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.41 8.24 87.06 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 124.306 0.955 . . . . 54.409999999999997 114.379 162.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.52 149.45 26.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.826 2.45 . . . . 74.530000000000001 108.849 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 23.6 p90 -76.1 161.46 28.83 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.421 -0.585 . . . . 74.109999999999999 109.421 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.36 -11.83 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.787 0.835 . . . . 63.43 112.359 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.36 -171.39 35.83 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 109.055 -1.618 . . . . 41.32 109.055 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -110.05 3.02 19.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.143 1.777 . . . . 70.109999999999999 111.181 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 p -173.36 117.11 0.27 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.53 1.132 . . . . 42.43 109.292 -166.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -171.48 -178.27 2.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.291 0.95 . . . . 73.230000000000004 111.177 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.93 161.78 18.8 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.702 1.601 . . . . 72.230000000000004 109.593 166.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.7 29.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.319 1.448 . . . . 32.439999999999998 107.586 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -111.81 141.19 45.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.926 2.09 . . . . 73.040000000000006 110.299 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.79 86.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 121.035 1.743 . . . . 72.25 110.317 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -108.66 18.63 20.63 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.889 0.876 . . . . 73.140000000000001 112.363 175.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -117.32 158.98 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.92 1.288 . . . . 53.140000000000001 108.782 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -49.94 62.07 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.543 -0.723 . . . . 61.530000000000001 109.125 168.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.5 p -141.29 113.77 8.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.398 0.679 . . . . 74.349999999999994 110.736 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mmm -115.18 167.98 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.113 2.165 . . . . 45.450000000000003 111.145 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.1 p -150.96 165.65 33.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.03 0.932 . . . . 61.520000000000003 110.524 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 m -143.88 159.14 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.594 -1.632 . . . . 53.409999999999997 106.594 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.5 p -148.09 -168.2 3.01 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.816 0.735 . . . . 64.049999999999997 109.792 166.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 t -124.7 179.25 5.05 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.893 1.677 . . . . 71.430000000000007 106.971 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.53 -176.39 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.831 0.853 . . . . 50.409999999999997 109.427 163.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.09 23.75 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.157 -0.802 . . . . 54.539999999999999 113.324 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -135.23 94.68 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.598 -1.63 . . . . 72.140000000000001 106.598 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.32 158.99 16.77 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.957 1.303 . . . . 63.240000000000002 110.02 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -114.12 -28.06 7.45 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.453 1.501 . . . . 64.409999999999997 112.214 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.75 170.49 19.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.512 -1.292 . . . . 61.329999999999998 107.512 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 ttt -146.93 154.09 40.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 102.935 -2.987 . . . . 73.439999999999998 102.935 171.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.0 t -140.78 149.02 41.55 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.234 -0.916 . . . . 52.439999999999998 110.421 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.606 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -125.6 66.09 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.119 -1.808 . . . . 65.219999999999999 106.119 -177.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.86 143.73 55.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.974 -1.491 . . . . 63.350000000000001 106.974 167.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.28 178.73 43.5 Favored Glycine 0 CA--C 1.509 -0.309 0 CA-C-N 119.999 1.272 . . . . 65.25 111.987 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -142.5 159.21 42.67 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.556 1.142 . . . . 50.219999999999999 110.38 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.81 131.59 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.232 -1.395 . . . . 62.450000000000003 107.232 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -137.92 169.3 18.02 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.931 -0.557 . . . . 61.210000000000001 110.379 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -142.09 169.88 16.75 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.539 1.136 . . . . 65.349999999999994 109.921 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.96 0.55 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.358 2.663 . . . . 64.430000000000007 111.244 167.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -73.81 177.47 5.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.682 1.193 . . . . 44.219999999999999 109.866 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -68.79 174.14 4.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.897 0.879 . . . . 53.409999999999997 111.817 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.32 158.52 23.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.785 2.034 . . . . 62.409999999999997 112.763 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.36 -0.4 41.19 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.605 1.098 . . . . 34.530000000000001 114.337 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -70.58 131.25 43.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 104.916 -2.253 . . . . 70.25 104.916 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -111.39 162.02 15.49 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.412 0.685 . . . . 61.450000000000003 109.47 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -165.17 121.43 1.43 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 105.905 -1.887 . . . . 65.420000000000002 105.905 176.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -111.3 137.06 49.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.311 -1.737 . . . . 74.340000000000003 106.311 169.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 mm -117.73 121.63 67.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.702 -1.592 . . . . 65.430000000000007 106.702 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -95.09 131.03 41.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.896 -1.891 . . . . 75.530000000000001 105.896 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.11 104.05 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.939 1.296 . . . . 73.329999999999998 110.176 -174.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.26 152.71 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 75.510000000000005 108.338 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.61 152.88 22.27 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 124.456 1.027 . . . . 64.150000000000006 112.403 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -136.45 155.25 50.26 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.953 1.301 . . . . 70.200000000000003 110.826 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -130.32 83.24 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.104 -1.813 . . . . 74.329999999999998 106.104 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.285 3.0 p-10 49.64 7.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 1 C-N-CA 132.126 4.17 . . . . 73.109999999999999 117.369 162.02 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.86 -41.34 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.767 2.027 . . . . 72.140000000000001 109.644 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 158.66 44.13 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.595 1.158 . . . . 64.400000000000006 110.603 -167.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.44 146.79 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.444 -2.428 . . . . 71.5 104.444 163.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.68 -3.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 123.448 0.699 . . . . 72.430000000000007 110.836 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -156.77 141.06 16.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.047 -1.033 . . . . 72.239999999999995 108.496 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.95 129.27 12.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.995 -1.113 . . . . 65.230000000000004 107.995 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -132.49 160.58 36.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.286 -1.005 . . . . 71.450000000000003 108.286 163.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -145.39 121.79 10.97 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.126 -1.805 . . . . 72.219999999999999 106.126 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -131.31 161.56 32.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.658 0.663 . . . . 72.25 109.892 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.82 156.17 47.55 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 126.625 1.97 . . . . 74.540000000000006 110.839 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 115' ' ' LEU . 39.1 m-85 -151.63 124.79 8.72 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.891 1.677 . . . . 71.310000000000002 107.092 -165.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -135.7 130.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.536 -1.283 . . . . 74.140000000000001 107.536 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -72.26 152.96 41.83 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.437 1.095 . . . . 65.109999999999999 110.0 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -148.31 28.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.38 -0.825 . . . . 73.329999999999998 111.966 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.94 -48.63 0.92 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.517 1.532 . . . . 71.329999999999998 109.793 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -74.76 173.42 10.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.915 1.286 . . . . 71.049999999999997 112.441 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -72.43 100.46 2.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.34 -1.355 . . . . 70.140000000000001 107.34 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 108' ' ' TYR . 8.3 tt -60.68 134.58 57.22 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.157 -0.925 . . . . 72.209999999999994 108.824 171.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 mt -152.57 133.5 4.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.526 1.53 . . . . 74.120000000000005 107.881 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 74.019999999999996 112.071 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 p -144.12 150.72 38.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.115 0.966 . . . . 64.109999999999999 112.196 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -133.3 173.85 11.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.595 1.558 . . . . 72.310000000000002 110.191 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 p -156.39 119.73 4.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.253 1.021 . . . . 70.049999999999997 108.611 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 74' ' ' CYS 0.313 10.4 p -121.88 86.42 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.964 1.364 . . . . 64.040000000000006 109.106 174.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 p -70.21 173.4 6.73 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.216 1.406 . . . . 62.229999999999997 110.127 164.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 p -130.55 9.69 5.11 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.316 -0.865 . . . . 64.420000000000002 112.877 166.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 tptt . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 105.852 -1.907 . . . . 74.140000000000001 105.852 177.181 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.4 p . . . . . 0 C--O 1.237 0.433 0 N-CA-C 110.446 -0.205 . . . . 52.340000000000003 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.57 -116.82 1.98 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 106.572 -2.611 . . . . 73.219999999999999 106.572 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.93 128.99 68.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.535 -1.283 . . . . 64.420000000000002 107.535 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -97.85 157.96 15.79 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.541 -0.911 . . . . 54.340000000000003 108.541 171.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -143.1 150.42 39.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.815 -1.55 . . . . 74.329999999999998 106.815 167.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.58 155.45 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 106.197 -1.779 . . . . 64.439999999999998 106.197 165.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.59 126.17 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.434 -2.432 . . . . 54.329999999999998 104.434 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.1 mt -121.93 154.27 26.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.582 -1.636 . . . . 73.129999999999995 106.582 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.12 168.22 20.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.457 0.572 . . . . 54.299999999999997 110.331 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -148.25 158.87 44.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.939 1.296 . . . . 74.329999999999998 109.193 164.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.175 1.39 . . . . 72.129999999999995 107.509 163.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.87 -120.04 4.12 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.463 -1.455 . . . . 51.329999999999998 109.463 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -96.22 118.09 32.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.275 -1.38 . . . . 63.100000000000001 107.275 159.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.5 p -100.54 -5.78 26.37 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.139 0.975 . . . . 74.120000000000005 112.108 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -37.32 38.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.07 0.948 . . . . 75.230000000000004 110.133 -169.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.33 18.74 13.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.533 1.133 . . . . 61.039999999999999 112.754 -161.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -121.44 113.4 19.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.693 0.797 . . . . 73.299999999999997 111.021 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.89 136.65 36.72 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.892 1.677 . . . . 72.040000000000006 108.112 168.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -148.77 106.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 105.497 -2.038 . . . . 73.400000000000006 105.497 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -114.96 123.51 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.421 1.009 . . . . 73.040000000000006 108.946 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.52 140.92 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.033 1.333 . . . . 53.32 110.036 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -76.12 145.41 40.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.857 -1.905 . . . . 73.439999999999998 105.857 157.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HG ' ' A' ' 40' ' ' LEU . 22.1 mt -127.57 110.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 104.962 -2.236 . . . . 71.109999999999999 104.962 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.67 172.41 35.54 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.91 -0.586 . . . . 65.510000000000005 111.774 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.35 41.74 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 128.014 2.721 . . . . 64.519999999999996 108.597 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.49 34.41 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.89 1.276 . . . . 24.149999999999999 109.792 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.07 -177.46 4.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.117 1.367 . . . . 72.329999999999998 112.501 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.98 79.25 0.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.708 -0.849 . . . . 61.200000000000003 108.708 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.12 -65.02 0.29 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.268 -1.933 . . . . 71.329999999999998 108.268 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.34 -154.32 6.87 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.849 1.214 . . . . 73.219999999999999 110.586 -156.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -67.04 142.25 60.97 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.526 2.151 . . . . 54.229999999999997 109.868 172.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.9 130.3 39.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.79 -1.189 . . . . 63.32 107.79 172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -59.47 137.73 57.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.968 -0.539 . . . . 65.329999999999998 109.592 168.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -110.45 154.56 23.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.572 1.149 . . . . 62.310000000000002 109.081 170.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -132.65 154.19 50.35 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.136 1.374 . . . . 63.43 108.737 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -77.63 178.28 7.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.726 1.61 . . . . 75.109999999999999 110.721 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.18 8.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.092 1.357 . . . . 62.439999999999998 113.551 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -119.18 -6.02 10.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.549 2.74 . . . . 75.420000000000002 111.147 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 9.38 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.304 -1.276 . . . . 60.219999999999999 114.576 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.66 142.25 27.66 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.528 2.164 . . . . 74.120000000000005 110.142 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -62.07 136.58 58.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.744 1.618 . . . . 60.119999999999997 110.856 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.38 9.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.562 0.949 . . . . 55.409999999999997 113.562 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.17 171.25 12.24 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.665 -1.374 . . . . 43.240000000000002 109.665 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.1 p30 -103.11 1.56 33.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.231 1.012 . . . . 52.329999999999998 110.774 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -159.14 129.04 5.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.238 2.215 . . . . 31.329999999999998 107.671 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -161.87 -179.64 7.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.69 1.196 . . . . 74.219999999999999 109.216 161.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 p -117.13 161.68 19.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.143 1.377 . . . . 53.140000000000001 109.614 159.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.02 166.7 24.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.834 0.854 . . . . 74.310000000000002 109.175 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -114.9 139.91 49.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.621 1.168 . . . . 62.039999999999999 111.033 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mm -82.04 72.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 107.288 -1.375 . . . . 65.030000000000001 107.288 172.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 17.06 7.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.088 1.355 . . . . 72.340000000000003 111.527 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 p -137.65 147.07 44.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.998 -0.741 . . . . 62.100000000000001 108.998 -171.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.92 66.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.152 0.981 . . . . 73.120000000000005 110.633 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.6 p -135.05 162.56 32.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.153 -1.055 . . . . 71.310000000000002 108.153 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.9 169.46 24.53 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.095 1.758 . . . . 71.109999999999999 109.388 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.66 148.61 6.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.125 1.37 . . . . 75.439999999999998 110.671 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 64.7 m -134.99 150.8 50.4 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.55 -0.907 . . . . 74.340000000000003 108.55 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.2 p -142.9 -179.08 6.14 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 112.09 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.3 p -132.26 -177.72 4.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.883 1.673 . . . . 73.310000000000002 109.438 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.76 -173.98 2.43 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.031 -1.1 . . . . 74.209999999999994 108.031 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.0 -13.43 26.8 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.697 -0.627 . . . . 53.119999999999997 114.362 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -88.23 83.75 6.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.458 1.129 . . . . 73.239999999999995 108.774 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.29 178.03 7.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.343 1.057 . . . . 73.209999999999994 110.961 157.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.75 -22.34 4.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.357 1.463 . . . . 74.319999999999993 112.81 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.48 177.21 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.353 1.461 . . . . 72.109999999999999 109.272 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.5 ttt -147.44 154.1 40.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.914 1.685 . . . . 73.200000000000003 106.589 163.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 t -128.34 155.55 44.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 72.310000000000002 109.905 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -140.51 42.37 1.88 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.629 2.371 . . . . 63.329999999999998 109.904 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 120' ' ' SER . . . -69.09 142.39 54.48 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.048 -1.032 . . . . 72.219999999999999 110.971 165.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.78 -176.03 39.81 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.852 -0.899 . . . . 64.530000000000001 110.852 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 86.7 p -131.81 167.53 19.4 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.076 0.95 . . . . 72.540000000000006 110.53 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.68 153.3 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.224 -1.399 . . . . 62.310000000000002 107.224 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p -159.79 142.89 14.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.254 0.934 . . . . 72.340000000000003 111.705 166.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -148.37 159.79 43.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.233 1.413 . . . . 64.129999999999995 108.509 173.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.86 25.75 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.267 1.827 . . . . 73.120000000000005 110.163 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -73.61 -159.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.075 1.35 . . . . 64.0 110.394 174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -83.99 169.02 15.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.156 0.982 . . . . 65.310000000000002 110.136 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 162.47 7.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 73.340000000000003 112.028 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.83 -2.27 80.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.276 1.417 . . . . 54.5 113.891 174.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -72.79 115.62 12.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.617 1.709 . . . . 72.329999999999998 106.658 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -96.05 164.81 12.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.638 -0.875 . . . . 62.109999999999999 108.638 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.1 tp -155.78 147.59 23.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.963 0.801 . . . . 72.319999999999993 109.035 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -148.15 98.17 2.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.813 1.645 . . . . 71.329999999999998 108.255 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.74 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.997 2.119 . . . . 71.400000000000006 108.124 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -128.19 146.46 50.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.103 1.361 . . . . 72.409999999999997 108.383 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.34 105.97 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.573 1.949 . . . . 54.229999999999997 110.749 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.02 139.05 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.198 1.399 . . . . 21.210000000000001 108.995 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.31 146.21 17.91 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.658 1.123 . . . . 61.130000000000003 111.464 -166.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -131.85 157.62 43.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.252 1.421 . . . . 73.340000000000003 110.2 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -131.41 130.76 63.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.949 -2.241 . . . . 73.329999999999998 104.949 167.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.65 -76.44 0.06 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.6 2.36 . . . . 70.230000000000004 111.031 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -149.37 1.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.519 1.928 . . . . 70.109999999999999 112.664 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.88 145.63 50.17 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.621 1.1 . . . . 70.310000000000002 111.412 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.81 126.08 33.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.353 1.461 . . . . 71.400000000000006 109.883 -172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.43 -1.44 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.687 0.995 . . . . 65.409999999999997 113.687 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -154.51 128.01 8.56 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 72.299999999999997 108.184 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.42 123.73 18.07 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.127 0.876 . . . . 70.239999999999995 110.204 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.43 175.11 9.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.562 0.696 . . . . 64.099999999999994 110.47 160.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.25 173.88 15.0 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.836 2.854 . . . . 71.040000000000006 107.104 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.48 176.0 9.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.062 0.945 . . . . 74.420000000000002 108.76 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -139.17 137.98 36.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.68 -1.23 . . . . 74.030000000000001 107.68 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.639 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 2.1 m-85 -132.43 160.88 35.12 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.138 -1.06 . . . . 73.230000000000004 108.138 170.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -143.51 148.11 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.646 -1.983 . . . . 74.430000000000007 105.646 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.4 p -76.32 139.35 41.0 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.038 -1.097 . . . . 73.319999999999993 108.038 164.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.91 2.9 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.194 1.398 . . . . 51.240000000000002 111.124 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.28 38.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.866 1.698 . . . . 41.100000000000001 111.366 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -90.6 159.99 16.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.682 1.241 . . . . 71.400000000000006 107.687 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.1 113.14 1.77 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.975 0.91 . . . . 73.319999999999993 109.775 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.82 130.24 41.75 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.55 -1.278 . . . . 72.219999999999999 107.55 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -162.18 153.73 3.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 103.901 -2.629 . . . . 62.299999999999997 103.901 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.639 ' HG2' ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp20? -165.58 176.15 8.35 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.004 2.121 . . . . 74.219999999999999 106.512 160.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.2 p -141.87 142.24 33.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.067 -0.716 . . . . 52.229999999999997 109.067 167.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -125.92 169.02 13.1 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.512 1.525 . . . . 73.219999999999999 109.865 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 10.5 p -170.23 143.11 2.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.362 1.065 . . . . 54.399999999999999 108.731 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 74' ' ' CYS . 6.3 p -162.77 128.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 102.641 -3.096 . . . . 62.409999999999997 102.641 -167.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 m -134.85 143.42 47.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.686 -1.227 . . . . 62.539999999999999 107.686 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.84 -16.71 58.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.325 -0.55 . . . . 64.099999999999994 111.28 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.7 tptm . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 105.888 -1.893 . . . . 71.409999999999997 105.888 171.462 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.745 0.307 . . . . 61.520000000000003 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.98 -129.15 6.91 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.642 -2.183 . . . . 64.230000000000004 107.642 -162.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.0 123.08 50.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.904 1.682 . . . . 73.540000000000006 110.427 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -95.11 147.06 23.84 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.504 1.122 . . . . 73.5 109.426 170.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 62' ' ' SER . 34.2 tttt -148.88 151.81 35.34 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.113 0.965 . . . . 72.200000000000003 109.044 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.25 149.46 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.702 2.401 . . . . 74.230000000000004 106.572 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.19 131.76 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.345 -2.094 . . . . 74.439999999999998 105.345 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 74' ' ' CYS . 51.7 mt -127.96 149.01 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.877 -1.527 . . . . 63.420000000000002 106.877 -173.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -145.58 161.72 39.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.536 -0.542 . . . . 72.409999999999997 109.536 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -153.32 159.86 42.59 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.756 0.788 . . . . 65.030000000000001 112.627 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -145.48 174.39 11.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.635 1.574 . . . . 52.149999999999999 108.882 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.12 -154.92 19.54 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.885 1.231 . . . . 75.030000000000001 110.538 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.12 50.67 0.15 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.09 2.156 . . . . 65.120000000000005 111.191 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -54.48 -36.22 63.92 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 129.454 3.102 . . . . 74.230000000000004 111.662 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.87 -28.68 64.38 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.645 1.178 . . . . 63.43 111.223 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.7 m -93.33 -0.48 56.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.809 1.644 . . . . 63.350000000000001 113.432 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.813 ' CE2' HG22 ' A' ' 25' ' ' VAL . 1.2 t80 -119.77 123.06 42.79 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 123.525 1.631 . . . . 73.420000000000002 110.964 -169.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.72 79.48 8.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.001 2.921 . . . . 72.140000000000001 110.697 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.813 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.0 t -75.88 91.83 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.331 1.453 . . . . 61.030000000000001 107.774 176.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -94.98 129.94 41.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.132 -1.433 . . . . 73.230000000000004 107.132 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.79 154.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.645 -1.613 . . . . 70.049999999999997 106.645 174.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 49.9 m -112.07 152.08 28.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.365 1.066 . . . . 65.409999999999997 109.172 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 40' ' ' LEU . 58.3 mt -122.15 157.39 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.035 -1.098 . . . . 53.299999999999997 108.035 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.96 179.54 48.05 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.824 1.202 . . . . 64.120000000000005 110.515 172.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.78 166.89 35.08 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 127.053 2.263 . . . . 65.299999999999997 108.438 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.46 165.51 27.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.959 1.379 . . . . 73.030000000000001 111.418 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -140.07 179.24 6.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.498 . . . . 73.239999999999995 110.587 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -75.5 72.01 2.47 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.534 1.534 . . . . 65.340000000000003 109.536 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.46 -5.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 118.459 -1.189 . . . . 63.119999999999997 114.333 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.41 -159.0 27.68 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.27 1.535 . . . . 54.520000000000003 110.872 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.35 161.72 41.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.605 2.87 . . . . 65.010000000000005 111.856 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -89.51 121.52 31.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.211 1.404 . . . . 70.439999999999998 109.29 166.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -62.4 153.77 30.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.163 0.892 . . . . 72.120000000000005 109.929 168.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD13 HG22 ' A' ' 29' ' ' ILE . 9.9 mt -133.26 160.55 36.97 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.702 1.201 . . . . 72.099999999999994 109.711 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -138.01 160.55 39.05 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.81 0.844 . . . . 75.530000000000001 110.077 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -94.85 -179.4 4.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.156 -0.929 . . . . 53.229999999999997 111.399 178.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.35 1.95 3.41 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.826 2.451 . . . . 61.43 113.709 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -112.11 -3.34 14.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.409 1.884 . . . . 72.230000000000004 112.908 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 6.19 85.3 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.279 0.942 . . . . 74.310000000000002 113.691 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -76.06 144.85 40.54 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.628 1.214 . . . . 73.239999999999995 107.856 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 122.96 20.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.362 2.265 . . . . 63.240000000000002 109.665 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.9 pt -132.86 9.79 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 115.251 1.575 . . . . 45.140000000000001 115.251 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.77 -158.77 23.65 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.302 -1.119 . . . . 71.420000000000002 110.302 167.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -128.18 -2.66 5.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.338 1.055 . . . . 74.409999999999997 111.911 162.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -151.84 123.06 7.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.601 0.76 . . . . 72.430000000000007 109.901 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -173.93 -179.46 1.73 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.678 0.791 . . . . 63.420000000000002 109.55 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 27.7 p -137.19 119.43 15.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.264 1.426 . . . . 51.329999999999998 108.012 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.81 111.12 23.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.771 1.629 . . . . 74.120000000000005 108.128 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.17 147.9 49.57 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.351 -0.981 . . . . 61.020000000000003 108.351 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mm -97.05 125.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.188 -0.671 . . . . 71.019999999999996 109.188 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 27.3 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.65 1.98 . . . . 71.25 111.777 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 p -124.8 175.47 7.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.206 1.002 . . . . 72.439999999999998 109.033 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.71 66.35 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 55.329999999999998 110.182 163.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -137.88 155.62 48.76 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.238 1.015 . . . . 35.009999999999998 111.404 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.9 mmm -139.26 167.98 20.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.826 2.051 . . . . 72.109999999999999 111.518 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' ' HE3' ' A' ' 11' ' ' LYS . 22.6 p -151.56 152.63 33.18 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.122 0.969 . . . . 71.430000000000007 110.161 168.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.6 m -145.69 148.63 33.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.208 1.403 . . . . 52.520000000000003 108.349 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.4 p -137.98 174.83 10.15 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.419 0.554 . . . . 73.439999999999998 111.295 167.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 p -108.09 168.25 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.535 -0.913 . . . . 73.099999999999994 108.535 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.5 169.77 3.6 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.319999999999993 108.795 159.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.01 -26.1 67.47 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.08 -0.844 . . . . 72.239999999999995 112.302 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.72 90.39 3.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.604 1.702 . . . . 74.430000000000007 108.09 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB2' ' CB ' ' A' ' 38' ' ' ALA . . . -161.89 173.35 14.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.038 1.335 . . . . 54.119999999999997 110.413 159.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -131.25 -12.79 3.54 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.539 2.336 . . . . 74.120000000000005 113.198 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -159.08 170.19 22.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.214 -1.402 . . . . 64.209999999999994 107.214 167.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.1 ttt -133.55 155.41 49.65 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 105.452 -2.055 . . . . 74.329999999999998 105.452 167.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -130.06 161.2 31.56 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.129 0.572 . . . . 63.039999999999999 109.505 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -149.85 41.64 0.85 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.734 1.214 . . . . 45.439999999999998 110.705 174.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 134.41 56.09 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.327 -0.858 . . . . 64.409999999999997 110.284 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.43 179.19 26.42 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.481 -0.648 . . . . 70.230000000000004 111.481 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.91 130.93 34.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.917 -1.142 . . . . 65.150000000000006 107.917 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.641 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 90.6 t -90.06 146.66 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.205 -1.035 . . . . 72.409999999999997 108.205 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.1 t -150.79 159.36 44.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 118.501 -1.279 . . . . 43.240000000000002 110.328 155.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 115' ' ' LEU . 12.5 t -147.88 143.97 27.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.614 -0.884 . . . . 65.25 108.614 164.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 pt -117.84 19.48 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.581 1.952 . . . . 73.150000000000006 109.404 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.8 p -79.45 175.69 10.38 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.719 1.208 . . . . 72.109999999999999 111.593 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -70.22 167.03 18.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.155 -0.93 . . . . 72.019999999999996 110.741 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.63 158.11 10.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.745 2.018 . . . . 64.030000000000001 113.055 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.73 -10.2 57.25 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.514 1.53 . . . . 71.340000000000003 114.046 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -67.09 159.31 29.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.744 1.617 . . . . 73.049999999999997 108.335 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -144.6 170.97 15.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.764 0.826 . . . . 70.420000000000002 111.06 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 tp -159.97 162.29 34.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.638 -1.245 . . . . 74.439999999999998 107.638 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -145.16 116.69 8.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.595 -1.261 . . . . 65.150000000000006 107.595 164.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.14 147.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 124.978 1.311 . . . . 74.010000000000005 107.624 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 m -127.7 138.64 52.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.304 -1.739 . . . . 73.349999999999994 106.304 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.2 112.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.527 1.931 . . . . 42.130000000000003 108.459 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -129.08 150.8 34.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.43 -1.693 . . . . 63.409999999999997 106.43 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.62 152.06 22.76 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.182 0.896 . . . . 70.439999999999998 111.245 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.54 150.23 46.15 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.795 0.838 . . . . 74.299999999999997 111.388 -164.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.8 mt -146.08 136.0 17.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 104.774 -2.306 . . . . 71.530000000000001 104.774 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.0 t70 44.5 52.68 7.42 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.744 2.018 . . . . 63.340000000000003 113.683 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t0 60.25 25.12 14.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.115 0.966 . . . . 71.129999999999995 112.795 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -126.75 156.92 40.4 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.326 -1.484 . . . . 74.129999999999995 111.308 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -97.49 119.58 36.29 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.97 1.708 . . . . 74.400000000000006 107.267 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.8 m -124.97 -2.6 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.647 0.98 . . . . 73.400000000000006 113.647 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -162.36 133.73 5.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.372 -1.344 . . . . 73.219999999999999 107.372 -172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.37 118.43 2.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.723 0.692 . . . . 74.329999999999998 111.703 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.06 168.83 18.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.59 0.709 . . . . 63.420000000000002 110.826 166.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.82 166.47 20.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.589 2.355 . . . . 74.010000000000005 108.423 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -149.14 162.33 40.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.835 -0.802 . . . . 74.310000000000002 108.835 171.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -147.94 118.37 7.41 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.008 -1.849 . . . . 72.420000000000002 106.008 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.641 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 30.6 m-85 -118.35 152.9 34.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.661 -0.866 . . . . 72.430000000000007 108.661 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.1 mt -138.36 153.77 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.281 1.432 . . . . 65.340000000000003 107.32 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -99.45 150.86 21.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.138 0.975 . . . . 62.030000000000001 110.214 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -130.45 15.1 5.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.908 1.683 . . . . 65.349999999999994 110.9 169.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.04 -24.44 18.81 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.549 1.547 . . . . 61.409999999999997 111.635 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 162.86 28.51 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.92 1.288 . . . . 73.319999999999993 109.345 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 106.73 2.68 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.254 0.622 . . . . 70.129999999999995 110.113 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 80' ' ' SER . 11.0 tp -60.85 136.28 58.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.46 -0.941 . . . . 72.049999999999997 108.46 174.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.4 mt -152.68 147.49 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 104.83 -2.285 . . . . 70.040000000000006 104.83 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.83 176.49 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.59 1.156 . . . . 71.140000000000001 109.467 163.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -131.15 160.87 33.49 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.307 1.043 . . . . 74.109999999999999 108.735 163.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -149.16 165.49 31.66 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.207 1.003 . . . . 73.030000000000001 108.704 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -165.74 142.07 5.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.447 0.641 . . . . 53.530000000000001 111.413 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.4 t -143.89 109.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.049 2.54 . . . . 63.200000000000003 104.825 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.1 144.91 29.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.983 -1.488 . . . . 70.109999999999999 106.983 169.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.0 p -92.36 44.2 1.15 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.598 1.09 . . . . 54.539999999999999 109.011 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.7 tttm . . . . . 0 C--O 1.234 0.269 0 C-N-CA 124.795 1.238 . . . . 74.319999999999993 108.034 171.54 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 106.934 -1.506 . . . . 75.010000000000005 106.934 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.64 -91.1 0.14 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.444 -1.462 . . . . 53.229999999999997 109.444 163.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -139.78 110.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 105.824 -1.917 . . . . 63.409999999999997 105.824 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -78.23 140.97 38.89 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.544 -1.28 . . . . 72.409999999999997 107.544 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -135.74 157.47 46.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.55 -1.648 . . . . 74.340000000000003 106.55 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 74' ' ' CYS . 1.1 tt -135.41 153.94 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 106.266 -1.753 . . . . 74.120000000000005 106.266 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.69 125.91 26.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 105.713 -1.958 . . . . 51.240000000000002 105.713 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.0 133.79 63.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 105.529 -2.026 . . . . 72.230000000000004 105.529 -170.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -140.68 159.97 41.05 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 119.562 1.074 . . . . 72.329999999999998 109.103 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -140.27 150.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.051 0.453 . . . . 42.140000000000001 110.76 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -134.34 163.24 30.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.388 -1.338 . . . . 54.32 107.388 158.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -152.15 18.81 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.752 0.691 . . . . 72.439999999999998 111.719 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.22 72.07 9.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.399 1.095 . . . . 75.450000000000003 109.209 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -70.93 17.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.883 2.073 . . . . 74.530000000000001 115.099 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.87 -3.89 5.81 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.866 1.061 . . . . 64.409999999999997 113.866 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 t -101.22 1.32 38.83 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.945 0.793 . . . . 74.329999999999998 112.942 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -117.81 148.47 42.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.137 0.975 . . . . 74.230000000000004 112.112 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -92.29 141.55 28.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.799 -1.926 . . . . 64.310000000000002 105.799 163.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 56' ' ' ILE . 1.4 p -153.45 81.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 63.310000000000002 111.714 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 109.36 21.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.557 0.694 . . . . 75.319999999999993 110.366 -167.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 m -91.76 122.29 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.246 1.019 . . . . 62.119999999999997 109.695 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -66.77 133.72 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.175 -1.787 . . . . 35.520000000000003 106.175 160.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.38 126.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.733 -1.951 . . . . 63.329999999999998 105.733 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.22 177.86 38.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.022 0.82 . . . . 63.340000000000003 111.896 -171.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.85 167.16 29.08 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.039 2.257 . . . . 62.109999999999999 110.179 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.86 162.66 32.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.131 0.972 . . . . 75.239999999999995 111.637 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.99 -171.2 2.62 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.766 2.026 . . . . 75.140000000000001 112.332 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -78.62 65.74 3.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.586 0.755 . . . . 64.120000000000005 111.415 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.85 43.77 0.29 Allowed Glycine 0 C--N 1.323 -0.169 0 O-C-N 121.88 -0.512 . . . . 73.439999999999998 111.976 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.54 -154.9 22.75 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.053 -0.859 . . . . 74.230000000000004 111.961 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.03 159.78 37.31 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 124.267 3.311 . . . . 73.409999999999997 110.721 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.983 -1.118 . . . . 75.140000000000001 107.983 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -72.21 141.67 49.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.427 -0.953 . . . . 61.43 108.427 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 HG22 ' A' ' 65' ' ' THR . 5.0 mt -121.63 150.42 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.088 -1.449 . . . . 73.430000000000007 107.088 -171.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -131.46 134.22 45.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.542 1.137 . . . . 71.140000000000001 108.16 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -77.07 175.78 9.29 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.398 -0.819 . . . . 63.310000000000002 109.787 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -5.87 48.13 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 62.039999999999999 113.825 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.08 -5.21 50.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.277 1.431 . . . . 72.019999999999996 110.445 165.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.51 84.14 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.72 2.105 . . . . 73.319999999999993 113.131 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -101.96 142.42 33.27 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.045 1.338 . . . . 55.32 110.24 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -67.54 128.13 35.29 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.55 1.54 . . . . 75.299999999999997 109.159 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.57 20.57 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.544 0.738 . . . . 63.439999999999998 112.0 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -172.71 14.35 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.336 0.969 . . . . 65.400000000000006 110.958 174.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -118.68 9.25 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.957 1.303 . . . . 73.420000000000002 112.109 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -156.93 159.22 37.9 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.448 0.699 . . . . 71.430000000000007 110.196 150.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 p90 179.37 -175.39 0.24 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.988 1.715 . . . . 55.420000000000002 107.683 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 p -127.43 161.79 27.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.795 0.807 . . . . 62.5 109.333 157.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.77 155.23 50.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.244 -1.762 . . . . 75.040000000000006 106.244 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 20.0 tt0 -105.77 144.79 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.412 -0.959 . . . . 72.530000000000001 108.412 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 25' ' ' VAL . 38.4 mm -86.78 83.17 2.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 N-CA-C 107.338 -1.356 . . . . 74.409999999999997 107.338 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 44.4 mmm-85 -113.63 34.23 4.7 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 123.912 0.885 . . . . 73.310000000000002 111.546 176.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 p -140.92 146.95 38.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.637 -1.616 . . . . 52.350000000000001 106.637 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.78 -37.47 63.49 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.491 1.116 . . . . 71.030000000000001 110.171 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.0 p -140.94 142.62 34.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.543 1.537 . . . . 51.450000000000003 107.88 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.21 169.8 17.02 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.543 2.337 . . . . 71.409999999999997 109.485 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.9 p -167.43 161.95 14.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.993 2.117 . . . . 73.040000000000006 108.792 172.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.1 m -144.41 165.24 28.48 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.417 -1.697 . . . . 74.400000000000006 106.417 157.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.16 -178.73 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.537 0.735 . . . . 55.420000000000002 110.256 172.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.434 HG22 HD23 ' A' ' 40' ' ' LEU . 69.2 p -125.84 177.18 6.45 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.632 1.173 . . . . 73.340000000000003 108.79 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -87.49 178.96 6.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.298 -1.001 . . . . 72.040000000000006 108.298 162.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.23 17.74 3.82 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.382 -0.824 . . . . 63.100000000000001 114.647 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -105.25 85.87 2.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.094 -1.817 . . . . 61.030000000000001 106.094 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.05 172.62 18.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.563 1.074 . . . . 75.329999999999998 111.509 165.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -122.95 -17.96 6.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.2 -1.363 . . . . 75.430000000000007 111.652 164.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -157.12 173.72 16.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.999 0.92 . . . . 75.209999999999994 110.267 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.1 ttt -140.59 161.79 36.91 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.104 2.161 . . . . 74.120000000000005 105.86 165.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -140.35 160.23 40.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.478 1.111 . . . . 42.140000000000001 110.178 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HB2' HD13 ' A' ' 12' ' ' ILE . 43.9 t -148.7 39.25 0.86 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.037 2.535 . . . . 60.130000000000003 108.94 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 123.53 22.25 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.231 1.012 . . . . 73.099999999999994 109.973 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.92 29.03 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.8 -0.92 . . . . 63.350000000000001 110.8 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 95.1 p -127.24 167.43 16.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.905 0.482 . . . . 75.439999999999998 111.448 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.32 132.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 126.744 2.018 . . . . 75.409999999999997 105.952 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -144.5 162.66 35.99 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.456 0.571 . . . . 73.329999999999998 111.575 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.13 159.76 38.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.135 0.974 . . . . 60.350000000000001 110.531 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.48 32.03 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.204 1.802 . . . . 73.209999999999994 110.91 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -132.78 176.34 8.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.921 1.289 . . . . 52.229999999999997 110.742 -167.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -45.35 160.72 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.877 2.471 . . . . 75.540000000000006 116.096 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.72 157.21 21.57 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.09 -1.868 . . . . 62.32 113.002 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.1 -0.64 82.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.389 -0.673 . . . . 55.210000000000001 113.795 172.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -75.16 114.64 13.89 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.408 1.604 . . . . 55.219999999999999 106.739 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -95.88 158.66 15.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.704 -0.851 . . . . 72.430000000000007 108.704 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.7 103.0 1.53 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.502 -1.666 . . . . 75.109999999999999 106.502 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -105.07 118.53 36.76 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.881 -1.137 . . . . 75.319999999999993 109.207 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mm -107.56 134.82 48.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.759 -1.2 . . . . 73.430000000000007 107.759 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.9 m -113.13 126.53 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.77 -1.937 . . . . 73.310000000000002 105.77 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.4 127.67 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 106.976 -1.49 . . . . 74.150000000000006 106.976 175.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.8 mt -137.55 134.42 46.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.535 -1.654 . . . . 52.219999999999999 106.535 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.13 124.13 5.75 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 109.861 -1.295 . . . . 52.219999999999999 109.861 -169.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -113.95 144.22 43.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.788 1.235 . . . . 64.439999999999998 112.192 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 101' ' ' VAL . 22.8 mt -135.22 107.85 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 104.475 -2.417 . . . . 74.340000000000003 104.475 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t0 44.44 66.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.275 1.03 . . . . 64.400000000000006 111.317 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 74.79 0.78 3.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.93 2.492 . . . . 75.019999999999996 116.069 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -117.38 163.25 16.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 120.665 1.575 . . . . 71.340000000000003 113.46 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -98.91 153.86 18.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.613 -1.254 . . . . 63.329999999999998 107.613 165.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 96' ' ' ILE . 33.1 m -137.77 3.93 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.091 0.404 . . . . 54.530000000000001 112.091 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -165.18 132.96 3.1 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.515 -1.291 . . . . 73.040000000000006 107.515 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -158.61 130.25 6.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.199 0.6 . . . . 74.040000000000006 110.083 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.41 108.05 5.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.313 1.054 . . . . 64.519999999999996 110.863 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.61 156.92 34.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.341 -1.355 . . . . 73.329999999999998 107.341 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 119' ' ' PHE . 22.4 mtmm -142.72 170.21 16.12 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.113 -1.44 . . . . 74.549999999999997 107.113 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -145.6 145.31 30.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.093 -1.817 . . . . 71.329999999999998 106.093 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.26 153.42 46.51 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.523 -1.288 . . . . 71.319999999999993 107.523 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.0 mt -144.31 140.15 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.301 -1.37 . . . . 74.349999999999994 107.301 166.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -66.15 145.7 55.5 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.939 1.296 . . . . 72.150000000000006 111.168 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.8 63.77 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.667 1.222 . . . . 61.32 111.125 163.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.05 -32.13 4.16 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.821 2.153 . . . . 53.210000000000001 112.634 168.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.73 174.33 10.58 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.557 1.943 . . . . 74.420000000000002 110.065 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.4 168.7 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.391 -0.596 . . . . 60.450000000000003 109.391 159.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.71 134.0 44.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.902 -1.147 . . . . 75.109999999999999 107.902 168.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.4 mt -150.9 133.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.148 -1.427 . . . . 75.340000000000003 107.148 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -152.5 169.35 22.83 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.034 1.734 . . . . 72.209999999999994 109.876 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 53.6 p -134.74 167.84 20.11 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.755 0.822 . . . . 75.150000000000006 109.514 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.501 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 22.9 p90 -156.04 168.62 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.398 -0.819 . . . . 61.530000000000001 109.836 172.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -161.12 138.85 9.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.878 0.847 . . . . 62.119999999999997 108.989 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -145.67 100.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 104.653 -2.351 . . . . 63.149999999999999 104.653 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.06 140.3 29.9 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.632 -1.618 . . . . 64.400000000000006 106.632 168.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.449 ' O ' HD11 ' A' ' 96' ' ' ILE . 2.8 p -94.78 27.73 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.087 1.312 . . . . 44.539999999999999 111.007 170.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 tptm . . . . . 0 CA--C 1.512 -0.488 0 O-C-N 120.049 -1.657 . . . . 72.219999999999999 108.53 161.506 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.936 0 N-CA-C 108.485 -0.932 . . . . 64.540000000000006 108.485 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.57 -101.4 0.15 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.826 1.203 . . . . 64.109999999999999 110.88 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -134.14 117.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.202 -2.148 . . . . 75.530000000000001 105.202 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -84.38 151.16 24.87 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.759 -1.213 . . . . 74.25 109.236 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -137.67 158.43 44.39 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.387 1.075 . . . . 75.230000000000004 108.125 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.548 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.1 mm -139.3 129.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 105.315 -2.106 . . . . 63.450000000000003 105.315 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.0 t -113.11 140.17 34.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.927 1.691 . . . . 74.540000000000006 106.459 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mt -130.55 144.27 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.471 -1.677 . . . . 55.049999999999997 106.471 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.13 162.4 35.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.589 -0.893 . . . . 75.439999999999998 108.589 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -153.25 173.76 15.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.165 0.507 . . . . 72.450000000000003 112.192 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.24 150.85 20.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.052 0.941 . . . . 44.130000000000003 108.621 161.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.2 -108.38 0.37 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.145 -0.782 . . . . 61.240000000000002 111.145 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -130.34 54.88 1.84 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.547 1.539 . . . . 71.349999999999994 108.917 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.7 p -54.92 -4.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 130.938 3.695 . . . . 55.049999999999997 116.586 -165.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -95.26 -11.94 27.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.359 1.064 . . . . 71.25 111.877 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.57 33.78 4.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.545 2.338 . . . . 55.130000000000003 110.366 -170.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 88.7 m-85 -133.14 143.61 49.36 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.086 0.954 . . . . 73.129999999999995 110.098 171.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.14 58.38 0.6 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.595 1.558 . . . . 75.420000000000002 108.629 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 25' ' ' VAL . 1.5 p -62.13 125.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 124.759 1.223 . . . . 73.349999999999994 108.377 165.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.29 121.98 18.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.245 -1.02 . . . . 51.119999999999997 108.245 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.8 120.83 55.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.603 1.161 . . . . 74.230000000000004 110.004 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 t -66.1 134.63 53.21 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.54 -1.652 . . . . 73.450000000000003 106.54 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.82 112.95 27.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.589 -2.004 . . . . 63.119999999999997 105.589 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.9 35.29 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.531 -1.028 . . . . 64.319999999999993 110.531 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 168.81 38.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.638 -1.385 . . . . 72.010000000000005 109.638 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.21 153.41 31.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.275 1.43 . . . . 75.219999999999999 110.331 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.08 170.83 14.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.302 1.441 . . . . 62.210000000000001 111.219 174.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -66.58 73.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.397 1.879 . . . . 74.420000000000002 110.195 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.47 6.18 2.74 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.332 -1.815 . . . . 64.030000000000001 113.992 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.49 -156.41 27.25 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 120.99 2.395 . . . . 60.049999999999997 115.427 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.67 125.79 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.698 2.932 . . . . 73.150000000000006 110.022 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.81 120.13 14.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.267 -1.333 . . . . 75.219999999999999 108.832 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 144.89 55.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.678 0.217 . . . . 74.230000000000004 111.057 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 145.41 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.716 2.006 . . . . 75.219999999999999 108.62 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.848 1.259 . . . . 74.439999999999998 110.945 -170.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -82.12 175.67 10.14 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.311 0.645 . . . . 64.219999999999999 110.651 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.09 -12.73 61.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.736 1.013 . . . . 52.32 113.736 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -87.35 -7.54 57.65 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.058 -1.026 . . . . 73.430000000000007 110.928 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.66 56.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.449 1.976 . . . . 75.319999999999993 113.596 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.25 148.99 21.71 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.892 1.346 . . . . 72.310000000000002 109.855 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.54 144.83 56.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.426 -1.324 . . . . 73.510000000000005 107.426 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.73 5.8 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.411 0.685 . . . . 64.219999999999999 112.397 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.08 -175.3 36.89 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.001 0.818 . . . . 44.149999999999999 111.495 166.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -121.0 0.29 10.2 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.911 1.284 . . . . 74.319999999999993 112.183 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.7 m -165.84 115.6 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.217 1.807 . . . . 73.310000000000002 108.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -153.49 -178.84 7.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.745 1.157 . . . . 75.439999999999998 111.958 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.3 155.59 39.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.648 0.779 . . . . 75.230000000000004 109.488 163.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.54 171.61 10.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.945 1.698 . . . . 33.210000000000001 107.683 171.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -124.05 139.15 54.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 128.062 2.545 . . . . 74.450000000000003 109.269 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mm -90.65 98.88 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 119.262 -0.975 . . . . 74.549999999999997 110.102 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.47 14.35 13.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.948 1.092 . . . . 73.519999999999996 113.948 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.7 p -128.69 173.89 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.713 0.688 . . . . 62.109999999999999 109.837 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.78 90.52 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.736 0.415 . . . . 61.310000000000002 110.597 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.6 p -145.7 143.46 29.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.001 0.429 . . . . 71.230000000000004 110.465 -166.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -138.22 163.48 31.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.843 2.057 . . . . 61.210000000000001 109.754 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.64 152.53 6.9 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.042 1.337 . . . . 75.219999999999999 108.849 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 53.0 m -147.36 160.36 42.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.506 1.923 . . . . 75.430000000000007 109.409 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.2 p -152.42 173.39 15.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.486 0.714 . . . . 53.420000000000002 111.834 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -109.29 -174.98 2.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.56 1.144 . . . . 61.229999999999997 109.694 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -91.97 -171.65 2.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.544 -0.91 . . . . 63.439999999999998 108.544 151.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.56 -17.72 79.17 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.54 -0.725 . . . . 74.209999999999994 114.068 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -78.17 89.65 4.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.383 1.092 . . . . 64.510000000000005 108.207 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.38 15.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.662 0.785 . . . . 55.039999999999999 109.758 154.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -123.7 -10.28 7.83 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.191 0.811 . . . . 75.230000000000004 113.191 172.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.62 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 52.5 p90 -152.2 -170.64 3.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.011 1.324 . . . . 74.319999999999993 108.84 172.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.1 ttt -142.37 162.4 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 104.561 -2.385 . . . . 72.340000000000003 104.561 146.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -133.74 158.66 42.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.301 1.048 . . . . 61.229999999999997 108.874 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.542 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -134.13 99.11 4.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 102.089 -3.3 . . . . 53.420000000000002 102.089 166.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.14 113.45 14.5 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.519 -1.66 . . . . 71.420000000000002 106.519 168.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.8 -151.22 6.81 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.72 -1.752 . . . . 60.340000000000003 108.72 -161.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.8 p -149.28 -179.2 6.87 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.707 -0.479 . . . . 73.140000000000001 109.707 151.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.38 157.27 21.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.955 1.302 . . . . 75.030000000000001 109.434 170.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.02 171.72 14.07 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.924 0.89 . . . . 64.140000000000001 109.358 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HD23 ' A' ' 115' ' ' LEU . 36.8 t -159.26 162.46 36.12 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.267 1.027 . . . . 60.329999999999998 108.534 162.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.26 12.36 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.359 1.864 . . . . 63.310000000000002 111.597 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 p -83.88 176.64 8.76 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.254 1.022 . . . . 73.25 111.002 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -59.55 164.5 3.46 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.731 -0.668 . . . . 74.040000000000006 110.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 166.6 4.17 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.44 1.114 . . . . 72.409999999999997 112.938 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.09 -8.71 50.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.041 1.781 . . . . 71.439999999999998 114.348 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -62.62 158.85 17.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.532 1.166 . . . . 51.240000000000002 108.886 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -135.65 156.6 48.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.459 -0.571 . . . . 72.420000000000002 109.459 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -162.71 109.41 1.23 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.549 -2.019 . . . . 72.420000000000002 105.549 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -101.11 137.44 39.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.196 -1.779 . . . . 74.209999999999994 106.196 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.17 129.14 74.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.023 -1.103 . . . . 72.450000000000003 108.023 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -106.97 126.09 51.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.126 2.17 . . . . 73.329999999999998 106.008 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.39 109.84 16.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 125.297 1.439 . . . . 71.5 110.857 -165.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 mp -128.67 138.63 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.354 1.862 . . . . 73.209999999999994 106.747 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 12' ' ' ILE . . . -107.49 177.07 21.24 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.167 -1.173 . . . . 62.119999999999997 110.167 166.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -156.26 153.95 29.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 118.674 1.237 . . . . 75.5 109.742 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' HE2' ' A' ' 99' ' ' LYS . 11.9 mt -129.16 110.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 108.239 -1.023 . . . . 72.340000000000003 108.239 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.0 -74.21 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.885 2.474 . . . . 71.140000000000001 110.107 -171.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.7 -1.41 2.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.717 1.006 . . . . 75.099999999999994 113.717 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE2' ' HB ' ' A' ' 96' ' ' ILE . 12.9 pttt -105.8 156.9 17.87 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.104 -0.997 . . . . 72.420000000000002 113.459 -171.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -118.22 103.8 10.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.817 1.247 . . . . 61.310000000000002 109.161 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.37 -6.92 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 115.022 1.49 . . . . 72.439999999999998 115.022 -168.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.85 99.49 1.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.382 -1.34 . . . . 73.329999999999998 107.382 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.89 123.11 11.54 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.347 1.059 . . . . 71.099999999999994 110.915 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.43 176.63 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 73.439999999999998 110.487 171.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -136.55 158.01 45.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.113 2.165 . . . . 54.229999999999997 107.97 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -160.51 166.86 28.35 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.349 0.66 . . . . 72.200000000000003 109.61 169.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -140.05 147.42 40.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.264 1.826 . . . . 73.209999999999994 111.322 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -139.08 134.44 32.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.948 1.699 . . . . 63.299999999999997 108.251 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.0 mt -144.59 126.96 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.494 -1.669 . . . . 74.420000000000002 106.494 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 134.34 48.43 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.814 -0.439 . . . . 74.430000000000007 109.814 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.45 -17.04 33.1 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.564 1.146 . . . . 75.129999999999995 112.576 168.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.21 10.23 11.0 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.085 0.85 . . . . 63.329999999999998 112.486 -172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.34 -177.39 4.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.347 1.859 . . . . 53.32 108.989 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.55 111.85 2.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.598 1.159 . . . . 72.310000000000002 112.593 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 116' ' ' ILE . 4.3 tp -81.13 135.63 35.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 124.528 1.131 . . . . 74.450000000000003 108.304 170.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 115' ' ' LEU . 22.4 mt -150.2 132.22 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.999 2.52 . . . . 74.25 106.04 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.38 171.25 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.779 0.832 . . . . 71.319999999999993 111.279 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -142.71 160.96 39.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.194 1.397 . . . . 72.319999999999993 110.159 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -148.01 163.32 37.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.731 -1.122 . . . . 73.109999999999999 108.997 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.6 p -152.93 135.23 15.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.629 -0.67 . . . . 75.400000000000006 112.671 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 74' ' ' CYS . 7.6 p -135.5 103.64 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 128.207 2.603 . . . . 60.340000000000003 105.495 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.57 -158.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.454 -0.943 . . . . 74.400000000000006 108.454 170.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 82.8 p -134.24 -3.88 2.73 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.831 1.048 . . . . 74.319999999999993 113.831 161.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HE3' ' CG ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 124.565 2.126 . . . . 74.409999999999997 112.793 -154.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.238 0.462 0 N-CA-C 108.229 -1.026 . . . . 73.329999999999998 108.229 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.49 -96.88 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.653 -2.179 . . . . 63.439999999999998 107.653 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.76 118.38 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.775 1.23 . . . . 71.030000000000001 108.264 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -80.88 141.02 35.01 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.475 -0.784 . . . . 64.25 109.951 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.39 144.63 42.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.637 2.375 . . . . 53.310000000000002 108.829 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.95 156.2 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.475 -1.676 . . . . 74.129999999999995 106.475 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.02 138.89 45.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.918 -1.882 . . . . 54.229999999999997 105.918 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.0 142.42 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.591 -1.263 . . . . 63.549999999999997 107.591 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.35 173.27 11.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.377 1.071 . . . . 62.049999999999997 109.41 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -152.17 170.93 18.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.407 0.683 . . . . 73.140000000000001 111.79 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p -158.99 136.88 10.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.948 0.499 . . . . 73.329999999999998 111.523 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.88 -128.81 5.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.086 1.327 . . . . 55.149999999999999 111.722 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 61.41 3.58 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.402 1.881 . . . . 71.420000000000002 110.642 -166.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 p -75.91 48.11 0.47 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.32 1.848 . . . . 71.519999999999996 111.452 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.62 -20.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.0 0.92 . . . . 73.519999999999996 112.733 -172.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -142.19 42.06 1.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.205 2.202 . . . . 72.420000000000002 109.735 -170.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.53 160.04 36.4 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.371 2.269 . . . . 71.319999999999993 109.359 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -133.87 107.91 8.13 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.16 1.784 . . . . 74.5 108.319 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 1.3 p -125.1 80.7 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 125.438 1.495 . . . . 75.230000000000004 113.386 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.42 117.61 30.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.109 -0.7 . . . . 64.5 109.109 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 76' ' ' GLY . 35.5 m -115.59 133.53 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.854 -0.795 . . . . 75.340000000000003 108.854 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -66.08 151.28 47.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.579 -0.897 . . . . 51.299999999999997 108.579 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 95.9 mt -129.51 117.52 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.231 -2.137 . . . . 71.400000000000006 105.231 169.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 173.47 35.99 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.786 -0.926 . . . . 62.340000000000003 110.786 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.64 179.67 44.88 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.086 -2.806 . . . . 75.420000000000002 106.086 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.2 163.47 28.48 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.296 0.569 . . . . 72.420000000000002 109.498 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -174.32 3.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.963 1.705 . . . . 75.239999999999995 110.055 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -64.22 -28.81 69.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.741 1.015 . . . . 75.239999999999995 113.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.68 -52.67 11.54 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.203 -1.959 . . . . 64.329999999999998 108.203 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.96 -80.32 0.19 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.284 -1.526 . . . . 74.299999999999997 109.284 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.48 131.72 15.29 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.207 2.004 . . . . 73.319999999999993 111.751 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.63 134.77 34.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.809 -1.091 . . . . 64.319999999999993 108.885 165.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -83.95 128.59 34.65 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.339 0.972 . . . . 72.329999999999998 109.243 159.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.3 mm? -100.3 152.58 20.15 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.877 1.271 . . . . 52.32 108.314 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -124.36 155.06 39.41 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.05 0.928 . . . . 73.099999999999994 110.594 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.67 160.76 14.63 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.494 1.518 . . . . 72.099999999999994 109.795 168.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.83 0.93 9.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.649 1.98 . . . . 64.209999999999994 113.803 -171.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -77.23 -24.73 51.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.795 2.838 . . . . 65.129999999999995 110.743 165.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 4.35 50.32 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.22 1.867 . . . . 64.239999999999995 112.808 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -89.07 165.74 14.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.001 1.401 . . . . 70.430000000000007 108.183 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -84.77 151.94 24.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.861 -0.792 . . . . 65.400000000000006 108.861 165.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.29 -5.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.942 0.897 . . . . 63.240000000000002 112.659 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.81 40.69 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 119.708 1.14 . . . . 63.43 110.613 169.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.328 0.8 OUTLIER -121.87 14.96 10.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.289 2.235 . . . . 71.329999999999998 110.438 169.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 149.09 9.59 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 127.724 2.41 . . . . 70.140000000000001 106.947 151.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -169.23 179.86 3.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.146 0.979 . . . . 74.299999999999997 109.921 157.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -140.04 106.26 5.25 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 126.155 1.782 . . . . 74.519999999999996 107.185 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.12 150.26 20.39 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.483 -0.932 . . . . 62.310000000000002 108.483 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 9.6 tt0 -85.27 147.33 26.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.502 1.121 . . . . 72.219999999999999 109.251 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 15.1 mm -85.32 71.16 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.977 -1.12 . . . . 64.329999999999998 107.977 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -92.59 38.09 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.416 -1.427 . . . . 62.210000000000001 113.195 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 p -147.29 128.34 14.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.126 -1.435 . . . . 73.019999999999996 107.126 -165.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.95 65.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.549 0.613 . . . . 62.219999999999999 110.447 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 p -140.7 134.3 30.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.946 1.298 . . . . 72.239999999999995 107.95 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE2' ' H ' ' A' ' 62' ' ' SER . 6.0 tpt -125.26 159.93 30.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.469 2.308 . . . . 74.109999999999999 106.999 176.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 61' ' ' MET . 11.9 p -164.62 143.82 7.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.679 1.592 . . . . 74.030000000000001 107.409 168.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' A' ' 29' ' ' ILE . 12.6 m -136.86 147.63 46.62 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.417 -1.327 . . . . 75.010000000000005 107.417 176.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 p -146.56 -173.43 4.2 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.039 0.381 . . . . 63.0 110.735 170.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 p -135.49 172.92 12.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.705 1.202 . . . . 72.239999999999995 111.436 -162.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.99 170.2 11.32 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.569 -0.9 . . . . 51.119999999999997 108.569 163.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.96 60.96 3.78 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.124 0.869 . . . . 71.319999999999993 111.641 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.83 89.84 1.72 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.824 -2.658 . . . . 75.040000000000006 103.824 169.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.83 23.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.232 -0.413 . . . . 60.450000000000003 111.272 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.4 -8.18 2.92 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.04 0.756 . . . . 64.540000000000006 113.04 166.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -163.01 169.31 19.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.879 1.272 . . . . 73.519999999999996 107.736 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.3 ttt -138.74 151.47 47.14 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 104.382 -2.451 . . . . 64.540000000000006 104.382 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.0 t -138.53 157.84 45.4 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.615 0.766 . . . . 74.219999999999999 108.999 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.58 45.85 1.03 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.089 0.956 . . . . 62.350000000000001 111.244 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.59 141.29 58.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.787 0.835 . . . . 75.239999999999995 110.037 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 27' ' ' VAL . . . -149.13 -149.13 4.9 Favored Glycine 0 C--N 1.336 0.532 0 O-C-N 121.427 -0.795 . . . . 64.140000000000001 111.201 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.6 p -142.85 178.52 7.6 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.217 -1.031 . . . . 43.32 108.217 149.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.67 149.71 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.988 0.915 . . . . 72.549999999999997 109.045 160.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.4 t -152.51 161.77 42.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.32 -0.622 . . . . 73.319999999999993 109.32 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -157.25 153.51 27.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.3 1.84 . . . . 75.329999999999998 106.323 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 26.8 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 127.07 2.148 . . . . 73.439999999999998 108.0 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -90.44 173.52 8.05 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.823 -1.173 . . . . 71.129999999999995 109.021 169.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.12 169.29 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.141 -1.845 . . . . 74.5 110.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.62 162.63 6.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.429 0.692 . . . . 75.430000000000007 112.243 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.95 71.53 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.71 0.672 . . . . 73.25 113.309 172.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -111.97 136.39 51.37 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.214 1.806 . . . . 75.540000000000006 106.846 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -125.6 159.38 32.28 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.581 -0.699 . . . . 61.149999999999999 110.605 -166.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 tm? -154.87 102.5 2.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.516 -2.402 . . . . 44.340000000000003 104.516 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.22 149.04 22.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.267 -1.753 . . . . 64.349999999999994 106.267 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.99 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.227 -1.768 . . . . 55.329999999999998 106.227 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -119.17 135.97 54.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.450000000000003 106.172 163.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -138.52 119.55 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.895 -1.521 . . . . 75.319999999999993 106.895 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 mt -135.06 134.68 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 107.358 -1.349 . . . . 51.140000000000001 107.358 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -119.98 132.44 9.41 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.701 -1.359 . . . . 75.349999999999994 109.701 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -126.44 152.94 45.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.145 1.378 . . . . 72.420000000000002 110.055 -170.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.429 HD11 ' O ' ' A' ' 123' ' ' THR . 26.2 mt -136.85 112.4 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.536 -2.394 . . . . 72.430000000000007 104.536 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 74.38 -54.12 0.67 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 127.726 2.411 . . . . 73.140000000000001 112.962 163.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.34 6.57 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.183 1.793 . . . . 75.040000000000006 112.947 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.98 155.65 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.239 -2.163 . . . . 74.030000000000001 109.996 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -72.11 159.0 34.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.955 -1.128 . . . . 64.019999999999996 107.955 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.11 -6.02 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.377 0.51 . . . . 71.439999999999998 112.377 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.1 136.64 12.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.846 -1.168 . . . . 64.319999999999993 107.846 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.49 158.36 26.42 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 119.308 0.958 . . . . 73.510000000000005 111.432 168.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.43 171.41 14.67 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.302 1.049 . . . . 64.340000000000003 108.692 155.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.72 161.56 24.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.091 -1.818 . . . . 75.209999999999994 106.091 160.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.63 169.21 24.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.633 -0.877 . . . . 62.210000000000001 108.633 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -155.48 149.06 25.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.05 -0.352 . . . . 73.549999999999997 110.05 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.502 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.5 m-85 -148.29 138.4 22.55 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.774 1.23 . . . . 61.25 108.864 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.81 137.67 53.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.452 -0.944 . . . . 75.409999999999997 108.452 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -74.42 133.79 42.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.694 -0.854 . . . . 71.25 108.694 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.24 57.43 1.13 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.252 1.025 . . . . 75.530000000000001 108.921 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.67 -38.15 1.68 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.799 2.142 . . . . 62.149999999999999 111.774 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -62.8 152.43 35.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.363 1.065 . . . . 75.329999999999998 108.991 172.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 m -74.29 113.94 12.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.021 1.329 . . . . 52.109999999999999 109.044 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -67.03 115.14 6.41 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.712 -1.588 . . . . 73.329999999999998 106.712 175.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.8 mt -149.71 138.53 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 103.043 -2.947 . . . . 74.519999999999996 103.043 170.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 170.58 21.01 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.965 1.416 . . . . 73.129999999999995 108.846 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -138.29 153.83 49.03 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.316 -0.994 . . . . 73.340000000000003 108.316 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.71 161.71 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.718 1.207 . . . . 71.340000000000003 108.165 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.6 t -160.2 144.37 14.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.853 -1.165 . . . . 75.420000000000002 107.853 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.469 HG21 ' HB ' ' A' ' 92' ' ' VAL . 40.5 t -146.32 118.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.1 -2.556 . . . . 71.219999999999999 104.1 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 132.5 51.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.335 1.054 . . . . 73.519999999999996 108.249 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.429 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.8 p -95.14 14.13 23.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.484 -0.76 . . . . 72.420000000000002 112.17 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.46 0 N-CA-C 105.217 -2.142 . . . . 74.430000000000007 105.217 162.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.731 0.301 . . . . 64.340000000000003 111.689 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.58 -105.94 0.44 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.174 -1.57 . . . . 74.430000000000007 109.174 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.87 83.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.430000000000007 106.172 -162.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -84.04 122.97 29.52 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.847 -1.538 . . . . 54.229999999999997 106.847 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.05 151.43 49.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.755 1.161 . . . . 63.439999999999998 110.574 -167.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 mm -135.01 146.38 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.357 1.463 . . . . 52.240000000000002 107.696 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 t -141.84 133.62 27.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.912 -1.514 . . . . 71.340000000000003 106.912 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mt -130.5 149.67 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.067 0.947 . . . . 70.109999999999999 109.214 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -135.84 167.34 21.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.677 0.672 . . . . 74.349999999999994 111.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -140.7 139.88 34.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.776 1.231 . . . . 72.209999999999994 109.239 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -149.82 152.9 35.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.484 2.313 . . . . 72.310000000000002 108.147 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.7 -145.33 18.68 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.55 -1.42 . . . . 63.43 109.55 -168.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -85.57 75.41 10.15 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.038 -1.467 . . . . 50.350000000000001 107.038 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.1 p -75.16 71.02 2.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.395 -1.706 . . . . 72.109999999999999 106.395 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.72 -48.31 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.506 1.122 . . . . 71.430000000000007 108.71 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.93 67.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 124.002 1.858 . . . . 72.420000000000002 109.462 -163.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 1.1 p90 -148.27 166.69 27.24 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 128.251 2.62 . . . . 70.430000000000007 108.22 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.79 150.52 49.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.556 1.943 . . . . 74.150000000000006 108.423 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.13 85.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.576 -0.898 . . . . 74.310000000000002 108.576 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -86.63 136.04 33.19 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.809 0.814 . . . . 73.150000000000006 108.874 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.09 132.91 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.836 -1.913 . . . . 71.430000000000007 105.836 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -85.34 140.8 30.5 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.778 1.631 . . . . 74.549999999999997 106.926 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.434 HG22 ' HG ' ' A' ' 40' ' ' LEU . 94.7 mt -124.64 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.409 -1.7 . . . . 74.340000000000003 106.409 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.56 172.88 42.57 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.193 -0.763 . . . . 61.450000000000003 111.193 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.46 175.29 40.51 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 127.176 2.322 . . . . 43.119999999999997 108.25 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.45 46.47 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.857 -0.79 . . . . 73.310000000000002 109.031 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -136.85 -178.55 5.24 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 125.835 1.654 . . . . 71.519999999999996 110.688 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -80.25 70.33 6.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.081 0.553 . . . . 64.549999999999997 110.29 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.68 -34.74 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.228 0.918 . . . . 73.340000000000003 111.652 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.24 -164.89 26.72 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 117.698 0.749 . . . . 63.340000000000003 113.273 -164.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.42 140.02 26.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.906 3.071 . . . . 72.310000000000002 109.337 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.62 26.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.314 -0.403 . . . . 74.409999999999997 110.293 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -54.49 120.1 6.17 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.039 0.935 . . . . 73.25 109.701 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.5 mm? -82.67 168.6 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.497 -0.927 . . . . 71.439999999999998 108.497 169.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.74 142.09 46.65 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.837 0.855 . . . . 74.430000000000007 109.079 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.34 170.81 16.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.552 1.141 . . . . 73.25 109.773 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -74.93 15.28 0.41 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 63.520000000000003 113.877 -169.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -100.37 -16.56 17.6 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.315 . . . . 72.510000000000005 111.559 162.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.48 67.36 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.37 0.986 . . . . 54.229999999999997 113.124 -168.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -79.97 161.52 25.44 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 1.116 . . . . 70.430000000000007 109.626 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.02 137.59 34.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.812 -0.81 . . . . 54.119999999999997 108.812 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.33 16.72 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.012 1.325 . . . . 71.430000000000007 112.944 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.17 172.21 14.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.867 1.222 . . . . 73.109999999999999 110.462 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -112.17 9.83 20.17 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.227 1.411 . . . . 62.340000000000003 111.159 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -167.05 148.78 5.96 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.071 2.148 . . . . 72.150000000000006 108.097 165.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -179.96 179.34 0.55 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.141 2.576 . . . . 74.430000000000007 109.186 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.4 p -129.39 159.09 37.32 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.33 1.052 . . . . 73.109999999999999 109.426 163.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.45 114.72 7.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.1 -1.074 . . . . 64.319999999999993 108.1 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -71.69 128.18 34.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.967 -1.123 . . . . 64.219999999999999 107.967 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.36 117.05 3.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.417 -1.327 . . . . 63.310000000000002 107.417 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 2.4 mmm180 -137.51 35.95 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.861 0.839 . . . . 74.329999999999998 110.856 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.21 147.71 26.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.456 -1.683 . . . . 73.120000000000005 106.456 -161.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.75 -37.47 71.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.95 0.5 . . . . 65.420000000000002 111.771 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 t -149.72 161.99 41.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.228 -1.027 . . . . 74.310000000000002 108.228 167.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 mmm -134.75 165.93 24.13 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 128.632 2.773 . . . . 71.219999999999999 108.883 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.5 p -164.94 162.28 20.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.507 -1.224 . . . . 64.120000000000005 110.058 171.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.2 m -150.94 166.02 31.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.046 2.138 . . . . 70.120000000000005 107.261 165.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.05 -178.68 6.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.934 0.894 . . . . 62.25 111.839 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 p -129.07 175.6 8.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.649 1.979 . . . . 64.25 108.987 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.2 172.32 7.66 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.398 -0.814 . . . . 74.25 109.162 159.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 55.01 4.99 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.092 0.853 . . . . 53.210000000000001 113.06 -169.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -133.38 -8.79 2.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.586 1.154 . . . . 63.509999999999998 111.215 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.59 165.12 23.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.834 0.826 . . . . 73.549999999999997 111.121 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -119.72 -1.8 10.51 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.906 1.682 . . . . 70.450000000000003 112.065 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -177.12 172.03 2.0 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.289 1.835 . . . . 71.409999999999997 108.022 171.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ttt -132.66 163.64 28.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.832 -2.284 . . . . 53.409999999999997 104.832 161.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -146.94 166.59 26.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.277 0.561 . . . . 62.25 110.253 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.11 65.18 0.9 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.595 2.358 . . . . 61.119999999999997 107.711 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.39 41.03 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 108.95 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.65 179.74 32.25 Favored Glycine 0 CA--C 1.502 -0.731 0 CA-C-N 119.082 0.856 . . . . 70.230000000000004 111.9 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 90.3 p -135.34 169.37 17.58 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.377 -1.411 . . . . 54.25 109.535 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.54 153.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.422 1.489 . . . . 45.039999999999999 107.254 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.0 164.0 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.914 -0.772 . . . . 71.340000000000003 108.914 166.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.7 p -145.65 162.45 37.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.612 -0.514 . . . . 71.319999999999993 109.612 154.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 pt -133.63 15.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 128.653 2.781 . . . . 62.210000000000001 109.313 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -81.02 174.55 11.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.015 1.726 . . . . 74.120000000000005 111.28 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.3 163.83 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.227 -2.261 . . . . 71.209999999999994 110.626 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.89 160.16 15.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.203 1.401 . . . . 71.150000000000006 113.289 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.42 87.0 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.907 1.241 . . . . 61.130000000000003 114.164 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -66.66 167.47 11.05 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.564 1.182 . . . . 53.329999999999998 108.273 167.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -149.5 160.05 43.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 121.572 -0.705 . . . . 74.439999999999998 110.083 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.3 tp -152.87 130.45 11.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.591 -1.633 . . . . 74.239999999999995 106.591 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -129.16 109.25 11.0 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.389 1.876 . . . . 72.340000000000003 106.185 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.83 134.18 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.053 -2.203 . . . . 54.409999999999997 105.053 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 m -112.06 137.49 50.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.142 -1.799 . . . . 70.310000000000002 106.142 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.16 113.31 3.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.583 1.553 . . . . 74.329999999999998 109.194 -171.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.84 141.09 45.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.727 -1.583 . . . . 74.129999999999995 106.727 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.82 155.85 25.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 123.869 0.747 . . . . 61.210000000000001 111.483 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.13 154.46 42.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.051 0.94 . . . . 73.230000000000004 110.366 -165.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG13 HG11 ' A' ' 101' ' ' VAL . 39.9 mt -122.89 117.89 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.824 -1.176 . . . . 73.340000000000003 107.824 163.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 t70 69.28 -58.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 129.06 2.944 . . . . 74.209999999999994 111.666 165.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.68 8.5 0.51 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.043 1.497 . . . . 74.450000000000003 115.043 158.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.44 143.51 32.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.992 1.317 . . . . 74.349999999999994 111.267 -170.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.16 118.2 12.68 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.043 1.737 . . . . 64.120000000000005 107.203 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.42 HG11 HG13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -129.31 -8.31 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.735 0.779 . . . . 65.140000000000001 109.825 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -162.44 130.85 4.05 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.215 -1.402 . . . . 73.209999999999994 107.215 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -153.65 110.79 3.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.188 -0.671 . . . . 73.120000000000005 109.188 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 pp -142.25 179.51 6.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.783 -1.099 . . . . 73.430000000000007 111.296 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -145.9 171.27 15.07 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.171 2.589 . . . . 74.540000000000006 106.301 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -146.99 160.42 42.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.687 -0.857 . . . . 53.25 108.687 170.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -128.25 136.16 50.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.437 1.495 . . . . 72.329999999999998 107.057 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.655 ' HB3' HD11 ' A' ' 115' ' ' LEU . 9.3 m-85 -136.16 152.8 51.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.141 0.977 . . . . 62.409999999999997 109.055 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.0 mt -144.21 154.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.219 1.808 . . . . 74.209999999999994 107.424 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -95.79 141.17 29.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.928 0.891 . . . . 72.120000000000005 110.223 176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -121.67 4.99 10.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.343 1.857 . . . . 73.230000000000004 110.489 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 113.61 -34.91 4.78 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.715 2.102 . . . . 51.43 110.309 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -79.42 161.67 25.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.939 1.296 . . . . 73.409999999999997 110.622 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.36 105.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.765 0.826 . . . . 74.129999999999995 110.126 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 108' ' ' TYR . 7.8 tt -68.02 134.61 50.96 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.392 -0.966 . . . . 70.450000000000003 108.392 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -150.61 133.97 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.026 -1.842 . . . . 70.540000000000006 106.026 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.17 174.55 14.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.958 0.786 . . . . 52.350000000000001 111.608 171.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 73.9 p -139.65 161.64 37.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.81 1.644 . . . . 72.409999999999997 110.797 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -151.2 176.7 10.95 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.309 1.444 . . . . 74.239999999999995 109.606 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -160.74 147.48 15.34 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.561 -0.903 . . . . 54.020000000000003 108.561 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.2 t -146.31 88.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.236 -1.765 . . . . 63.32 106.236 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.5 m -77.82 166.78 22.49 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.06 -0.718 . . . . 53.210000000000001 109.06 165.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.1 p -135.17 58.3 1.77 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.11 -1.07 . . . . 43.439999999999998 108.11 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 124.507 2.098 . . . . 73.209999999999994 110.724 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 109.81 -1.316 . . . . 52.030000000000001 109.81 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.19 73.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.134 -1.802 . . . . 70.519999999999996 106.134 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -160.03 -165.98 1.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.864 2.466 . . . . 73.239999999999995 107.435 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.86 83.77 0.66 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.367 2.667 . . . . 52.399999999999999 114.216 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.72 104.32 5.99 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.16 -1.422 . . . . 73.099999999999994 107.16 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -142.92 127.65 18.15 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 126.223 1.809 . . . . 72.129999999999995 106.733 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -133.98 179.66 6.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.337 2.255 . . . . 72.540000000000006 110.005 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.42 -95.08 0.29 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.458 -1.057 . . . . 64.540000000000006 110.458 156.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.34 126.95 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 104.667 -2.345 . . . . 74.430000000000007 104.667 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -108.87 142.14 39.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.432 -1.692 . . . . 73.200000000000003 106.432 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -137.23 152.74 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.658 -1.238 . . . . 52.420000000000002 107.658 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.29 154.38 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.695 -1.224 . . . . 62.409999999999997 107.695 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 t -136.67 142.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.272 -1.751 . . . . 71.450000000000003 106.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.9 mt -133.84 148.58 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.309 -1.737 . . . . 63.350000000000001 106.309 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -135.51 153.46 51.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.302 -1.37 . . . . 74.120000000000005 107.302 172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -140.87 154.0 45.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.769 0.795 . . . . 70.239999999999995 109.888 166.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 p -151.64 173.09 15.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.712 -0.676 . . . . 72.340000000000003 109.333 171.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.68 -143.13 16.55 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.537 -1.425 . . . . 61.109999999999999 109.537 -172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -73.34 65.59 0.88 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.783 1.233 . . . . 75.019999999999996 112.17 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -64.21 -30.48 71.53 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.466 -1.396 . . . . 64.439999999999998 110.517 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.25 -30.82 64.97 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.783 1.233 . . . . 73.230000000000004 111.52 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.47 23.48 5.12 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.516 1.126 . . . . 71.319999999999993 112.644 -168.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -124.88 118.49 26.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.273 1.029 . . . . 73.319999999999993 108.72 171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -78.69 136.92 37.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.44 -1.319 . . . . 72.209999999999994 107.44 163.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -141.98 111.21 2.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.1 -1.815 . . . . 63.310000000000002 106.1 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -125.61 126.77 45.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 120.648 1.567 . . . . 65.010000000000005 110.662 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.4 m -116.53 130.56 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 C-N-CA 125.025 1.33 . . . . 52.5 109.696 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -78.13 127.43 32.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.595 -1.632 . . . . 72.239999999999995 106.595 165.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 57.6 mt -113.47 138.83 41.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.689 -1.967 . . . . 71.129999999999995 105.689 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.32 179.82 46.98 Favored Glycine 0 C--N 1.334 0.451 0 O-C-N 121.356 -0.84 . . . . 74.5 112.661 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.76 -176.63 48.02 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.185 1.374 . . . . 73.530000000000001 110.437 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.31 159.83 40.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.905 0.882 . . . . 31.239999999999998 110.295 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.74 -177.34 5.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.431 1.093 . . . . 74.299999999999997 111.116 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.78 59.28 0.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.756 2.022 . . . . 54.310000000000002 108.909 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.74 21.87 0.02 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.582 -0.566 . . . . 61.299999999999997 112.665 -160.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.98 -154.0 20.15 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.459 1.129 . . . . 74.340000000000003 111.439 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -62.58 142.81 91.3 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.83 1.686 . . . . 61.329999999999998 109.191 166.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.52 149.07 31.57 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.997 -0.742 . . . . 63.420000000000002 108.997 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -69.32 146.94 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.764 0.711 . . . . 75.120000000000005 109.781 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 2.3 mm? -113.84 154.81 26.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 126.119 1.768 . . . . 73.109999999999999 108.59 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.33 151.29 50.99 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.404 2.281 . . . . 75.400000000000006 107.902 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -95.04 173.97 7.32 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.848 1.259 . . . . 74.420000000000002 110.4 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.99 21.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.229 1.411 . . . . 71.030000000000001 113.903 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -109.83 6.54 23.51 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.678 1.991 . . . . 75.319999999999993 110.102 163.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.92 7.05 80.66 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.335 -1.258 . . . . 41.409999999999997 112.87 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -103.18 143.77 32.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.888 1.844 . . . . 73.5 109.895 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -65.26 151.38 46.34 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.83 -0.804 . . . . 75.299999999999997 108.83 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.17 1.03 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.005 0.743 . . . . 63.109999999999999 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.29 -174.06 33.45 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 120.288 1.404 . . . . 63.130000000000003 110.328 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -121.18 -2.88 9.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.017 2.127 . . . . 74.5 112.165 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -153.17 142.38 21.48 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.692 1.597 . . . . 34.509999999999998 108.822 161.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -173.0 176.78 2.93 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.578 1.951 . . . . 73.420000000000002 108.038 164.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.0 p -122.17 159.25 27.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.508 1.123 . . . . 63.119999999999997 109.057 165.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.97 130.48 29.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.088 -1.078 . . . . 62.420000000000002 108.088 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.85 140.08 40.51 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.066 -1.087 . . . . 64.200000000000003 108.066 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -73.99 94.61 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 104.51 -2.404 . . . . 75.230000000000004 104.51 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -120.23 44.29 2.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.852 -1.166 . . . . 73.219999999999999 107.852 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -141.71 166.43 24.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.221 -1.399 . . . . 75.319999999999993 107.221 167.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.49 78.79 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.136 0.974 . . . . 63.219999999999999 110.391 170.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.7 p -130.32 156.86 43.98 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.367 -0.975 . . . . 75.340000000000003 108.367 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -146.66 159.63 43.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.023 1.329 . . . . 75.239999999999995 109.52 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 p -165.31 155.55 13.41 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.412 1.085 . . . . 74.140000000000001 108.453 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.6 m -143.0 157.67 44.33 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.072 -1.455 . . . . 74.409999999999997 107.072 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.9 p -144.1 169.23 18.25 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.685 -0.635 . . . . 75.540000000000006 110.839 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.1 p -105.82 -170.25 1.71 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.121 -1.437 . . . . 73.209999999999994 107.121 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.75 -167.91 1.41 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.51 -0.922 . . . . 74.530000000000001 108.51 148.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.36 172.57 7.41 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.89 -0.884 . . . . 70.400000000000006 110.89 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.96 84.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.596 1.159 . . . . 72.510000000000005 108.861 -164.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.69 165.58 35.84 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.53 1.132 . . . . 64.230000000000004 108.305 156.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -132.91 -0.45 3.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.326 1.05 . . . . 73.219999999999999 113.404 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -166.88 175.59 7.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.964 -2.236 . . . . 65.329999999999998 104.964 162.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.0 ttt -140.55 145.48 36.84 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.705 -2.702 . . . . 70.299999999999997 103.705 157.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -116.58 150.9 37.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.003 -1.11 . . . . 53.420000000000002 108.003 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.5 t -147.91 89.54 1.75 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.564 -2.013 . . . . 65.319999999999993 105.564 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.25 135.15 55.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.94 -1.133 . . . . 74.150000000000006 107.94 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.09 32.8 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 118.724 0.693 . . . . 62.009999999999998 112.011 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 79.4 p -139.41 167.28 22.44 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.331 -0.934 . . . . 73.109999999999999 110.336 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.67 148.21 31.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.2 1.8 . . . . 73.049999999999997 106.736 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 p -142.97 160.89 39.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.173 0.442 . . . . 62.450000000000003 111.139 155.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.81 156.17 41.97 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.745 1.218 . . . . 54.340000000000003 108.173 164.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.22 49.81 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 126.26 1.824 . . . . 73.310000000000002 109.463 -172.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.0 p -129.07 -173.9 3.12 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.196 0.999 . . . . 51.340000000000003 111.809 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -66.71 165.33 15.18 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.118 0.967 . . . . 73.019999999999996 112.118 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 161.04 14.62 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 112.998 -1.91 . . . . 73.209999999999994 113.514 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.99 2.32 81.95 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 117.861 -1.522 . . . . 24.41 114.431 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.2 mmtm -70.12 114.82 8.64 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 120.1 1.95 . . . . 73.109999999999999 106.001 165.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -104.4 155.9 18.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.313 -0.995 . . . . 72.109999999999999 108.313 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 tp -143.16 159.13 42.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.543 -2.021 . . . . 65.25 105.543 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -143.97 145.97 32.6 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.946 -1.501 . . . . 73.430000000000007 106.946 165.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mm -134.37 140.59 45.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 105.677 -1.971 . . . . 64.329999999999998 105.677 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.495 HG22 HD11 ' A' ' 93' ' ' ILE . 6.3 m -131.43 125.83 33.56 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.89 -2.263 . . . . 73.329999999999998 104.89 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.24 116.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.737 1.215 . . . . 73.409999999999997 107.93 -170.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 91' ' ' THR . 2.1 mp -138.62 131.22 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.066 0.946 . . . . 72.319999999999993 108.719 -162.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.79 141.44 16.39 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.792 1.187 . . . . 62.340000000000003 111.4 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -131.45 153.94 49.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 127.122 2.169 . . . . 72.239999999999995 108.72 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -129.72 139.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.179 -2.526 . . . . 73.409999999999997 104.179 167.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 t0 49.82 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.121 2.968 . . . . 71.519999999999996 110.954 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -133.75 15.49 3.97 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 120.599 1.545 . . . . 72.340000000000003 113.948 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.85 155.71 42.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.529 -1.357 . . . . 65.409999999999997 111.467 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -84.82 135.32 34.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.907 2.083 . . . . 72.030000000000001 106.341 165.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -138.09 -1.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.831 0.678 . . . . 61.140000000000001 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -155.94 145.61 21.11 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 120.771 -1.206 . . . . 64.340000000000003 109.769 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -158.3 142.79 16.03 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 124.073 0.949 . . . . 71.25 109.973 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.07 170.55 15.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.872 0.844 . . . . 73.019999999999996 108.935 155.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -129.23 155.71 45.12 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.615 -1.624 . . . . 74.129999999999995 106.615 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.88 160.34 43.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.727 -0.842 . . . . 52.329999999999998 108.727 173.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.15 138.29 28.06 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 106.345 -1.724 . . . . 71.420000000000002 106.345 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' HD11 ' A' ' 115' ' ' LEU . 21.2 m-85 -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 123.544 0.527 . . . . 72.430000000000007 109.661 176.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.56 136.35 21.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.159 -1.423 . . . . 73.109999999999999 107.159 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 p -67.33 136.84 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.301 0.64 . . . . 71.25 110.255 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -109.19 -5.9 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.736 1.214 . . . . 74.409999999999997 112.615 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.59 -29.97 5.05 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.132 1.825 . . . . 65.310000000000002 110.913 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -82.68 170.52 15.02 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.035 0.934 . . . . 64.209999999999994 110.554 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -54.26 136.63 42.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.412 -0.959 . . . . 65.329999999999998 108.412 164.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.0 tt -93.21 135.6 34.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.057 -1.09 . . . . 63.149999999999999 108.057 168.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.7 mt -149.05 142.35 18.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 105.151 -2.166 . . . . 53.119999999999997 105.151 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.28 171.09 17.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.888 1.275 . . . . 74.450000000000003 109.339 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.1 p -140.06 157.68 45.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.736 1.214 . . . . 63.219999999999999 109.859 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 169.75 22.55 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.482 0.713 . . . . 73.420000000000002 110.638 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.89 134.57 1.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.72 0.808 . . . . 71.329999999999998 110.364 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.9 t -142.64 100.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.374 1.87 . . . . 71.109999999999999 106.112 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.45 139.49 41.86 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 72.140000000000001 109.762 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.7 p -92.73 26.69 2.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.232 -0.917 . . . . 71.420000000000002 112.551 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.37 144.85 5.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.345 -1.354 . . . . 70.099999999999994 107.345 161.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -128.67 164.3 23.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 127.407 2.283 . . . . 70.340000000000003 108.386 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.024 0 C-N-CA 127.293 2.237 . . . . 52.0 106.117 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 109.259 -1.536 . . . . 51.439999999999998 109.259 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.01 92.92 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.61 -1.256 . . . . 64.530000000000001 107.61 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t -174.74 108.29 0.11 Allowed 'General case' 0 C--O 1.237 0.427 0 N-CA-C 104.324 -2.472 . . . . 52.020000000000003 104.324 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.12 133.3 37.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.571 -1.27 . . . . 70.439999999999998 107.571 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -144.41 91.39 2.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.483 1.913 . . . . 70.510000000000005 108.346 -165.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -117.22 123.15 45.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.072 1.749 . . . . 62.420000000000002 108.467 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -129.77 176.1 8.3 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.895 2.078 . . . . 73.319999999999993 109.796 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.66 -133.56 5.8 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.04 -2.424 . . . . 43.340000000000003 107.04 -166.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.03 136.91 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.045 -1.465 . . . . 73.340000000000003 107.045 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -113.69 158.05 21.39 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.724 -1.213 . . . . 74.519999999999996 107.724 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -154.11 147.27 24.71 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.798 -0.815 . . . . 74.049999999999997 108.798 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mm -135.53 120.45 28.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.909 -1.886 . . . . 65.030000000000001 105.909 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.5 t -91.41 153.44 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.688 -1.967 . . . . 74.109999999999999 105.688 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 74' ' ' CYS . 2.9 mt -130.53 155.2 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.304 -0.999 . . . . 62.0 108.304 165.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.519 ' HG3' HG22 ' A' ' 60' ' ' THR . 23.8 mp0 -138.46 164.17 30.05 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.367 0.667 . . . . 72.430000000000007 110.747 163.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -142.39 156.29 45.2 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.624 0.77 . . . . 71.120000000000005 109.553 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.93 161.47 40.69 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.123 1.369 . . . . 65.230000000000004 108.059 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.5 -117.66 4.41 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.857 1.218 . . . . 72.420000000000002 110.685 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.37 104.11 16.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.36 1.064 . . . . 65.030000000000001 109.222 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.4 p -115.26 16.84 16.82 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.829 0.451 . . . . 72.120000000000005 111.23 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.99 -13.05 15.59 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.405 0.682 . . . . 54.509999999999998 110.48 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.81 23.69 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.462 1.105 . . . . 70.019999999999996 113.131 -164.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.865 ' CE2' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.97 119.33 20.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.022 0.915 . . . . 70.409999999999997 110.274 172.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.53 81.25 7.69 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.937 2.095 . . . . 72.209999999999994 109.141 174.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.865 HG22 ' CE2' ' A' ' 23' ' ' PHE . 3.0 t -72.88 106.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.947 -1.501 . . . . 70.299999999999997 106.947 171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -98.14 146.05 25.97 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.799 -1.556 . . . . 70.299999999999997 106.799 161.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.77 152.22 28.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.043 -0.98 . . . . 71.430000000000007 108.67 156.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.3 t -97.25 148.25 23.3 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.11 -1.811 . . . . 71.010000000000005 106.11 159.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.455 HG22 ' HG ' ' A' ' 40' ' ' LEU . 82.5 mt -128.07 145.74 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.309 -1.738 . . . . 70.430000000000007 106.309 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.55 176.42 47.85 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.517 -1.033 . . . . 50.219999999999999 110.517 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.61 173.1 43.84 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.771 2.129 . . . . 61.520000000000003 107.925 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.26 159.73 41.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.548 1.174 . . . . 52.32 111.116 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -137.22 -173.29 3.42 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.42 2.288 . . . . 71.219999999999999 110.013 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -65.62 -10.73 38.26 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.673 1.189 . . . . 65.129999999999995 113.624 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.87 36.53 1.97 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 124.676 1.131 . . . . 52.43 113.316 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.88 -160.16 13.35 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.693 1.246 . . . . 74.239999999999995 111.752 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.08 156.2 67.39 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.033 1.822 . . . . 71.409999999999997 110.065 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.4 144.8 25.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.502 1.121 . . . . 72.430000000000007 109.942 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -69.51 139.78 53.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.05 0.841 . . . . 72.099999999999994 109.745 170.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -102.63 157.46 16.92 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.611 1.164 . . . . 74.340000000000003 108.413 171.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -132.2 146.81 52.27 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.703 1.201 . . . . 72.099999999999994 109.837 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -82.11 179.62 7.74 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.633 1.573 . . . . 70.120000000000005 111.109 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -71.49 1.43 6.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.128 1.529 . . . . 71.099999999999994 115.128 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -101.01 -9.57 21.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.595 1.089 . . . . 73.010000000000005 111.007 165.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.77 13.92 76.79 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.654 -1.081 . . . . 12.34 112.426 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.48 148.24 27.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.556 1.942 . . . . 65.120000000000005 106.69 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.96 152.83 26.56 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.111 -0.7 . . . . 74.099999999999994 109.111 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -144.08 12.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 114.442 1.275 . . . . 72.209999999999994 114.442 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 -173.74 22.16 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.345 -1.102 . . . . 74.530000000000001 110.345 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.266 21.3 p30 -125.29 2.51 7.8 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.928 1.291 . . . . 74.319999999999993 112.856 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.5 m -153.63 140.5 19.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.525 1.93 . . . . 51.009999999999998 108.41 162.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -168.85 171.71 8.27 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.281 1.032 . . . . 74.299999999999997 110.594 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 m -118.28 145.99 44.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.96 1.704 . . . . 73.400000000000006 108.163 167.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -133.54 157.06 46.64 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.564 1.946 . . . . 52.219999999999999 107.939 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -109.49 135.68 50.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.648 1.579 . . . . 64.129999999999995 108.465 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.23 87.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.445 -1.317 . . . . 74.109999999999999 107.445 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 35.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.873 1.269 . . . . 74.209999999999994 110.303 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -146.2 160.05 42.5 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.178 -0.464 . . . . 71.439999999999998 110.756 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.99 -37.85 75.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.815 0.446 . . . . 72.340000000000003 111.341 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 15' ' ' GLN . 7.5 p -135.07 142.74 46.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.78 1.632 . . . . 72.209999999999994 108.516 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -135.54 163.33 30.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.626 2.37 . . . . 63.039999999999999 109.388 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.9 p -165.62 130.44 2.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.987 0.915 . . . . 71.239999999999995 110.456 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.8 m -139.53 154.4 47.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.905 1.282 . . . . 64.340000000000003 108.947 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -146.75 -179.81 7.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.209 1.004 . . . . 74.019999999999996 111.243 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -124.81 178.92 5.22 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.912 1.285 . . . . 71.439999999999998 110.695 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -91.56 -178.29 5.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.455 1.102 . . . . 74.120000000000005 108.691 162.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.24 10.74 52.99 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.37 0.986 . . . . 73.120000000000005 113.694 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -98.82 69.65 1.82 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.797 -1.927 . . . . 65.109999999999999 105.797 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -170.08 172.28 6.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.043 1.337 . . . . 52.310000000000002 110.638 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -130.36 -13.01 3.94 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.084 1.754 . . . . 72.549999999999997 112.782 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -159.86 174.66 14.1 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.052 0.941 . . . . 70.329999999999998 108.754 170.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.2 ttt -136.89 155.21 50.05 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.465 1.906 . . . . 70.010000000000005 106.21 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.8 p -113.14 177.5 4.61 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.706 1.203 . . . . 73.219999999999999 108.841 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 14' ' ' ILE . 1.9 t -157.84 33.24 0.26 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 119.104 -1.039 . . . . 72.040000000000006 113.157 150.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.51 132.53 53.43 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.488 -0.758 . . . . 73.010000000000005 110.746 -172.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.69 175.65 29.6 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 109.711 -1.356 . . . . 71.200000000000003 109.711 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.6 p -136.79 160.12 39.81 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.908 0.861 . . . . 74.129999999999995 110.721 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 69.1 t -117.52 135.36 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 106.678 -1.601 . . . . 72.430000000000007 106.678 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.35 124.85 10.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.114 -0.699 . . . . 74.140000000000001 109.114 167.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -119.2 142.98 47.52 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.232 -1.395 . . . . 74.010000000000005 107.232 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.86 17.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.179 2.192 . . . . 63.009999999999998 109.315 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -88.3 179.33 6.37 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.706 1.241 . . . . 64.329999999999998 110.733 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.2 165.48 18.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 113.258 -1.792 . . . . 74.409999999999997 112.369 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.94 155.09 20.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.608 -1.178 . . . . 71.239999999999995 113.293 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.86 79.68 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.386 -0.674 . . . . 72.329999999999998 113.486 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -67.85 156.91 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.306 -1.739 . . . . 73.420000000000002 106.306 155.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -139.51 158.35 44.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.359 -1.719 . . . . 73.120000000000005 106.359 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tp -156.15 157.25 35.63 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.438 -0.949 . . . . 74.420000000000002 108.438 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -147.32 111.71 5.23 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.172 -1.788 . . . . 70.340000000000003 106.172 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mm -101.66 143.44 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.777 -1.564 . . . . 73.140000000000001 106.777 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.2 m -119.34 136.21 54.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.023 -1.843 . . . . 71.040000000000006 106.023 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 108.47 3.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.481 1.512 . . . . 64.409999999999997 109.696 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.0 mt -123.66 140.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.796 -1.187 . . . . 61.32 107.796 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.9 154.18 20.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 124.569 1.081 . . . . 44.450000000000003 111.531 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -142.84 152.12 41.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.183 -1.008 . . . . 70.349999999999994 110.265 -161.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.1 125.88 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 104.798 -2.297 . . . . 62.130000000000003 104.798 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 44.95 55.89 5.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.584 1.154 . . . . 72.109999999999999 112.19 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 67.31 26.85 8.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.036 2.134 . . . . 70.310000000000002 114.43 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -134.94 161.6 34.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 120.15 -1.594 . . . . 74.219999999999999 110.196 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -97.25 127.68 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.032 -1.84 . . . . 70.430000000000007 106.032 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.15 -2.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 113.33 0.863 . . . . 50.149999999999999 113.33 -172.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.32 138.56 13.65 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.576 -1.639 . . . . 72.340000000000003 106.576 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -155.17 128.87 8.57 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.163 0.438 . . . . 72.409999999999997 110.839 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -142.61 171.49 13.98 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.934 0.873 . . . . 63.32 110.897 166.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -137.95 165.87 25.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.001 1.72 . . . . 74.239999999999995 106.386 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -146.46 166.57 26.01 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.422 -0.584 . . . . 74.219999999999999 109.422 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.44 132.59 33.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.126 1.37 . . . . 70.109999999999999 107.838 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.543 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 34.1 m-85 -127.43 154.15 45.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.442 -0.948 . . . . 74.400000000000006 108.442 171.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.3 mt -147.03 139.91 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.355 -2.091 . . . . 72.409999999999997 105.355 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 p -86.54 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.448 -0.783 . . . . 74.010000000000005 110.224 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -123.75 8.83 8.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.219 . . . . 72.019999999999996 111.564 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.78 -6.85 41.32 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.328 1.442 . . . . 62.329999999999998 111.505 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -102.22 174.85 5.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.84 1.256 . . . . 71.040000000000006 110.313 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.09 111.75 6.7 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.402 -1.333 . . . . 71.230000000000004 107.402 169.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.94 138.0 49.69 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.756 -1.201 . . . . 74.430000000000007 107.756 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -153.58 131.16 2.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.901 -1.518 . . . . 73.329999999999998 106.901 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -158.07 175.66 13.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.453 1.501 . . . . 70.420000000000002 111.87 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -146.64 152.29 38.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.139 1.776 . . . . 73.430000000000007 110.059 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -147.43 168.45 21.84 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.739 1.215 . . . . 73.219999999999999 109.318 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 p -168.89 128.11 1.08 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.543 0.687 . . . . 74.209999999999994 111.897 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.09 113.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.664 1.986 . . . . 73.310000000000002 106.1 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 m -97.25 158.35 15.5 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.575 -1.269 . . . . 50.520000000000003 107.575 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -107.39 38.48 2.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.705 0.684 . . . . 61.329999999999998 109.165 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -174.1 145.04 1.03 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.555 1.542 . . . . 73.430000000000007 107.561 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -147.76 131.3 16.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.723 2.809 . . . . 70.409999999999997 104.15 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.109 1.363 . . . . 72.329999999999998 110.536 -167.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 109.398 -1.481 . . . . 73.519999999999996 109.398 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.25 166.0 15.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.818 0.847 . . . . 54.039999999999999 109.65 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 p -162.14 177.3 9.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.49 1.116 . . . . 62.539999999999999 109.226 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -66.35 160.63 24.24 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.797 -0.565 . . . . 70.120000000000005 109.652 164.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -148.78 103.5 3.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.276 -1.75 . . . . 65.349999999999994 106.276 161.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.09 103.64 9.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.999 -1.482 . . . . 73.239999999999995 106.999 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -160.7 173.47 15.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.152 1.381 . . . . 72.129999999999995 108.699 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.68 -98.41 0.11 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 127.62 2.533 . . . . 53.140000000000001 107.106 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.23 135.66 61.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 125.502 1.521 . . . . 73.329999999999998 107.093 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -97.58 145.15 26.55 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.55 1.14 . . . . 72.510000000000005 108.7 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -141.05 159.69 41.68 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.901 0.88 . . . . 70.230000000000004 111.678 166.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.9 mm -130.86 152.16 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.035 1.734 . . . . 74.519999999999996 106.59 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.63 141.31 46.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.714 1.606 . . . . 70.109999999999999 106.942 166.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 56' ' ' ILE . 53.0 mt -131.62 151.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.028 -1.101 . . . . 74.530000000000001 108.028 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -142.72 164.63 29.59 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.723 0.809 . . . . 65.340000000000003 110.992 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -156.65 139.89 15.6 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.515 1.126 . . . . 51.310000000000002 109.687 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -152.9 147.72 26.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 128.313 2.645 . . . . 70.239999999999995 107.647 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.83 -134.8 11.29 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.323 -1.111 . . . . 50.329999999999998 110.323 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.19 58.75 0.72 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.022 1.729 . . . . 42.299999999999997 111.428 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.8 p -76.13 63.22 1.8 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.365 -1.46 . . . . 72.319999999999993 109.031 172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -148.93 -40.06 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.858 1.263 . . . . 63.509999999999998 110.653 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.84 60.88 1.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 124.268 1.985 . . . . 72.430000000000007 110.114 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 0.2 OUTLIER -141.53 160.18 40.69 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.582 2.753 . . . . 71.510000000000005 108.449 176.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.69 107.17 3.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.17 0.895 . . . . 74.120000000000005 108.806 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.46 92.84 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.419 1.887 . . . . 43.409999999999997 109.568 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.92 113.74 27.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 75.239999999999995 109.414 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.03 149.12 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.537 1.062 . . . . 72.239999999999995 110.078 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t -82.52 150.32 27.03 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.278 1.431 . . . . 75.140000000000001 109.413 176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.439 HG22 HD22 ' A' ' 40' ' ' LEU . 47.6 mt -130.61 116.01 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.56 -2.015 . . . . 75.140000000000001 105.56 165.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 173.53 35.15 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.811 -0.516 . . . . 54.439999999999998 111.811 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.34 169.49 36.49 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.582 2.039 . . . . 71.109999999999999 111.039 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.89 159.83 39.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.577 1.151 . . . . 74.200000000000003 111.026 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.48 -168.39 1.77 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.711 2.004 . . . . 74.430000000000007 113.258 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -77.74 77.62 4.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.146 -0.687 . . . . 64.099999999999994 109.146 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.04 49.56 0.72 Allowed Glycine 0 N--CA 1.453 -0.231 0 O-C-N 124.609 1.193 . . . . 75.530000000000001 111.768 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.79 -164.07 28.83 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 120.12 -0.267 . . . . 61.119999999999997 112.923 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.27 173.09 13.74 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.921 3.747 . . . . 72.510000000000005 110.56 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.39 117.82 35.72 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.477 1.111 . . . . 75.420000000000002 109.46 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -60.02 124.14 19.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.285 0.948 . . . . 73.439999999999998 110.396 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 65' ' ' THR . 0.8 OUTLIER -113.02 162.83 15.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.163 1.385 . . . . 75.230000000000004 109.455 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -131.03 152.76 49.99 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.358 -0.979 . . . . 62.520000000000003 108.358 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.287 1.5 p30 -79.05 -152.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.596 1.558 . . . . 61.210000000000001 110.228 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.86 2.32 32.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 119.727 -1.858 . . . . 75.109999999999999 113.231 174.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -106.2 -2.52 22.38 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.838 2.055 . . . . 71.430000000000007 111.63 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.46 56.87 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.46 1.505 . . . . 44.109999999999999 113.262 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -113.99 141.2 47.71 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.874 1.337 . . . . 63.530000000000001 109.86 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -66.94 135.06 53.22 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.208 1.803 . . . . 74.329999999999998 109.309 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.68 32.1 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.205 1.002 . . . . 74.5 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.1 176.18 27.81 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-O 122.432 1.018 . . . . 71.540000000000006 110.702 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.22 6.53 35.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.872 1.269 . . . . 62.420000000000002 112.524 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.7 p -167.48 125.62 1.26 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.908 0.883 . . . . 62.399999999999999 112.139 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -167.86 -175.43 2.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.561 0.744 . . . . 73.099999999999994 111.007 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -122.84 160.74 25.42 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.068 1.347 . . . . 72.430000000000007 108.571 162.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.16 127.83 17.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.83 -1.545 . . . . 61.530000000000001 106.83 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -78.69 149.84 32.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.921 -1.14 . . . . 63.229999999999997 107.921 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 14' ' ' ILE . 5.3 mm -86.42 112.75 23.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.108 -1.071 . . . . 65.340000000000003 108.108 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.26 37.77 3.69 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.861 1.265 . . . . 64.439999999999998 108.902 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -142.0 160.44 40.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.722 -1.214 . . . . 73.540000000000006 107.722 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.93 -16.92 62.69 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.277 -0.889 . . . . 33.229999999999997 113.235 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 p -145.22 150.85 37.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.703 1.601 . . . . 53.140000000000001 107.506 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmm -142.69 166.96 23.24 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.783 1.633 . . . . 74.209999999999994 110.641 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 77.6 p -162.26 151.89 16.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.251 1.42 . . . . 61.32 109.566 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.9 m -143.25 145.66 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.363 1.865 . . . . 64.319999999999993 107.665 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.8 p -143.82 -179.86 6.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.492 0.587 . . . . 54.299999999999997 111.254 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.543 HG22 HD23 ' A' ' 40' ' ' LEU . 26.1 p -129.34 -171.24 2.45 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.462 1.105 . . . . 71.519999999999996 110.633 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.6 -154.47 0.46 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.17 -1.048 . . . . 73.329999999999998 108.17 165.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.38 35.83 4.63 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.914 1.245 . . . . 72.099999999999994 112.526 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -135.86 87.95 2.36 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.694 -1.595 . . . . 74.200000000000003 106.694 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -171.2 166.17 7.23 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.33 1.452 . . . . 74.109999999999999 111.025 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.81 -16.11 7.23 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.476 1.51 . . . . 74.200000000000003 112.815 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.78 165.19 36.15 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.892 -1.151 . . . . 74.099999999999994 107.892 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 ttt -131.1 156.38 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 104.569 -2.382 . . . . 61.399999999999999 104.569 164.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -130.94 152.4 50.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.682 -0.859 . . . . 72.540000000000006 108.682 167.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.17 87.78 2.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.381 -2.081 . . . . 71.120000000000005 105.381 167.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.4 136.77 53.1 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.15 1.78 . . . . 71.230000000000004 107.123 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.98 -148.65 5.06 Favored Glycine 0 C--O 1.237 0.328 0 O-C-N 121.564 -0.71 . . . . 73.120000000000005 111.477 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -150.25 171.49 16.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.388 1.475 . . . . 64.129999999999995 109.427 161.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.53 143.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.058 1.343 . . . . 65.400000000000006 108.1 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -142.18 163.05 33.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.267 0.354 . . . . 62.520000000000003 110.777 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.9 t -135.68 160.01 39.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.946 1.698 . . . . 75.200000000000003 107.885 165.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 pt -133.95 21.08 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 128.233 2.613 . . . . 73.409999999999997 108.987 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -81.19 -177.75 6.6 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 123.145 1.45 . . . . 55.299999999999997 109.881 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -73.99 170.62 15.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.029 -1.896 . . . . 64.200000000000003 109.275 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 165.29 3.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.669 1.188 . . . . 70.430000000000007 112.514 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.1 -9.64 71.77 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.579 1.561 . . . . 61.299999999999997 114.111 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.45 134.94 36.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.736 1.768 . . . . 74.400000000000006 108.269 -176.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -125.99 129.16 48.66 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.745 1.157 . . . . 70.319999999999993 111.124 -169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.29 158.95 25.05 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.285 2.234 . . . . 74.209999999999994 105.756 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -161.14 101.38 1.24 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.146 -1.798 . . . . 64.329999999999998 106.146 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.71 143.78 21.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 106.258 -1.756 . . . . 72.340000000000003 106.258 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m -131.46 144.74 51.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.716 -1.587 . . . . 73.540000000000006 106.716 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -147.24 112.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 125.702 1.601 . . . . 53.200000000000003 109.231 -164.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.6 mt -128.22 143.96 39.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.395 1.478 . . . . 74.209999999999994 107.046 -170.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.67 140.49 11.84 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.897 -0.881 . . . . 61.219999999999999 110.897 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -134.64 144.91 48.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.158 1.383 . . . . 73.530000000000001 110.099 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.65 118.6 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 105.193 -2.151 . . . . 65.340000000000003 105.193 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 t70 43.91 71.32 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.64 1.576 . . . . 61.340000000000003 112.153 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.08 27.29 3.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.251 2.221 . . . . 70.329999999999998 113.694 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -129.8 158.56 39.11 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 120.799 -1.188 . . . . 65.540000000000006 110.94 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.82 134.87 40.39 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.228 1.411 . . . . 72.150000000000006 107.456 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.51 -0.06 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.852 0.861 . . . . 65.319999999999993 112.101 -172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -161.87 153.52 18.8 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.399 -0.963 . . . . 73.510000000000005 108.399 165.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.62 122.86 3.19 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.691 -1.596 . . . . 73.150000000000006 106.691 170.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.49 171.25 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.895 0.747 . . . . 71.219999999999999 110.753 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.05 168.8 14.81 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.614 1.966 . . . . 74.439999999999998 109.376 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -150.86 170.6 18.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.585 -1.265 . . . . 70.319999999999993 107.585 162.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.55 154.91 51.23 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 127.852 2.461 . . . . 71.120000000000005 107.727 169.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.571 ' HB3' HD11 ' A' ' 115' ' ' LEU . 22.8 m-85 -137.79 154.83 49.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.987 -0.746 . . . . 71.140000000000001 108.987 164.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -145.27 134.16 17.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.707 -1.22 . . . . 74.099999999999994 107.707 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 p -75.58 131.81 40.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.687 0.795 . . . . 74.140000000000001 109.929 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -128.64 66.26 1.41 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.06 0.933 . . . . 71.120000000000005 108.793 161.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.21 15.71 79.78 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.703 -0.68 . . . . 63.530000000000001 114.26 163.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.55 162.97 32.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.58 1.552 . . . . 74.209999999999994 110.273 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 105.69 1.35 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.342 -0.844 . . . . 52.119999999999997 109.896 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -66.08 133.14 50.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.335 -0.987 . . . . 61.329999999999998 108.335 175.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -149.37 138.62 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.854 -2.276 . . . . 71.129999999999995 104.854 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.58 166.92 32.01 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.66 1.184 . . . . 63.119999999999997 111.484 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.1 p -136.81 153.7 50.74 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.143 0.977 . . . . 74.439999999999998 111.182 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -142.97 174.47 10.64 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.005 1.722 . . . . 73.530000000000001 108.943 175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 t -164.38 144.08 7.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.503 -0.748 . . . . 52.0 109.621 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 92' ' ' VAL . 48.0 t -143.19 109.61 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.134 -2.173 . . . . 70.530000000000001 105.134 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.39 128.1 55.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.172 1.389 . . . . 65.5 107.574 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 5.4 44.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.924 1.083 . . . . 72.420000000000002 113.924 -172.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.3 116.52 6.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.116 -1.615 . . . . 73.340000000000003 106.775 171.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -133.65 168.34 18.86 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.125 1.37 . . . . 64.420000000000002 107.951 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--O 1.251 1.149 0 N-CA-C 105.153 -2.166 . . . . 74.109999999999999 105.153 -175.897 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.58 0 N-CA-C 108.889 -1.684 . . . . 54.520000000000003 108.889 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.63 167.51 12.94 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.109 0.954 . . . . 60.450000000000003 109.357 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -153.89 72.92 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.66 1.184 . . . . 74.409999999999997 107.942 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.98 136.29 36.58 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.502 -0.925 . . . . 72.150000000000006 108.502 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -151.51 119.92 6.42 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.076 1.751 . . . . 75.439999999999998 108.789 167.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.37 99.8 6.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.39 1.876 . . . . 75.049999999999997 108.091 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -135.65 -174.36 3.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 128.415 2.686 . . . . 53.25 108.777 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.49 -97.72 0.11 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 106.859 -2.496 . . . . 53.210000000000001 106.859 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.49 147.65 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.624 -2.362 . . . . 71.230000000000004 104.624 167.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -107.12 146.73 30.91 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.725 -1.583 . . . . 75.140000000000001 106.725 166.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -142.66 145.36 33.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.932 -1.507 . . . . 72.400000000000006 106.932 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.446 HD12 ' CA ' ' A' ' 94' ' ' GLY . 2.5 tp -119.95 152.28 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.792 -1.558 . . . . 61.509999999999998 106.792 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.2 t -126.82 137.43 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.561 -2.385 . . . . 73.400000000000006 104.561 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 74' ' ' CYS . 53.2 mt -122.1 151.6 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.358 -2.09 . . . . 54.43 105.358 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.62 166.35 24.97 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.29 -1.004 . . . . 72.510000000000005 108.29 170.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -138.4 171.63 14.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.413 0.685 . . . . 63.420000000000002 109.426 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -161.78 174.14 13.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 127.053 2.141 . . . . 50.439999999999998 107.686 164.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.82 -147.68 18.58 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.317 -1.513 . . . . 65.329999999999998 109.317 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.88 78.67 3.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.056 0.931 . . . . 72.099999999999994 111.197 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -73.29 39.63 0.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.676 1.59 . . . . 73.329999999999998 112.534 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -142.49 -11.38 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.439 1.496 . . . . 74.230000000000004 113.239 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 14.05 1.04 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.579 1.081 . . . . 73.219999999999999 113.134 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.49 167.19 18.65 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.008 0.923 . . . . 73.129999999999995 110.061 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.3 111.62 6.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.264 -1.754 . . . . 70.299999999999997 106.264 163.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 90' ' ' ILE . 62.1 t -125.01 112.83 33.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.801 -1.926 . . . . 65.400000000000006 105.801 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -110.03 121.71 45.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.783 -1.192 . . . . 53.439999999999998 107.783 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 m -95.26 137.53 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.368 -1.345 . . . . 72.219999999999999 107.368 163.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.94 145.36 34.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.161 -1.422 . . . . 73.239999999999995 107.161 155.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -130.08 123.26 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.041 -2.207 . . . . 62.100000000000001 105.041 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.81 167.78 37.38 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.913 0.768 . . . . 50.020000000000003 111.487 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.72 39.38 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.972 1.748 . . . . 44.210000000000001 109.003 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.96 164.32 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.654 1.227 . . . . 71.209999999999994 111.425 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.18 175.85 9.25 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.923 1.689 . . . . 74.340000000000003 112.722 -165.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -74.71 78.54 2.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.526 -0.916 . . . . 74.019999999999996 108.526 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.54 35.82 1.38 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-O 118.572 -1.127 . . . . 74.200000000000003 113.554 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.21 -172.12 30.8 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.918 1.859 . . . . 72.319999999999993 112.692 162.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.06 134.28 21.09 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.423 2.082 . . . . 70.329999999999998 107.662 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.91 131.06 42.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.406 1.082 . . . . 45.399999999999999 109.625 -167.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.2 mttt -61.68 122.24 14.83 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.433 -0.58 . . . . 70.219999999999999 109.433 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD23 HG22 ' A' ' 65' ' ' THR . 2.4 mt -97.09 154.97 17.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.177 1.791 . . . . 71.340000000000003 107.768 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -133.84 141.96 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.718 -1.586 . . . . 65.310000000000002 106.718 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.604 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -73.58 -154.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.439 1.896 . . . . 61.340000000000003 111.457 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -100.14 -3.17 32.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.02 1.728 . . . . 64.120000000000005 112.773 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -111.48 17.37 20.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.198 2.199 . . . . 54.409999999999997 110.109 -174.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.09 19.06 69.71 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.634 1.588 . . . . 50.210000000000001 114.234 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.604 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -102.58 156.52 17.56 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 119.694 1.747 . . . . 71.219999999999999 107.958 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -85.43 150.48 24.68 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.47 -1.307 . . . . 72.200000000000003 107.47 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.2 pt -150.67 23.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.876 0.87 . . . . 74.310000000000002 112.927 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.32 -172.18 14.08 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 120.578 -1.326 . . . . 54.130000000000003 111.955 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -119.18 -4.99 10.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.843 2.057 . . . . 73.430000000000007 112.544 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -164.38 134.87 4.14 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.208 -1.405 . . . . 73.340000000000003 107.208 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -168.4 -173.86 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.013 1.725 . . . . 72.420000000000002 108.651 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.44 165.58 14.75 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.206 1.002 . . . . 74.329999999999998 110.17 159.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.84 133.06 26.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.963 1.305 . . . . 73.319999999999993 107.985 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -78.95 136.46 37.25 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.605 -0.517 . . . . 71.200000000000003 109.605 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 mm -78.86 74.43 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.778 0.831 . . . . 72.519999999999996 109.516 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -89.38 13.78 12.8 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.178 1.177 . . . . 65.340000000000003 114.178 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.4 p -118.52 161.11 20.56 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.989 0.916 . . . . 63.399999999999999 109.386 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.7 92.57 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.29 -0.633 . . . . 73.129999999999995 109.29 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.4 p -132.82 140.23 47.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.721 1.208 . . . . 64.140000000000001 108.671 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.05 168.42 19.64 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.325 1.85 . . . . 73.530000000000001 110.956 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.5 p -165.92 144.18 5.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.396 0.678 . . . . 45.119999999999997 110.885 174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.3 m -127.1 157.77 38.78 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.487 -1.301 . . . . 64.409999999999997 107.487 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -146.86 -176.92 5.39 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.152 0.887 . . . . 72.299999999999997 110.611 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.496 HG22 HD23 ' A' ' 40' ' ' LEU . 20.0 p -134.91 177.75 7.55 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.353 0.661 . . . . 74.319999999999993 110.571 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -73.45 -172.53 1.2 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.074 1.35 . . . . 64.430000000000007 112.0 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.42 -5.54 72.98 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.783 -1.198 . . . . 72.209999999999994 115.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -130.82 109.25 10.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.767 2.027 . . . . 73.0 107.99 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.2 165.56 24.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.178 2.191 . . . . 74.5 110.103 166.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -117.55 -19.29 9.48 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.203 1.401 . . . . 74.519999999999996 113.268 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -159.86 172.51 17.5 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.89 0.768 . . . . 73.299999999999997 109.327 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.3 ttt -141.17 155.83 46.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.529 -2.026 . . . . 65.120000000000005 105.529 167.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -139.3 156.95 46.69 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.966 0.906 . . . . 51.229999999999997 108.911 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.637 ' HB3' HG12 ' A' ' 121' ' ' VAL . 2.1 t -123.94 16.27 9.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.727 1.611 . . . . 71.519999999999996 111.798 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.4 129.14 21.36 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 125.752 1.621 . . . . 73.299999999999997 110.632 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.7 -179.83 31.09 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 42.219999999999999 111.263 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.89 150.73 43.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.246 2.218 . . . . 61.539999999999999 107.809 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.67 HG13 ' CG ' ' A' ' 117' ' ' GLU 0.295 1.6 p -138.04 155.89 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 124.572 1.149 . . . . 50.420000000000002 110.552 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 m -151.73 179.18 8.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.214 -1.402 . . . . 72.400000000000006 107.214 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.5 t -161.91 164.69 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.218 1.407 . . . . 65.519999999999996 108.417 165.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.11 -0.11 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.914 1.286 . . . . 71.239999999999995 112.115 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.84 -176.5 1.69 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.752 1.263 . . . . 72.219999999999999 109.253 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -72.51 175.59 6.15 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.29 1.436 . . . . 73.109999999999999 111.107 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 166.88 8.61 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.693 1.597 . . . . 74.530000000000001 113.169 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 3.43 37.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.312 1.911 . . . . 51.020000000000003 114.805 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -87.67 115.34 25.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.382 1.873 . . . . 51.200000000000003 106.987 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 167.59 9.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.573 1.149 . . . . 74.439999999999998 109.776 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -157.87 97.15 1.54 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.757 -1.201 . . . . 74.299999999999997 107.757 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -87.86 138.9 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.621 -1.622 . . . . 75.329999999999998 106.621 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 25' ' ' VAL . 6.2 mm -128.28 140.05 50.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 106.157 -1.794 . . . . 74.219999999999999 106.157 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m -124.03 135.72 53.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.156 -1.794 . . . . 74.340000000000003 106.156 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -137.59 110.94 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 108.126 -1.065 . . . . 61.229999999999997 108.126 -172.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.2 mt -128.55 141.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.929 1.292 . . . . 75.209999999999994 108.497 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' CA ' HD12 ' A' ' 12' ' ' ILE . . . -138.58 144.56 15.69 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.361 0.981 . . . . 75.129999999999995 113.3 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -128.82 158.58 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.049 1.74 . . . . 74.329999999999998 110.82 -169.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.72 110.35 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.454 -2.054 . . . . 73.540000000000006 105.454 168.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 t0 72.6 -67.41 0.27 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 127.924 2.489 . . . . 72.450000000000003 110.012 168.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -153.97 10.45 0.4 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.784 1.634 . . . . 74.209999999999994 112.971 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -123.15 152.38 41.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.571 1.078 . . . . 55.219999999999999 111.486 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -97.46 121.51 39.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.537 1.535 . . . . 73.310000000000002 108.091 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.09 -15.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 62.240000000000002 112.881 -169.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.38 141.63 25.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.545 1.066 . . . . 75.510000000000005 108.689 -170.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.61 158.08 3.3 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.661 0.784 . . . . 72.519999999999996 111.469 173.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -152.14 172.62 16.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.119 1.512 . . . . 74.549999999999997 108.432 156.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.21 163.96 16.97 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.789 -1.189 . . . . 63.219999999999999 107.789 169.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -143.68 165.95 26.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 125.043 1.337 . . . . 64.209999999999994 109.409 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -162.53 120.95 2.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.439 -2.164 . . . . 75.310000000000002 109.507 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 117' ' ' GLU . 26.8 m-85 -131.5 149.43 52.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.077 0.861 . . . . 75.510000000000005 110.316 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mt -144.73 118.32 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.81 -1.552 . . . . 61.32 106.81 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 p -64.6 142.43 58.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.925 1.29 . . . . 71.420000000000002 110.993 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.56 51.73 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.313 2.245 . . . . 73.299999999999997 107.675 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.5 7.21 85.27 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.927 1.251 . . . . 73.420000000000002 114.338 167.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -127.68 179.59 5.44 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.295 2.238 . . . . 62.509999999999998 108.98 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -63.5 134.7 56.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.164 -0.68 . . . . 70.299999999999997 109.164 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.5 tp -95.39 135.36 37.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.7 2.0 . . . . 64.519999999999996 107.563 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.7 mt -164.76 133.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 128.68 2.792 . . . . 73.319999999999993 110.643 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.67 ' CG ' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -159.55 167.03 29.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.268 2.627 . . . . 74.519999999999996 112.838 -176.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -136.33 158.57 44.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.554 1.541 . . . . 71.439999999999998 110.42 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.11 164.92 28.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.365 1.866 . . . . 74.409999999999997 108.512 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -150.89 129.54 12.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.089 0.471 . . . . 75.400000000000006 110.081 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 74' ' ' CYS . 8.8 p -129.9 131.06 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.274 -1.75 . . . . 63.149999999999999 106.274 175.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.9 m -128.69 -179.61 5.16 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.517 -1.29 . . . . 71.340000000000003 107.517 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.3 p -135.28 33.84 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.566 -0.709 . . . . 52.119999999999997 109.103 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -173.74 117.74 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.585 -1.635 . . . . 75.420000000000002 106.585 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -134.3 169.31 17.41 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.753 1.221 . . . . 73.310000000000002 108.111 163.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.382 1.473 . . . . 62.229999999999997 107.904 -175.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 108.982 -1.647 . . . . 74.329999999999998 108.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.72 86.89 2.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 103.068 -2.938 . . . . 74.25 103.068 163.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -163.02 151.92 14.67 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.63 -1.618 . . . . 73.129999999999995 106.63 -162.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.82 87.74 1.64 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.432 -0.951 . . . . 45.420000000000002 108.432 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -136.2 98.93 3.98 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.007 0.923 . . . . 64.420000000000002 108.869 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -110.94 106.09 15.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.969 1.708 . . . . 64.530000000000001 108.114 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 p -147.72 172.42 14.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.726 2.41 . . . . 73.109999999999999 107.185 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.42 -90.76 0.08 OUTLIER Glycine 0 C--N 1.338 0.64 0 O-C-N 121.032 -1.043 . . . . 54.140000000000001 110.706 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.8 145.68 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 104.965 -2.235 . . . . 74.409999999999997 104.965 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 23.6 m-70 -120.73 148.97 43.24 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.912 1.233 . . . . 63.43 108.601 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 161.22 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.832 . . . . 74.150000000000006 109.714 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mm -140.35 136.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.25 -1.759 . . . . 65.219999999999999 106.25 170.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.5 t -113.95 144.87 20.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.17 2.188 . . . . 42.229999999999997 107.031 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.22 154.13 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.84 -1.541 . . . . 70.420000000000002 106.84 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -144.73 168.35 20.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.696 -1.224 . . . . 65.219999999999999 107.696 172.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -146.72 164.53 32.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.301 0.572 . . . . 72.439999999999998 111.358 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 m -157.05 172.14 19.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.159 2.584 . . . . 65.219999999999999 108.291 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.46 -151.56 19.37 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.026 -1.23 . . . . 61.030000000000001 110.026 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -76.04 64.86 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 123.444 1.592 . . . . 75.25 110.423 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -61.57 -14.28 28.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.495 . . . . 72.409999999999997 113.151 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.82 -30.64 62.82 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.397 0.679 . . . . 73.340000000000003 112.146 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.0 1.14 11.42 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.122 0.786 . . . . 60.229999999999997 113.122 -162.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.17 111.46 21.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.751 -1.574 . . . . 73.349999999999994 106.751 -173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 150.88 38.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.138 -0.69 . . . . 54.229999999999997 109.138 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.04 111.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 106.899 -1.519 . . . . 74.140000000000001 106.899 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -112.73 127.69 56.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.946 -1.131 . . . . 73.540000000000006 107.946 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.26 147.96 32.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.777 0.831 . . . . 53.350000000000001 109.361 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 t -117.92 120.68 38.6 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.201 2.201 . . . . 74.530000000000001 107.739 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.3 mt -120.35 125.31 74.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 74.540000000000006 108.39 -156.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.01 169.1 35.87 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 121.267 0.37 . . . . 72.219999999999999 113.099 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.05 174.21 39.34 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 127.303 2.383 . . . . 73.209999999999994 108.239 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.43 147.23 50.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 119.898 1.849 . . . . 54.009999999999998 110.227 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.07 179.49 4.03 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.752 2.421 . . . . 44.100000000000001 111.383 -172.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -67.37 76.2 0.16 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.825 0.85 . . . . 50.200000000000003 110.561 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.42 34.0 4.32 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.775 1.178 . . . . 74.340000000000003 111.734 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.9 175.42 47.5 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.637 1.218 . . . . 72.319999999999993 112.759 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -66.48 134.16 34.78 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.66 2.24 . . . . 72.319999999999993 108.921 159.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.87 128.23 34.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.831 -0.804 . . . . 73.140000000000001 108.831 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -56.0 123.25 13.75 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.271 -0.64 . . . . 72.439999999999998 109.271 169.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -92.69 164.6 13.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 124.222 0.951 . . . . 74.510000000000005 109.16 169.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -137.38 143.36 41.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.417 1.887 . . . . 72.120000000000005 107.926 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -69.59 -152.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.267 2.627 . . . . 75.230000000000004 110.944 174.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -99.91 -3.64 31.97 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.403 -1.435 . . . . 74.319999999999993 114.322 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -98.74 -3.5 35.62 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.321 -1.487 . . . . 75.299999999999997 111.6 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.99 9.49 56.01 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 127.356 2.407 . . . . 55.5 112.396 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -110.32 142.39 42.01 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 120.589 2.195 . . . . 75.120000000000005 108.334 -165.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -64.32 131.32 46.93 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.439 1.496 . . . . 74.129999999999995 108.704 165.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.54 9.53 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.063 0.945 . . . . 73.329999999999998 111.81 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.87 175.62 22.99 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.441 -1.063 . . . . 73.510000000000005 110.441 172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.98 11.62 17.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.075 0.95 . . . . 75.329999999999998 110.727 166.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.5 t -162.3 157.13 22.36 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 126.791 2.036 . . . . 52.119999999999997 106.415 151.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 40' ' ' LEU . 17.5 p90 -176.99 -174.99 0.56 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.493 1.917 . . . . 75.140000000000001 110.878 171.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.7 p -122.38 158.3 29.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.613 2.365 . . . . 71.519999999999996 108.369 161.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.96 106.06 3.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.299 -0.63 . . . . 72.099999999999994 109.299 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.43 145.09 52.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.598 0.714 . . . . 75.530000000000001 110.049 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mm -75.68 135.58 26.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.058 -1.46 . . . . 75.230000000000004 107.058 167.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.1 7.74 3.71 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.356 1.062 . . . . 61.43 110.816 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 p -139.51 152.39 46.91 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.073 -1.017 . . . . 72.319999999999993 108.874 -148.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -31.22 64.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.99 0.359 . . . . 64.349999999999994 111.937 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -134.99 164.18 28.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.827 1.251 . . . . 71.25 109.328 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -146.28 171.2 15.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.814 2.045 . . . . 62.329999999999998 109.912 170.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 p -173.46 156.78 3.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.668 1.587 . . . . 74.439999999999998 111.17 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.6 m -150.06 165.81 31.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.482 2.713 . . . . 62.229999999999997 107.416 162.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 p -147.88 -179.85 7.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.125 0.97 . . . . 54.009999999999998 111.28 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.8 p -102.9 164.91 11.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.662 1.185 . . . . 74.409999999999997 109.334 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.42 169.42 4.75 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.235 -0.586 . . . . 62.32 109.608 152.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.36 36.94 1.78 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.072 0.844 . . . . 65.540000000000006 113.123 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -146.33 90.17 1.93 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.237 -2.134 . . . . 65.430000000000007 105.237 170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.6 141.94 17.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.319 1.847 . . . . 74.349999999999994 106.977 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -86.09 -22.43 27.15 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.446 1.098 . . . . 73.439999999999998 111.832 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 25.6 p90 -157.38 167.33 30.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.697 1.199 . . . . 74.209999999999994 108.481 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.57 148.86 49.24 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.302 -2.11 . . . . 74.25 105.302 159.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.6 t -140.55 157.83 44.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.302 -0.999 . . . . 54.340000000000003 108.302 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.47 79.06 1.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.923 1.289 . . . . 73.109999999999999 109.157 -169.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.43 156.33 31.19 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.222 -0.659 . . . . 64.430000000000007 109.222 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.4 174.49 41.21 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 121.947 0.748 . . . . 72.450000000000003 112.662 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.6 t -146.33 148.59 32.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 126.337 1.855 . . . . 74.510000000000005 107.724 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.05 136.41 53.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 126.097 1.759 . . . . 72.439999999999998 106.718 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -148.57 151.86 35.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.698 0.799 . . . . 74.450000000000003 110.906 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -150.15 151.08 32.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.126 0.97 . . . . 72.319999999999993 108.462 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.54 5.15 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.367 2.267 . . . . 72.120000000000005 110.827 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 p -63.01 169.46 3.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.185 0.994 . . . . 50.310000000000002 110.322 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 168.18 9.68 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.319 1.057 . . . . 73.049999999999997 112.252 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.4 19.14 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 113.561 -1.654 . . . . 70.120000000000005 112.854 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.85 57.88 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.873 1.225 . . . . 73.129999999999995 114.014 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -75.19 167.07 22.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.21 1.505 . . . . 74.140000000000001 107.313 162.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.6 ptt-85 -153.87 174.03 15.14 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.952 -1.093 . . . . 74.319999999999993 111.118 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tp -158.46 152.78 24.21 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.338 -0.986 . . . . 45.229999999999997 108.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -140.57 131.38 25.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.409 -1.7 . . . . 73.140000000000001 106.409 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.51 116.97 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 106.429 -1.693 . . . . 72.439999999999998 106.429 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -96.99 139.33 33.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.24 -1.763 . . . . 73.129999999999995 106.24 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.36 132.07 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.004 -2.221 . . . . 73.129999999999995 105.004 -172.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.1 mt -142.58 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 107.727 -1.212 . . . . 74.25 107.727 -172.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.27 143.95 17.97 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 109.002 -1.639 . . . . 42.030000000000001 109.002 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -132.88 152.59 51.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.239 1.015 . . . . 72.549999999999997 110.333 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.1 mt -132.52 124.26 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.609 -2.367 . . . . 73.140000000000001 104.609 167.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 44.77 68.4 0.56 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.198 1.799 . . . . 70.540000000000006 110.804 163.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.6 1.83 3.66 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.148 1.536 . . . . 43.450000000000003 115.148 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -132.11 153.11 50.82 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.072 1.306 . . . . 74.219999999999999 111.227 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -86.02 148.23 25.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.113 0.482 . . . . 73.540000000000006 110.034 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 m -135.27 1.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.938 1.295 . . . . 65.109999999999999 111.657 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.56 140.68 8.53 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 120.908 -1.12 . . . . 74.129999999999995 108.605 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -158.54 144.47 16.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.999 0.919 . . . . 70.409999999999997 109.311 162.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.18 108.02 2.53 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.829 0.823 . . . . 71.329999999999998 109.435 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.64 157.76 37.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.621 -1.299 . . . . 53.229999999999997 108.997 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 173.69 7.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.823 -1.547 . . . . 72.329999999999998 106.823 159.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -145.94 132.29 19.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 74.329999999999998 106.301 171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 115' ' ' LEU . 8.4 m-85 -128.5 165.62 20.36 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.898 0.772 . . . . 72.349999999999994 110.246 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.9 mt -150.47 137.03 12.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.968 2.507 . . . . 73.239999999999995 105.783 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.2 144.72 30.49 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.993 0.917 . . . . 63.030000000000001 108.875 170.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -129.68 13.5 5.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 64.019999999999996 111.599 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.57 11.5 55.36 Favored Glycine 0 CA--C 1.527 0.821 0 O-C-N 121.314 -0.866 . . . . 71.230000000000004 112.94 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -90.17 170.27 10.44 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.559 1.544 . . . . 65.319999999999993 107.892 160.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.59 139.66 58.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.808 -1.182 . . . . 62.25 107.808 161.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.1 tt -97.65 134.22 41.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.699 -1.223 . . . . 74.129999999999995 107.699 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.8 mt -145.5 141.93 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.251 -2.129 . . . . 71.549999999999997 105.251 165.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.74 168.23 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.632 1.573 . . . . 65.409999999999997 109.318 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.2 p -140.91 157.61 45.11 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.687 1.195 . . . . 73.430000000000007 109.152 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.25 171.88 18.51 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.394 -0.821 . . . . 70.519999999999996 109.129 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -151.93 142.83 23.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.421 1.088 . . . . 61.219999999999999 108.419 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.87 85.78 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.767 -1.938 . . . . 73.310000000000002 105.767 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -64.88 170.02 4.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.59 -0.893 . . . . 71.129999999999995 108.59 160.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 p -127.87 -12.13 5.36 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.549 -0.719 . . . . 72.109999999999999 111.444 159.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.13 112.76 5.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.413 -1.699 . . . . 74.450000000000003 106.413 -169.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -151.23 -172.56 4.24 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.741 -1.207 . . . . 73.349999999999994 107.741 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.31 -1.329 . . . . 74.420000000000002 108.436 165.47 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.242 -2.343 . . . . 72.349999999999994 107.242 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.27 58.85 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.036 -1.098 . . . . 70.230000000000004 108.036 162.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -136.23 155.96 49.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.833 -1.543 . . . . 62.210000000000001 106.833 163.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -126.25 113.2 16.66 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.082 -0.386 . . . . 43.210000000000001 110.474 -153.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -126.26 94.39 4.07 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.13 0.972 . . . . 70.340000000000003 110.022 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -115.59 102.03 9.4 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.537 1.935 . . . . 74.409999999999997 106.846 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -153.78 -178.32 6.97 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.815 0.817 . . . . 52.109999999999999 111.338 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.02 -119.8 0.93 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.799 3.095 . . . . 50.43 106.311 -166.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.01 103.93 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 125.899 1.68 . . . . 53.340000000000003 108.456 -167.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.453 ' CE1' ' HA ' ' A' ' 71' ' ' PHE . 50.1 m-70 -74.38 154.86 38.64 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.962 -0.461 . . . . 71.340000000000003 109.771 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -145.86 152.26 39.19 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.817 1.247 . . . . 61.420000000000002 107.905 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -127.24 152.43 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.294 2.238 . . . . 71.109999999999999 105.489 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.83 136.04 54.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.396 -2.076 . . . . 72.230000000000004 105.396 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.4 mt -122.91 150.82 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 105.959 -1.867 . . . . 62.140000000000001 105.959 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -142.9 163.36 33.01 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.053 -1.462 . . . . 64.209999999999994 107.053 166.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -136.93 154.45 50.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.625 -1.25 . . . . 72.25 107.625 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 t -145.36 171.01 15.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 159.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.29 -137.47 14.22 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.023 -1.631 . . . . 32.020000000000003 109.023 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -89.98 65.42 6.58 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.521 1.529 . . . . 40.119999999999997 109.79 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.8 p -75.42 35.5 0.12 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.161 2.184 . . . . 72.040000000000006 113.338 -164.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -142.6 8.48 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.244 1.417 . . . . 72.439999999999998 111.644 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 m -149.19 7.64 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.106 1.762 . . . . 60.009999999999998 111.412 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -120.75 141.91 50.03 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.074 -1.016 . . . . 73.430000000000007 109.103 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -116.1 116.56 28.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.229 -1.767 . . . . 74.219999999999999 106.229 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.75 90.14 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.462 -0.94 . . . . 72.340000000000003 108.462 -171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -86.89 145.23 26.64 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.046 -1.033 . . . . 71.439999999999998 108.298 169.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.14 129.12 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.316 1.046 . . . . 65.329999999999998 109.469 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -64.59 138.12 58.22 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.723 -1.584 . . . . 74.439999999999998 106.723 160.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 122.27 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.129 -2.175 . . . . 73.310000000000002 105.129 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.69 167.38 35.22 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.048 -0.821 . . . . 41.420000000000002 111.048 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.04 170.95 44.13 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.388 1.947 . . . . 73.200000000000003 109.065 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.69 164.78 21.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.852 0.861 . . . . 62.009999999999998 109.999 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -131.24 -164.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.255 1.822 . . . . 74.420000000000002 111.074 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -79.82 71.59 6.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.845 -0.428 . . . . 71.420000000000002 109.845 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.58 -22.6 2.01 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-O 119.035 -0.869 . . . . 50.229999999999997 114.2 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.69 -154.8 8.09 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.102 -1.199 . . . . 74.140000000000001 110.102 -167.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.1 154.92 42.4 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.726 2.284 . . . . 72.329999999999998 110.515 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 110.79 20.77 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.214 1.406 . . . . 74.409999999999997 108.993 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -45.46 116.25 1.11 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.988 1.715 . . . . 61.439999999999998 111.531 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.71 160.2 15.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.956 0.884 . . . . 71.129999999999995 110.09 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -129.09 152.09 49.06 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.677 1.591 . . . . 75.420000000000002 107.897 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -96.5 172.75 7.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 73.299999999999997 110.424 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -65.47 -9.47 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.096 1.758 . . . . 73.430000000000007 113.978 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -87.52 -8.52 56.28 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.652 1.581 . . . . 61.43 111.152 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.1 59.09 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.921 1.724 . . . . 71.140000000000001 113.741 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -104.7 147.15 27.99 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.698 1.249 . . . . 74.019999999999996 109.251 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -66.29 135.76 54.87 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.003 -1.11 . . . . 61.229999999999997 108.003 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -136.63 28.83 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.713 0.805 . . . . 60.43 111.509 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.34 160.06 18.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.4 -1.08 . . . . 73.0 110.4 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -95.04 2.95 55.35 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.134 1.773 . . . . 70.239999999999995 113.246 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.7 t -165.77 157.38 14.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.565 1.546 . . . . 72.230000000000004 108.375 165.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.3 p90 177.92 -173.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.578 2.351 . . . . 74.230000000000004 109.726 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 m -119.28 153.0 35.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.648 1.179 . . . . 62.310000000000002 108.246 154.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.79 110.29 7.02 Favored 'General case' 0 CA--C 1.523 -0.086 0 C-N-CA 124.328 1.051 . . . . 64.040000000000006 108.332 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -73.19 145.1 46.52 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.096 0.958 . . . . 64.319999999999993 110.383 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -80.51 118.78 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.734 -1.58 . . . . 75.219999999999999 106.734 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.55 29.37 2.67 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.037 1.335 . . . . 73.099999999999994 108.604 167.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 p -135.51 157.25 47.35 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.446 1.098 . . . . 54.32 108.862 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.52 -40.66 79.22 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.28 0.632 . . . . 63.240000000000002 110.408 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.5 p -133.76 163.67 28.96 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.74 0.816 . . . . 44.130000000000003 110.878 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 mmm -142.43 170.62 15.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.297 1.839 . . . . 74.030000000000001 111.563 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 p -160.9 154.76 22.49 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.22 1.808 . . . . 72.340000000000003 108.641 165.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.8 m -143.91 150.43 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.203 1.801 . . . . 64.010000000000005 107.851 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.6 p -149.15 179.74 7.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.164 0.983 . . . . 62.43 110.529 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -119.29 -174.65 2.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.28 -1.748 . . . . 64.200000000000003 106.28 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -92.37 -176.57 4.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.533 -1.284 . . . . 75.019999999999996 107.533 158.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.76 64.33 2.63 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.961 -1.087 . . . . 34.43 111.684 173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.94 71.75 1.35 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 103.883 -2.636 . . . . 71.400000000000006 103.883 169.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.89 32.94 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.134 -0.978 . . . . 63.140000000000001 111.247 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.09 -7.13 2.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.172 1.789 . . . . 74.099999999999994 112.552 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 10' ' ' HIS . 29.6 p90 -157.29 170.66 21.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.36 -1.348 . . . . 73.239999999999995 107.36 163.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.7 ttt -146.29 147.66 31.61 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 105.136 -2.172 . . . . 74.430000000000007 105.136 167.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.5 t -135.36 164.97 26.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.82 0.819 . . . . 63.439999999999998 110.002 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.32 106.91 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.703 -2.332 . . . . 74.219999999999999 104.703 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 142.97 41.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 105.906 -1.887 . . . . 70.019999999999996 105.906 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.54 -151.05 5.55 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 120.94 -0.648 . . . . 34.130000000000003 111.813 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.24 175.49 10.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.137 -0.69 . . . . 74.239999999999995 109.137 147.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -137.15 147.46 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.661 1.584 . . . . 73.150000000000006 109.273 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.5 m -149.32 167.71 25.35 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.43 -0.794 . . . . 73.040000000000006 112.743 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 t -143.47 151.61 40.51 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.771 2.029 . . . . 65.239999999999995 107.05 158.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.02 48.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.839 . . . . 73.230000000000004 107.616 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.1 m -127.72 174.62 8.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.292 1.037 . . . . 70.150000000000006 112.499 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -55.14 158.53 2.91 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.631 1.972 . . . . 63.049999999999997 110.817 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.8 167.14 1.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.196 1.398 . . . . 52.219999999999999 112.974 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.52 -13.65 33.75 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.043 1.306 . . . . 50.539999999999999 114.157 170.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -67.43 132.45 47.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.119 1.46 . . . . 74.219999999999999 108.215 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.0 mtt85 -110.38 159.78 17.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.711 -1.218 . . . . 70.25 107.711 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -146.67 141.42 26.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.87 -1.529 . . . . 71.329999999999998 106.87 177.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -145.79 92.92 2.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.993 -1.484 . . . . 73.25 106.993 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.61 143.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.442 -1.688 . . . . 73.140000000000001 106.442 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -119.28 136.47 54.22 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.493 -1.669 . . . . 65.230000000000004 106.493 165.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.51 115.07 12.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 125.655 1.582 . . . . 71.040000000000006 108.842 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.67 153.03 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.348 -1.723 . . . . 65.329999999999998 106.348 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.16 158.18 27.61 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.695 -0.962 . . . . 71.450000000000003 110.695 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -143.35 152.92 42.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.947 0.899 . . . . 74.239999999999995 110.369 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.8 mt -121.81 120.76 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.288 -2.115 . . . . 73.239999999999995 105.288 165.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.5 t0 72.39 -83.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 129.122 2.969 . . . . 73.019999999999996 110.197 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.73 24.73 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.58 1.952 . . . . 64.409999999999997 108.702 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -135.74 132.85 37.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.266 -0.896 . . . . 75.420000000000002 110.746 -166.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.31 136.17 57.96 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.992 -0.744 . . . . 70.120000000000005 108.992 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.59 -25.55 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 124.16 0.984 . . . . 52.350000000000001 108.823 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -145.89 142.92 29.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.512 1.525 . . . . 74.230000000000004 107.768 -168.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -167.23 112.0 0.72 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.642 1.177 . . . . 74.430000000000007 109.095 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.07 173.31 11.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.551 0.532 . . . . 50.109999999999999 109.893 162.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -128.3 172.76 10.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.695 1.198 . . . . 72.209999999999994 108.068 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 147.12 33.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.704 -0.85 . . . . 71.129999999999995 108.704 164.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -120.61 136.11 54.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.655 -0.869 . . . . 65.409999999999997 108.655 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -138.65 155.45 48.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.044 0.938 . . . . 72.209999999999994 108.849 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.88 135.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.17 -1.419 . . . . 64.340000000000003 107.17 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -65.86 144.23 56.95 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.076 0.95 . . . . 53.549999999999997 109.328 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -137.0 21.34 3.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.97 0.804 . . . . 73.340000000000003 112.546 164.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.12 -24.1 31.62 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.15 1.833 . . . . 72.120000000000005 111.336 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -66.47 159.08 27.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.789 -0.819 . . . . 63.329999999999998 108.789 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.42 120.64 21.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.759 -1.571 . . . . 63.439999999999998 106.759 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.1 21.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.42 -1.696 . . . . 70.420000000000002 106.42 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.03 142.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 105.699 -1.963 . . . . 73.120000000000005 105.699 166.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.59 179.1 8.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.835 0.826 . . . . 72.109999999999999 109.555 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -135.68 173.01 12.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.387 1.875 . . . . 62.340000000000003 107.692 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -164.81 165.62 20.44 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.245 2.218 . . . . 74.319999999999993 108.621 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.5 149.82 27.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.558 0.617 . . . . 73.040000000000006 110.717 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.4 t -145.28 84.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.943 -1.502 . . . . 70.450000000000003 106.943 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.62 129.2 37.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.177 -1.786 . . . . 44.229999999999997 106.177 175.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.0 p -85.72 5.84 30.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.38 0.991 . . . . 74.129999999999995 112.049 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -143.17 133.69 24.93 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.563 -1.273 . . . . 74.140000000000001 107.563 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.29 134.98 33.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 105.709 -1.96 . . . . 62.310000000000002 105.709 162.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.248 1.017 0 CA-C-O 115.803 -2.046 . . . . 73.219999999999999 109.619 178.076 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.702 -0.959 . . . . 64.109999999999999 110.702 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.18 169.38 24.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.298 2.239 . . . . 35.549999999999997 108.129 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 p -89.64 -21.99 22.52 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.001 1.111 . . . . 62.119999999999997 114.001 -168.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -106.52 118.26 36.21 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.656 1.182 . . . . 75.310000000000002 111.503 -166.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -124.93 96.83 5.01 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.878 1.271 . . . . 71.010000000000005 110.185 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -136.91 110.78 8.18 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.452 1.901 . . . . 64.030000000000001 108.982 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -165.58 -178.55 4.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.139 -1.43 . . . . 75.329999999999998 107.139 165.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.0 -90.52 0.08 OUTLIER Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.85 2.166 . . . . 64.109999999999999 109.437 -163.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -139.36 135.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 127.468 2.307 . . . . 62.32 107.378 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -103.71 152.6 21.63 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.529 -0.732 . . . . 72.239999999999995 109.725 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -142.68 147.37 35.59 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.841 -1.17 . . . . 72.120000000000005 107.841 169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.9 mm -119.16 151.08 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.349 1.86 . . . . 75.430000000000007 106.267 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.93 139.13 46.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.118 -1.808 . . . . 73.439999999999998 106.118 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.67 154.36 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.325 -1.361 . . . . 73.099999999999994 107.325 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -142.8 168.9 18.64 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.52 1.128 . . . . 75.439999999999998 109.106 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -136.39 150.38 48.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.674 1.59 . . . . 74.409999999999997 108.355 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -154.25 162.39 41.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.303 1.841 . . . . 61.539999999999999 108.107 167.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.11 -163.69 31.84 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.329 -1.508 . . . . 75.400000000000006 109.329 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.1 99.13 3.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.953 1.701 . . . . 62.109999999999999 109.049 -169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.9 p -85.76 -10.24 55.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.836 1.254 . . . . 73.120000000000005 114.259 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -87.1 -12.66 46.48 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.709 -1.244 . . . . 71.239999999999995 111.661 -171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.59 30.84 1.88 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.221 1.408 . . . . 71.340000000000003 112.613 -169.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.618 ' CD2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -126.83 155.23 43.23 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 120.794 -1.192 . . . . 71.120000000000005 108.443 170.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -137.06 121.68 18.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.369 -1.345 . . . . 72.299999999999997 107.369 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.97 105.08 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 123.908 0.883 . . . . 54.439999999999998 109.079 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -89.24 145.98 25.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.694 -0.854 . . . . 64.430000000000007 108.694 162.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.45 131.59 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.605 1.562 . . . . 73.329999999999998 108.996 163.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 t -68.39 140.08 55.82 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.257 -1.386 . . . . 62.240000000000002 107.257 161.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.5 mt -130.43 108.54 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 104.297 -2.482 . . . . 71.299999999999997 104.297 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -143.39 166.43 26.82 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 109.382 -1.487 . . . . 52.439999999999998 109.382 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 172.04 44.96 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 108.314 -1.915 . . . . 71.340000000000003 108.314 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 164.75 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.521 1.129 . . . . 75.140000000000001 108.773 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -144.08 145.46 32.17 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.196 0.998 . . . . 64.040000000000006 109.306 156.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 45.2 -8.15 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 130.525 3.53 . . . . 60.210000000000001 117.829 -160.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 33' ' ' ASP . . . 138.51 -19.47 3.19 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 126.408 1.956 . . . . 63.100000000000001 110.796 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.96 -171.5 32.69 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.213 2.34 . . . . 41.409999999999997 111.711 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.7 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.281 2.654 . . . . 75.540000000000006 110.688 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.84 138.73 47.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.103 0.478 . . . . 62.240000000000002 111.902 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -65.14 110.59 2.59 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.749 1.62 . . . . 72.019999999999996 110.485 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' A' ' 30' ' ' GLY . 2.8 mt -89.14 160.93 16.76 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 119.439 1.018 . . . . 74.329999999999998 108.745 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -130.4 144.29 51.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.335 1.054 . . . . 74.200000000000003 109.797 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.03 176.99 6.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.816 1.246 . . . . 64.099999999999994 110.808 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -72.03 -13.25 61.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.83 0.852 . . . . 63.210000000000001 112.86 -169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.82 -13.85 62.47 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.814 1.246 . . . . 64.030000000000001 110.635 168.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 14.27 72.69 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 126.542 2.02 . . . . 71.010000000000005 112.544 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -106.64 154.81 20.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.697 1.599 . . . . 73.319999999999993 110.337 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -76.03 152.02 37.01 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.211 -0.663 . . . . 74.430000000000007 109.211 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 pt -153.49 10.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.877 1.066 . . . . 63.109999999999999 113.877 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.19 167.09 11.13 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.814 -1.179 . . . . 53.439999999999998 110.574 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -111.66 -0.65 15.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.805 1.242 . . . . 73.299999999999997 112.443 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.5 m -148.34 141.85 25.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.068 -1.827 . . . . 74.329999999999998 106.068 159.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.06 -173.63 2.4 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.422 1.089 . . . . 73.129999999999995 108.578 166.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.3 m -130.23 153.87 48.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.493 1.117 . . . . 72.200000000000003 108.116 161.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.68 160.71 38.01 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.322 1.049 . . . . 61.520000000000003 108.827 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.196 0.598 . . . . 72.239999999999995 110.565 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.96 81.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.859 1.264 . . . . 63.520000000000003 108.417 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 29.42 7.93 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.623 1.169 . . . . 75.310000000000002 110.359 172.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -141.89 138.61 32.19 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.991 -1.115 . . . . 72.120000000000005 107.991 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.86 49.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.687 0.795 . . . . 60.109999999999999 111.94 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.9 p -141.6 159.87 41.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.931 1.292 . . . . 52.030000000000001 107.515 166.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -145.23 163.67 33.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.028 1.331 . . . . 73.340000000000003 109.897 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 p -172.59 153.82 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.365 1.466 . . . . 75.230000000000004 110.912 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.1 m -143.73 152.66 41.56 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.375 1.87 . . . . 73.209999999999994 107.292 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.4 p -142.35 177.62 8.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.842 0.857 . . . . 71.409999999999997 110.589 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.4 p -101.08 171.21 7.76 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.837 1.255 . . . . 63.0 109.923 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.48 177.2 1.6 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.269 -1.011 . . . . 71.319999999999993 108.269 152.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.01 34.69 0.9 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.73 -1.039 . . . . 32.119999999999997 113.13 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.11 131.35 11.98 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.778 1.789 . . . . 75.219999999999999 107.769 164.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -174.2 152.31 1.81 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.814 2.446 . . . . 64.310000000000002 108.315 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.23 -18.11 12.61 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.571 1.548 . . . . 73.420000000000002 112.856 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.39 177.35 11.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.688 2.395 . . . . 73.519999999999996 107.072 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 ttt -150.93 150.15 30.49 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 104.803 -2.295 . . . . 72.340000000000003 104.803 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.4 t -122.41 155.44 36.07 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.204 -1.406 . . . . 74.319999999999993 107.204 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 t -155.19 98.45 2.0 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.19 -2.152 . . . . 72.109999999999999 105.19 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -129.84 144.3 51.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.048 -1.464 . . . . 23.530000000000001 107.048 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.98 -149.74 5.08 Favored Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.577 -0.609 . . . . 63.439999999999998 111.577 -164.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.06 175.46 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.901 -0.777 . . . . 63.119999999999997 108.901 145.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -122.34 156.08 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.753 1.621 . . . . 72.5 107.674 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t -151.38 163.8 38.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.836 1.254 . . . . 61.509999999999998 109.289 161.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -151.44 134.84 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.47 2.308 . . . . 73.329999999999998 105.392 168.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.68 12.48 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.242 -1.022 . . . . 75.219999999999999 108.242 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -75.0 -176.66 3.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.796 -1.187 . . . . 72.099999999999994 107.796 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -62.38 167.3 4.32 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.368 1.08 . . . . 75.400000000000006 112.254 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.45 153.03 16.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.312 -1.767 . . . . 64.129999999999995 113.3 163.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.78 6.35 85.46 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.403 -1.221 . . . . 51.310000000000002 113.574 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -76.11 172.51 12.67 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.604 1.702 . . . . 54.439999999999998 108.599 160.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -147.47 150.86 35.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.591 -1.263 . . . . 75.150000000000006 107.591 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.618 HD21 ' CD2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -154.69 115.34 3.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.088 -0.708 . . . . 61.399999999999999 109.088 -175.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -118.89 124.66 47.66 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.982 1.713 . . . . 75.549999999999997 108.401 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.3 mm -113.75 142.88 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.526 -1.287 . . . . 52.299999999999997 107.526 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -122.87 133.66 54.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.21 -1.774 . . . . 75.150000000000006 106.21 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -139.59 132.23 35.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 125.73 1.612 . . . . 73.519999999999996 109.517 -173.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mt -143.76 152.31 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.540000000000006 108.333 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.2 151.24 23.51 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.554 1.074 . . . . 54.210000000000001 111.553 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -136.19 155.79 49.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.327 1.851 . . . . 73.319999999999993 110.372 -166.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mt -141.89 138.12 31.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 127.003 2.121 . . . . 71.299999999999997 105.395 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.75 -85.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 130.739 3.616 . . . . 64.439999999999998 109.955 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -152.27 37.2 0.54 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.444 1.498 . . . . 75.0 110.593 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -141.49 153.43 44.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.623 1.169 . . . . 75.329999999999998 110.975 171.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.54 148.36 42.39 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.041 0.936 . . . . 64.140000000000001 108.906 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.39 -18.38 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 54.43 112.685 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -136.6 137.69 40.42 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.23 1.377 . . . . 74.219999999999999 108.765 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -151.8 138.4 18.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.544 1.138 . . . . 74.510000000000005 109.751 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -143.8 168.95 18.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.648 0.737 . . . . 74.25 110.498 155.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.06 156.12 43.28 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.414 -1.698 . . . . 72.420000000000002 106.414 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 164.14 34.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.684 -0.858 . . . . 75.319999999999993 108.684 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -153.5 148.45 26.62 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.276 -0.268 . . . . 73.129999999999995 110.276 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.443 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.6 m-85 -148.44 137.69 21.9 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.582 1.153 . . . . 74.310000000000002 110.358 -167.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.2 mt -124.85 135.92 62.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.007 -1.479 . . . . 62.530000000000001 107.007 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.54 137.91 38.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.634 1.973 . . . . 63.329999999999998 108.634 174.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -141.75 31.16 1.65 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.777 0.798 . . . . 74.140000000000001 112.02 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.39 -3.92 86.3 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.368 0.985 . . . . 64.409999999999997 112.607 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.63 -155.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.497 1.919 . . . . 71.319999999999993 108.512 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -118.9 110.82 17.62 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.188 -1.782 . . . . 71.200000000000003 106.188 166.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 108' ' ' TYR . 1.4 tm? -62.13 120.28 10.58 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 107.426 -1.324 . . . . 63.549999999999997 107.426 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.6 mt -148.19 144.11 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 103.976 -2.602 . . . . 75.439999999999998 103.976 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.48 169.72 18.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.991 -0.744 . . . . 74.530000000000001 108.991 169.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 p -134.85 162.47 32.31 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.797 1.239 . . . . 75.420000000000002 108.361 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -151.8 175.78 12.09 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.036 1.334 . . . . 75.319999999999993 108.68 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 t -160.58 148.52 16.19 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.716 0.769 . . . . 72.120000000000005 109.445 168.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.6 107.16 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 127.314 2.246 . . . . 61.210000000000001 106.393 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.24 118.47 30.54 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.084 1.354 . . . . 72.400000000000006 108.437 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.1 p -86.43 33.93 0.63 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.92 0.888 . . . . 71.230000000000004 111.847 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -169.47 114.68 0.55 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.199 -1.408 . . . . 74.439999999999998 107.199 167.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -130.53 -165.0 1.49 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.034 0.933 . . . . 71.129999999999995 109.373 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--O 1.248 0.984 0 CA-C-O 117.024 -1.465 . . . . 52.340000000000003 111.944 171.558 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 N-CA-C 110.742 -0.943 . . . . 43.240000000000002 110.742 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.7 94.68 2.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.026 -1.472 . . . . 72.120000000000005 107.026 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -158.0 132.17 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.215 -1.031 . . . . 71.430000000000007 108.215 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -142.95 22.43 1.93 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.266 0.626 . . . . 64.329999999999998 111.769 -159.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -120.77 91.55 3.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.737 0.78 . . . . 73.420000000000002 110.628 -174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.09 97.04 3.21 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.836 1.655 . . . . 72.129999999999995 109.438 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -73.96 178.42 4.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.284 1.033 . . . . 74.200000000000003 111.285 166.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.43 -90.04 0.11 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 108.808 -1.717 . . . . 53.509999999999998 108.808 154.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.24 131.93 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.638 -1.986 . . . . 71.219999999999999 105.638 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -126.69 157.16 39.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.568 -1.271 . . . . 73.120000000000005 107.568 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -148.94 151.33 34.44 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.317 1.047 . . . . 62.039999999999999 108.257 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.34 134.94 52.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.858 -1.905 . . . . 74.340000000000003 105.858 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.54 131.26 50.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.711 -1.589 . . . . 70.049999999999997 106.711 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.3 mt -135.2 143.09 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.475 -0.935 . . . . 64.120000000000005 108.475 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -134.47 161.75 34.15 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.381 1.072 . . . . 75.209999999999994 110.3 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.23 141.86 29.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.33 2.652 . . . . 63.350000000000001 109.961 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -141.83 172.49 12.62 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.56 1.544 . . . . 60.219999999999999 107.343 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.33 -155.63 24.4 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.886 -1.286 . . . . 73.450000000000003 109.886 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -77.21 33.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.548 2.339 . . . . 61.25 111.106 -173.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 t -65.04 8.29 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.163 2.185 . . . . 73.540000000000006 113.798 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -17.83 64.92 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.841 1.656 . . . . 72.510000000000005 111.149 162.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.7 m -130.95 16.33 5.18 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.937 1.295 . . . . 72.450000000000003 113.019 -163.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 88' ' ' LEU . 53.1 m-85 -126.26 116.02 20.61 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.352 1.061 . . . . 70.140000000000001 109.261 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.22 127.08 31.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.28 -1.378 . . . . 71.109999999999999 107.28 166.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 t -136.74 106.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 105.557 -2.016 . . . . 61.539999999999999 105.557 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -114.87 145.86 41.72 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.768 1.167 . . . . 53.43 110.082 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.77 139.19 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.363 1.065 . . . . 63.43 109.595 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -66.84 139.39 57.76 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.768 -1.567 . . . . 64.439999999999998 106.768 161.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -132.9 124.54 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.591 -2.003 . . . . 44.409999999999997 105.591 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.631 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . -179.98 176.97 47.8 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.702 -1.359 . . . . 52.409999999999997 109.702 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.44 172.76 43.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.337 -1.905 . . . . 64.409999999999997 108.337 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.8 163.61 27.85 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.783 0.833 . . . . 54.140000000000001 109.863 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.39 -170.82 2.68 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.215 1.006 . . . . 74.200000000000003 112.039 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -74.94 67.47 1.68 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.317 1.047 . . . . 74.129999999999995 110.674 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.36 -32.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.533 -0.593 . . . . 53.140000000000001 112.729 171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.93 -156.71 15.52 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 119.907 -1.139 . . . . 70.319999999999993 114.627 -162.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.18 139.44 9.38 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.927 3.084 . . . . 65.400000000000006 110.567 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.14 117.95 23.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.081 1.352 . . . . 73.400000000000006 110.576 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -60.21 117.61 5.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.661 1.119 . . . . 74.430000000000007 110.482 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD21 ' HA2' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -91.39 159.16 16.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.004 1.321 . . . . 74.120000000000005 109.401 171.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -128.16 143.88 51.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.0 1.32 . . . . 74.209999999999994 109.306 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.75 165.87 20.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.182 -0.917 . . . . 53.420000000000002 109.864 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -74.45 19.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.654 1.582 . . . . 73.129999999999995 113.457 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -100.76 -10.95 20.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.159 1.383 . . . . 70.219999999999999 110.9 163.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.59 56.54 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.001 1.762 . . . . 73.129999999999995 113.339 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -105.19 160.88 14.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.553 1.141 . . . . 72.099999999999994 109.429 -172.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -74.96 157.7 34.53 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.815 -0.553 . . . . 74.409999999999997 109.923 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.22 6.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.127 0.788 . . . . 43.520000000000003 113.127 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.18 -172.45 24.18 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.186 -1.565 . . . . 63.0 109.186 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 40' ' ' LEU . 14.6 p30 -125.03 8.73 8.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.037 1.335 . . . . 72.040000000000006 111.943 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -170.85 124.48 0.65 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 129.477 3.111 . . . . 74.299999999999997 106.864 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -163.18 -173.39 3.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.238 1.015 . . . . 73.239999999999995 110.211 171.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -121.11 157.46 30.06 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.261 1.024 . . . . 64.109999999999999 109.249 164.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.55 142.27 50.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.923 -1.139 . . . . 62.450000000000003 107.923 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -96.29 132.71 41.48 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.554 -1.647 . . . . 72.349999999999994 106.554 170.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -74.99 100.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.673 -1.603 . . . . 64.430000000000007 106.673 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -127.09 35.1 4.63 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.87 1.668 . . . . 65.239999999999995 109.875 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -134.31 169.01 17.85 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.117 -1.068 . . . . 63.409999999999997 108.117 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.33 9.95 34.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 118.643 -0.694 . . . . 54.450000000000003 111.443 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -178.51 159.85 1.2 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.901 2.48 . . . . 71.340000000000003 107.485 145.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 mmm -125.42 165.13 18.97 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.173 2.189 . . . . 73.409999999999997 109.572 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.4 p -159.56 163.07 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.238 -0.892 . . . . 61.049999999999997 111.317 158.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.4 m -147.87 163.09 37.86 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.469 2.308 . . . . 73.230000000000004 106.624 162.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.35 -176.81 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.23 1.812 . . . . 61.109999999999999 108.789 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.27 156.42 47.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.565 1.946 . . . . 73.400000000000006 107.362 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -82.4 179.61 7.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.217 0.207 . . . . 65.219999999999999 110.699 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.07 32.56 0.52 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.784 1.659 . . . . 73.319999999999993 115.752 -171.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -128.2 80.74 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.705 -2.331 . . . . 72.129999999999995 104.705 168.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.76 18.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.123 1.329 . . . . 65.340000000000003 107.546 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -128.62 -13.89 4.71 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.363 1.065 . . . . 70.299999999999997 112.955 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -164.11 167.88 19.71 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.407 1.883 . . . . 65.219999999999999 107.5 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 ttt -130.87 145.5 52.02 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.225 -2.139 . . . . 72.010000000000005 105.225 169.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 t -111.85 161.98 15.78 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.57 0.7 . . . . 65.010000000000005 109.981 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.42 40.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.312 1.445 . . . . 74.040000000000006 110.284 170.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.64 58.28 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 121.439 -0.788 . . . . 63.25 108.993 168.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.47 -174.95 38.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.747 -0.941 . . . . 74.230000000000004 110.747 -173.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.8 p -134.9 168.42 19.12 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.722 0.772 . . . . 72.409999999999997 110.892 -173.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.69 147.14 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.046 1.738 . . . . 71.439999999999998 106.731 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.4 t -152.09 164.5 37.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.092 -0.707 . . . . 44.350000000000001 109.092 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.12 155.64 43.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.667 -1.235 . . . . 72.349999999999994 107.667 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.82 22.39 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.421 1.488 . . . . 71.209999999999994 109.343 167.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.36 173.75 12.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.498 1.919 . . . . 54.049999999999997 110.368 -178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 176.39 8.18 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 124.687 1.195 . . . . 71.219999999999999 112.474 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.98 153.92 42.71 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 113.652 -1.613 . . . . 61.119999999999997 112.959 -173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.65 -10.51 44.89 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.663 1.125 . . . . 43.130000000000003 114.278 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -64.6 117.34 7.26 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 106.622 -1.621 . . . . 71.319999999999993 106.622 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -102.4 168.37 9.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.155 0.582 . . . . 72.140000000000001 110.074 -168.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 23' ' ' PHE . 12.6 tp -157.53 150.19 23.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.41 -1.7 . . . . 73.340000000000003 106.41 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -141.04 132.92 27.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 105.814 -1.921 . . . . 71.150000000000006 105.814 166.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 mm -127.64 133.81 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.767 -1.568 . . . . 72.150000000000006 106.767 -172.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.81 129.03 41.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.882 -1.525 . . . . 70.120000000000005 106.882 -168.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.17 121.05 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.315 1.046 . . . . 75.049999999999997 108.399 -173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.51 141.54 45.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.013 -1.477 . . . . 72.150000000000006 107.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.97 144.35 15.93 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 124.76 1.171 . . . . 73.120000000000005 111.155 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 100' ' ' GLU . 88.1 m-85 -131.63 151.39 51.65 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.67 1.588 . . . . 74.150000000000006 111.303 -165.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.5 mt -137.92 140.96 39.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.109 -1.812 . . . . 60.030000000000001 106.109 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.8 t0 61.02 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.678 1.991 . . . . 74.109999999999999 110.829 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.67 20.82 1.31 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.52 1.528 . . . . 74.030000000000001 111.076 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -143.94 158.01 43.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 120.55 -1.344 . . . . 60.140000000000001 111.954 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 5.9 pm0 -80.82 156.1 26.3 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.249 -1.019 . . . . 63.049999999999997 108.249 168.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.88 -5.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.01 0.524 . . . . 73.349999999999994 112.181 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -151.8 130.15 12.08 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.802 -1.186 . . . . 74.140000000000001 109.226 -170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.53 142.88 18.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.642 0.777 . . . . 74.439999999999998 110.153 173.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.48 169.21 21.43 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.896 -0.779 . . . . 72.150000000000006 108.896 159.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.98 135.73 37.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.617 -1.623 . . . . 73.25 106.617 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -128.72 167.35 17.37 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 123.83 0.852 . . . . 73.209999999999994 109.547 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -158.56 131.22 7.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.774 -1.103 . . . . 74.340000000000003 108.143 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 16.5 m-85 -145.16 146.97 31.99 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.849 -0.797 . . . . 72.430000000000007 108.849 -171.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.25 147.02 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.716 -1.216 . . . . 71.530000000000001 107.716 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -77.07 138.66 39.68 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.627 2.371 . . . . 65.530000000000001 111.172 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -125.88 55.11 1.47 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.467 1.107 . . . . 73.129999999999995 109.281 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.59 3.96 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.047 1.308 . . . . 73.519999999999996 112.558 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.07 -174.97 5.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.505 1.522 . . . . 72.519999999999996 113.967 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.0 142.4 58.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.098 1.359 . . . . 64.120000000000005 109.161 165.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 108' ' ' TYR . 2.6 tt -108.05 143.08 37.26 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.743 -0.836 . . . . 63.219999999999999 108.743 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mm -143.21 158.83 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 128.929 2.891 . . . . 73.450000000000003 106.017 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -172.82 170.61 4.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.606 2.362 . . . . 63.450000000000003 109.074 158.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.5 p -143.13 150.69 39.79 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 72.340000000000003 110.179 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -147.04 168.73 20.82 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.617 0.767 . . . . 51.140000000000001 110.689 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.4 p -158.39 111.58 2.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.102 -0.374 . . . . 74.209999999999994 111.185 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.62 88.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.189 -1.411 . . . . 74.140000000000001 107.189 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 155.52 19.97 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.449 -1.315 . . . . 63.409999999999997 107.449 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.9 p -91.78 30.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.725 -1.234 . . . . 70.200000000000003 109.727 174.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -170.51 145.27 2.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.605 -1.31 . . . . 74.140000000000001 108.517 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -166.34 -171.57 1.98 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 129.313 3.045 . . . . 63.229999999999997 104.792 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 pt . . . . . 0 C--O 1.255 1.359 0 N-CA-C 108.363 -0.977 . . . . 60.109999999999999 108.363 162.925 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.158 0 N-CA-C 111.16 -0.776 . . . . 70.439999999999998 111.16 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.99 30.32 0.59 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.61 1.564 . . . . 70.109999999999999 112.865 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -91.23 176.56 6.53 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.52 1.128 . . . . 65.200000000000003 108.141 161.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -134.18 111.71 10.51 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.798 1.639 . . . . 73.209999999999994 107.082 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -147.26 105.63 3.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.355 1.062 . . . . 52.409999999999997 109.914 -158.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -121.82 115.24 22.28 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.064 1.345 . . . . 74.430000000000007 107.403 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 p -118.05 170.44 8.84 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.717 1.207 . . . . 74.140000000000001 109.249 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.22 -115.42 0.65 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 107.929 -2.068 . . . . 54.240000000000002 107.929 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.52 82.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.621 -0.881 . . . . 74.109999999999999 108.621 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -64.16 153.33 38.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.864 -0.791 . . . . 73.040000000000006 108.864 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -138.33 153.01 48.99 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.367 -1.345 . . . . 74.420000000000002 107.367 167.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -122.28 140.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.982 -2.599 . . . . 73.120000000000005 103.982 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.37 133.7 61.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 105.753 -1.943 . . . . 74.299999999999997 105.753 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -138.57 129.06 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.65 -0.87 . . . . 63.140000000000001 108.65 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -117.05 161.72 18.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.014 0.526 . . . . 73.209999999999994 110.517 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -147.77 146.35 29.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.784 0.834 . . . . 61.130000000000003 109.766 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.78 -177.16 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.111 0.964 . . . . 64.129999999999995 109.713 166.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.64 -95.49 0.7 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 109.714 -1.355 . . . . 50.439999999999998 109.714 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -122.81 122.62 39.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.175 -2.528 . . . . 62.0 104.175 157.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 p -118.66 9.54 12.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.361 0.665 . . . . 73.409999999999997 111.274 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -88.48 -33.62 17.75 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.827 1.651 . . . . 71.299999999999997 110.032 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.87 26.15 6.68 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.921 1.688 . . . . 70.409999999999997 110.049 -167.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 80' ' ' SER . 81.2 m-85 -128.93 148.06 50.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.929 0.891 . . . . 73.430000000000007 109.504 165.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.04 154.38 19.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.262 1.825 . . . . 64.340000000000003 108.748 163.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.76 102.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.413 -2.439 . . . . 74.299999999999997 104.413 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 p -97.44 148.15 23.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.419 -0.956 . . . . 73.310000000000002 108.419 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.62 120.42 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.234 1.014 . . . . 62.229999999999997 110.667 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 t -59.58 136.04 57.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.359 -1.349 . . . . 63.200000000000003 107.359 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 40' ' ' LEU . 41.7 mt -130.43 116.37 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 105.124 -2.176 . . . . 64.299999999999997 105.124 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.12 174.57 36.08 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.01 0.814 . . . . 64.439999999999998 111.5 -169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.34 172.17 35.75 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.139 1.828 . . . . 72.430000000000007 110.219 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.07 168.94 18.55 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.108 0.963 . . . . 70.319999999999993 111.439 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.06 179.31 7.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.316 1.446 . . . . 73.219999999999999 113.987 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.69 71.81 1.01 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 74.209999999999994 109.946 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.24 -0.5 3.22 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 117.73 -1.594 . . . . 65.400000000000006 115.336 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.91 -166.78 39.46 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 120.509 2.154 . . . . 61.299999999999997 115.037 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.07 135.97 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.186 3.257 . . . . 65.510000000000005 109.102 163.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.77 102.78 12.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.954 -1.022 . . . . 70.140000000000001 108.864 -172.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -46.22 118.02 1.77 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.204 1.001 . . . . 65.040000000000006 110.898 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.2 mm? -81.42 154.67 26.27 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 120.254 1.388 . . . . 71.019999999999996 108.953 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -123.6 141.15 52.29 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.819 1.247 . . . . 74.430000000000007 110.346 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.9 173.36 12.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.799 -1.091 . . . . 65.129999999999995 110.9 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -80.48 8.36 7.88 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.44 0.904 . . . . 73.109999999999999 113.44 -170.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -105.43 -1.87 24.46 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.8 1.64 . . . . 73.099999999999994 111.266 165.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.81 55.51 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 118.766 -1.019 . . . . 74.040000000000006 114.656 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -107.28 150.79 26.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.15 1.475 . . . . 74.310000000000002 111.393 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -70.49 152.63 43.8 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.472 -0.566 . . . . 61.340000000000003 109.472 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -137.88 2.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 114.034 1.124 . . . . 74.129999999999995 114.034 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.25 -173.63 35.41 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 108.429 -1.868 . . . . 53.509999999999998 108.429 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -124.76 0.21 8.06 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.915 1.358 . . . . 74.329999999999998 113.451 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 m -151.3 150.72 30.87 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.938 2.495 . . . . 71.400000000000006 105.979 158.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -171.68 -178.08 2.16 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.397 1.879 . . . . 74.140000000000001 107.552 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -135.73 103.97 5.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.631 0.772 . . . . 73.409999999999997 109.434 172.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.44 154.52 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.528 0.604 . . . . 70.230000000000004 109.801 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.885 -1.524 . . . . 51.420000000000002 106.885 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -71.45 96.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.415 -1.328 . . . . 64.409999999999997 107.415 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -109.04 22.92 15.27 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.691 -1.256 . . . . 72.400000000000006 110.067 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -137.16 154.54 50.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.478 1.111 . . . . 63.219999999999999 108.69 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.3 67.22 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.605 0.595 . . . . 73.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -151.54 173.66 14.35 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.484 -0.76 . . . . 74.310000000000002 109.644 164.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -152.6 163.29 39.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 129.388 3.075 . . . . 70.340000000000003 108.801 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -158.8 157.82 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.383 1.473 . . . . 74.409999999999997 109.564 159.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.31 144.81 33.41 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.285 1.834 . . . . 64.430000000000007 106.804 168.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 p -127.77 -172.78 2.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.801 1.24 . . . . 53.219999999999999 110.044 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 p -125.01 -179.47 4.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.642 1.177 . . . . 64.140000000000001 109.2 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.1 p30 -74.22 -177.25 2.91 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.84 -0.8 . . . . 72.299999999999997 108.84 153.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.58 44.58 1.83 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.405 1.002 . . . . 54.5 110.896 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -142.92 89.4 2.12 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.878 -1.527 . . . . 72.019999999999996 106.878 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.07 179.83 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.895 1.678 . . . . 61.020000000000003 109.991 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -132.36 -16.0 2.78 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.888 1.07 . . . . 73.239999999999995 113.888 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -161.36 169.57 21.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.577 -1.268 . . . . 72.430000000000007 107.577 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.0 ttt -136.98 158.7 43.87 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 105.607 -1.997 . . . . 73.230000000000004 105.607 164.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -135.26 161.52 35.15 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.657 0.783 . . . . 70.239999999999995 109.935 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 104.48 3.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.798 1.239 . . . . 73.230000000000004 108.592 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.84 140.21 42.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.425 -1.324 . . . . 41.229999999999997 107.425 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.96 -150.73 5.83 Favored Glycine 0 C--N 1.331 0.269 0 O-C-N 121.186 -0.946 . . . . 65.010000000000005 113.176 -159.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -148.85 171.04 16.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.978 0.911 . . . . 41.229999999999997 110.325 159.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.31 147.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.301 1.841 . . . . 70.120000000000005 106.472 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -155.02 167.59 29.86 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.09 -1.006 . . . . 61.43 111.655 171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 10.2 t -139.42 148.98 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.237 1.815 . . . . 64.010000000000005 107.54 166.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.77 32.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.376 1.871 . . . . 62.420000000000002 107.737 170.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.16 -175.08 2.7 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.836 1.254 . . . . 74.120000000000005 110.522 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.34 163.31 23.33 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.402 1.881 . . . . 73.200000000000003 110.123 176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.59 163.05 2.63 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.321 1.848 . . . . 50.409999999999997 111.965 165.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.93 36.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 118.422 -1.21 . . . . 62.140000000000001 114.23 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -64.14 154.3 35.09 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.674 1.737 . . . . 74.030000000000001 108.066 170.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -136.98 161.72 35.27 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.043 0.937 . . . . 72.420000000000002 109.001 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 tp -155.8 133.69 11.27 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.982 -1.118 . . . . 74.030000000000001 107.982 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -132.26 88.76 2.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.196 1.398 . . . . 63.310000000000002 109.068 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.5 mm -79.31 138.12 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.076 2.15 . . . . 63.219999999999999 108.441 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.9 m -126.14 140.3 52.68 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.161 -1.422 . . . . 74.430000000000007 107.161 169.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.515 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -135.64 124.58 39.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.468 1.507 . . . . 72.129999999999995 107.565 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mt -133.38 147.7 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.472 1.509 . . . . 72.310000000000002 107.532 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.5 141.8 11.42 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 124.458 1.028 . . . . 61.399999999999999 113.067 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.66 153.31 47.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.722 1.609 . . . . 74.010000000000005 110.896 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mt -121.24 107.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 N-CA-C 106.47 -1.678 . . . . 72.409999999999997 106.47 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 t0 73.36 -64.7 0.39 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.864 2.066 . . . . 61.329999999999998 110.62 172.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 -7.66 1.03 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.311 2.244 . . . . 71.019999999999996 111.78 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.5 129.93 56.17 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 114.075 1.139 . . . . 65.329999999999998 114.075 -163.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.39 121.73 26.6 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.689 -0.856 . . . . 74.129999999999995 108.689 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 -1.53 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.698 . . . . 64.129999999999995 112.886 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -149.0 139.5 22.52 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.606 1.094 . . . . 65.140000000000001 108.225 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -157.42 149.21 22.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.578 -0.897 . . . . 63.32 108.578 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.9 pp -149.72 164.06 36.27 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.474 -0.565 . . . . 74.239999999999995 109.474 160.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -137.03 147.55 46.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.987 1.315 . . . . 70.239999999999995 108.129 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -142.85 169.15 18.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.703 0.683 . . . . 61.329999999999998 110.391 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -139.91 139.86 36.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.376 -1.713 . . . . 63.210000000000001 106.376 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.93 153.26 51.89 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.55 1.14 . . . . 72.439999999999998 108.375 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -141.29 138.23 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.754 -1.573 . . . . 74.140000000000001 106.754 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 p -81.01 147.67 30.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.173 0.897 . . . . 44.520000000000003 110.214 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -136.62 28.85 2.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.712 0.805 . . . . 74.0 111.46 168.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.45 -26.33 13.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.132 1.349 . . . . 31.34 112.601 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -77.34 168.31 20.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.562 1.545 . . . . 74.430000000000007 109.278 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 m -67.12 112.34 4.37 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.847 -1.168 . . . . 74.420000000000002 107.847 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.07 135.65 44.85 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.782 -1.192 . . . . 74.040000000000006 107.782 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -146.64 153.64 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.274 -2.491 . . . . 70.120000000000005 104.274 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.33 169.63 15.59 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.023 0.929 . . . . 63.229999999999997 110.697 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.3 p -138.25 148.64 44.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.408 0.623 . . . . 73.219999999999999 109.453 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.01 173.89 11.15 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.404 1.882 . . . . 70.0 109.09 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -168.61 119.78 0.77 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.855 -0.528 . . . . 62.210000000000001 111.026 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.06 92.27 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.089 1.356 . . . . 71.439999999999998 108.335 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 m -88.27 159.82 17.94 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 71.120000000000005 108.878 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.15 -2.81 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.634 -1.291 . . . . 53.329999999999998 112.608 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -158.69 127.33 5.36 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.95 -1.5 . . . . 71.430000000000007 106.95 -166.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -172.55 126.46 0.51 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.379 1.072 . . . . 73.239999999999995 109.753 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.253 1.258 0 CA-C-O 116.987 -1.483 . . . . 53.200000000000003 108.966 171.357 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.617 0 N-CA-C 110.165 -1.174 . . . . 52.109999999999999 110.165 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.64 168.6 19.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.861 0.864 . . . . 71.040000000000006 109.354 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 t -149.39 13.03 0.84 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.966 0.728 . . . . 55.240000000000002 112.966 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -93.84 85.09 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.232 1.413 . . . . 73.299999999999997 112.297 -162.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -129.03 104.27 7.48 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.474 1.109 . . . . 64.219999999999999 109.367 174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.94 107.68 18.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.851 2.061 . . . . 73.0 107.87 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.61 170.68 18.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.342 2.257 . . . . 72.299999999999997 110.24 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.19 -114.93 0.84 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 106.132 -2.787 . . . . 32.229999999999997 106.132 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.3 mt -130.24 110.15 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.359 1.064 . . . . 73.329999999999998 108.265 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -68.76 148.81 49.79 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.767 -0.583 . . . . 72.239999999999995 109.779 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -135.41 154.61 51.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.552 1.541 . . . . 64.140000000000001 107.414 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mm -130.87 148.92 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.312 -2.106 . . . . 63.420000000000002 105.312 170.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.32 140.79 45.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.974 -1.861 . . . . 75.329999999999998 105.974 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -139.2 134.52 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.247 -1.02 . . . . 72.519999999999996 108.247 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -137.1 161.7 35.4 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.146 -0.687 . . . . 74.329999999999998 109.146 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -136.47 155.05 50.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.332 1.053 . . . . 75.510000000000005 110.739 -175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.5 m -140.58 166.27 25.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.688 -1.227 . . . . 55.229999999999997 107.688 150.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.08 -161.48 19.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 124.717 1.151 . . . . 75.219999999999999 111.539 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.06 61.87 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.397 2.279 . . . . 73.530000000000001 107.909 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.3 p -66.82 11.26 0.1 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.635 2.774 . . . . 75.319999999999993 114.343 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -8.22 46.16 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.1 -1.625 . . . . 72.109999999999999 112.31 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.57 25.86 2.85 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.639 1.976 . . . . 73.450000000000003 111.853 -160.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.0 166.59 21.36 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.151 -0.968 . . . . 71.109999999999999 112.265 -170.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -134.65 126.79 29.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 127.657 2.383 . . . . 73.510000000000005 105.46 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 78' ' ' VAL . 22.4 t -140.93 110.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.155 -1.054 . . . . 74.109999999999999 108.155 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -125.26 121.3 33.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.867 -0.79 . . . . 62.409999999999997 108.867 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 m -110.96 126.39 68.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.324 1.449 . . . . 62.219999999999999 109.806 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 t -72.01 130.25 40.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.623 -1.991 . . . . 65.319999999999993 105.623 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.1 mt -120.18 110.41 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.392 -2.077 . . . . 54.100000000000001 105.392 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.11 177.26 30.03 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.602 -0.727 . . . . 64.400000000000006 111.351 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.63 170.11 38.79 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 127.337 2.399 . . . . 74.310000000000002 107.568 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.48 161.89 32.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.531 0.666 . . . . 73.239999999999995 110.601 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -140.5 178.27 7.43 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.474 2.31 . . . . 73.219999999999999 110.426 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -78.62 81.18 4.95 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.82 -1.178 . . . . 72.329999999999998 107.82 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.65 -31.6 0.57 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-O 118.68 -1.067 . . . . 51.530000000000001 111.607 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.14 26.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.722 1.761 . . . . 64.540000000000006 111.488 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.36 141.54 56.7 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.034 2.489 . . . . 33.149999999999999 110.254 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.14 118.79 15.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.96 1.304 . . . . 53.219999999999999 110.469 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -57.23 109.83 0.74 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.969 1.258 . . . . 74.120000000000005 110.717 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.63 162.93 16.07 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.41 1.484 . . . . 74.299999999999997 110.77 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -131.94 138.73 48.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.035 1.734 . . . . 72.230000000000004 107.863 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -77.67 173.41 12.08 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.364 -0.835 . . . . 60.210000000000001 110.402 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.07 -8.87 33.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.344 1.458 . . . . 73.219999999999999 114.435 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -88.59 -14.79 36.71 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.842 1.657 . . . . 61.130000000000003 111.631 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.58 19.16 30.51 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.994 1.283 . . . . 61.329999999999998 114.1 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -109.59 147.25 33.34 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.619 1.709 . . . . 75.239999999999995 111.715 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -69.81 131.7 44.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.542 1.537 . . . . 64.409999999999997 110.163 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -130.63 4.32 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.781 1.233 . . . . 73.340000000000003 112.926 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.25 169.26 11.78 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 109.945 -1.262 . . . . 71.0 109.945 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -101.14 10.7 40.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.42 1.088 . . . . 73.420000000000002 111.426 172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 139.01 1.07 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.394 1.877 . . . . 70.319999999999993 108.24 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -175.82 -173.33 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.406 1.482 . . . . 74.409999999999997 108.65 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 p -134.79 122.13 21.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.788 1.235 . . . . 65.209999999999994 108.722 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.59 147.82 22.58 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.13 -1.063 . . . . 72.340000000000003 108.13 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -95.61 148.57 22.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.193 -1.04 . . . . 74.400000000000006 108.193 166.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.6 mm -86.38 118.05 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.874 -1.158 . . . . 71.400000000000006 107.874 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.44 18.29 6.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.599 1.16 . . . . 74.430000000000007 110.954 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 p -134.26 153.98 51.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.719 0.808 . . . . 72.129999999999995 110.157 -163.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.64 -53.66 55.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.636 -0.505 . . . . 62.420000000000002 109.636 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 p -140.31 120.36 13.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.485 0.66 . . . . 71.310000000000002 110.636 -170.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 mmm -110.69 165.01 12.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 126.281 1.832 . . . . 72.0 111.013 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 p -157.06 166.16 34.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.679 -1.146 . . . . 75.420000000000002 110.536 160.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 61.3 m -144.03 163.47 33.41 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.005 2.122 . . . . 55.310000000000002 106.419 165.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 13.9 p -142.51 -172.06 3.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.978 -0.749 . . . . 55.530000000000001 108.978 168.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.76 176.73 5.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.473 1.909 . . . . 74.400000000000006 107.092 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -77.27 169.78 17.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.373 -0.973 . . . . 75.329999999999998 108.373 155.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.83 78.63 1.99 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 110.567 -1.013 . . . . 54.43 110.567 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -151.44 -17.16 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.674 0.789 . . . . 73.230000000000004 112.602 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 167.02 16.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.188 1.395 . . . . 64.019999999999996 111.581 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -124.39 -7.22 7.56 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.083 1.353 . . . . 75.409999999999997 113.223 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -162.05 170.95 18.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.631 1.572 . . . . 75.519999999999996 107.408 168.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.4 ttt -143.44 138.75 29.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 105.412 -2.07 . . . . 64.099999999999994 105.412 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.9 t -126.57 143.92 51.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.297 0.953 . . . . 72.340000000000003 110.438 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.701 ' HB3' HG22 ' A' ' 121' ' ' VAL . 22.7 t -129.3 46.23 2.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 129.409 3.083 . . . . 74.310000000000002 108.527 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.91 35.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.178 0.991 . . . . 63.130000000000003 109.562 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.41 -151.71 6.03 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 120.44 1.473 . . . . 63.130000000000003 113.297 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 100.0 p -153.86 171.34 19.11 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.888 0.475 . . . . 75.329999999999998 112.263 160.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' VAL . 98.9 t -129.5 150.66 34.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.597 1.959 . . . . 73.540000000000006 107.661 170.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -152.62 165.79 34.13 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.509 -0.744 . . . . 74.450000000000003 111.236 167.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.6 t -144.44 158.75 43.6 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.926 2.09 . . . . 74.209999999999994 106.265 159.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 pt -132.07 13.45 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.068 2.147 . . . . 71.329999999999998 108.472 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -73.64 -177.35 2.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 73.310000000000002 108.805 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.84 167.71 21.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.627 -1.17 . . . . 62.450000000000003 110.85 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.47 168.32 2.18 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.937 1.295 . . . . 54.210000000000001 112.247 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.19 -0.78 78.45 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.479 1.038 . . . . 75.420000000000002 114.288 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -88.75 114.33 25.26 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.2 1.4 . . . . 72.519999999999996 108.663 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 159.92 15.62 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.339 1.056 . . . . 74.219999999999999 108.385 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -154.19 135.76 14.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.013 -1.477 . . . . 53.420000000000002 107.013 175.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -132.9 127.79 35.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.409 -1.33 . . . . 75.420000000000002 107.409 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.0 140.11 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 124.982 1.313 . . . . 74.540000000000006 107.629 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.9 m -127.25 131.15 50.64 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.214 -1.772 . . . . 61.340000000000003 106.214 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 112.71 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.463 1.505 . . . . 75.439999999999998 108.658 -169.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.91 152.99 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.18 1.392 . . . . 71.209999999999994 108.594 -169.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -147.64 144.75 12.83 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.761 1.172 . . . . 61.039999999999999 113.531 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.64 159.78 35.36 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.235 1.814 . . . . 71.099999999999994 110.993 -168.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 mt -132.22 111.99 18.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 105.149 -2.167 . . . . 63.399999999999999 105.149 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.6 t0 60.93 -72.84 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.898 2.479 . . . . 60.020000000000003 113.292 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.77 15.07 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.177 2.191 . . . . 73.040000000000006 110.942 -173.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -128.11 153.16 47.15 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 120.003 -1.686 . . . . 53.340000000000003 109.987 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -93.9 139.53 30.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.113 -1.069 . . . . 54.43 108.113 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.94 -26.23 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.958 1.095 . . . . 53.100000000000001 113.958 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -118.75 135.34 54.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.615 2.007 . . . . 72.310000000000002 107.568 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -154.25 145.76 23.15 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.183 0.516 . . . . 75.510000000000005 112.009 159.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -141.92 174.37 10.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.917 -1.038 . . . . 73.120000000000005 111.145 152.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -130.59 165.66 22.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.763 1.625 . . . . 74.25 107.418 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 162.77 39.78 Favored 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.677 -0.64 . . . . 64.329999999999998 109.481 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -142.29 146.51 35.15 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.07 0.948 . . . . 74.129999999999995 109.587 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -148.88 153.62 38.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.021 1.328 . . . . 61.329999999999998 108.959 -173.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.59 134.75 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.54 -1.282 . . . . 74.540000000000006 107.54 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -62.47 128.69 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.621 1.168 . . . . 74.549999999999997 108.543 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -116.45 -5.12 11.74 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.418 1.487 . . . . 64.239999999999995 112.073 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.29 8.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.093 2.283 . . . . 31.52 110.981 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -76.61 170.45 16.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.293 1.047 . . . . 71.409999999999997 108.649 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.9 m -72.37 113.15 9.09 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.205 -0.934 . . . . 73.329999999999998 108.816 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -67.18 113.95 5.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.117 -1.438 . . . . 74.150000000000006 107.117 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.52 141.06 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 104.433 -2.432 . . . . 60.409999999999997 104.433 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.95 166.77 31.05 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.638 1.175 . . . . 75.120000000000005 109.223 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -139.61 155.23 47.57 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.757 1.623 . . . . 75.310000000000002 106.743 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -154.76 164.03 39.4 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.76 1.224 . . . . 74.510000000000005 108.616 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -166.45 146.78 6.1 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 123.185 1.469 . . . . 64.340000000000003 113.576 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 74' ' ' CYS . 3.5 m -141.67 134.27 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 112.177 -2.283 . . . . 74.099999999999994 109.428 -174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.23 135.27 35.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.638 -1.616 . . . . 41.329999999999998 106.638 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.25 -10.74 51.68 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.098 0.863 . . . . 71.109999999999999 113.139 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 123.11 13.29 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 106.61 -1.626 . . . . 72.420000000000002 106.61 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -136.34 44.77 2.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.845 1.258 . . . . 72.140000000000001 108.197 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.25 1.1 0 C-N-CA 129.232 3.013 . . . . 62.43 107.168 -168.645 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.667 0 CA-C-O 119.803 -0.443 . . . . 62.100000000000001 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.02 158.05 38.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.083 0.941 . . . . 72.329999999999998 108.733 171.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -9.3 28.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.356 1.063 . . . . 64.040000000000006 112.343 168.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -68.2 94.73 0.53 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.103 1.361 . . . . 71.439999999999998 110.196 -171.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -126.91 16.27 7.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 63.229999999999997 111.943 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -116.95 138.81 51.3 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.12 2.168 . . . . 64.329999999999998 107.333 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -149.8 -164.19 1.96 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 130.484 3.514 . . . . 74.230000000000004 106.445 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.83 -109.49 0.54 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 107.153 -2.379 . . . . 33.409999999999997 107.153 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -140.65 110.71 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 129.665 3.186 . . . . 63.210000000000001 103.638 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -74.2 158.75 33.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.258 -1.016 . . . . 62.229999999999997 108.258 167.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 153.42 34.11 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.008 1.323 . . . . 54.329999999999998 108.789 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mm -141.54 149.78 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 106.238 -1.764 . . . . 72.329999999999998 106.238 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.5 OUTLIER -142.64 135.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 112.323 -2.217 . . . . 71.420000000000002 106.626 -164.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -133.55 144.1 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 107.382 -1.34 . . . . 74.310000000000002 107.382 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -129.95 165.45 22.07 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.422 0.689 . . . . 73.049999999999997 109.437 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -139.47 169.88 16.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 71.420000000000002 108.283 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.21 168.42 25.41 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.62 -1.622 . . . . 63.340000000000003 106.62 161.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.62 -144.37 18.22 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 119.579 1.081 . . . . 51.43 112.607 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -78.44 74.01 4.98 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 123.724 1.726 . . . . 42.25 108.276 166.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -73.76 15.05 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.935 1.294 . . . . 72.120000000000005 113.372 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.37 16.79 4.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.046 1.738 . . . . 72.049999999999997 111.951 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -145.41 7.6 1.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.543 1.537 . . . . 72.420000000000002 112.48 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.78 112.17 13.35 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.813 1.245 . . . . 72.450000000000003 109.1 -159.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.64 126.01 28.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.185 1.394 . . . . 42.240000000000002 108.51 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.8 113.57 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.397 -1.705 . . . . 73.010000000000005 106.397 164.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -112.33 148.57 33.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.79 0.805 . . . . 65.430000000000007 109.732 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -122.81 118.19 54.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.704 1.602 . . . . 74.040000000000006 108.65 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -77.94 129.86 35.85 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.344 -1.725 . . . . 72.030000000000001 106.344 166.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -126.86 149.32 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.732 -1.21 . . . . 74.120000000000005 107.732 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.21 174.46 46.76 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.711 -0.956 . . . . 73.409999999999997 110.711 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.78 169.45 42.52 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.125 -1.99 . . . . 43.100000000000001 108.125 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 126.28 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.947 1.699 . . . . 44.119999999999997 109.679 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.6 -171.14 1.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.332 1.053 . . . . 72.340000000000003 110.759 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -72.28 79.35 0.99 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.079 -0.712 . . . . 73.310000000000002 109.079 171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.21 61.57 0.93 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.436 -1.466 . . . . 53.210000000000001 109.436 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.43 -176.48 30.64 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-O 119.566 -0.574 . . . . 71.420000000000002 113.199 158.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.78 135.78 24.24 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.986 2.457 . . . . 73.099999999999994 108.827 155.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.14 115.61 24.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 117.884 -1.055 . . . . 41.420000000000002 109.173 -170.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -47.72 111.58 0.44 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.824 1.193 . . . . 44.109999999999999 112.123 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.73 168.71 19.34 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.768 0.827 . . . . 74.420000000000002 109.678 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -135.33 163.11 30.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.637 1.975 . . . . 70.230000000000004 109.824 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -111.7 -176.96 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.008 1.723 . . . . 72.400000000000006 110.827 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.89 -16.26 60.67 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.504 0.927 . . . . 74.299999999999997 113.504 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -71.37 -24.06 62.02 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.984 -1.073 . . . . 73.209999999999994 109.375 168.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.21 27.56 25.25 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 125.684 1.611 . . . . 43.240000000000002 112.118 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.75 152.37 20.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.257 -1.386 . . . . 74.400000000000006 107.257 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.43 35.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.639 1.109 . . . . 74.010000000000005 108.066 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 pt -138.21 37.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.105 0.78 . . . . 74.340000000000003 113.105 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 174.48 40.27 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.465 -1.454 . . . . 63.420000000000002 109.465 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.95 0.58 18.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.757 1.223 . . . . 72.200000000000003 112.563 -173.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 97.7 p -170.55 165.7 8.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.383 1.473 . . . . 54.210000000000001 109.536 152.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -179.52 -179.25 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.966 1.706 . . . . 73.219999999999999 107.853 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m -116.11 154.44 29.98 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.237 -1.394 . . . . 73.230000000000004 107.237 155.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.28 172.44 11.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.206 1.403 . . . . 72.0 108.018 171.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.14 129.01 37.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.71 0.804 . . . . 63.420000000000002 109.205 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -74.74 104.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.178 -1.416 . . . . 71.430000000000007 107.178 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 38.35 3.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.909 1.284 . . . . 63.32 109.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -147.92 169.76 19.16 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.704 0.802 . . . . 74.010000000000005 109.017 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.41 -43.33 77.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.101 -0.999 . . . . 63.340000000000003 110.327 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 p -137.64 147.44 44.95 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.277 1.431 . . . . 54.340000000000003 109.019 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mmm -140.12 165.96 25.95 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.163 1.785 . . . . 51.119999999999997 110.008 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.6 p -171.4 162.54 6.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.768 -1.56 . . . . 51.219999999999999 111.016 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 72.2 m -142.08 163.53 32.61 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.657 1.983 . . . . 74.310000000000002 107.339 160.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.6 p -140.09 -166.9 2.19 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.655 1.182 . . . . 71.420000000000002 109.902 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.02 156.96 43.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.405 1.082 . . . . 71.239999999999995 109.222 -168.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -77.91 159.27 28.99 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.012 0.911 . . . . 44.409999999999997 109.464 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.58 66.9 3.82 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 114.95 -1.023 . . . . 51.100000000000001 111.006 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -140.67 -12.68 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.611 1.565 . . . . 70.239999999999995 110.25 162.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.11 166.4 7.8 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.529 1.132 . . . . 52.399999999999999 112.31 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -127.61 -0.8 6.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.744 2.018 . . . . 74.120000000000005 113.152 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.31 -179.07 4.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.187 2.595 . . . . 74.099999999999994 107.99 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.4 ttt -154.28 146.24 23.56 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.009 -1.848 . . . . 64.0 106.009 160.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -124.36 170.41 10.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.503 0.721 . . . . 74.319999999999993 110.751 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.6 t -151.63 21.09 0.71 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.461 1.504 . . . . 74.420000000000002 111.944 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 115.3 2.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 127.017 2.127 . . . . 44.119999999999997 109.78 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.25 -179.62 30.53 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 109.638 -1.385 . . . . 52.509999999999998 109.638 -156.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 34.4 p -149.15 158.53 44.26 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.905 -0.647 . . . . 63.329999999999998 110.772 -165.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.8 146.62 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 105.216 -2.142 . . . . 45.109999999999999 105.216 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.5 m -152.32 170.55 19.78 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.444 -1.41 . . . . 74.310000000000002 110.932 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.78 165.98 27.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.427 1.491 . . . . 61.439999999999998 109.071 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.5 pt -155.73 10.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 127.564 2.345 . . . . 64.25 110.993 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -99.39 -170.6 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.045 0.926 . . . . 62.450000000000003 109.964 -167.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.32 163.07 8.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.41 1.084 . . . . 70.409999999999997 109.339 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.55 158.88 9.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.416 1.086 . . . . 51.450000000000003 111.318 165.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.01 1.5 59.66 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.708 1.147 . . . . 74.549999999999997 113.989 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -72.93 114.82 11.51 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.446 -1.687 . . . . 73.420000000000002 106.446 167.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -83.65 163.13 20.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.484 0.714 . . . . 72.519999999999996 109.864 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.41 136.65 10.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.588 -1.634 . . . . 64.230000000000004 106.588 171.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -129.28 143.98 51.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.219 -1.771 . . . . 60.119999999999997 106.219 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 mm -128.74 144.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 126.068 1.747 . . . . 44.420000000000002 108.25 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -146.88 133.83 20.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.602 -1.629 . . . . 73.430000000000007 106.602 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.42 120.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 107.211 -1.403 . . . . 75.040000000000006 107.211 -168.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.542 ' HB ' HG23 ' A' ' 13' ' ' VAL . 51.5 mt -133.06 156.3 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 107.965 -1.124 . . . . 63.420000000000002 107.965 -168.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.05 138.2 8.69 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.257 1.408 . . . . 72.140000000000001 111.11 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HE2' HG21 ' A' ' 13' ' ' VAL . 43.0 m-85 -132.45 147.64 52.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.733 2.013 . . . . 73.439999999999998 109.83 -162.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.02 114.66 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.953 1.701 . . . . 75.0 108.281 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.261 7.1 t0 49.51 -64.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 131.475 3.91 . . . . 63.229999999999997 114.267 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.38 39.43 0.66 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.939 1.245 . . . . 75.140000000000001 112.984 166.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.21 148.65 49.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.807 1.243 . . . . 64.010000000000005 111.184 177.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -79.4 143.7 34.81 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.225 -1.769 . . . . 63.409999999999997 106.225 161.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.91 -28.08 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.052 1.13 . . . . 41.210000000000001 114.052 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -148.11 142.32 26.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.391 1.45 . . . . 54.450000000000003 108.255 -163.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -172.13 155.91 3.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.264 1.026 . . . . 74.310000000000002 111.105 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -150.1 173.48 13.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.532 0.606 . . . . 61.43 109.782 161.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -134.75 152.9 52.12 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.432 -0.951 . . . . 75.349999999999994 108.432 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.1 170.55 15.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.415 0.686 . . . . 73.439999999999998 110.383 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.64 153.08 41.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.289 -1.745 . . . . 61.210000000000001 106.289 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.401 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 55.5 m-85 -142.58 154.57 44.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.242 2.217 . . . . 74.310000000000002 106.977 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.64 134.13 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.222 -2.881 . . . . 61.439999999999998 103.222 162.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -70.88 148.54 47.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.657 -1.238 . . . . 74.120000000000005 107.657 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.81 10.19 3.63 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.671 0.388 . . . . 53.109999999999999 111.07 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.59 -9.93 16.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.828 2.156 . . . . 65.530000000000001 112.152 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -85.06 168.51 14.82 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.355 -1.085 . . . . 74.109999999999999 109.873 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -59.94 160.99 7.07 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.648 -0.501 . . . . 61.439999999999998 109.648 154.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.19 129.96 36.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.306 -0.998 . . . . 65.549999999999997 108.306 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 mt -152.98 141.14 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.292 1.837 . . . . 65.120000000000005 106.501 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -161.78 168.11 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.389 1.875 . . . . 74.549999999999997 109.319 177.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 64.7 p -130.97 172.9 11.54 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.76 1.624 . . . . 74.150000000000006 108.764 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -151.55 166.9 29.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.158 0.583 . . . . 72.040000000000006 110.519 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -152.5 132.07 13.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 122.508 1.147 . . . . 74.209999999999994 111.532 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.9 t -141.85 96.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 130.415 3.486 . . . . 54.240000000000002 103.759 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.5 t -81.5 -179.13 7.24 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.836 -1.542 . . . . 71.030000000000001 106.836 157.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.0 p -130.04 14.42 5.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.385 1.074 . . . . 71.230000000000004 111.055 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.16 113.16 3.68 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.449 -1.407 . . . . 62.030000000000001 107.62 166.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.94 139.14 22.29 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 128.432 2.693 . . . . 75.439999999999998 104.892 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 C--O 1.25 1.106 0 N-CA-C 104.195 -2.52 . . . . 75.319999999999993 104.195 -179.515 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.661 0 N-CA-C 110.978 -0.849 . . . . 72.310000000000002 110.978 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.07 110.62 23.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.948 1.299 . . . . 74.140000000000001 109.213 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 m -149.93 162.85 39.53 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.561 -1.274 . . . . 43.329999999999998 107.561 165.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.24 136.47 57.22 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.631 0.772 . . . . 71.420000000000002 109.944 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -139.68 15.62 2.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.91 1.448 . . . . 75.430000000000007 114.91 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -133.86 113.56 12.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.813 2.445 . . . . 63.240000000000002 108.24 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -171.42 -173.77 1.3 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.035 2.134 . . . . 62.439999999999998 106.511 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.74 -100.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 125.122 1.344 . . . . 64.239999999999995 109.906 168.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.2 mt -108.63 97.49 5.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.255 -2.128 . . . . 60.210000000000001 105.255 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.73 154.13 22.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.87 -1.159 . . . . 74.299999999999997 107.87 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -142.04 150.41 41.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.224 -1.398 . . . . 55.149999999999999 107.224 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 mm -120.92 150.44 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.56 -2.015 . . . . 75.25 105.56 165.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -129.88 133.37 64.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.047 -2.205 . . . . 75.349999999999994 105.047 171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -129.97 140.88 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 108.399 -0.963 . . . . 74.430000000000007 108.399 -171.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -147.58 156.02 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.105 0.866 . . . . 74.230000000000004 111.798 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -139.72 154.03 47.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.652 1.581 . . . . 73.230000000000004 110.637 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 m -150.03 156.14 41.16 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.674 2.79 . . . . 64.129999999999995 106.712 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.88 -112.71 2.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.373 -1.491 . . . . 72.540000000000006 109.373 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -117.1 99.09 6.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.352 1.461 . . . . 74.420000000000002 107.381 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 p -74.78 -1.03 20.23 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.571 0.952 . . . . 53.020000000000003 113.571 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.1 -19.86 13.21 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.851 1.26 . . . . 53.009999999999998 110.32 -166.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.3 m -120.15 37.44 4.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.641 1.976 . . . . 75.209999999999994 110.888 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.898 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -150.23 122.93 8.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.544 1.164 . . . . 73.209999999999994 109.16 171.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.23 90.87 6.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.433 -1.692 . . . . 73.140000000000001 106.433 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.829 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.8 t -81.16 113.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.939 2.096 . . . . 52.32 108.042 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -114.63 144.57 43.2 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 119.485 1.039 . . . . 63.310000000000002 109.231 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 m -137.65 122.87 24.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.393 -1.276 . . . . 74.329999999999998 110.328 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -68.98 141.66 54.86 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.677 -1.601 . . . . 71.430000000000007 106.677 160.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.4 mt -130.7 107.41 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 103.916 -2.624 . . . . 63.149999999999999 103.916 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.1 30.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.367 0.508 . . . . 60.039999999999999 111.907 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.82 172.01 43.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.429 1.966 . . . . 61.240000000000002 109.483 176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.86 163.28 16.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 121.599 -0.942 . . . . 71.010000000000005 110.759 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -138.88 -172.76 3.39 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.933 2.493 . . . . 61.130000000000003 109.502 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -71.65 -19.48 62.09 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 55.219999999999999 113.014 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 -31.52 10.74 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.446 -1.062 . . . . 75.430000000000007 110.446 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.41 -95.69 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.522 2.011 . . . . 72.120000000000005 108.416 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.68 135.2 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.695 2.263 . . . . 75.349999999999994 111.532 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.93 122.99 28.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.588 0.755 . . . . 73.319999999999993 109.103 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -61.13 121.34 12.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.044 0.538 . . . . 63.329999999999998 110.26 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.0 165.89 14.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.945 0.898 . . . . 75.219999999999999 109.526 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -129.98 157.37 42.51 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.803 1.241 . . . . 75.140000000000001 109.103 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -89.43 171.17 9.93 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.726 0.81 . . . . 72.219999999999999 109.487 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.05 -25.34 66.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.975 0.731 . . . . 75.310000000000002 112.975 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -71.63 -25.18 62.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.081 1.353 . . . . 74.329999999999998 110.668 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.35 17.73 9.74 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 125.085 1.326 . . . . 74.349999999999994 113.612 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -94.53 145.95 24.45 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.771 1.786 . . . . 73.140000000000001 110.253 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -65.16 146.64 54.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.553 -0.906 . . . . 71.019999999999996 108.553 173.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 pt -139.09 -16.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.998 1.481 . . . . 75.450000000000003 114.998 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.65 164.17 29.07 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 120.062 1.301 . . . . 54.549999999999997 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.7 5.68 23.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.381 1.091 . . . . 64.010000000000005 112.445 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -166.29 145.55 5.87 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.503 2.321 . . . . 74.049999999999997 107.055 156.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -168.59 -179.76 3.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.96 1.304 . . . . 75.010000000000005 108.433 168.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -120.11 161.52 20.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.924 0.89 . . . . 60.450000000000003 108.94 160.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 120.79 14.07 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.129 -1.434 . . . . 40.219999999999999 107.129 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.39 134.33 45.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.197 -1.038 . . . . 73.040000000000006 108.197 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.13 91.35 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.315 -1.735 . . . . 64.450000000000003 106.315 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -100.58 46.08 0.96 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.136 0.974 . . . . 75.230000000000004 109.591 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -150.35 163.39 38.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.536 1.134 . . . . 75.329999999999998 108.411 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.7 -35.92 73.0 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.191 -0.943 . . . . 74.150000000000006 110.802 169.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.2 p -140.23 152.3 45.84 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.071 0.948 . . . . 64.25 110.951 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mmm -153.08 172.46 16.84 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 126.571 1.948 . . . . 63.32 111.326 -168.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 p -167.4 166.09 14.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.418 1.887 . . . . 63.43 111.163 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -156.98 160.87 39.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.921 2.888 . . . . 60.420000000000002 106.983 160.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.82 -179.78 6.68 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.478 0.656 . . . . 63.009999999999998 111.658 165.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -123.85 -176.87 3.58 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.784 1.634 . . . . 64.019999999999996 110.148 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.17 157.49 26.86 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.657 0.741 . . . . 75.219999999999999 111.735 173.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.69 96.53 0.1 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.015 2.245 . . . . 64.239999999999995 108.607 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 178.78 -47.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 130.874 3.67 . . . . 75.099999999999994 105.731 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.4 173.03 0.74 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.648 1.979 . . . . 63.130000000000003 114.857 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -134.88 -12.47 2.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.711 2.005 . . . . 60.340000000000003 113.757 172.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -158.21 174.41 15.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.43 1.014 . . . . 73.140000000000001 108.887 166.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.3 ttt -137.81 155.13 49.34 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.635 1.974 . . . . 74.340000000000003 106.65 170.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -143.94 167.03 23.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.875 0.761 . . . . 73.019999999999996 110.72 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.0 t -143.9 29.61 1.35 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.614 2.766 . . . . 72.030000000000001 109.351 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.08 113.14 3.72 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.795 1.238 . . . . 72.209999999999994 109.209 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.49 -154.13 8.08 Favored Glycine 0 C--O 1.239 0.422 0 N-CA-C 110.367 -1.093 . . . . 54.43 110.367 -166.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -154.51 171.73 18.93 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.702 0.763 . . . . 52.310000000000002 111.477 155.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.898 HG13 ' CE1' ' A' ' 23' ' ' PHE . 93.9 t -120.97 145.58 27.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 125.932 1.693 . . . . 72.329999999999998 107.983 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.1 t -151.87 160.67 43.46 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.506 0.594 . . . . 61.240000000000002 111.173 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 t -140.69 158.77 43.5 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.927 1.691 . . . . 64.239999999999995 109.057 166.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.85 24.07 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 126.69 1.996 . . . . 72.409999999999997 110.032 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -97.08 -176.48 3.56 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.494 1.043 . . . . 64.310000000000002 110.595 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.32 167.73 3.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.238 1.415 . . . . 72.430000000000007 110.276 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.92 167.16 1.26 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.958 1.303 . . . . 74.019999999999996 112.937 159.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.24 -13.07 52.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 117.753 -1.582 . . . . 40.439999999999998 114.776 168.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -57.11 161.13 3.28 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 119.432 1.616 . . . . 51.549999999999997 108.413 159.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -140.16 162.0 36.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.627 -1.249 . . . . 74.409999999999997 107.627 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.34 145.57 22.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.596 -1.261 . . . . 60.25 107.596 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -140.69 117.99 11.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.65 -1.982 . . . . 60.149999999999999 105.65 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 23' ' ' PHE . 13.5 mm -96.52 151.22 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.508 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -139.11 131.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.648 -1.612 . . . . 71.049999999999997 106.648 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -132.3 126.38 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.399 1.479 . . . . 40.310000000000002 109.114 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.88 140.32 46.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.597 -1.631 . . . . 63.420000000000002 106.597 -173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.75 133.13 6.9 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.224 -1.15 . . . . 72.219999999999999 110.224 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -120.24 154.59 34.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.286 1.834 . . . . 75.340000000000003 109.973 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.8 mt -148.62 137.19 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.803 2.041 . . . . 72.299999999999997 105.693 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t0 44.52 53.88 6.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.19 1.796 . . . . 75.299999999999997 111.982 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.27 23.87 14.05 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.038 1.735 . . . . 72.340000000000003 113.969 176.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 45.5 mtpt -132.52 153.78 50.61 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 120.751 -1.218 . . . . 71.420000000000002 111.923 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.78 145.6 46.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.95 -1.5 . . . . 64.200000000000003 106.95 164.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.43 -6.14 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.618 -0.706 . . . . 52.5 112.847 161.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -159.77 143.47 14.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.542 1.519 . . . . 75.400000000000006 110.046 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -165.45 124.47 1.7 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.511 -0.922 . . . . 74.030000000000001 108.511 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 92' ' ' VAL . 3.7 pp -138.57 169.14 18.32 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.106 0.879 . . . . 75.120000000000005 110.932 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -126.59 171.61 10.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.274 . . . . 62.149999999999999 108.703 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 161.13 43.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.303 -0.629 . . . . 75.150000000000006 109.303 166.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -127.37 135.89 51.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.179 -1.415 . . . . 73.040000000000006 107.179 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.26 151.77 48.89 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.509 1.124 . . . . 71.439999999999998 108.581 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mt -143.62 124.46 10.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.361 -2.089 . . . . 55.109999999999999 105.361 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.1 p -64.13 130.41 43.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.329 -0.619 . . . . 62.020000000000003 109.329 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -105.4 -1.18 25.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.081 1.352 . . . . 64.439999999999998 111.863 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.33 -24.65 10.38 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.46 1.505 . . . . 74.230000000000004 111.129 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -82.22 163.63 21.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.009 0.923 . . . . 75.349999999999994 109.531 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.13 106.18 1.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.426 1.09 . . . . 62.229999999999997 110.296 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 131.55 46.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.618 -0.882 . . . . 60.210000000000001 108.618 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 mt -148.87 138.36 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.708 1.603 . . . . 63.329999999999998 107.715 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.8 170.13 4.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.051 1.74 . . . . 64.019999999999996 110.164 -171.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.4 p -141.55 170.41 15.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.471 2.308 . . . . 74.109999999999999 108.161 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.8 164.88 38.18 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.097 1.759 . . . . 75.120000000000005 107.61 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.4 p -152.64 123.73 7.54 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.186 -0.946 . . . . 72.230000000000004 110.475 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.7 t -135.67 92.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.755 -2.313 . . . . 60.119999999999997 104.755 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.53 148.59 24.05 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.342 -1.725 . . . . 74.230000000000004 106.342 163.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.1 p -110.71 29.39 7.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.089 0.956 . . . . 54.409999999999997 110.113 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -156.68 117.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 105.8 -1.926 . . . . 74.239999999999995 105.8 166.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.23 89.33 3.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.39 -1.337 . . . . 75.409999999999997 107.39 176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.593 -1.194 . . . . 63.140000000000001 109.241 164.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.654 0 N-CA-C 108.373 -1.891 . . . . 74.450000000000003 108.373 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.06 177.04 9.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.525 -1.287 . . . . 75.430000000000007 107.525 152.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -163.75 175.71 10.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.0 0.92 . . . . 64.450000000000003 108.767 163.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.3 93.04 4.12 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.264 1.026 . . . . 75.109999999999999 109.762 -160.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -141.96 118.47 10.94 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 127.074 2.15 . . . . 75.150000000000006 109.946 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -127.06 140.76 52.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.663 1.585 . . . . 64.140000000000001 107.041 159.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t -135.66 172.95 12.27 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 128.47 2.708 . . . . 63.409999999999997 107.712 161.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.29 -98.24 0.3 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 106.777 -2.529 . . . . 73.319999999999993 106.777 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.89 159.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.337 1.855 . . . . 63.329999999999998 107.093 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -125.57 137.5 53.92 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.446 1.899 . . . . 74.450000000000003 107.579 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.93 150.52 44.64 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.251 -0.906 . . . . 63.219999999999999 108.887 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mm -140.74 150.34 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 105.748 -1.945 . . . . 75.329999999999998 105.748 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 93' ' ' ILE . 1.3 m -143.26 132.15 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 127.221 2.209 . . . . 44.030000000000001 106.861 -165.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.33 153.13 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 107.699 -1.223 . . . . 61.350000000000001 107.699 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -141.49 163.48 32.83 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.067 0.947 . . . . 75.230000000000004 109.53 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -152.28 156.15 39.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.86 1.264 . . . . 55.109999999999999 108.824 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -159.17 147.88 18.18 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.498 1.519 . . . . 61.439999999999998 109.92 164.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.89 -131.39 6.61 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.783 -0.927 . . . . 73.030000000000001 110.783 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.415 ' OD1' HD13 ' A' ' 88' ' ' LEU . 1.7 p-10 -71.94 50.5 0.2 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.845 2.858 . . . . 72.120000000000005 113.577 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -63.22 7.19 0.1 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 74.140000000000001 114.552 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.08 -18.01 12.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.779 2.032 . . . . 74.0 112.062 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.34 36.64 3.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.755 2.022 . . . . 75.120000000000005 112.111 -169.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CD2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -123.42 155.47 37.36 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.466 1.106 . . . . 71.030000000000001 108.689 175.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.51 121.0 29.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.93 -1.878 . . . . 73.5 105.93 171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' CD2' ' A' ' 23' ' ' PHE . 90.4 t -137.84 106.84 4.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.081 -1.822 . . . . 60.130000000000003 106.081 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 112.32 20.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.015 -1.476 . . . . 75.109999999999999 107.015 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.34 135.09 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 106.285 -1.746 . . . . 64.120000000000005 106.285 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -90.82 139.14 31.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.952 2.101 . . . . 75.239999999999995 107.778 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.42 133.1 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.293 -2.114 . . . . 75.450000000000003 105.293 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.16 168.18 41.12 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.965 2.221 . . . . 63.43 108.976 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.68 175.74 39.85 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.074 -2.01 . . . . 73.209999999999994 108.074 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.25 157.32 31.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.403 1.101 . . . . 53.210000000000001 109.487 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.59 -171.13 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.956 1.702 . . . . 74.120000000000005 111.852 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -78.06 64.01 3.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.713 1.205 . . . . 73.540000000000006 110.101 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.21 3.1 1.97 Allowed Glycine 0 CA--C 1.517 0.172 0 CA-C-O 118.0 -1.444 . . . . 53.039999999999999 113.798 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.93 -167.26 35.16 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 119.709 1.754 . . . . 74.340000000000003 112.588 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.86 144.3 24.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.467 2.778 . . . . 74.209999999999994 109.14 162.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.42 115.42 16.15 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.502 1.121 . . . . 61.119999999999997 109.699 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -64.31 128.7 36.94 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.382 0.992 . . . . 75.129999999999995 108.543 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 166.49 11.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.008 0.923 . . . . 73.439999999999998 109.732 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.7 155.73 42.22 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.758 1.623 . . . . 73.209999999999994 111.07 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.93 169.16 9.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.57 -1.65 . . . . 64.540000000000006 110.238 166.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.13 5.57 2.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.726 1.611 . . . . 73.519999999999996 112.908 -170.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -90.4 -8.88 49.5 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.488 1.515 . . . . 74.129999999999995 111.133 168.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.17 17.37 69.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.961 -0.911 . . . . 60.350000000000001 112.974 -175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.35 147.0 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.126 1.463 . . . . 62.130000000000003 108.522 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -75.0 159.58 31.6 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.03 -0.73 . . . . 73.239999999999995 109.03 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 pt -144.88 23.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.73 0.812 . . . . 63.140000000000001 112.799 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.92 -176.99 16.51 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.41 -1.476 . . . . 40.020000000000003 109.41 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -121.15 11.51 10.9 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.538 1.135 . . . . 73.420000000000002 111.876 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 p -169.39 150.65 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.902 1.281 . . . . 75.540000000000006 110.459 165.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -176.19 -175.15 0.68 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.454 1.502 . . . . 63.450000000000003 109.218 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -141.21 102.84 4.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.113 0.965 . . . . 63.409999999999997 109.689 172.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.24 115.4 21.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.766 -0.828 . . . . 73.549999999999997 108.766 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -66.23 142.39 57.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.844 -1.169 . . . . 72.409999999999997 107.844 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -82.8 120.96 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.065 -1.828 . . . . 75.420000000000002 106.065 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -142.51 43.55 1.62 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.573 1.549 . . . . 74.420000000000002 108.961 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.3 p -146.24 168.72 20.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.986 -1.116 . . . . 55.509999999999998 107.986 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.09 72.09 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.624 -0.672 . . . . 55.130000000000003 111.661 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -154.26 162.14 41.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.37 1.068 . . . . 64.349999999999994 108.971 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 mmm -143.38 171.72 13.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.75 2.82 . . . . 62.43 110.546 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.17 166.63 23.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.291 1.436 . . . . 61.119999999999997 110.928 169.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 33.3 m -149.9 167.64 26.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.999 2.519 . . . . 71.439999999999998 107.963 160.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.67 -174.89 4.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.853 1.261 . . . . 51.229999999999997 111.007 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.8 p -128.43 175.77 8.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.278 1.831 . . . . 74.340000000000003 109.748 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.85 -169.48 2.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.55 -0.908 . . . . 73.150000000000006 108.55 159.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 37.54 0.54 Allowed Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.833 -1.167 . . . . 61.420000000000002 113.976 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -140.73 78.14 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.158 1.383 . . . . 63.530000000000001 107.572 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.55 34.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.525 1.53 . . . . 74.140000000000001 109.954 159.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.46 -9.13 9.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.037 1.735 . . . . 75.310000000000002 111.693 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -161.49 172.37 16.54 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.608 -1.256 . . . . 75.439999999999998 107.608 167.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.9 ttt -152.59 111.67 3.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.462 -2.051 . . . . 75.450000000000003 105.462 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -95.51 154.62 17.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.530000000000001 110.026 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.593 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -137.18 90.92 2.57 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.962 2.105 . . . . 63.240000000000002 105.498 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.79 46.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.542 -0.91 . . . . 75.329999999999998 108.542 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.93 -152.79 6.49 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 109.935 -1.266 . . . . 62.530000000000001 109.935 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.38 168.13 23.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.163 -1.051 . . . . 73.450000000000003 108.163 156.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.63 148.08 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.988 1.315 . . . . 75.319999999999993 108.844 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.88 171.32 14.99 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.296 -0.631 . . . . 41.340000000000003 109.296 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.613 ' CB ' HD23 ' A' ' 115' ' ' LEU . 20.8 t -151.38 149.44 29.31 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.374 -1.713 . . . . 75.040000000000006 106.374 163.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.44 10.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 124.526 1.131 . . . . 74.019999999999996 110.031 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -80.48 -173.54 4.15 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.034 0.934 . . . . 62.140000000000001 111.321 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -72.08 163.44 27.89 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.983 -0.448 . . . . 72.310000000000002 111.387 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.5 162.27 3.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.701 1.6 . . . . 72.200000000000003 113.539 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.33 4.33 90.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.431 1.015 . . . . 62.100000000000001 114.36 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -83.63 163.91 20.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.349 -1.352 . . . . 63.409999999999997 107.349 168.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -153.35 153.24 32.2 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.307 -0.854 . . . . 74.430000000000007 110.812 -163.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD13 ' OD1' ' A' ' 19' ' ' ASP . 11.9 tp -154.95 136.43 14.2 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.843 -1.54 . . . . 74.439999999999998 106.843 -172.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -136.93 97.8 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.453 1.501 . . . . 74.340000000000003 108.775 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.43 132.42 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.916 1.286 . . . . 61.119999999999997 108.176 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.0 m -110.2 147.55 33.54 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.269 -1.012 . . . . 41.25 108.269 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.76 103.71 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.064 1.746 . . . . 74.530000000000001 110.201 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 13' ' ' VAL . 24.4 mt -112.59 157.43 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 107.472 -1.307 . . . . 63.310000000000002 107.472 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.71 132.81 4.56 Favored Glycine 0 C--N 1.336 0.529 0 O-C-N 120.454 -1.404 . . . . 41.329999999999998 111.324 -170.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.443 ' HE2' HG21 ' A' ' 13' ' ' VAL . 83.9 m-85 -125.01 147.83 48.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.44 1.496 . . . . 75.239999999999995 111.455 -170.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.506 HD11 ' O ' ' A' ' 123' ' ' THR . 33.0 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 128.939 2.895 . . . . 64.349999999999994 105.161 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 44.63 63.49 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.771 1.229 . . . . 43.030000000000001 111.749 164.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.42 18.75 5.85 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.414 2.286 . . . . 71.510000000000005 116.101 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.11 151.77 46.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 120.316 -1.49 . . . . 72.510000000000005 112.552 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -86.81 136.46 32.97 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.433 -1.321 . . . . 75.129999999999995 107.433 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 96' ' ' ILE . 23.0 m -130.42 -10.51 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 62.520000000000003 113.12 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -144.9 141.02 28.71 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.737 1.153 . . . . 73.530000000000001 107.907 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.94 132.04 9.99 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.602 -0.518 . . . . 71.219999999999999 109.602 167.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.16 -175.8 4.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.575 0.702 . . . . 63.420000000000002 109.861 160.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.8 179.87 7.52 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.832 2.053 . . . . 71.519999999999996 108.399 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 176.22 12.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.05 -1.463 . . . . 60.539999999999999 107.05 171.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -147.29 137.88 23.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.391 -1.337 . . . . 55.409999999999997 107.391 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.22 157.45 46.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.571 0.748 . . . . 53.439999999999998 110.213 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mt -147.02 142.95 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.221 -1.77 . . . . 72.040000000000006 106.221 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -82.48 147.3 28.78 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 118.92 0.782 . . . . 73.430000000000007 110.394 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.57 26.25 2.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.923 0.868 . . . . 74.409999999999997 112.235 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.9 -16.02 61.36 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.196 1.855 . . . . 61.0 111.883 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -83.17 171.68 13.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.076 1.35 . . . . 75.109999999999999 109.463 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.69 111.09 2.25 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.855 -1.153 . . . . 41.130000000000003 109.425 162.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.613 HD23 ' CB ' ' A' ' 80' ' ' SER . 13.1 tp -73.12 132.23 43.03 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.808 -1.923 . . . . 72.219999999999999 105.808 163.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.3 mt -154.31 148.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.375 -2.454 . . . . 60.299999999999997 104.375 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.16 173.17 10.49 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 125.849 1.66 . . . . 54.350000000000001 109.357 168.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.0 p -129.33 172.95 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 123.234 1.492 . . . . 74.409999999999997 108.09 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.87 154.41 29.76 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 126.675 1.99 . . . . 71.420000000000002 106.103 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.4 p -155.97 127.13 7.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.228 0.537 . . . . 75.150000000000006 110.222 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' A' ' 74' ' ' CYS . 15.0 p -133.03 152.35 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.317 1.447 . . . . 74.340000000000003 107.874 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.6 t -134.82 -175.75 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.996 -1.113 . . . . 35.219999999999999 107.996 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.506 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.0 p -134.05 38.74 3.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.571 1.149 . . . . 75.450000000000003 109.061 167.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.72 122.6 0.51 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.532 -1.284 . . . . 63.329999999999998 107.532 166.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -116.04 112.91 22.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.336 -1.357 . . . . 75.219999999999999 107.336 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.079 -2.563 . . . . 74.549999999999997 104.079 178.238 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.519 0 N-CA-C 111.533 -0.627 . . . . 72.010000000000005 111.533 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.42 157.2 38.47 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.224 -1.399 . . . . 70.040000000000006 107.224 147.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -163.15 61.88 0.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.571 0.749 . . . . 71.299999999999997 110.038 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.02 88.18 1.38 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.928 -0.767 . . . . 72.0 108.928 172.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -140.76 103.5 4.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.36 1.464 . . . . 72.329999999999998 107.157 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.48 107.48 4.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.725 2.01 . . . . 72.409999999999997 106.531 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p -130.12 172.7 11.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.716 1.606 . . . . 65.340000000000003 107.703 169.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.76 -106.23 0.24 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 107.684 -2.166 . . . . 72.129999999999995 107.684 -172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.38 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 N-CA-C 106.129 -1.804 . . . . 71.140000000000001 106.129 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.99 143.44 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.497 -0.927 . . . . 74.019999999999996 108.497 171.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 162.84 34.39 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.171 0.588 . . . . 72.209999999999994 109.98 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 mm -129.66 153.24 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.065 1.746 . . . . 72.430000000000007 107.322 166.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 t -124.66 134.57 66.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 104.128 -2.545 . . . . 71.420000000000002 104.128 163.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -125.32 129.13 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 105.972 -1.862 . . . . 74.349999999999994 105.972 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.15 165.85 17.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.671 -0.492 . . . . 62.549999999999997 109.671 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.03 155.56 40.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 123.692 0.62 . . . . 73.340000000000003 111.623 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.0 m -145.1 142.94 30.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.578 1.151 . . . . 53.420000000000002 108.328 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.52 -150.71 23.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.29 -0.881 . . . . 74.420000000000002 111.545 -169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.4 68.82 9.87 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.781 2.032 . . . . 72.120000000000005 107.258 170.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.1 p -78.79 24.73 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.174 1.546 . . . . 61.409999999999997 115.174 -158.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -135.33 12.82 3.53 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.47 1.108 . . . . 61.25 110.427 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -131.81 17.44 4.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 62.549999999999997 111.87 -168.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -133.25 130.19 38.67 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.366 0.985 . . . . 73.239999999999995 109.433 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -89.73 68.29 7.51 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.256 1.822 . . . . 74.409999999999997 109.069 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.31 92.08 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 127.518 2.327 . . . . 62.149999999999999 113.173 174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -89.57 139.62 30.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.745 1.157 . . . . 73.340000000000003 109.519 165.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.56 164.5 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.345 -0.983 . . . . 71.450000000000003 108.345 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -127.23 129.83 48.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.868 2.867 . . . . 72.150000000000006 105.499 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.53 121.27 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.54 -1.652 . . . . 65.209999999999994 106.54 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 40' ' ' LEU . . . -162.18 172.44 38.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.63 1.11 . . . . 24.140000000000001 110.392 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.2 176.26 43.33 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.11 1.338 . . . . 73.349999999999994 110.01 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.01 46.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.262 0.625 . . . . 70.049999999999997 111.884 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.92 139.35 50.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.945 2.098 . . . . 61.030000000000001 110.865 162.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.308 16.1 ttpp 43.16 32.93 0.5 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.521 1.929 . . . . 63.130000000000003 114.308 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 33.98 23.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.529 -0.732 . . . . 71.439999999999998 111.86 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.69 175.23 36.57 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.314 1.911 . . . . 74.129999999999995 109.856 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.01 152.04 45.59 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.56 2.174 . . . . 74.230000000000004 112.492 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.09 130.61 56.24 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.44 1.096 . . . . 73.430000000000007 110.627 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -64.06 116.68 6.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.087 0.858 . . . . 72.230000000000004 110.612 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD11 ' HA2' ' A' ' 30' ' ' GLY . 1.1 mt -96.05 158.58 15.38 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.921 2.088 . . . . 61.119999999999997 109.51 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 11.6 m-85 -130.84 139.83 50.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.021 1.328 . . . . 70.129999999999995 110.988 -170.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -78.35 177.19 8.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 113.748 -1.569 . . . . 74.150000000000006 110.777 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.11 -5.62 18.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.535 1.534 . . . . 74.340000000000003 114.51 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -114.19 20.63 15.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.122 1.769 . . . . 74.329999999999998 110.938 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.41 8.24 87.06 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 124.306 0.955 . . . . 54.409999999999997 114.379 162.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.52 149.45 26.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.826 2.45 . . . . 74.530000000000001 108.849 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . 23.6 p90 -76.1 161.46 28.83 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.421 -0.585 . . . . 74.109999999999999 109.421 175.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.36 -11.83 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.787 0.835 . . . . 63.43 112.359 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.36 -171.39 35.83 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 109.055 -1.618 . . . . 41.32 109.055 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -110.05 3.02 19.94 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.143 1.777 . . . . 70.109999999999999 111.181 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.9 p -173.36 117.11 0.27 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.53 1.132 . . . . 42.43 109.292 -166.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -171.48 -178.27 2.27 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.291 0.95 . . . . 73.230000000000004 111.177 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.93 161.78 18.8 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.702 1.601 . . . . 72.230000000000004 109.593 166.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.7 29.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.319 1.448 . . . . 32.439999999999998 107.586 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -111.81 141.19 45.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.926 2.09 . . . . 73.040000000000006 110.299 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.79 86.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 121.035 1.743 . . . . 72.25 110.317 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -108.66 18.63 20.63 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.889 0.876 . . . . 73.140000000000001 112.363 175.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -117.32 158.98 23.45 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.92 1.288 . . . . 53.140000000000001 108.782 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -49.94 62.07 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.543 -0.723 . . . . 61.530000000000001 109.125 168.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.5 p -141.29 113.77 8.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.398 0.679 . . . . 74.349999999999994 110.736 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mmm -115.18 167.98 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.113 2.165 . . . . 45.450000000000003 111.145 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 96.1 p -150.96 165.65 33.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.03 0.932 . . . . 61.520000000000003 110.524 164.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 8.4 m -143.88 159.14 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.594 -1.632 . . . . 53.409999999999997 106.594 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 15.5 p -148.09 -168.2 3.01 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.816 0.735 . . . . 64.049999999999997 109.792 166.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.5 t -124.7 179.25 5.05 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.893 1.677 . . . . 71.430000000000007 106.971 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.53 -176.39 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.831 0.853 . . . . 50.409999999999997 109.427 163.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.09 23.75 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.157 -0.802 . . . . 54.539999999999999 113.324 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -135.23 94.68 3.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.598 -1.63 . . . . 72.140000000000001 106.598 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.32 158.99 16.77 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.957 1.303 . . . . 63.240000000000002 110.02 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -114.12 -28.06 7.45 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.453 1.501 . . . . 64.409999999999997 112.214 170.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.75 170.49 19.62 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.512 -1.292 . . . . 61.329999999999998 107.512 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 ttt -146.93 154.09 40.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 102.935 -2.987 . . . . 73.439999999999998 102.935 171.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.0 t -140.78 149.02 41.55 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.234 -0.916 . . . . 52.439999999999998 110.421 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.606 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -125.6 66.09 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.119 -1.808 . . . . 65.219999999999999 106.119 -177.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.86 143.73 55.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.974 -1.491 . . . . 63.350000000000001 106.974 167.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.28 178.73 43.5 Favored Glycine 0 CA--C 1.509 -0.309 0 CA-C-N 119.999 1.272 . . . . 65.25 111.987 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.8 p -142.5 159.21 42.67 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.556 1.142 . . . . 50.219999999999999 110.38 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.81 131.59 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.232 -1.395 . . . . 62.450000000000003 107.232 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -137.92 169.3 18.02 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.931 -0.557 . . . . 61.210000000000001 110.379 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -142.09 169.88 16.75 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.539 1.136 . . . . 65.349999999999994 109.921 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.96 0.55 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.358 2.663 . . . . 64.430000000000007 111.244 167.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -73.81 177.47 5.5 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.682 1.193 . . . . 44.219999999999999 109.866 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -68.79 174.14 4.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.897 0.879 . . . . 53.409999999999997 111.817 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.32 158.52 23.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.785 2.034 . . . . 62.409999999999997 112.763 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.36 -0.4 41.19 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.605 1.098 . . . . 34.530000000000001 114.337 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -70.58 131.25 43.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 104.916 -2.253 . . . . 70.25 104.916 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -111.39 162.02 15.49 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.412 0.685 . . . . 61.450000000000003 109.47 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -165.17 121.43 1.43 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 105.905 -1.887 . . . . 65.420000000000002 105.905 176.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -111.3 137.06 49.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.311 -1.737 . . . . 74.340000000000003 106.311 169.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.0 mm -117.73 121.63 67.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.702 -1.592 . . . . 65.430000000000007 106.702 172.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -95.09 131.03 41.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.896 -1.891 . . . . 75.530000000000001 105.896 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.11 104.05 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.939 1.296 . . . . 73.329999999999998 110.176 -174.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mt -123.26 152.71 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 75.510000000000005 108.338 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.61 152.88 22.27 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 124.456 1.027 . . . . 64.150000000000006 112.403 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -136.45 155.25 50.26 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.953 1.301 . . . . 70.200000000000003 110.826 -173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -130.32 83.24 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.104 -1.813 . . . . 74.329999999999998 106.104 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.285 3.0 p-10 49.64 7.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.74 1 C-N-CA 132.126 4.17 . . . . 73.109999999999999 117.369 162.02 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.86 -41.34 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.767 2.027 . . . . 72.140000000000001 109.644 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 158.66 44.13 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.595 1.158 . . . . 64.400000000000006 110.603 -167.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.44 146.79 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.444 -2.428 . . . . 71.5 104.444 163.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.68 -3.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 123.448 0.699 . . . . 72.430000000000007 110.836 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -156.77 141.06 16.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.047 -1.033 . . . . 72.239999999999995 108.496 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.95 129.27 12.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.995 -1.113 . . . . 65.230000000000004 107.995 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -132.49 160.58 36.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.286 -1.005 . . . . 71.450000000000003 108.286 163.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -145.39 121.79 10.97 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.126 -1.805 . . . . 72.219999999999999 106.126 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -131.31 161.56 32.05 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 118.658 0.663 . . . . 72.25 109.892 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.82 156.17 47.55 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 126.625 1.97 . . . . 74.540000000000006 110.839 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.427 ' HB3' HD11 ' A' ' 115' ' ' LEU . 39.1 m-85 -151.63 124.79 8.72 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.891 1.677 . . . . 71.310000000000002 107.092 -165.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -135.7 130.96 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.536 -1.283 . . . . 74.140000000000001 107.536 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -72.26 152.96 41.83 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.437 1.095 . . . . 65.109999999999999 110.0 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -148.31 28.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.38 -0.825 . . . . 73.329999999999998 111.966 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.94 -48.63 0.92 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.517 1.532 . . . . 71.329999999999998 109.793 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -74.76 173.42 10.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.915 1.286 . . . . 71.049999999999997 112.441 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -72.43 100.46 2.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.34 -1.355 . . . . 70.140000000000001 107.34 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 108' ' ' TYR . 8.3 tt -60.68 134.58 57.22 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 118.157 -0.925 . . . . 72.209999999999994 108.824 171.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 mt -152.57 133.5 4.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.526 1.53 . . . . 74.120000000000005 107.881 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 74.019999999999996 112.071 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 p -144.12 150.72 38.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.115 0.966 . . . . 64.109999999999999 112.196 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -133.3 173.85 11.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.595 1.558 . . . . 72.310000000000002 110.191 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.4 p -156.39 119.73 4.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.253 1.021 . . . . 70.049999999999997 108.611 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 74' ' ' CYS 0.313 10.4 p -121.88 86.42 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 122.964 1.364 . . . . 64.040000000000006 109.106 174.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.3 p -70.21 173.4 6.73 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.216 1.406 . . . . 62.229999999999997 110.127 164.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 p -130.55 9.69 5.11 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.316 -0.865 . . . . 64.420000000000002 112.877 166.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -146.86 125.7 12.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.852 -1.907 . . . . 74.140000000000001 105.852 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -142.13 155.85 45.35 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.807 0.843 . . . . 74.040000000000006 108.792 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.251 1.183 0 C-N-CA 129.533 3.133 . . . . 70.120000000000005 110.087 -167.451 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 110.135 -1.186 . . . . 63.340000000000003 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.03 121.02 26.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.974 0.91 . . . . 43.43 108.84 167.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.4 m -143.43 174.35 10.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.263 1.425 . . . . 62.539999999999999 107.562 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -132.3 146.58 52.09 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.186 -1.042 . . . . 73.319999999999993 108.186 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.92 84.99 2.04 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.478 1.511 . . . . 64.310000000000002 108.622 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -120.4 104.42 10.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 127.263 2.225 . . . . 72.319999999999993 107.677 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.4 p -140.47 175.6 9.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.564 1.146 . . . . 52.340000000000003 110.446 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.57 -116.82 1.98 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 106.572 -2.611 . . . . 73.219999999999999 106.572 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.93 128.99 68.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.535 -1.283 . . . . 64.420000000000002 107.535 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -97.85 157.96 15.79 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.541 -0.911 . . . . 54.340000000000003 108.541 171.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 ttpp -143.1 150.42 39.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.815 -1.55 . . . . 74.329999999999998 106.815 167.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.58 155.45 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 106.197 -1.779 . . . . 64.439999999999998 106.197 165.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.59 126.17 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.434 -2.432 . . . . 54.329999999999998 104.434 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.1 mt -121.93 154.27 26.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.582 -1.636 . . . . 73.129999999999995 106.582 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.12 168.22 20.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.457 0.572 . . . . 54.299999999999997 110.331 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -148.25 158.87 44.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.939 1.296 . . . . 74.329999999999998 109.193 164.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.56 163.93 37.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.175 1.39 . . . . 72.129999999999995 107.509 163.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.87 -120.04 4.12 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.463 -1.455 . . . . 51.329999999999998 109.463 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -96.22 118.09 32.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.275 -1.38 . . . . 63.100000000000001 107.275 159.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.5 p -100.54 -5.78 26.37 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.139 0.975 . . . . 74.120000000000005 112.108 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -37.32 38.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.07 0.948 . . . . 75.230000000000004 110.133 -169.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.33 18.74 13.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.533 1.133 . . . . 61.039999999999999 112.754 -161.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -121.44 113.4 19.79 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.693 0.797 . . . . 73.299999999999997 111.021 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.89 136.65 36.72 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.892 1.677 . . . . 72.040000000000006 108.112 168.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -148.77 106.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 105.497 -2.038 . . . . 73.400000000000006 105.497 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -114.96 123.51 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.421 1.009 . . . . 73.040000000000006 108.946 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.52 140.92 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.033 1.333 . . . . 53.32 110.036 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -76.12 145.41 40.01 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.857 -1.905 . . . . 73.439999999999998 105.857 157.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 ' HG ' ' A' ' 40' ' ' LEU . 22.1 mt -127.57 110.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 104.962 -2.236 . . . . 71.109999999999999 104.962 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.67 172.41 35.54 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.91 -0.586 . . . . 65.510000000000005 111.774 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.35 41.74 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 128.014 2.721 . . . . 64.519999999999996 108.597 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.49 34.41 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.89 1.276 . . . . 24.149999999999999 109.792 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.07 -177.46 4.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.117 1.367 . . . . 72.329999999999998 112.501 -174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.98 79.25 0.48 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.708 -0.849 . . . . 61.200000000000003 108.708 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.12 -65.02 0.29 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.268 -1.933 . . . . 71.329999999999998 108.268 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.34 -154.32 6.87 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.849 1.214 . . . . 73.219999999999999 110.586 -156.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -67.04 142.25 60.97 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.526 2.151 . . . . 54.229999999999997 109.868 172.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.9 130.3 39.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.79 -1.189 . . . . 63.32 107.79 172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -59.47 137.73 57.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.968 -0.539 . . . . 65.329999999999998 109.592 168.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -110.45 154.56 23.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.572 1.149 . . . . 62.310000000000002 109.081 170.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -132.65 154.19 50.35 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.136 1.374 . . . . 63.43 108.737 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -77.63 178.28 7.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.726 1.61 . . . . 75.109999999999999 110.721 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.18 8.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.092 1.357 . . . . 62.439999999999998 113.551 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -119.18 -6.02 10.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.549 2.74 . . . . 75.420000000000002 111.147 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 9.38 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.304 -1.276 . . . . 60.219999999999999 114.576 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -94.66 142.25 27.66 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.528 2.164 . . . . 74.120000000000005 110.142 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -62.07 136.58 58.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.744 1.618 . . . . 60.119999999999997 110.856 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.38 9.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.562 0.949 . . . . 55.409999999999997 113.562 173.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 136.17 171.25 12.24 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.665 -1.374 . . . . 43.240000000000002 109.665 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.1 p30 -103.11 1.56 33.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.231 1.012 . . . . 52.329999999999998 110.774 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -159.14 129.04 5.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.238 2.215 . . . . 31.329999999999998 107.671 170.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -161.87 -179.64 7.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.69 1.196 . . . . 74.219999999999999 109.216 161.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 p -117.13 161.68 19.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.143 1.377 . . . . 53.140000000000001 109.614 159.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.02 166.7 24.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.834 0.854 . . . . 74.310000000000002 109.175 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -114.9 139.91 49.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.621 1.168 . . . . 62.039999999999999 111.033 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mm -82.04 72.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 107.288 -1.375 . . . . 65.030000000000001 107.288 172.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 17.06 7.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.088 1.355 . . . . 72.340000000000003 111.527 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 p -137.65 147.07 44.62 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.998 -0.741 . . . . 62.100000000000001 108.998 -171.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.92 66.63 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.152 0.981 . . . . 73.120000000000005 110.633 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.6 p -135.05 162.56 32.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.153 -1.055 . . . . 71.310000000000002 108.153 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.9 169.46 24.53 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.095 1.758 . . . . 71.109999999999999 109.388 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.66 148.61 6.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.125 1.37 . . . . 75.439999999999998 110.671 171.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 64.7 m -134.99 150.8 50.4 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.55 -0.907 . . . . 74.340000000000003 108.55 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.2 p -142.9 -179.08 6.14 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 112.09 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.3 p -132.26 -177.72 4.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.883 1.673 . . . . 73.310000000000002 109.438 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.76 -173.98 2.43 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.031 -1.1 . . . . 74.209999999999994 108.031 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.0 -13.43 26.8 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.697 -0.627 . . . . 53.119999999999997 114.362 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -88.23 83.75 6.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.458 1.129 . . . . 73.239999999999995 108.774 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.29 178.03 7.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.343 1.057 . . . . 73.209999999999994 110.961 157.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.75 -22.34 4.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.357 1.463 . . . . 74.319999999999993 112.81 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.48 177.21 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.353 1.461 . . . . 72.109999999999999 109.272 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.5 ttt -147.44 154.1 40.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.914 1.685 . . . . 73.200000000000003 106.589 163.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 t -128.34 155.55 44.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.982 0.913 . . . . 72.310000000000002 109.905 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -140.51 42.37 1.88 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.629 2.371 . . . . 63.329999999999998 109.904 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 120' ' ' SER . . . -69.09 142.39 54.48 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.048 -1.032 . . . . 72.219999999999999 110.971 165.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.78 -176.03 39.81 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.852 -0.899 . . . . 64.530000000000001 110.852 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 86.7 p -131.81 167.53 19.4 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.076 0.95 . . . . 72.540000000000006 110.53 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.68 153.3 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.224 -1.399 . . . . 62.310000000000002 107.224 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p -159.79 142.89 14.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.254 0.934 . . . . 72.340000000000003 111.705 166.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -148.37 159.79 43.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.233 1.413 . . . . 64.129999999999995 108.509 173.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.86 25.75 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.267 1.827 . . . . 73.120000000000005 110.163 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -73.61 -159.88 0.08 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.075 1.35 . . . . 64.0 110.394 174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -83.99 169.02 15.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.156 0.982 . . . . 65.310000000000002 110.136 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 162.47 7.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 73.340000000000003 112.028 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.83 -2.27 80.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.276 1.417 . . . . 54.5 113.891 174.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -72.79 115.62 12.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.617 1.709 . . . . 72.329999999999998 106.658 169.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -96.05 164.81 12.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.638 -0.875 . . . . 62.109999999999999 108.638 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.1 tp -155.78 147.59 23.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.963 0.801 . . . . 72.319999999999993 109.035 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -148.15 98.17 2.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.813 1.645 . . . . 71.329999999999998 108.255 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.74 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.997 2.119 . . . . 71.400000000000006 108.124 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -128.19 146.46 50.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.103 1.361 . . . . 72.409999999999997 108.383 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.34 105.97 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.573 1.949 . . . . 54.229999999999997 110.749 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.0 mt -124.02 139.05 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.198 1.399 . . . . 21.210000000000001 108.995 -174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -138.31 146.21 17.91 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.658 1.123 . . . . 61.130000000000003 111.464 -166.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -131.85 157.62 43.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.252 1.421 . . . . 73.340000000000003 110.2 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -131.41 130.76 63.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.949 -2.241 . . . . 73.329999999999998 104.949 167.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.6 t0 68.65 -76.44 0.06 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.6 2.36 . . . . 70.230000000000004 111.031 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -149.37 1.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.519 1.928 . . . . 70.109999999999999 112.664 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.88 145.63 50.17 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.621 1.1 . . . . 70.310000000000002 111.412 -170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.81 126.08 33.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.353 1.461 . . . . 71.400000000000006 109.883 -172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.43 -1.44 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 113.687 0.995 . . . . 65.409999999999997 113.687 -171.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -154.51 128.01 8.56 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 72.299999999999997 108.184 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.42 123.73 18.07 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.127 0.876 . . . . 70.239999999999995 110.204 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.43 175.11 9.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.562 0.696 . . . . 64.099999999999994 110.47 160.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.25 173.88 15.0 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.836 2.854 . . . . 71.040000000000006 107.104 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.48 176.0 9.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.062 0.945 . . . . 74.420000000000002 108.76 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -139.17 137.98 36.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.68 -1.23 . . . . 74.030000000000001 107.68 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.639 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 2.1 m-85 -132.43 160.88 35.12 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.138 -1.06 . . . . 73.230000000000004 108.138 170.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -143.51 148.11 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.646 -1.983 . . . . 74.430000000000007 105.646 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.4 p -76.32 139.35 41.0 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.038 -1.097 . . . . 73.319999999999993 108.038 164.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.91 2.9 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.194 1.398 . . . . 51.240000000000002 111.124 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.28 38.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.866 1.698 . . . . 41.100000000000001 111.366 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -90.6 159.99 16.15 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.682 1.241 . . . . 71.400000000000006 107.687 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.1 113.14 1.77 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.975 0.91 . . . . 73.319999999999993 109.775 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.82 130.24 41.75 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.55 -1.278 . . . . 72.219999999999999 107.55 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -162.18 153.73 3.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 103.901 -2.629 . . . . 62.299999999999997 103.901 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.639 ' HG2' ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp20? -165.58 176.15 8.35 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.004 2.121 . . . . 74.219999999999999 106.512 160.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.2 p -141.87 142.24 33.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.067 -0.716 . . . . 52.229999999999997 109.067 167.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -125.92 169.02 13.1 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.512 1.525 . . . . 73.219999999999999 109.865 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 10.5 p -170.23 143.11 2.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.362 1.065 . . . . 54.399999999999999 108.731 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 74' ' ' CYS . 6.3 p -162.77 128.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 102.641 -3.096 . . . . 62.409999999999997 102.641 -167.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 m -134.85 143.42 47.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.686 -1.227 . . . . 62.539999999999999 107.686 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.84 -16.71 58.1 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.325 -0.55 . . . . 64.099999999999994 111.28 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -132.44 137.09 47.15 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 105.888 -1.893 . . . . 71.409999999999997 105.888 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -167.23 123.96 1.18 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 102.432 -3.173 . . . . 53.229999999999997 102.432 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.25 1.104 0 CA-C-N 119.035 0.834 . . . . 73.530000000000001 110.028 179.596 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 110.014 -1.234 . . . . 61.140000000000001 110.014 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.33 155.61 32.54 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.474 1.11 . . . . 51.310000000000002 108.331 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 p -154.36 152.95 30.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.726 -1.212 . . . . 73.239999999999995 107.726 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -167.33 122.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.157 -1.794 . . . . 72.109999999999999 106.157 -170.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -149.45 103.91 3.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.898 2.079 . . . . 70.109999999999999 110.553 -169.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -127.99 109.21 11.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.659 1.584 . . . . 64.120000000000005 109.894 -166.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.5 p -132.64 177.46 7.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.599 1.96 . . . . 61.520000000000003 110.496 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 124.98 -129.15 6.91 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.642 -2.183 . . . . 64.230000000000004 107.642 -162.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -98.0 123.08 50.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.904 1.682 . . . . 73.540000000000006 110.427 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -95.11 147.06 23.84 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.504 1.122 . . . . 73.5 109.426 170.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 62' ' ' SER . 34.2 tttt -148.88 151.81 35.34 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.113 0.965 . . . . 72.200000000000003 109.044 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.25 149.46 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.702 2.401 . . . . 74.230000000000004 106.572 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.19 131.76 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 105.345 -2.094 . . . . 74.439999999999998 105.345 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 74' ' ' CYS . 51.7 mt -127.96 149.01 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 106.877 -1.527 . . . . 63.420000000000002 106.877 -173.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -145.58 161.72 39.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.536 -0.542 . . . . 72.409999999999997 109.536 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -153.32 159.86 42.59 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.756 0.788 . . . . 65.030000000000001 112.627 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -145.48 174.39 11.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.635 1.574 . . . . 52.149999999999999 108.882 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.12 -154.92 19.54 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.885 1.231 . . . . 75.030000000000001 110.538 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.12 50.67 0.15 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.09 2.156 . . . . 65.120000000000005 111.191 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -54.48 -36.22 63.92 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 129.454 3.102 . . . . 74.230000000000004 111.662 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.87 -28.68 64.38 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.645 1.178 . . . . 63.43 111.223 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.7 m -93.33 -0.48 56.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.809 1.644 . . . . 63.350000000000001 113.432 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.813 ' CE2' HG22 ' A' ' 25' ' ' VAL . 1.2 t80 -119.77 123.06 42.79 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 123.525 1.631 . . . . 73.420000000000002 110.964 -169.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.72 79.48 8.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.001 2.921 . . . . 72.140000000000001 110.697 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.813 HG22 ' CE2' ' A' ' 23' ' ' PHE . 4.0 t -75.88 91.83 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.331 1.453 . . . . 61.030000000000001 107.774 176.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -94.98 129.94 41.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.132 -1.433 . . . . 73.230000000000004 107.132 171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.79 154.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.645 -1.613 . . . . 70.049999999999997 106.645 174.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 49.9 m -112.07 152.08 28.64 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.365 1.066 . . . . 65.409999999999997 109.172 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 40' ' ' LEU . 58.3 mt -122.15 157.39 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.035 -1.098 . . . . 53.299999999999997 108.035 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.96 179.54 48.05 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.824 1.202 . . . . 64.120000000000005 110.515 172.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.78 166.89 35.08 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 127.053 2.263 . . . . 65.299999999999997 108.438 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.46 165.51 27.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.959 1.379 . . . . 73.030000000000001 111.418 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -140.07 179.24 6.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.498 . . . . 73.239999999999995 110.587 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -75.5 72.01 2.47 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.534 1.534 . . . . 65.340000000000003 109.536 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.46 -5.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 118.459 -1.189 . . . . 63.119999999999997 114.333 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.41 -159.0 27.68 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 119.27 1.535 . . . . 54.520000000000003 110.872 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -67.35 161.72 41.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.605 2.87 . . . . 65.010000000000005 111.856 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -89.51 121.52 31.81 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.211 1.404 . . . . 70.439999999999998 109.29 166.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -62.4 153.77 30.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.163 0.892 . . . . 72.120000000000005 109.929 168.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD13 HG22 ' A' ' 29' ' ' ILE . 9.9 mt -133.26 160.55 36.97 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.702 1.201 . . . . 72.099999999999994 109.711 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -138.01 160.55 39.05 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.81 0.844 . . . . 75.530000000000001 110.077 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -94.85 -179.4 4.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.156 -0.929 . . . . 53.229999999999997 111.399 178.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.35 1.95 3.41 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.826 2.451 . . . . 61.43 113.709 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -112.11 -3.34 14.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.409 1.884 . . . . 72.230000000000004 112.908 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 6.19 85.3 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.279 0.942 . . . . 74.310000000000002 113.691 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -76.06 144.85 40.54 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.628 1.214 . . . . 73.239999999999995 107.856 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 122.96 20.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.362 2.265 . . . . 63.240000000000002 109.665 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.9 pt -132.86 9.79 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 115.251 1.575 . . . . 45.140000000000001 115.251 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.77 -158.77 23.65 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.302 -1.119 . . . . 71.420000000000002 110.302 167.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -128.18 -2.66 5.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.338 1.055 . . . . 74.409999999999997 111.911 162.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -151.84 123.06 7.7 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.601 0.76 . . . . 72.430000000000007 109.901 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -173.93 -179.46 1.73 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.678 0.791 . . . . 63.420000000000002 109.55 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 27.7 p -137.19 119.43 15.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.264 1.426 . . . . 51.329999999999998 108.012 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.81 111.12 23.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.771 1.629 . . . . 74.120000000000005 108.128 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.17 147.9 49.57 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.351 -0.981 . . . . 61.020000000000003 108.351 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mm -97.05 125.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.188 -0.671 . . . . 71.019999999999996 109.188 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 27.3 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.65 1.98 . . . . 71.25 111.777 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 p -124.8 175.47 7.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.206 1.002 . . . . 72.439999999999998 109.033 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.71 66.35 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 55.329999999999998 110.182 163.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -137.88 155.62 48.76 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.238 1.015 . . . . 35.009999999999998 111.404 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.9 mmm -139.26 167.98 20.86 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.826 2.051 . . . . 72.109999999999999 111.518 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' ' HE3' ' A' ' 11' ' ' LYS . 22.6 p -151.56 152.63 33.18 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.122 0.969 . . . . 71.430000000000007 110.161 168.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 77.6 m -145.69 148.63 33.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.208 1.403 . . . . 52.520000000000003 108.349 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 29.4 p -137.98 174.83 10.15 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.419 0.554 . . . . 73.439999999999998 111.295 167.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 p -108.09 168.25 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.535 -0.913 . . . . 73.099999999999994 108.535 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.5 169.77 3.6 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.319999999999993 108.795 159.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.01 -26.1 67.47 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.08 -0.844 . . . . 72.239999999999995 112.302 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.72 90.39 3.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 119.604 1.702 . . . . 74.430000000000007 108.09 169.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB2' ' CB ' ' A' ' 38' ' ' ALA . . . -161.89 173.35 14.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.038 1.335 . . . . 54.119999999999997 110.413 159.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -131.25 -12.79 3.54 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.539 2.336 . . . . 74.120000000000005 113.198 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -159.08 170.19 22.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.214 -1.402 . . . . 64.209999999999994 107.214 167.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.1 ttt -133.55 155.41 49.65 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 105.452 -2.055 . . . . 74.329999999999998 105.452 167.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -130.06 161.2 31.56 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.129 0.572 . . . . 63.039999999999999 109.505 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -149.85 41.64 0.85 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.734 1.214 . . . . 45.439999999999998 110.705 174.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 134.41 56.09 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.327 -0.858 . . . . 64.409999999999997 110.284 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -149.43 179.19 26.42 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.481 -0.648 . . . . 70.230000000000004 111.481 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.91 130.93 34.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.917 -1.142 . . . . 65.150000000000006 107.917 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.641 HG21 ' CZ ' ' A' ' 108' ' ' TYR . 90.6 t -90.06 146.66 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.205 -1.035 . . . . 72.409999999999997 108.205 172.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.1 t -150.79 159.36 44.59 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 118.501 -1.279 . . . . 43.240000000000002 110.328 155.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.622 ' HB2' HD23 ' A' ' 115' ' ' LEU . 12.5 t -147.88 143.97 27.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.614 -0.884 . . . . 65.25 108.614 164.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.9 pt -117.84 19.48 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.581 1.952 . . . . 73.150000000000006 109.404 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.8 p -79.45 175.69 10.38 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.719 1.208 . . . . 72.109999999999999 111.593 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -70.22 167.03 18.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.155 -0.93 . . . . 72.019999999999996 110.741 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.63 158.11 10.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.745 2.018 . . . . 64.030000000000001 113.055 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.73 -10.2 57.25 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.514 1.53 . . . . 71.340000000000003 114.046 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -67.09 159.31 29.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.744 1.617 . . . . 73.049999999999997 108.335 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -144.6 170.97 15.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.764 0.826 . . . . 70.420000000000002 111.06 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 tp -159.97 162.29 34.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.638 -1.245 . . . . 74.439999999999998 107.638 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -145.16 116.69 8.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.595 -1.261 . . . . 65.150000000000006 107.595 164.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.14 147.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 124.978 1.311 . . . . 74.010000000000005 107.624 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.9 m -127.7 138.64 52.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.304 -1.739 . . . . 73.349999999999994 106.304 171.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.2 112.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.527 1.931 . . . . 42.130000000000003 108.459 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.1 mt -129.08 150.8 34.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.43 -1.693 . . . . 63.409999999999997 106.43 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.62 152.06 22.76 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.182 0.896 . . . . 70.439999999999998 111.245 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.54 150.23 46.15 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.795 0.838 . . . . 74.299999999999997 111.388 -164.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.8 mt -146.08 136.0 17.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 104.774 -2.306 . . . . 71.530000000000001 104.774 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.0 t70 44.5 52.68 7.42 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.744 2.018 . . . . 63.340000000000003 113.683 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 t0 60.25 25.12 14.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.115 0.966 . . . . 71.129999999999995 112.795 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -126.75 156.92 40.4 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 120.326 -1.484 . . . . 74.129999999999995 111.308 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -97.49 119.58 36.29 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.97 1.708 . . . . 74.400000000000006 107.267 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.8 m -124.97 -2.6 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.647 0.98 . . . . 73.400000000000006 113.647 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -162.36 133.73 5.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.372 -1.344 . . . . 73.219999999999999 107.372 -172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.37 118.43 2.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.723 0.692 . . . . 74.329999999999998 111.703 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.06 168.83 18.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.59 0.709 . . . . 63.420000000000002 110.826 166.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.82 166.47 20.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.589 2.355 . . . . 74.010000000000005 108.423 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -149.14 162.33 40.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.835 -0.802 . . . . 74.310000000000002 108.835 171.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -147.94 118.37 7.41 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.008 -1.849 . . . . 72.420000000000002 106.008 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.641 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 30.6 m-85 -118.35 152.9 34.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.661 -0.866 . . . . 72.430000000000007 108.661 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 77.1 mt -138.36 153.77 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.281 1.432 . . . . 65.340000000000003 107.32 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -99.45 150.86 21.75 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.138 0.975 . . . . 62.030000000000001 110.214 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -130.45 15.1 5.52 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.908 1.683 . . . . 65.349999999999994 110.9 169.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.04 -24.44 18.81 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.549 1.547 . . . . 61.409999999999997 111.635 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.22 162.86 28.51 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.92 1.288 . . . . 73.319999999999993 109.345 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 106.73 2.68 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.254 0.622 . . . . 70.129999999999995 110.113 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 80' ' ' SER . 11.0 tp -60.85 136.28 58.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.46 -0.941 . . . . 72.049999999999997 108.46 174.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.4 mt -152.68 147.49 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 104.83 -2.285 . . . . 70.040000000000006 104.83 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.83 176.49 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.59 1.156 . . . . 71.140000000000001 109.467 163.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -131.15 160.87 33.49 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.307 1.043 . . . . 74.109999999999999 108.735 163.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -149.16 165.49 31.66 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.207 1.003 . . . . 73.030000000000001 108.704 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -165.74 142.07 5.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.447 0.641 . . . . 53.530000000000001 111.413 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.4 t -143.89 109.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 128.049 2.54 . . . . 63.200000000000003 104.825 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.1 144.91 29.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.983 -1.488 . . . . 70.109999999999999 106.983 169.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.0 p -92.36 44.2 1.15 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.598 1.09 . . . . 54.539999999999999 109.011 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -171.07 146.4 2.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.795 1.238 . . . . 74.319999999999993 108.034 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -101.48 138.97 37.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.566 -1.642 . . . . 73.219999999999999 106.566 157.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 126' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.248 1.019 0 C-N-CA 126.417 1.887 . . . . 50.219999999999999 106.595 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.062 -1.215 . . . . 72.319999999999993 110.062 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.12 168.78 21.52 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.63 1.572 . . . . 35.219999999999999 110.811 -176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.4 m -137.1 46.42 2.18 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.307 2.243 . . . . 62.130000000000003 109.51 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -137.64 41.67 2.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.561 1.172 . . . . 73.0 113.196 -143.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.8 24.27 3.24 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 119.842 -1.787 . . . . 71.230000000000004 111.756 -152.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -112.3 112.53 24.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 130.339 3.456 . . . . 51.109999999999999 107.748 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -132.56 -163.74 1.38 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 128.123 2.569 . . . . 75.010000000000005 106.934 172.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.64 -91.1 0.14 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.444 -1.462 . . . . 53.229999999999997 109.444 163.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -139.78 110.07 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 105.824 -1.917 . . . . 63.409999999999997 105.824 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -78.23 140.97 38.89 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.544 -1.28 . . . . 72.409999999999997 107.544 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -135.74 157.47 46.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.55 -1.648 . . . . 74.340000000000003 106.55 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 74' ' ' CYS . 1.1 tt -135.41 153.94 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 106.266 -1.753 . . . . 74.120000000000005 106.266 173.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.69 125.91 26.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 105.713 -1.958 . . . . 51.240000000000002 105.713 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.0 133.79 63.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 105.529 -2.026 . . . . 72.230000000000004 105.529 -170.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -140.68 159.97 41.05 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 119.562 1.074 . . . . 72.329999999999998 109.103 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -140.27 150.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.051 0.453 . . . . 42.140000000000001 110.76 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 m -134.34 163.24 30.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.388 -1.338 . . . . 54.32 107.388 158.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -152.15 18.81 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.752 0.691 . . . . 72.439999999999998 111.719 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.22 72.07 9.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.399 1.095 . . . . 75.450000000000003 109.209 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -70.93 17.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.883 2.073 . . . . 74.530000000000001 115.099 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.87 -3.89 5.81 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.866 1.061 . . . . 64.409999999999997 113.866 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 t -101.22 1.32 38.83 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.945 0.793 . . . . 74.329999999999998 112.942 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -117.81 148.47 42.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.137 0.975 . . . . 74.230000000000004 112.112 -169.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -92.29 141.55 28.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.799 -1.926 . . . . 64.310000000000002 105.799 163.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 56' ' ' ILE . 1.4 p -153.45 81.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 125.288 1.435 . . . . 63.310000000000002 111.714 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 109.36 21.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.557 0.694 . . . . 75.319999999999993 110.366 -167.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 m -91.76 122.29 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 124.246 1.019 . . . . 62.119999999999997 109.695 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 t -66.77 133.72 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.175 -1.787 . . . . 35.520000000000003 106.175 160.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.3 mt -121.38 126.41 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 105.733 -1.951 . . . . 63.329999999999998 105.733 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.22 177.86 38.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.022 0.82 . . . . 63.340000000000003 111.896 -171.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.85 167.16 29.08 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 127.039 2.257 . . . . 62.109999999999999 110.179 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.86 162.66 32.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.131 0.972 . . . . 75.239999999999995 111.637 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.99 -171.2 2.62 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.766 2.026 . . . . 75.140000000000001 112.332 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -78.62 65.74 3.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.586 0.755 . . . . 64.120000000000005 111.415 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.85 43.77 0.29 Allowed Glycine 0 C--N 1.323 -0.169 0 O-C-N 121.88 -0.512 . . . . 73.439999999999998 111.976 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.54 -154.9 22.75 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.053 -0.859 . . . . 74.230000000000004 111.961 170.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.03 159.78 37.31 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 124.267 3.311 . . . . 73.409999999999997 110.721 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.983 -1.118 . . . . 75.140000000000001 107.983 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -72.21 141.67 49.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.427 -0.953 . . . . 61.43 108.427 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD23 HG22 ' A' ' 65' ' ' THR . 5.0 mt -121.63 150.42 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.088 -1.449 . . . . 73.430000000000007 107.088 -171.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -131.46 134.22 45.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.542 1.137 . . . . 71.140000000000001 108.16 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -77.07 175.78 9.29 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.398 -0.819 . . . . 63.310000000000002 109.787 173.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -5.87 48.13 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 62.039999999999999 113.825 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -78.08 -5.21 50.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.277 1.431 . . . . 72.019999999999996 110.445 165.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.51 84.14 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.72 2.105 . . . . 73.319999999999993 113.131 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -101.96 142.42 33.27 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.045 1.338 . . . . 55.32 110.24 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -67.54 128.13 35.29 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.55 1.54 . . . . 75.299999999999997 109.159 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.57 20.57 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.544 0.738 . . . . 63.439999999999998 112.0 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -172.71 14.35 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.336 0.969 . . . . 65.400000000000006 110.958 174.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -118.68 9.25 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.957 1.303 . . . . 73.420000000000002 112.109 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -156.93 159.22 37.9 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.448 0.699 . . . . 71.430000000000007 110.196 150.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.8 p90 179.37 -175.39 0.24 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.988 1.715 . . . . 55.420000000000002 107.683 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.4 p -127.43 161.79 27.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.795 0.807 . . . . 62.5 109.333 157.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.77 155.23 50.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.244 -1.762 . . . . 75.040000000000006 106.244 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 20.0 tt0 -105.77 144.79 32.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.412 -0.959 . . . . 72.530000000000001 108.412 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 25' ' ' VAL . 38.4 mm -86.78 83.17 2.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 N-CA-C 107.338 -1.356 . . . . 74.409999999999997 107.338 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 44.4 mmm-85 -113.63 34.23 4.7 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 123.912 0.885 . . . . 73.310000000000002 111.546 176.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 p -140.92 146.95 38.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.637 -1.616 . . . . 52.350000000000001 106.637 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.78 -37.47 63.49 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.491 1.116 . . . . 71.030000000000001 110.171 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.0 p -140.94 142.62 34.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.543 1.537 . . . . 51.450000000000003 107.88 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.21 169.8 17.02 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.543 2.337 . . . . 71.409999999999997 109.485 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.9 p -167.43 161.95 14.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.993 2.117 . . . . 73.040000000000006 108.792 172.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.1 m -144.41 165.24 28.48 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.417 -1.697 . . . . 74.400000000000006 106.417 157.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.16 -178.73 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.537 0.735 . . . . 55.420000000000002 110.256 172.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.434 HG22 HD23 ' A' ' 40' ' ' LEU . 69.2 p -125.84 177.18 6.45 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.632 1.173 . . . . 73.340000000000003 108.79 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -87.49 178.96 6.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.298 -1.001 . . . . 72.040000000000006 108.298 162.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.23 17.74 3.82 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.382 -0.824 . . . . 63.100000000000001 114.647 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -105.25 85.87 2.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.094 -1.817 . . . . 61.030000000000001 106.094 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.05 172.62 18.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.563 1.074 . . . . 75.329999999999998 111.509 165.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -122.95 -17.96 6.58 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.2 -1.363 . . . . 75.430000000000007 111.652 164.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -157.12 173.72 16.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.999 0.92 . . . . 75.209999999999994 110.267 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.1 ttt -140.59 161.79 36.91 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.104 2.161 . . . . 74.120000000000005 105.86 165.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -140.35 160.23 40.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.478 1.111 . . . . 42.140000000000001 110.178 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HB2' HD13 ' A' ' 12' ' ' ILE . 43.9 t -148.7 39.25 0.86 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.037 2.535 . . . . 60.130000000000003 108.94 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 123.53 22.25 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.231 1.012 . . . . 73.099999999999994 109.973 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.92 29.03 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.8 -0.92 . . . . 63.350000000000001 110.8 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 95.1 p -127.24 167.43 16.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.905 0.482 . . . . 75.439999999999998 111.448 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.32 132.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 126.744 2.018 . . . . 75.409999999999997 105.952 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 m -144.5 162.66 35.99 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.456 0.571 . . . . 73.329999999999998 111.575 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.13 159.76 38.13 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.135 0.974 . . . . 60.350000000000001 110.531 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.48 32.03 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.204 1.802 . . . . 73.209999999999994 110.91 -169.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -132.78 176.34 8.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.921 1.289 . . . . 52.229999999999997 110.742 -167.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -45.35 160.72 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.877 2.471 . . . . 75.540000000000006 116.096 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.72 157.21 21.57 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.09 -1.868 . . . . 62.32 113.002 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.1 -0.64 82.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.389 -0.673 . . . . 55.210000000000001 113.795 172.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -75.16 114.64 13.89 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 119.408 1.604 . . . . 55.219999999999999 106.739 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -95.88 158.66 15.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.704 -0.851 . . . . 72.430000000000007 108.704 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.7 103.0 1.53 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.502 -1.666 . . . . 75.109999999999999 106.502 -178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -105.07 118.53 36.76 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.881 -1.137 . . . . 75.319999999999993 109.207 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mm -107.56 134.82 48.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.759 -1.2 . . . . 73.430000000000007 107.759 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.9 m -113.13 126.53 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.77 -1.937 . . . . 73.310000000000002 105.77 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.4 127.67 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 106.976 -1.49 . . . . 74.150000000000006 106.976 175.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.8 mt -137.55 134.42 46.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.535 -1.654 . . . . 52.219999999999999 106.535 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.13 124.13 5.75 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 109.861 -1.295 . . . . 52.219999999999999 109.861 -169.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -113.95 144.22 43.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.788 1.235 . . . . 64.439999999999998 112.192 -166.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 101' ' ' VAL . 22.8 mt -135.22 107.85 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 104.475 -2.417 . . . . 74.340000000000003 104.475 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 t0 44.44 66.98 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.275 1.03 . . . . 64.400000000000006 111.317 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 74.79 0.78 3.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.93 2.492 . . . . 75.019999999999996 116.069 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -117.38 163.25 16.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 120.665 1.575 . . . . 71.340000000000003 113.46 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -98.91 153.86 18.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.613 -1.254 . . . . 63.329999999999998 107.613 165.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 96' ' ' ILE . 33.1 m -137.77 3.93 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.091 0.404 . . . . 54.530000000000001 112.091 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -165.18 132.96 3.1 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.515 -1.291 . . . . 73.040000000000006 107.515 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -158.61 130.25 6.56 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.199 0.6 . . . . 74.040000000000006 110.083 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pp -139.41 108.05 5.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.313 1.054 . . . . 64.519999999999996 110.863 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.61 156.92 34.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.341 -1.355 . . . . 73.329999999999998 107.341 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 119' ' ' PHE . 22.4 mtmm -142.72 170.21 16.12 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.113 -1.44 . . . . 74.549999999999997 107.113 170.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -145.6 145.31 30.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.093 -1.817 . . . . 71.329999999999998 106.093 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.26 153.42 46.51 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.523 -1.288 . . . . 71.319999999999993 107.523 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.0 mt -144.31 140.15 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.301 -1.37 . . . . 74.349999999999994 107.301 166.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.2 p -66.15 145.7 55.5 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.939 1.296 . . . . 72.150000000000006 111.168 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -136.8 63.77 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 122.667 1.222 . . . . 61.32 111.125 163.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.05 -32.13 4.16 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.821 2.153 . . . . 53.210000000000001 112.634 168.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.73 174.33 10.58 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.557 1.943 . . . . 74.420000000000002 110.065 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.4 168.7 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.391 -0.596 . . . . 60.450000000000003 109.391 159.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.71 134.0 44.24 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.902 -1.147 . . . . 75.109999999999999 107.902 168.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.4 mt -150.9 133.29 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.148 -1.427 . . . . 75.340000000000003 107.148 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -152.5 169.35 22.83 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.034 1.734 . . . . 72.209999999999994 109.876 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 53.6 p -134.74 167.84 20.11 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.755 0.822 . . . . 75.150000000000006 109.514 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.501 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 22.9 p90 -156.04 168.62 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.398 -0.819 . . . . 61.530000000000001 109.836 172.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -161.12 138.85 9.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.878 0.847 . . . . 62.119999999999997 108.989 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -145.67 100.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 104.653 -2.351 . . . . 63.149999999999999 104.653 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.06 140.3 29.9 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.632 -1.618 . . . . 64.400000000000006 106.632 168.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.449 ' O ' HD11 ' A' ' 96' ' ' ILE . 2.8 p -94.78 27.73 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.087 1.312 . . . . 44.539999999999999 111.007 170.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -161.68 118.92 2.2 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 120.049 -1.657 . . . . 72.219999999999999 108.53 161.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -147.89 115.34 6.29 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.343 -1.354 . . . . 62.439999999999998 107.343 170.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.257 1.464 0 C-N-CA 126.711 2.004 . . . . 61.32 109.93 167.581 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 109.608 -1.397 . . . . 64.420000000000002 109.608 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.98 119.93 8.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.981 -1.859 . . . . 73.329999999999998 105.981 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.3 m -131.69 88.27 2.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.475 -2.046 . . . . 64.430000000000007 105.475 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -156.65 108.77 2.49 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.32 -1.363 . . . . 63.219999999999999 107.32 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -132.7 91.32 2.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.639 1.209 . . . . 75.140000000000001 111.483 -168.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -83.59 98.56 9.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.137 -1.431 . . . . 74.409999999999997 107.137 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.92 159.94 31.7 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.485 -0.932 . . . . 64.540000000000006 108.485 153.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.57 -101.4 0.15 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.826 1.203 . . . . 64.109999999999999 110.88 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.5 mt -134.14 117.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.202 -2.148 . . . . 75.530000000000001 105.202 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -84.38 151.16 24.87 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.759 -1.213 . . . . 74.25 109.236 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -137.67 158.43 44.39 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.387 1.075 . . . . 75.230000000000004 108.125 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.548 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.1 mm -139.3 129.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 105.315 -2.106 . . . . 63.450000000000003 105.315 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 64.0 t -113.11 140.17 34.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.927 1.691 . . . . 74.540000000000006 106.459 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mt -130.55 144.27 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.471 -1.677 . . . . 55.049999999999997 106.471 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -139.13 162.4 35.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.589 -0.893 . . . . 75.439999999999998 108.589 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -153.25 173.76 15.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.165 0.507 . . . . 72.450000000000003 112.192 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.24 150.85 20.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.052 0.941 . . . . 44.130000000000003 108.621 161.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.2 -108.38 0.37 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.145 -0.782 . . . . 61.240000000000002 111.145 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -130.34 54.88 1.84 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.547 1.539 . . . . 71.349999999999994 108.917 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.7 p -54.92 -4.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 130.938 3.695 . . . . 55.049999999999997 116.586 -165.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -95.26 -11.94 27.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.359 1.064 . . . . 71.25 111.877 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.57 33.78 4.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.545 2.338 . . . . 55.130000000000003 110.366 -170.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 88.7 m-85 -133.14 143.61 49.36 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.086 0.954 . . . . 73.129999999999995 110.098 171.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.14 58.38 0.6 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.595 1.558 . . . . 75.420000000000002 108.629 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 25' ' ' VAL . 1.5 p -62.13 125.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 124.759 1.223 . . . . 73.349999999999994 108.377 165.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.29 121.98 18.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.245 -1.02 . . . . 51.119999999999997 108.245 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.8 120.83 55.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.603 1.161 . . . . 74.230000000000004 110.004 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 t -66.1 134.63 53.21 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.54 -1.652 . . . . 73.450000000000003 106.54 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.82 112.95 27.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.589 -2.004 . . . . 63.119999999999997 105.589 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.9 35.29 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.531 -1.028 . . . . 64.319999999999993 110.531 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 168.81 38.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.638 -1.385 . . . . 72.010000000000005 109.638 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.21 153.41 31.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.275 1.43 . . . . 75.219999999999999 110.331 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.08 170.83 14.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.302 1.441 . . . . 62.210000000000001 111.219 174.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -66.58 73.09 0.09 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.397 1.879 . . . . 74.420000000000002 110.195 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.47 6.18 2.74 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.332 -1.815 . . . . 64.030000000000001 113.992 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.49 -156.41 27.25 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-N 120.99 2.395 . . . . 60.049999999999997 115.427 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.67 125.79 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.698 2.932 . . . . 73.150000000000006 110.022 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.81 120.13 14.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.267 -1.333 . . . . 75.219999999999999 108.832 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.46 144.89 55.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.678 0.217 . . . . 74.230000000000004 111.057 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 145.41 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.716 2.006 . . . . 75.219999999999999 108.62 -175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.848 1.259 . . . . 74.439999999999998 110.945 -170.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -82.12 175.67 10.14 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.311 0.645 . . . . 64.219999999999999 110.651 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.09 -12.73 61.39 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.736 1.013 . . . . 52.32 113.736 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -87.35 -7.54 57.65 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.058 -1.026 . . . . 73.430000000000007 110.928 175.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.66 56.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.449 1.976 . . . . 75.319999999999993 113.596 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.25 148.99 21.71 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.892 1.346 . . . . 72.310000000000002 109.855 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.54 144.83 56.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.426 -1.324 . . . . 73.510000000000005 107.426 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.73 5.8 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.411 0.685 . . . . 64.219999999999999 112.397 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.08 -175.3 36.89 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.001 0.818 . . . . 44.149999999999999 111.495 166.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -121.0 0.29 10.2 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.911 1.284 . . . . 74.319999999999993 112.183 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.7 m -165.84 115.6 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.217 1.807 . . . . 73.310000000000002 108.888 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -153.49 -178.84 7.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.745 1.157 . . . . 75.439999999999998 111.958 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.3 155.59 39.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.648 0.779 . . . . 75.230000000000004 109.488 163.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -126.54 171.61 10.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.945 1.698 . . . . 33.210000000000001 107.683 171.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -124.05 139.15 54.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 128.062 2.545 . . . . 74.450000000000003 109.269 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mm -90.65 98.88 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 119.262 -0.975 . . . . 74.549999999999997 110.102 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.47 14.35 13.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.948 1.092 . . . . 73.519999999999996 113.948 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.7 p -128.69 173.89 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.713 0.688 . . . . 62.109999999999999 109.837 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.78 90.52 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.736 0.415 . . . . 61.310000000000002 110.597 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.6 p -145.7 143.46 29.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.001 0.429 . . . . 71.230000000000004 110.465 -166.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -138.22 163.48 31.62 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.843 2.057 . . . . 61.210000000000001 109.754 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.64 152.53 6.9 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.042 1.337 . . . . 75.219999999999999 108.849 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 53.0 m -147.36 160.36 42.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.506 1.923 . . . . 75.430000000000007 109.409 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.2 p -152.42 173.39 15.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.486 0.714 . . . . 53.420000000000002 111.834 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -109.29 -174.98 2.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.56 1.144 . . . . 61.229999999999997 109.694 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -91.97 -171.65 2.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.544 -0.91 . . . . 63.439999999999998 108.544 151.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.56 -17.72 79.17 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.54 -0.725 . . . . 74.209999999999994 114.068 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -78.17 89.65 4.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.383 1.092 . . . . 64.510000000000005 108.207 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.38 15.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.662 0.785 . . . . 55.039999999999999 109.758 154.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -123.7 -10.28 7.83 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.191 0.811 . . . . 75.230000000000004 113.191 172.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.62 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 52.5 p90 -152.2 -170.64 3.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.011 1.324 . . . . 74.319999999999993 108.84 172.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.1 ttt -142.37 162.4 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 104.561 -2.385 . . . . 72.340000000000003 104.561 146.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -133.74 158.66 42.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.301 1.048 . . . . 61.229999999999997 108.874 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.542 ' HB3' HG12 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -134.13 99.11 4.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 102.089 -3.3 . . . . 53.420000000000002 102.089 166.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.14 113.45 14.5 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.519 -1.66 . . . . 71.420000000000002 106.519 168.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.8 -151.22 6.81 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.72 -1.752 . . . . 60.340000000000003 108.72 -161.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 95.8 p -149.28 -179.2 6.87 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.707 -0.479 . . . . 73.140000000000001 109.707 151.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.38 157.27 21.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.955 1.302 . . . . 75.030000000000001 109.434 170.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.02 171.72 14.07 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.924 0.89 . . . . 64.140000000000001 109.358 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HD23 ' A' ' 115' ' ' LEU . 36.8 t -159.26 162.46 36.12 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.267 1.027 . . . . 60.329999999999998 108.534 162.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.26 12.36 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.359 1.864 . . . . 63.310000000000002 111.597 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 p -83.88 176.64 8.76 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.254 1.022 . . . . 73.25 111.002 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -59.55 164.5 3.46 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.731 -0.668 . . . . 74.040000000000006 110.812 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 166.6 4.17 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.44 1.114 . . . . 72.409999999999997 112.938 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.09 -8.71 50.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.041 1.781 . . . . 71.439999999999998 114.348 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -62.62 158.85 17.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.532 1.166 . . . . 51.240000000000002 108.886 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -135.65 156.6 48.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.459 -0.571 . . . . 72.420000000000002 109.459 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -162.71 109.41 1.23 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.549 -2.019 . . . . 72.420000000000002 105.549 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -101.11 137.44 39.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.196 -1.779 . . . . 74.209999999999994 106.196 169.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.17 129.14 74.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.023 -1.103 . . . . 72.450000000000003 108.023 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -106.97 126.09 51.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.126 2.17 . . . . 73.329999999999998 106.008 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.39 109.84 16.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 125.297 1.439 . . . . 71.5 110.857 -165.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 mp -128.67 138.63 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.354 1.862 . . . . 73.209999999999994 106.747 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 12' ' ' ILE . . . -107.49 177.07 21.24 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.167 -1.173 . . . . 62.119999999999997 110.167 166.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -156.26 153.95 29.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 118.674 1.237 . . . . 75.5 109.742 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' HE2' ' A' ' 99' ' ' LYS . 11.9 mt -129.16 110.87 21.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 108.239 -1.023 . . . . 72.340000000000003 108.239 170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.0 -74.21 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.885 2.474 . . . . 71.140000000000001 110.107 -171.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -137.7 -1.41 2.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.717 1.006 . . . . 75.099999999999994 113.717 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE2' ' HB ' ' A' ' 96' ' ' ILE . 12.9 pttt -105.8 156.9 17.87 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.104 -0.997 . . . . 72.420000000000002 113.459 -171.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -118.22 103.8 10.18 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.817 1.247 . . . . 61.310000000000002 109.161 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 m -114.37 -6.92 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 115.022 1.49 . . . . 72.439999999999998 115.022 -168.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.85 99.49 1.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.382 -1.34 . . . . 73.329999999999998 107.382 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.89 123.11 11.54 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.347 1.059 . . . . 71.099999999999994 110.915 -170.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.43 176.63 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 73.439999999999998 110.487 171.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -136.55 158.01 45.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.113 2.165 . . . . 54.229999999999997 107.97 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -160.51 166.86 28.35 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.349 0.66 . . . . 72.200000000000003 109.61 169.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -140.05 147.42 40.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.264 1.826 . . . . 73.209999999999994 111.322 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -139.08 134.44 32.94 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.948 1.699 . . . . 63.299999999999997 108.251 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.0 mt -144.59 126.96 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.494 -1.669 . . . . 74.420000000000002 106.494 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.79 134.34 48.43 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.814 -0.439 . . . . 74.430000000000007 109.814 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.45 -17.04 33.1 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.564 1.146 . . . . 75.129999999999995 112.576 168.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.21 10.23 11.0 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.085 0.85 . . . . 63.329999999999998 112.486 -172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.34 -177.39 4.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.347 1.859 . . . . 53.32 108.989 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.55 111.85 2.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.598 1.159 . . . . 72.310000000000002 112.593 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 116' ' ' ILE . 4.3 tp -81.13 135.63 35.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 124.528 1.131 . . . . 74.450000000000003 108.304 170.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 115' ' ' LEU . 22.4 mt -150.2 132.22 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.999 2.52 . . . . 74.25 106.04 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.38 171.25 17.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.779 0.832 . . . . 71.319999999999993 111.279 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.8 p -142.71 160.96 39.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.194 1.397 . . . . 72.319999999999993 110.159 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -148.01 163.32 37.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.731 -1.122 . . . . 73.109999999999999 108.997 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 77.6 p -152.93 135.23 15.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.629 -0.67 . . . . 75.400000000000006 112.671 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 74' ' ' CYS . 7.6 p -135.5 103.64 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 128.207 2.603 . . . . 60.340000000000003 105.495 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.57 -158.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.454 -0.943 . . . . 74.400000000000006 108.454 170.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 82.8 p -134.24 -3.88 2.73 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.831 1.048 . . . . 74.319999999999993 113.831 161.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HE3' ' CG ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -97.13 73.05 2.49 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.565 2.126 . . . . 74.409999999999997 112.793 -154.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.69 143.47 48.72 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.281 -2.236 . . . . 72.239999999999995 111.712 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . 0.286 66.9 mt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 129.807 3.243 . . . . 74.430000000000007 109.981 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 108.945 -1.662 . . . . 55.43 108.945 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.95 132.49 42.49 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.023 -1.103 . . . . 75.129999999999995 108.023 168.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 p -159.14 143.79 15.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.922 0.889 . . . . 75.209999999999994 108.931 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.21 113.06 12.24 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.387 1.075 . . . . 75.109999999999999 110.146 -170.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -131.68 113.57 13.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.48 2.312 . . . . 61.25 104.928 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -139.67 104.58 4.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.43 1.492 . . . . 72.129999999999995 109.273 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -159.58 171.12 20.21 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.497 1.919 . . . . 73.329999999999998 108.229 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.49 -96.88 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.653 -2.179 . . . . 63.439999999999998 107.653 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.76 118.38 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.775 1.23 . . . . 71.030000000000001 108.264 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -80.88 141.02 35.01 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.475 -0.784 . . . . 64.25 109.951 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.39 144.63 42.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.637 2.375 . . . . 53.310000000000002 108.829 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 tt -132.95 156.2 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.475 -1.676 . . . . 74.129999999999995 106.475 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.02 138.89 45.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.918 -1.882 . . . . 54.229999999999997 105.918 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.0 142.42 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.591 -1.263 . . . . 63.549999999999997 107.591 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.35 173.27 11.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.377 1.071 . . . . 62.049999999999997 109.41 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -152.17 170.93 18.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.407 0.683 . . . . 73.140000000000001 111.79 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p -158.99 136.88 10.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.948 0.499 . . . . 73.329999999999998 111.523 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.88 -128.81 5.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.086 1.327 . . . . 55.149999999999999 111.722 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 61.41 3.58 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.402 1.881 . . . . 71.420000000000002 110.642 -166.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 p -75.91 48.11 0.47 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.32 1.848 . . . . 71.519999999999996 111.452 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.62 -20.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.0 0.92 . . . . 73.519999999999996 112.733 -172.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -142.19 42.06 1.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.205 2.202 . . . . 72.420000000000002 109.735 -170.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.53 160.04 36.4 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.371 2.269 . . . . 71.319999999999993 109.359 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -133.87 107.91 8.13 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.16 1.784 . . . . 74.5 108.319 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 1.3 p -125.1 80.7 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 125.438 1.495 . . . . 75.230000000000004 113.386 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.42 117.61 30.1 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.109 -0.7 . . . . 64.5 109.109 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 76' ' ' GLY . 35.5 m -115.59 133.53 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.854 -0.795 . . . . 75.340000000000003 108.854 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -66.08 151.28 47.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.579 -0.897 . . . . 51.299999999999997 108.579 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' HG ' ' A' ' 40' ' ' LEU . 95.9 mt -129.51 117.52 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.231 -2.137 . . . . 71.400000000000006 105.231 169.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 173.47 35.99 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.786 -0.926 . . . . 62.340000000000003 110.786 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.64 179.67 44.88 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.086 -2.806 . . . . 75.420000000000002 106.086 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.2 163.47 28.48 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.296 0.569 . . . . 72.420000000000002 109.498 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -174.32 3.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.963 1.705 . . . . 75.239999999999995 110.055 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -64.22 -28.81 69.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 113.741 1.015 . . . . 75.239999999999995 113.741 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.68 -52.67 11.54 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.203 -1.959 . . . . 64.329999999999998 108.203 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.96 -80.32 0.19 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.284 -1.526 . . . . 74.299999999999997 109.284 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.48 131.72 15.29 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 CA-C-N 120.207 2.004 . . . . 73.319999999999993 111.751 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.63 134.77 34.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 117.809 -1.091 . . . . 64.319999999999993 108.885 165.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -83.95 128.59 34.65 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.339 0.972 . . . . 72.329999999999998 109.243 159.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.3 mm? -100.3 152.58 20.15 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.877 1.271 . . . . 52.32 108.314 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -124.36 155.06 39.41 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.05 0.928 . . . . 73.099999999999994 110.594 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.67 160.76 14.63 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.494 1.518 . . . . 72.099999999999994 109.795 168.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.83 0.93 9.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.649 1.98 . . . . 64.209999999999994 113.803 -171.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -77.23 -24.73 51.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.795 2.838 . . . . 65.129999999999995 110.743 165.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.29 4.35 50.32 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.22 1.867 . . . . 64.239999999999995 112.808 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -89.07 165.74 14.32 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.001 1.401 . . . . 70.430000000000007 108.183 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -84.77 151.94 24.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.861 -0.792 . . . . 65.400000000000006 108.861 165.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.29 -5.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.942 0.897 . . . . 63.240000000000002 112.659 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.81 40.69 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 119.708 1.14 . . . . 63.43 110.613 169.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.328 0.8 OUTLIER -121.87 14.96 10.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.289 2.235 . . . . 71.329999999999998 110.438 169.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 149.09 9.59 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 127.724 2.41 . . . . 70.140000000000001 106.947 151.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -169.23 179.86 3.8 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.146 0.979 . . . . 74.299999999999997 109.921 157.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -140.04 106.26 5.25 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 126.155 1.782 . . . . 74.519999999999996 107.185 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.12 150.26 20.39 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.483 -0.932 . . . . 62.310000000000002 108.483 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 9.6 tt0 -85.27 147.33 26.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.502 1.121 . . . . 72.219999999999999 109.251 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 15.1 mm -85.32 71.16 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.977 -1.12 . . . . 64.329999999999998 107.977 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -92.59 38.09 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.416 -1.427 . . . . 62.210000000000001 113.195 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 p -147.29 128.34 14.59 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.126 -1.435 . . . . 73.019999999999996 107.126 -165.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.95 65.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.549 0.613 . . . . 62.219999999999999 110.447 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 p -140.7 134.3 30.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.946 1.298 . . . . 72.239999999999995 107.95 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE2' ' H ' ' A' ' 62' ' ' SER . 6.0 tpt -125.26 159.93 30.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.469 2.308 . . . . 74.109999999999999 106.999 176.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 61' ' ' MET . 11.9 p -164.62 143.82 7.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.679 1.592 . . . . 74.030000000000001 107.409 168.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' A' ' 29' ' ' ILE . 12.6 m -136.86 147.63 46.62 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.417 -1.327 . . . . 75.010000000000005 107.417 176.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 p -146.56 -173.43 4.2 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.039 0.381 . . . . 63.0 110.735 170.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 p -135.49 172.92 12.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.705 1.202 . . . . 72.239999999999995 111.436 -162.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.99 170.2 11.32 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.569 -0.9 . . . . 51.119999999999997 108.569 163.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.96 60.96 3.78 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.124 0.869 . . . . 71.319999999999993 111.641 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.83 89.84 1.72 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.824 -2.658 . . . . 75.040000000000006 103.824 169.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.83 23.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.232 -0.413 . . . . 60.450000000000003 111.272 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.4 -8.18 2.92 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.04 0.756 . . . . 64.540000000000006 113.04 166.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -163.01 169.31 19.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.879 1.272 . . . . 73.519999999999996 107.736 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.3 ttt -138.74 151.47 47.14 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 104.382 -2.451 . . . . 64.540000000000006 104.382 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.0 t -138.53 157.84 45.4 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.615 0.766 . . . . 74.219999999999999 108.999 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.58 45.85 1.03 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.089 0.956 . . . . 62.350000000000001 111.244 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.59 141.29 58.82 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.787 0.835 . . . . 75.239999999999995 110.037 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 27' ' ' VAL . . . -149.13 -149.13 4.9 Favored Glycine 0 C--N 1.336 0.532 0 O-C-N 121.427 -0.795 . . . . 64.140000000000001 111.201 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.6 p -142.85 178.52 7.6 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.217 -1.031 . . . . 43.32 108.217 149.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.67 149.71 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.988 0.915 . . . . 72.549999999999997 109.045 160.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.4 t -152.51 161.77 42.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.32 -0.622 . . . . 73.319999999999993 109.32 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -157.25 153.51 27.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.3 1.84 . . . . 75.329999999999998 106.323 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 26.8 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 127.07 2.148 . . . . 73.439999999999998 108.0 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -90.44 173.52 8.05 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.823 -1.173 . . . . 71.129999999999995 109.021 169.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.12 169.29 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.141 -1.845 . . . . 74.5 110.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.62 162.63 6.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.429 0.692 . . . . 75.430000000000007 112.243 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.95 71.53 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.71 0.672 . . . . 73.25 113.309 172.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -111.97 136.39 51.37 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.214 1.806 . . . . 75.540000000000006 106.846 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -125.6 159.38 32.28 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.581 -0.699 . . . . 61.149999999999999 110.605 -166.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 tm? -154.87 102.5 2.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.516 -2.402 . . . . 44.340000000000003 104.516 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.22 149.04 22.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.267 -1.753 . . . . 64.349999999999994 106.267 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mm -127.99 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.227 -1.768 . . . . 55.329999999999998 106.227 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -119.17 135.97 54.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.450000000000003 106.172 163.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HB ' HG21 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -138.52 119.55 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.895 -1.521 . . . . 75.319999999999993 106.895 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 mt -135.06 134.68 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 107.358 -1.349 . . . . 51.140000000000001 107.358 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -119.98 132.44 9.41 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.701 -1.359 . . . . 75.349999999999994 109.701 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -126.44 152.94 45.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.145 1.378 . . . . 72.420000000000002 110.055 -170.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 HD11 ' O ' ' A' ' 123' ' ' THR . 26.2 mt -136.85 112.4 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.536 -2.394 . . . . 72.430000000000007 104.536 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 74.38 -54.12 0.67 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 127.726 2.411 . . . . 73.140000000000001 112.962 163.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.34 6.57 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.183 1.793 . . . . 75.040000000000006 112.947 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.98 155.65 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 119.239 -2.163 . . . . 74.030000000000001 109.996 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -72.11 159.0 34.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.955 -1.128 . . . . 64.019999999999996 107.955 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.11 -6.02 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.377 0.51 . . . . 71.439999999999998 112.377 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.1 136.64 12.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.846 -1.168 . . . . 64.319999999999993 107.846 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.49 158.36 26.42 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 119.308 0.958 . . . . 73.510000000000005 111.432 168.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.43 171.41 14.67 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.302 1.049 . . . . 64.340000000000003 108.692 155.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.72 161.56 24.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.091 -1.818 . . . . 75.209999999999994 106.091 160.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.63 169.21 24.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.633 -0.877 . . . . 62.210000000000001 108.633 173.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -155.48 149.06 25.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.05 -0.352 . . . . 73.549999999999997 110.05 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.502 ' HB3' HD21 ' A' ' 115' ' ' LEU . 8.5 m-85 -148.29 138.4 22.55 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.774 1.23 . . . . 61.25 108.864 -169.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.81 137.67 53.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.452 -0.944 . . . . 75.409999999999997 108.452 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 p -74.42 133.79 42.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.694 -0.854 . . . . 71.25 108.694 173.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.24 57.43 1.13 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.252 1.025 . . . . 75.530000000000001 108.921 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.67 -38.15 1.68 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.799 2.142 . . . . 62.149999999999999 111.774 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -62.8 152.43 35.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.363 1.065 . . . . 75.329999999999998 108.991 172.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 m -74.29 113.94 12.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.021 1.329 . . . . 52.109999999999999 109.044 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -67.03 115.14 6.41 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.712 -1.588 . . . . 73.329999999999998 106.712 175.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 45.8 mt -149.71 138.53 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 103.043 -2.947 . . . . 74.519999999999996 103.043 170.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 170.58 21.01 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.965 1.416 . . . . 73.129999999999995 108.846 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -138.29 153.83 49.03 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.316 -0.994 . . . . 73.340000000000003 108.316 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.71 161.71 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.718 1.207 . . . . 71.340000000000003 108.165 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.6 t -160.2 144.37 14.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.853 -1.165 . . . . 75.420000000000002 107.853 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.469 HG21 ' HB ' ' A' ' 92' ' ' VAL . 40.5 t -146.32 118.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.1 -2.556 . . . . 71.219999999999999 104.1 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 132.5 51.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.335 1.054 . . . . 73.519999999999996 108.249 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.429 ' O ' HD11 ' A' ' 96' ' ' ILE . 18.8 p -95.14 14.13 23.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.484 -0.76 . . . . 72.420000000000002 112.17 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 118.66 6.19 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.217 -2.142 . . . . 74.430000000000007 105.217 162.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.42 71.4 1.43 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 105.395 -2.076 . . . . 74.150000000000006 105.395 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . 0.254 12.3 mm . . . . . 0 C--O 1.244 0.803 0 C-N-CA 126.555 1.942 . . . . 62.509999999999998 109.742 -165.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.545 0 N-CA-C 111.363 -0.695 . . . . 72.530000000000001 111.363 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.23 104.86 4.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.159 1.384 . . . . 70.239999999999995 107.976 163.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.1 p -158.82 159.4 35.05 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.001 -1.481 . . . . 74.549999999999997 107.001 160.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.49 121.99 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.115 -1.068 . . . . 64.340000000000003 108.115 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -142.33 105.93 4.67 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.363 1.465 . . . . 74.239999999999995 109.993 168.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -119.29 124.82 47.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.105 2.562 . . . . 72.140000000000001 104.484 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.48 154.14 51.51 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.327 0.651 . . . . 64.340000000000003 111.689 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.58 -105.94 0.44 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.174 -1.57 . . . . 74.430000000000007 109.174 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.87 83.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.172 -1.788 . . . . 71.430000000000007 106.172 -162.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -84.04 122.97 29.52 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.847 -1.538 . . . . 54.229999999999997 106.847 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.05 151.43 49.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.755 1.161 . . . . 63.439999999999998 110.574 -167.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.3 mm -135.01 146.38 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.357 1.463 . . . . 52.240000000000002 107.696 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 t -141.84 133.62 27.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.912 -1.514 . . . . 71.340000000000003 106.912 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mt -130.5 149.67 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.067 0.947 . . . . 70.109999999999999 109.214 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -135.84 167.34 21.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.677 0.672 . . . . 74.349999999999994 111.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -140.7 139.88 34.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.776 1.231 . . . . 72.209999999999994 109.239 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -149.82 152.9 35.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 127.484 2.313 . . . . 72.310000000000002 108.147 171.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.7 -145.33 18.68 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.55 -1.42 . . . . 63.43 109.55 -168.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -85.57 75.41 10.15 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.038 -1.467 . . . . 50.350000000000001 107.038 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 23' ' ' PHE . 16.1 p -75.16 71.02 2.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.395 -1.706 . . . . 72.109999999999999 106.395 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.72 -48.31 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.506 1.122 . . . . 71.430000000000007 108.71 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.93 67.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 124.002 1.858 . . . . 72.420000000000002 109.462 -163.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 20' ' ' THR . 1.1 p90 -148.27 166.69 27.24 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 128.251 2.62 . . . . 70.430000000000007 108.22 174.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.79 150.52 49.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.556 1.943 . . . . 74.150000000000006 108.423 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.13 85.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.576 -0.898 . . . . 74.310000000000002 108.576 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -86.63 136.04 33.19 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.809 0.814 . . . . 73.150000000000006 108.874 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.09 132.91 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.836 -1.913 . . . . 71.430000000000007 105.836 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -85.34 140.8 30.5 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.778 1.631 . . . . 74.549999999999997 106.926 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.434 HG22 ' HG ' ' A' ' 40' ' ' LEU . 94.7 mt -124.64 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.409 -1.7 . . . . 74.340000000000003 106.409 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.56 172.88 42.57 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.193 -0.763 . . . . 61.450000000000003 111.193 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.46 175.29 40.51 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 127.176 2.322 . . . . 43.119999999999997 108.25 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.45 46.47 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.857 -0.79 . . . . 73.310000000000002 109.031 175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -136.85 -178.55 5.24 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 125.835 1.654 . . . . 71.519999999999996 110.688 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -80.25 70.33 6.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.081 0.553 . . . . 64.549999999999997 110.29 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.68 -34.74 0.5 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.228 0.918 . . . . 73.340000000000003 111.652 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.24 -164.89 26.72 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 117.698 0.749 . . . . 63.340000000000003 113.273 -164.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.42 140.02 26.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.906 3.071 . . . . 72.310000000000002 109.337 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.62 26.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.314 -0.403 . . . . 74.409999999999997 110.293 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -54.49 120.1 6.17 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.039 0.935 . . . . 73.25 109.701 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 29' ' ' ILE . 1.5 mm? -82.67 168.6 17.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.497 -0.927 . . . . 71.439999999999998 108.497 169.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -134.74 142.09 46.65 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.837 0.855 . . . . 74.430000000000007 109.079 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.34 170.81 16.06 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.552 1.141 . . . . 73.25 109.773 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -74.93 15.28 0.41 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 63.520000000000003 113.877 -169.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -100.37 -16.56 17.6 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.315 . . . . 72.510000000000005 111.559 162.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.48 67.36 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.37 0.986 . . . . 54.229999999999997 113.124 -168.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -79.97 161.52 25.44 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.432 1.116 . . . . 70.430000000000007 109.626 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.02 137.59 34.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.812 -0.81 . . . . 54.119999999999997 108.812 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.33 16.72 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.012 1.325 . . . . 71.430000000000007 112.944 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.17 172.21 14.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.867 1.222 . . . . 73.109999999999999 110.462 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -112.17 9.83 20.17 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.227 1.411 . . . . 62.340000000000003 111.159 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 t -167.05 148.78 5.96 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.071 2.148 . . . . 72.150000000000006 108.097 165.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -179.96 179.34 0.55 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.141 2.576 . . . . 74.430000000000007 109.186 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.4 p -129.39 159.09 37.32 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.33 1.052 . . . . 73.109999999999999 109.426 163.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.45 114.72 7.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.1 -1.074 . . . . 64.319999999999993 108.1 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -71.69 128.18 34.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.967 -1.123 . . . . 64.219999999999999 107.967 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.36 117.05 3.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.417 -1.327 . . . . 63.310000000000002 107.417 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 57' ' ' ARG . 2.4 mmm180 -137.51 35.95 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.861 0.839 . . . . 74.329999999999998 110.856 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.21 147.71 26.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.456 -1.683 . . . . 73.120000000000005 106.456 -161.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.75 -37.47 71.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.95 0.5 . . . . 65.420000000000002 111.771 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 t -149.72 161.99 41.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.228 -1.027 . . . . 74.310000000000002 108.228 167.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 mmm -134.75 165.93 24.13 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 128.632 2.773 . . . . 71.219999999999999 108.883 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 72.5 p -164.94 162.28 20.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.507 -1.224 . . . . 64.120000000000005 110.058 171.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.2 m -150.94 166.02 31.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.046 2.138 . . . . 70.120000000000005 107.261 165.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.05 -178.68 6.25 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.934 0.894 . . . . 62.25 111.839 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 p -129.07 175.6 8.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.649 1.979 . . . . 64.25 108.987 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -98.2 172.32 7.66 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.398 -0.814 . . . . 74.25 109.162 159.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 55.01 4.99 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.092 0.853 . . . . 53.210000000000001 113.06 -169.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -133.38 -8.79 2.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.586 1.154 . . . . 63.509999999999998 111.215 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.59 165.12 23.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.834 0.826 . . . . 73.549999999999997 111.121 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -119.72 -1.8 10.51 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.906 1.682 . . . . 70.450000000000003 112.065 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -177.12 172.03 2.0 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.289 1.835 . . . . 71.409999999999997 108.022 171.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.0 ttt -132.66 163.64 28.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.832 -2.284 . . . . 53.409999999999997 104.832 161.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -146.94 166.59 26.31 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.277 0.561 . . . . 62.25 110.253 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.11 65.18 0.9 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.595 2.358 . . . . 61.119999999999997 107.711 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.39 41.03 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.742 0.817 . . . . 74.519999999999996 108.95 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.65 179.74 32.25 Favored Glycine 0 CA--C 1.502 -0.731 0 CA-C-N 119.082 0.856 . . . . 70.230000000000004 111.9 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 118' ' ' THR . 90.3 p -135.34 169.37 17.58 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.377 -1.411 . . . . 54.25 109.535 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.54 153.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.422 1.489 . . . . 45.039999999999999 107.254 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.0 164.0 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.914 -0.772 . . . . 71.340000000000003 108.914 166.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.7 p -145.65 162.45 37.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.612 -0.514 . . . . 71.319999999999993 109.612 154.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 pt -133.63 15.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 128.653 2.781 . . . . 62.210000000000001 109.313 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -81.02 174.55 11.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.015 1.726 . . . . 74.120000000000005 111.28 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.3 163.83 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 112.227 -2.261 . . . . 71.209999999999994 110.626 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.89 160.16 15.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.203 1.401 . . . . 71.150000000000006 113.289 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.42 87.0 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.907 1.241 . . . . 61.130000000000003 114.164 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -66.66 167.47 11.05 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.564 1.182 . . . . 53.329999999999998 108.273 167.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -149.5 160.05 43.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 121.572 -0.705 . . . . 74.439999999999998 110.083 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.3 tp -152.87 130.45 11.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.591 -1.633 . . . . 74.239999999999995 106.591 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -129.16 109.25 11.0 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.389 1.876 . . . . 72.340000000000003 106.185 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mm -105.83 134.18 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.053 -2.203 . . . . 54.409999999999997 105.053 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 m -112.06 137.49 50.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.142 -1.799 . . . . 70.310000000000002 106.142 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.16 113.31 3.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.583 1.553 . . . . 74.329999999999998 109.194 -171.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.84 141.09 45.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.727 -1.583 . . . . 74.129999999999995 106.727 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.82 155.85 25.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 123.869 0.747 . . . . 61.210000000000001 111.483 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.13 154.46 42.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.051 0.94 . . . . 73.230000000000004 110.366 -165.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG13 HG11 ' A' ' 101' ' ' VAL . 39.9 mt -122.89 117.89 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.824 -1.176 . . . . 73.340000000000003 107.824 163.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 t70 69.28 -58.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 129.06 2.944 . . . . 74.209999999999994 111.666 165.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.68 8.5 0.51 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.043 1.497 . . . . 74.450000000000003 115.043 158.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.44 143.51 32.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.992 1.317 . . . . 74.349999999999994 111.267 -170.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.16 118.2 12.68 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.043 1.737 . . . . 64.120000000000005 107.203 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.42 HG11 HG13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -129.31 -8.31 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.735 0.779 . . . . 65.140000000000001 109.825 -167.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -162.44 130.85 4.05 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.215 -1.402 . . . . 73.209999999999994 107.215 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -153.65 110.79 3.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.188 -0.671 . . . . 73.120000000000005 109.188 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 pp -142.25 179.51 6.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.783 -1.099 . . . . 73.430000000000007 111.296 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -145.9 171.27 15.07 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.171 2.589 . . . . 74.540000000000006 106.301 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -146.99 160.42 42.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.687 -0.857 . . . . 53.25 108.687 170.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -128.25 136.16 50.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.437 1.495 . . . . 72.329999999999998 107.057 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.655 ' HB3' HD11 ' A' ' 115' ' ' LEU . 9.3 m-85 -136.16 152.8 51.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.141 0.977 . . . . 62.409999999999997 109.055 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.0 mt -144.21 154.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.219 1.808 . . . . 74.209999999999994 107.424 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -95.79 141.17 29.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.928 0.891 . . . . 72.120000000000005 110.223 176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -121.67 4.99 10.05 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.343 1.857 . . . . 73.230000000000004 110.489 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 113.61 -34.91 4.78 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.715 2.102 . . . . 51.43 110.309 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -79.42 161.67 25.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.939 1.296 . . . . 73.409999999999997 110.622 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.36 105.65 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.765 0.826 . . . . 74.129999999999995 110.126 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 108' ' ' TYR . 7.8 tt -68.02 134.61 50.96 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.392 -0.966 . . . . 70.450000000000003 108.392 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -150.61 133.97 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 106.026 -1.842 . . . . 70.540000000000006 106.026 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.17 174.55 14.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.958 0.786 . . . . 52.350000000000001 111.608 171.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 77' ' ' SER . 73.9 p -139.65 161.64 37.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.81 1.644 . . . . 72.409999999999997 110.797 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -151.2 176.7 10.95 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.309 1.444 . . . . 74.239999999999995 109.606 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -160.74 147.48 15.34 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.561 -0.903 . . . . 54.020000000000003 108.561 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.2 t -146.31 88.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.236 -1.765 . . . . 63.32 106.236 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.5 m -77.82 166.78 22.49 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.06 -0.718 . . . . 53.210000000000001 109.06 165.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.1 p -135.17 58.3 1.77 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.11 -1.07 . . . . 43.439999999999998 108.11 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 72.14 1.01 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 124.507 2.098 . . . . 73.209999999999994 110.724 164.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -154.98 135.52 13.43 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 126.59 1.956 . . . . 74.349999999999994 108.533 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.243 0.749 0 C-N-CA 128.551 2.74 . . . . 61.530000000000001 111.573 167.494 . . . . . . . . 0 0 . 1 stop_ save_